*********** PTASSAMj00 ******** FILEIN user.vek ../../CSA/PIK_SPRITE/ ULMN 5 1ez1_c00 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 1 5 # 1 A 160 SER A 99 SER.? 28.11 CL CL B 129 A 162 GLY A 98 GLY.? 32.74 CL CL B 129 A 286 ASP A 72 ASP.? 29.77 CL CL A 129 A 287 THR A 27 THR~? 25.15 CL CL A 129 A 362 ARG A 76 ARG^? 19.15 CL CL B 129 coo 28.09 46.53 29.79 29.56 44.82 29.11 72.94 56.76 -81.82 74.18 58.03 -80.16 coo 27.40 51.35 28.03 26.92 50.87 28.37 72.21 53.86 -84.18 72.69 54.50 -84.21 coo 28.01 42.60 20.34 28.92 44.38 21.13 81.04 48.95 -86.11 82.18 49.75 -87.74 coo 31.00 43.32 17.01 32.49 44.68 17.79 85.32 47.55 -82.88 85.94 49.08 -84.30 coo 15.44 43.40 24.16 15.16 40.95 26.12 82.62 63.89 -86.56 80.46 65.21 -84.78 1ez1_c00 source 1ez1 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANSFERASE 2 : 1 hits 1ez1_c00 naa= 5 ULMN 4 1a6d_c00 THERMOSOME user 1 4 # 1 A 63 ASP D 5 ASP^? 32.88 CL CL D 129 A 96 THR D 82 THR^? 27.41 CL CL D 129 A 97 THR D 81 THR^? 28.71 CL CL D 129 A 390 ASP D 4 ASP^? 37.41 CL CL D 129 coo 16.18 44.42 -24.56 14.59 45.14 -25.79 50.37 96.25 -41.36 49.69 98.16 -40.70 coo 9.05 49.19 -22.25 9.14 47.35 -23.29 55.03 89.38 -43.21 56.11 90.23 -44.91 coo 10.51 49.37 -18.77 12.36 48.66 -18.03 53.52 86.11 -44.51 51.45 85.78 -44.13 coo 17.04 49.84 -29.27 15.57 48.57 -28.45 46.79 97.75 -45.68 46.52 99.27 -44.27 1a6d_c00 source 1a6d THERMOSOME : 1 hits 1a6d_c00 naa= 4 ULMN 4 1a6d_c01 THERMOSOME user 1 4 # 1 B 62 ASP D 5 ASP^? 32.88 CL CL D 129 B 95 THR D 81 THR^? 28.71 CL CL D 129 B 96 THR D 82 THR^? 27.41 CL CL D 129 B 391 ASP D 4 ASP^? 37.41 CL CL D 129 coo 43.28 19.55 -23.92 42.88 20.98 -25.36 50.37 96.25 -41.36 49.69 98.16 -40.70 coo 41.59 28.72 -22.17 40.06 27.69 -23.27 53.52 86.11 -44.51 51.45 85.78 -44.13 coo 42.85 27.27 -18.86 43.84 25.46 -18.26 55.03 89.38 -43.21 56.11 90.23 -44.91 coo 48.74 21.71 -27.93 47.43 22.77 -26.72 46.79 97.75 -45.68 46.52 99.27 -44.27 ULMN 4 1a6d_c01 THERMOSOME user 2 4 # 2 B 62 ASP D 5 ASP^? 32.88 CL CL D 129 B 95 THR D 82 THR^? 27.41 CL CL D 129 B 96 THR D 81 THR^? 28.71 CL CL D 129 B 391 ASP D 4 ASP^? 37.41 CL CL D 129 coo 43.28 19.55 -23.92 42.88 20.98 -25.36 50.37 96.25 -41.36 49.69 98.16 -40.70 coo 41.59 28.72 -22.17 40.06 27.69 -23.27 55.03 89.38 -43.21 56.11 90.23 -44.91 coo 42.85 27.27 -18.86 43.84 25.46 -18.26 53.52 86.11 -44.51 51.45 85.78 -44.13 coo 48.74 21.71 -27.93 47.43 22.77 -26.72 46.79 97.75 -45.68 46.52 99.27 -44.27 1a6d_c01 source 1a6d THERMOSOME : 2 hits 1a6d_c01 naa= 4 ULMN 4 1bwl_c00 NADPH DEHYDROGENASE 1 user 1 4 # 1 37 THR A 44 THR.? 7.93 CL CL A 129 191 ASN A 52 ASN^? 15.85 CL CL A 129 194 HIS A 122 HIS^? 19.05 CL CL A 129 196 TYR A 47 TYR^? 14.66 CL CL A 129 coo 30.43 73.37 22.91 31.95 74.71 22.14 95.29 52.07 -64.55 95.81 50.95 -66.27 coo 40.94 71.26 25.74 40.29 70.59 23.82 83.96 54.83 -62.44 82.65 56.42 -62.87 coo 38.86 67.47 19.31 37.78 65.73 19.79 86.83 60.37 -69.40 85.20 61.24 -68.40 coo 41.10 73.64 20.13 38.52 73.39 19.02 86.78 57.70 -65.64 87.73 58.42 -63.11 ULMN 4 1bwl_c00 NADPH DEHYDROGENASE 1 user 2 4 # 2 37 THR B 44 THR^? 7.91 CL CL B 129 191 ASN B 52 ASN^? 15.82 CL CL B 129 194 HIS B 122 HIS^? 19.12 CL CL B 129 196 TYR B 47 TYR^? 14.72 CL CL B 129 coo 30.43 73.37 22.91 31.95 74.71 22.14 95.21 71.44 -76.44 95.74 72.60 -74.74 coo 40.94 71.26 25.74 40.29 70.59 23.82 83.95 68.72 -78.66 82.81 66.95 -78.31 coo 38.86 67.47 19.31 37.78 65.73 19.79 86.93 63.10 -71.62 85.35 62.06 -72.53 coo 41.10 73.64 20.13 38.52 73.39 19.02 86.74 65.69 -75.43 87.82 65.07 -77.96 ULMN 4 1bwl_c00 NADPH DEHYDROGENASE 1 user 3 4 # 3 37 THR C 44 THR^? 7.82 CL CL C 129 191 ASN C 52 ASN^? 15.85 CL CL C 129 194 HIS C 122 HIS^? 19.06 CL CL C 129 196 TYR C 47 TYR^? 14.59 CL CL C 129 coo 30.43 73.37 22.91 31.95 74.71 22.14 93.28 69.34 -29.36 92.05 68.81 -31.01 coo 40.94 71.26 25.74 40.29 70.59 23.82 96.20 80.63 -27.08 97.82 81.88 -27.59 coo 38.86 67.47 19.31 37.78 65.73 19.79 101.68 77.71 -34.10 102.65 79.31 -33.15 coo 41.10 73.64 20.13 38.52 73.39 19.02 99.01 77.81 -30.16 99.72 76.81 -27.69 ULMN 4 1bwl_c00 NADPH DEHYDROGENASE 1 user 4 4 # 4 37 THR D 44 THR^? 7.93 CL CL D 129 191 ASN D 52 ASN^? 15.83 CL CL D 129 194 HIS D 122 HIS^? 19.08 CL CL D 129 196 TYR D 47 TYR^? 14.69 CL CL D 129 coo 30.43 73.37 22.91 31.95 74.71 22.14 65.95 81.28 -29.36 67.15 81.78 -31.05 coo 40.94 71.26 25.74 40.29 70.59 23.82 63.25 69.92 -27.12 61.56 68.74 -27.55 coo 38.86 67.47 19.31 37.78 65.73 19.79 57.69 72.86 -34.13 56.74 71.23 -33.18 coo 41.10 73.64 20.13 38.52 73.39 19.02 60.23 72.82 -30.22 59.55 73.80 -27.71 1bwl_c00 source 1bwl NADPH DEHYDROGENASE 1 : 4 hits 1bwl_c00 naa= 4 ULMN 4 1c17_c11 ATP SYNTHASE SUBUNIT C user 1 4 # 1 A 61 ASP A 30 ASP~? 20.80 CL CL A 129 M 206 SER A 127 SER^? 22.87 CL CL B 129 M 210 ARG A 104 ARG^? 18.53 CL CL B 129 M 214 ASN B 52 ASN^? 15.82 CL CL B 129 coo 2.15 -17.14 -6.89 2.91 -15.59 -8.10 90.38 41.71 -80.87 92.04 40.39 -80.79 coo -2.55 -23.32 19.81 -3.48 -21.59 18.38 75.13 65.62 -72.89 75.19 67.88 -72.00 coo 1.98 -17.11 17.69 1.79 -15.15 15.33 82.19 63.80 -76.53 82.09 65.30 -73.83 coo 8.13 -16.73 20.92 6.75 -15.93 19.51 83.95 68.72 -78.66 82.81 66.95 -78.31 ULMN 4 1c17_c11 ATP SYNTHASE SUBUNIT C user 2 4 # 2 A 61 ASP A 30 ASP~? 20.80 CL CL A 129 M 206 SER B 124 SER^? 21.49 CL CL A 129 M 210 ARG A 104 ARG^? 18.53 CL CL B 129 M 214 ASN B 52 ASN^? 15.82 CL CL B 129 coo 2.15 -17.14 -6.89 2.91 -15.59 -8.10 90.38 41.71 -80.87 92.04 40.39 -80.79 coo -2.55 -23.32 19.81 -3.48 -21.59 18.38 81.67 64.01 -68.38 82.23 61.67 -68.72 coo 1.98 -17.11 17.69 1.79 -15.15 15.33 82.19 63.80 -76.53 82.09 65.30 -73.83 coo 8.13 -16.73 20.92 6.75 -15.93 19.51 83.95 68.72 -78.66 82.81 66.95 -78.31 ULMN 4 1c17_c11 ATP SYNTHASE SUBUNIT C user 3 4 # 3 A 61 ASP B 30 ASP^? 20.91 CL CL B 129 M 206 SER A 124 SER^? 21.51 CL CL B 129 M 210 ARG B 104 ARG^? 18.51 CL CL A 129 M 214 ASN A 52 ASN^? 15.85 CL CL A 129 coo 2.15 -17.14 -6.89 2.91 -15.59 -8.10 90.60 81.40 -60.16 92.15 82.83 -59.97 coo -2.55 -23.32 19.81 -3.48 -21.59 18.38 81.71 59.41 -72.63 82.35 61.73 -72.29 coo 1.98 -17.11 17.69 1.79 -15.15 15.33 82.09 59.72 -64.70 82.21 58.19 -67.39 coo 8.13 -16.73 20.92 6.75 -15.93 19.51 83.96 54.83 -62.44 82.65 56.42 -62.87 ULMN 4 1c17_c11 ATP SYNTHASE SUBUNIT C user 4 4 # 4 A 61 ASP B 30 ASP^? 20.91 CL CL B 129 M 206 SER B 127 SER^? 22.99 CL CL A 129 M 210 ARG B 104 ARG^? 18.51 CL CL A 129 M 214 ASN A 52 ASN^? 15.85 CL CL A 129 coo 2.15 -17.14 -6.89 2.91 -15.59 -8.10 90.60 81.40 -60.16 92.15 82.83 -59.97 coo -2.55 -23.32 19.81 -3.48 -21.59 18.38 75.24 57.91 -68.31 76.20 56.67 -70.14 coo 1.98 -17.11 17.69 1.79 -15.15 15.33 82.09 59.72 -64.70 82.21 58.19 -67.39 coo 8.13 -16.73 20.92 6.75 -15.93 19.51 83.96 54.83 -62.44 82.65 56.42 -62.87 ULMN 4 1c17_c11 ATP SYNTHASE SUBUNIT C user 5 4 # 5 A 61 ASP B 35 ASP^? 10.19 CL CL B 129 M 206 SER B 127 SER^? 22.99 CL CL A 129 M 210 ARG B 104 ARG^? 18.51 CL CL A 129 M 214 ASN A 52 ASN^? 15.85 CL CL A 129 coo 2.15 -17.14 -6.89 2.91 -15.59 -8.10 93.79 80.98 -68.72 94.61 81.32 -70.62 coo -2.55 -23.32 19.81 -3.48 -21.59 18.38 75.24 57.91 -68.31 76.20 56.67 -70.14 coo 1.98 -17.11 17.69 1.79 -15.15 15.33 82.09 59.72 -64.70 82.21 58.19 -67.39 coo 8.13 -16.73 20.92 6.75 -15.93 19.51 83.96 54.83 -62.44 82.65 56.42 -62.87 ULMN 4 1c17_c11 ATP SYNTHASE SUBUNIT C user 6 4 # 6 A 61 ASP D 30 ASP^? 20.62 CL CL D 129 M 206 SER B 127 SER^? 22.99 CL CL A 129 M 210 ARG B 104 ARG^? 18.51 CL CL A 129 M 214 ASN A 52 ASN^? 15.85 CL CL A 129 coo 2.15 -17.14 -6.89 2.91 -15.59 -8.10 76.16 76.40 -45.40 77.49 78.05 -45.35 coo -2.55 -23.32 19.81 -3.48 -21.59 18.38 75.24 57.91 -68.31 76.20 56.67 -70.14 coo 1.98 -17.11 17.69 1.79 -15.15 15.33 82.09 59.72 -64.70 82.21 58.19 -67.39 coo 8.13 -16.73 20.92 6.75 -15.93 19.51 83.96 54.83 -62.44 82.65 56.42 -62.87 1c17_c11 source 1c17 ATP SYNTHASE SUBUNIT C : 6 hits 1c17_c11 naa= 4 ULMN 4 1f75_c00 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 1 4 # 1 A 33 ARG A 73 ARG.? 22.19 CL CL A 129 A 42 ARG A 104 ARG^? 18.53 CL CL B 129 A 197 ARG A 46 ARG^? 15.11 CL CL A 129 A 203 ARG A 63 ARG~? 13.95 CL CL A 129 coo 23.24 19.51 21.94 24.57 16.76 21.61 83.82 53.79 -81.61 86.00 54.30 -79.51 coo 16.08 17.48 28.78 19.09 16.85 28.49 82.19 63.80 -76.53 82.09 65.30 -73.83 coo 28.26 9.63 19.68 28.71 10.56 22.55 87.96 51.20 -70.32 85.08 51.60 -71.34 coo 33.62 12.31 23.18 30.84 12.90 24.36 87.85 45.63 -72.60 88.58 48.58 -73.24 ULMN 4 1f75_c00 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 2 4 # 2 A 33 ARG A 73 ARG.? 22.19 CL CL A 129 A 42 ARG A 104 ARG^? 18.53 CL CL B 129 A 197 ARG A 66 ARG~? 18.83 CL CL A 129 A 203 ARG A 63 ARG~? 13.95 CL CL A 129 coo 23.24 19.51 21.94 24.57 16.76 21.61 83.82 53.79 -81.61 86.00 54.30 -79.51 coo 16.08 17.48 28.78 19.09 16.85 28.49 82.19 63.80 -76.53 82.09 65.30 -73.83 coo 28.26 9.63 19.68 28.71 10.56 22.55 82.10 46.84 -74.28 82.78 49.65 -75.31 coo 33.62 12.31 23.18 30.84 12.90 24.36 87.85 45.63 -72.60 88.58 48.58 -73.24 ULMN 4 1f75_c00 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 3 4 # 3 A 33 ARG B 73 ARG^? 22.29 CL CL B 129 A 42 ARG B 104 ARG^? 18.51 CL CL A 129 A 197 ARG B 66 ARG^? 19.13 CL CL B 129 A 203 ARG B 63 ARG^? 13.99 CL CL B 129 coo 23.24 19.51 21.94 24.57 16.76 21.61 83.86 69.55 -59.16 85.91 69.18 -61.42 coo 16.08 17.48 28.78 19.09 16.85 28.49 82.09 59.72 -64.70 82.21 58.19 -67.39 coo 28.26 9.63 19.68 28.71 10.56 22.55 82.06 76.49 -66.55 82.68 73.67 -65.41 coo 33.62 12.31 23.18 30.84 12.90 24.36 87.72 77.76 -68.29 88.60 74.86 -67.71 ULMN 4 1f75_c00 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 4 4 # 4 A 33 ARG C 73 ARG^? 22.24 CL CL C 129 A 42 ARG C 104 ARG^? 26.38 CL CL C 129 A 197 ARG C 46 ARG^? 15.12 CL CL C 129 A 203 ARG C 63 ARG^? 14.10 CL CL C 129 coo 23.24 19.51 21.94 24.57 16.76 21.61 95.26 80.79 -46.47 95.45 78.63 -44.29 coo 16.08 17.48 28.78 19.09 16.85 28.49 105.08 82.46 -41.08 106.56 82.47 -38.36 coo 28.26 9.63 19.68 28.71 10.56 22.55 92.47 76.70 -34.87 92.87 79.50 -36.04 coo 33.62 12.31 23.18 30.84 12.90 24.36 86.96 77.03 -37.50 89.89 76.13 -38.00 ULMN 4 1f75_c00 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 5 4 # 5 A 33 ARG C 73 ARG^? 22.24 CL CL C 129 A 42 ARG C 104 ARG^? 26.38 CL CL C 129 A 197 ARG C 66 ARG^? 18.88 CL CL C 129 A 203 ARG C 63 ARG^? 14.10 CL CL C 129 coo 23.24 19.51 21.94 24.57 16.76 21.61 95.26 80.79 -46.47 95.45 78.63 -44.29 coo 16.08 17.48 28.78 19.09 16.85 28.49 105.08 82.46 -41.08 106.56 82.47 -38.36 coo 28.26 9.63 19.68 28.71 10.56 22.55 88.18 82.59 -38.84 90.98 81.94 -39.92 coo 33.62 12.31 23.18 30.84 12.90 24.36 86.96 77.03 -37.50 89.89 76.13 -38.00 ULMN 4 1f75_c00 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 6 4 # 6 A 33 ARG D 73 ARG^? 22.15 CL CL D 129 A 42 ARG D 104 ARG^? 26.47 CL CL D 129 A 197 ARG D 66 ARG^? 18.85 CL CL D 129 A 203 ARG D 63 ARG^? 14.07 CL CL D 129 coo 23.24 19.51 21.94 24.57 16.76 21.61 64.06 69.83 -46.45 63.93 71.88 -44.19 coo 16.08 17.48 28.78 19.09 16.85 28.49 54.44 68.08 -41.08 52.76 68.11 -38.51 coo 28.26 9.63 19.68 28.71 10.56 22.55 71.05 68.08 -38.82 68.22 68.66 -39.87 coo 33.62 12.31 23.18 30.84 12.90 24.36 72.33 73.68 -37.44 69.36 74.46 -37.99 1f75_c00 source 1f75 UNDECAPRENYL PYROPHOSPHATE SYNTHETASE : 6 hits 1f75_c00 naa= 4 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 1 4 # 1 B 33 ARG A 73 ARG.? 22.19 CL CL A 129 B 42 ARG A 76 ARG^? 19.15 CL CL B 129 B 197 ARG A 46 ARG^? 15.11 CL CL A 129 B 203 ARG A 63 ARG~? 13.95 CL CL A 129 coo 42.69 1.07 -0.40 42.64 1.65 2.61 83.82 53.79 -81.61 86.00 54.30 -79.51 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 82.62 63.89 -86.56 80.46 65.21 -84.78 coo 40.75 3.79 10.50 41.03 0.76 9.97 87.96 51.20 -70.32 85.08 51.60 -71.34 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 87.85 45.63 -72.60 88.58 48.58 -73.24 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 2 4 # 2 B 33 ARG A 73 ARG.? 22.19 CL CL A 129 B 42 ARG A 76 ARG^? 19.15 CL CL B 129 B 197 ARG A 66 ARG~? 18.83 CL CL A 129 B 203 ARG A 46 ARG^? 15.11 CL CL A 129 coo 42.69 1.07 -0.40 42.64 1.65 2.61 83.82 53.79 -81.61 86.00 54.30 -79.51 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 82.62 63.89 -86.56 80.46 65.21 -84.78 coo 40.75 3.79 10.50 41.03 0.76 9.97 82.10 46.84 -74.28 82.78 49.65 -75.31 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 87.96 51.20 -70.32 85.08 51.60 -71.34 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 3 4 # 3 B 33 ARG A 73 ARG.? 22.19 CL CL A 129 B 42 ARG A 76 ARG^? 19.15 CL CL B 129 B 197 ARG A 66 ARG~? 18.83 CL CL A 129 B 203 ARG A 63 ARG~? 13.95 CL CL A 129 coo 42.69 1.07 -0.40 42.64 1.65 2.61 83.82 53.79 -81.61 86.00 54.30 -79.51 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 82.62 63.89 -86.56 80.46 65.21 -84.78 coo 40.75 3.79 10.50 41.03 0.76 9.97 82.10 46.84 -74.28 82.78 49.65 -75.31 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 87.85 45.63 -72.60 88.58 48.58 -73.24 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 4 4 # 4 B 33 ARG A 104 ARG^? 18.53 CL CL B 129 B 42 ARG B 46 ARG^? 15.06 CL CL B 129 B 197 ARG A 73 ARG.? 22.19 CL CL A 129 B 203 ARG A 96 ARG.? 24.34 CL CL A 129 coo 42.69 1.07 -0.40 42.64 1.65 2.61 82.19 63.80 -76.53 82.09 65.30 -73.83 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 87.96 72.13 -70.71 85.05 71.84 -69.78 coo 40.75 3.79 10.50 41.03 0.76 9.97 83.82 53.79 -81.61 86.00 54.30 -79.51 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 78.03 52.93 -81.60 80.41 52.60 -79.67 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 5 4 # 5 B 33 ARG B 73 ARG^? 22.29 CL CL B 129 B 42 ARG B 76 ARG^? 18.98 CL CL A 129 B 197 ARG B 46 ARG^? 15.06 CL CL B 129 B 203 ARG B 63 ARG^? 13.99 CL CL B 129 coo 42.69 1.07 -0.40 42.64 1.65 2.61 83.86 69.55 -59.16 85.91 69.18 -61.42 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 82.73 59.03 -54.76 80.31 57.91 -56.24 coo 40.75 3.79 10.50 41.03 0.76 9.97 87.96 72.13 -70.71 85.05 71.84 -69.78 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 87.72 77.76 -68.29 88.60 74.86 -67.71 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 6 4 # 6 B 33 ARG B 73 ARG^? 22.29 CL CL B 129 B 42 ARG B 76 ARG^? 18.98 CL CL A 129 B 197 ARG B 66 ARG^? 19.13 CL CL B 129 B 203 ARG B 46 ARG^? 15.06 CL CL B 129 coo 42.69 1.07 -0.40 42.64 1.65 2.61 83.86 69.55 -59.16 85.91 69.18 -61.42 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 82.73 59.03 -54.76 80.31 57.91 -56.24 coo 40.75 3.79 10.50 41.03 0.76 9.97 82.06 76.49 -66.55 82.68 73.67 -65.41 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 87.96 72.13 -70.71 85.05 71.84 -69.78 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 7 4 # 7 B 33 ARG B 73 ARG^? 22.29 CL CL B 129 B 42 ARG B 76 ARG^? 18.98 CL CL A 129 B 197 ARG B 66 ARG^? 19.13 CL CL B 129 B 203 ARG B 63 ARG^? 13.99 CL CL B 129 coo 42.69 1.07 -0.40 42.64 1.65 2.61 83.86 69.55 -59.16 85.91 69.18 -61.42 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 82.73 59.03 -54.76 80.31 57.91 -56.24 coo 40.75 3.79 10.50 41.03 0.76 9.97 82.06 76.49 -66.55 82.68 73.67 -65.41 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 87.72 77.76 -68.29 88.60 74.86 -67.71 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 8 4 # 8 B 33 ARG B 104 ARG^? 18.51 CL CL A 129 B 42 ARG A 46 ARG^? 15.11 CL CL A 129 B 197 ARG B 73 ARG^? 22.29 CL CL B 129 B 203 ARG B 96 ARG^? 24.18 CL CL B 129 coo 42.69 1.07 -0.40 42.64 1.65 2.61 82.09 59.72 -64.70 82.21 58.19 -67.39 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 87.96 51.20 -70.32 85.08 51.60 -71.34 coo 40.75 3.79 10.50 41.03 0.76 9.97 83.86 69.55 -59.16 85.91 69.18 -61.42 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 78.35 70.58 -59.29 80.55 70.83 -61.45 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 9 4 # 9 B 33 ARG C 60 ARG^? 8.92 CL CL C 129 B 42 ARG C 46 ARG^? 15.12 CL CL C 129 B 197 ARG D 63 ARG^? 14.07 CL CL D 129 B 203 ARG D 66 ARG^? 18.85 CL CL D 129 coo 42.69 1.07 -0.40 42.64 1.65 2.61 82.52 72.20 -31.52 80.97 69.57 -31.97 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 92.47 76.70 -34.87 92.87 79.50 -36.04 coo 40.75 3.79 10.50 41.03 0.76 9.97 72.33 73.68 -37.44 69.36 74.46 -37.99 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 71.05 68.08 -38.82 68.22 68.66 -39.87 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 10 4 # 10 B 33 ARG C 73 ARG^? 22.24 CL CL C 129 B 42 ARG C 76 ARG^? 33.92 CL CL B 129 B 197 ARG C 46 ARG^? 15.12 CL CL C 129 B 203 ARG C 63 ARG^? 14.10 CL CL C 129 coo 42.69 1.07 -0.40 42.64 1.65 2.61 95.26 80.79 -46.47 95.45 78.63 -44.29 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 105.54 81.89 -51.05 106.65 84.23 -49.40 coo 40.75 3.79 10.50 41.03 0.76 9.97 92.47 76.70 -34.87 92.87 79.50 -36.04 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 86.96 77.03 -37.50 89.89 76.13 -38.00 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 11 4 # 11 B 33 ARG C 73 ARG^? 22.24 CL CL C 129 B 42 ARG C 76 ARG^? 33.92 CL CL B 129 B 197 ARG C 66 ARG^? 18.88 CL CL C 129 B 203 ARG C 46 ARG^? 15.12 CL CL C 129 coo 42.69 1.07 -0.40 42.64 1.65 2.61 95.26 80.79 -46.47 95.45 78.63 -44.29 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 105.54 81.89 -51.05 106.65 84.23 -49.40 coo 40.75 3.79 10.50 41.03 0.76 9.97 88.18 82.59 -38.84 90.98 81.94 -39.92 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 92.47 76.70 -34.87 92.87 79.50 -36.04 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 12 4 # 12 B 33 ARG C 73 ARG^? 22.24 CL CL C 129 B 42 ARG C 76 ARG^? 33.92 CL CL B 129 B 197 ARG C 66 ARG^? 18.88 CL CL C 129 B 203 ARG C 63 ARG^? 14.10 CL CL C 129 coo 42.69 1.07 -0.40 42.64 1.65 2.61 95.26 80.79 -46.47 95.45 78.63 -44.29 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 105.54 81.89 -51.05 106.65 84.23 -49.40 coo 40.75 3.79 10.50 41.03 0.76 9.97 88.18 82.59 -38.84 90.98 81.94 -39.92 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 86.96 77.03 -37.50 89.89 76.13 -38.00 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 13 4 # 13 B 33 ARG D 60 ARG^? 8.57 CL CL D 129 B 42 ARG D 46 ARG^? 15.13 CL CL D 129 B 197 ARG C 63 ARG^? 14.10 CL CL C 129 B 203 ARG C 66 ARG^? 18.88 CL CL C 129 coo 42.69 1.07 -0.40 42.64 1.65 2.61 76.65 78.50 -31.75 78.13 81.14 -31.78 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 66.74 73.93 -35.00 66.45 71.02 -36.02 coo 40.75 3.79 10.50 41.03 0.76 9.97 86.96 77.03 -37.50 89.89 76.13 -38.00 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 88.18 82.59 -38.84 90.98 81.94 -39.92 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 14 4 # 14 B 33 ARG D 73 ARG^? 22.15 CL CL D 129 B 42 ARG D 76 ARG^? 33.75 CL CL D 129 B 197 ARG D 46 ARG^? 15.13 CL CL D 129 B 203 ARG D 63 ARG^? 14.07 CL CL D 129 coo 42.69 1.07 -0.40 42.64 1.65 2.61 64.06 69.83 -46.45 63.93 71.88 -44.19 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 54.15 68.69 -51.19 53.07 66.38 -49.46 coo 40.75 3.79 10.50 41.03 0.76 9.97 66.74 73.93 -35.00 66.45 71.02 -36.02 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 72.33 73.68 -37.44 69.36 74.46 -37.99 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 15 4 # 15 B 33 ARG D 73 ARG^? 22.15 CL CL D 129 B 42 ARG D 76 ARG^? 33.75 CL CL D 129 B 197 ARG D 66 ARG^? 18.85 CL CL D 129 B 203 ARG D 46 ARG^? 15.13 CL CL D 129 coo 42.69 1.07 -0.40 42.64 1.65 2.61 64.06 69.83 -46.45 63.93 71.88 -44.19 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 54.15 68.69 -51.19 53.07 66.38 -49.46 coo 40.75 3.79 10.50 41.03 0.76 9.97 71.05 68.08 -38.82 68.22 68.66 -39.87 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 66.74 73.93 -35.00 66.45 71.02 -36.02 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 16 4 # 16 B 33 ARG D 73 ARG^? 22.15 CL CL D 129 B 42 ARG D 76 ARG^? 33.75 CL CL D 129 B 197 ARG D 66 ARG^? 18.85 CL CL D 129 B 203 ARG D 63 ARG^? 14.07 CL CL D 129 coo 42.69 1.07 -0.40 42.64 1.65 2.61 64.06 69.83 -46.45 63.93 71.88 -44.19 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 54.15 68.69 -51.19 53.07 66.38 -49.46 coo 40.75 3.79 10.50 41.03 0.76 9.97 71.05 68.08 -38.82 68.22 68.66 -39.87 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 72.33 73.68 -37.44 69.36 74.46 -37.99 1f75_c01 source 1f75 UNDECAPRENYL PYROPHOSPHATE SYNTHETASE : 16 hits 1f75_c01 naa= 4 ULMN 4 1i8t_c02 UDP-GALACTOPYRANOSE MUTASE user 1 4 # 1 A 170 ARG B 117 ARG^? 16.04 CL CL B 129 A 278 ARG C 76 ARG^? 33.92 CL CL B 129 A 298 GLU C 93 GLU^? 31.51 CL CL C 129 A 348 ASP B 14 ASP^? 27.62 CL CL A 129 coo -23.99 -12.72 0.77 -26.03 -13.46 2.92 100.63 75.34 -68.25 102.08 77.36 -66.41 coo -18.98 -3.88 -14.05 -18.01 -5.56 -11.69 105.54 81.89 -51.05 106.65 84.23 -49.40 coo -18.09 -5.55 -18.88 -17.66 -5.99 -16.85 105.96 79.95 -45.75 107.72 80.63 -46.81 coo -11.04 -13.38 -5.15 -13.10 -12.92 -5.14 105.60 69.00 -58.44 107.49 69.47 -57.66 ULMN 4 1i8t_c02 UDP-GALACTOPYRANOSE MUTASE user 2 4 # 2 A 170 ARG C 63 ARG^? 14.10 CL CL C 129 A 278 ARG D 117 ARG^? 15.96 CL CL D 129 A 298 GLU D 114 GLU^? 14.88 CL CL D 129 A 348 ASP D 30 ASP^? 20.62 CL CL D 129 coo -23.99 -12.72 0.77 -26.03 -13.46 2.92 86.96 77.03 -37.50 89.89 76.13 -38.00 coo -18.98 -3.88 -14.05 -18.01 -5.56 -11.69 69.91 86.62 -37.36 71.94 88.06 -39.21 coo -18.09 -5.55 -18.88 -17.66 -5.99 -16.85 72.08 90.81 -36.72 71.29 91.48 -34.84 coo -11.04 -13.38 -5.15 -13.10 -12.92 -5.14 76.16 76.40 -45.40 77.49 78.05 -45.35 ULMN 4 1i8t_c02 UDP-GALACTOPYRANOSE MUTASE user 3 4 # 3 A 170 ARG D 63 ARG^? 14.07 CL CL D 129 A 278 ARG C 117 ARG^? 16.02 CL CL C 129 A 298 GLU C 114 GLU^? 14.88 CL CL C 129 A 348 ASP C 30 ASP^? 20.67 CL CL C 129 coo -23.99 -12.72 0.77 -26.03 -13.46 2.92 72.33 73.68 -37.44 69.36 74.46 -37.99 coo -18.98 -3.88 -14.05 -18.01 -5.56 -11.69 89.36 64.01 -37.29 87.40 62.56 -39.24 coo -18.09 -5.55 -18.88 -17.66 -5.99 -16.85 87.05 59.85 -36.57 87.99 59.11 -34.78 coo -11.04 -13.38 -5.15 -13.10 -12.92 -5.14 83.14 74.18 -45.33 81.79 72.55 -45.31 1i8t_c02 source 1i8t UDP-GALACTOPYRANOSE MUTASE : 3 hits 1i8t_c02 naa= 4 ULMN 4 1i8t_c03 UDP-GALACTOPYRANOSE MUTASE user 1 4 # 1 B 170 ARG A 63 ARG~? 13.95 CL CL A 129 B 278 ARG A 104 ARG^? 18.53 CL CL B 129 B 298 GLU A 93 GLU.? 15.26 CL CL B 129 B 348 ASP A 72 ASP.? 29.77 CL CL A 129 coo -8.10 23.98 3.08 -8.58 21.04 2.27 87.85 45.63 -72.60 88.58 48.58 -73.24 coo -19.09 15.00 16.26 -16.38 15.21 14.84 82.19 63.80 -76.53 82.09 65.30 -73.83 coo -19.42 16.58 21.15 -18.01 16.20 19.59 84.83 64.69 -81.14 84.26 66.42 -82.32 coo -3.61 14.95 13.27 -5.31 15.62 12.23 81.04 48.95 -86.11 82.18 49.75 -87.74 ULMN 4 1i8t_c03 UDP-GALACTOPYRANOSE MUTASE user 2 4 # 2 B 170 ARG A 73 ARG.? 22.19 CL CL A 129 B 278 ARG A 117 ARG^? 16.03 CL CL A 129 B 298 GLU A 114 GLU^? 14.59 CL CL A 129 B 348 ASP A 30 ASP~? 20.80 CL CL A 129 coo -8.10 23.98 3.08 -8.58 21.04 2.27 83.82 53.79 -81.61 86.00 54.30 -79.51 coo -19.09 15.00 16.26 -16.38 15.21 14.84 100.59 48.03 -72.66 102.04 46.10 -74.59 coo -19.42 16.58 21.15 -18.01 16.20 19.59 104.53 45.97 -71.95 105.17 46.78 -70.05 coo -3.61 14.95 13.27 -5.31 15.62 12.23 90.38 41.71 -80.87 92.04 40.39 -80.79 ULMN 4 1i8t_c03 UDP-GALACTOPYRANOSE MUTASE user 3 4 # 3 B 170 ARG A 76 ARG^? 19.15 CL CL B 129 B 278 ARG A 46 ARG^? 15.11 CL CL A 129 B 298 GLU A 51 GLU^? 16.44 CL CL A 129 B 348 ASP A 72 ASP.? 29.77 CL CL A 129 coo -8.10 23.98 3.08 -8.58 21.04 2.27 82.62 63.89 -86.56 80.46 65.21 -84.78 coo -19.09 15.00 16.26 -16.38 15.21 14.84 87.96 51.20 -70.32 85.08 51.60 -71.34 coo -19.42 16.58 21.15 -18.01 16.20 19.59 82.00 50.89 -67.09 80.89 51.23 -68.89 coo -3.61 14.95 13.27 -5.31 15.62 12.23 81.04 48.95 -86.11 82.18 49.75 -87.74 ULMN 4 1i8t_c03 UDP-GALACTOPYRANOSE MUTASE user 4 4 # 4 B 170 ARG B 63 ARG^? 13.99 CL CL B 129 B 278 ARG B 104 ARG^? 18.51 CL CL A 129 B 298 GLU B 93 GLU^? 15.32 CL CL A 129 B 348 ASP B 72 ASP^? 28.57 CL CL C 129 coo -8.10 23.98 3.08 -8.58 21.04 2.27 87.72 77.76 -68.29 88.60 74.86 -67.71 coo -19.09 15.00 16.26 -16.38 15.21 14.84 82.09 59.72 -64.70 82.21 58.19 -67.39 coo -19.42 16.58 21.15 -18.01 16.20 19.59 84.67 58.80 -60.02 84.04 57.06 -58.91 coo -3.61 14.95 13.27 -5.31 15.62 12.23 80.87 74.36 -54.99 81.74 73.36 -53.35 ULMN 4 1i8t_c03 UDP-GALACTOPYRANOSE MUTASE user 5 4 # 5 B 170 ARG B 73 ARG^? 22.29 CL CL B 129 B 278 ARG B 117 ARG^? 16.04 CL CL B 129 B 298 GLU B 114 GLU^? 14.94 CL CL B 129 B 348 ASP B 30 ASP^? 20.91 CL CL B 129 coo -8.10 23.98 3.08 -8.58 21.04 2.27 83.86 69.55 -59.16 85.91 69.18 -61.42 coo -19.09 15.00 16.26 -16.38 15.21 14.84 100.63 75.34 -68.25 102.08 77.36 -66.41 coo -19.42 16.58 21.15 -18.01 16.20 19.59 104.70 77.68 -68.99 105.48 76.80 -70.78 coo -3.61 14.95 13.27 -5.31 15.62 12.23 90.60 81.40 -60.16 92.15 82.83 -59.97 ULMN 4 1i8t_c03 UDP-GALACTOPYRANOSE MUTASE user 6 4 # 6 B 170 ARG B 76 ARG^? 18.98 CL CL A 129 B 278 ARG B 46 ARG^? 15.06 CL CL B 129 B 298 GLU B 51 GLU^? 16.46 CL CL B 129 B 348 ASP B 72 ASP^? 28.57 CL CL C 129 coo -8.10 23.98 3.08 -8.58 21.04 2.27 82.73 59.03 -54.76 80.31 57.91 -56.24 coo -19.09 15.00 16.26 -16.38 15.21 14.84 87.96 72.13 -70.71 85.05 71.84 -69.78 coo -19.42 16.58 21.15 -18.01 16.20 19.59 81.98 72.56 -73.89 80.95 72.05 -72.12 coo -3.61 14.95 13.27 -5.31 15.62 12.23 80.87 74.36 -54.99 81.74 73.36 -53.35 ULMN 4 1i8t_c03 UDP-GALACTOPYRANOSE MUTASE user 7 4 # 7 B 170 ARG B 117 ARG^? 16.04 CL CL B 129 B 278 ARG C 76 ARG^? 33.92 CL CL B 129 B 298 GLU C 93 GLU^? 31.51 CL CL C 129 B 348 ASP B 14 ASP^? 27.62 CL CL A 129 coo -8.10 23.98 3.08 -8.58 21.04 2.27 100.63 75.34 -68.25 102.08 77.36 -66.41 coo -19.09 15.00 16.26 -16.38 15.21 14.84 105.54 81.89 -51.05 106.65 84.23 -49.40 coo -19.42 16.58 21.15 -18.01 16.20 19.59 105.96 79.95 -45.75 107.72 80.63 -46.81 coo -3.61 14.95 13.27 -5.31 15.62 12.23 105.60 69.00 -58.44 107.49 69.47 -57.66 ULMN 4 1i8t_c03 UDP-GALACTOPYRANOSE MUTASE user 8 4 # 8 B 170 ARG C 60 ARG^? 8.92 CL CL C 129 B 278 ARG D 117 ARG^? 15.96 CL CL D 129 B 298 GLU D 114 GLU^? 14.88 CL CL D 129 B 348 ASP D 30 ASP^? 20.62 CL CL D 129 coo -8.10 23.98 3.08 -8.58 21.04 2.27 82.52 72.20 -31.52 80.97 69.57 -31.97 coo -19.09 15.00 16.26 -16.38 15.21 14.84 69.91 86.62 -37.36 71.94 88.06 -39.21 coo -19.42 16.58 21.15 -18.01 16.20 19.59 72.08 90.81 -36.72 71.29 91.48 -34.84 coo -3.61 14.95 13.27 -5.31 15.62 12.23 76.16 76.40 -45.40 77.49 78.05 -45.35 ULMN 4 1i8t_c03 UDP-GALACTOPYRANOSE MUTASE user 9 4 # 9 B 170 ARG C 63 ARG^? 14.10 CL CL C 129 B 278 ARG C 104 ARG^? 26.38 CL CL C 129 B 298 GLU C 93 GLU^? 31.51 CL CL C 129 B 348 ASP C 72 ASP^? 28.53 CL CL B 129 coo -8.10 23.98 3.08 -8.58 21.04 2.27 86.96 77.03 -37.50 89.89 76.13 -38.00 coo -19.09 15.00 16.26 -16.38 15.21 14.84 105.08 82.46 -41.08 106.56 82.47 -38.36 coo -19.42 16.58 21.15 -18.01 16.20 19.59 105.96 79.95 -45.75 107.72 80.63 -46.81 coo -3.61 14.95 13.27 -5.31 15.62 12.23 90.38 83.76 -50.64 91.24 82.68 -52.23 ULMN 4 1i8t_c03 UDP-GALACTOPYRANOSE MUTASE user 10 4 # 10 B 170 ARG C 63 ARG^? 14.10 CL CL C 129 B 278 ARG D 46 ARG^? 15.13 CL CL D 129 B 298 GLU D 51 GLU^? 16.56 CL CL D 129 B 348 ASP D 30 ASP^? 20.62 CL CL D 129 coo -8.10 23.98 3.08 -8.58 21.04 2.27 86.96 77.03 -37.50 89.89 76.13 -38.00 coo -19.09 15.00 16.26 -16.38 15.21 14.84 66.74 73.93 -35.00 66.45 71.02 -36.02 coo -19.42 16.58 21.15 -18.01 16.20 19.59 66.99 68.03 -31.91 66.63 66.88 -33.67 coo -3.61 14.95 13.27 -5.31 15.62 12.23 76.16 76.40 -45.40 77.49 78.05 -45.35 ULMN 4 1i8t_c03 UDP-GALACTOPYRANOSE MUTASE user 11 4 # 11 B 170 ARG C 73 ARG^? 22.24 CL CL C 129 B 278 ARG C 117 ARG^? 16.02 CL CL C 129 B 298 GLU C 114 GLU^? 14.88 CL CL C 129 B 348 ASP C 30 ASP^? 20.67 CL CL C 129 coo -8.10 23.98 3.08 -8.58 21.04 2.27 95.26 80.79 -46.47 95.45 78.63 -44.29 coo -19.09 15.00 16.26 -16.38 15.21 14.84 89.36 64.01 -37.29 87.40 62.56 -39.24 coo -19.42 16.58 21.15 -18.01 16.20 19.59 87.05 59.85 -36.57 87.99 59.11 -34.78 coo -3.61 14.95 13.27 -5.31 15.62 12.23 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 4 1i8t_c03 UDP-GALACTOPYRANOSE MUTASE user 12 4 # 12 B 170 ARG C 117 ARG^? 16.02 CL CL C 129 B 278 ARG B 76 ARG^? 18.98 CL CL A 129 B 298 GLU B 93 GLU^? 15.32 CL CL A 129 B 348 ASP C 14 ASP^? 16.95 CL CL A 129 coo -8.10 23.98 3.08 -8.58 21.04 2.27 89.36 64.01 -37.29 87.40 62.56 -39.24 coo -19.09 15.00 16.26 -16.38 15.21 14.84 82.73 59.03 -54.76 80.31 57.91 -56.24 coo -19.42 16.58 21.15 -18.01 16.20 19.59 84.67 58.80 -60.02 84.04 57.06 -58.91 coo -3.61 14.95 13.27 -5.31 15.62 12.23 95.50 58.88 -47.37 95.04 57.01 -48.29 ULMN 4 1i8t_c03 UDP-GALACTOPYRANOSE MUTASE user 13 4 # 13 B 170 ARG D 60 ARG^? 8.57 CL CL D 129 B 278 ARG C 117 ARG^? 16.02 CL CL C 129 B 298 GLU C 114 GLU^? 14.88 CL CL C 129 B 348 ASP C 30 ASP^? 20.67 CL CL C 129 coo -8.10 23.98 3.08 -8.58 21.04 2.27 76.65 78.50 -31.75 78.13 81.14 -31.78 coo -19.09 15.00 16.26 -16.38 15.21 14.84 89.36 64.01 -37.29 87.40 62.56 -39.24 coo -19.42 16.58 21.15 -18.01 16.20 19.59 87.05 59.85 -36.57 87.99 59.11 -34.78 coo -3.61 14.95 13.27 -5.31 15.62 12.23 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 4 1i8t_c03 UDP-GALACTOPYRANOSE MUTASE user 14 4 # 14 B 170 ARG D 63 ARG^? 14.07 CL CL D 129 B 278 ARG C 46 ARG^? 15.12 CL CL C 129 B 298 GLU C 51 GLU^? 16.39 CL CL C 129 B 348 ASP C 30 ASP^? 20.67 CL CL C 129 coo -8.10 23.98 3.08 -8.58 21.04 2.27 72.33 73.68 -37.44 69.36 74.46 -37.99 coo -19.09 15.00 16.26 -16.38 15.21 14.84 92.47 76.70 -34.87 92.87 79.50 -36.04 coo -19.42 16.58 21.15 -18.01 16.20 19.59 92.20 82.64 -31.68 92.61 83.59 -33.56 coo -3.61 14.95 13.27 -5.31 15.62 12.23 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 4 1i8t_c03 UDP-GALACTOPYRANOSE MUTASE user 15 4 # 15 B 170 ARG D 63 ARG^? 14.07 CL CL D 129 B 278 ARG D 104 ARG^? 26.47 CL CL D 129 B 298 GLU D 93 GLU^? 31.46 CL CL D 129 B 348 ASP D 72 ASP^? 29.64 CL CL D 129 coo -8.10 23.98 3.08 -8.58 21.04 2.27 72.33 73.68 -37.44 69.36 74.46 -37.99 coo -19.09 15.00 16.26 -16.38 15.21 14.84 54.44 68.08 -41.08 52.76 68.11 -38.51 coo -19.42 16.58 21.15 -18.01 16.20 19.59 53.41 70.78 -45.84 51.64 70.26 -46.90 coo -3.61 14.95 13.27 -5.31 15.62 12.23 69.04 67.18 -50.81 68.23 68.38 -52.37 ULMN 4 1i8t_c03 UDP-GALACTOPYRANOSE MUTASE user 16 4 # 16 B 170 ARG D 73 ARG^? 22.15 CL CL D 129 B 278 ARG D 117 ARG^? 15.96 CL CL D 129 B 298 GLU D 114 GLU^? 14.88 CL CL D 129 B 348 ASP D 30 ASP^? 20.62 CL CL D 129 coo -8.10 23.98 3.08 -8.58 21.04 2.27 64.06 69.83 -46.45 63.93 71.88 -44.19 coo -19.09 15.00 16.26 -16.38 15.21 14.84 69.91 86.62 -37.36 71.94 88.06 -39.21 coo -19.42 16.58 21.15 -18.01 16.20 19.59 72.08 90.81 -36.72 71.29 91.48 -34.84 coo -3.61 14.95 13.27 -5.31 15.62 12.23 76.16 76.40 -45.40 77.49 78.05 -45.35 ULMN 4 1i8t_c03 UDP-GALACTOPYRANOSE MUTASE user 17 4 # 17 B 170 ARG D 76 ARG^? 33.75 CL CL D 129 B 278 ARG D 46 ARG^? 15.13 CL CL D 129 B 298 GLU D 51 GLU^? 16.56 CL CL D 129 B 348 ASP D 72 ASP^? 29.64 CL CL D 129 coo -8.10 23.98 3.08 -8.58 21.04 2.27 54.15 68.69 -51.19 53.07 66.38 -49.46 coo -19.09 15.00 16.26 -16.38 15.21 14.84 66.74 73.93 -35.00 66.45 71.02 -36.02 coo -19.42 16.58 21.15 -18.01 16.20 19.59 66.99 68.03 -31.91 66.63 66.88 -33.67 coo -3.61 14.95 13.27 -5.31 15.62 12.23 69.04 67.18 -50.81 68.23 68.38 -52.37 1i8t_c03 source 1i8t UDP-GALACTOPYRANOSE MUTASE : 17 hits 1i8t_c03 naa= 4 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 1 4 # 1 A 151 VAL C 110 VAL^? 17.49 CL CL C 129 A 194 GLY C 115 GLY^? 19.09 CL CL C 129 A 417 ILE A 80 ILE^? 18.01 CL CL B 129 A 457 ALA A 88 ALA.? 20.00 CL CL B 129 coo 60.43 93.31 8.03 62.16 94.30 8.93 96.93 61.48 -37.01 97.53 61.06 -34.97 coo 59.34 89.99 13.88 59.24 89.18 13.73 89.73 59.33 -40.54 89.93 59.44 -39.76 coo 39.61 128.90 22.54 40.04 128.24 23.80 97.60 61.21 -82.44 97.71 59.82 -82.68 coo 43.27 124.32 20.47 43.79 125.29 21.53 101.16 60.49 -76.11 101.18 59.57 -77.33 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 2 4 # 2 A 151 VAL C 123 VAL^? 19.18 CL CL C 129 A 194 GLY C 103 GLY^? 26.43 CL CL C 129 A 417 ILE A 118 ILE^? 14.73 CL CL A 129 A 457 ALA A 120 ALA^? 13.72 CL CL A 129 coo 60.43 93.31 8.03 62.16 94.30 8.93 98.82 79.54 -37.57 97.12 79.51 -38.94 coo 59.34 89.99 13.88 59.24 89.18 13.73 101.51 83.72 -43.08 102.15 83.46 -43.54 coo 39.61 128.90 22.54 40.04 128.24 23.80 95.73 52.77 -73.03 94.62 53.00 -73.89 coo 43.27 124.32 20.47 43.79 125.29 21.53 94.30 56.05 -68.63 94.53 57.34 -67.75 1pix_c00 source 1pix GLUTACONYL-COA DECARBOXYLASE A SUBUNIT : 2 hits 1pix_c00 naa= 4 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 1 4 # 1 B 151 VAL C 110 VAL^? 17.49 CL CL C 129 B 194 GLY C 115 GLY^? 19.09 CL CL C 129 B 417 ILE A 80 ILE^? 18.01 CL CL B 129 B 457 ALA A 88 ALA.? 20.00 CL CL B 129 coo 52.95 126.71 13.21 51.34 125.24 13.19 96.93 61.48 -37.01 97.53 61.06 -34.97 coo 50.40 126.23 20.48 50.46 127.00 20.75 89.73 59.33 -40.54 89.93 59.44 -39.76 coo 68.38 85.45 19.33 67.41 85.52 20.41 97.60 61.21 -82.44 97.71 59.82 -82.68 coo 65.50 91.13 17.77 64.65 89.88 18.00 101.16 60.49 -76.11 101.18 59.57 -77.33 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 2 4 # 2 B 151 VAL C 123 VAL^? 19.18 CL CL C 129 B 194 GLY C 103 GLY^? 26.43 CL CL C 129 B 417 ILE A 118 ILE^? 14.73 CL CL A 129 B 457 ALA A 120 ALA^? 13.72 CL CL A 129 coo 52.95 126.71 13.21 51.34 125.24 13.19 98.82 79.54 -37.57 97.12 79.51 -38.94 coo 50.40 126.23 20.48 50.46 127.00 20.75 101.51 83.72 -43.08 102.15 83.46 -43.54 coo 68.38 85.45 19.33 67.41 85.52 20.41 95.73 52.77 -73.03 94.62 53.00 -73.89 coo 65.50 91.13 17.77 64.65 89.88 18.00 94.30 56.05 -68.63 94.53 57.34 -67.75 1pix_c01 source 1pix GLUTACONYL-COA DECARBOXYLASE A SUBUNIT : 2 hits 1pix_c01 naa= 4 ULMN 4 1r4f_c01 IAG-NUCLEOSIDE HYDROLASE user 1 4 # 1 B 10 ASP A 5 ASP~? 21.13 CL CL B 129 B 83 TRP B 39 TRP^? 10.25 CL CL B 129 B 186 ASN A 7 ASN.? 14.61 CL CL B 129 B 260 ALA A 88 ALA.? 20.00 CL CL B 129 coo 32.41 24.46 38.87 30.66 25.57 39.24 110.30 67.66 -76.72 112.26 68.26 -76.10 coo 21.58 23.61 33.02 20.95 24.04 36.89 101.26 73.91 -73.75 100.85 71.27 -76.60 coo 27.66 25.11 45.19 28.06 26.34 43.52 104.28 66.29 -83.02 102.35 66.19 -82.19 coo 25.52 34.62 42.47 24.97 33.24 42.72 101.16 60.49 -76.11 101.18 59.57 -77.33 ULMN 4 1r4f_c01 IAG-NUCLEOSIDE HYDROLASE user 2 4 # 2 B 10 ASP B 5 ASP^? 20.93 CL CL A 129 B 83 TRP A 39 TRP.? 10.30 CL CL A 129 B 186 ASN B 7 ASN^? 14.42 CL CL A 129 B 260 ALA B 88 ALA^? 19.82 CL CL A 129 coo 32.41 24.46 38.87 30.66 25.57 39.24 110.10 55.77 -64.66 112.04 55.13 -65.31 coo 21.58 23.61 33.02 20.95 24.04 36.89 101.24 49.64 -67.32 101.01 52.25 -64.41 coo 27.66 25.11 45.19 28.06 26.34 43.52 104.35 57.09 -58.15 102.38 57.14 -58.88 coo 25.52 34.62 42.47 24.97 33.24 42.72 101.17 62.84 -65.03 101.19 63.76 -63.80 1r4f_c01 source 1r4f IAG-NUCLEOSIDE HYDROLASE : 2 hits 1r4f_c01 naa= 4 ULMN 4 1x9h_c00 GLUCOSE-6-PHOSPHATE ISOMERASE user 1 4 # 1 A 135 ARG C 117 ARG^? 16.02 CL CL C 129 A 203 GLU C 36 GLU^? 18.27 CL CL C 129 A 219 HIS D 122 HIS^? 19.08 CL CL D 129 A 298 LYS C 24 LYS^? 26.64 CL CL C 129 coo 46.78 3.24 25.36 49.46 4.02 24.06 89.36 64.01 -37.29 87.40 62.56 -39.24 coo 45.62 7.41 24.38 46.18 6.66 26.27 84.85 65.27 -40.53 84.47 64.86 -42.56 coo 17.74 16.81 28.99 16.41 15.60 30.09 57.69 72.86 -34.13 56.74 71.23 -33.18 coo 54.03 15.54 30.62 51.73 9.72 31.19 88.99 74.10 -49.29 84.03 71.99 -51.83 1x9h_c00 source 1x9h GLUCOSE-6-PHOSPHATE ISOMERASE : 1 hits 1x9h_c00 naa= 4 ULMN 4 1x9h_c01 GLUCOSE-6-PHOSPHATE ISOMERASE user 1 4 # 1 B 135 ARG C 117 ARG^? 16.02 CL CL C 129 B 203 GLU C 36 GLU^? 18.27 CL CL C 129 B 219 HIS D 122 HIS^? 19.08 CL CL D 129 B 298 LYS C 24 LYS^? 26.64 CL CL C 129 coo 18.36 26.71 24.52 15.92 26.01 22.78 89.36 64.01 -37.29 87.40 62.56 -39.24 coo 19.67 22.60 23.25 18.70 23.07 25.03 84.85 65.27 -40.53 84.47 64.86 -42.56 coo 46.63 12.38 30.98 47.80 13.39 32.39 57.69 72.86 -34.13 56.74 71.23 -33.18 coo 10.17 13.56 26.79 12.26 19.06 29.15 88.99 74.10 -49.29 84.03 71.99 -51.83 1x9h_c01 source 1x9h GLUCOSE-6-PHOSPHATE ISOMERASE : 1 hits 1x9h_c01 naa= 4 ULMN 3 1a41_c01 TOPOISOMERASE I user 1 3 # 1 223 ARG A 46 ARG^? 15.11 CL CL A 129 265 HIS A 122 HIS^? 19.05 CL CL A 129 274 TYR B 83 TYR^? 15.32 CL CL A 129 coo -15.18 55.46 8.55 -14.82 52.98 10.38 87.96 51.20 -70.32 85.08 51.60 -71.34 coo -14.48 45.59 11.18 -14.02 47.49 10.42 86.83 60.37 -69.40 85.20 61.24 -68.40 coo 0.94 52.26 9.16 1.95 54.78 9.91 103.38 58.05 -66.28 101.08 56.65 -65.75 ULMN 3 1a41_c01 TOPOISOMERASE I user 2 3 # 2 223 ARG A 46 ARG^? 15.11 CL CL A 129 265 HIS B 122 HIS^? 19.12 CL CL B 129 274 TYR B 83 TYR^? 15.32 CL CL A 129 coo -15.18 55.46 8.55 -14.82 52.98 10.38 87.96 51.20 -70.32 85.08 51.60 -71.34 coo -14.48 45.59 11.18 -14.02 47.49 10.42 86.93 63.10 -71.62 85.35 62.06 -72.53 coo 0.94 52.26 9.16 1.95 54.78 9.91 103.38 58.05 -66.28 101.08 56.65 -65.75 ULMN 3 1a41_c01 TOPOISOMERASE I user 3 3 # 3 223 ARG B 46 ARG^? 15.06 CL CL B 129 265 HIS A 122 HIS^? 19.05 CL CL A 129 274 TYR A 83 TYR.? 15.31 CL CL B 129 coo -15.18 55.46 8.55 -14.82 52.98 10.38 87.96 72.13 -70.71 85.05 71.84 -69.78 coo -14.48 45.59 11.18 -14.02 47.49 10.42 86.83 60.37 -69.40 85.20 61.24 -68.40 coo 0.94 52.26 9.16 1.95 54.78 9.91 103.43 65.48 -74.92 101.03 66.78 -75.48 ULMN 3 1a41_c01 TOPOISOMERASE I user 4 3 # 4 223 ARG B 46 ARG^? 15.06 CL CL B 129 265 HIS B 122 HIS^? 19.12 CL CL B 129 274 TYR A 83 TYR.? 15.31 CL CL B 129 coo -15.18 55.46 8.55 -14.82 52.98 10.38 87.96 72.13 -70.71 85.05 71.84 -69.78 coo -14.48 45.59 11.18 -14.02 47.49 10.42 86.93 63.10 -71.62 85.35 62.06 -72.53 coo 0.94 52.26 9.16 1.95 54.78 9.91 103.43 65.48 -74.92 101.03 66.78 -75.48 ULMN 3 1a41_c01 TOPOISOMERASE I user 5 3 # 5 223 ARG B 117 ARG^? 16.04 CL CL B 129 265 HIS B 40 HIS^? 7.04 CL CL B 129 274 TYR B 47 TYR^? 14.72 CL CL B 129 coo -15.18 55.46 8.55 -14.82 52.98 10.38 100.63 75.34 -68.25 102.08 77.36 -66.41 coo -14.48 45.59 11.18 -14.02 47.49 10.42 98.79 79.91 -74.95 97.97 81.53 -75.99 coo 0.94 52.26 9.16 1.95 54.78 9.91 86.74 65.69 -75.43 87.82 65.07 -77.96 1a41_c01 source 1a41 TOPOISOMERASE I : 5 hits 1a41_c01 naa= 3 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 1 3 # 1 A 49 GLU A 23 GLU~? 24.22 CL CL A 129 A 60 ASP A 30 ASP~? 20.80 CL CL A 129 A 175 TYR A 20 TYR~? 23.51 CL CL B 129 coo 46.10 28.27 19.27 45.48 26.99 20.84 89.42 52.54 -84.47 88.08 53.22 -82.95 coo 56.42 28.06 12.93 55.01 27.92 14.50 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 45.02 22.04 15.38 46.16 24.00 13.76 94.54 54.15 -86.74 93.79 56.81 -87.24 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 2 3 # 2 A 49 GLU A 58 GLU~? 7.41 CL CL A 129 A 60 ASP A 41 ASP.? 7.60 CL CL A 129 A 175 TYR A 54 TYR^? 10.29 CL CL A 129 coo 46.10 28.27 19.27 45.48 26.99 20.84 87.85 46.74 -60.89 87.27 48.56 -59.93 coo 56.42 28.06 12.93 55.01 27.92 14.50 99.56 48.98 -63.34 100.43 49.52 -61.53 coo 45.02 22.04 15.38 46.16 24.00 13.76 89.27 53.06 -59.98 88.13 55.63 -59.94 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 3 3 # 3 A 49 GLU B 23 GLU^? 24.68 CL CL B 129 A 60 ASP B 30 ASP^? 20.91 CL CL B 129 A 175 TYR B 20 TYR^? 23.21 CL CL A 129 coo 46.10 28.27 19.27 45.48 26.99 20.84 89.49 70.79 -56.44 87.96 70.01 -57.68 coo 56.42 28.06 12.93 55.01 27.92 14.50 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 45.02 22.04 15.38 46.16 24.00 13.76 94.47 69.13 -54.42 93.73 66.50 -53.85 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 4 3 # 4 A 49 GLU B 23 GLU^? 24.68 CL CL B 129 A 60 ASP C 30 ASP^? 20.67 CL CL C 129 A 175 TYR C 20 TYR^? 26.72 CL CL A 129 coo 46.10 28.27 19.27 45.48 26.99 20.84 89.49 70.79 -56.44 87.96 70.01 -57.68 coo 56.42 28.06 12.93 55.01 27.92 14.50 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 45.02 22.04 15.38 46.16 24.00 13.76 95.56 70.07 -51.22 98.17 70.86 -51.76 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 5 3 # 5 A 49 GLU B 58 GLU^? 7.34 CL CL B 129 A 60 ASP B 41 ASP^? 7.64 CL CL B 129 A 175 TYR B 54 TYR^? 10.36 CL CL B 129 coo 46.10 28.27 19.27 45.48 26.99 20.84 87.90 76.66 -80.19 87.42 74.86 -81.30 coo 56.42 28.06 12.93 55.01 27.92 14.50 99.50 74.51 -77.69 100.41 73.95 -79.49 coo 45.02 22.04 15.38 46.16 24.00 13.76 89.19 70.43 -81.07 88.03 67.93 -81.20 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 6 3 # 6 A 49 GLU C 23 GLU^? 24.69 CL CL C 129 A 60 ASP B 30 ASP^? 20.91 CL CL B 129 A 175 TYR B 20 TYR^? 23.21 CL CL A 129 coo 46.10 28.27 19.27 45.48 26.99 20.84 93.85 75.25 -49.20 94.57 76.88 -48.00 coo 56.42 28.06 12.93 55.01 27.92 14.50 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 45.02 22.04 15.38 46.16 24.00 13.76 94.47 69.13 -54.42 93.73 66.50 -53.85 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 7 3 # 7 A 49 GLU C 23 GLU^? 24.69 CL CL C 129 A 60 ASP C 30 ASP^? 20.67 CL CL C 129 A 175 TYR C 20 TYR^? 26.72 CL CL A 129 coo 46.10 28.27 19.27 45.48 26.99 20.84 93.85 75.25 -49.20 94.57 76.88 -48.00 coo 56.42 28.06 12.93 55.01 27.92 14.50 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 45.02 22.04 15.38 46.16 24.00 13.76 95.56 70.07 -51.22 98.17 70.86 -51.76 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 8 3 # 8 A 49 GLU C 58 GLU^? 7.49 CL CL C 129 A 60 ASP C 41 ASP^? 7.58 CL CL C 129 A 175 TYR C 54 TYR^? 10.32 CL CL C 129 coo 46.10 28.27 19.27 45.48 26.99 20.84 88.02 76.82 -25.55 89.85 77.43 -24.60 coo 56.42 28.06 12.93 55.01 27.92 14.50 90.28 65.09 -27.98 90.77 64.12 -26.18 coo 45.02 22.04 15.38 46.16 24.00 13.76 94.43 75.36 -24.67 96.94 76.58 -24.67 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 9 3 # 9 A 49 GLU D 23 GLU^? 24.49 CL CL D 129 A 60 ASP D 30 ASP^? 20.62 CL CL D 129 A 175 TYR D 20 TYR^? 27.97 CL CL D 129 coo 46.10 28.27 19.27 45.48 26.99 20.84 65.41 75.40 -49.12 64.81 73.78 -47.86 coo 56.42 28.06 12.93 55.01 27.92 14.50 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 45.02 22.04 15.38 46.16 24.00 13.76 63.79 80.64 -51.29 61.18 79.77 -51.83 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 10 3 # 10 A 49 GLU D 58 GLU^? 7.39 CL CL D 129 A 60 ASP D 41 ASP^? 7.55 CL CL D 129 A 175 TYR D 54 TYR^? 10.35 CL CL D 129 coo 46.10 28.27 19.27 45.48 26.99 20.84 71.21 74.03 -25.57 69.46 73.32 -24.61 coo 56.42 28.06 12.93 55.01 27.92 14.50 69.10 85.54 -28.07 68.60 86.44 -26.19 coo 45.02 22.04 15.38 46.16 24.00 13.76 64.95 75.15 -24.65 62.40 74.09 -24.68 1a50_c03 source 1a50 TRYPTOPHAN SYNTHASE : 10 hits 1a50_c03 naa= 3 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 1 3 # 1 16 ALA A 121 ALA^? 14.99 CL CL A 129 19 HIS A 122 HIS^? 19.05 CL CL A 129 22 HIS B 122 HIS^? 19.12 CL CL B 129 coo 53.27 36.51 45.29 51.98 36.45 44.47 91.20 56.45 -70.80 90.97 55.26 -71.77 coo 46.88 33.59 48.26 46.24 34.32 46.40 86.83 60.37 -69.40 85.20 61.24 -68.40 coo 48.05 31.12 44.60 48.20 33.05 43.77 86.93 63.10 -71.62 85.35 62.06 -72.53 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 2 3 # 2 16 ALA A 121 ALA^? 14.99 CL CL A 129 19 HIS B 122 HIS^? 19.12 CL CL B 129 22 HIS A 122 HIS^? 19.05 CL CL A 129 coo 53.27 36.51 45.29 51.98 36.45 44.47 91.20 56.45 -70.80 90.97 55.26 -71.77 coo 46.88 33.59 48.26 46.24 34.32 46.40 86.93 63.10 -71.62 85.35 62.06 -72.53 coo 48.05 31.12 44.60 48.20 33.05 43.77 86.83 60.37 -69.40 85.20 61.24 -68.40 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 3 3 # 3 16 ALA B 121 ALA^? 14.81 CL CL B 129 19 HIS A 122 HIS^? 19.05 CL CL A 129 22 HIS B 122 HIS^? 19.12 CL CL B 129 coo 53.27 36.51 45.29 51.98 36.45 44.47 91.23 67.08 -70.26 91.04 68.33 -69.41 coo 46.88 33.59 48.26 46.24 34.32 46.40 86.83 60.37 -69.40 85.20 61.24 -68.40 coo 48.05 31.12 44.60 48.20 33.05 43.77 86.93 63.10 -71.62 85.35 62.06 -72.53 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 4 3 # 4 16 ALA B 121 ALA^? 14.81 CL CL B 129 19 HIS B 122 HIS^? 19.12 CL CL B 129 22 HIS A 122 HIS^? 19.05 CL CL A 129 coo 53.27 36.51 45.29 51.98 36.45 44.47 91.23 67.08 -70.26 91.04 68.33 -69.41 coo 46.88 33.59 48.26 46.24 34.32 46.40 86.93 63.10 -71.62 85.35 62.06 -72.53 coo 48.05 31.12 44.60 48.20 33.05 43.77 86.83 60.37 -69.40 85.20 61.24 -68.40 1a8h_c02 source 1a8h METHIONYL-TRNA SYNTHETASE : 4 hits 1a8h_c02 naa= 3 ULMN 3 1ab4_c00 GYRASE A user 1 3 # 1 32 ARG A 46 ARG^? 15.11 CL CL A 129 78 HIS A 122 HIS^? 19.05 CL CL A 129 122 TYR C 20 TYR^? 26.72 CL CL A 129 coo 48.32 72.26 30.89 48.69 69.28 31.53 87.96 51.20 -70.32 85.08 51.60 -71.34 coo 53.63 68.24 34.99 53.08 69.10 33.16 86.83 60.37 -69.40 85.20 61.24 -68.40 coo 75.01 61.87 32.93 75.34 59.26 31.96 95.56 70.07 -51.22 98.17 70.86 -51.76 ULMN 3 1ab4_c00 GYRASE A user 2 3 # 2 32 ARG A 60 ARG~? 8.61 CL CL A 129 78 HIS A 40 HIS.? 7.30 CL CL A 129 122 TYR A 83 TYR.? 15.31 CL CL B 129 coo 48.32 72.26 30.89 48.69 69.28 31.53 92.49 41.37 -66.87 95.11 39.81 -67.06 coo 53.63 68.24 34.99 53.08 69.10 33.16 98.96 43.60 -66.18 98.11 41.92 -65.26 coo 75.01 61.87 32.93 75.34 59.26 31.96 103.43 65.48 -74.92 101.03 66.78 -75.48 ULMN 3 1ab4_c00 GYRASE A user 3 3 # 3 32 ARG A 104 ARG^? 18.53 CL CL B 129 78 HIS A 122 HIS^? 19.05 CL CL A 129 122 TYR C 20 TYR^? 26.72 CL CL A 129 coo 48.32 72.26 30.89 48.69 69.28 31.53 82.19 63.80 -76.53 82.09 65.30 -73.83 coo 53.63 68.24 34.99 53.08 69.10 33.16 86.83 60.37 -69.40 85.20 61.24 -68.40 coo 75.01 61.87 32.93 75.34 59.26 31.96 95.56 70.07 -51.22 98.17 70.86 -51.76 ULMN 3 1ab4_c00 GYRASE A user 4 3 # 4 32 ARG A 104 ARG^? 18.53 CL CL B 129 78 HIS B 122 HIS^? 19.12 CL CL B 129 122 TYR C 20 TYR^? 26.72 CL CL A 129 coo 48.32 72.26 30.89 48.69 69.28 31.53 82.19 63.80 -76.53 82.09 65.30 -73.83 coo 53.63 68.24 34.99 53.08 69.10 33.16 86.93 63.10 -71.62 85.35 62.06 -72.53 coo 75.01 61.87 32.93 75.34 59.26 31.96 95.56 70.07 -51.22 98.17 70.86 -51.76 ULMN 3 1ab4_c00 GYRASE A user 5 3 # 5 32 ARG B 60 ARG^? 8.76 CL CL B 129 78 HIS B 40 HIS^? 7.04 CL CL B 129 122 TYR B 83 TYR^? 15.32 CL CL A 129 coo 48.32 72.26 30.89 48.69 69.28 31.53 92.45 82.18 -73.93 95.13 83.66 -73.65 coo 53.63 68.24 34.99 53.08 69.10 33.16 98.79 79.91 -74.95 97.97 81.53 -75.99 coo 75.01 61.87 32.93 75.34 59.26 31.96 103.38 58.05 -66.28 101.08 56.65 -65.75 ULMN 3 1ab4_c00 GYRASE A user 6 3 # 6 32 ARG C 60 ARG^? 8.92 CL CL C 129 78 HIS C 40 HIS^? 7.21 CL CL C 129 122 TYR C 83 TYR^? 26.27 CL CL C 129 coo 48.32 72.26 30.89 48.69 69.28 31.53 82.52 72.20 -31.52 80.97 69.57 -31.97 coo 53.63 68.24 34.99 53.08 69.10 33.16 84.82 65.72 -30.75 83.18 66.51 -29.70 coo 75.01 61.87 32.93 75.34 59.26 31.96 106.70 61.17 -39.39 108.02 63.54 -39.97 ULMN 3 1ab4_c00 GYRASE A user 7 3 # 7 32 ARG C 117 ARG^? 16.02 CL CL C 129 78 HIS C 40 HIS^? 7.21 CL CL C 129 122 TYR D 54 TYR^? 10.35 CL CL D 129 coo 48.32 72.26 30.89 48.69 69.28 31.53 89.36 64.01 -37.29 87.40 62.56 -39.24 coo 53.63 68.24 34.99 53.08 69.10 33.16 84.82 65.72 -30.75 83.18 66.51 -29.70 coo 75.01 61.87 32.93 75.34 59.26 31.96 64.95 75.15 -24.65 62.40 74.09 -24.68 ULMN 3 1ab4_c00 GYRASE A user 8 3 # 8 32 ARG D 60 ARG^? 8.57 CL CL D 129 78 HIS D 40 HIS^? 7.31 CL CL D 129 122 TYR D 83 TYR^? 26.42 CL CL D 129 coo 48.32 72.26 30.89 48.69 69.28 31.53 76.65 78.50 -31.75 78.13 81.14 -31.78 coo 53.63 68.24 34.99 53.08 69.10 33.16 74.49 84.96 -30.93 76.13 84.16 -29.90 coo 75.01 61.87 32.93 75.34 59.26 31.96 52.51 89.53 -39.47 51.30 87.12 -40.13 ULMN 3 1ab4_c00 GYRASE A user 9 3 # 9 32 ARG D 117 ARG^? 15.96 CL CL D 129 78 HIS D 40 HIS^? 7.31 CL CL D 129 122 TYR C 54 TYR^? 10.32 CL CL C 129 coo 48.32 72.26 30.89 48.69 69.28 31.53 69.91 86.62 -37.36 71.94 88.06 -39.21 coo 53.63 68.24 34.99 53.08 69.10 33.16 74.49 84.96 -30.93 76.13 84.16 -29.90 coo 75.01 61.87 32.93 75.34 59.26 31.96 94.43 75.36 -24.67 96.94 76.58 -24.67 1ab4_c00 source 1ab4 GYRASE A : 9 hits 1ab4_c00 naa= 3 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 1 3 # 1 22 ASN A 29 ASN.? 19.56 CL CL A 129 63 ARG A 63 ARG~? 13.95 CL CL A 129 255 ARG A 73 ARG.? 22.19 CL CL A 129 coo 42.10 13.02 11.14 41.85 11.12 10.23 84.48 42.44 -79.38 84.07 42.43 -77.31 coo 44.36 11.24 3.39 41.81 12.78 4.00 87.85 45.63 -72.60 88.58 48.58 -73.24 coo 38.40 3.83 10.26 40.02 6.30 9.25 83.82 53.79 -81.61 86.00 54.30 -79.51 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 2 3 # 2 22 ASN A 29 ASN.? 19.56 CL CL A 129 63 ARG A 66 ARG~? 18.83 CL CL A 129 255 ARG A 73 ARG.? 22.19 CL CL A 129 coo 42.10 13.02 11.14 41.85 11.12 10.23 84.48 42.44 -79.38 84.07 42.43 -77.31 coo 44.36 11.24 3.39 41.81 12.78 4.00 82.10 46.84 -74.28 82.78 49.65 -75.31 coo 38.40 3.83 10.26 40.02 6.30 9.25 83.82 53.79 -81.61 86.00 54.30 -79.51 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 3 3 # 3 22 ASN B 29 ASN^? 19.59 CL CL B 129 63 ARG B 63 ARG^? 13.99 CL CL B 129 255 ARG B 73 ARG^? 22.29 CL CL B 129 coo 42.10 13.02 11.14 41.85 11.12 10.23 84.68 80.89 -61.45 84.18 80.98 -63.53 coo 44.36 11.24 3.39 41.81 12.78 4.00 87.72 77.76 -68.29 88.60 74.86 -67.71 coo 38.40 3.83 10.26 40.02 6.30 9.25 83.86 69.55 -59.16 85.91 69.18 -61.42 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 4 3 # 4 22 ASN B 29 ASN^? 19.59 CL CL B 129 63 ARG B 66 ARG^? 19.13 CL CL B 129 255 ARG B 73 ARG^? 22.29 CL CL B 129 coo 42.10 13.02 11.14 41.85 11.12 10.23 84.68 80.89 -61.45 84.18 80.98 -63.53 coo 44.36 11.24 3.39 41.81 12.78 4.00 82.06 76.49 -66.55 82.68 73.67 -65.41 coo 38.40 3.83 10.26 40.02 6.30 9.25 83.86 69.55 -59.16 85.91 69.18 -61.42 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 5 3 # 5 22 ASN C 29 ASN^? 19.55 CL CL C 129 63 ARG C 63 ARG^? 14.10 CL CL C 129 255 ARG C 73 ARG^? 22.24 CL CL C 129 coo 42.10 13.02 11.14 41.85 11.12 10.23 83.86 80.07 -44.03 83.70 80.47 -41.95 coo 44.36 11.24 3.39 41.81 12.78 4.00 86.96 77.03 -37.50 89.89 76.13 -38.00 coo 38.40 3.83 10.26 40.02 6.30 9.25 95.26 80.79 -46.47 95.45 78.63 -44.29 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 6 3 # 6 22 ASN C 29 ASN^? 19.55 CL CL C 129 63 ARG C 66 ARG^? 18.88 CL CL C 129 255 ARG C 73 ARG^? 22.24 CL CL C 129 coo 42.10 13.02 11.14 41.85 11.12 10.23 83.86 80.07 -44.03 83.70 80.47 -41.95 coo 44.36 11.24 3.39 41.81 12.78 4.00 88.18 82.59 -38.84 90.98 81.94 -39.92 coo 38.40 3.83 10.26 40.02 6.30 9.25 95.26 80.79 -46.47 95.45 78.63 -44.29 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 7 3 # 7 22 ASN D 29 ASN^? 19.54 CL CL D 129 63 ARG D 63 ARG^? 14.07 CL CL D 129 255 ARG D 73 ARG^? 22.15 CL CL D 129 coo 42.10 13.02 11.14 41.85 11.12 10.23 75.38 70.46 -44.12 75.55 70.12 -42.00 coo 44.36 11.24 3.39 41.81 12.78 4.00 72.33 73.68 -37.44 69.36 74.46 -37.99 coo 38.40 3.83 10.26 40.02 6.30 9.25 64.06 69.83 -46.45 63.93 71.88 -44.19 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 8 3 # 8 22 ASN D 29 ASN^? 19.54 CL CL D 129 63 ARG D 66 ARG^? 18.85 CL CL D 129 255 ARG D 73 ARG^? 22.15 CL CL D 129 coo 42.10 13.02 11.14 41.85 11.12 10.23 75.38 70.46 -44.12 75.55 70.12 -42.00 coo 44.36 11.24 3.39 41.81 12.78 4.00 71.05 68.08 -38.82 68.22 68.66 -39.87 coo 38.40 3.83 10.26 40.02 6.30 9.25 64.06 69.83 -46.45 63.93 71.88 -44.19 1aj0_c00 source 1aj0 DIHYDROPTEROATE SYNTHASE : 8 hits 1aj0_c00 naa= 3 ULMN 3 1al6_c00 CITRATE SYNTHASE user 1 3 # 1 274 HIS B 85 HIS^? 26.88 CL CL A 129 320 HIS A 85 HIS.? 26.94 CL CL B 129 375 ASP B 5 ASP^? 20.93 CL CL A 129 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 111.98 64.21 -65.30 113.02 64.33 -67.11 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 112.09 59.31 -75.65 113.04 59.28 -73.77 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 110.10 55.77 -64.66 112.04 55.13 -65.31 1al6_c00 source 1al6 CITRATE SYNTHASE : 1 hits 1al6_c00 naa= 3 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 1 3 # 1 33 ASP B 30 ASP^? 20.91 CL CL B 129 187 GLU C 23 GLU^? 24.69 CL CL C 129 229 LYS C 24 LYS^? 26.64 CL CL C 129 coo -52.57 56.60 47.75 -51.52 54.87 46.95 90.60 81.40 -60.16 92.15 82.83 -59.97 coo -45.08 48.37 46.81 -46.53 49.74 45.96 93.85 75.25 -49.20 94.57 76.88 -48.00 coo -47.40 44.36 48.48 -50.80 49.18 46.20 88.99 74.10 -49.29 84.03 71.99 -51.83 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 2 3 # 2 33 ASP C 10 ASP^? 12.83 CL CL A 129 187 GLU A 42 GLU.? 5.77 CL CL A 129 229 LYS A 43 LYS.? 9.42 CL CL A 129 coo -52.57 56.60 47.75 -51.52 54.87 46.95 99.63 54.02 -49.94 99.45 52.98 -51.81 coo -45.08 48.37 46.81 -46.53 49.74 45.96 98.04 48.44 -58.38 99.25 46.68 -58.65 coo -47.40 44.36 48.48 -50.80 49.18 46.20 96.70 52.33 -61.01 101.40 51.27 -59.62 1ald_c00 source 1ald ALDOLASE A (E.C.4.1.2.13) : 2 hits 1ald_c00 naa= 3 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 5 ASP~? 21.13 CL CL B 129 214 ASP A 30 ASP~? 20.80 CL CL A 129 289 ASP A 86 ASP.? 23.33 CL CL A 129 coo -0.62 65.95 29.97 0.31 67.47 31.05 110.30 67.66 -76.72 112.26 68.26 -76.10 coo 26.86 59.76 46.36 25.42 58.23 45.92 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 9.42 68.07 30.27 7.35 68.27 30.10 108.46 57.22 -73.78 109.48 58.49 -72.45 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 5 ASP~? 21.13 CL CL B 129 214 ASP C 10 ASP^? 12.83 CL CL A 129 289 ASP A 86 ASP.? 23.33 CL CL A 129 coo -0.62 65.95 29.97 0.31 67.47 31.05 110.30 67.66 -76.72 112.26 68.26 -76.10 coo 26.86 59.76 46.36 25.42 58.23 45.92 99.63 54.02 -49.94 99.45 52.98 -51.81 coo 9.42 68.07 30.27 7.35 68.27 30.10 108.46 57.22 -73.78 109.48 58.49 -72.45 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP A 5 ASP~? 21.13 CL CL B 129 214 ASP C 14 ASP^? 16.95 CL CL A 129 289 ASP B 86 ASP^? 23.14 CL CL B 129 coo -0.62 65.95 29.97 0.31 67.47 31.05 110.30 67.66 -76.72 112.26 68.26 -76.10 coo 26.86 59.76 46.36 25.42 58.23 45.92 95.50 58.88 -47.37 95.04 57.01 -48.29 coo 9.42 68.07 30.27 7.35 68.27 30.10 108.40 66.17 -67.38 109.32 64.97 -68.84 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP A 14 ASP~? 27.67 CL CL B 129 214 ASP C 10 ASP^? 12.83 CL CL A 129 289 ASP A 86 ASP.? 23.33 CL CL A 129 coo -0.62 65.95 29.97 0.31 67.47 31.05 105.70 54.30 -82.61 107.63 54.15 -83.44 coo 26.86 59.76 46.36 25.42 58.23 45.92 99.63 54.02 -49.94 99.45 52.98 -51.81 coo 9.42 68.07 30.27 7.35 68.27 30.10 108.46 57.22 -73.78 109.48 58.49 -72.45 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 5 3 # 5 179 ASP A 30 ASP~? 20.80 CL CL A 129 214 ASP C 10 ASP^? 12.83 CL CL A 129 289 ASP A 35 ASP~? 10.31 CL CL A 129 coo -0.62 65.95 29.97 0.31 67.47 31.05 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 26.86 59.76 46.36 25.42 58.23 45.92 99.63 54.02 -49.94 99.45 52.98 -51.81 coo 9.42 68.07 30.27 7.35 68.27 30.10 93.79 42.35 -72.20 94.79 41.97 -70.38 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 6 3 # 6 179 ASP A 86 ASP.? 23.33 CL CL A 129 214 ASP A 72 ASP.? 29.77 CL CL A 129 289 ASP A 14 ASP~? 27.67 CL CL B 129 coo -0.62 65.95 29.97 0.31 67.47 31.05 108.46 57.22 -73.78 109.48 58.49 -72.45 coo 26.86 59.76 46.36 25.42 58.23 45.92 81.04 48.95 -86.11 82.18 49.75 -87.74 coo 9.42 68.07 30.27 7.35 68.27 30.10 105.70 54.30 -82.61 107.63 54.15 -83.44 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 7 3 # 7 179 ASP A 86 ASP.? 23.33 CL CL A 129 214 ASP B 30 ASP^? 20.91 CL CL B 129 289 ASP B 86 ASP^? 23.14 CL CL B 129 coo -0.62 65.95 29.97 0.31 67.47 31.05 108.46 57.22 -73.78 109.48 58.49 -72.45 coo 26.86 59.76 46.36 25.42 58.23 45.92 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 9.42 68.07 30.27 7.35 68.27 30.10 108.40 66.17 -67.38 109.32 64.97 -68.84 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 8 3 # 8 179 ASP A 86 ASP.? 23.33 CL CL A 129 214 ASP C 5 ASP^? 26.16 CL CL A 129 289 ASP B 5 ASP^? 20.93 CL CL A 129 coo -0.62 65.95 29.97 0.31 67.47 31.05 108.46 57.22 -73.78 109.48 58.49 -72.45 coo 26.86 59.76 46.36 25.42 58.23 45.92 108.85 54.21 -41.41 109.64 52.31 -40.89 coo 9.42 68.07 30.27 7.35 68.27 30.10 110.10 55.77 -64.66 112.04 55.13 -65.31 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 9 3 # 9 179 ASP B 5 ASP^? 20.93 CL CL A 129 214 ASP B 30 ASP^? 20.91 CL CL B 129 289 ASP B 86 ASP^? 23.14 CL CL B 129 coo -0.62 65.95 29.97 0.31 67.47 31.05 110.10 55.77 -64.66 112.04 55.13 -65.31 coo 26.86 59.76 46.36 25.42 58.23 45.92 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 9.42 68.07 30.27 7.35 68.27 30.10 108.40 66.17 -67.38 109.32 64.97 -68.84 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 10 3 # 10 179 ASP B 35 ASP^? 10.19 CL CL B 129 214 ASP C 14 ASP^? 16.95 CL CL A 129 289 ASP B 30 ASP^? 20.91 CL CL B 129 coo -0.62 65.95 29.97 0.31 67.47 31.05 93.79 80.98 -68.72 94.61 81.32 -70.62 coo 26.86 59.76 46.36 25.42 58.23 45.92 95.50 58.88 -47.37 95.04 57.01 -48.29 coo 9.42 68.07 30.27 7.35 68.27 30.10 90.60 81.40 -60.16 92.15 82.83 -59.97 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 11 3 # 11 179 ASP B 72 ASP^? 28.57 CL CL C 129 214 ASP D 41 ASP^? 7.55 CL CL D 129 289 ASP C 30 ASP^? 20.67 CL CL C 129 coo -0.62 65.95 29.97 0.31 67.47 31.05 80.87 74.36 -54.99 81.74 73.36 -53.35 coo 26.86 59.76 46.36 25.42 58.23 45.92 69.10 85.54 -28.07 68.60 86.44 -26.19 coo 9.42 68.07 30.27 7.35 68.27 30.10 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 12 3 # 12 179 ASP B 72 ASP^? 28.57 CL CL C 129 214 ASP D 86 ASP^? 23.19 CL CL D 129 289 ASP D 30 ASP^? 20.62 CL CL D 129 coo -0.62 65.95 29.97 0.31 67.47 31.05 80.87 74.36 -54.99 81.74 73.36 -53.35 coo 26.86 59.76 46.36 25.42 58.23 45.92 60.79 94.39 -38.32 59.49 95.38 -36.98 coo 9.42 68.07 30.27 7.35 68.27 30.10 76.16 76.40 -45.40 77.49 78.05 -45.35 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 13 3 # 13 179 ASP B 86 ASP^? 23.14 CL CL B 129 214 ASP A 30 ASP~? 20.80 CL CL A 129 289 ASP A 86 ASP.? 23.33 CL CL A 129 coo -0.62 65.95 29.97 0.31 67.47 31.05 108.40 66.17 -67.38 109.32 64.97 -68.84 coo 26.86 59.76 46.36 25.42 58.23 45.92 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 9.42 68.07 30.27 7.35 68.27 30.10 108.46 57.22 -73.78 109.48 58.49 -72.45 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 14 3 # 14 179 ASP B 86 ASP^? 23.14 CL CL B 129 214 ASP B 72 ASP^? 28.57 CL CL C 129 289 ASP B 14 ASP^? 27.62 CL CL A 129 coo -0.62 65.95 29.97 0.31 67.47 31.05 108.40 66.17 -67.38 109.32 64.97 -68.84 coo 26.86 59.76 46.36 25.42 58.23 45.92 80.87 74.36 -54.99 81.74 73.36 -53.35 coo 9.42 68.07 30.27 7.35 68.27 30.10 105.60 69.00 -58.44 107.49 69.47 -57.66 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 15 3 # 15 179 ASP B 86 ASP^? 23.14 CL CL B 129 214 ASP C 30 ASP^? 20.67 CL CL C 129 289 ASP B 14 ASP^? 27.62 CL CL A 129 coo -0.62 65.95 29.97 0.31 67.47 31.05 108.40 66.17 -67.38 109.32 64.97 -68.84 coo 26.86 59.76 46.36 25.42 58.23 45.92 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 9.42 68.07 30.27 7.35 68.27 30.10 105.60 69.00 -58.44 107.49 69.47 -57.66 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 16 3 # 16 179 ASP B 86 ASP^? 23.14 CL CL B 129 214 ASP C 86 ASP^? 23.12 CL CL C 129 289 ASP B 10 ASP^? 27.46 CL CL A 129 coo -0.62 65.95 29.97 0.31 67.47 31.05 108.40 66.17 -67.38 109.32 64.97 -68.84 coo 26.86 59.76 46.36 25.42 58.23 45.92 98.39 56.19 -38.35 99.60 55.15 -36.99 coo 9.42 68.07 30.27 7.35 68.27 30.10 110.59 65.11 -56.28 111.89 65.48 -54.65 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 17 3 # 17 179 ASP B 86 ASP^? 23.14 CL CL B 129 214 ASP C 86 ASP^? 23.12 CL CL C 129 289 ASP B 14 ASP^? 27.62 CL CL A 129 coo -0.62 65.95 29.97 0.31 67.47 31.05 108.40 66.17 -67.38 109.32 64.97 -68.84 coo 26.86 59.76 46.36 25.42 58.23 45.92 98.39 56.19 -38.35 99.60 55.15 -36.99 coo 9.42 68.07 30.27 7.35 68.27 30.10 105.60 69.00 -58.44 107.49 69.47 -57.66 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 18 3 # 18 179 ASP C 5 ASP^? 26.16 CL CL A 129 214 ASP C 30 ASP^? 20.67 CL CL C 129 289 ASP C 86 ASP^? 23.12 CL CL C 129 coo -0.62 65.95 29.97 0.31 67.47 31.05 108.85 54.21 -41.41 109.64 52.31 -40.89 coo 26.86 59.76 46.36 25.42 58.23 45.92 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 9.42 68.07 30.27 7.35 68.27 30.10 98.39 56.19 -38.35 99.60 55.15 -36.99 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 19 3 # 19 179 ASP C 35 ASP^? 10.26 CL CL C 129 214 ASP B 14 ASP^? 27.62 CL CL A 129 289 ASP C 30 ASP^? 20.67 CL CL C 129 coo -0.62 65.95 29.97 0.31 67.47 31.05 83.63 70.73 -36.85 83.32 69.81 -34.96 coo 26.86 59.76 46.36 25.42 58.23 45.92 105.60 69.00 -58.44 107.49 69.47 -57.66 coo 9.42 68.07 30.27 7.35 68.27 30.10 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 20 3 # 20 179 ASP C 35 ASP^? 10.26 CL CL C 129 214 ASP D 14 ASP^? 27.52 CL CL D 129 289 ASP C 30 ASP^? 20.67 CL CL C 129 coo -0.62 65.95 29.97 0.31 67.47 31.05 83.63 70.73 -36.85 83.32 69.81 -34.96 coo 26.86 59.76 46.36 25.42 58.23 45.92 63.54 91.53 -47.18 63.81 93.48 -47.82 coo 9.42 68.07 30.27 7.35 68.27 30.10 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 21 3 # 21 179 ASP C 86 ASP^? 23.12 CL CL C 129 214 ASP B 30 ASP^? 20.91 CL CL B 129 289 ASP C 14 ASP^? 16.95 CL CL A 129 coo -0.62 65.95 29.97 0.31 67.47 31.05 98.39 56.19 -38.35 99.60 55.15 -36.99 coo 26.86 59.76 46.36 25.42 58.23 45.92 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 9.42 68.07 30.27 7.35 68.27 30.10 95.50 58.88 -47.37 95.04 57.01 -48.29 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 22 3 # 22 179 ASP C 86 ASP^? 23.12 CL CL C 129 214 ASP B 86 ASP^? 23.14 CL CL B 129 289 ASP C 14 ASP^? 16.95 CL CL A 129 coo -0.62 65.95 29.97 0.31 67.47 31.05 98.39 56.19 -38.35 99.60 55.15 -36.99 coo 26.86 59.76 46.36 25.42 58.23 45.92 108.40 66.17 -67.38 109.32 64.97 -68.84 coo 9.42 68.07 30.27 7.35 68.27 30.10 95.50 58.88 -47.37 95.04 57.01 -48.29 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 23 3 # 23 179 ASP C 86 ASP^? 23.12 CL CL C 129 214 ASP C 72 ASP^? 28.53 CL CL B 129 289 ASP C 14 ASP^? 16.95 CL CL A 129 coo -0.62 65.95 29.97 0.31 67.47 31.05 98.39 56.19 -38.35 99.60 55.15 -36.99 coo 26.86 59.76 46.36 25.42 58.23 45.92 90.38 83.76 -50.64 91.24 82.68 -52.23 coo 9.42 68.07 30.27 7.35 68.27 30.10 95.50 58.88 -47.37 95.04 57.01 -48.29 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 24 3 # 24 179 ASP C 86 ASP^? 23.12 CL CL C 129 214 ASP D 30 ASP^? 20.62 CL CL D 129 289 ASP C 14 ASP^? 16.95 CL CL A 129 coo -0.62 65.95 29.97 0.31 67.47 31.05 98.39 56.19 -38.35 99.60 55.15 -36.99 coo 26.86 59.76 46.36 25.42 58.23 45.92 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 9.42 68.07 30.27 7.35 68.27 30.10 95.50 58.88 -47.37 95.04 57.01 -48.29 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 25 3 # 25 179 ASP D 5 ASP^? 32.88 CL CL D 129 214 ASP D 30 ASP^? 20.62 CL CL D 129 289 ASP D 86 ASP^? 23.19 CL CL D 129 coo -0.62 65.95 29.97 0.31 67.47 31.05 50.37 96.25 -41.36 49.69 98.16 -40.70 coo 26.86 59.76 46.36 25.42 58.23 45.92 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 9.42 68.07 30.27 7.35 68.27 30.10 60.79 94.39 -38.32 59.49 95.38 -36.98 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 26 3 # 26 179 ASP D 30 ASP^? 20.62 CL CL D 129 214 ASP B 14 ASP^? 27.62 CL CL A 129 289 ASP B 72 ASP^? 28.57 CL CL C 129 coo -0.62 65.95 29.97 0.31 67.47 31.05 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 26.86 59.76 46.36 25.42 58.23 45.92 105.60 69.00 -58.44 107.49 69.47 -57.66 coo 9.42 68.07 30.27 7.35 68.27 30.10 80.87 74.36 -54.99 81.74 73.36 -53.35 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 27 3 # 27 179 ASP D 35 ASP^? 10.18 CL CL D 129 214 ASP C 14 ASP^? 16.95 CL CL A 129 289 ASP D 30 ASP^? 20.62 CL CL D 129 coo -0.62 65.95 29.97 0.31 67.47 31.05 75.66 79.96 -36.93 75.99 80.66 -34.97 coo 26.86 59.76 46.36 25.42 58.23 45.92 95.50 58.88 -47.37 95.04 57.01 -48.29 coo 9.42 68.07 30.27 7.35 68.27 30.10 76.16 76.40 -45.40 77.49 78.05 -45.35 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 28 3 # 28 179 ASP D 86 ASP^? 23.19 CL CL D 129 214 ASP B 72 ASP^? 28.57 CL CL C 129 289 ASP D 14 ASP^? 27.52 CL CL D 129 coo -0.62 65.95 29.97 0.31 67.47 31.05 60.79 94.39 -38.32 59.49 95.38 -36.98 coo 26.86 59.76 46.36 25.42 58.23 45.92 80.87 74.36 -54.99 81.74 73.36 -53.35 coo 9.42 68.07 30.27 7.35 68.27 30.10 63.54 91.53 -47.18 63.81 93.48 -47.82 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 29 3 # 29 179 ASP D 86 ASP^? 23.19 CL CL D 129 214 ASP C 30 ASP^? 20.67 CL CL C 129 289 ASP D 14 ASP^? 27.52 CL CL D 129 coo -0.62 65.95 29.97 0.31 67.47 31.05 60.79 94.39 -38.32 59.49 95.38 -36.98 coo 26.86 59.76 46.36 25.42 58.23 45.92 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 9.42 68.07 30.27 7.35 68.27 30.10 63.54 91.53 -47.18 63.81 93.48 -47.82 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 30 3 # 30 179 ASP D 86 ASP^? 23.19 CL CL D 129 214 ASP D 72 ASP^? 29.64 CL CL D 129 289 ASP D 14 ASP^? 27.52 CL CL D 129 coo -0.62 65.95 29.97 0.31 67.47 31.05 60.79 94.39 -38.32 59.49 95.38 -36.98 coo 26.86 59.76 46.36 25.42 58.23 45.92 69.04 67.18 -50.81 68.23 68.38 -52.37 coo 9.42 68.07 30.27 7.35 68.27 30.10 63.54 91.53 -47.18 63.81 93.48 -47.82 1amy_c01 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 30 hits 1amy_c01 naa= 3 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 14 ASP~? 27.67 CL CL B 129 227 GLU A 36 GLU~? 18.47 CL CL A 129 289 ASP A 86 ASP.? 23.33 CL CL A 129 coo -0.62 65.95 29.97 0.31 67.47 31.05 105.70 54.30 -82.61 107.63 54.15 -83.44 coo 3.96 55.76 41.24 4.83 57.69 41.17 99.16 43.45 -76.17 99.38 43.10 -78.24 coo 9.42 68.07 30.27 7.35 68.27 30.10 108.46 57.22 -73.78 109.48 58.49 -72.45 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 35 ASP~? 10.31 CL CL A 129 227 GLU A 51 GLU^? 16.44 CL CL A 129 289 ASP A 30 ASP~? 20.80 CL CL A 129 coo -0.62 65.95 29.97 0.31 67.47 31.05 93.79 42.35 -72.20 94.79 41.97 -70.38 coo 3.96 55.76 41.24 4.83 57.69 41.17 82.00 50.89 -67.09 80.89 51.23 -68.89 coo 9.42 68.07 30.27 7.35 68.27 30.10 90.38 41.71 -80.87 92.04 40.39 -80.79 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP B 14 ASP^? 27.62 CL CL A 129 227 GLU B 36 GLU^? 18.40 CL CL B 129 289 ASP B 86 ASP^? 23.14 CL CL B 129 coo -0.62 65.95 29.97 0.31 67.47 31.05 105.60 69.00 -58.44 107.49 69.47 -57.66 coo 3.96 55.76 41.24 4.83 57.69 41.17 99.20 79.77 -64.83 99.58 80.60 -62.91 coo 9.42 68.07 30.27 7.35 68.27 30.10 108.40 66.17 -67.38 109.32 64.97 -68.84 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP B 35 ASP^? 10.19 CL CL B 129 227 GLU B 51 GLU^? 16.46 CL CL B 129 289 ASP B 30 ASP^? 20.91 CL CL B 129 coo -0.62 65.95 29.97 0.31 67.47 31.05 93.79 80.98 -68.72 94.61 81.32 -70.62 coo 3.96 55.76 41.24 4.83 57.69 41.17 81.98 72.56 -73.89 80.95 72.05 -72.12 coo 9.42 68.07 30.27 7.35 68.27 30.10 90.60 81.40 -60.16 92.15 82.83 -59.97 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 5 3 # 5 179 ASP B 72 ASP^? 28.57 CL CL C 129 227 GLU C 23 GLU^? 24.69 CL CL C 129 289 ASP D 30 ASP^? 20.62 CL CL D 129 coo -0.62 65.95 29.97 0.31 67.47 31.05 80.87 74.36 -54.99 81.74 73.36 -53.35 coo 3.96 55.76 41.24 4.83 57.69 41.17 93.85 75.25 -49.20 94.57 76.88 -48.00 coo 9.42 68.07 30.27 7.35 68.27 30.10 76.16 76.40 -45.40 77.49 78.05 -45.35 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 6 3 # 6 179 ASP B 72 ASP^? 28.57 CL CL C 129 227 GLU D 23 GLU^? 24.49 CL CL D 129 289 ASP C 30 ASP^? 20.67 CL CL C 129 coo -0.62 65.95 29.97 0.31 67.47 31.05 80.87 74.36 -54.99 81.74 73.36 -53.35 coo 3.96 55.76 41.24 4.83 57.69 41.17 65.41 75.40 -49.12 64.81 73.78 -47.86 coo 9.42 68.07 30.27 7.35 68.27 30.10 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 7 3 # 7 179 ASP C 14 ASP^? 16.95 CL CL A 129 227 GLU C 36 GLU^? 18.27 CL CL C 129 289 ASP C 86 ASP^? 23.12 CL CL C 129 coo -0.62 65.95 29.97 0.31 67.47 31.05 95.50 58.88 -47.37 95.04 57.01 -48.29 coo 3.96 55.76 41.24 4.83 57.69 41.17 84.85 65.27 -40.53 84.47 64.86 -42.56 coo 9.42 68.07 30.27 7.35 68.27 30.10 98.39 56.19 -38.35 99.60 55.15 -36.99 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 8 3 # 8 179 ASP C 30 ASP^? 20.67 CL CL C 129 227 GLU D 36 GLU^? 18.42 CL CL D 129 289 ASP B 72 ASP^? 28.57 CL CL C 129 coo -0.62 65.95 29.97 0.31 67.47 31.05 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 3.96 55.76 41.24 4.83 57.69 41.17 74.52 85.40 -40.74 74.64 85.74 -42.81 coo 9.42 68.07 30.27 7.35 68.27 30.10 80.87 74.36 -54.99 81.74 73.36 -53.35 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 9 3 # 9 179 ASP C 30 ASP^? 20.67 CL CL C 129 227 GLU D 36 GLU^? 18.42 CL CL D 129 289 ASP C 35 ASP^? 10.26 CL CL C 129 coo -0.62 65.95 29.97 0.31 67.47 31.05 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 3.96 55.76 41.24 4.83 57.69 41.17 74.52 85.40 -40.74 74.64 85.74 -42.81 coo 9.42 68.07 30.27 7.35 68.27 30.10 83.63 70.73 -36.85 83.32 69.81 -34.96 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 10 3 # 10 179 ASP C 35 ASP^? 10.26 CL CL C 129 227 GLU C 51 GLU^? 16.39 CL CL C 129 289 ASP C 30 ASP^? 20.67 CL CL C 129 coo -0.62 65.95 29.97 0.31 67.47 31.05 83.63 70.73 -36.85 83.32 69.81 -34.96 coo 3.96 55.76 41.24 4.83 57.69 41.17 92.20 82.64 -31.68 92.61 83.59 -33.56 coo 9.42 68.07 30.27 7.35 68.27 30.10 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 11 3 # 11 179 ASP C 35 ASP^? 10.26 CL CL C 129 227 GLU C 51 GLU^? 16.39 CL CL C 129 289 ASP D 35 ASP^? 10.18 CL CL D 129 coo -0.62 65.95 29.97 0.31 67.47 31.05 83.63 70.73 -36.85 83.32 69.81 -34.96 coo 3.96 55.76 41.24 4.83 57.69 41.17 92.20 82.64 -31.68 92.61 83.59 -33.56 coo 9.42 68.07 30.27 7.35 68.27 30.10 75.66 79.96 -36.93 75.99 80.66 -34.97 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 12 3 # 12 179 ASP C 35 ASP^? 10.26 CL CL C 129 227 GLU D 51 GLU^? 16.56 CL CL D 129 289 ASP D 35 ASP^? 10.18 CL CL D 129 coo -0.62 65.95 29.97 0.31 67.47 31.05 83.63 70.73 -36.85 83.32 69.81 -34.96 coo 3.96 55.76 41.24 4.83 57.69 41.17 66.99 68.03 -31.91 66.63 66.88 -33.67 coo 9.42 68.07 30.27 7.35 68.27 30.10 75.66 79.96 -36.93 75.99 80.66 -34.97 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 13 3 # 13 179 ASP D 14 ASP^? 27.52 CL CL D 129 227 GLU D 36 GLU^? 18.42 CL CL D 129 289 ASP D 86 ASP^? 23.19 CL CL D 129 coo -0.62 65.95 29.97 0.31 67.47 31.05 63.54 91.53 -47.18 63.81 93.48 -47.82 coo 3.96 55.76 41.24 4.83 57.69 41.17 74.52 85.40 -40.74 74.64 85.74 -42.81 coo 9.42 68.07 30.27 7.35 68.27 30.10 60.79 94.39 -38.32 59.49 95.38 -36.98 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 14 3 # 14 179 ASP D 30 ASP^? 20.62 CL CL D 129 227 GLU C 36 GLU^? 18.27 CL CL C 129 289 ASP B 72 ASP^? 28.57 CL CL C 129 coo -0.62 65.95 29.97 0.31 67.47 31.05 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 3.96 55.76 41.24 4.83 57.69 41.17 84.85 65.27 -40.53 84.47 64.86 -42.56 coo 9.42 68.07 30.27 7.35 68.27 30.10 80.87 74.36 -54.99 81.74 73.36 -53.35 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 15 3 # 15 179 ASP D 30 ASP^? 20.62 CL CL D 129 227 GLU C 36 GLU^? 18.27 CL CL C 129 289 ASP D 35 ASP^? 10.18 CL CL D 129 coo -0.62 65.95 29.97 0.31 67.47 31.05 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 3.96 55.76 41.24 4.83 57.69 41.17 84.85 65.27 -40.53 84.47 64.86 -42.56 coo 9.42 68.07 30.27 7.35 68.27 30.10 75.66 79.96 -36.93 75.99 80.66 -34.97 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 16 3 # 16 179 ASP D 35 ASP^? 10.18 CL CL D 129 227 GLU C 51 GLU^? 16.39 CL CL C 129 289 ASP C 35 ASP^? 10.26 CL CL C 129 coo -0.62 65.95 29.97 0.31 67.47 31.05 75.66 79.96 -36.93 75.99 80.66 -34.97 coo 3.96 55.76 41.24 4.83 57.69 41.17 92.20 82.64 -31.68 92.61 83.59 -33.56 coo 9.42 68.07 30.27 7.35 68.27 30.10 83.63 70.73 -36.85 83.32 69.81 -34.96 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 17 3 # 17 179 ASP D 35 ASP^? 10.18 CL CL D 129 227 GLU D 51 GLU^? 16.56 CL CL D 129 289 ASP C 35 ASP^? 10.26 CL CL C 129 coo -0.62 65.95 29.97 0.31 67.47 31.05 75.66 79.96 -36.93 75.99 80.66 -34.97 coo 3.96 55.76 41.24 4.83 57.69 41.17 66.99 68.03 -31.91 66.63 66.88 -33.67 coo 9.42 68.07 30.27 7.35 68.27 30.10 83.63 70.73 -36.85 83.32 69.81 -34.96 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 18 3 # 18 179 ASP D 35 ASP^? 10.18 CL CL D 129 227 GLU D 51 GLU^? 16.56 CL CL D 129 289 ASP D 30 ASP^? 20.62 CL CL D 129 coo -0.62 65.95 29.97 0.31 67.47 31.05 75.66 79.96 -36.93 75.99 80.66 -34.97 coo 3.96 55.76 41.24 4.83 57.69 41.17 66.99 68.03 -31.91 66.63 66.88 -33.67 coo 9.42 68.07 30.27 7.35 68.27 30.10 76.16 76.40 -45.40 77.49 78.05 -45.35 1amy_c06 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 18 hits 1amy_c06 naa= 3 ULMN 3 1aq2_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE user 1 3 # 1 232 HIS A 40 HIS.? 7.30 CL CL A 129 254 LYS A 43 LYS.? 9.42 CL CL A 129 333 ARG A 46 ARG^? 15.11 CL CL A 129 coo 28.11 -1.15 8.51 29.21 0.63 8.34 98.96 43.60 -66.18 98.11 41.92 -65.26 coo 26.09 4.87 14.60 27.89 3.33 10.26 96.70 52.33 -61.01 101.40 51.27 -59.62 coo 37.35 7.47 11.84 34.90 6.11 10.60 87.96 51.20 -70.32 85.08 51.60 -71.34 ULMN 3 1aq2_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE user 2 3 # 2 232 HIS B 40 HIS^? 7.04 CL CL B 129 254 LYS B 43 LYS^? 9.52 CL CL B 129 333 ARG B 46 ARG^? 15.06 CL CL B 129 coo 28.11 -1.15 8.51 29.21 0.63 8.34 98.79 79.91 -74.95 97.97 81.53 -75.99 coo 26.09 4.87 14.60 27.89 3.33 10.26 96.64 71.22 -80.00 101.30 72.05 -81.50 coo 37.35 7.47 11.84 34.90 6.11 10.60 87.96 72.13 -70.71 85.05 71.84 -69.78 ULMN 3 1aq2_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE user 3 3 # 3 232 HIS C 40 HIS^? 7.21 CL CL C 129 254 LYS C 43 LYS^? 9.54 CL CL C 129 333 ARG C 46 ARG^? 15.12 CL CL C 129 coo 28.11 -1.15 8.51 29.21 0.63 8.34 84.82 65.72 -30.75 83.18 66.51 -29.70 coo 26.09 4.87 14.60 27.89 3.33 10.26 93.55 67.94 -25.84 92.76 63.12 -24.35 coo 37.35 7.47 11.84 34.90 6.11 10.60 92.47 76.70 -34.87 92.87 79.50 -36.04 ULMN 3 1aq2_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE user 4 3 # 4 232 HIS D 40 HIS^? 7.31 CL CL D 129 254 LYS D 43 LYS^? 9.72 CL CL D 129 333 ARG D 46 ARG^? 15.13 CL CL D 129 coo 28.11 -1.15 8.51 29.21 0.63 8.34 74.49 84.96 -30.93 76.13 84.16 -29.90 coo 26.09 4.87 14.60 27.89 3.33 10.26 65.85 82.66 -25.79 66.37 87.54 -24.61 coo 37.35 7.47 11.84 34.90 6.11 10.60 66.74 73.93 -35.00 66.45 71.02 -36.02 1aq2_c00 source 1aq2 PHOSPHOENOLPYRUVATE CARBOXYKINASE : 4 hits 1aq2_c00 naa= 3 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 1 3 # 1 B 325 ARG A 21 ARG~? 20.44 CL CL A 129 B 342 ASP A 14 ASP~? 27.67 CL CL B 129 B 531 ARG A 117 ARG^? 16.03 CL CL A 129 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 98.35 46.51 -82.89 98.57 44.40 -80.63 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 105.70 54.30 -82.61 107.63 54.15 -83.44 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 100.59 48.03 -72.66 102.04 46.10 -74.59 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 2 3 # 2 B 325 ARG A 60 ARG~? 8.61 CL CL A 129 B 342 ASP A 41 ASP.? 7.60 CL CL A 129 B 531 ARG A 46 ARG^? 15.11 CL CL A 129 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 92.49 41.37 -66.87 95.11 39.81 -67.06 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 99.56 48.98 -63.34 100.43 49.52 -61.53 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 87.96 51.20 -70.32 85.08 51.60 -71.34 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 3 3 # 3 B 325 ARG A 66 ARG~? 18.83 CL CL A 129 B 342 ASP A 30 ASP~? 20.80 CL CL A 129 B 531 ARG A 73 ARG.? 22.19 CL CL A 129 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 82.10 46.84 -74.28 82.78 49.65 -75.31 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 83.82 53.79 -81.61 86.00 54.30 -79.51 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 4 3 # 4 B 325 ARG A 66 ARG~? 18.83 CL CL A 129 B 342 ASP A 30 ASP~? 20.80 CL CL A 129 B 531 ARG A 96 ARG.? 24.34 CL CL A 129 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 82.10 46.84 -74.28 82.78 49.65 -75.31 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 78.03 52.93 -81.60 80.41 52.60 -79.67 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 5 3 # 5 B 325 ARG A 73 ARG.? 22.19 CL CL A 129 B 342 ASP A 30 ASP~? 20.80 CL CL A 129 B 531 ARG A 46 ARG^? 15.11 CL CL A 129 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 83.82 53.79 -81.61 86.00 54.30 -79.51 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 87.96 51.20 -70.32 85.08 51.60 -71.34 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 6 3 # 6 B 325 ARG B 21 ARG^? 20.28 CL CL B 129 B 342 ASP B 14 ASP^? 27.62 CL CL A 129 B 531 ARG C 76 ARG^? 33.92 CL CL B 129 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 98.33 76.92 -58.24 98.68 79.03 -60.54 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 105.60 69.00 -58.44 107.49 69.47 -57.66 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 105.54 81.89 -51.05 106.65 84.23 -49.40 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 7 3 # 7 B 325 ARG B 21 ARG^? 20.28 CL CL B 129 B 342 ASP C 72 ASP^? 28.53 CL CL B 129 B 531 ARG C 76 ARG^? 33.92 CL CL B 129 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 98.33 76.92 -58.24 98.68 79.03 -60.54 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 90.38 83.76 -50.64 91.24 82.68 -52.23 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 105.54 81.89 -51.05 106.65 84.23 -49.40 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 8 3 # 8 B 325 ARG B 60 ARG^? 8.76 CL CL B 129 B 342 ASP B 41 ASP^? 7.64 CL CL B 129 B 531 ARG B 46 ARG^? 15.06 CL CL B 129 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 92.45 82.18 -73.93 95.13 83.66 -73.65 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 99.50 74.51 -77.69 100.41 73.95 -79.49 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 87.96 72.13 -70.71 85.05 71.84 -69.78 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 9 3 # 9 B 325 ARG B 66 ARG^? 19.13 CL CL B 129 B 342 ASP B 30 ASP^? 20.91 CL CL B 129 B 531 ARG B 73 ARG^? 22.29 CL CL B 129 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 82.06 76.49 -66.55 82.68 73.67 -65.41 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 83.86 69.55 -59.16 85.91 69.18 -61.42 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 10 3 # 10 B 325 ARG B 66 ARG^? 19.13 CL CL B 129 B 342 ASP B 30 ASP^? 20.91 CL CL B 129 B 531 ARG B 96 ARG^? 24.18 CL CL B 129 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 82.06 76.49 -66.55 82.68 73.67 -65.41 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 78.35 70.58 -59.29 80.55 70.83 -61.45 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 11 3 # 11 B 325 ARG B 73 ARG^? 22.29 CL CL B 129 B 342 ASP B 30 ASP^? 20.91 CL CL B 129 B 531 ARG B 46 ARG^? 15.06 CL CL B 129 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 83.86 69.55 -59.16 85.91 69.18 -61.42 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 87.96 72.13 -70.71 85.05 71.84 -69.78 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 12 3 # 12 B 325 ARG B 96 ARG^? 24.18 CL CL B 129 B 342 ASP D 72 ASP^? 29.64 CL CL D 129 B 531 ARG B 76 ARG^? 18.98 CL CL A 129 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 78.35 70.58 -59.29 80.55 70.83 -61.45 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 69.04 67.18 -50.81 68.23 68.38 -52.37 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 82.73 59.03 -54.76 80.31 57.91 -56.24 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 13 3 # 13 B 325 ARG C 21 ARG^? 20.59 CL CL C 129 B 342 ASP B 72 ASP^? 28.57 CL CL C 129 B 531 ARG B 76 ARG^? 18.98 CL CL A 129 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 87.78 66.49 -47.10 85.32 65.73 -45.33 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 80.87 74.36 -54.99 81.74 73.36 -53.35 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 82.73 59.03 -54.76 80.31 57.91 -56.24 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 14 3 # 14 B 325 ARG C 21 ARG^? 20.59 CL CL C 129 B 342 ASP C 14 ASP^? 16.95 CL CL A 129 B 531 ARG B 76 ARG^? 18.98 CL CL A 129 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 87.78 66.49 -47.10 85.32 65.73 -45.33 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 95.50 58.88 -47.37 95.04 57.01 -48.29 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 82.73 59.03 -54.76 80.31 57.91 -56.24 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 15 3 # 15 B 325 ARG C 21 ARG^? 20.59 CL CL C 129 B 342 ASP C 14 ASP^? 16.95 CL CL A 129 B 531 ARG C 117 ARG^? 16.02 CL CL C 129 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 87.78 66.49 -47.10 85.32 65.73 -45.33 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 95.50 58.88 -47.37 95.04 57.01 -48.29 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 89.36 64.01 -37.29 87.40 62.56 -39.24 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 16 3 # 16 B 325 ARG C 60 ARG^? 8.92 CL CL C 129 B 342 ASP C 41 ASP^? 7.58 CL CL C 129 B 531 ARG C 46 ARG^? 15.12 CL CL C 129 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 82.52 72.20 -31.52 80.97 69.57 -31.97 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 90.28 65.09 -27.98 90.77 64.12 -26.18 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 92.47 76.70 -34.87 92.87 79.50 -36.04 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 17 3 # 17 B 325 ARG C 63 ARG^? 14.10 CL CL C 129 B 342 ASP D 30 ASP^? 20.62 CL CL D 129 B 531 ARG D 60 ARG^? 8.57 CL CL D 129 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 86.96 77.03 -37.50 89.89 76.13 -38.00 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 76.65 78.50 -31.75 78.13 81.14 -31.78 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 18 3 # 18 B 325 ARG C 66 ARG^? 18.88 CL CL C 129 B 342 ASP C 30 ASP^? 20.67 CL CL C 129 B 531 ARG C 73 ARG^? 22.24 CL CL C 129 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 88.18 82.59 -38.84 90.98 81.94 -39.92 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 95.26 80.79 -46.47 95.45 78.63 -44.29 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 19 3 # 19 B 325 ARG C 66 ARG^? 18.88 CL CL C 129 B 342 ASP C 30 ASP^? 20.67 CL CL C 129 B 531 ARG C 96 ARG^? 24.31 CL CL C 129 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 88.18 82.59 -38.84 90.98 81.94 -39.92 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 94.28 86.51 -46.29 94.08 84.26 -44.17 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 20 3 # 20 B 325 ARG D 60 ARG^? 8.57 CL CL D 129 B 342 ASP D 41 ASP^? 7.55 CL CL D 129 B 531 ARG D 46 ARG^? 15.13 CL CL D 129 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 76.65 78.50 -31.75 78.13 81.14 -31.78 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 69.10 85.54 -28.07 68.60 86.44 -26.19 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 66.74 73.93 -35.00 66.45 71.02 -36.02 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 21 3 # 21 B 325 ARG D 63 ARG^? 14.07 CL CL D 129 B 342 ASP C 30 ASP^? 20.67 CL CL C 129 B 531 ARG C 60 ARG^? 8.92 CL CL C 129 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 72.33 73.68 -37.44 69.36 74.46 -37.99 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 82.52 72.20 -31.52 80.97 69.57 -31.97 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 22 3 # 22 B 325 ARG D 66 ARG^? 18.85 CL CL D 129 B 342 ASP D 30 ASP^? 20.62 CL CL D 129 B 531 ARG D 73 ARG^? 22.15 CL CL D 129 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 71.05 68.08 -38.82 68.22 68.66 -39.87 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 64.06 69.83 -46.45 63.93 71.88 -44.19 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 23 3 # 23 B 325 ARG D 66 ARG^? 18.85 CL CL D 129 B 342 ASP D 30 ASP^? 20.62 CL CL D 129 B 531 ARG D 96 ARG^? 24.04 CL CL D 129 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 71.05 68.08 -38.82 68.22 68.66 -39.87 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 64.79 64.44 -46.28 65.73 66.42 -44.08 1asy_c00 source 1asy TRANSFER RIBONUCLEIC ACID (TRNAASP) : 23 hits 1asy_c00 naa= 3 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 1 3 # 1 A 325 ARG A 46 ARG^? 15.11 CL CL A 129 A 342 ASP A 30 ASP~? 20.80 CL CL A 129 A 531 ARG A 60 ARG~? 8.61 CL CL A 129 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 87.96 51.20 -70.32 85.08 51.60 -71.34 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 92.49 41.37 -66.87 95.11 39.81 -67.06 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 2 3 # 2 A 325 ARG A 46 ARG^? 15.11 CL CL A 129 A 342 ASP A 30 ASP~? 20.80 CL CL A 129 A 531 ARG A 73 ARG.? 22.19 CL CL A 129 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 87.96 51.20 -70.32 85.08 51.60 -71.34 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 83.82 53.79 -81.61 86.00 54.30 -79.51 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 3 3 # 3 A 325 ARG A 46 ARG^? 15.11 CL CL A 129 A 342 ASP A 30 ASP~? 20.80 CL CL A 129 A 531 ARG A 117 ARG^? 16.03 CL CL A 129 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 87.96 51.20 -70.32 85.08 51.60 -71.34 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 100.59 48.03 -72.66 102.04 46.10 -74.59 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 4 3 # 4 A 325 ARG A 60 ARG~? 8.61 CL CL A 129 A 342 ASP A 30 ASP~? 20.80 CL CL A 129 A 531 ARG A 46 ARG^? 15.11 CL CL A 129 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 92.49 41.37 -66.87 95.11 39.81 -67.06 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 87.96 51.20 -70.32 85.08 51.60 -71.34 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 5 3 # 5 A 325 ARG A 60 ARG~? 8.61 CL CL A 129 A 342 ASP A 30 ASP~? 20.80 CL CL A 129 A 531 ARG A 117 ARG^? 16.03 CL CL A 129 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 92.49 41.37 -66.87 95.11 39.81 -67.06 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 100.59 48.03 -72.66 102.04 46.10 -74.59 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 6 3 # 6 A 325 ARG A 66 ARG~? 18.83 CL CL A 129 A 342 ASP A 30 ASP~? 20.80 CL CL A 129 A 531 ARG A 73 ARG.? 22.19 CL CL A 129 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 82.10 46.84 -74.28 82.78 49.65 -75.31 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 83.82 53.79 -81.61 86.00 54.30 -79.51 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 7 3 # 7 A 325 ARG A 66 ARG~? 18.83 CL CL A 129 A 342 ASP A 30 ASP~? 20.80 CL CL A 129 A 531 ARG A 96 ARG.? 24.34 CL CL A 129 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 82.10 46.84 -74.28 82.78 49.65 -75.31 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 78.03 52.93 -81.60 80.41 52.60 -79.67 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 8 3 # 8 A 325 ARG A 73 ARG.? 22.19 CL CL A 129 A 342 ASP A 30 ASP~? 20.80 CL CL A 129 A 531 ARG A 46 ARG^? 15.11 CL CL A 129 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 83.82 53.79 -81.61 86.00 54.30 -79.51 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 87.96 51.20 -70.32 85.08 51.60 -71.34 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 9 3 # 9 A 325 ARG A 117 ARG^? 16.03 CL CL A 129 A 342 ASP A 30 ASP~? 20.80 CL CL A 129 A 531 ARG A 46 ARG^? 15.11 CL CL A 129 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 100.59 48.03 -72.66 102.04 46.10 -74.59 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 87.96 51.20 -70.32 85.08 51.60 -71.34 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 10 3 # 10 A 325 ARG A 117 ARG^? 16.03 CL CL A 129 A 342 ASP A 30 ASP~? 20.80 CL CL A 129 A 531 ARG A 60 ARG~? 8.61 CL CL A 129 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 100.59 48.03 -72.66 102.04 46.10 -74.59 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 92.49 41.37 -66.87 95.11 39.81 -67.06 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 11 3 # 11 A 325 ARG B 21 ARG^? 20.28 CL CL B 129 A 342 ASP C 72 ASP^? 28.53 CL CL B 129 A 531 ARG C 76 ARG^? 33.92 CL CL B 129 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 98.33 76.92 -58.24 98.68 79.03 -60.54 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 90.38 83.76 -50.64 91.24 82.68 -52.23 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 105.54 81.89 -51.05 106.65 84.23 -49.40 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 12 3 # 12 A 325 ARG B 46 ARG^? 15.06 CL CL B 129 A 342 ASP B 30 ASP^? 20.91 CL CL B 129 A 531 ARG B 60 ARG^? 8.76 CL CL B 129 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 87.96 72.13 -70.71 85.05 71.84 -69.78 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 92.45 82.18 -73.93 95.13 83.66 -73.65 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 13 3 # 13 A 325 ARG B 46 ARG^? 15.06 CL CL B 129 A 342 ASP B 30 ASP^? 20.91 CL CL B 129 A 531 ARG B 73 ARG^? 22.29 CL CL B 129 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 87.96 72.13 -70.71 85.05 71.84 -69.78 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 83.86 69.55 -59.16 85.91 69.18 -61.42 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 14 3 # 14 A 325 ARG B 46 ARG^? 15.06 CL CL B 129 A 342 ASP B 30 ASP^? 20.91 CL CL B 129 A 531 ARG B 117 ARG^? 16.04 CL CL B 129 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 87.96 72.13 -70.71 85.05 71.84 -69.78 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 100.63 75.34 -68.25 102.08 77.36 -66.41 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 15 3 # 15 A 325 ARG B 60 ARG^? 8.76 CL CL B 129 A 342 ASP B 30 ASP^? 20.91 CL CL B 129 A 531 ARG B 46 ARG^? 15.06 CL CL B 129 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 92.45 82.18 -73.93 95.13 83.66 -73.65 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 87.96 72.13 -70.71 85.05 71.84 -69.78 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 16 3 # 16 A 325 ARG B 60 ARG^? 8.76 CL CL B 129 A 342 ASP B 30 ASP^? 20.91 CL CL B 129 A 531 ARG B 117 ARG^? 16.04 CL CL B 129 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 92.45 82.18 -73.93 95.13 83.66 -73.65 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 100.63 75.34 -68.25 102.08 77.36 -66.41 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 17 3 # 17 A 325 ARG B 66 ARG^? 19.13 CL CL B 129 A 342 ASP B 30 ASP^? 20.91 CL CL B 129 A 531 ARG B 73 ARG^? 22.29 CL CL B 129 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 82.06 76.49 -66.55 82.68 73.67 -65.41 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 83.86 69.55 -59.16 85.91 69.18 -61.42 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 18 3 # 18 A 325 ARG B 66 ARG^? 19.13 CL CL B 129 A 342 ASP B 30 ASP^? 20.91 CL CL B 129 A 531 ARG B 96 ARG^? 24.18 CL CL B 129 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 82.06 76.49 -66.55 82.68 73.67 -65.41 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 78.35 70.58 -59.29 80.55 70.83 -61.45 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 19 3 # 19 A 325 ARG B 73 ARG^? 22.29 CL CL B 129 A 342 ASP B 30 ASP^? 20.91 CL CL B 129 A 531 ARG B 46 ARG^? 15.06 CL CL B 129 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 83.86 69.55 -59.16 85.91 69.18 -61.42 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 87.96 72.13 -70.71 85.05 71.84 -69.78 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 20 3 # 20 A 325 ARG B 96 ARG^? 24.18 CL CL B 129 A 342 ASP D 72 ASP^? 29.64 CL CL D 129 A 531 ARG B 76 ARG^? 18.98 CL CL A 129 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 78.35 70.58 -59.29 80.55 70.83 -61.45 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 69.04 67.18 -50.81 68.23 68.38 -52.37 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 82.73 59.03 -54.76 80.31 57.91 -56.24 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 21 3 # 21 A 325 ARG B 117 ARG^? 16.04 CL CL B 129 A 342 ASP B 30 ASP^? 20.91 CL CL B 129 A 531 ARG B 46 ARG^? 15.06 CL CL B 129 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 100.63 75.34 -68.25 102.08 77.36 -66.41 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 87.96 72.13 -70.71 85.05 71.84 -69.78 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 22 3 # 22 A 325 ARG B 117 ARG^? 16.04 CL CL B 129 A 342 ASP B 30 ASP^? 20.91 CL CL B 129 A 531 ARG B 60 ARG^? 8.76 CL CL B 129 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 100.63 75.34 -68.25 102.08 77.36 -66.41 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 92.45 82.18 -73.93 95.13 83.66 -73.65 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 23 3 # 23 A 325 ARG C 21 ARG^? 20.59 CL CL C 129 A 342 ASP B 72 ASP^? 28.57 CL CL C 129 A 531 ARG B 76 ARG^? 18.98 CL CL A 129 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 87.78 66.49 -47.10 85.32 65.73 -45.33 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 80.87 74.36 -54.99 81.74 73.36 -53.35 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 82.73 59.03 -54.76 80.31 57.91 -56.24 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 24 3 # 24 A 325 ARG C 46 ARG^? 15.12 CL CL C 129 A 342 ASP C 30 ASP^? 20.67 CL CL C 129 A 531 ARG C 60 ARG^? 8.92 CL CL C 129 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 92.47 76.70 -34.87 92.87 79.50 -36.04 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 82.52 72.20 -31.52 80.97 69.57 -31.97 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 25 3 # 25 A 325 ARG C 46 ARG^? 15.12 CL CL C 129 A 342 ASP C 30 ASP^? 20.67 CL CL C 129 A 531 ARG C 73 ARG^? 22.24 CL CL C 129 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 92.47 76.70 -34.87 92.87 79.50 -36.04 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 95.26 80.79 -46.47 95.45 78.63 -44.29 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 26 3 # 26 A 325 ARG C 46 ARG^? 15.12 CL CL C 129 A 342 ASP C 30 ASP^? 20.67 CL CL C 129 A 531 ARG C 117 ARG^? 16.02 CL CL C 129 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 92.47 76.70 -34.87 92.87 79.50 -36.04 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 89.36 64.01 -37.29 87.40 62.56 -39.24 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 27 3 # 27 A 325 ARG C 60 ARG^? 8.92 CL CL C 129 A 342 ASP C 30 ASP^? 20.67 CL CL C 129 A 531 ARG C 46 ARG^? 15.12 CL CL C 129 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 82.52 72.20 -31.52 80.97 69.57 -31.97 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 92.47 76.70 -34.87 92.87 79.50 -36.04 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 28 3 # 28 A 325 ARG C 60 ARG^? 8.92 CL CL C 129 A 342 ASP C 30 ASP^? 20.67 CL CL C 129 A 531 ARG C 117 ARG^? 16.02 CL CL C 129 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 82.52 72.20 -31.52 80.97 69.57 -31.97 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 89.36 64.01 -37.29 87.40 62.56 -39.24 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 29 3 # 29 A 325 ARG C 60 ARG^? 8.92 CL CL C 129 A 342 ASP C 30 ASP^? 20.67 CL CL C 129 A 531 ARG D 63 ARG^? 14.07 CL CL D 129 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 82.52 72.20 -31.52 80.97 69.57 -31.97 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 72.33 73.68 -37.44 69.36 74.46 -37.99 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 30 3 # 30 A 325 ARG C 60 ARG^? 8.92 CL CL C 129 A 342 ASP C 41 ASP^? 7.58 CL CL C 129 A 531 ARG C 46 ARG^? 15.12 CL CL C 129 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 82.52 72.20 -31.52 80.97 69.57 -31.97 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 90.28 65.09 -27.98 90.77 64.12 -26.18 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 92.47 76.70 -34.87 92.87 79.50 -36.04 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 31 3 # 31 A 325 ARG C 63 ARG^? 14.10 CL CL C 129 A 342 ASP D 30 ASP^? 20.62 CL CL D 129 A 531 ARG D 60 ARG^? 8.57 CL CL D 129 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 86.96 77.03 -37.50 89.89 76.13 -38.00 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 76.65 78.50 -31.75 78.13 81.14 -31.78 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 32 3 # 32 A 325 ARG C 66 ARG^? 18.88 CL CL C 129 A 342 ASP C 30 ASP^? 20.67 CL CL C 129 A 531 ARG C 73 ARG^? 22.24 CL CL C 129 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 88.18 82.59 -38.84 90.98 81.94 -39.92 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 95.26 80.79 -46.47 95.45 78.63 -44.29 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 33 3 # 33 A 325 ARG C 66 ARG^? 18.88 CL CL C 129 A 342 ASP C 30 ASP^? 20.67 CL CL C 129 A 531 ARG C 96 ARG^? 24.31 CL CL C 129 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 88.18 82.59 -38.84 90.98 81.94 -39.92 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 94.28 86.51 -46.29 94.08 84.26 -44.17 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 34 3 # 34 A 325 ARG C 73 ARG^? 22.24 CL CL C 129 A 342 ASP C 30 ASP^? 20.67 CL CL C 129 A 531 ARG C 46 ARG^? 15.12 CL CL C 129 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 95.26 80.79 -46.47 95.45 78.63 -44.29 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 92.47 76.70 -34.87 92.87 79.50 -36.04 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 35 3 # 35 A 325 ARG C 117 ARG^? 16.02 CL CL C 129 A 342 ASP C 30 ASP^? 20.67 CL CL C 129 A 531 ARG C 46 ARG^? 15.12 CL CL C 129 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 89.36 64.01 -37.29 87.40 62.56 -39.24 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 92.47 76.70 -34.87 92.87 79.50 -36.04 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 36 3 # 36 A 325 ARG C 117 ARG^? 16.02 CL CL C 129 A 342 ASP C 30 ASP^? 20.67 CL CL C 129 A 531 ARG C 60 ARG^? 8.92 CL CL C 129 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 89.36 64.01 -37.29 87.40 62.56 -39.24 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 82.52 72.20 -31.52 80.97 69.57 -31.97 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 37 3 # 37 A 325 ARG D 46 ARG^? 15.13 CL CL D 129 A 342 ASP D 30 ASP^? 20.62 CL CL D 129 A 531 ARG D 60 ARG^? 8.57 CL CL D 129 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 66.74 73.93 -35.00 66.45 71.02 -36.02 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 76.65 78.50 -31.75 78.13 81.14 -31.78 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 38 3 # 38 A 325 ARG D 46 ARG^? 15.13 CL CL D 129 A 342 ASP D 30 ASP^? 20.62 CL CL D 129 A 531 ARG D 73 ARG^? 22.15 CL CL D 129 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 66.74 73.93 -35.00 66.45 71.02 -36.02 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 64.06 69.83 -46.45 63.93 71.88 -44.19 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 39 3 # 39 A 325 ARG D 46 ARG^? 15.13 CL CL D 129 A 342 ASP D 30 ASP^? 20.62 CL CL D 129 A 531 ARG D 117 ARG^? 15.96 CL CL D 129 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 66.74 73.93 -35.00 66.45 71.02 -36.02 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 69.91 86.62 -37.36 71.94 88.06 -39.21 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 40 3 # 40 A 325 ARG D 60 ARG^? 8.57 CL CL D 129 A 342 ASP D 30 ASP^? 20.62 CL CL D 129 A 531 ARG C 63 ARG^? 14.10 CL CL C 129 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 76.65 78.50 -31.75 78.13 81.14 -31.78 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 86.96 77.03 -37.50 89.89 76.13 -38.00 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 41 3 # 41 A 325 ARG D 60 ARG^? 8.57 CL CL D 129 A 342 ASP D 30 ASP^? 20.62 CL CL D 129 A 531 ARG D 46 ARG^? 15.13 CL CL D 129 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 76.65 78.50 -31.75 78.13 81.14 -31.78 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 66.74 73.93 -35.00 66.45 71.02 -36.02 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 42 3 # 42 A 325 ARG D 60 ARG^? 8.57 CL CL D 129 A 342 ASP D 30 ASP^? 20.62 CL CL D 129 A 531 ARG D 117 ARG^? 15.96 CL CL D 129 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 76.65 78.50 -31.75 78.13 81.14 -31.78 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 69.91 86.62 -37.36 71.94 88.06 -39.21 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 43 3 # 43 A 325 ARG D 63 ARG^? 14.07 CL CL D 129 A 342 ASP C 30 ASP^? 20.67 CL CL C 129 A 531 ARG C 60 ARG^? 8.92 CL CL C 129 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 72.33 73.68 -37.44 69.36 74.46 -37.99 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 82.52 72.20 -31.52 80.97 69.57 -31.97 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 44 3 # 44 A 325 ARG D 66 ARG^? 18.85 CL CL D 129 A 342 ASP D 30 ASP^? 20.62 CL CL D 129 A 531 ARG D 73 ARG^? 22.15 CL CL D 129 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 71.05 68.08 -38.82 68.22 68.66 -39.87 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 64.06 69.83 -46.45 63.93 71.88 -44.19 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 45 3 # 45 A 325 ARG D 66 ARG^? 18.85 CL CL D 129 A 342 ASP D 30 ASP^? 20.62 CL CL D 129 A 531 ARG D 96 ARG^? 24.04 CL CL D 129 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 71.05 68.08 -38.82 68.22 68.66 -39.87 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 64.79 64.44 -46.28 65.73 66.42 -44.08 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 46 3 # 46 A 325 ARG D 73 ARG^? 22.15 CL CL D 129 A 342 ASP D 30 ASP^? 20.62 CL CL D 129 A 531 ARG D 46 ARG^? 15.13 CL CL D 129 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 64.06 69.83 -46.45 63.93 71.88 -44.19 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 66.74 73.93 -35.00 66.45 71.02 -36.02 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 47 3 # 47 A 325 ARG D 117 ARG^? 15.96 CL CL D 129 A 342 ASP D 30 ASP^? 20.62 CL CL D 129 A 531 ARG D 46 ARG^? 15.13 CL CL D 129 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 69.91 86.62 -37.36 71.94 88.06 -39.21 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 66.74 73.93 -35.00 66.45 71.02 -36.02 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 48 3 # 48 A 325 ARG D 117 ARG^? 15.96 CL CL D 129 A 342 ASP D 30 ASP^? 20.62 CL CL D 129 A 531 ARG D 60 ARG^? 8.57 CL CL D 129 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 69.91 86.62 -37.36 71.94 88.06 -39.21 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 76.65 78.50 -31.75 78.13 81.14 -31.78 1asy_c01 source 1asy TRANSFER RIBONUCLEIC ACID (TRNAASP) : 48 hits 1asy_c01 naa= 3 ULMN 3 1ax4_c04 TRYPTOPHANASE user 1 3 # 1 A 130 PHE B 38 PHE^? 11.74 CL CL B 129 A 223 ASP B 30 ASP^? 20.91 CL CL B 129 A 265 LYS C 24 LYS^? 26.64 CL CL C 129 coo 39.74 52.86 65.74 41.15 55.14 66.52 93.75 74.07 -69.88 91.89 72.11 -69.38 coo 30.70 47.50 67.53 29.83 49.47 67.39 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 19.99 54.53 64.11 20.55 58.78 68.33 88.99 74.10 -49.29 84.03 71.99 -51.83 ULMN 3 1ax4_c04 TRYPTOPHANASE user 2 3 # 2 A 130 PHE C 38 PHE^? 11.87 CL CL C 129 A 223 ASP C 30 ASP^? 20.67 CL CL C 129 A 265 LYS B 24 LYS^? 27.82 CL CL B 129 coo 39.74 52.86 65.74 41.15 55.14 66.52 90.71 70.84 -35.90 92.71 72.72 -36.44 coo 30.70 47.50 67.53 29.83 49.47 67.39 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 19.99 54.53 64.11 20.55 58.78 68.33 90.54 75.59 -56.27 92.78 80.12 -52.52 1ax4_c04 source 1ax4 TRYPTOPHANASE : 2 hits 1ax4_c04 naa= 3 ULMN 3 1ax4_c05 TRYPTOPHANASE user 1 3 # 1 B 130 PHE B 38 PHE^? 11.74 CL CL B 129 B 223 ASP B 30 ASP^? 20.91 CL CL B 129 B 265 LYS C 24 LYS^? 26.64 CL CL C 129 coo 7.48 54.94 99.62 7.67 52.27 100.42 93.75 74.07 -69.88 91.89 72.11 -69.38 coo 10.43 61.66 91.81 9.80 60.04 90.61 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 5.43 58.06 80.08 8.57 53.00 79.37 88.99 74.10 -49.29 84.03 71.99 -51.83 ULMN 3 1ax4_c05 TRYPTOPHANASE user 2 3 # 2 B 130 PHE C 38 PHE^? 11.87 CL CL C 129 B 223 ASP C 30 ASP^? 20.67 CL CL C 129 B 265 LYS B 24 LYS^? 27.82 CL CL B 129 coo 7.48 54.94 99.62 7.67 52.27 100.42 90.71 70.84 -35.90 92.71 72.72 -36.44 coo 10.43 61.66 91.81 9.80 60.04 90.61 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 5.43 58.06 80.08 8.57 53.00 79.37 90.54 75.59 -56.27 92.78 80.12 -52.52 1ax4_c05 source 1ax4 TRYPTOPHANASE : 2 hits 1ax4_c05 naa= 3 ULMN 3 1ax4_c06 TRYPTOPHANASE user 1 3 # 1 C 130 PHE B 38 PHE^? 11.74 CL CL B 129 C 223 ASP B 30 ASP^? 20.91 CL CL B 129 C 265 LYS C 24 LYS^? 26.64 CL CL C 129 coo -6.55 73.45 23.60 -6.77 71.48 21.66 93.75 74.07 -69.88 91.89 72.11 -69.38 coo -9.52 75.74 33.62 -8.85 73.74 33.93 90.60 81.40 -60.16 92.15 82.83 -59.97 coo -4.44 67.20 42.32 -7.50 62.41 40.49 88.99 74.10 -49.29 84.03 71.99 -51.83 ULMN 3 1ax4_c06 TRYPTOPHANASE user 2 3 # 2 C 130 PHE C 38 PHE^? 11.87 CL CL C 129 C 223 ASP C 30 ASP^? 20.67 CL CL C 129 C 265 LYS B 24 LYS^? 27.82 CL CL B 129 coo -6.55 73.45 23.60 -6.77 71.48 21.66 90.71 70.84 -35.90 92.71 72.72 -36.44 coo -9.52 75.74 33.62 -8.85 73.74 33.93 83.14 74.18 -45.33 81.79 72.55 -45.31 coo -4.44 67.20 42.32 -7.50 62.41 40.49 90.54 75.59 -56.27 92.78 80.12 -52.52 1ax4_c06 source 1ax4 TRYPTOPHANASE : 2 hits 1ax4_c06 naa= 3 ULMN 3 1ax4_c07 TRYPTOPHANASE user 1 3 # 1 D 130 PHE B 38 PHE^? 11.74 CL CL B 129 D 223 ASP B 30 ASP^? 20.91 CL CL B 129 D 265 LYS C 24 LYS^? 26.64 CL CL C 129 coo -38.60 55.38 52.70 -40.06 57.72 53.04 93.75 74.07 -69.88 91.89 72.11 -69.38 coo -29.46 51.67 48.51 -28.63 53.31 49.56 90.60 81.40 -60.16 92.15 82.83 -59.97 coo -18.87 56.53 54.79 -19.47 62.22 53.03 88.99 74.10 -49.29 84.03 71.99 -51.83 ULMN 3 1ax4_c07 TRYPTOPHANASE user 2 3 # 2 D 130 PHE C 38 PHE^? 11.87 CL CL C 129 D 223 ASP C 30 ASP^? 20.67 CL CL C 129 D 265 LYS B 24 LYS^? 27.82 CL CL B 129 coo -38.60 55.38 52.70 -40.06 57.72 53.04 90.71 70.84 -35.90 92.71 72.72 -36.44 coo -29.46 51.67 48.51 -28.63 53.31 49.56 83.14 74.18 -45.33 81.79 72.55 -45.31 coo -18.87 56.53 54.79 -19.47 62.22 53.03 90.54 75.59 -56.27 92.78 80.12 -52.52 1ax4_c07 source 1ax4 TRYPTOPHANASE : 2 hits 1ax4_c07 naa= 3 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 1 3 # 1 A 109 ASP C 30 ASP^? 20.67 CL CL C 129 A 182 GLU C 36 GLU^? 18.27 CL CL C 129 A 286 ASN D 29 ASN^? 19.54 CL CL D 129 coo 26.03 44.66 108.90 25.67 42.61 108.82 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 18.06 44.02 105.38 18.08 45.37 107.03 84.85 65.27 -40.53 84.47 64.86 -42.56 coo 25.47 38.28 112.06 27.26 39.30 111.54 75.38 70.46 -44.12 75.55 70.12 -42.00 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 2 3 # 2 A 109 ASP D 30 ASP^? 20.62 CL CL D 129 A 182 GLU D 36 GLU^? 18.42 CL CL D 129 A 286 ASN C 29 ASN^? 19.55 CL CL C 129 coo 26.03 44.66 108.90 25.67 42.61 108.82 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 18.06 44.02 105.38 18.08 45.37 107.03 74.52 85.40 -40.74 74.64 85.74 -42.81 coo 25.47 38.28 112.06 27.26 39.30 111.54 83.86 80.07 -44.03 83.70 80.47 -41.95 1b57_c00 source 1b57 FRUCTOSE-BISPHOSPHATE ALDOLASE II : 2 hits 1b57_c00 naa= 3 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 1 3 # 1 B 109 ASP C 30 ASP^? 20.67 CL CL C 129 B 182 GLU C 36 GLU^? 18.27 CL CL C 129 B 286 ASN D 29 ASN^? 19.54 CL CL D 129 coo 13.82 69.26 132.27 11.87 70.14 132.51 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 8.74 63.05 136.42 9.87 62.19 134.79 84.85 65.27 -40.53 84.47 64.86 -42.56 coo 8.26 72.60 129.22 10.14 73.45 129.80 75.38 70.46 -44.12 75.55 70.12 -42.00 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 2 3 # 2 B 109 ASP D 30 ASP^? 20.62 CL CL D 129 B 182 GLU D 36 GLU^? 18.42 CL CL D 129 B 286 ASN C 29 ASN^? 19.55 CL CL C 129 coo 13.82 69.26 132.27 11.87 70.14 132.51 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 8.74 63.05 136.42 9.87 62.19 134.79 74.52 85.40 -40.74 74.64 85.74 -42.81 coo 8.26 72.60 129.22 10.14 73.45 129.80 83.86 80.07 -44.03 83.70 80.47 -41.95 1b57_c01 source 1b57 FRUCTOSE-BISPHOSPHATE ALDOLASE II : 2 hits 1b57_c01 naa= 3 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 1 3 # 1 A 133 GLU A 58 GLU~? 7.41 CL CL A 129 B 88 ASP D 86 ASP^? 23.19 CL CL D 129 B 89 HIS D 85 HIS^? 27.00 CL CL D 129 coo 44.53 38.98 5.35 43.53 40.60 6.22 87.85 46.74 -60.89 87.27 48.56 -59.93 coo 58.74 13.49 55.78 58.72 14.38 57.67 60.79 94.39 -38.32 59.49 95.38 -36.98 coo 60.89 12.20 60.42 60.43 13.81 61.68 58.77 98.13 -40.30 58.69 99.11 -38.44 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 2 3 # 2 A 133 GLU D 51 GLU^? 16.56 CL CL D 129 B 88 ASP A 86 ASP.? 23.33 CL CL A 129 B 89 HIS A 85 HIS.? 26.94 CL CL B 129 coo 44.53 38.98 5.35 43.53 40.60 6.22 66.99 68.03 -31.91 66.63 66.88 -33.67 coo 58.74 13.49 55.78 58.72 14.38 57.67 108.46 57.22 -73.78 109.48 58.49 -72.45 coo 60.89 12.20 60.42 60.43 13.81 61.68 112.09 59.31 -75.65 113.04 59.28 -73.77 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 3 3 # 3 A 133 GLU D 93 GLU^? 31.46 CL CL D 129 B 88 ASP B 86 ASP^? 23.14 CL CL B 129 B 89 HIS B 85 HIS^? 26.88 CL CL A 129 coo 44.53 38.98 5.35 43.53 40.60 6.22 53.41 70.78 -45.84 51.64 70.26 -46.90 coo 58.74 13.49 55.78 58.72 14.38 57.67 108.40 66.17 -67.38 109.32 64.97 -68.84 coo 60.89 12.20 60.42 60.43 13.81 61.68 111.98 64.21 -65.30 113.02 64.33 -67.11 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 4 3 # 4 A 133 GLU D 114 GLU^? 14.88 CL CL D 129 B 88 ASP A 41 ASP.? 7.60 CL CL A 129 B 89 HIS A 40 HIS.? 7.30 CL CL A 129 coo 44.53 38.98 5.35 43.53 40.60 6.22 72.08 90.81 -36.72 71.29 91.48 -34.84 coo 58.74 13.49 55.78 58.72 14.38 57.67 99.56 48.98 -63.34 100.43 49.52 -61.53 coo 60.89 12.20 60.42 60.43 13.81 61.68 98.96 43.60 -66.18 98.11 41.92 -65.26 1b66_c00 source 1b66 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASE : 4 hits 1b66_c00 naa= 3 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 1 3 # 1 A 133 GLU A 58 GLU~? 7.41 CL CL A 129 B 88 ASP D 86 ASP^? 23.19 CL CL D 129 B 89 HIS D 85 HIS^? 27.00 CL CL D 129 coo 44.53 38.98 5.35 43.53 40.60 6.22 87.85 46.74 -60.89 87.27 48.56 -59.93 coo 58.74 13.49 55.78 58.72 14.38 57.67 60.79 94.39 -38.32 59.49 95.38 -36.98 coo 60.89 12.20 60.42 60.43 13.81 61.68 58.77 98.13 -40.30 58.69 99.11 -38.44 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 2 3 # 2 A 133 GLU D 51 GLU^? 16.56 CL CL D 129 B 88 ASP A 86 ASP.? 23.33 CL CL A 129 B 89 HIS A 85 HIS.? 26.94 CL CL B 129 coo 44.53 38.98 5.35 43.53 40.60 6.22 66.99 68.03 -31.91 66.63 66.88 -33.67 coo 58.74 13.49 55.78 58.72 14.38 57.67 108.46 57.22 -73.78 109.48 58.49 -72.45 coo 60.89 12.20 60.42 60.43 13.81 61.68 112.09 59.31 -75.65 113.04 59.28 -73.77 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 3 3 # 3 A 133 GLU D 93 GLU^? 31.46 CL CL D 129 B 88 ASP B 86 ASP^? 23.14 CL CL B 129 B 89 HIS B 85 HIS^? 26.88 CL CL A 129 coo 44.53 38.98 5.35 43.53 40.60 6.22 53.41 70.78 -45.84 51.64 70.26 -46.90 coo 58.74 13.49 55.78 58.72 14.38 57.67 108.40 66.17 -67.38 109.32 64.97 -68.84 coo 60.89 12.20 60.42 60.43 13.81 61.68 111.98 64.21 -65.30 113.02 64.33 -67.11 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 4 3 # 4 A 133 GLU D 114 GLU^? 14.88 CL CL D 129 B 88 ASP A 41 ASP.? 7.60 CL CL A 129 B 89 HIS A 40 HIS.? 7.30 CL CL A 129 coo 44.53 38.98 5.35 43.53 40.60 6.22 72.08 90.81 -36.72 71.29 91.48 -34.84 coo 58.74 13.49 55.78 58.72 14.38 57.67 99.56 48.98 -63.34 100.43 49.52 -61.53 coo 60.89 12.20 60.42 60.43 13.81 61.68 98.96 43.60 -66.18 98.11 41.92 -65.26 1b66_c02 source 1b66 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASE : 4 hits 1b66_c02 naa= 3 ULMN 3 1b6t_c00 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 1 3 # 1 A 18 HIS A 122 HIS^? 19.05 CL CL A 129 A 91 ARG A 104 ARG^? 18.53 CL CL B 129 A 129 SER A 124 SER^? 21.51 CL CL B 129 coo 24.39 47.01 49.70 26.42 47.04 49.21 86.83 60.37 -69.40 85.20 61.24 -68.40 coo 25.98 44.20 42.23 28.53 42.98 43.43 82.19 63.80 -76.53 82.09 65.30 -73.83 coo 30.00 49.76 45.68 28.73 48.72 47.47 81.71 59.41 -72.63 82.35 61.73 -72.29 ULMN 3 1b6t_c00 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 2 3 # 2 A 18 HIS A 122 HIS^? 19.05 CL CL A 129 A 91 ARG A 104 ARG^? 18.53 CL CL B 129 A 129 SER B 124 SER^? 21.49 CL CL A 129 coo 24.39 47.01 49.70 26.42 47.04 49.21 86.83 60.37 -69.40 85.20 61.24 -68.40 coo 25.98 44.20 42.23 28.53 42.98 43.43 82.19 63.80 -76.53 82.09 65.30 -73.83 coo 30.00 49.76 45.68 28.73 48.72 47.47 81.67 64.01 -68.38 82.23 61.67 -68.72 ULMN 3 1b6t_c00 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 3 3 # 3 A 18 HIS A 122 HIS^? 19.05 CL CL A 129 A 91 ARG B 104 ARG^? 18.51 CL CL A 129 A 129 SER A 124 SER^? 21.51 CL CL B 129 coo 24.39 47.01 49.70 26.42 47.04 49.21 86.83 60.37 -69.40 85.20 61.24 -68.40 coo 25.98 44.20 42.23 28.53 42.98 43.43 82.09 59.72 -64.70 82.21 58.19 -67.39 coo 30.00 49.76 45.68 28.73 48.72 47.47 81.71 59.41 -72.63 82.35 61.73 -72.29 ULMN 3 1b6t_c00 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 4 3 # 4 A 18 HIS B 122 HIS^? 19.12 CL CL B 129 A 91 ARG A 104 ARG^? 18.53 CL CL B 129 A 129 SER A 124 SER^? 21.51 CL CL B 129 coo 24.39 47.01 49.70 26.42 47.04 49.21 86.93 63.10 -71.62 85.35 62.06 -72.53 coo 25.98 44.20 42.23 28.53 42.98 43.43 82.19 63.80 -76.53 82.09 65.30 -73.83 coo 30.00 49.76 45.68 28.73 48.72 47.47 81.71 59.41 -72.63 82.35 61.73 -72.29 ULMN 3 1b6t_c00 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 5 3 # 5 A 18 HIS B 122 HIS^? 19.12 CL CL B 129 A 91 ARG A 104 ARG^? 18.53 CL CL B 129 A 129 SER B 124 SER^? 21.49 CL CL A 129 coo 24.39 47.01 49.70 26.42 47.04 49.21 86.93 63.10 -71.62 85.35 62.06 -72.53 coo 25.98 44.20 42.23 28.53 42.98 43.43 82.19 63.80 -76.53 82.09 65.30 -73.83 coo 30.00 49.76 45.68 28.73 48.72 47.47 81.67 64.01 -68.38 82.23 61.67 -68.72 ULMN 3 1b6t_c00 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 6 3 # 6 A 18 HIS B 122 HIS^? 19.12 CL CL B 129 A 91 ARG B 104 ARG^? 18.51 CL CL A 129 A 129 SER A 124 SER^? 21.51 CL CL B 129 coo 24.39 47.01 49.70 26.42 47.04 49.21 86.93 63.10 -71.62 85.35 62.06 -72.53 coo 25.98 44.20 42.23 28.53 42.98 43.43 82.09 59.72 -64.70 82.21 58.19 -67.39 coo 30.00 49.76 45.68 28.73 48.72 47.47 81.71 59.41 -72.63 82.35 61.73 -72.29 ULMN 3 1b6t_c00 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 7 3 # 7 A 18 HIS C 122 HIS^? 19.06 CL CL C 129 A 91 ARG C 104 ARG^? 26.38 CL CL C 129 A 129 SER C 124 SER^? 23.20 CL CL C 129 coo 24.39 47.01 49.70 26.42 47.04 49.21 101.68 77.71 -34.10 102.65 79.31 -33.15 coo 25.98 44.20 42.23 28.53 42.98 43.43 105.08 82.46 -41.08 106.56 82.47 -38.36 coo 30.00 49.76 45.68 28.73 48.72 47.47 100.74 82.83 -37.31 103.10 82.20 -37.27 1b6t_c00 source 1b6t PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE : 7 hits 1b6t_c00 naa= 3 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 1 3 # 1 B 18 HIS A 122 HIS^? 19.05 CL CL A 129 B 91 ARG A 46 ARG^? 15.11 CL CL A 129 B 129 SER A 124 SER^? 21.51 CL CL B 129 coo 18.19 17.03 40.71 18.55 17.18 38.64 86.83 60.37 -69.40 85.20 61.24 -68.40 coo 25.60 21.10 38.54 23.57 20.93 36.25 87.96 51.20 -70.32 85.08 51.60 -71.34 coo 21.33 14.29 34.62 19.25 14.88 35.71 81.71 59.41 -72.63 82.35 61.73 -72.29 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 2 3 # 2 B 18 HIS A 122 HIS^? 19.05 CL CL A 129 B 91 ARG A 104 ARG^? 18.53 CL CL B 129 B 129 SER B 124 SER^? 21.49 CL CL A 129 coo 18.19 17.03 40.71 18.55 17.18 38.64 86.83 60.37 -69.40 85.20 61.24 -68.40 coo 25.60 21.10 38.54 23.57 20.93 36.25 82.19 63.80 -76.53 82.09 65.30 -73.83 coo 21.33 14.29 34.62 19.25 14.88 35.71 81.67 64.01 -68.38 82.23 61.67 -68.72 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 3 3 # 3 B 18 HIS A 122 HIS^? 19.05 CL CL A 129 B 91 ARG B 104 ARG^? 18.51 CL CL A 129 B 129 SER A 124 SER^? 21.51 CL CL B 129 coo 18.19 17.03 40.71 18.55 17.18 38.64 86.83 60.37 -69.40 85.20 61.24 -68.40 coo 25.60 21.10 38.54 23.57 20.93 36.25 82.09 59.72 -64.70 82.21 58.19 -67.39 coo 21.33 14.29 34.62 19.25 14.88 35.71 81.71 59.41 -72.63 82.35 61.73 -72.29 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 4 3 # 4 B 18 HIS A 122 HIS^? 19.05 CL CL A 129 B 91 ARG B 104 ARG^? 18.51 CL CL A 129 B 129 SER B 91 SER^? 14.45 CL CL A 129 coo 18.19 17.03 40.71 18.55 17.18 38.64 86.83 60.37 -69.40 85.20 61.24 -68.40 coo 25.60 21.10 38.54 23.57 20.93 36.25 82.09 59.72 -64.70 82.21 58.19 -67.39 coo 21.33 14.29 34.62 19.25 14.88 35.71 91.67 61.18 -62.59 92.49 59.52 -64.12 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 5 3 # 5 B 18 HIS B 122 HIS^? 19.12 CL CL B 129 B 91 ARG A 104 ARG^? 18.53 CL CL B 129 B 129 SER A 91 SER.? 14.42 CL CL B 129 coo 18.19 17.03 40.71 18.55 17.18 38.64 86.93 63.10 -71.62 85.35 62.06 -72.53 coo 25.60 21.10 38.54 23.57 20.93 36.25 82.19 63.80 -76.53 82.09 65.30 -73.83 coo 21.33 14.29 34.62 19.25 14.88 35.71 91.69 62.31 -78.52 92.31 64.05 -76.96 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 6 3 # 6 B 18 HIS B 122 HIS^? 19.12 CL CL B 129 B 91 ARG A 104 ARG^? 18.53 CL CL B 129 B 129 SER B 124 SER^? 21.49 CL CL A 129 coo 18.19 17.03 40.71 18.55 17.18 38.64 86.93 63.10 -71.62 85.35 62.06 -72.53 coo 25.60 21.10 38.54 23.57 20.93 36.25 82.19 63.80 -76.53 82.09 65.30 -73.83 coo 21.33 14.29 34.62 19.25 14.88 35.71 81.67 64.01 -68.38 82.23 61.67 -68.72 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 7 3 # 7 B 18 HIS B 122 HIS^? 19.12 CL CL B 129 B 91 ARG B 46 ARG^? 15.06 CL CL B 129 B 129 SER B 124 SER^? 21.49 CL CL A 129 coo 18.19 17.03 40.71 18.55 17.18 38.64 86.93 63.10 -71.62 85.35 62.06 -72.53 coo 25.60 21.10 38.54 23.57 20.93 36.25 87.96 72.13 -70.71 85.05 71.84 -69.78 coo 21.33 14.29 34.62 19.25 14.88 35.71 81.67 64.01 -68.38 82.23 61.67 -68.72 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 8 3 # 8 B 18 HIS B 122 HIS^? 19.12 CL CL B 129 B 91 ARG B 104 ARG^? 18.51 CL CL A 129 B 129 SER A 124 SER^? 21.51 CL CL B 129 coo 18.19 17.03 40.71 18.55 17.18 38.64 86.93 63.10 -71.62 85.35 62.06 -72.53 coo 25.60 21.10 38.54 23.57 20.93 36.25 82.09 59.72 -64.70 82.21 58.19 -67.39 coo 21.33 14.29 34.62 19.25 14.88 35.71 81.71 59.41 -72.63 82.35 61.73 -72.29 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 9 3 # 9 B 18 HIS C 122 HIS^? 19.06 CL CL C 129 B 91 ARG C 46 ARG^? 15.12 CL CL C 129 B 129 SER C 124 SER^? 23.20 CL CL C 129 coo 18.19 17.03 40.71 18.55 17.18 38.64 101.68 77.71 -34.10 102.65 79.31 -33.15 coo 25.60 21.10 38.54 23.57 20.93 36.25 92.47 76.70 -34.87 92.87 79.50 -36.04 coo 21.33 14.29 34.62 19.25 14.88 35.71 100.74 82.83 -37.31 103.10 82.20 -37.27 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 10 3 # 10 B 18 HIS D 122 HIS^? 19.08 CL CL D 129 B 91 ARG D 46 ARG^? 15.13 CL CL D 129 B 129 SER D 124 SER^? 23.07 CL CL D 129 coo 18.19 17.03 40.71 18.55 17.18 38.64 57.69 72.86 -34.13 56.74 71.23 -33.18 coo 25.60 21.10 38.54 23.57 20.93 36.25 66.74 73.93 -35.00 66.45 71.02 -36.02 coo 21.33 14.29 34.62 19.25 14.88 35.71 58.66 67.61 -37.34 56.37 68.29 -37.09 1b6t_c01 source 1b6t PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE : 10 hits 1b6t_c01 naa= 3 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 1 3 # 1 A 88 PHE A 38 PHE~? 11.90 CL CL A 129 A 159 ASP A 41 ASP.? 7.60 CL CL A 129 A 188 LYS A 111 LYS^? 25.43 CL CL A 129 coo 13.91 34.58 14.67 12.95 36.00 12.47 93.74 49.34 -71.31 91.91 51.35 -71.82 coo 20.97 28.40 16.26 20.19 30.15 15.34 99.56 48.98 -63.34 100.43 49.52 -61.53 coo 22.55 41.65 15.60 18.92 37.20 14.63 105.91 53.60 -74.08 110.80 53.18 -78.24 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 2 3 # 2 A 88 PHE B 38 PHE^? 11.74 CL CL B 129 A 159 ASP B 41 ASP^? 7.64 CL CL B 129 A 188 LYS B 111 LYS^? 25.35 CL CL B 129 coo 13.91 34.58 14.67 12.95 36.00 12.47 93.75 74.07 -69.88 91.89 72.11 -69.38 coo 20.97 28.40 16.26 20.19 30.15 15.34 99.50 74.51 -77.69 100.41 73.95 -79.49 coo 22.55 41.65 15.60 18.92 37.20 14.63 105.89 69.85 -67.01 110.53 70.43 -62.59 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 3 3 # 3 A 88 PHE C 38 PHE^? 11.87 CL CL C 129 A 159 ASP C 41 ASP^? 7.58 CL CL C 129 A 188 LYS C 111 LYS^? 20.47 CL CL A 129 coo 13.91 34.58 14.67 12.95 36.00 12.47 90.71 70.84 -35.90 92.71 72.72 -36.44 coo 20.97 28.40 16.26 20.19 30.15 15.34 90.28 65.09 -27.98 90.77 64.12 -26.18 coo 22.55 41.65 15.60 18.92 37.20 14.63 94.84 58.73 -38.66 94.21 53.88 -42.04 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 4 3 # 4 A 88 PHE D 38 PHE^? 11.82 CL CL D 129 A 159 ASP D 41 ASP^? 7.55 CL CL D 129 A 188 LYS D 111 LYS^? 25.57 CL CL D 129 coo 13.91 34.58 14.67 12.95 36.00 12.47 68.57 79.81 -35.85 66.58 77.94 -36.43 coo 20.97 28.40 16.26 20.19 30.15 15.34 69.10 85.54 -28.07 68.60 86.44 -26.19 coo 22.55 41.65 15.60 18.92 37.20 14.63 64.48 91.99 -38.71 64.71 96.91 -42.99 1b9h_c02 source 1b9h 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHASE : 4 hits 1b9h_c02 naa= 3 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 A 137 ARG A 21 ARG~? 20.44 CL CL A 129 A 141 THR A 16 THR~? 21.54 CL CL B 129 A 235 ASP A 35 ASP~? 10.31 CL CL A 129 coo 6.21 93.81 36.58 4.58 96.33 37.17 98.35 46.51 -82.89 98.57 44.40 -80.63 coo 6.80 92.87 28.33 4.91 92.74 27.40 99.47 56.28 -84.34 99.11 57.82 -85.77 coo 12.98 90.36 47.57 11.26 89.62 46.62 93.79 42.35 -72.20 94.79 41.97 -70.38 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 A 137 ARG A 46 ARG^? 15.11 CL CL A 129 A 141 THR A 44 THR.? 7.93 CL CL A 129 A 235 ASP A 30 ASP~? 20.80 CL CL A 129 coo 6.21 93.81 36.58 4.58 96.33 37.17 87.96 51.20 -70.32 85.08 51.60 -71.34 coo 6.80 92.87 28.33 4.91 92.74 27.40 95.29 52.07 -64.55 95.81 50.95 -66.27 coo 12.98 90.36 47.57 11.26 89.62 46.62 90.38 41.71 -80.87 92.04 40.39 -80.79 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 A 137 ARG A 73 ARG.? 22.19 CL CL A 129 A 141 THR A 92 THR.? 19.17 CL CL B 129 A 235 ASP A 30 ASP~? 20.80 CL CL A 129 coo 6.21 93.81 36.58 4.58 96.33 37.17 83.82 53.79 -81.61 86.00 54.30 -79.51 coo 6.80 92.87 28.33 4.91 92.74 27.40 88.80 61.61 -80.86 88.36 59.74 -81.92 coo 12.98 90.36 47.57 11.26 89.62 46.62 90.38 41.71 -80.87 92.04 40.39 -80.79 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 A 137 ARG A 73 ARG.? 22.19 CL CL A 129 A 141 THR A 95 THR.? 23.66 CL CL B 129 A 235 ASP A 30 ASP~? 20.80 CL CL A 129 coo 6.21 93.81 36.58 4.58 96.33 37.17 83.82 53.79 -81.61 86.00 54.30 -79.51 coo 6.80 92.87 28.33 4.91 92.74 27.40 79.48 58.54 -83.85 79.37 60.11 -85.39 coo 12.98 90.36 47.57 11.26 89.62 46.62 90.38 41.71 -80.87 92.04 40.39 -80.79 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 A 137 ARG B 21 ARG^? 20.28 CL CL B 129 A 141 THR B 16 THR^? 21.09 CL CL A 129 A 235 ASP B 35 ASP^? 10.19 CL CL B 129 coo 6.21 93.81 36.58 4.58 96.33 37.17 98.33 76.92 -58.24 98.68 79.03 -60.54 coo 6.80 92.87 28.33 4.91 92.74 27.40 99.48 66.86 -56.72 99.31 65.24 -55.32 coo 12.98 90.36 47.57 11.26 89.62 46.62 93.79 80.98 -68.72 94.61 81.32 -70.62 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 A 137 ARG B 21 ARG^? 20.28 CL CL B 129 A 141 THR B 16 THR^? 21.09 CL CL A 129 A 235 ASP C 72 ASP^? 28.53 CL CL B 129 coo 6.21 93.81 36.58 4.58 96.33 37.17 98.33 76.92 -58.24 98.68 79.03 -60.54 coo 6.80 92.87 28.33 4.91 92.74 27.40 99.48 66.86 -56.72 99.31 65.24 -55.32 coo 12.98 90.36 47.57 11.26 89.62 46.62 90.38 83.76 -50.64 91.24 82.68 -52.23 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 7 3 # 7 A 137 ARG B 46 ARG^? 15.06 CL CL B 129 A 141 THR B 44 THR^? 7.91 CL CL B 129 A 235 ASP B 30 ASP^? 20.91 CL CL B 129 coo 6.21 93.81 36.58 4.58 96.33 37.17 87.96 72.13 -70.71 85.05 71.84 -69.78 coo 6.80 92.87 28.33 4.91 92.74 27.40 95.21 71.44 -76.44 95.74 72.60 -74.74 coo 12.98 90.36 47.57 11.26 89.62 46.62 90.60 81.40 -60.16 92.15 82.83 -59.97 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 8 3 # 8 A 137 ARG B 73 ARG^? 22.29 CL CL B 129 A 141 THR B 92 THR^? 18.96 CL CL A 129 A 235 ASP B 30 ASP^? 20.91 CL CL B 129 coo 6.21 93.81 36.58 4.58 96.33 37.17 83.86 69.55 -59.16 85.91 69.18 -61.42 coo 6.80 92.87 28.33 4.91 92.74 27.40 88.84 61.70 -60.19 88.43 63.62 -59.28 coo 12.98 90.36 47.57 11.26 89.62 46.62 90.60 81.40 -60.16 92.15 82.83 -59.97 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 9 3 # 9 A 137 ARG B 73 ARG^? 22.29 CL CL B 129 A 141 THR B 92 THR^? 18.96 CL CL A 129 A 235 ASP C 30 ASP^? 20.67 CL CL C 129 coo 6.21 93.81 36.58 4.58 96.33 37.17 83.86 69.55 -59.16 85.91 69.18 -61.42 coo 6.80 92.87 28.33 4.91 92.74 27.40 88.84 61.70 -60.19 88.43 63.62 -59.28 coo 12.98 90.36 47.57 11.26 89.62 46.62 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 10 3 # 10 A 137 ARG B 73 ARG^? 22.29 CL CL B 129 A 141 THR B 95 THR^? 23.42 CL CL A 129 A 235 ASP B 30 ASP^? 20.91 CL CL B 129 coo 6.21 93.81 36.58 4.58 96.33 37.17 83.86 69.55 -59.16 85.91 69.18 -61.42 coo 6.80 92.87 28.33 4.91 92.74 27.40 79.47 64.83 -57.24 79.55 63.29 -55.69 coo 12.98 90.36 47.57 11.26 89.62 46.62 90.60 81.40 -60.16 92.15 82.83 -59.97 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 11 3 # 11 A 137 ARG B 76 ARG^? 18.98 CL CL A 129 A 141 THR B 95 THR^? 23.42 CL CL A 129 A 235 ASP C 14 ASP^? 16.95 CL CL A 129 coo 6.21 93.81 36.58 4.58 96.33 37.17 82.73 59.03 -54.76 80.31 57.91 -56.24 coo 6.80 92.87 28.33 4.91 92.74 27.40 79.47 64.83 -57.24 79.55 63.29 -55.69 coo 12.98 90.36 47.57 11.26 89.62 46.62 95.50 58.88 -47.37 95.04 57.01 -48.29 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 12 3 # 12 A 137 ARG B 96 ARG^? 24.18 CL CL B 129 A 141 THR B 27 THR^? 25.10 CL CL B 129 A 235 ASP D 72 ASP^? 29.64 CL CL D 129 coo 6.21 93.81 36.58 4.58 96.33 37.17 78.35 70.58 -59.29 80.55 70.83 -61.45 coo 6.80 92.87 28.33 4.91 92.74 27.40 85.40 75.83 -58.05 86.15 74.42 -56.65 coo 12.98 90.36 47.57 11.26 89.62 46.62 69.04 67.18 -50.81 68.23 68.38 -52.37 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 13 3 # 13 A 137 ARG B 96 ARG^? 24.18 CL CL B 129 A 141 THR B 100 THR^? 28.81 CL CL A 129 A 235 ASP C 30 ASP^? 20.67 CL CL C 129 coo 6.21 93.81 36.58 4.58 96.33 37.17 78.35 70.58 -59.29 80.55 70.83 -61.45 coo 6.80 92.87 28.33 4.91 92.74 27.40 72.27 62.59 -58.79 70.28 61.78 -58.67 coo 12.98 90.36 47.57 11.26 89.62 46.62 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 14 3 # 14 A 137 ARG B 96 ARG^? 24.18 CL CL B 129 A 141 THR B 100 THR^? 28.81 CL CL A 129 A 235 ASP D 30 ASP^? 20.62 CL CL D 129 coo 6.21 93.81 36.58 4.58 96.33 37.17 78.35 70.58 -59.29 80.55 70.83 -61.45 coo 6.80 92.87 28.33 4.91 92.74 27.40 72.27 62.59 -58.79 70.28 61.78 -58.67 coo 12.98 90.36 47.57 11.26 89.62 46.62 76.16 76.40 -45.40 77.49 78.05 -45.35 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 15 3 # 15 A 137 ARG C 21 ARG^? 20.59 CL CL C 129 A 141 THR C 16 THR^? 23.09 CL CL A 129 A 235 ASP B 72 ASP^? 28.57 CL CL C 129 coo 6.21 93.81 36.58 4.58 96.33 37.17 87.78 66.49 -47.10 85.32 65.73 -45.33 coo 6.80 92.87 28.33 4.91 92.74 27.40 97.77 65.15 -48.94 99.37 65.45 -50.33 coo 12.98 90.36 47.57 11.26 89.62 46.62 80.87 74.36 -54.99 81.74 73.36 -53.35 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 16 3 # 16 A 137 ARG C 21 ARG^? 20.59 CL CL C 129 A 141 THR C 16 THR^? 23.09 CL CL A 129 A 235 ASP C 35 ASP^? 10.26 CL CL C 129 coo 6.21 93.81 36.58 4.58 96.33 37.17 87.78 66.49 -47.10 85.32 65.73 -45.33 coo 6.80 92.87 28.33 4.91 92.74 27.40 97.77 65.15 -48.94 99.37 65.45 -50.33 coo 12.98 90.36 47.57 11.26 89.62 46.62 83.63 70.73 -36.85 83.32 69.81 -34.96 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 17 3 # 17 A 137 ARG C 46 ARG^? 15.12 CL CL C 129 A 141 THR C 44 THR^? 7.82 CL CL C 129 A 235 ASP C 30 ASP^? 20.67 CL CL C 129 coo 6.21 93.81 36.58 4.58 96.33 37.17 92.47 76.70 -34.87 92.87 79.50 -36.04 coo 6.80 92.87 28.33 4.91 92.74 27.40 93.28 69.34 -29.36 92.05 68.81 -31.01 coo 12.98 90.36 47.57 11.26 89.62 46.62 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 18 3 # 18 A 137 ARG C 73 ARG^? 22.24 CL CL C 129 A 141 THR C 92 THR^? 26.08 CL CL C 129 A 235 ASP B 30 ASP^? 20.91 CL CL B 129 coo 6.21 93.81 36.58 4.58 96.33 37.17 95.26 80.79 -46.47 95.45 78.63 -44.29 coo 6.80 92.87 28.33 4.91 92.74 27.40 103.00 75.79 -45.49 101.15 76.17 -46.51 coo 12.98 90.36 47.57 11.26 89.62 46.62 90.60 81.40 -60.16 92.15 82.83 -59.97 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 19 3 # 19 A 137 ARG C 73 ARG^? 22.24 CL CL C 129 A 141 THR C 92 THR^? 26.08 CL CL C 129 A 235 ASP C 30 ASP^? 20.67 CL CL C 129 coo 6.21 93.81 36.58 4.58 96.33 37.17 95.26 80.79 -46.47 95.45 78.63 -44.29 coo 6.80 92.87 28.33 4.91 92.74 27.40 103.00 75.79 -45.49 101.15 76.17 -46.51 coo 12.98 90.36 47.57 11.26 89.62 46.62 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 20 3 # 20 A 137 ARG C 73 ARG^? 22.24 CL CL C 129 A 141 THR C 95 THR^? 31.97 CL CL C 129 A 235 ASP C 30 ASP^? 20.67 CL CL C 129 coo 6.21 93.81 36.58 4.58 96.33 37.17 95.26 80.79 -46.47 95.45 78.63 -44.29 coo 6.80 92.87 28.33 4.91 92.74 27.40 99.92 85.14 -48.37 101.51 85.07 -49.86 coo 12.98 90.36 47.57 11.26 89.62 46.62 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 21 3 # 21 A 137 ARG C 76 ARG^? 33.92 CL CL B 129 A 141 THR C 95 THR^? 31.97 CL CL C 129 A 235 ASP B 14 ASP^? 27.62 CL CL A 129 coo 6.21 93.81 36.58 4.58 96.33 37.17 105.54 81.89 -51.05 106.65 84.23 -49.40 coo 6.80 92.87 28.33 4.91 92.74 27.40 99.92 85.14 -48.37 101.51 85.07 -49.86 coo 12.98 90.36 47.57 11.26 89.62 46.62 105.60 69.00 -58.44 107.49 69.47 -57.66 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 22 3 # 22 A 137 ARG D 21 ARG^? 20.73 CL CL D 129 A 141 THR D 16 THR^? 28.44 CL CL D 129 A 235 ASP D 35 ASP^? 10.18 CL CL D 129 coo 6.21 93.81 36.58 4.58 96.33 37.17 71.50 84.01 -47.23 73.85 84.97 -45.52 coo 6.80 92.87 28.33 4.91 92.74 27.40 61.61 85.42 -49.02 60.10 85.21 -50.52 coo 12.98 90.36 47.57 11.26 89.62 46.62 75.66 79.96 -36.93 75.99 80.66 -34.97 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 23 3 # 23 A 137 ARG D 46 ARG^? 15.13 CL CL D 129 A 141 THR D 44 THR^? 7.93 CL CL D 129 A 235 ASP D 30 ASP^? 20.62 CL CL D 129 coo 6.21 93.81 36.58 4.58 96.33 37.17 66.74 73.93 -35.00 66.45 71.02 -36.02 coo 6.80 92.87 28.33 4.91 92.74 27.40 65.95 81.28 -29.36 67.15 81.78 -31.05 coo 12.98 90.36 47.57 11.26 89.62 46.62 76.16 76.40 -45.40 77.49 78.05 -45.35 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 24 3 # 24 A 137 ARG D 73 ARG^? 22.15 CL CL D 129 A 141 THR D 92 THR^? 25.97 CL CL D 129 A 235 ASP D 30 ASP^? 20.62 CL CL D 129 coo 6.21 93.81 36.58 4.58 96.33 37.17 64.06 69.83 -46.45 63.93 71.88 -44.19 coo 6.80 92.87 28.33 4.91 92.74 27.40 56.38 74.82 -45.46 58.23 74.40 -46.42 coo 12.98 90.36 47.57 11.26 89.62 46.62 76.16 76.40 -45.40 77.49 78.05 -45.35 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 25 3 # 25 A 137 ARG D 73 ARG^? 22.15 CL CL D 129 A 141 THR D 95 THR^? 32.06 CL CL D 129 A 235 ASP D 30 ASP^? 20.62 CL CL D 129 coo 6.21 93.81 36.58 4.58 96.33 37.17 64.06 69.83 -46.45 63.93 71.88 -44.19 coo 6.80 92.87 28.33 4.91 92.74 27.40 59.52 65.53 -48.53 57.85 65.41 -49.95 coo 12.98 90.36 47.57 11.26 89.62 46.62 76.16 76.40 -45.40 77.49 78.05 -45.35 1bd3_c00 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 25 hits 1bd3_c00 naa= 3 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 D 137 ARG A 21 ARG~? 20.44 CL CL A 129 D 141 THR A 16 THR~? 21.54 CL CL B 129 D 235 ASP A 35 ASP~? 10.31 CL CL A 129 coo -8.33 92.80 100.06 -7.71 95.33 98.44 98.35 46.51 -82.89 98.57 44.40 -80.63 coo -9.24 93.49 108.77 -7.37 94.21 109.61 99.47 56.28 -84.34 99.11 57.82 -85.77 coo -14.64 87.74 89.51 -12.89 87.43 90.65 93.79 42.35 -72.20 94.79 41.97 -70.38 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 D 137 ARG A 46 ARG^? 15.11 CL CL A 129 D 141 THR A 44 THR.? 7.93 CL CL A 129 D 235 ASP A 30 ASP~? 20.80 CL CL A 129 coo -8.33 92.80 100.06 -7.71 95.33 98.44 87.96 51.20 -70.32 85.08 51.60 -71.34 coo -9.24 93.49 108.77 -7.37 94.21 109.61 95.29 52.07 -64.55 95.81 50.95 -66.27 coo -14.64 87.74 89.51 -12.89 87.43 90.65 90.38 41.71 -80.87 92.04 40.39 -80.79 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 D 137 ARG A 73 ARG.? 22.19 CL CL A 129 D 141 THR A 92 THR.? 19.17 CL CL B 129 D 235 ASP A 30 ASP~? 20.80 CL CL A 129 coo -8.33 92.80 100.06 -7.71 95.33 98.44 83.82 53.79 -81.61 86.00 54.30 -79.51 coo -9.24 93.49 108.77 -7.37 94.21 109.61 88.80 61.61 -80.86 88.36 59.74 -81.92 coo -14.64 87.74 89.51 -12.89 87.43 90.65 90.38 41.71 -80.87 92.04 40.39 -80.79 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 D 137 ARG A 73 ARG.? 22.19 CL CL A 129 D 141 THR A 95 THR.? 23.66 CL CL B 129 D 235 ASP A 30 ASP~? 20.80 CL CL A 129 coo -8.33 92.80 100.06 -7.71 95.33 98.44 83.82 53.79 -81.61 86.00 54.30 -79.51 coo -9.24 93.49 108.77 -7.37 94.21 109.61 79.48 58.54 -83.85 79.37 60.11 -85.39 coo -14.64 87.74 89.51 -12.89 87.43 90.65 90.38 41.71 -80.87 92.04 40.39 -80.79 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 D 137 ARG A 117 ARG^? 16.03 CL CL A 129 D 141 THR A 44 THR.? 7.93 CL CL A 129 D 235 ASP A 14 ASP~? 27.67 CL CL B 129 coo -8.33 92.80 100.06 -7.71 95.33 98.44 100.59 48.03 -72.66 102.04 46.10 -74.59 coo -9.24 93.49 108.77 -7.37 94.21 109.61 95.29 52.07 -64.55 95.81 50.95 -66.27 coo -14.64 87.74 89.51 -12.89 87.43 90.65 105.70 54.30 -82.61 107.63 54.15 -83.44 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 D 137 ARG A 117 ARG^? 16.03 CL CL A 129 D 141 THR A 44 THR.? 7.93 CL CL A 129 D 235 ASP A 30 ASP~? 20.80 CL CL A 129 coo -8.33 92.80 100.06 -7.71 95.33 98.44 100.59 48.03 -72.66 102.04 46.10 -74.59 coo -9.24 93.49 108.77 -7.37 94.21 109.61 95.29 52.07 -64.55 95.81 50.95 -66.27 coo -14.64 87.74 89.51 -12.89 87.43 90.65 90.38 41.71 -80.87 92.04 40.39 -80.79 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 7 3 # 7 D 137 ARG B 21 ARG^? 20.28 CL CL B 129 D 141 THR B 16 THR^? 21.09 CL CL A 129 D 235 ASP B 35 ASP^? 10.19 CL CL B 129 coo -8.33 92.80 100.06 -7.71 95.33 98.44 98.33 76.92 -58.24 98.68 79.03 -60.54 coo -9.24 93.49 108.77 -7.37 94.21 109.61 99.48 66.86 -56.72 99.31 65.24 -55.32 coo -14.64 87.74 89.51 -12.89 87.43 90.65 93.79 80.98 -68.72 94.61 81.32 -70.62 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 8 3 # 8 D 137 ARG B 21 ARG^? 20.28 CL CL B 129 D 141 THR B 16 THR^? 21.09 CL CL A 129 D 235 ASP C 72 ASP^? 28.53 CL CL B 129 coo -8.33 92.80 100.06 -7.71 95.33 98.44 98.33 76.92 -58.24 98.68 79.03 -60.54 coo -9.24 93.49 108.77 -7.37 94.21 109.61 99.48 66.86 -56.72 99.31 65.24 -55.32 coo -14.64 87.74 89.51 -12.89 87.43 90.65 90.38 83.76 -50.64 91.24 82.68 -52.23 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 9 3 # 9 D 137 ARG B 46 ARG^? 15.06 CL CL B 129 D 141 THR B 44 THR^? 7.91 CL CL B 129 D 235 ASP B 30 ASP^? 20.91 CL CL B 129 coo -8.33 92.80 100.06 -7.71 95.33 98.44 87.96 72.13 -70.71 85.05 71.84 -69.78 coo -9.24 93.49 108.77 -7.37 94.21 109.61 95.21 71.44 -76.44 95.74 72.60 -74.74 coo -14.64 87.74 89.51 -12.89 87.43 90.65 90.60 81.40 -60.16 92.15 82.83 -59.97 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 10 3 # 10 D 137 ARG B 73 ARG^? 22.29 CL CL B 129 D 141 THR B 92 THR^? 18.96 CL CL A 129 D 235 ASP B 30 ASP^? 20.91 CL CL B 129 coo -8.33 92.80 100.06 -7.71 95.33 98.44 83.86 69.55 -59.16 85.91 69.18 -61.42 coo -9.24 93.49 108.77 -7.37 94.21 109.61 88.84 61.70 -60.19 88.43 63.62 -59.28 coo -14.64 87.74 89.51 -12.89 87.43 90.65 90.60 81.40 -60.16 92.15 82.83 -59.97 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 11 3 # 11 D 137 ARG B 73 ARG^? 22.29 CL CL B 129 D 141 THR B 92 THR^? 18.96 CL CL A 129 D 235 ASP C 30 ASP^? 20.67 CL CL C 129 coo -8.33 92.80 100.06 -7.71 95.33 98.44 83.86 69.55 -59.16 85.91 69.18 -61.42 coo -9.24 93.49 108.77 -7.37 94.21 109.61 88.84 61.70 -60.19 88.43 63.62 -59.28 coo -14.64 87.74 89.51 -12.89 87.43 90.65 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 12 3 # 12 D 137 ARG B 73 ARG^? 22.29 CL CL B 129 D 141 THR B 97 THR^? 28.75 CL CL D 129 D 235 ASP B 30 ASP^? 20.91 CL CL B 129 coo -8.33 92.80 100.06 -7.71 95.33 98.44 83.86 69.55 -59.16 85.91 69.18 -61.42 coo -9.24 93.49 108.77 -7.37 94.21 109.61 74.83 68.80 -53.92 74.73 70.43 -52.45 coo -14.64 87.74 89.51 -12.89 87.43 90.65 90.60 81.40 -60.16 92.15 82.83 -59.97 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 13 3 # 13 D 137 ARG B 76 ARG^? 18.98 CL CL A 129 D 141 THR B 95 THR^? 23.42 CL CL A 129 D 235 ASP C 14 ASP^? 16.95 CL CL A 129 coo -8.33 92.80 100.06 -7.71 95.33 98.44 82.73 59.03 -54.76 80.31 57.91 -56.24 coo -9.24 93.49 108.77 -7.37 94.21 109.61 79.47 64.83 -57.24 79.55 63.29 -55.69 coo -14.64 87.74 89.51 -12.89 87.43 90.65 95.50 58.88 -47.37 95.04 57.01 -48.29 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 14 3 # 14 D 137 ARG B 96 ARG^? 24.18 CL CL B 129 D 141 THR B 27 THR^? 25.10 CL CL B 129 D 235 ASP D 72 ASP^? 29.64 CL CL D 129 coo -8.33 92.80 100.06 -7.71 95.33 98.44 78.35 70.58 -59.29 80.55 70.83 -61.45 coo -9.24 93.49 108.77 -7.37 94.21 109.61 85.40 75.83 -58.05 86.15 74.42 -56.65 coo -14.64 87.74 89.51 -12.89 87.43 90.65 69.04 67.18 -50.81 68.23 68.38 -52.37 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 15 3 # 15 D 137 ARG B 96 ARG^? 24.18 CL CL B 129 D 141 THR B 100 THR^? 28.81 CL CL A 129 D 235 ASP C 30 ASP^? 20.67 CL CL C 129 coo -8.33 92.80 100.06 -7.71 95.33 98.44 78.35 70.58 -59.29 80.55 70.83 -61.45 coo -9.24 93.49 108.77 -7.37 94.21 109.61 72.27 62.59 -58.79 70.28 61.78 -58.67 coo -14.64 87.74 89.51 -12.89 87.43 90.65 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 16 3 # 16 D 137 ARG B 96 ARG^? 24.18 CL CL B 129 D 141 THR B 100 THR^? 28.81 CL CL A 129 D 235 ASP D 30 ASP^? 20.62 CL CL D 129 coo -8.33 92.80 100.06 -7.71 95.33 98.44 78.35 70.58 -59.29 80.55 70.83 -61.45 coo -9.24 93.49 108.77 -7.37 94.21 109.61 72.27 62.59 -58.79 70.28 61.78 -58.67 coo -14.64 87.74 89.51 -12.89 87.43 90.65 76.16 76.40 -45.40 77.49 78.05 -45.35 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 17 3 # 17 D 137 ARG B 117 ARG^? 16.04 CL CL B 129 D 141 THR B 44 THR^? 7.91 CL CL B 129 D 235 ASP B 14 ASP^? 27.62 CL CL A 129 coo -8.33 92.80 100.06 -7.71 95.33 98.44 100.63 75.34 -68.25 102.08 77.36 -66.41 coo -9.24 93.49 108.77 -7.37 94.21 109.61 95.21 71.44 -76.44 95.74 72.60 -74.74 coo -14.64 87.74 89.51 -12.89 87.43 90.65 105.60 69.00 -58.44 107.49 69.47 -57.66 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 18 3 # 18 D 137 ARG B 117 ARG^? 16.04 CL CL B 129 D 141 THR B 44 THR^? 7.91 CL CL B 129 D 235 ASP B 30 ASP^? 20.91 CL CL B 129 coo -8.33 92.80 100.06 -7.71 95.33 98.44 100.63 75.34 -68.25 102.08 77.36 -66.41 coo -9.24 93.49 108.77 -7.37 94.21 109.61 95.21 71.44 -76.44 95.74 72.60 -74.74 coo -14.64 87.74 89.51 -12.89 87.43 90.65 90.60 81.40 -60.16 92.15 82.83 -59.97 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 19 3 # 19 D 137 ARG C 21 ARG^? 20.59 CL CL C 129 D 141 THR C 16 THR^? 23.09 CL CL A 129 D 235 ASP B 72 ASP^? 28.57 CL CL C 129 coo -8.33 92.80 100.06 -7.71 95.33 98.44 87.78 66.49 -47.10 85.32 65.73 -45.33 coo -9.24 93.49 108.77 -7.37 94.21 109.61 97.77 65.15 -48.94 99.37 65.45 -50.33 coo -14.64 87.74 89.51 -12.89 87.43 90.65 80.87 74.36 -54.99 81.74 73.36 -53.35 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 20 3 # 20 D 137 ARG C 21 ARG^? 20.59 CL CL C 129 D 141 THR C 16 THR^? 23.09 CL CL A 129 D 235 ASP C 35 ASP^? 10.26 CL CL C 129 coo -8.33 92.80 100.06 -7.71 95.33 98.44 87.78 66.49 -47.10 85.32 65.73 -45.33 coo -9.24 93.49 108.77 -7.37 94.21 109.61 97.77 65.15 -48.94 99.37 65.45 -50.33 coo -14.64 87.74 89.51 -12.89 87.43 90.65 83.63 70.73 -36.85 83.32 69.81 -34.96 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 21 3 # 21 D 137 ARG C 46 ARG^? 15.12 CL CL C 129 D 141 THR C 44 THR^? 7.82 CL CL C 129 D 235 ASP C 30 ASP^? 20.67 CL CL C 129 coo -8.33 92.80 100.06 -7.71 95.33 98.44 92.47 76.70 -34.87 92.87 79.50 -36.04 coo -9.24 93.49 108.77 -7.37 94.21 109.61 93.28 69.34 -29.36 92.05 68.81 -31.01 coo -14.64 87.74 89.51 -12.89 87.43 90.65 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 22 3 # 22 D 137 ARG C 73 ARG^? 22.24 CL CL C 129 D 141 THR C 92 THR^? 26.08 CL CL C 129 D 235 ASP B 30 ASP^? 20.91 CL CL B 129 coo -8.33 92.80 100.06 -7.71 95.33 98.44 95.26 80.79 -46.47 95.45 78.63 -44.29 coo -9.24 93.49 108.77 -7.37 94.21 109.61 103.00 75.79 -45.49 101.15 76.17 -46.51 coo -14.64 87.74 89.51 -12.89 87.43 90.65 90.60 81.40 -60.16 92.15 82.83 -59.97 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 23 3 # 23 D 137 ARG C 73 ARG^? 22.24 CL CL C 129 D 141 THR C 92 THR^? 26.08 CL CL C 129 D 235 ASP C 30 ASP^? 20.67 CL CL C 129 coo -8.33 92.80 100.06 -7.71 95.33 98.44 95.26 80.79 -46.47 95.45 78.63 -44.29 coo -9.24 93.49 108.77 -7.37 94.21 109.61 103.00 75.79 -45.49 101.15 76.17 -46.51 coo -14.64 87.74 89.51 -12.89 87.43 90.65 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 24 3 # 24 D 137 ARG C 73 ARG^? 22.24 CL CL C 129 D 141 THR C 97 THR^? 29.17 CL CL B 129 D 235 ASP C 30 ASP^? 20.67 CL CL C 129 coo -8.33 92.80 100.06 -7.71 95.33 98.44 95.26 80.79 -46.47 95.45 78.63 -44.29 coo -9.24 93.49 108.77 -7.37 94.21 109.61 96.29 89.95 -51.83 94.80 89.38 -53.40 coo -14.64 87.74 89.51 -12.89 87.43 90.65 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 25 3 # 25 D 137 ARG C 76 ARG^? 33.92 CL CL B 129 D 141 THR C 95 THR^? 31.97 CL CL C 129 D 235 ASP B 14 ASP^? 27.62 CL CL A 129 coo -8.33 92.80 100.06 -7.71 95.33 98.44 105.54 81.89 -51.05 106.65 84.23 -49.40 coo -9.24 93.49 108.77 -7.37 94.21 109.61 99.92 85.14 -48.37 101.51 85.07 -49.86 coo -14.64 87.74 89.51 -12.89 87.43 90.65 105.60 69.00 -58.44 107.49 69.47 -57.66 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 26 3 # 26 D 137 ARG C 117 ARG^? 16.02 CL CL C 129 D 141 THR C 44 THR^? 7.82 CL CL C 129 D 235 ASP C 14 ASP^? 16.95 CL CL A 129 coo -8.33 92.80 100.06 -7.71 95.33 98.44 89.36 64.01 -37.29 87.40 62.56 -39.24 coo -9.24 93.49 108.77 -7.37 94.21 109.61 93.28 69.34 -29.36 92.05 68.81 -31.01 coo -14.64 87.74 89.51 -12.89 87.43 90.65 95.50 58.88 -47.37 95.04 57.01 -48.29 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 27 3 # 27 D 137 ARG C 117 ARG^? 16.02 CL CL C 129 D 141 THR C 44 THR^? 7.82 CL CL C 129 D 235 ASP C 30 ASP^? 20.67 CL CL C 129 coo -8.33 92.80 100.06 -7.71 95.33 98.44 89.36 64.01 -37.29 87.40 62.56 -39.24 coo -9.24 93.49 108.77 -7.37 94.21 109.61 93.28 69.34 -29.36 92.05 68.81 -31.01 coo -14.64 87.74 89.51 -12.89 87.43 90.65 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 28 3 # 28 D 137 ARG D 21 ARG^? 20.73 CL CL D 129 D 141 THR D 16 THR^? 28.44 CL CL D 129 D 235 ASP D 35 ASP^? 10.18 CL CL D 129 coo -8.33 92.80 100.06 -7.71 95.33 98.44 71.50 84.01 -47.23 73.85 84.97 -45.52 coo -9.24 93.49 108.77 -7.37 94.21 109.61 61.61 85.42 -49.02 60.10 85.21 -50.52 coo -14.64 87.74 89.51 -12.89 87.43 90.65 75.66 79.96 -36.93 75.99 80.66 -34.97 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 29 3 # 29 D 137 ARG D 46 ARG^? 15.13 CL CL D 129 D 141 THR D 44 THR^? 7.93 CL CL D 129 D 235 ASP D 30 ASP^? 20.62 CL CL D 129 coo -8.33 92.80 100.06 -7.71 95.33 98.44 66.74 73.93 -35.00 66.45 71.02 -36.02 coo -9.24 93.49 108.77 -7.37 94.21 109.61 65.95 81.28 -29.36 67.15 81.78 -31.05 coo -14.64 87.74 89.51 -12.89 87.43 90.65 76.16 76.40 -45.40 77.49 78.05 -45.35 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 30 3 # 30 D 137 ARG D 73 ARG^? 22.15 CL CL D 129 D 141 THR D 92 THR^? 25.97 CL CL D 129 D 235 ASP D 30 ASP^? 20.62 CL CL D 129 coo -8.33 92.80 100.06 -7.71 95.33 98.44 64.06 69.83 -46.45 63.93 71.88 -44.19 coo -9.24 93.49 108.77 -7.37 94.21 109.61 56.38 74.82 -45.46 58.23 74.40 -46.42 coo -14.64 87.74 89.51 -12.89 87.43 90.65 76.16 76.40 -45.40 77.49 78.05 -45.35 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 31 3 # 31 D 137 ARG D 73 ARG^? 22.15 CL CL D 129 D 141 THR D 97 THR^? 33.73 CL CL A 129 D 235 ASP D 30 ASP^? 20.62 CL CL D 129 coo -8.33 92.80 100.06 -7.71 95.33 98.44 64.06 69.83 -46.45 63.93 71.88 -44.19 coo -9.24 93.49 108.77 -7.37 94.21 109.61 63.35 60.51 -51.69 64.51 60.28 -53.55 coo -14.64 87.74 89.51 -12.89 87.43 90.65 76.16 76.40 -45.40 77.49 78.05 -45.35 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 32 3 # 32 D 137 ARG D 117 ARG^? 15.96 CL CL D 129 D 141 THR D 44 THR^? 7.93 CL CL D 129 D 235 ASP D 14 ASP^? 27.52 CL CL D 129 coo -8.33 92.80 100.06 -7.71 95.33 98.44 69.91 86.62 -37.36 71.94 88.06 -39.21 coo -9.24 93.49 108.77 -7.37 94.21 109.61 65.95 81.28 -29.36 67.15 81.78 -31.05 coo -14.64 87.74 89.51 -12.89 87.43 90.65 63.54 91.53 -47.18 63.81 93.48 -47.82 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 33 3 # 33 D 137 ARG D 117 ARG^? 15.96 CL CL D 129 D 141 THR D 44 THR^? 7.93 CL CL D 129 D 235 ASP D 30 ASP^? 20.62 CL CL D 129 coo -8.33 92.80 100.06 -7.71 95.33 98.44 69.91 86.62 -37.36 71.94 88.06 -39.21 coo -9.24 93.49 108.77 -7.37 94.21 109.61 65.95 81.28 -29.36 67.15 81.78 -31.05 coo -14.64 87.74 89.51 -12.89 87.43 90.65 76.16 76.40 -45.40 77.49 78.05 -45.35 1bd3_c01 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 33 hits 1bd3_c01 naa= 3 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 C 137 ARG A 21 ARG~? 20.44 CL CL A 129 C 141 THR A 16 THR~? 21.54 CL CL B 129 C 235 ASP A 35 ASP~? 10.31 CL CL A 129 coo -5.79 67.26 36.83 -4.57 64.58 37.74 98.35 46.51 -82.89 98.57 44.40 -80.63 coo -6.81 68.31 28.28 -4.82 68.47 27.57 99.47 56.28 -84.34 99.11 57.82 -85.77 coo -13.01 70.96 47.58 -11.44 71.65 46.34 93.79 42.35 -72.20 94.79 41.97 -70.38 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 C 137 ARG A 46 ARG^? 15.11 CL CL A 129 C 141 THR A 44 THR.? 7.93 CL CL A 129 C 235 ASP A 30 ASP~? 20.80 CL CL A 129 coo -5.79 67.26 36.83 -4.57 64.58 37.74 87.96 51.20 -70.32 85.08 51.60 -71.34 coo -6.81 68.31 28.28 -4.82 68.47 27.57 95.29 52.07 -64.55 95.81 50.95 -66.27 coo -13.01 70.96 47.58 -11.44 71.65 46.34 90.38 41.71 -80.87 92.04 40.39 -80.79 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 C 137 ARG A 73 ARG.? 22.19 CL CL A 129 C 141 THR A 92 THR.? 19.17 CL CL B 129 C 235 ASP A 30 ASP~? 20.80 CL CL A 129 coo -5.79 67.26 36.83 -4.57 64.58 37.74 83.82 53.79 -81.61 86.00 54.30 -79.51 coo -6.81 68.31 28.28 -4.82 68.47 27.57 88.80 61.61 -80.86 88.36 59.74 -81.92 coo -13.01 70.96 47.58 -11.44 71.65 46.34 90.38 41.71 -80.87 92.04 40.39 -80.79 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 C 137 ARG A 73 ARG.? 22.19 CL CL A 129 C 141 THR A 95 THR.? 23.66 CL CL B 129 C 235 ASP A 30 ASP~? 20.80 CL CL A 129 coo -5.79 67.26 36.83 -4.57 64.58 37.74 83.82 53.79 -81.61 86.00 54.30 -79.51 coo -6.81 68.31 28.28 -4.82 68.47 27.57 79.48 58.54 -83.85 79.37 60.11 -85.39 coo -13.01 70.96 47.58 -11.44 71.65 46.34 90.38 41.71 -80.87 92.04 40.39 -80.79 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 C 137 ARG A 117 ARG^? 16.03 CL CL A 129 C 141 THR A 44 THR.? 7.93 CL CL A 129 C 235 ASP A 14 ASP~? 27.67 CL CL B 129 coo -5.79 67.26 36.83 -4.57 64.58 37.74 100.59 48.03 -72.66 102.04 46.10 -74.59 coo -6.81 68.31 28.28 -4.82 68.47 27.57 95.29 52.07 -64.55 95.81 50.95 -66.27 coo -13.01 70.96 47.58 -11.44 71.65 46.34 105.70 54.30 -82.61 107.63 54.15 -83.44 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 C 137 ARG A 117 ARG^? 16.03 CL CL A 129 C 141 THR A 44 THR.? 7.93 CL CL A 129 C 235 ASP A 30 ASP~? 20.80 CL CL A 129 coo -5.79 67.26 36.83 -4.57 64.58 37.74 100.59 48.03 -72.66 102.04 46.10 -74.59 coo -6.81 68.31 28.28 -4.82 68.47 27.57 95.29 52.07 -64.55 95.81 50.95 -66.27 coo -13.01 70.96 47.58 -11.44 71.65 46.34 90.38 41.71 -80.87 92.04 40.39 -80.79 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 7 3 # 7 C 137 ARG B 21 ARG^? 20.28 CL CL B 129 C 141 THR B 16 THR^? 21.09 CL CL A 129 C 235 ASP B 35 ASP^? 10.19 CL CL B 129 coo -5.79 67.26 36.83 -4.57 64.58 37.74 98.33 76.92 -58.24 98.68 79.03 -60.54 coo -6.81 68.31 28.28 -4.82 68.47 27.57 99.48 66.86 -56.72 99.31 65.24 -55.32 coo -13.01 70.96 47.58 -11.44 71.65 46.34 93.79 80.98 -68.72 94.61 81.32 -70.62 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 8 3 # 8 C 137 ARG B 21 ARG^? 20.28 CL CL B 129 C 141 THR B 16 THR^? 21.09 CL CL A 129 C 235 ASP C 72 ASP^? 28.53 CL CL B 129 coo -5.79 67.26 36.83 -4.57 64.58 37.74 98.33 76.92 -58.24 98.68 79.03 -60.54 coo -6.81 68.31 28.28 -4.82 68.47 27.57 99.48 66.86 -56.72 99.31 65.24 -55.32 coo -13.01 70.96 47.58 -11.44 71.65 46.34 90.38 83.76 -50.64 91.24 82.68 -52.23 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 9 3 # 9 C 137 ARG B 46 ARG^? 15.06 CL CL B 129 C 141 THR B 44 THR^? 7.91 CL CL B 129 C 235 ASP B 30 ASP^? 20.91 CL CL B 129 coo -5.79 67.26 36.83 -4.57 64.58 37.74 87.96 72.13 -70.71 85.05 71.84 -69.78 coo -6.81 68.31 28.28 -4.82 68.47 27.57 95.21 71.44 -76.44 95.74 72.60 -74.74 coo -13.01 70.96 47.58 -11.44 71.65 46.34 90.60 81.40 -60.16 92.15 82.83 -59.97 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 10 3 # 10 C 137 ARG B 73 ARG^? 22.29 CL CL B 129 C 141 THR B 92 THR^? 18.96 CL CL A 129 C 235 ASP B 30 ASP^? 20.91 CL CL B 129 coo -5.79 67.26 36.83 -4.57 64.58 37.74 83.86 69.55 -59.16 85.91 69.18 -61.42 coo -6.81 68.31 28.28 -4.82 68.47 27.57 88.84 61.70 -60.19 88.43 63.62 -59.28 coo -13.01 70.96 47.58 -11.44 71.65 46.34 90.60 81.40 -60.16 92.15 82.83 -59.97 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 11 3 # 11 C 137 ARG B 73 ARG^? 22.29 CL CL B 129 C 141 THR B 92 THR^? 18.96 CL CL A 129 C 235 ASP C 30 ASP^? 20.67 CL CL C 129 coo -5.79 67.26 36.83 -4.57 64.58 37.74 83.86 69.55 -59.16 85.91 69.18 -61.42 coo -6.81 68.31 28.28 -4.82 68.47 27.57 88.84 61.70 -60.19 88.43 63.62 -59.28 coo -13.01 70.96 47.58 -11.44 71.65 46.34 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 12 3 # 12 C 137 ARG B 73 ARG^? 22.29 CL CL B 129 C 141 THR B 95 THR^? 23.42 CL CL A 129 C 235 ASP B 30 ASP^? 20.91 CL CL B 129 coo -5.79 67.26 36.83 -4.57 64.58 37.74 83.86 69.55 -59.16 85.91 69.18 -61.42 coo -6.81 68.31 28.28 -4.82 68.47 27.57 79.47 64.83 -57.24 79.55 63.29 -55.69 coo -13.01 70.96 47.58 -11.44 71.65 46.34 90.60 81.40 -60.16 92.15 82.83 -59.97 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 13 3 # 13 C 137 ARG B 73 ARG^? 22.29 CL CL B 129 C 141 THR B 97 THR^? 28.75 CL CL D 129 C 235 ASP B 30 ASP^? 20.91 CL CL B 129 coo -5.79 67.26 36.83 -4.57 64.58 37.74 83.86 69.55 -59.16 85.91 69.18 -61.42 coo -6.81 68.31 28.28 -4.82 68.47 27.57 74.83 68.80 -53.92 74.73 70.43 -52.45 coo -13.01 70.96 47.58 -11.44 71.65 46.34 90.60 81.40 -60.16 92.15 82.83 -59.97 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 14 3 # 14 C 137 ARG B 76 ARG^? 18.98 CL CL A 129 C 141 THR B 95 THR^? 23.42 CL CL A 129 C 235 ASP C 14 ASP^? 16.95 CL CL A 129 coo -5.79 67.26 36.83 -4.57 64.58 37.74 82.73 59.03 -54.76 80.31 57.91 -56.24 coo -6.81 68.31 28.28 -4.82 68.47 27.57 79.47 64.83 -57.24 79.55 63.29 -55.69 coo -13.01 70.96 47.58 -11.44 71.65 46.34 95.50 58.88 -47.37 95.04 57.01 -48.29 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 15 3 # 15 C 137 ARG B 96 ARG^? 24.18 CL CL B 129 C 141 THR B 27 THR^? 25.10 CL CL B 129 C 235 ASP D 72 ASP^? 29.64 CL CL D 129 coo -5.79 67.26 36.83 -4.57 64.58 37.74 78.35 70.58 -59.29 80.55 70.83 -61.45 coo -6.81 68.31 28.28 -4.82 68.47 27.57 85.40 75.83 -58.05 86.15 74.42 -56.65 coo -13.01 70.96 47.58 -11.44 71.65 46.34 69.04 67.18 -50.81 68.23 68.38 -52.37 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 16 3 # 16 C 137 ARG B 96 ARG^? 24.18 CL CL B 129 C 141 THR B 100 THR^? 28.81 CL CL A 129 C 235 ASP C 30 ASP^? 20.67 CL CL C 129 coo -5.79 67.26 36.83 -4.57 64.58 37.74 78.35 70.58 -59.29 80.55 70.83 -61.45 coo -6.81 68.31 28.28 -4.82 68.47 27.57 72.27 62.59 -58.79 70.28 61.78 -58.67 coo -13.01 70.96 47.58 -11.44 71.65 46.34 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 17 3 # 17 C 137 ARG B 96 ARG^? 24.18 CL CL B 129 C 141 THR B 100 THR^? 28.81 CL CL A 129 C 235 ASP D 30 ASP^? 20.62 CL CL D 129 coo -5.79 67.26 36.83 -4.57 64.58 37.74 78.35 70.58 -59.29 80.55 70.83 -61.45 coo -6.81 68.31 28.28 -4.82 68.47 27.57 72.27 62.59 -58.79 70.28 61.78 -58.67 coo -13.01 70.96 47.58 -11.44 71.65 46.34 76.16 76.40 -45.40 77.49 78.05 -45.35 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 18 3 # 18 C 137 ARG B 117 ARG^? 16.04 CL CL B 129 C 141 THR B 44 THR^? 7.91 CL CL B 129 C 235 ASP B 14 ASP^? 27.62 CL CL A 129 coo -5.79 67.26 36.83 -4.57 64.58 37.74 100.63 75.34 -68.25 102.08 77.36 -66.41 coo -6.81 68.31 28.28 -4.82 68.47 27.57 95.21 71.44 -76.44 95.74 72.60 -74.74 coo -13.01 70.96 47.58 -11.44 71.65 46.34 105.60 69.00 -58.44 107.49 69.47 -57.66 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 19 3 # 19 C 137 ARG B 117 ARG^? 16.04 CL CL B 129 C 141 THR B 44 THR^? 7.91 CL CL B 129 C 235 ASP B 30 ASP^? 20.91 CL CL B 129 coo -5.79 67.26 36.83 -4.57 64.58 37.74 100.63 75.34 -68.25 102.08 77.36 -66.41 coo -6.81 68.31 28.28 -4.82 68.47 27.57 95.21 71.44 -76.44 95.74 72.60 -74.74 coo -13.01 70.96 47.58 -11.44 71.65 46.34 90.60 81.40 -60.16 92.15 82.83 -59.97 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 20 3 # 20 C 137 ARG C 21 ARG^? 20.59 CL CL C 129 C 141 THR C 16 THR^? 23.09 CL CL A 129 C 235 ASP B 72 ASP^? 28.57 CL CL C 129 coo -5.79 67.26 36.83 -4.57 64.58 37.74 87.78 66.49 -47.10 85.32 65.73 -45.33 coo -6.81 68.31 28.28 -4.82 68.47 27.57 97.77 65.15 -48.94 99.37 65.45 -50.33 coo -13.01 70.96 47.58 -11.44 71.65 46.34 80.87 74.36 -54.99 81.74 73.36 -53.35 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 21 3 # 21 C 137 ARG C 21 ARG^? 20.59 CL CL C 129 C 141 THR C 16 THR^? 23.09 CL CL A 129 C 235 ASP C 35 ASP^? 10.26 CL CL C 129 coo -5.79 67.26 36.83 -4.57 64.58 37.74 87.78 66.49 -47.10 85.32 65.73 -45.33 coo -6.81 68.31 28.28 -4.82 68.47 27.57 97.77 65.15 -48.94 99.37 65.45 -50.33 coo -13.01 70.96 47.58 -11.44 71.65 46.34 83.63 70.73 -36.85 83.32 69.81 -34.96 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 22 3 # 22 C 137 ARG C 46 ARG^? 15.12 CL CL C 129 C 141 THR C 44 THR^? 7.82 CL CL C 129 C 235 ASP C 30 ASP^? 20.67 CL CL C 129 coo -5.79 67.26 36.83 -4.57 64.58 37.74 92.47 76.70 -34.87 92.87 79.50 -36.04 coo -6.81 68.31 28.28 -4.82 68.47 27.57 93.28 69.34 -29.36 92.05 68.81 -31.01 coo -13.01 70.96 47.58 -11.44 71.65 46.34 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 23 3 # 23 C 137 ARG C 73 ARG^? 22.24 CL CL C 129 C 141 THR C 92 THR^? 26.08 CL CL C 129 C 235 ASP B 30 ASP^? 20.91 CL CL B 129 coo -5.79 67.26 36.83 -4.57 64.58 37.74 95.26 80.79 -46.47 95.45 78.63 -44.29 coo -6.81 68.31 28.28 -4.82 68.47 27.57 103.00 75.79 -45.49 101.15 76.17 -46.51 coo -13.01 70.96 47.58 -11.44 71.65 46.34 90.60 81.40 -60.16 92.15 82.83 -59.97 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 24 3 # 24 C 137 ARG C 73 ARG^? 22.24 CL CL C 129 C 141 THR C 92 THR^? 26.08 CL CL C 129 C 235 ASP C 30 ASP^? 20.67 CL CL C 129 coo -5.79 67.26 36.83 -4.57 64.58 37.74 95.26 80.79 -46.47 95.45 78.63 -44.29 coo -6.81 68.31 28.28 -4.82 68.47 27.57 103.00 75.79 -45.49 101.15 76.17 -46.51 coo -13.01 70.96 47.58 -11.44 71.65 46.34 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 25 3 # 25 C 137 ARG C 73 ARG^? 22.24 CL CL C 129 C 141 THR C 97 THR^? 29.17 CL CL B 129 C 235 ASP C 30 ASP^? 20.67 CL CL C 129 coo -5.79 67.26 36.83 -4.57 64.58 37.74 95.26 80.79 -46.47 95.45 78.63 -44.29 coo -6.81 68.31 28.28 -4.82 68.47 27.57 96.29 89.95 -51.83 94.80 89.38 -53.40 coo -13.01 70.96 47.58 -11.44 71.65 46.34 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 26 3 # 26 C 137 ARG C 76 ARG^? 33.92 CL CL B 129 C 141 THR C 95 THR^? 31.97 CL CL C 129 C 235 ASP B 14 ASP^? 27.62 CL CL A 129 coo -5.79 67.26 36.83 -4.57 64.58 37.74 105.54 81.89 -51.05 106.65 84.23 -49.40 coo -6.81 68.31 28.28 -4.82 68.47 27.57 99.92 85.14 -48.37 101.51 85.07 -49.86 coo -13.01 70.96 47.58 -11.44 71.65 46.34 105.60 69.00 -58.44 107.49 69.47 -57.66 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 27 3 # 27 C 137 ARG C 117 ARG^? 16.02 CL CL C 129 C 141 THR C 44 THR^? 7.82 CL CL C 129 C 235 ASP C 14 ASP^? 16.95 CL CL A 129 coo -5.79 67.26 36.83 -4.57 64.58 37.74 89.36 64.01 -37.29 87.40 62.56 -39.24 coo -6.81 68.31 28.28 -4.82 68.47 27.57 93.28 69.34 -29.36 92.05 68.81 -31.01 coo -13.01 70.96 47.58 -11.44 71.65 46.34 95.50 58.88 -47.37 95.04 57.01 -48.29 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 28 3 # 28 C 137 ARG C 117 ARG^? 16.02 CL CL C 129 C 141 THR C 44 THR^? 7.82 CL CL C 129 C 235 ASP C 30 ASP^? 20.67 CL CL C 129 coo -5.79 67.26 36.83 -4.57 64.58 37.74 89.36 64.01 -37.29 87.40 62.56 -39.24 coo -6.81 68.31 28.28 -4.82 68.47 27.57 93.28 69.34 -29.36 92.05 68.81 -31.01 coo -13.01 70.96 47.58 -11.44 71.65 46.34 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 29 3 # 29 C 137 ARG D 21 ARG^? 20.73 CL CL D 129 C 141 THR D 16 THR^? 28.44 CL CL D 129 C 235 ASP D 35 ASP^? 10.18 CL CL D 129 coo -5.79 67.26 36.83 -4.57 64.58 37.74 71.50 84.01 -47.23 73.85 84.97 -45.52 coo -6.81 68.31 28.28 -4.82 68.47 27.57 61.61 85.42 -49.02 60.10 85.21 -50.52 coo -13.01 70.96 47.58 -11.44 71.65 46.34 75.66 79.96 -36.93 75.99 80.66 -34.97 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 30 3 # 30 C 137 ARG D 46 ARG^? 15.13 CL CL D 129 C 141 THR D 44 THR^? 7.93 CL CL D 129 C 235 ASP D 30 ASP^? 20.62 CL CL D 129 coo -5.79 67.26 36.83 -4.57 64.58 37.74 66.74 73.93 -35.00 66.45 71.02 -36.02 coo -6.81 68.31 28.28 -4.82 68.47 27.57 65.95 81.28 -29.36 67.15 81.78 -31.05 coo -13.01 70.96 47.58 -11.44 71.65 46.34 76.16 76.40 -45.40 77.49 78.05 -45.35 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 31 3 # 31 C 137 ARG D 73 ARG^? 22.15 CL CL D 129 C 141 THR D 92 THR^? 25.97 CL CL D 129 C 235 ASP D 30 ASP^? 20.62 CL CL D 129 coo -5.79 67.26 36.83 -4.57 64.58 37.74 64.06 69.83 -46.45 63.93 71.88 -44.19 coo -6.81 68.31 28.28 -4.82 68.47 27.57 56.38 74.82 -45.46 58.23 74.40 -46.42 coo -13.01 70.96 47.58 -11.44 71.65 46.34 76.16 76.40 -45.40 77.49 78.05 -45.35 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 32 3 # 32 C 137 ARG D 117 ARG^? 15.96 CL CL D 129 C 141 THR D 44 THR^? 7.93 CL CL D 129 C 235 ASP D 14 ASP^? 27.52 CL CL D 129 coo -5.79 67.26 36.83 -4.57 64.58 37.74 69.91 86.62 -37.36 71.94 88.06 -39.21 coo -6.81 68.31 28.28 -4.82 68.47 27.57 65.95 81.28 -29.36 67.15 81.78 -31.05 coo -13.01 70.96 47.58 -11.44 71.65 46.34 63.54 91.53 -47.18 63.81 93.48 -47.82 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 33 3 # 33 C 137 ARG D 117 ARG^? 15.96 CL CL D 129 C 141 THR D 44 THR^? 7.93 CL CL D 129 C 235 ASP D 30 ASP^? 20.62 CL CL D 129 coo -5.79 67.26 36.83 -4.57 64.58 37.74 69.91 86.62 -37.36 71.94 88.06 -39.21 coo -6.81 68.31 28.28 -4.82 68.47 27.57 65.95 81.28 -29.36 67.15 81.78 -31.05 coo -13.01 70.96 47.58 -11.44 71.65 46.34 76.16 76.40 -45.40 77.49 78.05 -45.35 1bd3_c02 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 33 hits 1bd3_c02 naa= 3 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 B 137 ARG A 21 ARG~? 20.44 CL CL A 129 B 141 THR A 16 THR~? 21.54 CL CL B 129 B 235 ASP A 35 ASP~? 10.31 CL CL A 129 coo 8.13 67.41 100.27 7.18 68.35 97.45 98.35 46.51 -82.89 98.57 44.40 -80.63 coo 8.28 67.78 108.81 6.22 67.65 109.43 99.47 56.28 -84.34 99.11 57.82 -85.77 coo 14.55 73.52 89.47 12.81 73.95 90.56 93.79 42.35 -72.20 94.79 41.97 -70.38 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 B 137 ARG A 46 ARG^? 15.11 CL CL A 129 B 141 THR A 44 THR.? 7.93 CL CL A 129 B 235 ASP A 30 ASP~? 20.80 CL CL A 129 coo 8.13 67.41 100.27 7.18 68.35 97.45 87.96 51.20 -70.32 85.08 51.60 -71.34 coo 8.28 67.78 108.81 6.22 67.65 109.43 95.29 52.07 -64.55 95.81 50.95 -66.27 coo 14.55 73.52 89.47 12.81 73.95 90.56 90.38 41.71 -80.87 92.04 40.39 -80.79 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 B 137 ARG A 73 ARG.? 22.19 CL CL A 129 B 141 THR A 92 THR.? 19.17 CL CL B 129 B 235 ASP A 30 ASP~? 20.80 CL CL A 129 coo 8.13 67.41 100.27 7.18 68.35 97.45 83.82 53.79 -81.61 86.00 54.30 -79.51 coo 8.28 67.78 108.81 6.22 67.65 109.43 88.80 61.61 -80.86 88.36 59.74 -81.92 coo 14.55 73.52 89.47 12.81 73.95 90.56 90.38 41.71 -80.87 92.04 40.39 -80.79 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 B 137 ARG A 73 ARG.? 22.19 CL CL A 129 B 141 THR A 95 THR.? 23.66 CL CL B 129 B 235 ASP A 30 ASP~? 20.80 CL CL A 129 coo 8.13 67.41 100.27 7.18 68.35 97.45 83.82 53.79 -81.61 86.00 54.30 -79.51 coo 8.28 67.78 108.81 6.22 67.65 109.43 79.48 58.54 -83.85 79.37 60.11 -85.39 coo 14.55 73.52 89.47 12.81 73.95 90.56 90.38 41.71 -80.87 92.04 40.39 -80.79 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 B 137 ARG A 117 ARG^? 16.03 CL CL A 129 B 141 THR A 44 THR.? 7.93 CL CL A 129 B 235 ASP A 14 ASP~? 27.67 CL CL B 129 coo 8.13 67.41 100.27 7.18 68.35 97.45 100.59 48.03 -72.66 102.04 46.10 -74.59 coo 8.28 67.78 108.81 6.22 67.65 109.43 95.29 52.07 -64.55 95.81 50.95 -66.27 coo 14.55 73.52 89.47 12.81 73.95 90.56 105.70 54.30 -82.61 107.63 54.15 -83.44 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 B 137 ARG A 117 ARG^? 16.03 CL CL A 129 B 141 THR A 44 THR.? 7.93 CL CL A 129 B 235 ASP A 30 ASP~? 20.80 CL CL A 129 coo 8.13 67.41 100.27 7.18 68.35 97.45 100.59 48.03 -72.66 102.04 46.10 -74.59 coo 8.28 67.78 108.81 6.22 67.65 109.43 95.29 52.07 -64.55 95.81 50.95 -66.27 coo 14.55 73.52 89.47 12.81 73.95 90.56 90.38 41.71 -80.87 92.04 40.39 -80.79 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 7 3 # 7 B 137 ARG B 21 ARG^? 20.28 CL CL B 129 B 141 THR B 16 THR^? 21.09 CL CL A 129 B 235 ASP B 35 ASP^? 10.19 CL CL B 129 coo 8.13 67.41 100.27 7.18 68.35 97.45 98.33 76.92 -58.24 98.68 79.03 -60.54 coo 8.28 67.78 108.81 6.22 67.65 109.43 99.48 66.86 -56.72 99.31 65.24 -55.32 coo 14.55 73.52 89.47 12.81 73.95 90.56 93.79 80.98 -68.72 94.61 81.32 -70.62 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 8 3 # 8 B 137 ARG B 21 ARG^? 20.28 CL CL B 129 B 141 THR B 16 THR^? 21.09 CL CL A 129 B 235 ASP C 72 ASP^? 28.53 CL CL B 129 coo 8.13 67.41 100.27 7.18 68.35 97.45 98.33 76.92 -58.24 98.68 79.03 -60.54 coo 8.28 67.78 108.81 6.22 67.65 109.43 99.48 66.86 -56.72 99.31 65.24 -55.32 coo 14.55 73.52 89.47 12.81 73.95 90.56 90.38 83.76 -50.64 91.24 82.68 -52.23 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 9 3 # 9 B 137 ARG B 46 ARG^? 15.06 CL CL B 129 B 141 THR B 44 THR^? 7.91 CL CL B 129 B 235 ASP B 30 ASP^? 20.91 CL CL B 129 coo 8.13 67.41 100.27 7.18 68.35 97.45 87.96 72.13 -70.71 85.05 71.84 -69.78 coo 8.28 67.78 108.81 6.22 67.65 109.43 95.21 71.44 -76.44 95.74 72.60 -74.74 coo 14.55 73.52 89.47 12.81 73.95 90.56 90.60 81.40 -60.16 92.15 82.83 -59.97 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 10 3 # 10 B 137 ARG B 73 ARG^? 22.29 CL CL B 129 B 141 THR B 92 THR^? 18.96 CL CL A 129 B 235 ASP B 30 ASP^? 20.91 CL CL B 129 coo 8.13 67.41 100.27 7.18 68.35 97.45 83.86 69.55 -59.16 85.91 69.18 -61.42 coo 8.28 67.78 108.81 6.22 67.65 109.43 88.84 61.70 -60.19 88.43 63.62 -59.28 coo 14.55 73.52 89.47 12.81 73.95 90.56 90.60 81.40 -60.16 92.15 82.83 -59.97 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 11 3 # 11 B 137 ARG B 73 ARG^? 22.29 CL CL B 129 B 141 THR B 92 THR^? 18.96 CL CL A 129 B 235 ASP C 30 ASP^? 20.67 CL CL C 129 coo 8.13 67.41 100.27 7.18 68.35 97.45 83.86 69.55 -59.16 85.91 69.18 -61.42 coo 8.28 67.78 108.81 6.22 67.65 109.43 88.84 61.70 -60.19 88.43 63.62 -59.28 coo 14.55 73.52 89.47 12.81 73.95 90.56 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 12 3 # 12 B 137 ARG B 73 ARG^? 22.29 CL CL B 129 B 141 THR B 95 THR^? 23.42 CL CL A 129 B 235 ASP B 30 ASP^? 20.91 CL CL B 129 coo 8.13 67.41 100.27 7.18 68.35 97.45 83.86 69.55 -59.16 85.91 69.18 -61.42 coo 8.28 67.78 108.81 6.22 67.65 109.43 79.47 64.83 -57.24 79.55 63.29 -55.69 coo 14.55 73.52 89.47 12.81 73.95 90.56 90.60 81.40 -60.16 92.15 82.83 -59.97 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 13 3 # 13 B 137 ARG B 73 ARG^? 22.29 CL CL B 129 B 141 THR B 97 THR^? 28.75 CL CL D 129 B 235 ASP B 30 ASP^? 20.91 CL CL B 129 coo 8.13 67.41 100.27 7.18 68.35 97.45 83.86 69.55 -59.16 85.91 69.18 -61.42 coo 8.28 67.78 108.81 6.22 67.65 109.43 74.83 68.80 -53.92 74.73 70.43 -52.45 coo 14.55 73.52 89.47 12.81 73.95 90.56 90.60 81.40 -60.16 92.15 82.83 -59.97 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 14 3 # 14 B 137 ARG B 76 ARG^? 18.98 CL CL A 129 B 141 THR B 95 THR^? 23.42 CL CL A 129 B 235 ASP C 14 ASP^? 16.95 CL CL A 129 coo 8.13 67.41 100.27 7.18 68.35 97.45 82.73 59.03 -54.76 80.31 57.91 -56.24 coo 8.28 67.78 108.81 6.22 67.65 109.43 79.47 64.83 -57.24 79.55 63.29 -55.69 coo 14.55 73.52 89.47 12.81 73.95 90.56 95.50 58.88 -47.37 95.04 57.01 -48.29 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 15 3 # 15 B 137 ARG B 96 ARG^? 24.18 CL CL B 129 B 141 THR B 27 THR^? 25.10 CL CL B 129 B 235 ASP D 72 ASP^? 29.64 CL CL D 129 coo 8.13 67.41 100.27 7.18 68.35 97.45 78.35 70.58 -59.29 80.55 70.83 -61.45 coo 8.28 67.78 108.81 6.22 67.65 109.43 85.40 75.83 -58.05 86.15 74.42 -56.65 coo 14.55 73.52 89.47 12.81 73.95 90.56 69.04 67.18 -50.81 68.23 68.38 -52.37 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 16 3 # 16 B 137 ARG B 96 ARG^? 24.18 CL CL B 129 B 141 THR B 100 THR^? 28.81 CL CL A 129 B 235 ASP C 30 ASP^? 20.67 CL CL C 129 coo 8.13 67.41 100.27 7.18 68.35 97.45 78.35 70.58 -59.29 80.55 70.83 -61.45 coo 8.28 67.78 108.81 6.22 67.65 109.43 72.27 62.59 -58.79 70.28 61.78 -58.67 coo 14.55 73.52 89.47 12.81 73.95 90.56 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 17 3 # 17 B 137 ARG B 96 ARG^? 24.18 CL CL B 129 B 141 THR B 100 THR^? 28.81 CL CL A 129 B 235 ASP D 30 ASP^? 20.62 CL CL D 129 coo 8.13 67.41 100.27 7.18 68.35 97.45 78.35 70.58 -59.29 80.55 70.83 -61.45 coo 8.28 67.78 108.81 6.22 67.65 109.43 72.27 62.59 -58.79 70.28 61.78 -58.67 coo 14.55 73.52 89.47 12.81 73.95 90.56 76.16 76.40 -45.40 77.49 78.05 -45.35 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 18 3 # 18 B 137 ARG C 21 ARG^? 20.59 CL CL C 129 B 141 THR C 16 THR^? 23.09 CL CL A 129 B 235 ASP B 72 ASP^? 28.57 CL CL C 129 coo 8.13 67.41 100.27 7.18 68.35 97.45 87.78 66.49 -47.10 85.32 65.73 -45.33 coo 8.28 67.78 108.81 6.22 67.65 109.43 97.77 65.15 -48.94 99.37 65.45 -50.33 coo 14.55 73.52 89.47 12.81 73.95 90.56 80.87 74.36 -54.99 81.74 73.36 -53.35 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 19 3 # 19 B 137 ARG C 46 ARG^? 15.12 CL CL C 129 B 141 THR C 44 THR^? 7.82 CL CL C 129 B 235 ASP C 30 ASP^? 20.67 CL CL C 129 coo 8.13 67.41 100.27 7.18 68.35 97.45 92.47 76.70 -34.87 92.87 79.50 -36.04 coo 8.28 67.78 108.81 6.22 67.65 109.43 93.28 69.34 -29.36 92.05 68.81 -31.01 coo 14.55 73.52 89.47 12.81 73.95 90.56 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 20 3 # 20 B 137 ARG C 73 ARG^? 22.24 CL CL C 129 B 141 THR C 92 THR^? 26.08 CL CL C 129 B 235 ASP B 30 ASP^? 20.91 CL CL B 129 coo 8.13 67.41 100.27 7.18 68.35 97.45 95.26 80.79 -46.47 95.45 78.63 -44.29 coo 8.28 67.78 108.81 6.22 67.65 109.43 103.00 75.79 -45.49 101.15 76.17 -46.51 coo 14.55 73.52 89.47 12.81 73.95 90.56 90.60 81.40 -60.16 92.15 82.83 -59.97 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 21 3 # 21 B 137 ARG C 73 ARG^? 22.24 CL CL C 129 B 141 THR C 92 THR^? 26.08 CL CL C 129 B 235 ASP C 30 ASP^? 20.67 CL CL C 129 coo 8.13 67.41 100.27 7.18 68.35 97.45 95.26 80.79 -46.47 95.45 78.63 -44.29 coo 8.28 67.78 108.81 6.22 67.65 109.43 103.00 75.79 -45.49 101.15 76.17 -46.51 coo 14.55 73.52 89.47 12.81 73.95 90.56 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 22 3 # 22 B 137 ARG C 73 ARG^? 22.24 CL CL C 129 B 141 THR C 95 THR^? 31.97 CL CL C 129 B 235 ASP C 30 ASP^? 20.67 CL CL C 129 coo 8.13 67.41 100.27 7.18 68.35 97.45 95.26 80.79 -46.47 95.45 78.63 -44.29 coo 8.28 67.78 108.81 6.22 67.65 109.43 99.92 85.14 -48.37 101.51 85.07 -49.86 coo 14.55 73.52 89.47 12.81 73.95 90.56 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 23 3 # 23 B 137 ARG C 76 ARG^? 33.92 CL CL B 129 B 141 THR C 95 THR^? 31.97 CL CL C 129 B 235 ASP B 14 ASP^? 27.62 CL CL A 129 coo 8.13 67.41 100.27 7.18 68.35 97.45 105.54 81.89 -51.05 106.65 84.23 -49.40 coo 8.28 67.78 108.81 6.22 67.65 109.43 99.92 85.14 -48.37 101.51 85.07 -49.86 coo 14.55 73.52 89.47 12.81 73.95 90.56 105.60 69.00 -58.44 107.49 69.47 -57.66 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 24 3 # 24 B 137 ARG C 117 ARG^? 16.02 CL CL C 129 B 141 THR C 44 THR^? 7.82 CL CL C 129 B 235 ASP C 14 ASP^? 16.95 CL CL A 129 coo 8.13 67.41 100.27 7.18 68.35 97.45 89.36 64.01 -37.29 87.40 62.56 -39.24 coo 8.28 67.78 108.81 6.22 67.65 109.43 93.28 69.34 -29.36 92.05 68.81 -31.01 coo 14.55 73.52 89.47 12.81 73.95 90.56 95.50 58.88 -47.37 95.04 57.01 -48.29 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 25 3 # 25 B 137 ARG C 117 ARG^? 16.02 CL CL C 129 B 141 THR C 44 THR^? 7.82 CL CL C 129 B 235 ASP C 30 ASP^? 20.67 CL CL C 129 coo 8.13 67.41 100.27 7.18 68.35 97.45 89.36 64.01 -37.29 87.40 62.56 -39.24 coo 8.28 67.78 108.81 6.22 67.65 109.43 93.28 69.34 -29.36 92.05 68.81 -31.01 coo 14.55 73.52 89.47 12.81 73.95 90.56 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 26 3 # 26 B 137 ARG D 21 ARG^? 20.73 CL CL D 129 B 141 THR D 16 THR^? 28.44 CL CL D 129 B 235 ASP B 72 ASP^? 28.57 CL CL C 129 coo 8.13 67.41 100.27 7.18 68.35 97.45 71.50 84.01 -47.23 73.85 84.97 -45.52 coo 8.28 67.78 108.81 6.22 67.65 109.43 61.61 85.42 -49.02 60.10 85.21 -50.52 coo 14.55 73.52 89.47 12.81 73.95 90.56 80.87 74.36 -54.99 81.74 73.36 -53.35 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 27 3 # 27 B 137 ARG D 46 ARG^? 15.13 CL CL D 129 B 141 THR D 44 THR^? 7.93 CL CL D 129 B 235 ASP D 30 ASP^? 20.62 CL CL D 129 coo 8.13 67.41 100.27 7.18 68.35 97.45 66.74 73.93 -35.00 66.45 71.02 -36.02 coo 8.28 67.78 108.81 6.22 67.65 109.43 65.95 81.28 -29.36 67.15 81.78 -31.05 coo 14.55 73.52 89.47 12.81 73.95 90.56 76.16 76.40 -45.40 77.49 78.05 -45.35 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 28 3 # 28 B 137 ARG D 73 ARG^? 22.15 CL CL D 129 B 141 THR D 92 THR^? 25.97 CL CL D 129 B 235 ASP D 30 ASP^? 20.62 CL CL D 129 coo 8.13 67.41 100.27 7.18 68.35 97.45 64.06 69.83 -46.45 63.93 71.88 -44.19 coo 8.28 67.78 108.81 6.22 67.65 109.43 56.38 74.82 -45.46 58.23 74.40 -46.42 coo 14.55 73.52 89.47 12.81 73.95 90.56 76.16 76.40 -45.40 77.49 78.05 -45.35 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 29 3 # 29 B 137 ARG D 73 ARG^? 22.15 CL CL D 129 B 141 THR D 95 THR^? 32.06 CL CL D 129 B 235 ASP D 30 ASP^? 20.62 CL CL D 129 coo 8.13 67.41 100.27 7.18 68.35 97.45 64.06 69.83 -46.45 63.93 71.88 -44.19 coo 8.28 67.78 108.81 6.22 67.65 109.43 59.52 65.53 -48.53 57.85 65.41 -49.95 coo 14.55 73.52 89.47 12.81 73.95 90.56 76.16 76.40 -45.40 77.49 78.05 -45.35 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 30 3 # 30 B 137 ARG D 117 ARG^? 15.96 CL CL D 129 B 141 THR D 44 THR^? 7.93 CL CL D 129 B 235 ASP D 14 ASP^? 27.52 CL CL D 129 coo 8.13 67.41 100.27 7.18 68.35 97.45 69.91 86.62 -37.36 71.94 88.06 -39.21 coo 8.28 67.78 108.81 6.22 67.65 109.43 65.95 81.28 -29.36 67.15 81.78 -31.05 coo 14.55 73.52 89.47 12.81 73.95 90.56 63.54 91.53 -47.18 63.81 93.48 -47.82 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 31 3 # 31 B 137 ARG D 117 ARG^? 15.96 CL CL D 129 B 141 THR D 44 THR^? 7.93 CL CL D 129 B 235 ASP D 30 ASP^? 20.62 CL CL D 129 coo 8.13 67.41 100.27 7.18 68.35 97.45 69.91 86.62 -37.36 71.94 88.06 -39.21 coo 8.28 67.78 108.81 6.22 67.65 109.43 65.95 81.28 -29.36 67.15 81.78 -31.05 coo 14.55 73.52 89.47 12.81 73.95 90.56 76.16 76.40 -45.40 77.49 78.05 -45.35 1bd3_c03 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 31 hits 1bd3_c03 naa= 3 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 1 3 # 1 14 ASP C 35 ASP^? 10.26 CL CL C 129 16 HIS C 40 HIS^? 7.21 CL CL C 129 67 GLY D 48 GLY^? 16.44 CL CL D 129 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 83.63 70.73 -36.85 83.32 69.81 -34.96 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 84.82 65.72 -30.75 83.18 66.51 -29.70 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 63.40 69.58 -34.34 62.88 69.33 -33.72 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 2 3 # 2 14 ASP C 35 ASP^? 10.26 CL CL C 129 16 HIS C 40 HIS^? 7.21 CL CL C 129 67 GLY D 50 GLY^? 19.27 CL CL D 129 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 83.63 70.73 -36.85 83.32 69.81 -34.96 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 84.82 65.72 -30.75 83.18 66.51 -29.70 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 63.87 64.31 -32.56 64.09 65.07 -32.58 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 3 3 # 3 14 ASP D 35 ASP^? 10.18 CL CL D 129 16 HIS D 40 HIS^? 7.31 CL CL D 129 67 GLY C 48 GLY^? 16.40 CL CL C 129 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 75.66 79.96 -36.93 75.99 80.66 -34.97 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 74.49 84.96 -30.93 76.13 84.16 -29.90 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 95.85 81.00 -34.38 96.37 81.26 -33.76 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 4 3 # 4 14 ASP D 35 ASP^? 10.18 CL CL D 129 16 HIS D 40 HIS^? 7.31 CL CL D 129 67 GLY C 50 GLY^? 19.22 CL CL C 129 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 75.66 79.96 -36.93 75.99 80.66 -34.97 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 74.49 84.96 -30.93 76.13 84.16 -29.90 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 95.41 86.26 -32.58 95.19 85.50 -32.58 1be1_c02 source 1be1 GLUTAMATE MUTASE : 4 hits 1be1_c02 naa= 3 ULMN 3 1bf2_c00 ISOAMYLASE user 1 3 # 1 375 ASP B 35 ASP^? 10.19 CL CL B 129 435 GLU B 36 GLU^? 18.40 CL CL B 129 510 ASP B 30 ASP^? 20.91 CL CL B 129 coo 88.62 69.90 41.16 89.05 70.67 43.04 93.79 80.98 -68.72 94.61 81.32 -70.62 coo 89.52 76.11 40.17 89.01 75.16 41.97 99.20 79.77 -64.83 99.58 80.60 -62.91 coo 84.89 77.60 46.67 85.63 75.79 46.03 90.60 81.40 -60.16 92.15 82.83 -59.97 1bf2_c00 source 1bf2 ISOAMYLASE : 1 hits 1bf2_c00 naa= 3 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 1 3 # 1 A 461 GLU A 51 GLU^? 16.44 CL CL A 129 A 503 TYR A 54 TYR^? 10.29 CL CL A 129 A 537 GLU A 58 GLU~? 7.41 CL CL A 129 coo 24.06 146.21 11.09 22.89 146.18 9.36 82.00 50.89 -67.09 80.89 51.23 -68.89 coo 15.91 140.69 8.32 15.71 143.39 9.13 89.27 53.06 -59.98 88.13 55.63 -59.94 coo 16.65 144.44 13.24 18.34 145.22 12.33 87.85 46.74 -60.89 87.27 48.56 -59.93 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 2 3 # 2 A 461 GLU A 57 GLU~? -5.56 CL CL A 129s A 503 TYR A 54 TYR^? 10.29 CL CL A 129 A 537 GLU A 58 GLU~? 7.41 CL CL A 129 coo 24.06 146.21 11.09 22.89 146.18 9.36 91.25 41.69 -61.23 91.08 41.09 -59.17 coo 15.91 140.69 8.32 15.71 143.39 9.13 89.27 53.06 -59.98 88.13 55.63 -59.94 coo 16.65 144.44 13.24 18.34 145.22 12.33 87.85 46.74 -60.89 87.27 48.56 -59.93 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 3 3 # 3 A 461 GLU B 51 GLU^? 16.46 CL CL B 129 A 503 TYR B 54 TYR^? 10.36 CL CL B 129 A 537 GLU B 58 GLU^? 7.34 CL CL B 129 coo 24.06 146.21 11.09 22.89 146.18 9.36 81.98 72.56 -73.89 80.95 72.05 -72.12 coo 15.91 140.69 8.32 15.71 143.39 9.13 89.19 70.43 -81.07 88.03 67.93 -81.20 coo 16.65 144.44 13.24 18.34 145.22 12.33 87.90 76.66 -80.19 87.42 74.86 -81.30 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 4 3 # 4 A 461 GLU B 57 GLU^? -5.29 CL CL B 129s A 503 TYR B 54 TYR^? 10.36 CL CL B 129 A 537 GLU B 58 GLU^? 7.34 CL CL B 129 coo 24.06 146.21 11.09 22.89 146.18 9.36 91.24 81.90 -79.46 91.48 82.48 -81.50 coo 15.91 140.69 8.32 15.71 143.39 9.13 89.19 70.43 -81.07 88.03 67.93 -81.20 coo 16.65 144.44 13.24 18.34 145.22 12.33 87.90 76.66 -80.19 87.42 74.86 -81.30 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 5 3 # 5 A 461 GLU C 51 GLU^? 16.39 CL CL C 129 A 503 TYR C 54 TYR^? 10.32 CL CL C 129 A 537 GLU C 58 GLU^? 7.49 CL CL C 129 coo 24.06 146.21 11.09 22.89 146.18 9.36 92.20 82.64 -31.68 92.61 83.59 -33.56 coo 15.91 140.69 8.32 15.71 143.39 9.13 94.43 75.36 -24.67 96.94 76.58 -24.67 coo 16.65 144.44 13.24 18.34 145.22 12.33 88.02 76.82 -25.55 89.85 77.43 -24.60 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 6 3 # 6 A 461 GLU C 57 GLU^? -5.48 CL CL C 129s A 503 TYR C 54 TYR^? 10.32 CL CL C 129 A 537 GLU C 58 GLU^? 7.49 CL CL C 129 coo 24.06 146.21 11.09 22.89 146.18 9.36 82.94 73.46 -26.00 82.34 73.25 -23.96 coo 15.91 140.69 8.32 15.71 143.39 9.13 94.43 75.36 -24.67 96.94 76.58 -24.67 coo 16.65 144.44 13.24 18.34 145.22 12.33 88.02 76.82 -25.55 89.85 77.43 -24.60 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 7 3 # 7 A 461 GLU D 51 GLU^? 16.56 CL CL D 129 A 503 TYR D 54 TYR^? 10.35 CL CL D 129 A 537 GLU D 58 GLU^? 7.39 CL CL D 129 coo 24.06 146.21 11.09 22.89 146.18 9.36 66.99 68.03 -31.91 66.63 66.88 -33.67 coo 15.91 140.69 8.32 15.71 143.39 9.13 64.95 75.15 -24.65 62.40 74.09 -24.68 coo 16.65 144.44 13.24 18.34 145.22 12.33 71.21 74.03 -25.57 69.46 73.32 -24.61 1bgl_c08 source 1bgl BETA-GALACTOSIDASE : 7 hits 1bgl_c08 naa= 3 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 1 3 # 1 B 382 ARG A 60 ARG~? 8.61 CL CL A 129 B 451 GLU A 58 GLU~? 7.41 CL CL A 129 B 540 GLU A 57 GLU~? -5.56 CL CL A 129s coo 82.21 41.07 119.14 83.95 40.66 116.59 92.49 41.37 -66.87 95.11 39.81 -67.06 coo 86.52 35.28 112.74 87.08 36.38 110.99 87.85 46.74 -60.89 87.27 48.56 -59.93 coo 83.38 41.19 112.55 85.47 40.59 112.72 91.25 41.69 -61.23 91.08 41.09 -59.17 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 2 3 # 2 B 382 ARG B 60 ARG^? 8.76 CL CL B 129 B 451 GLU B 58 GLU^? 7.34 CL CL B 129 B 540 GLU B 57 GLU^? -5.29 CL CL B 129s coo 82.21 41.07 119.14 83.95 40.66 116.59 92.45 82.18 -73.93 95.13 83.66 -73.65 coo 86.52 35.28 112.74 87.08 36.38 110.99 87.90 76.66 -80.19 87.42 74.86 -81.30 coo 83.38 41.19 112.55 85.47 40.59 112.72 91.24 81.90 -79.46 91.48 82.48 -81.50 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 3 3 # 3 B 382 ARG C 60 ARG^? 8.92 CL CL C 129 B 451 GLU C 58 GLU^? 7.49 CL CL C 129 B 540 GLU C 57 GLU^? -5.48 CL CL C 129s coo 82.21 41.07 119.14 83.95 40.66 116.59 82.52 72.20 -31.52 80.97 69.57 -31.97 coo 86.52 35.28 112.74 87.08 36.38 110.99 88.02 76.82 -25.55 89.85 77.43 -24.60 coo 83.38 41.19 112.55 85.47 40.59 112.72 82.94 73.46 -26.00 82.34 73.25 -23.96 1bhg_c05 source 1bhg BETA-GLUCURONIDASE : 3 hits 1bhg_c05 naa= 3 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 1 3 # 1 118 ARG A 63 ARG~? 13.95 CL CL A 129 183 LYS A 24 LYS~? 27.96 CL CL A 129 317 ARG A 76 ARG^? 19.15 CL CL B 129 coo 76.57 109.19 73.41 73.86 110.26 72.16 87.85 45.63 -72.60 88.58 48.58 -73.24 coo 82.09 117.51 66.37 80.60 114.32 71.44 90.40 47.78 -84.76 92.62 43.20 -88.57 coo 65.21 120.62 58.76 63.62 123.14 59.66 82.62 63.89 -86.56 80.46 65.21 -84.78 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 2 3 # 2 118 ARG A 66 ARG~? 18.83 CL CL A 129 183 LYS A 24 LYS~? 27.96 CL CL A 129 317 ARG A 76 ARG^? 19.15 CL CL B 129 coo 76.57 109.19 73.41 73.86 110.26 72.16 82.10 46.84 -74.28 82.78 49.65 -75.31 coo 82.09 117.51 66.37 80.60 114.32 71.44 90.40 47.78 -84.76 92.62 43.20 -88.57 coo 65.21 120.62 58.76 63.62 123.14 59.66 82.62 63.89 -86.56 80.46 65.21 -84.78 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 3 3 # 3 118 ARG A 96 ARG.? 24.34 CL CL A 129 183 LYS A 24 LYS~? 27.96 CL CL A 129 317 ARG A 60 ARG~? 8.61 CL CL A 129 coo 76.57 109.19 73.41 73.86 110.26 72.16 78.03 52.93 -81.60 80.41 52.60 -79.67 coo 82.09 117.51 66.37 80.60 114.32 71.44 90.40 47.78 -84.76 92.62 43.20 -88.57 coo 65.21 120.62 58.76 63.62 123.14 59.66 92.49 41.37 -66.87 95.11 39.81 -67.06 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 4 3 # 4 118 ARG B 63 ARG^? 13.99 CL CL B 129 183 LYS B 24 LYS^? 27.82 CL CL B 129 317 ARG B 76 ARG^? 18.98 CL CL A 129 coo 76.57 109.19 73.41 73.86 110.26 72.16 87.72 77.76 -68.29 88.60 74.86 -67.71 coo 82.09 117.51 66.37 80.60 114.32 71.44 90.54 75.59 -56.27 92.78 80.12 -52.52 coo 65.21 120.62 58.76 63.62 123.14 59.66 82.73 59.03 -54.76 80.31 57.91 -56.24 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 5 3 # 5 118 ARG B 66 ARG^? 19.13 CL CL B 129 183 LYS B 24 LYS^? 27.82 CL CL B 129 317 ARG B 76 ARG^? 18.98 CL CL A 129 coo 76.57 109.19 73.41 73.86 110.26 72.16 82.06 76.49 -66.55 82.68 73.67 -65.41 coo 82.09 117.51 66.37 80.60 114.32 71.44 90.54 75.59 -56.27 92.78 80.12 -52.52 coo 65.21 120.62 58.76 63.62 123.14 59.66 82.73 59.03 -54.76 80.31 57.91 -56.24 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 6 3 # 6 118 ARG B 73 ARG^? 22.29 CL CL B 129 183 LYS C 24 LYS^? 26.64 CL CL C 129 317 ARG D 21 ARG^? 20.73 CL CL D 129 coo 76.57 109.19 73.41 73.86 110.26 72.16 83.86 69.55 -59.16 85.91 69.18 -61.42 coo 82.09 117.51 66.37 80.60 114.32 71.44 88.99 74.10 -49.29 84.03 71.99 -51.83 coo 65.21 120.62 58.76 63.62 123.14 59.66 71.50 84.01 -47.23 73.85 84.97 -45.52 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 7 3 # 7 118 ARG B 96 ARG^? 24.18 CL CL B 129 183 LYS B 24 LYS^? 27.82 CL CL B 129 317 ARG B 60 ARG^? 8.76 CL CL B 129 coo 76.57 109.19 73.41 73.86 110.26 72.16 78.35 70.58 -59.29 80.55 70.83 -61.45 coo 82.09 117.51 66.37 80.60 114.32 71.44 90.54 75.59 -56.27 92.78 80.12 -52.52 coo 65.21 120.62 58.76 63.62 123.14 59.66 92.45 82.18 -73.93 95.13 83.66 -73.65 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 8 3 # 8 118 ARG C 63 ARG^? 14.10 CL CL C 129 183 LYS C 24 LYS^? 26.64 CL CL C 129 317 ARG C 76 ARG^? 33.92 CL CL B 129 coo 76.57 109.19 73.41 73.86 110.26 72.16 86.96 77.03 -37.50 89.89 76.13 -38.00 coo 82.09 117.51 66.37 80.60 114.32 71.44 88.99 74.10 -49.29 84.03 71.99 -51.83 coo 65.21 120.62 58.76 63.62 123.14 59.66 105.54 81.89 -51.05 106.65 84.23 -49.40 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 9 3 # 9 118 ARG C 66 ARG^? 18.88 CL CL C 129 183 LYS C 24 LYS^? 26.64 CL CL C 129 317 ARG C 76 ARG^? 33.92 CL CL B 129 coo 76.57 109.19 73.41 73.86 110.26 72.16 88.18 82.59 -38.84 90.98 81.94 -39.92 coo 82.09 117.51 66.37 80.60 114.32 71.44 88.99 74.10 -49.29 84.03 71.99 -51.83 coo 65.21 120.62 58.76 63.62 123.14 59.66 105.54 81.89 -51.05 106.65 84.23 -49.40 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 10 3 # 10 118 ARG C 96 ARG^? 24.31 CL CL C 129 183 LYS C 24 LYS^? 26.64 CL CL C 129 317 ARG C 60 ARG^? 8.92 CL CL C 129 coo 76.57 109.19 73.41 73.86 110.26 72.16 94.28 86.51 -46.29 94.08 84.26 -44.17 coo 82.09 117.51 66.37 80.60 114.32 71.44 88.99 74.10 -49.29 84.03 71.99 -51.83 coo 65.21 120.62 58.76 63.62 123.14 59.66 82.52 72.20 -31.52 80.97 69.57 -31.97 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 11 3 # 11 118 ARG C 96 ARG^? 24.31 CL CL C 129 183 LYS C 24 LYS^? 26.64 CL CL C 129 317 ARG D 21 ARG^? 20.73 CL CL D 129 coo 76.57 109.19 73.41 73.86 110.26 72.16 94.28 86.51 -46.29 94.08 84.26 -44.17 coo 82.09 117.51 66.37 80.60 114.32 71.44 88.99 74.10 -49.29 84.03 71.99 -51.83 coo 65.21 120.62 58.76 63.62 123.14 59.66 71.50 84.01 -47.23 73.85 84.97 -45.52 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 12 3 # 12 118 ARG C 117 ARG^? 16.02 CL CL C 129 183 LYS C 43 LYS^? 9.54 CL CL C 129 317 ARG D 60 ARG^? 8.57 CL CL D 129 coo 76.57 109.19 73.41 73.86 110.26 72.16 89.36 64.01 -37.29 87.40 62.56 -39.24 coo 82.09 117.51 66.37 80.60 114.32 71.44 93.55 67.94 -25.84 92.76 63.12 -24.35 coo 65.21 120.62 58.76 63.62 123.14 59.66 76.65 78.50 -31.75 78.13 81.14 -31.78 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 13 3 # 13 118 ARG D 117 ARG^? 15.96 CL CL D 129 183 LYS D 43 LYS^? 9.72 CL CL D 129 317 ARG C 60 ARG^? 8.92 CL CL C 129 coo 76.57 109.19 73.41 73.86 110.26 72.16 69.91 86.62 -37.36 71.94 88.06 -39.21 coo 82.09 117.51 66.37 80.60 114.32 71.44 65.85 82.66 -25.79 66.37 87.54 -24.61 coo 65.21 120.62 58.76 63.62 123.14 59.66 82.52 72.20 -31.52 80.97 69.57 -31.97 1bib_c00 source 1bib BIRA BIFUNCTIONAL PROTEIN (ACTS AS BIOTIN OPER: 13 hits 1bib_c00 naa= 3 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 1 3 # 1 30 GLY D 55 GLY^? -3.63 CL CL D 129s 48 HIS D 40 HIS^? 7.31 CL CL D 129 99 ASP D 35 ASP^? 10.18 CL CL D 129 coo 12.38 5.55 24.25 13.27 5.59 24.39 69.35 78.74 -26.78 69.17 78.19 -27.38 coo 18.80 12.68 24.53 17.69 13.54 26.08 74.49 84.96 -30.93 76.13 84.16 -29.90 coo 17.07 18.51 26.62 16.67 17.07 28.09 75.66 79.96 -36.93 75.99 80.66 -34.97 1bp2_c00 source 1bp2 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSPHATIDE AC: 1 hits 1bp2_c00 naa= 3 ULMN 3 1bqc_c01 BETA-MANNANASE user 1 3 # 1 A 50 ARG A 60 ARG~? 8.61 CL CL A 129 A 128 GLU A 58 GLU~? 7.41 CL CL A 129 A 225 GLU A 57 GLU~? -5.56 CL CL A 129s coo 38.56 19.11 14.83 37.12 21.00 16.76 92.49 41.37 -66.87 95.11 39.81 -67.06 coo 36.48 24.43 22.02 36.86 26.34 21.13 87.85 46.74 -60.89 87.27 48.56 -59.93 coo 40.16 23.71 17.01 38.52 24.96 17.40 91.25 41.69 -61.23 91.08 41.09 -59.17 ULMN 3 1bqc_c01 BETA-MANNANASE user 2 3 # 2 A 50 ARG B 60 ARG^? 8.76 CL CL B 129 A 128 GLU B 58 GLU^? 7.34 CL CL B 129 A 225 GLU B 57 GLU^? -5.29 CL CL B 129s coo 38.56 19.11 14.83 37.12 21.00 16.76 92.45 82.18 -73.93 95.13 83.66 -73.65 coo 36.48 24.43 22.02 36.86 26.34 21.13 87.90 76.66 -80.19 87.42 74.86 -81.30 coo 40.16 23.71 17.01 38.52 24.96 17.40 91.24 81.90 -79.46 91.48 82.48 -81.50 ULMN 3 1bqc_c01 BETA-MANNANASE user 3 3 # 3 A 50 ARG C 60 ARG^? 8.92 CL CL C 129 A 128 GLU C 58 GLU^? 7.49 CL CL C 129 A 225 GLU C 57 GLU^? -5.48 CL CL C 129s coo 38.56 19.11 14.83 37.12 21.00 16.76 82.52 72.20 -31.52 80.97 69.57 -31.97 coo 36.48 24.43 22.02 36.86 26.34 21.13 88.02 76.82 -25.55 89.85 77.43 -24.60 coo 40.16 23.71 17.01 38.52 24.96 17.40 82.94 73.46 -26.00 82.34 73.25 -23.96 1bqc_c01 source 1bqc BETA-MANNANASE : 3 hits 1bqc_c01 naa= 3 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 1 3 # 1 A 109 PHE B 19 PHE^? 21.35 CL CL A 129 A 205 ASP B 10 ASP^? 27.46 CL CL A 129 A 236 LYS B 111 LYS^? 25.35 CL CL B 129 coo 4.14 2.10 36.34 6.69 3.08 36.92 94.67 67.40 -58.99 92.14 66.26 -58.87 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 110.59 65.11 -56.28 111.89 65.48 -54.65 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 105.89 69.85 -67.01 110.53 70.43 -62.59 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 2 3 # 2 A 109 PHE B 19 PHE^? 21.35 CL CL A 129 A 205 ASP B 30 ASP^? 20.91 CL CL B 129 A 236 LYS C 24 LYS^? 26.64 CL CL C 129 coo 4.14 2.10 36.34 6.69 3.08 36.92 94.67 67.40 -58.99 92.14 66.26 -58.87 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 88.99 74.10 -49.29 84.03 71.99 -51.83 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 3 3 # 3 A 109 PHE B 19 PHE^? 21.35 CL CL A 129 A 205 ASP B 72 ASP^? 28.57 CL CL C 129 A 236 LYS C 24 LYS^? 26.64 CL CL C 129 coo 4.14 2.10 36.34 6.69 3.08 36.92 94.67 67.40 -58.99 92.14 66.26 -58.87 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 80.87 74.36 -54.99 81.74 73.36 -53.35 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 88.99 74.10 -49.29 84.03 71.99 -51.83 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 4 3 # 4 A 109 PHE B 19 PHE^? 21.35 CL CL A 129 A 205 ASP C 10 ASP^? 12.83 CL CL A 129 A 236 LYS A 43 LYS.? 9.42 CL CL A 129 coo 4.14 2.10 36.34 6.69 3.08 36.92 94.67 67.40 -58.99 92.14 66.26 -58.87 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 99.63 54.02 -49.94 99.45 52.98 -51.81 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 96.70 52.33 -61.01 101.40 51.27 -59.62 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 5 3 # 5 A 109 PHE C 19 PHE^? 23.84 CL CL C 129 A 205 ASP C 10 ASP^? 12.83 CL CL A 129 A 236 LYS C 111 LYS^? 20.47 CL CL A 129 coo 4.14 2.10 36.34 6.69 3.08 36.92 97.28 69.93 -46.47 98.43 72.47 -46.63 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 99.63 54.02 -49.94 99.45 52.98 -51.81 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 94.84 58.73 -38.66 94.21 53.88 -42.04 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 6 3 # 6 A 109 PHE C 19 PHE^? 23.84 CL CL C 129 A 205 ASP C 72 ASP^? 28.53 CL CL B 129 A 236 LYS B 24 LYS^? 27.82 CL CL B 129 coo 4.14 2.10 36.34 6.69 3.08 36.92 97.28 69.93 -46.47 98.43 72.47 -46.63 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 90.38 83.76 -50.64 91.24 82.68 -52.23 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 90.54 75.59 -56.27 92.78 80.12 -52.52 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 7 3 # 7 A 109 PHE C 94 PHE^? 24.69 CL CL C 129 A 205 ASP B 30 ASP^? 20.91 CL CL B 129 A 236 LYS C 24 LYS^? 26.64 CL CL C 129 coo 4.14 2.10 36.34 6.69 3.08 36.92 98.83 81.51 -45.44 98.16 82.08 -42.76 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 88.99 74.10 -49.29 84.03 71.99 -51.83 1bs0_c01 source 1bs0 8-AMINO-7-OXONANOATE SYNTHASE : 7 hits 1bs0_c01 naa= 3 ULMN 3 1bwl_c01 NADPH DEHYDROGENASE 1 user 1 3 # 1 191 ASN A 52 ASN^? 15.85 CL CL A 129 194 HIS A 122 HIS^? 19.05 CL CL A 129 196 TYR A 47 TYR^? 14.66 CL CL A 129 coo 40.94 71.26 25.74 40.29 70.59 23.82 83.96 54.83 -62.44 82.65 56.42 -62.87 coo 38.86 67.47 19.31 37.78 65.73 19.79 86.83 60.37 -69.40 85.20 61.24 -68.40 coo 41.10 73.64 20.13 38.52 73.39 19.02 86.78 57.70 -65.64 87.73 58.42 -63.11 ULMN 3 1bwl_c01 NADPH DEHYDROGENASE 1 user 2 3 # 2 191 ASN B 52 ASN^? 15.82 CL CL B 129 194 HIS B 122 HIS^? 19.12 CL CL B 129 196 TYR B 47 TYR^? 14.72 CL CL B 129 coo 40.94 71.26 25.74 40.29 70.59 23.82 83.95 68.72 -78.66 82.81 66.95 -78.31 coo 38.86 67.47 19.31 37.78 65.73 19.79 86.93 63.10 -71.62 85.35 62.06 -72.53 coo 41.10 73.64 20.13 38.52 73.39 19.02 86.74 65.69 -75.43 87.82 65.07 -77.96 ULMN 3 1bwl_c01 NADPH DEHYDROGENASE 1 user 3 3 # 3 191 ASN C 52 ASN^? 15.85 CL CL C 129 194 HIS C 122 HIS^? 19.06 CL CL C 129 196 TYR C 47 TYR^? 14.59 CL CL C 129 coo 40.94 71.26 25.74 40.29 70.59 23.82 96.20 80.63 -27.08 97.82 81.88 -27.59 coo 38.86 67.47 19.31 37.78 65.73 19.79 101.68 77.71 -34.10 102.65 79.31 -33.15 coo 41.10 73.64 20.13 38.52 73.39 19.02 99.01 77.81 -30.16 99.72 76.81 -27.69 ULMN 3 1bwl_c01 NADPH DEHYDROGENASE 1 user 4 3 # 4 191 ASN D 52 ASN^? 15.83 CL CL D 129 194 HIS D 122 HIS^? 19.08 CL CL D 129 196 TYR D 47 TYR^? 14.69 CL CL D 129 coo 40.94 71.26 25.74 40.29 70.59 23.82 63.25 69.92 -27.12 61.56 68.74 -27.55 coo 38.86 67.47 19.31 37.78 65.73 19.79 57.69 72.86 -34.13 56.74 71.23 -33.18 coo 41.10 73.64 20.13 38.52 73.39 19.02 60.23 72.82 -30.22 59.55 73.80 -27.71 1bwl_c01 source 1bwl NADPH DEHYDROGENASE 1 : 4 hits 1bwl_c01 naa= 3 ULMN 3 1c82_c00 HYALURONATE LYASE user 1 3 # 1 A 349 ASN A 52 ASN^? 15.85 CL CL A 129 A 399 HIS A 122 HIS^? 19.05 CL CL A 129 A 408 TYR A 47 TYR^? 14.66 CL CL A 129 coo 11.39 -18.14 26.77 11.56 -16.76 28.37 83.96 54.83 -62.44 82.65 56.42 -62.87 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 86.83 60.37 -69.40 85.20 61.24 -68.40 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 86.78 57.70 -65.64 87.73 58.42 -63.11 ULMN 3 1c82_c00 HYALURONATE LYASE user 2 3 # 2 A 349 ASN B 52 ASN^? 15.82 CL CL B 129 A 399 HIS B 122 HIS^? 19.12 CL CL B 129 A 408 TYR B 47 TYR^? 14.72 CL CL B 129 coo 11.39 -18.14 26.77 11.56 -16.76 28.37 83.95 68.72 -78.66 82.81 66.95 -78.31 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 86.93 63.10 -71.62 85.35 62.06 -72.53 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 86.74 65.69 -75.43 87.82 65.07 -77.96 ULMN 3 1c82_c00 HYALURONATE LYASE user 3 3 # 3 A 349 ASN C 52 ASN^? 15.85 CL CL C 129 A 399 HIS C 122 HIS^? 19.06 CL CL C 129 A 408 TYR C 47 TYR^? 14.59 CL CL C 129 coo 11.39 -18.14 26.77 11.56 -16.76 28.37 96.20 80.63 -27.08 97.82 81.88 -27.59 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 101.68 77.71 -34.10 102.65 79.31 -33.15 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 99.01 77.81 -30.16 99.72 76.81 -27.69 ULMN 3 1c82_c00 HYALURONATE LYASE user 4 3 # 4 A 349 ASN D 52 ASN^? 15.83 CL CL D 129 A 399 HIS D 122 HIS^? 19.08 CL CL D 129 A 408 TYR D 47 TYR^? 14.69 CL CL D 129 coo 11.39 -18.14 26.77 11.56 -16.76 28.37 63.25 69.92 -27.12 61.56 68.74 -27.55 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 57.69 72.86 -34.13 56.74 71.23 -33.18 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 60.23 72.82 -30.22 59.55 73.80 -27.71 1c82_c00 source 1c82 HYALURONATE LYASE : 4 hits 1c82_c00 naa= 3 ULMN 3 1c82_c01 HYALURONATE LYASE user 1 3 # 1 A 399 HIS A 122 HIS^? 19.05 CL CL A 129 A 408 TYR A 47 TYR^? 14.66 CL CL A 129 A 462 ARG A 46 ARG^? 15.11 CL CL A 129 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 86.83 60.37 -69.40 85.20 61.24 -68.40 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 86.78 57.70 -65.64 87.73 58.42 -63.11 coo 10.34 -11.56 38.02 10.61 -11.96 35.00 87.96 51.20 -70.32 85.08 51.60 -71.34 ULMN 3 1c82_c01 HYALURONATE LYASE user 2 3 # 2 A 399 HIS B 122 HIS^? 19.12 CL CL B 129 A 408 TYR B 47 TYR^? 14.72 CL CL B 129 A 462 ARG B 46 ARG^? 15.06 CL CL B 129 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 86.93 63.10 -71.62 85.35 62.06 -72.53 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 86.74 65.69 -75.43 87.82 65.07 -77.96 coo 10.34 -11.56 38.02 10.61 -11.96 35.00 87.96 72.13 -70.71 85.05 71.84 -69.78 ULMN 3 1c82_c01 HYALURONATE LYASE user 3 3 # 3 A 399 HIS C 122 HIS^? 19.06 CL CL C 129 A 408 TYR C 47 TYR^? 14.59 CL CL C 129 A 462 ARG C 46 ARG^? 15.12 CL CL C 129 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 101.68 77.71 -34.10 102.65 79.31 -33.15 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 99.01 77.81 -30.16 99.72 76.81 -27.69 coo 10.34 -11.56 38.02 10.61 -11.96 35.00 92.47 76.70 -34.87 92.87 79.50 -36.04 ULMN 3 1c82_c01 HYALURONATE LYASE user 4 3 # 4 A 399 HIS D 122 HIS^? 19.08 CL CL D 129 A 408 TYR D 47 TYR^? 14.69 CL CL D 129 A 462 ARG D 46 ARG^? 15.13 CL CL D 129 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 57.69 72.86 -34.13 56.74 71.23 -33.18 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 60.23 72.82 -30.22 59.55 73.80 -27.71 coo 10.34 -11.56 38.02 10.61 -11.96 35.00 66.74 73.93 -35.00 66.45 71.02 -36.02 1c82_c01 source 1c82 HYALURONATE LYASE : 4 hits 1c82_c01 naa= 3 ULMN 3 1c82_c02 HYALURONATE LYASE user 1 3 # 1 A 399 HIS A 122 HIS^? 19.05 CL CL A 129 A 408 TYR A 47 TYR^? 14.66 CL CL A 129 A 480 ARG A 60 ARG~? 8.61 CL CL A 129 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 86.83 60.37 -69.40 85.20 61.24 -68.40 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 86.78 57.70 -65.64 87.73 58.42 -63.11 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 92.49 41.37 -66.87 95.11 39.81 -67.06 ULMN 3 1c82_c02 HYALURONATE LYASE user 2 3 # 2 A 399 HIS B 122 HIS^? 19.12 CL CL B 129 A 408 TYR B 47 TYR^? 14.72 CL CL B 129 A 480 ARG B 60 ARG^? 8.76 CL CL B 129 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 86.93 63.10 -71.62 85.35 62.06 -72.53 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 86.74 65.69 -75.43 87.82 65.07 -77.96 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 92.45 82.18 -73.93 95.13 83.66 -73.65 ULMN 3 1c82_c02 HYALURONATE LYASE user 3 3 # 3 A 399 HIS C 122 HIS^? 19.06 CL CL C 129 A 408 TYR C 47 TYR^? 14.59 CL CL C 129 A 480 ARG C 60 ARG^? 8.92 CL CL C 129 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 101.68 77.71 -34.10 102.65 79.31 -33.15 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 99.01 77.81 -30.16 99.72 76.81 -27.69 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 82.52 72.20 -31.52 80.97 69.57 -31.97 ULMN 3 1c82_c02 HYALURONATE LYASE user 4 3 # 4 A 399 HIS D 122 HIS^? 19.08 CL CL D 129 A 408 TYR D 47 TYR^? 14.69 CL CL D 129 A 480 ARG D 60 ARG^? 8.57 CL CL D 129 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 57.69 72.86 -34.13 56.74 71.23 -33.18 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 60.23 72.82 -30.22 59.55 73.80 -27.71 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 76.65 78.50 -31.75 78.13 81.14 -31.78 1c82_c02 source 1c82 HYALURONATE LYASE : 4 hits 1c82_c02 naa= 3 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 1 3 # 1 A 14 ASP A 86 ASP.? 23.33 CL CL A 129 A 16 HIS A 85 HIS.? 26.94 CL CL B 129 A 67 GLY A 115 GLY^? 19.18 CL CL A 129 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 108.46 57.22 -73.78 109.48 58.49 -72.45 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 112.09 59.31 -75.65 113.04 59.28 -73.77 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 105.32 48.49 -75.94 105.17 48.69 -75.15 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 2 3 # 2 A 14 ASP A 86 ASP.? 23.33 CL CL A 129 A 16 HIS A 85 HIS.? 26.94 CL CL B 129 A 67 GLY B 84 GLY^? 21.30 CL CL A 129 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 108.46 57.22 -73.78 109.48 58.49 -72.45 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 112.09 59.31 -75.65 113.04 59.28 -73.77 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 109.15 59.88 -65.08 108.46 60.20 -64.65 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 3 3 # 3 A 14 ASP B 86 ASP^? 23.14 CL CL B 129 A 16 HIS B 85 HIS^? 26.88 CL CL A 129 A 67 GLY A 84 GLY.? 21.38 CL CL B 129 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 108.40 66.17 -67.38 109.32 64.97 -68.84 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 111.98 64.21 -65.30 113.02 64.33 -67.11 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 109.18 63.55 -76.11 108.53 63.22 -76.56 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 4 3 # 4 A 14 ASP B 86 ASP^? 23.14 CL CL B 129 A 16 HIS B 85 HIS^? 26.88 CL CL A 129 A 67 GLY B 115 GLY^? 19.14 CL CL B 129 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 108.40 66.17 -67.38 109.32 64.97 -68.84 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 111.98 64.21 -65.30 113.02 64.33 -67.11 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 105.34 74.85 -65.16 105.20 74.69 -65.93 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 5 3 # 5 A 14 ASP C 86 ASP^? 23.12 CL CL C 129 A 16 HIS C 85 HIS^? 23.16 CL CL A 129 A 67 GLY C 115 GLY^? 19.09 CL CL C 129 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 98.39 56.19 -38.35 99.60 55.15 -36.99 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 100.49 52.59 -40.39 100.40 51.57 -38.55 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 89.73 59.33 -40.54 89.93 59.44 -39.76 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 6 3 # 6 A 14 ASP D 86 ASP^? 23.19 CL CL D 129 A 16 HIS D 85 HIS^? 27.00 CL CL D 129 A 67 GLY D 115 GLY^? 19.26 CL CL D 129 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 60.79 94.39 -38.32 59.49 95.38 -36.98 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 58.77 98.13 -40.30 58.69 99.11 -38.44 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 69.45 91.40 -40.67 69.30 91.29 -39.87 1cb7_c06 source 1cb7 GLUTAMATE MUTASE : 6 hits 1cb7_c06 naa= 3 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 1 3 # 1 C 14 ASP A 86 ASP.? 23.33 CL CL A 129 C 16 HIS A 85 HIS.? 26.94 CL CL B 129 C 67 GLY A 115 GLY^? 19.18 CL CL A 129 coo 10.04 44.27 88.44 9.47 42.32 89.03 108.46 57.22 -73.78 109.48 58.49 -72.45 coo 6.38 39.80 88.71 6.88 38.89 86.87 112.09 59.31 -75.65 113.04 59.28 -73.77 coo 17.63 42.50 89.25 18.11 42.29 88.64 105.32 48.49 -75.94 105.17 48.69 -75.15 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 2 3 # 2 C 14 ASP A 86 ASP.? 23.33 CL CL A 129 C 16 HIS A 85 HIS.? 26.94 CL CL B 129 C 67 GLY B 84 GLY^? 21.30 CL CL A 129 coo 10.04 44.27 88.44 9.47 42.32 89.03 108.46 57.22 -73.78 109.48 58.49 -72.45 coo 6.38 39.80 88.71 6.88 38.89 86.87 112.09 59.31 -75.65 113.04 59.28 -73.77 coo 17.63 42.50 89.25 18.11 42.29 88.64 109.15 59.88 -65.08 108.46 60.20 -64.65 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 3 3 # 3 C 14 ASP B 86 ASP^? 23.14 CL CL B 129 C 16 HIS B 85 HIS^? 26.88 CL CL A 129 C 67 GLY A 84 GLY.? 21.38 CL CL B 129 coo 10.04 44.27 88.44 9.47 42.32 89.03 108.40 66.17 -67.38 109.32 64.97 -68.84 coo 6.38 39.80 88.71 6.88 38.89 86.87 111.98 64.21 -65.30 113.02 64.33 -67.11 coo 17.63 42.50 89.25 18.11 42.29 88.64 109.18 63.55 -76.11 108.53 63.22 -76.56 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 4 3 # 4 C 14 ASP B 86 ASP^? 23.14 CL CL B 129 C 16 HIS B 85 HIS^? 26.88 CL CL A 129 C 67 GLY B 115 GLY^? 19.14 CL CL B 129 coo 10.04 44.27 88.44 9.47 42.32 89.03 108.40 66.17 -67.38 109.32 64.97 -68.84 coo 6.38 39.80 88.71 6.88 38.89 86.87 111.98 64.21 -65.30 113.02 64.33 -67.11 coo 17.63 42.50 89.25 18.11 42.29 88.64 105.34 74.85 -65.16 105.20 74.69 -65.93 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 5 3 # 5 C 14 ASP C 86 ASP^? 23.12 CL CL C 129 C 16 HIS C 85 HIS^? 23.16 CL CL A 129 C 67 GLY C 115 GLY^? 19.09 CL CL C 129 coo 10.04 44.27 88.44 9.47 42.32 89.03 98.39 56.19 -38.35 99.60 55.15 -36.99 coo 6.38 39.80 88.71 6.88 38.89 86.87 100.49 52.59 -40.39 100.40 51.57 -38.55 coo 17.63 42.50 89.25 18.11 42.29 88.64 89.73 59.33 -40.54 89.93 59.44 -39.76 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 6 3 # 6 C 14 ASP D 86 ASP^? 23.19 CL CL D 129 C 16 HIS D 85 HIS^? 27.00 CL CL D 129 C 67 GLY D 115 GLY^? 19.26 CL CL D 129 coo 10.04 44.27 88.44 9.47 42.32 89.03 60.79 94.39 -38.32 59.49 95.38 -36.98 coo 6.38 39.80 88.71 6.88 38.89 86.87 58.77 98.13 -40.30 58.69 99.11 -38.44 coo 17.63 42.50 89.25 18.11 42.29 88.64 69.45 91.40 -40.67 69.30 91.29 -39.87 1cb7_c07 source 1cb7 GLUTAMATE MUTASE : 6 hits 1cb7_c07 naa= 3 ULMN 3 1cb8_c01 CHONDROITINASE AC user 1 3 # 1 A 225 HIS A 122 HIS^? 19.05 CL CL A 129 A 234 TYR A 47 TYR^? 14.66 CL CL A 129 A 288 ARG A 46 ARG^? 15.11 CL CL A 129 coo 27.04 28.61 41.75 26.86 28.65 43.84 86.83 60.37 -69.40 85.20 61.24 -68.40 coo 21.80 30.48 43.67 23.70 29.06 45.12 86.78 57.70 -65.64 87.73 58.42 -63.11 coo 24.79 22.62 45.60 24.87 25.42 46.81 87.96 51.20 -70.32 85.08 51.60 -71.34 ULMN 3 1cb8_c01 CHONDROITINASE AC user 2 3 # 2 A 225 HIS B 122 HIS^? 19.12 CL CL B 129 A 234 TYR B 47 TYR^? 14.72 CL CL B 129 A 288 ARG B 46 ARG^? 15.06 CL CL B 129 coo 27.04 28.61 41.75 26.86 28.65 43.84 86.93 63.10 -71.62 85.35 62.06 -72.53 coo 21.80 30.48 43.67 23.70 29.06 45.12 86.74 65.69 -75.43 87.82 65.07 -77.96 coo 24.79 22.62 45.60 24.87 25.42 46.81 87.96 72.13 -70.71 85.05 71.84 -69.78 ULMN 3 1cb8_c01 CHONDROITINASE AC user 3 3 # 3 A 225 HIS C 122 HIS^? 19.06 CL CL C 129 A 234 TYR C 47 TYR^? 14.59 CL CL C 129 A 288 ARG C 46 ARG^? 15.12 CL CL C 129 coo 27.04 28.61 41.75 26.86 28.65 43.84 101.68 77.71 -34.10 102.65 79.31 -33.15 coo 21.80 30.48 43.67 23.70 29.06 45.12 99.01 77.81 -30.16 99.72 76.81 -27.69 coo 24.79 22.62 45.60 24.87 25.42 46.81 92.47 76.70 -34.87 92.87 79.50 -36.04 ULMN 3 1cb8_c01 CHONDROITINASE AC user 4 3 # 4 A 225 HIS D 122 HIS^? 19.08 CL CL D 129 A 234 TYR D 47 TYR^? 14.69 CL CL D 129 A 288 ARG D 46 ARG^? 15.13 CL CL D 129 coo 27.04 28.61 41.75 26.86 28.65 43.84 57.69 72.86 -34.13 56.74 71.23 -33.18 coo 21.80 30.48 43.67 23.70 29.06 45.12 60.23 72.82 -30.22 59.55 73.80 -27.71 coo 24.79 22.62 45.60 24.87 25.42 46.81 66.74 73.93 -35.00 66.45 71.02 -36.02 1cb8_c01 source 1cb8 CHONDROITINASE AC : 4 hits 1cb8_c01 naa= 3 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 1 3 # 1 71 ARG A 46 ARG^? 15.11 CL CL A 129 127 ARG A 63 ARG~? 13.95 CL CL A 129 270 GLU A 23 GLU~? 24.22 CL CL A 129 coo -0.83 25.63 1.57 0.97 28.05 0.90 87.96 51.20 -70.32 85.08 51.60 -71.34 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 87.85 45.63 -72.60 88.58 48.58 -73.24 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 89.42 52.54 -84.47 88.08 53.22 -82.95 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 2 3 # 2 71 ARG A 46 ARG^? 15.11 CL CL A 129 127 ARG A 63 ARG~? 13.95 CL CL A 129 270 GLU A 36 GLU~? 18.47 CL CL A 129 coo -0.83 25.63 1.57 0.97 28.05 0.90 87.96 51.20 -70.32 85.08 51.60 -71.34 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 87.85 45.63 -72.60 88.58 48.58 -73.24 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 99.16 43.45 -76.17 99.38 43.10 -78.24 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 3 3 # 3 71 ARG A 46 ARG^? 15.11 CL CL A 129 127 ARG A 63 ARG~? 13.95 CL CL A 129 270 GLU A 57 GLU~? -5.56 CL CL A 129s coo -0.83 25.63 1.57 0.97 28.05 0.90 87.96 51.20 -70.32 85.08 51.60 -71.34 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 87.85 45.63 -72.60 88.58 48.58 -73.24 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 91.25 41.69 -61.23 91.08 41.09 -59.17 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 4 3 # 4 71 ARG A 63 ARG~? 13.95 CL CL A 129 127 ARG A 46 ARG^? 15.11 CL CL A 129 270 GLU A 23 GLU~? 24.22 CL CL A 129 coo -0.83 25.63 1.57 0.97 28.05 0.90 87.85 45.63 -72.60 88.58 48.58 -73.24 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 87.96 51.20 -70.32 85.08 51.60 -71.34 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 89.42 52.54 -84.47 88.08 53.22 -82.95 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 5 3 # 5 71 ARG A 63 ARG~? 13.95 CL CL A 129 127 ARG A 46 ARG^? 15.11 CL CL A 129 270 GLU A 57 GLU~? -5.56 CL CL A 129s coo -0.83 25.63 1.57 0.97 28.05 0.90 87.85 45.63 -72.60 88.58 48.58 -73.24 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 87.96 51.20 -70.32 85.08 51.60 -71.34 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 91.25 41.69 -61.23 91.08 41.09 -59.17 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 6 3 # 6 71 ARG A 63 ARG~? 13.95 CL CL A 129 127 ARG A 46 ARG^? 15.11 CL CL A 129 270 GLU A 58 GLU~? 7.41 CL CL A 129 coo -0.83 25.63 1.57 0.97 28.05 0.90 87.85 45.63 -72.60 88.58 48.58 -73.24 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 87.96 51.20 -70.32 85.08 51.60 -71.34 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 87.85 46.74 -60.89 87.27 48.56 -59.93 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 7 3 # 7 71 ARG A 63 ARG~? 13.95 CL CL A 129 127 ARG A 66 ARG~? 18.83 CL CL A 129 270 GLU A 23 GLU~? 24.22 CL CL A 129 coo -0.83 25.63 1.57 0.97 28.05 0.90 87.85 45.63 -72.60 88.58 48.58 -73.24 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 82.10 46.84 -74.28 82.78 49.65 -75.31 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 89.42 52.54 -84.47 88.08 53.22 -82.95 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 8 3 # 8 71 ARG A 66 ARG~? 18.83 CL CL A 129 127 ARG A 63 ARG~? 13.95 CL CL A 129 270 GLU A 23 GLU~? 24.22 CL CL A 129 coo -0.83 25.63 1.57 0.97 28.05 0.90 82.10 46.84 -74.28 82.78 49.65 -75.31 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 87.85 45.63 -72.60 88.58 48.58 -73.24 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 89.42 52.54 -84.47 88.08 53.22 -82.95 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 9 3 # 9 71 ARG A 66 ARG~? 18.83 CL CL A 129 127 ARG A 63 ARG~? 13.95 CL CL A 129 270 GLU A 58 GLU~? 7.41 CL CL A 129 coo -0.83 25.63 1.57 0.97 28.05 0.90 82.10 46.84 -74.28 82.78 49.65 -75.31 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 87.85 45.63 -72.60 88.58 48.58 -73.24 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 87.85 46.74 -60.89 87.27 48.56 -59.93 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 10 3 # 10 71 ARG A 73 ARG.? 22.19 CL CL A 129 127 ARG A 96 ARG.? 24.34 CL CL A 129 270 GLU A 93 GLU.? 15.26 CL CL B 129 coo -0.83 25.63 1.57 0.97 28.05 0.90 83.82 53.79 -81.61 86.00 54.30 -79.51 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 78.03 52.93 -81.60 80.41 52.60 -79.67 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 84.83 64.69 -81.14 84.26 66.42 -82.32 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 11 3 # 11 71 ARG A 96 ARG.? 24.34 CL CL A 129 127 ARG A 73 ARG.? 22.19 CL CL A 129 270 GLU A 93 GLU.? 15.26 CL CL B 129 coo -0.83 25.63 1.57 0.97 28.05 0.90 78.03 52.93 -81.60 80.41 52.60 -79.67 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 83.82 53.79 -81.61 86.00 54.30 -79.51 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 84.83 64.69 -81.14 84.26 66.42 -82.32 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 12 3 # 12 71 ARG B 46 ARG^? 15.06 CL CL B 129 127 ARG B 63 ARG^? 13.99 CL CL B 129 270 GLU B 23 GLU^? 24.68 CL CL B 129 coo -0.83 25.63 1.57 0.97 28.05 0.90 87.96 72.13 -70.71 85.05 71.84 -69.78 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 87.72 77.76 -68.29 88.60 74.86 -67.71 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 89.49 70.79 -56.44 87.96 70.01 -57.68 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 13 3 # 13 71 ARG B 46 ARG^? 15.06 CL CL B 129 127 ARG B 63 ARG^? 13.99 CL CL B 129 270 GLU B 36 GLU^? 18.40 CL CL B 129 coo -0.83 25.63 1.57 0.97 28.05 0.90 87.96 72.13 -70.71 85.05 71.84 -69.78 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 87.72 77.76 -68.29 88.60 74.86 -67.71 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 99.20 79.77 -64.83 99.58 80.60 -62.91 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 14 3 # 14 71 ARG B 46 ARG^? 15.06 CL CL B 129 127 ARG B 63 ARG^? 13.99 CL CL B 129 270 GLU B 57 GLU^? -5.29 CL CL B 129s coo -0.83 25.63 1.57 0.97 28.05 0.90 87.96 72.13 -70.71 85.05 71.84 -69.78 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 87.72 77.76 -68.29 88.60 74.86 -67.71 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 91.24 81.90 -79.46 91.48 82.48 -81.50 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 15 3 # 15 71 ARG B 63 ARG^? 13.99 CL CL B 129 127 ARG B 46 ARG^? 15.06 CL CL B 129 270 GLU B 57 GLU^? -5.29 CL CL B 129s coo -0.83 25.63 1.57 0.97 28.05 0.90 87.72 77.76 -68.29 88.60 74.86 -67.71 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 87.96 72.13 -70.71 85.05 71.84 -69.78 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 91.24 81.90 -79.46 91.48 82.48 -81.50 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 16 3 # 16 71 ARG B 63 ARG^? 13.99 CL CL B 129 127 ARG B 46 ARG^? 15.06 CL CL B 129 270 GLU B 58 GLU^? 7.34 CL CL B 129 coo -0.83 25.63 1.57 0.97 28.05 0.90 87.72 77.76 -68.29 88.60 74.86 -67.71 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 87.96 72.13 -70.71 85.05 71.84 -69.78 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 87.90 76.66 -80.19 87.42 74.86 -81.30 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 17 3 # 17 71 ARG B 63 ARG^? 13.99 CL CL B 129 127 ARG B 66 ARG^? 19.13 CL CL B 129 270 GLU B 23 GLU^? 24.68 CL CL B 129 coo -0.83 25.63 1.57 0.97 28.05 0.90 87.72 77.76 -68.29 88.60 74.86 -67.71 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 82.06 76.49 -66.55 82.68 73.67 -65.41 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 89.49 70.79 -56.44 87.96 70.01 -57.68 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 18 3 # 18 71 ARG B 66 ARG^? 19.13 CL CL B 129 127 ARG B 63 ARG^? 13.99 CL CL B 129 270 GLU B 23 GLU^? 24.68 CL CL B 129 coo -0.83 25.63 1.57 0.97 28.05 0.90 82.06 76.49 -66.55 82.68 73.67 -65.41 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 87.72 77.76 -68.29 88.60 74.86 -67.71 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 89.49 70.79 -56.44 87.96 70.01 -57.68 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 19 3 # 19 71 ARG B 66 ARG^? 19.13 CL CL B 129 127 ARG B 63 ARG^? 13.99 CL CL B 129 270 GLU B 58 GLU^? 7.34 CL CL B 129 coo -0.83 25.63 1.57 0.97 28.05 0.90 82.06 76.49 -66.55 82.68 73.67 -65.41 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 87.72 77.76 -68.29 88.60 74.86 -67.71 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 87.90 76.66 -80.19 87.42 74.86 -81.30 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 20 3 # 20 71 ARG B 96 ARG^? 24.18 CL CL B 129 127 ARG B 73 ARG^? 22.29 CL CL B 129 270 GLU B 93 GLU^? 15.32 CL CL A 129 coo -0.83 25.63 1.57 0.97 28.05 0.90 78.35 70.58 -59.29 80.55 70.83 -61.45 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 83.86 69.55 -59.16 85.91 69.18 -61.42 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 84.67 58.80 -60.02 84.04 57.06 -58.91 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 21 3 # 21 71 ARG C 46 ARG^? 15.12 CL CL C 129 127 ARG C 63 ARG^? 14.10 CL CL C 129 270 GLU C 23 GLU^? 24.69 CL CL C 129 coo -0.83 25.63 1.57 0.97 28.05 0.90 92.47 76.70 -34.87 92.87 79.50 -36.04 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 86.96 77.03 -37.50 89.89 76.13 -38.00 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 93.85 75.25 -49.20 94.57 76.88 -48.00 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 22 3 # 22 71 ARG C 46 ARG^? 15.12 CL CL C 129 127 ARG C 63 ARG^? 14.10 CL CL C 129 270 GLU C 36 GLU^? 18.27 CL CL C 129 coo -0.83 25.63 1.57 0.97 28.05 0.90 92.47 76.70 -34.87 92.87 79.50 -36.04 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 86.96 77.03 -37.50 89.89 76.13 -38.00 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 84.85 65.27 -40.53 84.47 64.86 -42.56 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 23 3 # 23 71 ARG C 46 ARG^? 15.12 CL CL C 129 127 ARG C 63 ARG^? 14.10 CL CL C 129 270 GLU C 57 GLU^? -5.48 CL CL C 129s coo -0.83 25.63 1.57 0.97 28.05 0.90 92.47 76.70 -34.87 92.87 79.50 -36.04 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 86.96 77.03 -37.50 89.89 76.13 -38.00 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 82.94 73.46 -26.00 82.34 73.25 -23.96 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 24 3 # 24 71 ARG C 63 ARG^? 14.10 CL CL C 129 127 ARG C 46 ARG^? 15.12 CL CL C 129 270 GLU C 57 GLU^? -5.48 CL CL C 129s coo -0.83 25.63 1.57 0.97 28.05 0.90 86.96 77.03 -37.50 89.89 76.13 -38.00 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 92.47 76.70 -34.87 92.87 79.50 -36.04 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 82.94 73.46 -26.00 82.34 73.25 -23.96 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 25 3 # 25 71 ARG C 63 ARG^? 14.10 CL CL C 129 127 ARG C 66 ARG^? 18.88 CL CL C 129 270 GLU C 23 GLU^? 24.69 CL CL C 129 coo -0.83 25.63 1.57 0.97 28.05 0.90 86.96 77.03 -37.50 89.89 76.13 -38.00 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 88.18 82.59 -38.84 90.98 81.94 -39.92 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 93.85 75.25 -49.20 94.57 76.88 -48.00 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 26 3 # 26 71 ARG C 66 ARG^? 18.88 CL CL C 129 127 ARG C 63 ARG^? 14.10 CL CL C 129 270 GLU C 23 GLU^? 24.69 CL CL C 129 coo -0.83 25.63 1.57 0.97 28.05 0.90 88.18 82.59 -38.84 90.98 81.94 -39.92 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 86.96 77.03 -37.50 89.89 76.13 -38.00 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 93.85 75.25 -49.20 94.57 76.88 -48.00 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 27 3 # 27 71 ARG C 66 ARG^? 18.88 CL CL C 129 127 ARG C 63 ARG^? 14.10 CL CL C 129 270 GLU C 58 GLU^? 7.49 CL CL C 129 coo -0.83 25.63 1.57 0.97 28.05 0.90 88.18 82.59 -38.84 90.98 81.94 -39.92 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 86.96 77.03 -37.50 89.89 76.13 -38.00 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 88.02 76.82 -25.55 89.85 77.43 -24.60 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 28 3 # 28 71 ARG C 96 ARG^? 24.31 CL CL C 129 127 ARG C 73 ARG^? 22.24 CL CL C 129 270 GLU C 93 GLU^? 31.51 CL CL C 129 coo -0.83 25.63 1.57 0.97 28.05 0.90 94.28 86.51 -46.29 94.08 84.26 -44.17 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 95.26 80.79 -46.47 95.45 78.63 -44.29 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 105.96 79.95 -45.75 107.72 80.63 -46.81 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 29 3 # 29 71 ARG D 46 ARG^? 15.13 CL CL D 129 127 ARG D 63 ARG^? 14.07 CL CL D 129 270 GLU D 23 GLU^? 24.49 CL CL D 129 coo -0.83 25.63 1.57 0.97 28.05 0.90 66.74 73.93 -35.00 66.45 71.02 -36.02 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 72.33 73.68 -37.44 69.36 74.46 -37.99 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 65.41 75.40 -49.12 64.81 73.78 -47.86 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 30 3 # 30 71 ARG D 63 ARG^? 14.07 CL CL D 129 127 ARG D 46 ARG^? 15.13 CL CL D 129 270 GLU D 23 GLU^? 24.49 CL CL D 129 coo -0.83 25.63 1.57 0.97 28.05 0.90 72.33 73.68 -37.44 69.36 74.46 -37.99 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 66.74 73.93 -35.00 66.45 71.02 -36.02 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 65.41 75.40 -49.12 64.81 73.78 -47.86 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 31 3 # 31 71 ARG D 63 ARG^? 14.07 CL CL D 129 127 ARG D 46 ARG^? 15.13 CL CL D 129 270 GLU D 58 GLU^? 7.39 CL CL D 129 coo -0.83 25.63 1.57 0.97 28.05 0.90 72.33 73.68 -37.44 69.36 74.46 -37.99 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 66.74 73.93 -35.00 66.45 71.02 -36.02 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 71.21 74.03 -25.57 69.46 73.32 -24.61 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 32 3 # 32 71 ARG D 63 ARG^? 14.07 CL CL D 129 127 ARG D 66 ARG^? 18.85 CL CL D 129 270 GLU D 23 GLU^? 24.49 CL CL D 129 coo -0.83 25.63 1.57 0.97 28.05 0.90 72.33 73.68 -37.44 69.36 74.46 -37.99 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 71.05 68.08 -38.82 68.22 68.66 -39.87 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 65.41 75.40 -49.12 64.81 73.78 -47.86 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 33 3 # 33 71 ARG D 66 ARG^? 18.85 CL CL D 129 127 ARG D 63 ARG^? 14.07 CL CL D 129 270 GLU D 23 GLU^? 24.49 CL CL D 129 coo -0.83 25.63 1.57 0.97 28.05 0.90 71.05 68.08 -38.82 68.22 68.66 -39.87 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 72.33 73.68 -37.44 69.36 74.46 -37.99 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 65.41 75.40 -49.12 64.81 73.78 -47.86 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 34 3 # 34 71 ARG D 66 ARG^? 18.85 CL CL D 129 127 ARG D 63 ARG^? 14.07 CL CL D 129 270 GLU D 58 GLU^? 7.39 CL CL D 129 coo -0.83 25.63 1.57 0.97 28.05 0.90 71.05 68.08 -38.82 68.22 68.66 -39.87 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 72.33 73.68 -37.44 69.36 74.46 -37.99 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 71.21 74.03 -25.57 69.46 73.32 -24.61 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 35 3 # 35 71 ARG D 96 ARG^? 24.04 CL CL D 129 127 ARG D 73 ARG^? 22.15 CL CL D 129 270 GLU D 93 GLU^? 31.46 CL CL D 129 coo -0.83 25.63 1.57 0.97 28.05 0.90 64.79 64.44 -46.28 65.73 66.42 -44.08 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 64.06 69.83 -46.45 63.93 71.88 -44.19 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 53.41 70.78 -45.84 51.64 70.26 -46.90 1cbx_c01 source 1cbx CARBOXYPEPTIDASE A (E.C.3.4.17.1) COMPLEX WITH: 35 hits 1cbx_c01 naa= 3 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 1 3 # 1 229 ASP A 30 ASP~? 20.80 CL CL A 129 264 GLU A 51 GLU^? 16.44 CL CL A 129 328 ASP A 35 ASP~? 10.31 CL CL A 129 coo 45.62 80.42 43.69 45.65 82.01 45.07 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 59.69 92.71 39.85 58.53 92.03 41.47 82.00 50.89 -67.09 80.89 51.23 -68.89 coo 45.39 90.72 40.63 45.07 89.14 41.90 93.79 42.35 -72.20 94.79 41.97 -70.38 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 2 3 # 2 229 ASP A 30 ASP~? 20.80 CL CL A 129 264 GLU A 58 GLU~? 7.41 CL CL A 129 328 ASP A 35 ASP~? 10.31 CL CL A 129 coo 45.62 80.42 43.69 45.65 82.01 45.07 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 59.69 92.71 39.85 58.53 92.03 41.47 87.85 46.74 -60.89 87.27 48.56 -59.93 coo 45.39 90.72 40.63 45.07 89.14 41.90 93.79 42.35 -72.20 94.79 41.97 -70.38 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 3 3 # 3 229 ASP A 41 ASP.? 7.60 CL CL A 129 264 GLU A 51 GLU^? 16.44 CL CL A 129 328 ASP A 35 ASP~? 10.31 CL CL A 129 coo 45.62 80.42 43.69 45.65 82.01 45.07 99.56 48.98 -63.34 100.43 49.52 -61.53 coo 59.69 92.71 39.85 58.53 92.03 41.47 82.00 50.89 -67.09 80.89 51.23 -68.89 coo 45.39 90.72 40.63 45.07 89.14 41.90 93.79 42.35 -72.20 94.79 41.97 -70.38 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 4 3 # 4 229 ASP A 86 ASP.? 23.33 CL CL A 129 264 GLU A 42 GLU.? 5.77 CL CL A 129 328 ASP B 5 ASP^? 20.93 CL CL A 129 coo 45.62 80.42 43.69 45.65 82.01 45.07 108.46 57.22 -73.78 109.48 58.49 -72.45 coo 59.69 92.71 39.85 58.53 92.03 41.47 98.04 48.44 -58.38 99.25 46.68 -58.65 coo 45.39 90.72 40.63 45.07 89.14 41.90 110.10 55.77 -64.66 112.04 55.13 -65.31 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 5 3 # 5 229 ASP B 5 ASP^? 20.93 CL CL A 129 264 GLU A 36 GLU~? 18.47 CL CL A 129 328 ASP A 41 ASP.? 7.60 CL CL A 129 coo 45.62 80.42 43.69 45.65 82.01 45.07 110.10 55.77 -64.66 112.04 55.13 -65.31 coo 59.69 92.71 39.85 58.53 92.03 41.47 99.16 43.45 -76.17 99.38 43.10 -78.24 coo 45.39 90.72 40.63 45.07 89.14 41.90 99.56 48.98 -63.34 100.43 49.52 -61.53 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 6 3 # 6 229 ASP B 10 ASP^? 27.46 CL CL A 129 264 GLU A 42 GLU.? 5.77 CL CL A 129 328 ASP B 5 ASP^? 20.93 CL CL A 129 coo 45.62 80.42 43.69 45.65 82.01 45.07 110.59 65.11 -56.28 111.89 65.48 -54.65 coo 59.69 92.71 39.85 58.53 92.03 41.47 98.04 48.44 -58.38 99.25 46.68 -58.65 coo 45.39 90.72 40.63 45.07 89.14 41.90 110.10 55.77 -64.66 112.04 55.13 -65.31 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 7 3 # 7 229 ASP B 30 ASP^? 20.91 CL CL B 129 264 GLU B 51 GLU^? 16.46 CL CL B 129 328 ASP B 35 ASP^? 10.19 CL CL B 129 coo 45.62 80.42 43.69 45.65 82.01 45.07 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 59.69 92.71 39.85 58.53 92.03 41.47 81.98 72.56 -73.89 80.95 72.05 -72.12 coo 45.39 90.72 40.63 45.07 89.14 41.90 93.79 80.98 -68.72 94.61 81.32 -70.62 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 8 3 # 8 229 ASP B 30 ASP^? 20.91 CL CL B 129 264 GLU B 58 GLU^? 7.34 CL CL B 129 328 ASP B 35 ASP^? 10.19 CL CL B 129 coo 45.62 80.42 43.69 45.65 82.01 45.07 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 59.69 92.71 39.85 58.53 92.03 41.47 87.90 76.66 -80.19 87.42 74.86 -81.30 coo 45.39 90.72 40.63 45.07 89.14 41.90 93.79 80.98 -68.72 94.61 81.32 -70.62 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 9 3 # 9 229 ASP B 35 ASP^? 10.19 CL CL B 129 264 GLU C 23 GLU^? 24.69 CL CL C 129 328 ASP B 30 ASP^? 20.91 CL CL B 129 coo 45.62 80.42 43.69 45.65 82.01 45.07 93.79 80.98 -68.72 94.61 81.32 -70.62 coo 59.69 92.71 39.85 58.53 92.03 41.47 93.85 75.25 -49.20 94.57 76.88 -48.00 coo 45.39 90.72 40.63 45.07 89.14 41.90 90.60 81.40 -60.16 92.15 82.83 -59.97 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 10 3 # 10 229 ASP B 41 ASP^? 7.64 CL CL B 129 264 GLU B 51 GLU^? 16.46 CL CL B 129 328 ASP B 35 ASP^? 10.19 CL CL B 129 coo 45.62 80.42 43.69 45.65 82.01 45.07 99.50 74.51 -77.69 100.41 73.95 -79.49 coo 59.69 92.71 39.85 58.53 92.03 41.47 81.98 72.56 -73.89 80.95 72.05 -72.12 coo 45.39 90.72 40.63 45.07 89.14 41.90 93.79 80.98 -68.72 94.61 81.32 -70.62 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 11 3 # 11 229 ASP B 72 ASP^? 28.57 CL CL C 129 264 GLU C 36 GLU^? 18.27 CL CL C 129 328 ASP D 30 ASP^? 20.62 CL CL D 129 coo 45.62 80.42 43.69 45.65 82.01 45.07 80.87 74.36 -54.99 81.74 73.36 -53.35 coo 59.69 92.71 39.85 58.53 92.03 41.47 84.85 65.27 -40.53 84.47 64.86 -42.56 coo 45.39 90.72 40.63 45.07 89.14 41.90 76.16 76.40 -45.40 77.49 78.05 -45.35 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 12 3 # 12 229 ASP B 72 ASP^? 28.57 CL CL C 129 264 GLU D 36 GLU^? 18.42 CL CL D 129 328 ASP C 30 ASP^? 20.67 CL CL C 129 coo 45.62 80.42 43.69 45.65 82.01 45.07 80.87 74.36 -54.99 81.74 73.36 -53.35 coo 59.69 92.71 39.85 58.53 92.03 41.47 74.52 85.40 -40.74 74.64 85.74 -42.81 coo 45.39 90.72 40.63 45.07 89.14 41.90 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 13 3 # 13 229 ASP B 86 ASP^? 23.14 CL CL B 129 264 GLU A 114 GLU^? 14.59 CL CL A 129 328 ASP B 5 ASP^? 20.93 CL CL A 129 coo 45.62 80.42 43.69 45.65 82.01 45.07 108.40 66.17 -67.38 109.32 64.97 -68.84 coo 59.69 92.71 39.85 58.53 92.03 41.47 104.53 45.97 -71.95 105.17 46.78 -70.05 coo 45.39 90.72 40.63 45.07 89.14 41.90 110.10 55.77 -64.66 112.04 55.13 -65.31 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 14 3 # 14 229 ASP B 86 ASP^? 23.14 CL CL B 129 264 GLU B 42 GLU^? 6.42 CL CL B 129 328 ASP A 5 ASP~? 21.13 CL CL B 129 coo 45.62 80.42 43.69 45.65 82.01 45.07 108.40 66.17 -67.38 109.32 64.97 -68.84 coo 59.69 92.71 39.85 58.53 92.03 41.47 97.73 74.53 -82.81 99.44 75.81 -82.79 coo 45.39 90.72 40.63 45.07 89.14 41.90 110.30 67.66 -76.72 112.26 68.26 -76.10 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 15 3 # 15 229 ASP C 10 ASP^? 12.83 CL CL A 129 264 GLU C 36 GLU^? 18.27 CL CL C 129 328 ASP C 86 ASP^? 23.12 CL CL C 129 coo 45.62 80.42 43.69 45.65 82.01 45.07 99.63 54.02 -49.94 99.45 52.98 -51.81 coo 59.69 92.71 39.85 58.53 92.03 41.47 84.85 65.27 -40.53 84.47 64.86 -42.56 coo 45.39 90.72 40.63 45.07 89.14 41.90 98.39 56.19 -38.35 99.60 55.15 -36.99 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 16 3 # 16 229 ASP C 30 ASP^? 20.67 CL CL C 129 264 GLU C 51 GLU^? 16.39 CL CL C 129 328 ASP C 35 ASP^? 10.26 CL CL C 129 coo 45.62 80.42 43.69 45.65 82.01 45.07 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 59.69 92.71 39.85 58.53 92.03 41.47 92.20 82.64 -31.68 92.61 83.59 -33.56 coo 45.39 90.72 40.63 45.07 89.14 41.90 83.63 70.73 -36.85 83.32 69.81 -34.96 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 17 3 # 17 229 ASP C 30 ASP^? 20.67 CL CL C 129 264 GLU C 57 GLU^? -5.48 CL CL C 129s 328 ASP D 35 ASP^? 10.18 CL CL D 129 coo 45.62 80.42 43.69 45.65 82.01 45.07 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 59.69 92.71 39.85 58.53 92.03 41.47 82.94 73.46 -26.00 82.34 73.25 -23.96 coo 45.39 90.72 40.63 45.07 89.14 41.90 75.66 79.96 -36.93 75.99 80.66 -34.97 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 18 3 # 18 229 ASP C 30 ASP^? 20.67 CL CL C 129 264 GLU C 58 GLU^? 7.49 CL CL C 129 328 ASP C 35 ASP^? 10.26 CL CL C 129 coo 45.62 80.42 43.69 45.65 82.01 45.07 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 59.69 92.71 39.85 58.53 92.03 41.47 88.02 76.82 -25.55 89.85 77.43 -24.60 coo 45.39 90.72 40.63 45.07 89.14 41.90 83.63 70.73 -36.85 83.32 69.81 -34.96 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 19 3 # 19 229 ASP C 35 ASP^? 10.26 CL CL C 129 264 GLU B 23 GLU^? 24.68 CL CL B 129 328 ASP C 30 ASP^? 20.67 CL CL C 129 coo 45.62 80.42 43.69 45.65 82.01 45.07 83.63 70.73 -36.85 83.32 69.81 -34.96 coo 59.69 92.71 39.85 58.53 92.03 41.47 89.49 70.79 -56.44 87.96 70.01 -57.68 coo 45.39 90.72 40.63 45.07 89.14 41.90 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 20 3 # 20 229 ASP C 35 ASP^? 10.26 CL CL C 129 264 GLU D 36 GLU^? 18.42 CL CL D 129 328 ASP C 30 ASP^? 20.67 CL CL C 129 coo 45.62 80.42 43.69 45.65 82.01 45.07 83.63 70.73 -36.85 83.32 69.81 -34.96 coo 59.69 92.71 39.85 58.53 92.03 41.47 74.52 85.40 -40.74 74.64 85.74 -42.81 coo 45.39 90.72 40.63 45.07 89.14 41.90 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 21 3 # 21 229 ASP C 35 ASP^? 10.26 CL CL C 129 264 GLU D 51 GLU^? 16.56 CL CL D 129 328 ASP D 35 ASP^? 10.18 CL CL D 129 coo 45.62 80.42 43.69 45.65 82.01 45.07 83.63 70.73 -36.85 83.32 69.81 -34.96 coo 59.69 92.71 39.85 58.53 92.03 41.47 66.99 68.03 -31.91 66.63 66.88 -33.67 coo 45.39 90.72 40.63 45.07 89.14 41.90 75.66 79.96 -36.93 75.99 80.66 -34.97 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 22 3 # 22 229 ASP C 41 ASP^? 7.58 CL CL C 129 264 GLU C 51 GLU^? 16.39 CL CL C 129 328 ASP C 35 ASP^? 10.26 CL CL C 129 coo 45.62 80.42 43.69 45.65 82.01 45.07 90.28 65.09 -27.98 90.77 64.12 -26.18 coo 59.69 92.71 39.85 58.53 92.03 41.47 92.20 82.64 -31.68 92.61 83.59 -33.56 coo 45.39 90.72 40.63 45.07 89.14 41.90 83.63 70.73 -36.85 83.32 69.81 -34.96 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 23 3 # 23 229 ASP D 30 ASP^? 20.62 CL CL D 129 264 GLU C 23 GLU^? 24.69 CL CL C 129 328 ASP B 72 ASP^? 28.57 CL CL C 129 coo 45.62 80.42 43.69 45.65 82.01 45.07 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 59.69 92.71 39.85 58.53 92.03 41.47 93.85 75.25 -49.20 94.57 76.88 -48.00 coo 45.39 90.72 40.63 45.07 89.14 41.90 80.87 74.36 -54.99 81.74 73.36 -53.35 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 24 3 # 24 229 ASP D 30 ASP^? 20.62 CL CL D 129 264 GLU C 57 GLU^? -5.48 CL CL C 129s 328 ASP D 35 ASP^? 10.18 CL CL D 129 coo 45.62 80.42 43.69 45.65 82.01 45.07 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 59.69 92.71 39.85 58.53 92.03 41.47 82.94 73.46 -26.00 82.34 73.25 -23.96 coo 45.39 90.72 40.63 45.07 89.14 41.90 75.66 79.96 -36.93 75.99 80.66 -34.97 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 25 3 # 25 229 ASP D 30 ASP^? 20.62 CL CL D 129 264 GLU D 51 GLU^? 16.56 CL CL D 129 328 ASP D 35 ASP^? 10.18 CL CL D 129 coo 45.62 80.42 43.69 45.65 82.01 45.07 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 59.69 92.71 39.85 58.53 92.03 41.47 66.99 68.03 -31.91 66.63 66.88 -33.67 coo 45.39 90.72 40.63 45.07 89.14 41.90 75.66 79.96 -36.93 75.99 80.66 -34.97 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 26 3 # 26 229 ASP D 30 ASP^? 20.62 CL CL D 129 264 GLU D 58 GLU^? 7.39 CL CL D 129 328 ASP D 35 ASP^? 10.18 CL CL D 129 coo 45.62 80.42 43.69 45.65 82.01 45.07 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 59.69 92.71 39.85 58.53 92.03 41.47 71.21 74.03 -25.57 69.46 73.32 -24.61 coo 45.39 90.72 40.63 45.07 89.14 41.90 75.66 79.96 -36.93 75.99 80.66 -34.97 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 27 3 # 27 229 ASP D 35 ASP^? 10.18 CL CL D 129 264 GLU C 36 GLU^? 18.27 CL CL C 129 328 ASP D 30 ASP^? 20.62 CL CL D 129 coo 45.62 80.42 43.69 45.65 82.01 45.07 75.66 79.96 -36.93 75.99 80.66 -34.97 coo 59.69 92.71 39.85 58.53 92.03 41.47 84.85 65.27 -40.53 84.47 64.86 -42.56 coo 45.39 90.72 40.63 45.07 89.14 41.90 76.16 76.40 -45.40 77.49 78.05 -45.35 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 28 3 # 28 229 ASP D 35 ASP^? 10.18 CL CL D 129 264 GLU C 51 GLU^? 16.39 CL CL C 129 328 ASP C 35 ASP^? 10.26 CL CL C 129 coo 45.62 80.42 43.69 45.65 82.01 45.07 75.66 79.96 -36.93 75.99 80.66 -34.97 coo 59.69 92.71 39.85 58.53 92.03 41.47 92.20 82.64 -31.68 92.61 83.59 -33.56 coo 45.39 90.72 40.63 45.07 89.14 41.90 83.63 70.73 -36.85 83.32 69.81 -34.96 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 29 3 # 29 229 ASP D 41 ASP^? 7.55 CL CL D 129 264 GLU C 57 GLU^? -5.48 CL CL C 129s 328 ASP D 35 ASP^? 10.18 CL CL D 129 coo 45.62 80.42 43.69 45.65 82.01 45.07 69.10 85.54 -28.07 68.60 86.44 -26.19 coo 59.69 92.71 39.85 58.53 92.03 41.47 82.94 73.46 -26.00 82.34 73.25 -23.96 coo 45.39 90.72 40.63 45.07 89.14 41.90 75.66 79.96 -36.93 75.99 80.66 -34.97 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 30 3 # 30 229 ASP D 41 ASP^? 7.55 CL CL D 129 264 GLU D 51 GLU^? 16.56 CL CL D 129 328 ASP D 35 ASP^? 10.18 CL CL D 129 coo 45.62 80.42 43.69 45.65 82.01 45.07 69.10 85.54 -28.07 68.60 86.44 -26.19 coo 59.69 92.71 39.85 58.53 92.03 41.47 66.99 68.03 -31.91 66.63 66.88 -33.67 coo 45.39 90.72 40.63 45.07 89.14 41.90 75.66 79.96 -36.93 75.99 80.66 -34.97 1cdg_c00 source 1cdg CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.C.2.4.1.19: 30 hits 1cdg_c00 naa= 3 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 1 3 # 1 A 232 HIS A 40 HIS.? 7.30 CL CL A 129 A 262 GLU A 114 GLU^? 14.59 CL CL A 129 A 358 GLU A 36 GLU~? 18.47 CL CL A 129 coo 26.19 60.87 43.98 27.48 59.27 43.30 98.96 43.60 -66.18 98.11 41.92 -65.26 coo 27.13 54.07 50.45 26.96 54.19 48.35 104.53 45.97 -71.95 105.17 46.78 -70.05 coo 27.06 50.43 44.36 27.99 52.27 44.74 99.16 43.45 -76.17 99.38 43.10 -78.24 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 2 3 # 2 A 232 HIS B 40 HIS^? 7.04 CL CL B 129 A 262 GLU B 36 GLU^? 18.40 CL CL B 129 A 358 GLU B 114 GLU^? 14.94 CL CL B 129 coo 26.19 60.87 43.98 27.48 59.27 43.30 98.79 79.91 -74.95 97.97 81.53 -75.99 coo 27.13 54.07 50.45 26.96 54.19 48.35 99.20 79.77 -64.83 99.58 80.60 -62.91 coo 27.06 50.43 44.36 27.99 52.27 44.74 104.70 77.68 -68.99 105.48 76.80 -70.78 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 3 3 # 3 A 232 HIS B 40 HIS^? 7.04 CL CL B 129 A 262 GLU B 114 GLU^? 14.94 CL CL B 129 A 358 GLU B 36 GLU^? 18.40 CL CL B 129 coo 26.19 60.87 43.98 27.48 59.27 43.30 98.79 79.91 -74.95 97.97 81.53 -75.99 coo 27.13 54.07 50.45 26.96 54.19 48.35 104.70 77.68 -68.99 105.48 76.80 -70.78 coo 27.06 50.43 44.36 27.99 52.27 44.74 99.20 79.77 -64.83 99.58 80.60 -62.91 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 4 3 # 4 A 232 HIS C 40 HIS^? 7.21 CL CL C 129 A 262 GLU C 36 GLU^? 18.27 CL CL C 129 A 358 GLU C 114 GLU^? 14.88 CL CL C 129 coo 26.19 60.87 43.98 27.48 59.27 43.30 84.82 65.72 -30.75 83.18 66.51 -29.70 coo 27.13 54.07 50.45 26.96 54.19 48.35 84.85 65.27 -40.53 84.47 64.86 -42.56 coo 27.06 50.43 44.36 27.99 52.27 44.74 87.05 59.85 -36.57 87.99 59.11 -34.78 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 5 3 # 5 A 232 HIS C 40 HIS^? 7.21 CL CL C 129 A 262 GLU C 114 GLU^? 14.88 CL CL C 129 A 358 GLU C 36 GLU^? 18.27 CL CL C 129 coo 26.19 60.87 43.98 27.48 59.27 43.30 84.82 65.72 -30.75 83.18 66.51 -29.70 coo 27.13 54.07 50.45 26.96 54.19 48.35 87.05 59.85 -36.57 87.99 59.11 -34.78 coo 27.06 50.43 44.36 27.99 52.27 44.74 84.85 65.27 -40.53 84.47 64.86 -42.56 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 6 3 # 6 A 232 HIS D 40 HIS^? 7.31 CL CL D 129 A 262 GLU D 36 GLU^? 18.42 CL CL D 129 A 358 GLU D 114 GLU^? 14.88 CL CL D 129 coo 26.19 60.87 43.98 27.48 59.27 43.30 74.49 84.96 -30.93 76.13 84.16 -29.90 coo 27.13 54.07 50.45 26.96 54.19 48.35 74.52 85.40 -40.74 74.64 85.74 -42.81 coo 27.06 50.43 44.36 27.99 52.27 44.74 72.08 90.81 -36.72 71.29 91.48 -34.84 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 7 3 # 7 A 232 HIS D 40 HIS^? 7.31 CL CL D 129 A 262 GLU D 114 GLU^? 14.88 CL CL D 129 A 358 GLU D 36 GLU^? 18.42 CL CL D 129 coo 26.19 60.87 43.98 27.48 59.27 43.30 74.49 84.96 -30.93 76.13 84.16 -29.90 coo 27.13 54.07 50.45 26.96 54.19 48.35 72.08 90.81 -36.72 71.29 91.48 -34.84 coo 27.06 50.43 44.36 27.99 52.27 44.74 74.52 85.40 -40.74 74.64 85.74 -42.81 1chm_c00 source 1chm CREATINE AMIDINOHYDROLASE (E.C.3.5.3.3) : 7 hits 1chm_c00 naa= 3 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 1 3 # 1 B 232 HIS A 40 HIS.? 7.30 CL CL A 129 B 262 GLU A 114 GLU^? 14.59 CL CL A 129 B 358 GLU A 36 GLU~? 18.47 CL CL A 129 coo 44.98 77.01 48.39 44.42 78.67 47.18 98.96 43.60 -66.18 98.11 41.92 -65.26 coo 41.60 83.57 54.16 42.46 83.24 52.25 104.53 45.97 -71.95 105.17 46.78 -70.05 coo 44.05 87.61 48.73 43.15 85.67 48.52 99.16 43.45 -76.17 99.38 43.10 -78.24 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 2 3 # 2 B 232 HIS B 40 HIS^? 7.04 CL CL B 129 B 262 GLU B 36 GLU^? 18.40 CL CL B 129 B 358 GLU B 114 GLU^? 14.94 CL CL B 129 coo 44.98 77.01 48.39 44.42 78.67 47.18 98.79 79.91 -74.95 97.97 81.53 -75.99 coo 41.60 83.57 54.16 42.46 83.24 52.25 99.20 79.77 -64.83 99.58 80.60 -62.91 coo 44.05 87.61 48.73 43.15 85.67 48.52 104.70 77.68 -68.99 105.48 76.80 -70.78 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 3 3 # 3 B 232 HIS B 40 HIS^? 7.04 CL CL B 129 B 262 GLU B 57 GLU^? -5.29 CL CL B 129s B 358 GLU B 58 GLU^? 7.34 CL CL B 129 coo 44.98 77.01 48.39 44.42 78.67 47.18 98.79 79.91 -74.95 97.97 81.53 -75.99 coo 41.60 83.57 54.16 42.46 83.24 52.25 91.24 81.90 -79.46 91.48 82.48 -81.50 coo 44.05 87.61 48.73 43.15 85.67 48.52 87.90 76.66 -80.19 87.42 74.86 -81.30 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 4 3 # 4 B 232 HIS B 40 HIS^? 7.04 CL CL B 129 B 262 GLU B 114 GLU^? 14.94 CL CL B 129 B 358 GLU B 36 GLU^? 18.40 CL CL B 129 coo 44.98 77.01 48.39 44.42 78.67 47.18 98.79 79.91 -74.95 97.97 81.53 -75.99 coo 41.60 83.57 54.16 42.46 83.24 52.25 104.70 77.68 -68.99 105.48 76.80 -70.78 coo 44.05 87.61 48.73 43.15 85.67 48.52 99.20 79.77 -64.83 99.58 80.60 -62.91 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 5 3 # 5 B 232 HIS C 40 HIS^? 7.21 CL CL C 129 B 262 GLU C 114 GLU^? 14.88 CL CL C 129 B 358 GLU C 36 GLU^? 18.27 CL CL C 129 coo 44.98 77.01 48.39 44.42 78.67 47.18 84.82 65.72 -30.75 83.18 66.51 -29.70 coo 41.60 83.57 54.16 42.46 83.24 52.25 87.05 59.85 -36.57 87.99 59.11 -34.78 coo 44.05 87.61 48.73 43.15 85.67 48.52 84.85 65.27 -40.53 84.47 64.86 -42.56 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 6 3 # 6 B 232 HIS D 40 HIS^? 7.31 CL CL D 129 B 262 GLU D 114 GLU^? 14.88 CL CL D 129 B 358 GLU D 36 GLU^? 18.42 CL CL D 129 coo 44.98 77.01 48.39 44.42 78.67 47.18 74.49 84.96 -30.93 76.13 84.16 -29.90 coo 41.60 83.57 54.16 42.46 83.24 52.25 72.08 90.81 -36.72 71.29 91.48 -34.84 coo 44.05 87.61 48.73 43.15 85.67 48.52 74.52 85.40 -40.74 74.64 85.74 -42.81 1chm_c01 source 1chm CREATINE AMIDINOHYDROLASE (E.C.3.5.3.3) : 6 hits 1chm_c01 naa= 3 ULMN 3 1cns_c01 CHITINASE user 1 3 # 1 B 67 GLU A 23 GLU~? 24.22 CL CL A 129 B 89 GLU A 93 GLU.? 15.26 CL CL B 129 B 120 SER A 91 SER.? 14.42 CL CL B 129 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 89.42 52.54 -84.47 88.08 53.22 -82.95 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 84.83 64.69 -81.14 84.26 66.42 -82.32 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 91.69 62.31 -78.52 92.31 64.05 -76.96 ULMN 3 1cns_c01 CHITINASE user 2 3 # 2 B 67 GLU A 93 GLU.? 15.26 CL CL B 129 B 89 GLU B 51 GLU^? 16.46 CL CL B 129 B 120 SER A 127 SER^? 22.87 CL CL B 129 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 84.83 64.69 -81.14 84.26 66.42 -82.32 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 81.98 72.56 -73.89 80.95 72.05 -72.12 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 75.13 65.62 -72.89 75.19 67.88 -72.00 ULMN 3 1cns_c01 CHITINASE user 3 3 # 3 B 67 GLU B 23 GLU^? 24.68 CL CL B 129 B 89 GLU B 93 GLU^? 15.32 CL CL A 129 B 120 SER B 91 SER^? 14.45 CL CL A 129 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 89.49 70.79 -56.44 87.96 70.01 -57.68 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 84.67 58.80 -60.02 84.04 57.06 -58.91 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 91.67 61.18 -62.59 92.49 59.52 -64.12 ULMN 3 1cns_c01 CHITINASE user 4 3 # 4 B 67 GLU B 93 GLU^? 15.32 CL CL A 129 B 89 GLU A 51 GLU^? 16.44 CL CL A 129 B 120 SER A 124 SER^? 21.51 CL CL B 129 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 84.67 58.80 -60.02 84.04 57.06 -58.91 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 82.00 50.89 -67.09 80.89 51.23 -68.89 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 81.71 59.41 -72.63 82.35 61.73 -72.29 ULMN 3 1cns_c01 CHITINASE user 5 3 # 5 B 67 GLU B 93 GLU^? 15.32 CL CL A 129 B 89 GLU A 51 GLU^? 16.44 CL CL A 129 B 120 SER B 127 SER^? 22.99 CL CL A 129 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 84.67 58.80 -60.02 84.04 57.06 -58.91 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 82.00 50.89 -67.09 80.89 51.23 -68.89 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 75.24 57.91 -68.31 76.20 56.67 -70.14 ULMN 3 1cns_c01 CHITINASE user 6 3 # 6 B 67 GLU C 23 GLU^? 24.69 CL CL C 129 B 89 GLU C 93 GLU^? 31.51 CL CL C 129 B 120 SER C 91 SER^? 24.66 CL CL C 129 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 93.85 75.25 -49.20 94.57 76.88 -48.00 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 105.96 79.95 -45.75 107.72 80.63 -46.81 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 103.64 72.95 -43.07 105.41 72.14 -41.61 ULMN 3 1cns_c01 CHITINASE user 7 3 # 7 B 67 GLU D 23 GLU^? 24.49 CL CL D 129 B 89 GLU D 93 GLU^? 31.46 CL CL D 129 B 120 SER D 91 SER^? 24.58 CL CL D 129 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 65.41 75.40 -49.12 64.81 73.78 -47.86 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 53.41 70.78 -45.84 51.64 70.26 -46.90 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 55.66 77.76 -43.22 54.00 78.42 -41.57 1cns_c01 source 1cns CHITINASE : 7 hits 1cns_c01 naa= 3 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 101 TYR A 22 TYR~? 17.56 CL CL A 129 A 173 ASP A 30 ASP~? 20.80 CL CL A 129 C 48 ARG A 46 ARG^? 15.11 CL CL A 129 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 92.72 50.62 -78.45 90.87 50.50 -76.41 coo 24.35 4.55 25.11 25.94 3.23 25.53 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 87.96 51.20 -70.32 85.08 51.60 -71.34 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 101 TYR A 22 TYR~? 17.56 CL CL A 129 A 173 ASP A 30 ASP~? 20.80 CL CL A 129 C 48 ARG A 73 ARG.? 22.19 CL CL A 129 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 92.72 50.62 -78.45 90.87 50.50 -76.41 coo 24.35 4.55 25.11 25.94 3.23 25.53 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 83.82 53.79 -81.61 86.00 54.30 -79.51 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 101 TYR A 22 TYR~? 17.56 CL CL A 129 A 173 ASP A 30 ASP~? 20.80 CL CL A 129 C 48 ARG A 117 ARG^? 16.03 CL CL A 129 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 92.72 50.62 -78.45 90.87 50.50 -76.41 coo 24.35 4.55 25.11 25.94 3.23 25.53 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 100.59 48.03 -72.66 102.04 46.10 -74.59 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 101 TYR B 22 TYR^? 17.56 CL CL B 129 A 173 ASP B 30 ASP^? 20.91 CL CL B 129 C 48 ARG B 46 ARG^? 15.06 CL CL B 129 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 24.35 4.55 25.11 25.94 3.23 25.53 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 87.96 72.13 -70.71 85.05 71.84 -69.78 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 101 TYR B 22 TYR^? 17.56 CL CL B 129 A 173 ASP B 30 ASP^? 20.91 CL CL B 129 C 48 ARG B 73 ARG^? 22.29 CL CL B 129 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 24.35 4.55 25.11 25.94 3.23 25.53 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 83.86 69.55 -59.16 85.91 69.18 -61.42 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 A 101 TYR B 22 TYR^? 17.56 CL CL B 129 A 173 ASP B 30 ASP^? 20.91 CL CL B 129 C 48 ARG B 117 ARG^? 16.04 CL CL B 129 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 24.35 4.55 25.11 25.94 3.23 25.53 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 100.63 75.34 -68.25 102.08 77.36 -66.41 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 A 101 TYR C 22 TYR^? 17.52 CL CL C 129 A 173 ASP C 30 ASP^? 20.67 CL CL C 129 C 48 ARG C 46 ARG^? 15.12 CL CL C 129 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 24.35 4.55 25.11 25.94 3.23 25.53 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 92.47 76.70 -34.87 92.87 79.50 -36.04 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 A 101 TYR C 22 TYR^? 17.52 CL CL C 129 A 173 ASP C 30 ASP^? 20.67 CL CL C 129 C 48 ARG C 73 ARG^? 22.24 CL CL C 129 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 24.35 4.55 25.11 25.94 3.23 25.53 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 95.26 80.79 -46.47 95.45 78.63 -44.29 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 A 101 TYR C 22 TYR^? 17.52 CL CL C 129 A 173 ASP C 30 ASP^? 20.67 CL CL C 129 C 48 ARG C 117 ARG^? 16.02 CL CL C 129 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 24.35 4.55 25.11 25.94 3.23 25.53 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 89.36 64.01 -37.29 87.40 62.56 -39.24 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 A 101 TYR D 22 TYR^? 17.52 CL CL D 129 A 173 ASP D 30 ASP^? 20.62 CL CL D 129 C 48 ARG D 46 ARG^? 15.13 CL CL D 129 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 67.44 78.74 -43.16 67.49 76.94 -41.01 coo 24.35 4.55 25.11 25.94 3.23 25.53 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 66.74 73.93 -35.00 66.45 71.02 -36.02 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 A 101 TYR D 22 TYR^? 17.52 CL CL D 129 A 173 ASP D 30 ASP^? 20.62 CL CL D 129 C 48 ARG D 73 ARG^? 22.15 CL CL D 129 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 67.44 78.74 -43.16 67.49 76.94 -41.01 coo 24.35 4.55 25.11 25.94 3.23 25.53 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 64.06 69.83 -46.45 63.93 71.88 -44.19 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 A 101 TYR D 22 TYR^? 17.52 CL CL D 129 A 173 ASP D 30 ASP^? 20.62 CL CL D 129 C 48 ARG D 117 ARG^? 15.96 CL CL D 129 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 67.44 78.74 -43.16 67.49 76.94 -41.01 coo 24.35 4.55 25.11 25.94 3.23 25.53 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 69.91 86.62 -37.36 71.94 88.06 -39.21 1cs1_c00 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 12 hits 1cs1_c00 naa= 3 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 48 ARG B 46 ARG^? 15.06 CL CL B 129 C 101 TYR B 22 TYR^? 17.56 CL CL B 129 C 173 ASP B 30 ASP^? 20.91 CL CL B 129 coo 32.27 5.62 48.15 31.93 6.48 51.06 87.96 72.13 -70.71 85.05 71.84 -69.78 coo 29.64 3.64 57.39 31.22 5.14 55.65 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 90.60 81.40 -60.16 92.15 82.83 -59.97 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 48 ARG B 73 ARG^? 22.29 CL CL B 129 C 101 TYR B 22 TYR^? 17.56 CL CL B 129 C 173 ASP B 30 ASP^? 20.91 CL CL B 129 coo 32.27 5.62 48.15 31.93 6.48 51.06 83.86 69.55 -59.16 85.91 69.18 -61.42 coo 29.64 3.64 57.39 31.22 5.14 55.65 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 90.60 81.40 -60.16 92.15 82.83 -59.97 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 48 ARG B 117 ARG^? 16.04 CL CL B 129 C 101 TYR B 22 TYR^? 17.56 CL CL B 129 C 173 ASP B 30 ASP^? 20.91 CL CL B 129 coo 32.27 5.62 48.15 31.93 6.48 51.06 100.63 75.34 -68.25 102.08 77.36 -66.41 coo 29.64 3.64 57.39 31.22 5.14 55.65 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 90.60 81.40 -60.16 92.15 82.83 -59.97 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 48 ARG C 46 ARG^? 15.12 CL CL C 129 C 101 TYR C 22 TYR^? 17.52 CL CL C 129 C 173 ASP C 30 ASP^? 20.67 CL CL C 129 coo 32.27 5.62 48.15 31.93 6.48 51.06 92.47 76.70 -34.87 92.87 79.50 -36.04 coo 29.64 3.64 57.39 31.22 5.14 55.65 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 48 ARG C 73 ARG^? 22.24 CL CL C 129 C 101 TYR C 22 TYR^? 17.52 CL CL C 129 C 173 ASP C 30 ASP^? 20.67 CL CL C 129 coo 32.27 5.62 48.15 31.93 6.48 51.06 95.26 80.79 -46.47 95.45 78.63 -44.29 coo 29.64 3.64 57.39 31.22 5.14 55.65 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 A 48 ARG C 117 ARG^? 16.02 CL CL C 129 C 101 TYR C 22 TYR^? 17.52 CL CL C 129 C 173 ASP C 30 ASP^? 20.67 CL CL C 129 coo 32.27 5.62 48.15 31.93 6.48 51.06 89.36 64.01 -37.29 87.40 62.56 -39.24 coo 29.64 3.64 57.39 31.22 5.14 55.65 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 A 48 ARG D 46 ARG^? 15.13 CL CL D 129 C 101 TYR D 22 TYR^? 17.52 CL CL D 129 C 173 ASP D 30 ASP^? 20.62 CL CL D 129 coo 32.27 5.62 48.15 31.93 6.48 51.06 66.74 73.93 -35.00 66.45 71.02 -36.02 coo 29.64 3.64 57.39 31.22 5.14 55.65 67.44 78.74 -43.16 67.49 76.94 -41.01 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 76.16 76.40 -45.40 77.49 78.05 -45.35 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 A 48 ARG D 73 ARG^? 22.15 CL CL D 129 C 101 TYR D 22 TYR^? 17.52 CL CL D 129 C 173 ASP D 30 ASP^? 20.62 CL CL D 129 coo 32.27 5.62 48.15 31.93 6.48 51.06 64.06 69.83 -46.45 63.93 71.88 -44.19 coo 29.64 3.64 57.39 31.22 5.14 55.65 67.44 78.74 -43.16 67.49 76.94 -41.01 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 76.16 76.40 -45.40 77.49 78.05 -45.35 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 A 48 ARG D 117 ARG^? 15.96 CL CL D 129 C 101 TYR D 22 TYR^? 17.52 CL CL D 129 C 173 ASP D 30 ASP^? 20.62 CL CL D 129 coo 32.27 5.62 48.15 31.93 6.48 51.06 69.91 86.62 -37.36 71.94 88.06 -39.21 coo 29.64 3.64 57.39 31.22 5.14 55.65 67.44 78.74 -43.16 67.49 76.94 -41.01 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 76.16 76.40 -45.40 77.49 78.05 -45.35 1cs1_c01 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 9 hits 1cs1_c01 naa= 3 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 48 ARG A 46 ARG^? 15.11 CL CL A 129 D 101 TYR A 22 TYR~? 17.56 CL CL A 129 D 173 ASP A 30 ASP~? 20.80 CL CL A 129 coo 69.08 8.58 32.60 69.70 10.81 30.58 87.96 51.20 -70.32 85.08 51.60 -71.34 coo 71.77 11.86 24.26 70.23 12.22 26.56 92.72 50.62 -78.45 90.87 50.50 -76.41 coo 71.60 6.14 19.25 70.26 6.87 20.69 90.38 41.71 -80.87 92.04 40.39 -80.79 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 48 ARG A 73 ARG.? 22.19 CL CL A 129 D 101 TYR A 22 TYR~? 17.56 CL CL A 129 D 173 ASP A 30 ASP~? 20.80 CL CL A 129 coo 69.08 8.58 32.60 69.70 10.81 30.58 83.82 53.79 -81.61 86.00 54.30 -79.51 coo 71.77 11.86 24.26 70.23 12.22 26.56 92.72 50.62 -78.45 90.87 50.50 -76.41 coo 71.60 6.14 19.25 70.26 6.87 20.69 90.38 41.71 -80.87 92.04 40.39 -80.79 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 48 ARG A 117 ARG^? 16.03 CL CL A 129 D 101 TYR A 22 TYR~? 17.56 CL CL A 129 D 173 ASP A 30 ASP~? 20.80 CL CL A 129 coo 69.08 8.58 32.60 69.70 10.81 30.58 100.59 48.03 -72.66 102.04 46.10 -74.59 coo 71.77 11.86 24.26 70.23 12.22 26.56 92.72 50.62 -78.45 90.87 50.50 -76.41 coo 71.60 6.14 19.25 70.26 6.87 20.69 90.38 41.71 -80.87 92.04 40.39 -80.79 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 48 ARG B 46 ARG^? 15.06 CL CL B 129 D 101 TYR B 22 TYR^? 17.56 CL CL B 129 D 173 ASP B 30 ASP^? 20.91 CL CL B 129 coo 69.08 8.58 32.60 69.70 10.81 30.58 87.96 72.13 -70.71 85.05 71.84 -69.78 coo 71.77 11.86 24.26 70.23 12.22 26.56 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 71.60 6.14 19.25 70.26 6.87 20.69 90.60 81.40 -60.16 92.15 82.83 -59.97 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 48 ARG B 73 ARG^? 22.29 CL CL B 129 D 101 TYR B 22 TYR^? 17.56 CL CL B 129 D 173 ASP B 30 ASP^? 20.91 CL CL B 129 coo 69.08 8.58 32.60 69.70 10.81 30.58 83.86 69.55 -59.16 85.91 69.18 -61.42 coo 71.77 11.86 24.26 70.23 12.22 26.56 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 71.60 6.14 19.25 70.26 6.87 20.69 90.60 81.40 -60.16 92.15 82.83 -59.97 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 48 ARG B 117 ARG^? 16.04 CL CL B 129 D 101 TYR B 22 TYR^? 17.56 CL CL B 129 D 173 ASP B 30 ASP^? 20.91 CL CL B 129 coo 69.08 8.58 32.60 69.70 10.81 30.58 100.63 75.34 -68.25 102.08 77.36 -66.41 coo 71.77 11.86 24.26 70.23 12.22 26.56 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 71.60 6.14 19.25 70.26 6.87 20.69 90.60 81.40 -60.16 92.15 82.83 -59.97 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 B 48 ARG C 46 ARG^? 15.12 CL CL C 129 D 101 TYR C 22 TYR^? 17.52 CL CL C 129 D 173 ASP C 30 ASP^? 20.67 CL CL C 129 coo 69.08 8.58 32.60 69.70 10.81 30.58 92.47 76.70 -34.87 92.87 79.50 -36.04 coo 71.77 11.86 24.26 70.23 12.22 26.56 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 71.60 6.14 19.25 70.26 6.87 20.69 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 B 48 ARG C 73 ARG^? 22.24 CL CL C 129 D 101 TYR C 22 TYR^? 17.52 CL CL C 129 D 173 ASP C 30 ASP^? 20.67 CL CL C 129 coo 69.08 8.58 32.60 69.70 10.81 30.58 95.26 80.79 -46.47 95.45 78.63 -44.29 coo 71.77 11.86 24.26 70.23 12.22 26.56 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 71.60 6.14 19.25 70.26 6.87 20.69 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 B 48 ARG C 117 ARG^? 16.02 CL CL C 129 D 101 TYR C 22 TYR^? 17.52 CL CL C 129 D 173 ASP C 30 ASP^? 20.67 CL CL C 129 coo 69.08 8.58 32.60 69.70 10.81 30.58 89.36 64.01 -37.29 87.40 62.56 -39.24 coo 71.77 11.86 24.26 70.23 12.22 26.56 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 71.60 6.14 19.25 70.26 6.87 20.69 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 B 48 ARG D 46 ARG^? 15.13 CL CL D 129 D 101 TYR D 22 TYR^? 17.52 CL CL D 129 D 173 ASP D 30 ASP^? 20.62 CL CL D 129 coo 69.08 8.58 32.60 69.70 10.81 30.58 66.74 73.93 -35.00 66.45 71.02 -36.02 coo 71.77 11.86 24.26 70.23 12.22 26.56 67.44 78.74 -43.16 67.49 76.94 -41.01 coo 71.60 6.14 19.25 70.26 6.87 20.69 76.16 76.40 -45.40 77.49 78.05 -45.35 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 B 48 ARG D 73 ARG^? 22.15 CL CL D 129 D 101 TYR D 22 TYR^? 17.52 CL CL D 129 D 173 ASP D 30 ASP^? 20.62 CL CL D 129 coo 69.08 8.58 32.60 69.70 10.81 30.58 64.06 69.83 -46.45 63.93 71.88 -44.19 coo 71.77 11.86 24.26 70.23 12.22 26.56 67.44 78.74 -43.16 67.49 76.94 -41.01 coo 71.60 6.14 19.25 70.26 6.87 20.69 76.16 76.40 -45.40 77.49 78.05 -45.35 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 B 48 ARG D 117 ARG^? 15.96 CL CL D 129 D 101 TYR D 22 TYR^? 17.52 CL CL D 129 D 173 ASP D 30 ASP^? 20.62 CL CL D 129 coo 69.08 8.58 32.60 69.70 10.81 30.58 69.91 86.62 -37.36 71.94 88.06 -39.21 coo 71.77 11.86 24.26 70.23 12.22 26.56 67.44 78.74 -43.16 67.49 76.94 -41.01 coo 71.60 6.14 19.25 70.26 6.87 20.69 76.16 76.40 -45.40 77.49 78.05 -45.35 1cs1_c02 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 12 hits 1cs1_c02 naa= 3 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 101 TYR A 22 TYR~? 17.56 CL CL A 129 B 173 ASP A 30 ASP~? 20.80 CL CL A 129 D 48 ARG A 46 ARG^? 15.11 CL CL A 129 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 92.72 50.62 -78.45 90.87 50.50 -76.41 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 87.96 51.20 -70.32 85.08 51.60 -71.34 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 101 TYR A 22 TYR~? 17.56 CL CL A 129 B 173 ASP A 30 ASP~? 20.80 CL CL A 129 D 48 ARG A 73 ARG.? 22.19 CL CL A 129 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 92.72 50.62 -78.45 90.87 50.50 -76.41 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 83.82 53.79 -81.61 86.00 54.30 -79.51 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 101 TYR A 22 TYR~? 17.56 CL CL A 129 B 173 ASP A 30 ASP~? 20.80 CL CL A 129 D 48 ARG A 117 ARG^? 16.03 CL CL A 129 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 92.72 50.62 -78.45 90.87 50.50 -76.41 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 100.59 48.03 -72.66 102.04 46.10 -74.59 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 101 TYR B 22 TYR^? 17.56 CL CL B 129 B 173 ASP B 30 ASP^? 20.91 CL CL B 129 D 48 ARG B 46 ARG^? 15.06 CL CL B 129 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 87.96 72.13 -70.71 85.05 71.84 -69.78 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 101 TYR B 22 TYR^? 17.56 CL CL B 129 B 173 ASP B 30 ASP^? 20.91 CL CL B 129 D 48 ARG B 73 ARG^? 22.29 CL CL B 129 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 83.86 69.55 -59.16 85.91 69.18 -61.42 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 101 TYR B 22 TYR^? 17.56 CL CL B 129 B 173 ASP B 30 ASP^? 20.91 CL CL B 129 D 48 ARG B 117 ARG^? 16.04 CL CL B 129 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 100.63 75.34 -68.25 102.08 77.36 -66.41 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 B 101 TYR C 22 TYR^? 17.52 CL CL C 129 B 173 ASP C 30 ASP^? 20.67 CL CL C 129 D 48 ARG C 46 ARG^? 15.12 CL CL C 129 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 92.47 76.70 -34.87 92.87 79.50 -36.04 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 B 101 TYR C 22 TYR^? 17.52 CL CL C 129 B 173 ASP C 30 ASP^? 20.67 CL CL C 129 D 48 ARG C 73 ARG^? 22.24 CL CL C 129 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 95.26 80.79 -46.47 95.45 78.63 -44.29 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 B 101 TYR C 22 TYR^? 17.52 CL CL C 129 B 173 ASP C 30 ASP^? 20.67 CL CL C 129 D 48 ARG C 117 ARG^? 16.02 CL CL C 129 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 89.36 64.01 -37.29 87.40 62.56 -39.24 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 B 101 TYR D 22 TYR^? 17.52 CL CL D 129 B 173 ASP D 30 ASP^? 20.62 CL CL D 129 D 48 ARG D 46 ARG^? 15.13 CL CL D 129 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 67.44 78.74 -43.16 67.49 76.94 -41.01 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 66.74 73.93 -35.00 66.45 71.02 -36.02 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 B 101 TYR D 22 TYR^? 17.52 CL CL D 129 B 173 ASP D 30 ASP^? 20.62 CL CL D 129 D 48 ARG D 73 ARG^? 22.15 CL CL D 129 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 67.44 78.74 -43.16 67.49 76.94 -41.01 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 64.06 69.83 -46.45 63.93 71.88 -44.19 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 B 101 TYR D 22 TYR^? 17.52 CL CL D 129 B 173 ASP D 30 ASP^? 20.62 CL CL D 129 D 48 ARG D 117 ARG^? 15.96 CL CL D 129 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 67.44 78.74 -43.16 67.49 76.94 -41.01 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 69.91 86.62 -37.36 71.94 88.06 -39.21 1cs1_c03 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 12 hits 1cs1_c03 naa= 3 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 1 3 # 1 313 ASP A 35 ASP~? 10.31 CL CL A 129 315 GLU A 36 GLU~? 18.47 CL CL A 129 390 TYR A 22 TYR~? 17.56 CL CL A 129 coo 32.46 99.13 19.34 30.94 100.38 20.07 93.79 42.35 -72.20 94.79 41.97 -70.38 coo 32.04 94.22 18.23 30.57 94.75 16.88 99.16 43.45 -76.17 99.38 43.10 -78.24 coo 21.10 94.74 18.36 23.09 96.71 18.59 92.72 50.62 -78.45 90.87 50.50 -76.41 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 2 3 # 2 313 ASP A 41 ASP.? 7.60 CL CL A 129 315 GLU A 42 GLU.? 5.77 CL CL A 129 390 TYR A 54 TYR^? 10.29 CL CL A 129 coo 32.46 99.13 19.34 30.94 100.38 20.07 99.56 48.98 -63.34 100.43 49.52 -61.53 coo 32.04 94.22 18.23 30.57 94.75 16.88 98.04 48.44 -58.38 99.25 46.68 -58.65 coo 21.10 94.74 18.36 23.09 96.71 18.59 89.27 53.06 -59.98 88.13 55.63 -59.94 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 3 3 # 3 313 ASP B 35 ASP^? 10.19 CL CL B 129 315 GLU B 36 GLU^? 18.40 CL CL B 129 390 TYR B 22 TYR^? 17.56 CL CL B 129 coo 32.46 99.13 19.34 30.94 100.38 20.07 93.79 80.98 -68.72 94.61 81.32 -70.62 coo 32.04 94.22 18.23 30.57 94.75 16.88 99.20 79.77 -64.83 99.58 80.60 -62.91 coo 21.10 94.74 18.36 23.09 96.71 18.59 92.70 72.76 -62.54 90.90 72.79 -64.68 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 4 3 # 4 313 ASP B 41 ASP^? 7.64 CL CL B 129 315 GLU B 42 GLU^? 6.42 CL CL B 129 390 TYR B 54 TYR^? 10.36 CL CL B 129 coo 32.46 99.13 19.34 30.94 100.38 20.07 99.50 74.51 -77.69 100.41 73.95 -79.49 coo 32.04 94.22 18.23 30.57 94.75 16.88 97.73 74.53 -82.81 99.44 75.81 -82.79 coo 21.10 94.74 18.36 23.09 96.71 18.59 89.19 70.43 -81.07 88.03 67.93 -81.20 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 5 3 # 5 313 ASP C 35 ASP^? 10.26 CL CL C 129 315 GLU C 36 GLU^? 18.27 CL CL C 129 390 TYR C 22 TYR^? 17.52 CL CL C 129 coo 32.46 99.13 19.34 30.94 100.38 20.07 83.63 70.73 -36.85 83.32 69.81 -34.96 coo 32.04 94.22 18.23 30.57 94.75 16.88 84.85 65.27 -40.53 84.47 64.86 -42.56 coo 21.10 94.74 18.36 23.09 96.71 18.59 91.93 71.84 -43.09 91.81 73.68 -41.00 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 6 3 # 6 313 ASP C 41 ASP^? 7.58 CL CL C 129 315 GLU C 42 GLU^? 6.54 CL CL C 129 390 TYR C 54 TYR^? 10.32 CL CL C 129 coo 32.46 99.13 19.34 30.94 100.38 20.07 90.28 65.09 -27.98 90.77 64.12 -26.18 coo 32.04 94.22 18.23 30.57 94.75 16.88 90.14 66.47 -23.00 88.99 64.66 -23.57 coo 21.10 94.74 18.36 23.09 96.71 18.59 94.43 75.36 -24.67 96.94 76.58 -24.67 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 7 3 # 7 313 ASP D 35 ASP^? 10.18 CL CL D 129 315 GLU D 36 GLU^? 18.42 CL CL D 129 390 TYR D 22 TYR^? 17.52 CL CL D 129 coo 32.46 99.13 19.34 30.94 100.38 20.07 75.66 79.96 -36.93 75.99 80.66 -34.97 coo 32.04 94.22 18.23 30.57 94.75 16.88 74.52 85.40 -40.74 74.64 85.74 -42.81 coo 21.10 94.74 18.36 23.09 96.71 18.59 67.44 78.74 -43.16 67.49 76.94 -41.01 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 8 3 # 8 313 ASP D 41 ASP^? 7.55 CL CL D 129 315 GLU D 42 GLU^? 6.22 CL CL D 129 390 TYR D 54 TYR^? 10.35 CL CL D 129 coo 32.46 99.13 19.34 30.94 100.38 20.07 69.10 85.54 -28.07 68.60 86.44 -26.19 coo 32.04 94.22 18.23 30.57 94.75 16.88 69.54 84.23 -23.20 71.02 85.79 -23.65 coo 21.10 94.74 18.36 23.09 96.71 18.59 64.95 75.15 -24.65 62.40 74.09 -24.68 1ctn_c00 source 1ctn CHITINASE A (E.C.3.2.1.14) (PH 5.5, 4 DEGREES : 8 hits 1ctn_c00 naa= 3 ULMN 3 1cwy_c00 AMYLOMALTASE user 1 3 # 1 A 293 ASP A 35 ASP~? 10.31 CL CL A 129 A 340 GLU A 36 GLU~? 18.47 CL CL A 129 A 395 ASP A 30 ASP~? 20.80 CL CL A 129 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 93.79 42.35 -72.20 94.79 41.97 -70.38 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 99.16 43.45 -76.17 99.38 43.10 -78.24 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 90.38 41.71 -80.87 92.04 40.39 -80.79 ULMN 3 1cwy_c00 AMYLOMALTASE user 2 3 # 2 A 293 ASP B 35 ASP^? 10.19 CL CL B 129 A 340 GLU B 36 GLU^? 18.40 CL CL B 129 A 395 ASP B 30 ASP^? 20.91 CL CL B 129 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 93.79 80.98 -68.72 94.61 81.32 -70.62 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 99.20 79.77 -64.83 99.58 80.60 -62.91 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 90.60 81.40 -60.16 92.15 82.83 -59.97 ULMN 3 1cwy_c00 AMYLOMALTASE user 3 3 # 3 A 293 ASP C 35 ASP^? 10.26 CL CL C 129 A 340 GLU C 36 GLU^? 18.27 CL CL C 129 A 395 ASP C 30 ASP^? 20.67 CL CL C 129 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 83.63 70.73 -36.85 83.32 69.81 -34.96 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 84.85 65.27 -40.53 84.47 64.86 -42.56 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1cwy_c00 AMYLOMALTASE user 4 3 # 4 A 293 ASP D 35 ASP^? 10.18 CL CL D 129 A 340 GLU D 36 GLU^? 18.42 CL CL D 129 A 395 ASP D 30 ASP^? 20.62 CL CL D 129 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 75.66 79.96 -36.93 75.99 80.66 -34.97 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 74.52 85.40 -40.74 74.64 85.74 -42.81 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 76.16 76.40 -45.40 77.49 78.05 -45.35 1cwy_c00 source 1cwy AMYLOMALTASE : 4 hits 1cwy_c00 naa= 3 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 1 3 # 1 A 37 ASP A 35 ASP~? 10.31 CL CL A 129 A 56 ILE A 118 ILE^? 14.73 CL CL A 129 A 82 TYR A 22 TYR~? 17.56 CL CL A 129 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 93.79 42.35 -72.20 94.79 41.97 -70.38 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 95.73 52.77 -73.03 94.62 53.00 -73.89 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 92.72 50.62 -78.45 90.87 50.50 -76.41 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 2 3 # 2 A 37 ASP B 35 ASP^? 10.19 CL CL B 129 A 56 ILE B 118 ILE^? 14.58 CL CL B 129 A 82 TYR B 22 TYR^? 17.56 CL CL B 129 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 93.79 80.98 -68.72 94.61 81.32 -70.62 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 95.74 70.66 -68.07 94.57 70.54 -67.38 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 92.70 72.76 -62.54 90.90 72.79 -64.68 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 3 3 # 3 A 37 ASP C 35 ASP^? 10.26 CL CL C 129 A 56 ILE C 118 ILE^? 14.65 CL CL C 129 A 82 TYR C 22 TYR^? 17.52 CL CL C 129 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 83.63 70.73 -36.85 83.32 69.81 -34.96 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 94.14 68.89 -37.58 94.43 70.05 -38.41 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 91.93 71.84 -43.09 91.81 73.68 -41.00 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 4 3 # 4 A 37 ASP D 35 ASP^? 10.18 CL CL D 129 A 56 ILE D 118 ILE^? 14.66 CL CL D 129 A 82 TYR D 22 TYR^? 17.52 CL CL D 129 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 75.66 79.96 -36.93 75.99 80.66 -34.97 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 65.25 81.72 -37.66 65.00 80.59 -38.49 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 67.44 78.74 -43.16 67.49 76.94 -41.01 1d6o_c00 source 1d6o FK506-BINDING PROTEIN : 4 hits 1d6o_c00 naa= 3 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 1 3 # 1 B 37 ASP A 35 ASP~? 10.31 CL CL A 129 B 56 ILE A 118 ILE^? 14.73 CL CL A 129 B 82 TYR A 22 TYR~? 17.56 CL CL A 129 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 93.79 42.35 -72.20 94.79 41.97 -70.38 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 95.73 52.77 -73.03 94.62 53.00 -73.89 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 92.72 50.62 -78.45 90.87 50.50 -76.41 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 2 3 # 2 B 37 ASP B 35 ASP^? 10.19 CL CL B 129 B 56 ILE B 118 ILE^? 14.58 CL CL B 129 B 82 TYR B 22 TYR^? 17.56 CL CL B 129 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 93.79 80.98 -68.72 94.61 81.32 -70.62 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 95.74 70.66 -68.07 94.57 70.54 -67.38 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 92.70 72.76 -62.54 90.90 72.79 -64.68 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 3 3 # 3 B 37 ASP C 35 ASP^? 10.26 CL CL C 129 B 56 ILE C 118 ILE^? 14.65 CL CL C 129 B 82 TYR C 22 TYR^? 17.52 CL CL C 129 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 83.63 70.73 -36.85 83.32 69.81 -34.96 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 94.14 68.89 -37.58 94.43 70.05 -38.41 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 91.93 71.84 -43.09 91.81 73.68 -41.00 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 4 3 # 4 B 37 ASP D 35 ASP^? 10.18 CL CL D 129 B 56 ILE D 118 ILE^? 14.66 CL CL D 129 B 82 TYR D 22 TYR^? 17.52 CL CL D 129 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 75.66 79.96 -36.93 75.99 80.66 -34.97 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 65.25 81.72 -37.66 65.00 80.59 -38.49 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 67.44 78.74 -43.16 67.49 76.94 -41.01 1d6o_c01 source 1d6o FK506-BINDING PROTEIN : 4 hits 1d6o_c01 naa= 3 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 1 3 # 1 A 173 TYR A 20 TYR~? 23.51 CL CL B 129 A 243 ASP A 5 ASP~? 21.13 CL CL B 129 A 272 LYS B 111 LYS^? 25.35 CL CL B 129 coo 2.03 68.31 21.46 0.66 68.36 23.90 94.54 54.15 -86.74 93.79 56.81 -87.24 coo 16.93 55.67 9.65 17.16 54.23 11.19 110.30 67.66 -76.72 112.26 68.26 -76.10 coo 14.13 45.79 13.40 14.25 49.41 18.30 105.89 69.85 -67.01 110.53 70.43 -62.59 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 2 3 # 2 A 173 TYR A 22 TYR~? 17.56 CL CL A 129 A 243 ASP A 5 ASP~? 21.13 CL CL B 129 A 272 LYS B 111 LYS^? 25.35 CL CL B 129 coo 2.03 68.31 21.46 0.66 68.36 23.90 92.72 50.62 -78.45 90.87 50.50 -76.41 coo 16.93 55.67 9.65 17.16 54.23 11.19 110.30 67.66 -76.72 112.26 68.26 -76.10 coo 14.13 45.79 13.40 14.25 49.41 18.30 105.89 69.85 -67.01 110.53 70.43 -62.59 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 3 3 # 3 A 173 TYR B 20 TYR^? 23.21 CL CL A 129 A 243 ASP B 5 ASP^? 20.93 CL CL A 129 A 272 LYS A 111 LYS^? 25.43 CL CL A 129 coo 2.03 68.31 21.46 0.66 68.36 23.90 94.47 69.13 -54.42 93.73 66.50 -53.85 coo 16.93 55.67 9.65 17.16 54.23 11.19 110.10 55.77 -64.66 112.04 55.13 -65.31 coo 14.13 45.79 13.40 14.25 49.41 18.30 105.91 53.60 -74.08 110.80 53.18 -78.24 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 4 3 # 4 A 173 TYR B 22 TYR^? 17.56 CL CL B 129 A 243 ASP B 5 ASP^? 20.93 CL CL A 129 A 272 LYS A 111 LYS^? 25.43 CL CL A 129 coo 2.03 68.31 21.46 0.66 68.36 23.90 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 16.93 55.67 9.65 17.16 54.23 11.19 110.10 55.77 -64.66 112.04 55.13 -65.31 coo 14.13 45.79 13.40 14.25 49.41 18.30 105.91 53.60 -74.08 110.80 53.18 -78.24 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 5 3 # 5 A 173 TYR B 47 TYR^? 14.72 CL CL B 129 A 243 ASP B 72 ASP^? 28.57 CL CL C 129 A 272 LYS C 24 LYS^? 26.64 CL CL C 129 coo 2.03 68.31 21.46 0.66 68.36 23.90 86.74 65.69 -75.43 87.82 65.07 -77.96 coo 16.93 55.67 9.65 17.16 54.23 11.19 80.87 74.36 -54.99 81.74 73.36 -53.35 coo 14.13 45.79 13.40 14.25 49.41 18.30 88.99 74.10 -49.29 84.03 71.99 -51.83 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 6 3 # 6 A 173 TYR C 22 TYR^? 17.52 CL CL C 129 A 243 ASP B 10 ASP^? 27.46 CL CL A 129 A 272 LYS B 111 LYS^? 25.35 CL CL B 129 coo 2.03 68.31 21.46 0.66 68.36 23.90 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 16.93 55.67 9.65 17.16 54.23 11.19 110.59 65.11 -56.28 111.89 65.48 -54.65 coo 14.13 45.79 13.40 14.25 49.41 18.30 105.89 69.85 -67.01 110.53 70.43 -62.59 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 7 3 # 7 A 173 TYR C 47 TYR^? 14.59 CL CL C 129 A 243 ASP C 72 ASP^? 28.53 CL CL B 129 A 272 LYS B 24 LYS^? 27.82 CL CL B 129 coo 2.03 68.31 21.46 0.66 68.36 23.90 99.01 77.81 -30.16 99.72 76.81 -27.69 coo 16.93 55.67 9.65 17.16 54.23 11.19 90.38 83.76 -50.64 91.24 82.68 -52.23 coo 14.13 45.79 13.40 14.25 49.41 18.30 90.54 75.59 -56.27 92.78 80.12 -52.52 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 8 3 # 8 A 173 TYR D 22 TYR^? 17.52 CL CL D 129 A 243 ASP C 72 ASP^? 28.53 CL CL B 129 A 272 LYS B 24 LYS^? 27.82 CL CL B 129 coo 2.03 68.31 21.46 0.66 68.36 23.90 67.44 78.74 -43.16 67.49 76.94 -41.01 coo 16.93 55.67 9.65 17.16 54.23 11.19 90.38 83.76 -50.64 91.24 82.68 -52.23 coo 14.13 45.79 13.40 14.25 49.41 18.30 90.54 75.59 -56.27 92.78 80.12 -52.52 1d7r_c02 source 1d7r 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYRUVATE) : 8 hits 1d7r_c02 naa= 3 ULMN 3 1ddj_c12 PLASMINOGEN user 1 3 # 1 A 603 HIS A 40 HIS.? 7.30 CL CL A 129 A 646 ASP A 35 ASP~? 10.31 CL CL A 129 A 739 GLY A 115 GLY^? 19.18 CL CL A 129 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 98.96 43.60 -66.18 98.11 41.92 -65.26 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 93.79 42.35 -72.20 94.79 41.97 -70.38 coo 11.37 50.89 2.29 11.05 51.63 2.25 105.32 48.49 -75.94 105.17 48.69 -75.15 ULMN 3 1ddj_c12 PLASMINOGEN user 2 3 # 2 A 603 HIS A 40 HIS.? 7.30 CL CL A 129 A 646 ASP A 41 ASP.? 7.60 CL CL A 129 A 739 GLY A 115 GLY^? 19.18 CL CL A 129 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 98.96 43.60 -66.18 98.11 41.92 -65.26 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 99.56 48.98 -63.34 100.43 49.52 -61.53 coo 11.37 50.89 2.29 11.05 51.63 2.25 105.32 48.49 -75.94 105.17 48.69 -75.15 ULMN 3 1ddj_c12 PLASMINOGEN user 3 3 # 3 A 603 HIS A 85 HIS.? 26.94 CL CL B 129 A 646 ASP A 86 ASP.? 23.33 CL CL A 129 A 739 GLY A 0 GLY.? 22.19 CL CL B 129 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 112.09 59.31 -75.65 113.04 59.28 -73.77 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 108.46 57.22 -73.78 109.48 58.49 -72.45 coo 11.37 50.89 2.29 11.05 51.63 2.25 110.86 69.25 -68.82 110.93 68.50 -69.21 ULMN 3 1ddj_c12 PLASMINOGEN user 4 3 # 4 A 603 HIS B 40 HIS^? 7.04 CL CL B 129 A 646 ASP B 35 ASP^? 10.19 CL CL B 129 A 739 GLY B 115 GLY^? 19.14 CL CL B 129 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 98.79 79.91 -74.95 97.97 81.53 -75.99 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 93.79 80.98 -68.72 94.61 81.32 -70.62 coo 11.37 50.89 2.29 11.05 51.63 2.25 105.34 74.85 -65.16 105.20 74.69 -65.93 ULMN 3 1ddj_c12 PLASMINOGEN user 5 3 # 5 A 603 HIS B 40 HIS^? 7.04 CL CL B 129 A 646 ASP B 41 ASP^? 7.64 CL CL B 129 A 739 GLY B 115 GLY^? 19.14 CL CL B 129 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 98.79 79.91 -74.95 97.97 81.53 -75.99 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 99.50 74.51 -77.69 100.41 73.95 -79.49 coo 11.37 50.89 2.29 11.05 51.63 2.25 105.34 74.85 -65.16 105.20 74.69 -65.93 ULMN 3 1ddj_c12 PLASMINOGEN user 6 3 # 6 A 603 HIS B 85 HIS^? 26.88 CL CL A 129 A 646 ASP B 86 ASP^? 23.14 CL CL B 129 A 739 GLY B 0 GLY^? 22.38 CL CL A 129 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 111.98 64.21 -65.30 113.02 64.33 -67.11 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 108.40 66.17 -67.38 109.32 64.97 -68.84 coo 11.37 50.89 2.29 11.05 51.63 2.25 111.19 54.19 -72.18 110.74 54.87 -72.04 ULMN 3 1ddj_c12 PLASMINOGEN user 7 3 # 7 A 603 HIS C 40 HIS^? 7.21 CL CL C 129 A 646 ASP C 35 ASP^? 10.26 CL CL C 129 A 739 GLY C 115 GLY^? 19.09 CL CL C 129 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 84.82 65.72 -30.75 83.18 66.51 -29.70 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 83.63 70.73 -36.85 83.32 69.81 -34.96 coo 11.37 50.89 2.29 11.05 51.63 2.25 89.73 59.33 -40.54 89.93 59.44 -39.76 ULMN 3 1ddj_c12 PLASMINOGEN user 8 3 # 8 A 603 HIS C 40 HIS^? 7.21 CL CL C 129 A 646 ASP C 41 ASP^? 7.58 CL CL C 129 A 739 GLY C 115 GLY^? 19.09 CL CL C 129 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 84.82 65.72 -30.75 83.18 66.51 -29.70 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 90.28 65.09 -27.98 90.77 64.12 -26.18 coo 11.37 50.89 2.29 11.05 51.63 2.25 89.73 59.33 -40.54 89.93 59.44 -39.76 ULMN 3 1ddj_c12 PLASMINOGEN user 9 3 # 9 A 603 HIS C 85 HIS^? 23.16 CL CL A 129 A 646 ASP C 86 ASP^? 23.12 CL CL C 129 A 739 GLY C 0 GLY^? 29.84 CL CL C 129 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 100.49 52.59 -40.39 100.40 51.57 -38.55 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 98.39 56.19 -38.35 99.60 55.15 -36.99 coo 11.37 50.89 2.29 11.05 51.63 2.25 110.33 53.90 -33.33 110.08 53.32 -33.88 ULMN 3 1ddj_c12 PLASMINOGEN user 10 3 # 10 A 603 HIS D 40 HIS^? 7.31 CL CL D 129 A 646 ASP D 35 ASP^? 10.18 CL CL D 129 A 739 GLY D 115 GLY^? 19.26 CL CL D 129 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 74.49 84.96 -30.93 76.13 84.16 -29.90 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 75.66 79.96 -36.93 75.99 80.66 -34.97 coo 11.37 50.89 2.29 11.05 51.63 2.25 69.45 91.40 -40.67 69.30 91.29 -39.87 ULMN 3 1ddj_c12 PLASMINOGEN user 11 3 # 11 A 603 HIS D 40 HIS^? 7.31 CL CL D 129 A 646 ASP D 41 ASP^? 7.55 CL CL D 129 A 739 GLY D 115 GLY^? 19.26 CL CL D 129 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 74.49 84.96 -30.93 76.13 84.16 -29.90 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 69.10 85.54 -28.07 68.60 86.44 -26.19 coo 11.37 50.89 2.29 11.05 51.63 2.25 69.45 91.40 -40.67 69.30 91.29 -39.87 ULMN 3 1ddj_c12 PLASMINOGEN user 12 3 # 12 A 603 HIS D 85 HIS^? 27.00 CL CL D 129 A 646 ASP D 86 ASP^? 23.19 CL CL D 129 A 739 GLY D 0 GLY^? 29.80 CL CL D 129 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 58.77 98.13 -40.30 58.69 99.11 -38.44 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 60.79 94.39 -38.32 59.49 95.38 -36.98 coo 11.37 50.89 2.29 11.05 51.63 2.25 49.06 96.65 -33.40 49.36 97.21 -33.92 1ddj_c12 source 1ddj PLASMINOGEN : 12 hits 1ddj_c12 naa= 3 ULMN 3 1ddj_c13 PLASMINOGEN user 1 3 # 1 B 603 HIS A 40 HIS.? 7.30 CL CL A 129 B 646 ASP A 35 ASP~? 10.31 CL CL A 129 B 739 GLY A 115 GLY^? 19.18 CL CL A 129 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 98.96 43.60 -66.18 98.11 41.92 -65.26 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 93.79 42.35 -72.20 94.79 41.97 -70.38 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 105.32 48.49 -75.94 105.17 48.69 -75.15 ULMN 3 1ddj_c13 PLASMINOGEN user 2 3 # 2 B 603 HIS A 40 HIS.? 7.30 CL CL A 129 B 646 ASP A 41 ASP.? 7.60 CL CL A 129 B 739 GLY A 115 GLY^? 19.18 CL CL A 129 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 98.96 43.60 -66.18 98.11 41.92 -65.26 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 99.56 48.98 -63.34 100.43 49.52 -61.53 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 105.32 48.49 -75.94 105.17 48.69 -75.15 ULMN 3 1ddj_c13 PLASMINOGEN user 3 3 # 3 B 603 HIS A 85 HIS.? 26.94 CL CL B 129 B 646 ASP A 86 ASP.? 23.33 CL CL A 129 B 739 GLY A 0 GLY.? 22.19 CL CL B 129 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 112.09 59.31 -75.65 113.04 59.28 -73.77 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 108.46 57.22 -73.78 109.48 58.49 -72.45 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 110.86 69.25 -68.82 110.93 68.50 -69.21 ULMN 3 1ddj_c13 PLASMINOGEN user 4 3 # 4 B 603 HIS B 40 HIS^? 7.04 CL CL B 129 B 646 ASP B 35 ASP^? 10.19 CL CL B 129 B 739 GLY B 115 GLY^? 19.14 CL CL B 129 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 98.79 79.91 -74.95 97.97 81.53 -75.99 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 93.79 80.98 -68.72 94.61 81.32 -70.62 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 105.34 74.85 -65.16 105.20 74.69 -65.93 ULMN 3 1ddj_c13 PLASMINOGEN user 5 3 # 5 B 603 HIS B 40 HIS^? 7.04 CL CL B 129 B 646 ASP B 41 ASP^? 7.64 CL CL B 129 B 739 GLY B 115 GLY^? 19.14 CL CL B 129 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 98.79 79.91 -74.95 97.97 81.53 -75.99 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 99.50 74.51 -77.69 100.41 73.95 -79.49 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 105.34 74.85 -65.16 105.20 74.69 -65.93 ULMN 3 1ddj_c13 PLASMINOGEN user 6 3 # 6 B 603 HIS B 85 HIS^? 26.88 CL CL A 129 B 646 ASP B 86 ASP^? 23.14 CL CL B 129 B 739 GLY B 0 GLY^? 22.38 CL CL A 129 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 111.98 64.21 -65.30 113.02 64.33 -67.11 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 108.40 66.17 -67.38 109.32 64.97 -68.84 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 111.19 54.19 -72.18 110.74 54.87 -72.04 ULMN 3 1ddj_c13 PLASMINOGEN user 7 3 # 7 B 603 HIS C 40 HIS^? 7.21 CL CL C 129 B 646 ASP C 35 ASP^? 10.26 CL CL C 129 B 739 GLY C 115 GLY^? 19.09 CL CL C 129 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 84.82 65.72 -30.75 83.18 66.51 -29.70 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 83.63 70.73 -36.85 83.32 69.81 -34.96 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 89.73 59.33 -40.54 89.93 59.44 -39.76 ULMN 3 1ddj_c13 PLASMINOGEN user 8 3 # 8 B 603 HIS C 40 HIS^? 7.21 CL CL C 129 B 646 ASP C 41 ASP^? 7.58 CL CL C 129 B 739 GLY C 115 GLY^? 19.09 CL CL C 129 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 84.82 65.72 -30.75 83.18 66.51 -29.70 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 90.28 65.09 -27.98 90.77 64.12 -26.18 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 89.73 59.33 -40.54 89.93 59.44 -39.76 ULMN 3 1ddj_c13 PLASMINOGEN user 9 3 # 9 B 603 HIS C 85 HIS^? 23.16 CL CL A 129 B 646 ASP C 86 ASP^? 23.12 CL CL C 129 B 739 GLY C 0 GLY^? 29.84 CL CL C 129 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 100.49 52.59 -40.39 100.40 51.57 -38.55 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 98.39 56.19 -38.35 99.60 55.15 -36.99 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 110.33 53.90 -33.33 110.08 53.32 -33.88 ULMN 3 1ddj_c13 PLASMINOGEN user 10 3 # 10 B 603 HIS D 40 HIS^? 7.31 CL CL D 129 B 646 ASP D 35 ASP^? 10.18 CL CL D 129 B 739 GLY D 115 GLY^? 19.26 CL CL D 129 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 74.49 84.96 -30.93 76.13 84.16 -29.90 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 75.66 79.96 -36.93 75.99 80.66 -34.97 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 69.45 91.40 -40.67 69.30 91.29 -39.87 ULMN 3 1ddj_c13 PLASMINOGEN user 11 3 # 11 B 603 HIS D 40 HIS^? 7.31 CL CL D 129 B 646 ASP D 41 ASP^? 7.55 CL CL D 129 B 739 GLY D 115 GLY^? 19.26 CL CL D 129 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 74.49 84.96 -30.93 76.13 84.16 -29.90 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 69.10 85.54 -28.07 68.60 86.44 -26.19 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 69.45 91.40 -40.67 69.30 91.29 -39.87 ULMN 3 1ddj_c13 PLASMINOGEN user 12 3 # 12 B 603 HIS D 85 HIS^? 27.00 CL CL D 129 B 646 ASP D 86 ASP^? 23.19 CL CL D 129 B 739 GLY D 0 GLY^? 29.80 CL CL D 129 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 58.77 98.13 -40.30 58.69 99.11 -38.44 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 60.79 94.39 -38.32 59.49 95.38 -36.98 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 49.06 96.65 -33.40 49.36 97.21 -33.92 1ddj_c13 source 1ddj PLASMINOGEN : 12 hits 1ddj_c13 naa= 3 ULMN 3 1ddj_c14 PLASMINOGEN user 1 3 # 1 C 603 HIS A 40 HIS.? 7.30 CL CL A 129 C 646 ASP A 35 ASP~? 10.31 CL CL A 129 C 739 GLY A 115 GLY^? 19.18 CL CL A 129 coo 15.33 59.81 59.60 13.98 60.99 60.69 98.96 43.60 -66.18 98.11 41.92 -65.26 coo 16.06 55.72 54.73 15.97 56.49 56.70 93.79 42.35 -72.20 94.79 41.97 -70.38 coo 9.38 49.29 65.28 9.01 50.03 65.31 105.32 48.49 -75.94 105.17 48.69 -75.15 ULMN 3 1ddj_c14 PLASMINOGEN user 2 3 # 2 C 603 HIS A 40 HIS.? 7.30 CL CL A 129 C 646 ASP A 41 ASP.? 7.60 CL CL A 129 C 739 GLY A 115 GLY^? 19.18 CL CL A 129 coo 15.33 59.81 59.60 13.98 60.99 60.69 98.96 43.60 -66.18 98.11 41.92 -65.26 coo 16.06 55.72 54.73 15.97 56.49 56.70 99.56 48.98 -63.34 100.43 49.52 -61.53 coo 9.38 49.29 65.28 9.01 50.03 65.31 105.32 48.49 -75.94 105.17 48.69 -75.15 ULMN 3 1ddj_c14 PLASMINOGEN user 3 3 # 3 C 603 HIS A 85 HIS.? 26.94 CL CL B 129 C 646 ASP A 86 ASP.? 23.33 CL CL A 129 C 739 GLY A 0 GLY.? 22.19 CL CL B 129 coo 15.33 59.81 59.60 13.98 60.99 60.69 112.09 59.31 -75.65 113.04 59.28 -73.77 coo 16.06 55.72 54.73 15.97 56.49 56.70 108.46 57.22 -73.78 109.48 58.49 -72.45 coo 9.38 49.29 65.28 9.01 50.03 65.31 110.86 69.25 -68.82 110.93 68.50 -69.21 ULMN 3 1ddj_c14 PLASMINOGEN user 4 3 # 4 C 603 HIS B 40 HIS^? 7.04 CL CL B 129 C 646 ASP B 35 ASP^? 10.19 CL CL B 129 C 739 GLY B 115 GLY^? 19.14 CL CL B 129 coo 15.33 59.81 59.60 13.98 60.99 60.69 98.79 79.91 -74.95 97.97 81.53 -75.99 coo 16.06 55.72 54.73 15.97 56.49 56.70 93.79 80.98 -68.72 94.61 81.32 -70.62 coo 9.38 49.29 65.28 9.01 50.03 65.31 105.34 74.85 -65.16 105.20 74.69 -65.93 ULMN 3 1ddj_c14 PLASMINOGEN user 5 3 # 5 C 603 HIS B 40 HIS^? 7.04 CL CL B 129 C 646 ASP B 41 ASP^? 7.64 CL CL B 129 C 739 GLY B 115 GLY^? 19.14 CL CL B 129 coo 15.33 59.81 59.60 13.98 60.99 60.69 98.79 79.91 -74.95 97.97 81.53 -75.99 coo 16.06 55.72 54.73 15.97 56.49 56.70 99.50 74.51 -77.69 100.41 73.95 -79.49 coo 9.38 49.29 65.28 9.01 50.03 65.31 105.34 74.85 -65.16 105.20 74.69 -65.93 ULMN 3 1ddj_c14 PLASMINOGEN user 6 3 # 6 C 603 HIS B 85 HIS^? 26.88 CL CL A 129 C 646 ASP B 86 ASP^? 23.14 CL CL B 129 C 739 GLY B 0 GLY^? 22.38 CL CL A 129 coo 15.33 59.81 59.60 13.98 60.99 60.69 111.98 64.21 -65.30 113.02 64.33 -67.11 coo 16.06 55.72 54.73 15.97 56.49 56.70 108.40 66.17 -67.38 109.32 64.97 -68.84 coo 9.38 49.29 65.28 9.01 50.03 65.31 111.19 54.19 -72.18 110.74 54.87 -72.04 ULMN 3 1ddj_c14 PLASMINOGEN user 7 3 # 7 C 603 HIS C 40 HIS^? 7.21 CL CL C 129 C 646 ASP C 35 ASP^? 10.26 CL CL C 129 C 739 GLY C 115 GLY^? 19.09 CL CL C 129 coo 15.33 59.81 59.60 13.98 60.99 60.69 84.82 65.72 -30.75 83.18 66.51 -29.70 coo 16.06 55.72 54.73 15.97 56.49 56.70 83.63 70.73 -36.85 83.32 69.81 -34.96 coo 9.38 49.29 65.28 9.01 50.03 65.31 89.73 59.33 -40.54 89.93 59.44 -39.76 ULMN 3 1ddj_c14 PLASMINOGEN user 8 3 # 8 C 603 HIS C 40 HIS^? 7.21 CL CL C 129 C 646 ASP C 41 ASP^? 7.58 CL CL C 129 C 739 GLY C 115 GLY^? 19.09 CL CL C 129 coo 15.33 59.81 59.60 13.98 60.99 60.69 84.82 65.72 -30.75 83.18 66.51 -29.70 coo 16.06 55.72 54.73 15.97 56.49 56.70 90.28 65.09 -27.98 90.77 64.12 -26.18 coo 9.38 49.29 65.28 9.01 50.03 65.31 89.73 59.33 -40.54 89.93 59.44 -39.76 ULMN 3 1ddj_c14 PLASMINOGEN user 9 3 # 9 C 603 HIS C 85 HIS^? 23.16 CL CL A 129 C 646 ASP C 86 ASP^? 23.12 CL CL C 129 C 739 GLY C 0 GLY^? 29.84 CL CL C 129 coo 15.33 59.81 59.60 13.98 60.99 60.69 100.49 52.59 -40.39 100.40 51.57 -38.55 coo 16.06 55.72 54.73 15.97 56.49 56.70 98.39 56.19 -38.35 99.60 55.15 -36.99 coo 9.38 49.29 65.28 9.01 50.03 65.31 110.33 53.90 -33.33 110.08 53.32 -33.88 ULMN 3 1ddj_c14 PLASMINOGEN user 10 3 # 10 C 603 HIS D 40 HIS^? 7.31 CL CL D 129 C 646 ASP D 35 ASP^? 10.18 CL CL D 129 C 739 GLY D 115 GLY^? 19.26 CL CL D 129 coo 15.33 59.81 59.60 13.98 60.99 60.69 74.49 84.96 -30.93 76.13 84.16 -29.90 coo 16.06 55.72 54.73 15.97 56.49 56.70 75.66 79.96 -36.93 75.99 80.66 -34.97 coo 9.38 49.29 65.28 9.01 50.03 65.31 69.45 91.40 -40.67 69.30 91.29 -39.87 ULMN 3 1ddj_c14 PLASMINOGEN user 11 3 # 11 C 603 HIS D 40 HIS^? 7.31 CL CL D 129 C 646 ASP D 41 ASP^? 7.55 CL CL D 129 C 739 GLY D 115 GLY^? 19.26 CL CL D 129 coo 15.33 59.81 59.60 13.98 60.99 60.69 74.49 84.96 -30.93 76.13 84.16 -29.90 coo 16.06 55.72 54.73 15.97 56.49 56.70 69.10 85.54 -28.07 68.60 86.44 -26.19 coo 9.38 49.29 65.28 9.01 50.03 65.31 69.45 91.40 -40.67 69.30 91.29 -39.87 ULMN 3 1ddj_c14 PLASMINOGEN user 12 3 # 12 C 603 HIS D 85 HIS^? 27.00 CL CL D 129 C 646 ASP D 86 ASP^? 23.19 CL CL D 129 C 739 GLY D 0 GLY^? 29.80 CL CL D 129 coo 15.33 59.81 59.60 13.98 60.99 60.69 58.77 98.13 -40.30 58.69 99.11 -38.44 coo 16.06 55.72 54.73 15.97 56.49 56.70 60.79 94.39 -38.32 59.49 95.38 -36.98 coo 9.38 49.29 65.28 9.01 50.03 65.31 49.06 96.65 -33.40 49.36 97.21 -33.92 1ddj_c14 source 1ddj PLASMINOGEN : 12 hits 1ddj_c14 naa= 3 ULMN 3 1ddj_c15 PLASMINOGEN user 1 3 # 1 D 603 HIS A 40 HIS.? 7.30 CL CL A 129 D 646 ASP A 35 ASP~? 10.31 CL CL A 129 D 739 GLY A 115 GLY^? 19.18 CL CL A 129 coo -30.51 33.83 43.05 -30.50 33.12 45.03 98.96 43.60 -66.18 98.11 41.92 -65.26 coo -25.73 33.05 39.28 -27.50 34.05 39.88 93.79 42.35 -72.20 94.79 41.97 -70.38 coo -27.66 47.32 40.66 -27.81 47.01 41.41 105.32 48.49 -75.94 105.17 48.69 -75.15 ULMN 3 1ddj_c15 PLASMINOGEN user 2 3 # 2 D 603 HIS A 40 HIS.? 7.30 CL CL A 129 D 646 ASP A 41 ASP.? 7.60 CL CL A 129 D 739 GLY A 115 GLY^? 19.18 CL CL A 129 coo -30.51 33.83 43.05 -30.50 33.12 45.03 98.96 43.60 -66.18 98.11 41.92 -65.26 coo -25.73 33.05 39.28 -27.50 34.05 39.88 99.56 48.98 -63.34 100.43 49.52 -61.53 coo -27.66 47.32 40.66 -27.81 47.01 41.41 105.32 48.49 -75.94 105.17 48.69 -75.15 ULMN 3 1ddj_c15 PLASMINOGEN user 3 3 # 3 D 603 HIS A 85 HIS.? 26.94 CL CL B 129 D 646 ASP A 86 ASP.? 23.33 CL CL A 129 D 739 GLY A 0 GLY.? 22.19 CL CL B 129 coo -30.51 33.83 43.05 -30.50 33.12 45.03 112.09 59.31 -75.65 113.04 59.28 -73.77 coo -25.73 33.05 39.28 -27.50 34.05 39.88 108.46 57.22 -73.78 109.48 58.49 -72.45 coo -27.66 47.32 40.66 -27.81 47.01 41.41 110.86 69.25 -68.82 110.93 68.50 -69.21 ULMN 3 1ddj_c15 PLASMINOGEN user 4 3 # 4 D 603 HIS B 40 HIS^? 7.04 CL CL B 129 D 646 ASP B 35 ASP^? 10.19 CL CL B 129 D 739 GLY B 115 GLY^? 19.14 CL CL B 129 coo -30.51 33.83 43.05 -30.50 33.12 45.03 98.79 79.91 -74.95 97.97 81.53 -75.99 coo -25.73 33.05 39.28 -27.50 34.05 39.88 93.79 80.98 -68.72 94.61 81.32 -70.62 coo -27.66 47.32 40.66 -27.81 47.01 41.41 105.34 74.85 -65.16 105.20 74.69 -65.93 ULMN 3 1ddj_c15 PLASMINOGEN user 5 3 # 5 D 603 HIS B 40 HIS^? 7.04 CL CL B 129 D 646 ASP B 41 ASP^? 7.64 CL CL B 129 D 739 GLY B 115 GLY^? 19.14 CL CL B 129 coo -30.51 33.83 43.05 -30.50 33.12 45.03 98.79 79.91 -74.95 97.97 81.53 -75.99 coo -25.73 33.05 39.28 -27.50 34.05 39.88 99.50 74.51 -77.69 100.41 73.95 -79.49 coo -27.66 47.32 40.66 -27.81 47.01 41.41 105.34 74.85 -65.16 105.20 74.69 -65.93 ULMN 3 1ddj_c15 PLASMINOGEN user 6 3 # 6 D 603 HIS B 85 HIS^? 26.88 CL CL A 129 D 646 ASP B 86 ASP^? 23.14 CL CL B 129 D 739 GLY B 0 GLY^? 22.38 CL CL A 129 coo -30.51 33.83 43.05 -30.50 33.12 45.03 111.98 64.21 -65.30 113.02 64.33 -67.11 coo -25.73 33.05 39.28 -27.50 34.05 39.88 108.40 66.17 -67.38 109.32 64.97 -68.84 coo -27.66 47.32 40.66 -27.81 47.01 41.41 111.19 54.19 -72.18 110.74 54.87 -72.04 ULMN 3 1ddj_c15 PLASMINOGEN user 7 3 # 7 D 603 HIS C 40 HIS^? 7.21 CL CL C 129 D 646 ASP C 35 ASP^? 10.26 CL CL C 129 D 739 GLY C 115 GLY^? 19.09 CL CL C 129 coo -30.51 33.83 43.05 -30.50 33.12 45.03 84.82 65.72 -30.75 83.18 66.51 -29.70 coo -25.73 33.05 39.28 -27.50 34.05 39.88 83.63 70.73 -36.85 83.32 69.81 -34.96 coo -27.66 47.32 40.66 -27.81 47.01 41.41 89.73 59.33 -40.54 89.93 59.44 -39.76 ULMN 3 1ddj_c15 PLASMINOGEN user 8 3 # 8 D 603 HIS C 40 HIS^? 7.21 CL CL C 129 D 646 ASP C 41 ASP^? 7.58 CL CL C 129 D 739 GLY C 115 GLY^? 19.09 CL CL C 129 coo -30.51 33.83 43.05 -30.50 33.12 45.03 84.82 65.72 -30.75 83.18 66.51 -29.70 coo -25.73 33.05 39.28 -27.50 34.05 39.88 90.28 65.09 -27.98 90.77 64.12 -26.18 coo -27.66 47.32 40.66 -27.81 47.01 41.41 89.73 59.33 -40.54 89.93 59.44 -39.76 ULMN 3 1ddj_c15 PLASMINOGEN user 9 3 # 9 D 603 HIS C 85 HIS^? 23.16 CL CL A 129 D 646 ASP C 86 ASP^? 23.12 CL CL C 129 D 739 GLY C 0 GLY^? 29.84 CL CL C 129 coo -30.51 33.83 43.05 -30.50 33.12 45.03 100.49 52.59 -40.39 100.40 51.57 -38.55 coo -25.73 33.05 39.28 -27.50 34.05 39.88 98.39 56.19 -38.35 99.60 55.15 -36.99 coo -27.66 47.32 40.66 -27.81 47.01 41.41 110.33 53.90 -33.33 110.08 53.32 -33.88 ULMN 3 1ddj_c15 PLASMINOGEN user 10 3 # 10 D 603 HIS D 40 HIS^? 7.31 CL CL D 129 D 646 ASP D 35 ASP^? 10.18 CL CL D 129 D 739 GLY D 115 GLY^? 19.26 CL CL D 129 coo -30.51 33.83 43.05 -30.50 33.12 45.03 74.49 84.96 -30.93 76.13 84.16 -29.90 coo -25.73 33.05 39.28 -27.50 34.05 39.88 75.66 79.96 -36.93 75.99 80.66 -34.97 coo -27.66 47.32 40.66 -27.81 47.01 41.41 69.45 91.40 -40.67 69.30 91.29 -39.87 ULMN 3 1ddj_c15 PLASMINOGEN user 11 3 # 11 D 603 HIS D 40 HIS^? 7.31 CL CL D 129 D 646 ASP D 41 ASP^? 7.55 CL CL D 129 D 739 GLY D 115 GLY^? 19.26 CL CL D 129 coo -30.51 33.83 43.05 -30.50 33.12 45.03 74.49 84.96 -30.93 76.13 84.16 -29.90 coo -25.73 33.05 39.28 -27.50 34.05 39.88 69.10 85.54 -28.07 68.60 86.44 -26.19 coo -27.66 47.32 40.66 -27.81 47.01 41.41 69.45 91.40 -40.67 69.30 91.29 -39.87 ULMN 3 1ddj_c15 PLASMINOGEN user 12 3 # 12 D 603 HIS D 85 HIS^? 27.00 CL CL D 129 D 646 ASP D 86 ASP^? 23.19 CL CL D 129 D 739 GLY D 0 GLY^? 29.80 CL CL D 129 coo -30.51 33.83 43.05 -30.50 33.12 45.03 58.77 98.13 -40.30 58.69 99.11 -38.44 coo -25.73 33.05 39.28 -27.50 34.05 39.88 60.79 94.39 -38.32 59.49 95.38 -36.98 coo -27.66 47.32 40.66 -27.81 47.01 41.41 49.06 96.65 -33.40 49.36 97.21 -33.92 1ddj_c15 source 1ddj PLASMINOGEN : 12 hits 1ddj_c15 naa= 3 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 A 57 GLU A 36 GLU~? 18.47 CL CL A 129 A 226 THR A 81 THR^? 12.77 CL CL B 129 A 229 LYS B 43 LYS^? 9.52 CL CL B 129 coo 9.66 102.78 70.07 9.79 101.18 71.42 99.16 43.45 -76.17 99.38 43.10 -78.24 coo 7.24 97.46 49.60 8.11 95.69 48.80 100.01 64.50 -79.91 99.59 66.56 -79.34 coo 10.53 97.56 43.71 9.33 93.71 47.17 96.64 71.22 -80.00 101.30 72.05 -81.50 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 A 57 GLU A 114 GLU^? 14.59 CL CL A 129 A 226 THR A 81 THR^? 12.77 CL CL B 129 A 229 LYS B 43 LYS^? 9.52 CL CL B 129 coo 9.66 102.78 70.07 9.79 101.18 71.42 104.53 45.97 -71.95 105.17 46.78 -70.05 coo 7.24 97.46 49.60 8.11 95.69 48.80 100.01 64.50 -79.91 99.59 66.56 -79.34 coo 10.53 97.56 43.71 9.33 93.71 47.17 96.64 71.22 -80.00 101.30 72.05 -81.50 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 A 57 GLU B 36 GLU^? 18.40 CL CL B 129 A 226 THR B 81 THR^? 12.74 CL CL A 129 A 229 LYS A 43 LYS.? 9.42 CL CL A 129 coo 9.66 102.78 70.07 9.79 101.18 71.42 99.20 79.77 -64.83 99.58 80.60 -62.91 coo 7.24 97.46 49.60 8.11 95.69 48.80 100.07 58.97 -61.29 99.70 56.90 -61.73 coo 10.53 97.56 43.71 9.33 93.71 47.17 96.70 52.33 -61.01 101.40 51.27 -59.62 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 A 57 GLU B 114 GLU^? 14.94 CL CL B 129 A 226 THR B 81 THR^? 12.74 CL CL A 129 A 229 LYS A 43 LYS.? 9.42 CL CL A 129 coo 9.66 102.78 70.07 9.79 101.18 71.42 104.70 77.68 -68.99 105.48 76.80 -70.78 coo 7.24 97.46 49.60 8.11 95.69 48.80 100.07 58.97 -61.29 99.70 56.90 -61.73 coo 10.53 97.56 43.71 9.33 93.71 47.17 96.70 52.33 -61.01 101.40 51.27 -59.62 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 A 57 GLU C 23 GLU^? 24.69 CL CL C 129 A 226 THR B 81 THR^? 12.74 CL CL A 129 A 229 LYS A 43 LYS.? 9.42 CL CL A 129 coo 9.66 102.78 70.07 9.79 101.18 71.42 93.85 75.25 -49.20 94.57 76.88 -48.00 coo 7.24 97.46 49.60 8.11 95.69 48.80 100.07 58.97 -61.29 99.70 56.90 -61.73 coo 10.53 97.56 43.71 9.33 93.71 47.17 96.70 52.33 -61.01 101.40 51.27 -59.62 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 A 57 GLU D 23 GLU^? 24.49 CL CL D 129 A 226 THR B 27 THR^? 25.10 CL CL B 129 A 229 LYS B 24 LYS^? 27.82 CL CL B 129 coo 9.66 102.78 70.07 9.79 101.18 71.42 65.41 75.40 -49.12 64.81 73.78 -47.86 coo 7.24 97.46 49.60 8.11 95.69 48.80 85.40 75.83 -58.05 86.15 74.42 -56.65 coo 10.53 97.56 43.71 9.33 93.71 47.17 90.54 75.59 -56.27 92.78 80.12 -52.52 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 A 57 GLU D 114 GLU^? 14.88 CL CL D 129 A 226 THR C 27 THR^? 25.08 CL CL C 129 A 229 LYS C 24 LYS^? 26.64 CL CL C 129 coo 9.66 102.78 70.07 9.79 101.18 71.42 72.08 90.81 -36.72 71.29 91.48 -34.84 coo 7.24 97.46 49.60 8.11 95.69 48.80 88.92 79.28 -47.47 90.32 78.59 -48.91 coo 10.53 97.56 43.71 9.33 93.71 47.17 88.99 74.10 -49.29 84.03 71.99 -51.83 1dfo_c04 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 7 hits 1dfo_c04 naa= 3 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 B 57 GLU A 36 GLU~? 18.47 CL CL A 129 B 226 THR A 81 THR^? 12.77 CL CL B 129 B 229 LYS B 43 LYS^? 9.52 CL CL B 129 coo 15.90 87.61 49.61 13.92 86.96 49.36 99.16 43.45 -76.17 99.38 43.10 -78.24 coo 20.74 95.78 68.68 19.29 96.84 69.83 100.01 64.50 -79.91 99.59 66.56 -79.34 coo 22.32 101.61 71.64 17.89 98.63 71.55 96.64 71.22 -80.00 101.30 72.05 -81.50 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 B 57 GLU A 114 GLU^? 14.59 CL CL A 129 B 226 THR A 81 THR^? 12.77 CL CL B 129 B 229 LYS B 43 LYS^? 9.52 CL CL B 129 coo 15.90 87.61 49.61 13.92 86.96 49.36 104.53 45.97 -71.95 105.17 46.78 -70.05 coo 20.74 95.78 68.68 19.29 96.84 69.83 100.01 64.50 -79.91 99.59 66.56 -79.34 coo 22.32 101.61 71.64 17.89 98.63 71.55 96.64 71.22 -80.00 101.30 72.05 -81.50 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 B 57 GLU B 36 GLU^? 18.40 CL CL B 129 B 226 THR B 81 THR^? 12.74 CL CL A 129 B 229 LYS A 43 LYS.? 9.42 CL CL A 129 coo 15.90 87.61 49.61 13.92 86.96 49.36 99.20 79.77 -64.83 99.58 80.60 -62.91 coo 20.74 95.78 68.68 19.29 96.84 69.83 100.07 58.97 -61.29 99.70 56.90 -61.73 coo 22.32 101.61 71.64 17.89 98.63 71.55 96.70 52.33 -61.01 101.40 51.27 -59.62 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 B 57 GLU B 114 GLU^? 14.94 CL CL B 129 B 226 THR B 81 THR^? 12.74 CL CL A 129 B 229 LYS A 43 LYS.? 9.42 CL CL A 129 coo 15.90 87.61 49.61 13.92 86.96 49.36 104.70 77.68 -68.99 105.48 76.80 -70.78 coo 20.74 95.78 68.68 19.29 96.84 69.83 100.07 58.97 -61.29 99.70 56.90 -61.73 coo 22.32 101.61 71.64 17.89 98.63 71.55 96.70 52.33 -61.01 101.40 51.27 -59.62 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 B 57 GLU C 23 GLU^? 24.69 CL CL C 129 B 226 THR B 81 THR^? 12.74 CL CL A 129 B 229 LYS A 43 LYS.? 9.42 CL CL A 129 coo 15.90 87.61 49.61 13.92 86.96 49.36 93.85 75.25 -49.20 94.57 76.88 -48.00 coo 20.74 95.78 68.68 19.29 96.84 69.83 100.07 58.97 -61.29 99.70 56.90 -61.73 coo 22.32 101.61 71.64 17.89 98.63 71.55 96.70 52.33 -61.01 101.40 51.27 -59.62 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 B 57 GLU D 23 GLU^? 24.49 CL CL D 129 B 226 THR B 27 THR^? 25.10 CL CL B 129 B 229 LYS B 24 LYS^? 27.82 CL CL B 129 coo 15.90 87.61 49.61 13.92 86.96 49.36 65.41 75.40 -49.12 64.81 73.78 -47.86 coo 20.74 95.78 68.68 19.29 96.84 69.83 85.40 75.83 -58.05 86.15 74.42 -56.65 coo 22.32 101.61 71.64 17.89 98.63 71.55 90.54 75.59 -56.27 92.78 80.12 -52.52 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 B 57 GLU D 114 GLU^? 14.88 CL CL D 129 B 226 THR C 27 THR^? 25.08 CL CL C 129 B 229 LYS C 24 LYS^? 26.64 CL CL C 129 coo 15.90 87.61 49.61 13.92 86.96 49.36 72.08 90.81 -36.72 71.29 91.48 -34.84 coo 20.74 95.78 68.68 19.29 96.84 69.83 88.92 79.28 -47.47 90.32 78.59 -48.91 coo 22.32 101.61 71.64 17.89 98.63 71.55 88.99 74.10 -49.29 84.03 71.99 -51.83 1dfo_c05 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 7 hits 1dfo_c05 naa= 3 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 C 57 GLU A 36 GLU~? 18.47 CL CL A 129 C 226 THR A 81 THR^? 12.77 CL CL B 129 C 229 LYS B 43 LYS^? 9.52 CL CL B 129 coo 5.43 40.40 61.63 4.27 41.99 60.90 99.16 43.45 -76.17 99.38 43.10 -78.24 coo 22.16 45.88 73.63 23.23 47.70 73.25 100.01 64.50 -79.91 99.59 66.56 -79.34 coo 28.90 45.91 73.55 25.22 49.72 72.97 96.64 71.22 -80.00 101.30 72.05 -81.50 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 C 57 GLU A 114 GLU^? 14.59 CL CL A 129 C 226 THR A 81 THR^? 12.77 CL CL B 129 C 229 LYS B 43 LYS^? 9.52 CL CL B 129 coo 5.43 40.40 61.63 4.27 41.99 60.90 104.53 45.97 -71.95 105.17 46.78 -70.05 coo 22.16 45.88 73.63 23.23 47.70 73.25 100.01 64.50 -79.91 99.59 66.56 -79.34 coo 28.90 45.91 73.55 25.22 49.72 72.97 96.64 71.22 -80.00 101.30 72.05 -81.50 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 C 57 GLU B 36 GLU^? 18.40 CL CL B 129 C 226 THR B 81 THR^? 12.74 CL CL A 129 C 229 LYS A 43 LYS.? 9.42 CL CL A 129 coo 5.43 40.40 61.63 4.27 41.99 60.90 99.20 79.77 -64.83 99.58 80.60 -62.91 coo 22.16 45.88 73.63 23.23 47.70 73.25 100.07 58.97 -61.29 99.70 56.90 -61.73 coo 28.90 45.91 73.55 25.22 49.72 72.97 96.70 52.33 -61.01 101.40 51.27 -59.62 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 C 57 GLU B 114 GLU^? 14.94 CL CL B 129 C 226 THR B 81 THR^? 12.74 CL CL A 129 C 229 LYS A 43 LYS.? 9.42 CL CL A 129 coo 5.43 40.40 61.63 4.27 41.99 60.90 104.70 77.68 -68.99 105.48 76.80 -70.78 coo 22.16 45.88 73.63 23.23 47.70 73.25 100.07 58.97 -61.29 99.70 56.90 -61.73 coo 28.90 45.91 73.55 25.22 49.72 72.97 96.70 52.33 -61.01 101.40 51.27 -59.62 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 C 57 GLU C 23 GLU^? 24.69 CL CL C 129 C 226 THR B 81 THR^? 12.74 CL CL A 129 C 229 LYS A 43 LYS.? 9.42 CL CL A 129 coo 5.43 40.40 61.63 4.27 41.99 60.90 93.85 75.25 -49.20 94.57 76.88 -48.00 coo 22.16 45.88 73.63 23.23 47.70 73.25 100.07 58.97 -61.29 99.70 56.90 -61.73 coo 28.90 45.91 73.55 25.22 49.72 72.97 96.70 52.33 -61.01 101.40 51.27 -59.62 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 C 57 GLU D 23 GLU^? 24.49 CL CL D 129 C 226 THR B 27 THR^? 25.10 CL CL B 129 C 229 LYS B 24 LYS^? 27.82 CL CL B 129 coo 5.43 40.40 61.63 4.27 41.99 60.90 65.41 75.40 -49.12 64.81 73.78 -47.86 coo 22.16 45.88 73.63 23.23 47.70 73.25 85.40 75.83 -58.05 86.15 74.42 -56.65 coo 28.90 45.91 73.55 25.22 49.72 72.97 90.54 75.59 -56.27 92.78 80.12 -52.52 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 C 57 GLU D 114 GLU^? 14.88 CL CL D 129 C 226 THR C 27 THR^? 25.08 CL CL C 129 C 229 LYS C 24 LYS^? 26.64 CL CL C 129 coo 5.43 40.40 61.63 4.27 41.99 60.90 72.08 90.81 -36.72 71.29 91.48 -34.84 coo 22.16 45.88 73.63 23.23 47.70 73.25 88.92 79.28 -47.47 90.32 78.59 -48.91 coo 28.90 45.91 73.55 25.22 49.72 72.97 88.99 74.10 -49.29 84.03 71.99 -51.83 1dfo_c06 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 7 hits 1dfo_c06 naa= 3 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 D 57 GLU A 36 GLU~? 18.47 CL CL A 129 D 226 THR A 81 THR^? 12.77 CL CL B 129 D 229 LYS B 43 LYS^? 9.52 CL CL B 129 coo 26.07 55.89 66.14 25.33 56.50 68.01 99.16 43.45 -76.17 99.38 43.10 -78.24 coo 11.79 47.62 52.67 10.10 46.51 53.39 100.01 64.50 -79.91 99.59 66.56 -79.34 coo 10.05 41.79 49.80 7.94 44.71 53.76 96.64 71.22 -80.00 101.30 72.05 -81.50 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 D 57 GLU A 114 GLU^? 14.59 CL CL A 129 D 226 THR A 81 THR^? 12.77 CL CL B 129 D 229 LYS B 43 LYS^? 9.52 CL CL B 129 coo 26.07 55.89 66.14 25.33 56.50 68.01 104.53 45.97 -71.95 105.17 46.78 -70.05 coo 11.79 47.62 52.67 10.10 46.51 53.39 100.01 64.50 -79.91 99.59 66.56 -79.34 coo 10.05 41.79 49.80 7.94 44.71 53.76 96.64 71.22 -80.00 101.30 72.05 -81.50 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 D 57 GLU B 36 GLU^? 18.40 CL CL B 129 D 226 THR B 81 THR^? 12.74 CL CL A 129 D 229 LYS A 43 LYS.? 9.42 CL CL A 129 coo 26.07 55.89 66.14 25.33 56.50 68.01 99.20 79.77 -64.83 99.58 80.60 -62.91 coo 11.79 47.62 52.67 10.10 46.51 53.39 100.07 58.97 -61.29 99.70 56.90 -61.73 coo 10.05 41.79 49.80 7.94 44.71 53.76 96.70 52.33 -61.01 101.40 51.27 -59.62 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 D 57 GLU B 114 GLU^? 14.94 CL CL B 129 D 226 THR B 81 THR^? 12.74 CL CL A 129 D 229 LYS A 43 LYS.? 9.42 CL CL A 129 coo 26.07 55.89 66.14 25.33 56.50 68.01 104.70 77.68 -68.99 105.48 76.80 -70.78 coo 11.79 47.62 52.67 10.10 46.51 53.39 100.07 58.97 -61.29 99.70 56.90 -61.73 coo 10.05 41.79 49.80 7.94 44.71 53.76 96.70 52.33 -61.01 101.40 51.27 -59.62 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 D 57 GLU C 23 GLU^? 24.69 CL CL C 129 D 226 THR B 81 THR^? 12.74 CL CL A 129 D 229 LYS A 43 LYS.? 9.42 CL CL A 129 coo 26.07 55.89 66.14 25.33 56.50 68.01 93.85 75.25 -49.20 94.57 76.88 -48.00 coo 11.79 47.62 52.67 10.10 46.51 53.39 100.07 58.97 -61.29 99.70 56.90 -61.73 coo 10.05 41.79 49.80 7.94 44.71 53.76 96.70 52.33 -61.01 101.40 51.27 -59.62 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 D 57 GLU D 23 GLU^? 24.49 CL CL D 129 D 226 THR B 27 THR^? 25.10 CL CL B 129 D 229 LYS B 24 LYS^? 27.82 CL CL B 129 coo 26.07 55.89 66.14 25.33 56.50 68.01 65.41 75.40 -49.12 64.81 73.78 -47.86 coo 11.79 47.62 52.67 10.10 46.51 53.39 85.40 75.83 -58.05 86.15 74.42 -56.65 coo 10.05 41.79 49.80 7.94 44.71 53.76 90.54 75.59 -56.27 92.78 80.12 -52.52 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 D 57 GLU D 114 GLU^? 14.88 CL CL D 129 D 226 THR C 27 THR^? 25.08 CL CL C 129 D 229 LYS C 24 LYS^? 26.64 CL CL C 129 coo 26.07 55.89 66.14 25.33 56.50 68.01 72.08 90.81 -36.72 71.29 91.48 -34.84 coo 11.79 47.62 52.67 10.10 46.51 53.39 88.92 79.28 -47.47 90.32 78.59 -48.91 coo 10.05 41.79 49.80 7.94 44.71 53.76 88.99 74.10 -49.29 84.03 71.99 -51.83 1dfo_c07 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 7 hits 1dfo_c07 naa= 3 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 A 123 HIS B 122 HIS^? 19.12 CL CL B 129 A 200 ASP B 41 ASP^? 7.64 CL CL B 129 A 229 LYS B 111 LYS^? 25.35 CL CL B 129 coo 1.13 77.49 40.64 0.62 75.57 39.98 86.93 63.10 -71.62 85.35 62.06 -72.53 coo 0.84 91.24 49.01 2.91 91.61 49.23 99.50 74.51 -77.69 100.41 73.95 -79.49 coo 10.53 97.56 43.71 9.33 93.71 47.17 105.89 69.85 -67.01 110.53 70.43 -62.59 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 A 123 HIS C 122 HIS^? 19.06 CL CL C 129 A 200 ASP C 41 ASP^? 7.58 CL CL C 129 A 229 LYS C 111 LYS^? 20.47 CL CL A 129 coo 1.13 77.49 40.64 0.62 75.57 39.98 101.68 77.71 -34.10 102.65 79.31 -33.15 coo 0.84 91.24 49.01 2.91 91.61 49.23 90.28 65.09 -27.98 90.77 64.12 -26.18 coo 10.53 97.56 43.71 9.33 93.71 47.17 94.84 58.73 -38.66 94.21 53.88 -42.04 1dfo_c12 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 2 hits 1dfo_c12 naa= 3 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 B 123 HIS B 122 HIS^? 19.12 CL CL B 129 B 200 ASP B 41 ASP^? 7.64 CL CL B 129 B 229 LYS B 111 LYS^? 25.35 CL CL B 129 coo 9.24 94.26 88.22 8.02 94.07 89.92 86.93 63.10 -71.62 85.35 62.06 -72.53 coo 17.54 90.31 75.01 17.17 92.01 73.80 99.50 74.51 -77.69 100.41 73.95 -79.49 coo 22.32 101.61 71.64 17.89 98.63 71.55 105.89 69.85 -67.01 110.53 70.43 -62.59 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 B 123 HIS C 122 HIS^? 19.06 CL CL C 129 B 200 ASP C 41 ASP^? 7.58 CL CL C 129 B 229 LYS C 111 LYS^? 20.47 CL CL A 129 coo 9.24 94.26 88.22 8.02 94.07 89.92 101.68 77.71 -34.10 102.65 79.31 -33.15 coo 17.54 90.31 75.01 17.17 92.01 73.80 90.28 65.09 -27.98 90.77 64.12 -26.18 coo 22.32 101.61 71.64 17.89 98.63 71.55 94.84 58.73 -38.66 94.21 53.88 -42.04 1dfo_c13 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 2 hits 1dfo_c13 naa= 3 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 C 123 HIS B 122 HIS^? 19.12 CL CL B 129 C 200 ASP B 41 ASP^? 7.64 CL CL B 129 C 229 LYS B 111 LYS^? 25.35 CL CL B 129 coo 26.77 65.84 83.49 27.06 67.76 84.27 86.93 63.10 -71.62 85.35 62.06 -72.53 coo 19.52 52.01 79.59 20.28 51.65 77.65 99.50 74.51 -77.69 100.41 73.95 -79.49 coo 28.90 45.91 73.55 25.22 49.72 72.97 105.89 69.85 -67.01 110.53 70.43 -62.59 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 C 123 HIS C 122 HIS^? 19.06 CL CL C 129 C 200 ASP C 41 ASP^? 7.58 CL CL C 129 C 229 LYS C 111 LYS^? 20.47 CL CL A 129 coo 26.77 65.84 83.49 27.06 67.76 84.27 101.68 77.71 -34.10 102.65 79.31 -33.15 coo 19.52 52.01 79.59 20.28 51.65 77.65 90.28 65.09 -27.98 90.77 64.12 -26.18 coo 28.90 45.91 73.55 25.22 49.72 72.97 94.84 58.73 -38.66 94.21 53.88 -42.04 1dfo_c14 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 2 hits 1dfo_c14 naa= 3 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 D 123 HIS B 122 HIS^? 19.12 CL CL B 129 D 200 ASP B 41 ASP^? 7.64 CL CL B 129 D 229 LYS B 111 LYS^? 25.35 CL CL B 129 coo -10.90 48.74 53.41 -12.98 48.90 53.67 86.93 63.10 -71.62 85.35 62.06 -72.53 coo 4.60 52.95 52.50 5.57 51.29 53.40 99.50 74.51 -77.69 100.41 73.95 -79.49 coo 10.05 41.79 49.80 7.94 44.71 53.76 105.89 69.85 -67.01 110.53 70.43 -62.59 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 D 123 HIS C 122 HIS^? 19.06 CL CL C 129 D 200 ASP C 41 ASP^? 7.58 CL CL C 129 D 229 LYS C 111 LYS^? 20.47 CL CL A 129 coo -10.90 48.74 53.41 -12.98 48.90 53.67 101.68 77.71 -34.10 102.65 79.31 -33.15 coo 4.60 52.95 52.50 5.57 51.29 53.40 90.28 65.09 -27.98 90.77 64.12 -26.18 coo 10.05 41.79 49.80 7.94 44.71 53.76 94.84 58.73 -38.66 94.21 53.88 -42.04 1dfo_c15 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 2 hits 1dfo_c15 naa= 3 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 A 133 TYR A 22 TYR~? 17.56 CL CL A 129 A 138 ARG A 63 ARG~? 13.95 CL CL A 129 A 161 LYS A 24 LYS~? 27.96 CL CL A 129 coo 29.03 88.95 86.80 28.09 90.57 84.75 92.72 50.62 -78.45 90.87 50.50 -76.41 coo 23.31 93.18 82.88 23.00 93.71 79.86 87.85 45.63 -72.60 88.58 48.58 -73.24 coo 33.83 91.15 88.62 31.07 91.06 83.02 90.40 47.78 -84.76 92.62 43.20 -88.57 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 A 133 TYR B 22 TYR^? 17.56 CL CL B 129 A 138 ARG B 63 ARG^? 13.99 CL CL B 129 A 161 LYS B 24 LYS^? 27.82 CL CL B 129 coo 29.03 88.95 86.80 28.09 90.57 84.75 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 23.31 93.18 82.88 23.00 93.71 79.86 87.72 77.76 -68.29 88.60 74.86 -67.71 coo 33.83 91.15 88.62 31.07 91.06 83.02 90.54 75.59 -56.27 92.78 80.12 -52.52 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 3 3 # 3 A 133 TYR C 22 TYR^? 17.52 CL CL C 129 A 138 ARG C 63 ARG^? 14.10 CL CL C 129 A 161 LYS C 24 LYS^? 26.64 CL CL C 129 coo 29.03 88.95 86.80 28.09 90.57 84.75 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 23.31 93.18 82.88 23.00 93.71 79.86 86.96 77.03 -37.50 89.89 76.13 -38.00 coo 33.83 91.15 88.62 31.07 91.06 83.02 88.99 74.10 -49.29 84.03 71.99 -51.83 1dhp_c00 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 3 hits 1dhp_c00 naa= 3 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 B 133 TYR A 22 TYR~? 17.56 CL CL A 129 B 138 ARG A 63 ARG~? 13.95 CL CL A 129 B 161 LYS A 24 LYS~? 27.96 CL CL A 129 coo 4.62 122.69 99.88 5.46 122.82 97.24 92.72 50.62 -78.45 90.87 50.50 -76.41 coo 10.44 122.27 94.08 11.02 123.87 91.53 87.85 45.63 -72.60 88.58 48.58 -73.24 coo -0.17 119.75 99.65 2.51 123.83 95.70 90.40 47.78 -84.76 92.62 43.20 -88.57 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 B 133 TYR B 22 TYR^? 17.56 CL CL B 129 B 138 ARG B 63 ARG^? 13.99 CL CL B 129 B 161 LYS B 24 LYS^? 27.82 CL CL B 129 coo 4.62 122.69 99.88 5.46 122.82 97.24 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 10.44 122.27 94.08 11.02 123.87 91.53 87.72 77.76 -68.29 88.60 74.86 -67.71 coo -0.17 119.75 99.65 2.51 123.83 95.70 90.54 75.59 -56.27 92.78 80.12 -52.52 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 3 3 # 3 B 133 TYR C 22 TYR^? 17.52 CL CL C 129 B 138 ARG C 63 ARG^? 14.10 CL CL C 129 B 161 LYS C 24 LYS^? 26.64 CL CL C 129 coo 4.62 122.69 99.88 5.46 122.82 97.24 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 10.44 122.27 94.08 11.02 123.87 91.53 86.96 77.03 -37.50 89.89 76.13 -38.00 coo -0.17 119.75 99.65 2.51 123.83 95.70 88.99 74.10 -49.29 84.03 71.99 -51.83 1dhp_c01 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 3 hits 1dhp_c01 naa= 3 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 A 44 THR A 78 THR^? 18.06 CL CL B 129 A 45 THR A 92 THR.? 19.17 CL CL B 129 A 161 LYS B 43 LYS^? 9.52 CL CL B 129 coo 26.16 88.25 79.16 25.22 89.47 80.71 91.16 62.77 -84.08 91.28 60.64 -84.40 coo 27.73 89.90 76.08 29.24 91.46 75.95 88.80 61.61 -80.86 88.36 59.74 -81.92 coo 33.83 91.15 88.62 31.07 91.06 83.02 96.64 71.22 -80.00 101.30 72.05 -81.50 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 A 44 THR A 82 THR^? 18.91 CL CL B 129 A 45 THR A 81 THR^? 12.77 CL CL B 129 A 161 LYS A 111 LYS^? 25.43 CL CL A 129 coo 26.16 88.25 79.16 25.22 89.47 80.71 103.30 63.05 -78.71 104.17 62.08 -80.47 coo 27.73 89.90 76.08 29.24 91.46 75.95 100.01 64.50 -79.91 99.59 66.56 -79.34 coo 33.83 91.15 88.62 31.07 91.06 83.02 105.91 53.60 -74.08 110.80 53.18 -78.24 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 3 3 # 3 A 44 THR A 82 THR^? 18.91 CL CL B 129 A 45 THR A 81 THR^? 12.77 CL CL B 129 A 161 LYS B 111 LYS^? 25.35 CL CL B 129 coo 26.16 88.25 79.16 25.22 89.47 80.71 103.30 63.05 -78.71 104.17 62.08 -80.47 coo 27.73 89.90 76.08 29.24 91.46 75.95 100.01 64.50 -79.91 99.59 66.56 -79.34 coo 33.83 91.15 88.62 31.07 91.06 83.02 105.89 69.85 -67.01 110.53 70.43 -62.59 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 4 3 # 4 A 44 THR A 92 THR.? 19.17 CL CL B 129 A 45 THR A 78 THR^? 18.06 CL CL B 129 A 161 LYS A 24 LYS~? 27.96 CL CL A 129 coo 26.16 88.25 79.16 25.22 89.47 80.71 88.80 61.61 -80.86 88.36 59.74 -81.92 coo 27.73 89.90 76.08 29.24 91.46 75.95 91.16 62.77 -84.08 91.28 60.64 -84.40 coo 33.83 91.15 88.62 31.07 91.06 83.02 90.40 47.78 -84.76 92.62 43.20 -88.57 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 5 3 # 5 A 44 THR B 78 THR^? 17.81 CL CL A 129 A 45 THR B 92 THR^? 18.96 CL CL A 129 A 161 LYS A 43 LYS.? 9.42 CL CL A 129 coo 26.16 88.25 79.16 25.22 89.47 80.71 91.10 60.53 -57.02 91.28 62.68 -56.65 coo 27.73 89.90 76.08 29.24 91.46 75.95 88.84 61.70 -60.19 88.43 63.62 -59.28 coo 33.83 91.15 88.62 31.07 91.06 83.02 96.70 52.33 -61.01 101.40 51.27 -59.62 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 6 3 # 6 A 44 THR B 82 THR^? 18.93 CL CL A 129 A 45 THR B 81 THR^? 12.74 CL CL A 129 A 161 LYS A 111 LYS^? 25.43 CL CL A 129 coo 26.16 88.25 79.16 25.22 89.47 80.71 103.32 60.51 -62.56 104.17 61.53 -60.86 coo 27.73 89.90 76.08 29.24 91.46 75.95 100.07 58.97 -61.29 99.70 56.90 -61.73 coo 33.83 91.15 88.62 31.07 91.06 83.02 105.91 53.60 -74.08 110.80 53.18 -78.24 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 7 3 # 7 A 44 THR B 82 THR^? 18.93 CL CL A 129 A 45 THR B 81 THR^? 12.74 CL CL A 129 A 161 LYS B 111 LYS^? 25.35 CL CL B 129 coo 26.16 88.25 79.16 25.22 89.47 80.71 103.32 60.51 -62.56 104.17 61.53 -60.86 coo 27.73 89.90 76.08 29.24 91.46 75.95 100.07 58.97 -61.29 99.70 56.90 -61.73 coo 33.83 91.15 88.62 31.07 91.06 83.02 105.89 69.85 -67.01 110.53 70.43 -62.59 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 8 3 # 8 A 44 THR C 82 THR^? 23.56 CL CL A 129 A 45 THR C 81 THR^? 28.72 CL CL C 129 A 161 LYS C 111 LYS^? 20.47 CL CL A 129 coo 26.16 88.25 79.16 25.22 89.47 80.71 104.35 61.24 -43.23 103.23 60.37 -44.92 coo 27.73 89.90 76.08 29.24 91.46 75.95 105.72 64.55 -44.54 107.87 64.94 -44.19 coo 33.83 91.15 88.62 31.07 91.06 83.02 94.84 58.73 -38.66 94.21 53.88 -42.04 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 9 3 # 9 A 44 THR D 82 THR^? 27.41 CL CL D 129 A 45 THR D 81 THR^? 28.71 CL CL D 129 A 161 LYS D 111 LYS^? 25.57 CL CL D 129 coo 26.16 88.25 79.16 25.22 89.47 80.71 55.03 89.38 -43.21 56.11 90.23 -44.91 coo 27.73 89.90 76.08 29.24 91.46 75.95 53.52 86.11 -44.51 51.45 85.78 -44.13 coo 33.83 91.15 88.62 31.07 91.06 83.02 64.48 91.99 -38.71 64.71 96.91 -42.99 1dhp_c02 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 9 hits 1dhp_c02 naa= 3 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 B 44 THR A 78 THR^? 18.06 CL CL B 129 B 45 THR A 92 THR.? 19.17 CL CL B 129 B 161 LYS B 43 LYS^? 9.52 CL CL B 129 coo 7.39 128.28 94.56 8.34 126.36 94.79 91.16 62.77 -84.08 91.28 60.64 -84.40 coo 5.75 129.25 91.25 4.29 128.16 90.07 88.80 61.61 -80.86 88.36 59.74 -81.92 coo -0.17 119.75 99.65 2.51 123.83 95.70 96.64 71.22 -80.00 101.30 72.05 -81.50 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 B 44 THR A 82 THR^? 18.91 CL CL B 129 B 45 THR A 81 THR^? 12.77 CL CL B 129 B 161 LYS A 111 LYS^? 25.43 CL CL A 129 coo 7.39 128.28 94.56 8.34 126.36 94.79 103.30 63.05 -78.71 104.17 62.08 -80.47 coo 5.75 129.25 91.25 4.29 128.16 90.07 100.01 64.50 -79.91 99.59 66.56 -79.34 coo -0.17 119.75 99.65 2.51 123.83 95.70 105.91 53.60 -74.08 110.80 53.18 -78.24 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 3 3 # 3 B 44 THR A 82 THR^? 18.91 CL CL B 129 B 45 THR A 81 THR^? 12.77 CL CL B 129 B 161 LYS B 111 LYS^? 25.35 CL CL B 129 coo 7.39 128.28 94.56 8.34 126.36 94.79 103.30 63.05 -78.71 104.17 62.08 -80.47 coo 5.75 129.25 91.25 4.29 128.16 90.07 100.01 64.50 -79.91 99.59 66.56 -79.34 coo -0.17 119.75 99.65 2.51 123.83 95.70 105.89 69.85 -67.01 110.53 70.43 -62.59 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 4 3 # 4 B 44 THR A 92 THR.? 19.17 CL CL B 129 B 45 THR A 78 THR^? 18.06 CL CL B 129 B 161 LYS A 24 LYS~? 27.96 CL CL A 129 coo 7.39 128.28 94.56 8.34 126.36 94.79 88.80 61.61 -80.86 88.36 59.74 -81.92 coo 5.75 129.25 91.25 4.29 128.16 90.07 91.16 62.77 -84.08 91.28 60.64 -84.40 coo -0.17 119.75 99.65 2.51 123.83 95.70 90.40 47.78 -84.76 92.62 43.20 -88.57 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 5 3 # 5 B 44 THR B 78 THR^? 17.81 CL CL A 129 B 45 THR B 92 THR^? 18.96 CL CL A 129 B 161 LYS A 43 LYS.? 9.42 CL CL A 129 coo 7.39 128.28 94.56 8.34 126.36 94.79 91.10 60.53 -57.02 91.28 62.68 -56.65 coo 5.75 129.25 91.25 4.29 128.16 90.07 88.84 61.70 -60.19 88.43 63.62 -59.28 coo -0.17 119.75 99.65 2.51 123.83 95.70 96.70 52.33 -61.01 101.40 51.27 -59.62 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 6 3 # 6 B 44 THR B 82 THR^? 18.93 CL CL A 129 B 45 THR B 81 THR^? 12.74 CL CL A 129 B 161 LYS A 111 LYS^? 25.43 CL CL A 129 coo 7.39 128.28 94.56 8.34 126.36 94.79 103.32 60.51 -62.56 104.17 61.53 -60.86 coo 5.75 129.25 91.25 4.29 128.16 90.07 100.07 58.97 -61.29 99.70 56.90 -61.73 coo -0.17 119.75 99.65 2.51 123.83 95.70 105.91 53.60 -74.08 110.80 53.18 -78.24 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 7 3 # 7 B 44 THR B 82 THR^? 18.93 CL CL A 129 B 45 THR B 81 THR^? 12.74 CL CL A 129 B 161 LYS B 111 LYS^? 25.35 CL CL B 129 coo 7.39 128.28 94.56 8.34 126.36 94.79 103.32 60.51 -62.56 104.17 61.53 -60.86 coo 5.75 129.25 91.25 4.29 128.16 90.07 100.07 58.97 -61.29 99.70 56.90 -61.73 coo -0.17 119.75 99.65 2.51 123.83 95.70 105.89 69.85 -67.01 110.53 70.43 -62.59 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 8 3 # 8 B 44 THR C 82 THR^? 23.56 CL CL A 129 B 45 THR C 81 THR^? 28.72 CL CL C 129 B 161 LYS C 111 LYS^? 20.47 CL CL A 129 coo 7.39 128.28 94.56 8.34 126.36 94.79 104.35 61.24 -43.23 103.23 60.37 -44.92 coo 5.75 129.25 91.25 4.29 128.16 90.07 105.72 64.55 -44.54 107.87 64.94 -44.19 coo -0.17 119.75 99.65 2.51 123.83 95.70 94.84 58.73 -38.66 94.21 53.88 -42.04 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 9 3 # 9 B 44 THR D 82 THR^? 27.41 CL CL D 129 B 45 THR D 81 THR^? 28.71 CL CL D 129 B 161 LYS D 111 LYS^? 25.57 CL CL D 129 coo 7.39 128.28 94.56 8.34 126.36 94.79 55.03 89.38 -43.21 56.11 90.23 -44.91 coo 5.75 129.25 91.25 4.29 128.16 90.07 53.52 86.11 -44.51 51.45 85.78 -44.13 coo -0.17 119.75 99.65 2.51 123.83 95.70 64.48 91.99 -38.71 64.71 96.91 -42.99 1dhp_c03 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 9 hits 1dhp_c03 naa= 3 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 1 3 # 1 146 TYR A 20 TYR~? 23.51 CL CL B 129 150 LYS A 24 LYS~? 27.96 CL CL A 129 186 ASN A 77 ASN^? 14.66 CL CL B 129 coo 32.88 50.55 24.33 31.89 51.78 26.65 94.54 54.15 -86.74 93.79 56.81 -87.24 coo 27.04 52.42 22.30 26.88 49.99 27.00 90.40 47.78 -84.76 92.62 43.20 -88.57 coo 36.98 50.30 37.29 35.85 50.29 35.50 87.29 65.89 -84.51 85.99 67.02 -85.80 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 2 3 # 2 146 TYR B 20 TYR^? 23.21 CL CL A 129 150 LYS B 24 LYS^? 27.82 CL CL B 129 186 ASN B 77 ASN^? 14.36 CL CL A 129 coo 32.88 50.55 24.33 31.89 51.78 26.65 94.47 69.13 -54.42 93.73 66.50 -53.85 coo 27.04 52.42 22.30 26.88 49.99 27.00 90.54 75.59 -56.27 92.78 80.12 -52.52 coo 36.98 50.30 37.29 35.85 50.29 35.50 87.37 57.25 -56.67 85.96 56.21 -55.44 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 3 3 # 3 146 TYR C 20 TYR^? 26.72 CL CL A 129 150 LYS C 24 LYS^? 26.64 CL CL C 129 186 ASN C 77 ASN^? 33.36 CL CL B 129 coo 32.88 50.55 24.33 31.89 51.78 26.65 95.56 70.07 -51.22 98.17 70.86 -51.76 coo 27.04 52.42 22.30 26.88 49.99 27.00 88.99 74.10 -49.29 84.03 71.99 -51.83 coo 36.98 50.30 37.29 35.85 50.29 35.50 107.30 77.29 -48.98 108.48 78.56 -50.20 1dhr_c00 source 1dhr DIHYDROPTERIDINE REDUCTASE (DHPR) (E.C.1.6.99.: 3 hits 1dhr_c00 naa= 3 ULMN 3 1dj1_c00 CYTOCHROME C PEROXIDASE user 1 3 # 1 A 48 ALA A 121 ALA^? 14.99 CL CL A 129 A 52 HIS A 122 HIS^? 19.05 CL CL A 129 A 191 TRP B 109 TRP^? 18.94 CL CL B 129 coo 0.32 19.13 2.10 -0.45 20.12 1.22 91.20 56.45 -70.80 90.97 55.26 -71.77 coo 0.08 14.87 -2.02 -1.94 15.16 -2.48 86.83 60.37 -69.40 85.20 61.24 -68.40 coo -12.27 21.19 4.26 -8.94 21.66 2.22 97.49 66.86 -64.62 97.45 70.64 -63.54 ULMN 3 1dj1_c00 CYTOCHROME C PEROXIDASE user 2 3 # 2 A 48 ALA B 121 ALA^? 14.81 CL CL B 129 A 52 HIS B 122 HIS^? 19.12 CL CL B 129 A 191 TRP A 109 TRP^? 18.93 CL CL A 129 coo 0.32 19.13 2.10 -0.45 20.12 1.22 91.23 67.08 -70.26 91.04 68.33 -69.41 coo 0.08 14.87 -2.02 -1.94 15.16 -2.48 86.93 63.10 -71.62 85.35 62.06 -72.53 coo -12.27 21.19 4.26 -8.94 21.66 2.22 97.51 56.63 -76.52 97.33 52.84 -77.37 1dj1_c00 source 1dj1 CYTOCHROME C PEROXIDASE : 2 hits 1dj1_c00 naa= 3 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 1 3 # 1 E 57 HIS A 85 HIS.? 26.94 CL CL B 129 E 102 ASP A 86 ASP.? 23.33 CL CL A 129 E 193 GLY A 0 GLY.? 22.19 CL CL B 129 coo 11.39 26.86 25.95 9.85 26.64 27.36 112.09 59.31 -75.65 113.04 59.28 -73.77 coo 10.90 32.83 25.96 10.83 30.68 25.98 108.46 57.22 -73.78 109.48 58.49 -72.45 coo 4.57 20.60 30.29 4.74 21.36 30.66 110.86 69.25 -68.82 110.93 68.50 -69.21 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 2 3 # 2 E 57 HIS B 85 HIS^? 26.88 CL CL A 129 E 102 ASP B 86 ASP^? 23.14 CL CL B 129 E 193 GLY B 0 GLY^? 22.38 CL CL A 129 coo 11.39 26.86 25.95 9.85 26.64 27.36 111.98 64.21 -65.30 113.02 64.33 -67.11 coo 10.90 32.83 25.96 10.83 30.68 25.98 108.40 66.17 -67.38 109.32 64.97 -68.84 coo 4.57 20.60 30.29 4.74 21.36 30.66 111.19 54.19 -72.18 110.74 54.87 -72.04 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 3 3 # 3 E 57 HIS C 85 HIS^? 23.16 CL CL A 129 E 102 ASP C 86 ASP^? 23.12 CL CL C 129 E 193 GLY C 0 GLY^? 29.84 CL CL C 129 coo 11.39 26.86 25.95 9.85 26.64 27.36 100.49 52.59 -40.39 100.40 51.57 -38.55 coo 10.90 32.83 25.96 10.83 30.68 25.98 98.39 56.19 -38.35 99.60 55.15 -36.99 coo 4.57 20.60 30.29 4.74 21.36 30.66 110.33 53.90 -33.33 110.08 53.32 -33.88 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 4 3 # 4 E 57 HIS D 85 HIS^? 27.00 CL CL D 129 E 102 ASP D 86 ASP^? 23.19 CL CL D 129 E 193 GLY D 0 GLY^? 29.80 CL CL D 129 coo 11.39 26.86 25.95 9.85 26.64 27.36 58.77 98.13 -40.30 58.69 99.11 -38.44 coo 10.90 32.83 25.96 10.83 30.68 25.98 60.79 94.39 -38.32 59.49 95.38 -36.98 coo 4.57 20.60 30.29 4.74 21.36 30.66 49.06 96.65 -33.40 49.36 97.21 -33.92 1ds2_c02 source 1ds2 PROTEINASE B (SGPB : 4 hits 1ds2_c02 naa= 3 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 1 3 # 1 B 141 GLY A 55 GLY~? -3.63 CL CL A 129s B 144 GLU A 58 GLU~? 7.41 CL CL A 129 B 164 GLU A 57 GLU~? -5.56 CL CL A 129s coo 88.87 114.43 152.30 88.45 115.15 152.32 92.85 48.69 -62.18 92.25 48.83 -62.75 coo 85.20 111.99 152.05 86.60 110.89 150.91 87.85 46.74 -60.89 87.27 48.56 -59.93 coo 88.14 113.46 145.73 86.79 113.92 147.30 91.25 41.69 -61.23 91.08 41.09 -59.17 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 2 3 # 2 B 141 GLY A 115 GLY^? 19.18 CL CL A 129 B 144 GLU A 114 GLU^? 14.59 CL CL A 129 B 164 GLU A 36 GLU~? 18.47 CL CL A 129 coo 88.87 114.43 152.30 88.45 115.15 152.32 105.32 48.49 -75.94 105.17 48.69 -75.15 coo 85.20 111.99 152.05 86.60 110.89 150.91 104.53 45.97 -71.95 105.17 46.78 -70.05 coo 88.14 113.46 145.73 86.79 113.92 147.30 99.16 43.45 -76.17 99.38 43.10 -78.24 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 3 3 # 3 B 141 GLY B 55 GLY^? 3.74 CL CL B 129 B 144 GLU B 58 GLU^? 7.34 CL CL B 129 B 164 GLU B 57 GLU^? -5.29 CL CL B 129s coo 88.87 114.43 152.30 88.45 115.15 152.32 92.76 74.76 -78.82 92.18 74.63 -78.24 coo 85.20 111.99 152.05 86.60 110.89 150.91 87.90 76.66 -80.19 87.42 74.86 -81.30 coo 88.14 113.46 145.73 86.79 113.92 147.30 91.24 81.90 -79.46 91.48 82.48 -81.50 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 4 3 # 4 B 141 GLY B 115 GLY^? 19.14 CL CL B 129 B 144 GLU B 114 GLU^? 14.94 CL CL B 129 B 164 GLU B 36 GLU^? 18.40 CL CL B 129 coo 88.87 114.43 152.30 88.45 115.15 152.32 105.34 74.85 -65.16 105.20 74.69 -65.93 coo 85.20 111.99 152.05 86.60 110.89 150.91 104.70 77.68 -68.99 105.48 76.80 -70.78 coo 88.14 113.46 145.73 86.79 113.92 147.30 99.20 79.77 -64.83 99.58 80.60 -62.91 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 5 3 # 5 B 141 GLY C 55 GLY^? -3.60 CL CL C 129s B 144 GLU C 58 GLU^? 7.49 CL CL C 129 B 164 GLU C 57 GLU^? -5.48 CL CL C 129s coo 88.87 114.43 152.30 88.45 115.15 152.32 90.01 71.78 -26.77 90.18 72.34 -27.33 coo 85.20 111.99 152.05 86.60 110.89 150.91 88.02 76.82 -25.55 89.85 77.43 -24.60 coo 88.14 113.46 145.73 86.79 113.92 147.30 82.94 73.46 -26.00 82.34 73.25 -23.96 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 6 3 # 6 B 141 GLY C 115 GLY^? 19.09 CL CL C 129 B 144 GLU C 114 GLU^? 14.88 CL CL C 129 B 164 GLU C 36 GLU^? 18.27 CL CL C 129 coo 88.87 114.43 152.30 88.45 115.15 152.32 89.73 59.33 -40.54 89.93 59.44 -39.76 coo 85.20 111.99 152.05 86.60 110.89 150.91 87.05 59.85 -36.57 87.99 59.11 -34.78 coo 88.14 113.46 145.73 86.79 113.92 147.30 84.85 65.27 -40.53 84.47 64.86 -42.56 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 7 3 # 7 B 141 GLY D 115 GLY^? 19.26 CL CL D 129 B 144 GLU D 114 GLU^? 14.88 CL CL D 129 B 164 GLU D 36 GLU^? 18.42 CL CL D 129 coo 88.87 114.43 152.30 88.45 115.15 152.32 69.45 91.40 -40.67 69.30 91.29 -39.87 coo 85.20 111.99 152.05 86.60 110.89 150.91 72.08 90.81 -36.72 71.29 91.48 -34.84 coo 88.14 113.46 145.73 86.79 113.92 147.30 74.52 85.40 -40.74 74.64 85.74 -42.81 1dub_c13 source 1dub 2-ENOYL-COA HYDRATASE : 7 hits 1dub_c13 naa= 3 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 1 3 # 1 C 141 GLY A 55 GLY~? -3.63 CL CL A 129s C 144 GLU A 58 GLU~? 7.41 CL CL A 129 C 164 GLU A 57 GLU~? -5.56 CL CL A 129s coo 56.28 104.55 135.84 56.09 105.34 136.05 92.85 48.69 -62.18 92.25 48.83 -62.75 coo 58.46 103.90 139.48 57.57 102.00 139.16 87.85 46.74 -60.89 87.27 48.56 -59.93 coo 51.71 102.03 140.09 53.02 103.62 140.54 91.25 41.69 -61.23 91.08 41.09 -59.17 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 2 3 # 2 C 141 GLY A 115 GLY^? 19.18 CL CL A 129 C 144 GLU A 114 GLU^? 14.59 CL CL A 129 C 164 GLU A 36 GLU~? 18.47 CL CL A 129 coo 56.28 104.55 135.84 56.09 105.34 136.05 105.32 48.49 -75.94 105.17 48.69 -75.15 coo 58.46 103.90 139.48 57.57 102.00 139.16 104.53 45.97 -71.95 105.17 46.78 -70.05 coo 51.71 102.03 140.09 53.02 103.62 140.54 99.16 43.45 -76.17 99.38 43.10 -78.24 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 3 3 # 3 C 141 GLY B 55 GLY^? 3.74 CL CL B 129 C 144 GLU B 58 GLU^? 7.34 CL CL B 129 C 164 GLU B 57 GLU^? -5.29 CL CL B 129s coo 56.28 104.55 135.84 56.09 105.34 136.05 92.76 74.76 -78.82 92.18 74.63 -78.24 coo 58.46 103.90 139.48 57.57 102.00 139.16 87.90 76.66 -80.19 87.42 74.86 -81.30 coo 51.71 102.03 140.09 53.02 103.62 140.54 91.24 81.90 -79.46 91.48 82.48 -81.50 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 4 3 # 4 C 141 GLY B 115 GLY^? 19.14 CL CL B 129 C 144 GLU B 114 GLU^? 14.94 CL CL B 129 C 164 GLU B 36 GLU^? 18.40 CL CL B 129 coo 56.28 104.55 135.84 56.09 105.34 136.05 105.34 74.85 -65.16 105.20 74.69 -65.93 coo 58.46 103.90 139.48 57.57 102.00 139.16 104.70 77.68 -68.99 105.48 76.80 -70.78 coo 51.71 102.03 140.09 53.02 103.62 140.54 99.20 79.77 -64.83 99.58 80.60 -62.91 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 5 3 # 5 C 141 GLY C 55 GLY^? -3.60 CL CL C 129s C 144 GLU C 58 GLU^? 7.49 CL CL C 129 C 164 GLU C 57 GLU^? -5.48 CL CL C 129s coo 56.28 104.55 135.84 56.09 105.34 136.05 90.01 71.78 -26.77 90.18 72.34 -27.33 coo 58.46 103.90 139.48 57.57 102.00 139.16 88.02 76.82 -25.55 89.85 77.43 -24.60 coo 51.71 102.03 140.09 53.02 103.62 140.54 82.94 73.46 -26.00 82.34 73.25 -23.96 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 6 3 # 6 C 141 GLY C 115 GLY^? 19.09 CL CL C 129 C 144 GLU C 114 GLU^? 14.88 CL CL C 129 C 164 GLU C 36 GLU^? 18.27 CL CL C 129 coo 56.28 104.55 135.84 56.09 105.34 136.05 89.73 59.33 -40.54 89.93 59.44 -39.76 coo 58.46 103.90 139.48 57.57 102.00 139.16 87.05 59.85 -36.57 87.99 59.11 -34.78 coo 51.71 102.03 140.09 53.02 103.62 140.54 84.85 65.27 -40.53 84.47 64.86 -42.56 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 7 3 # 7 C 141 GLY D 115 GLY^? 19.26 CL CL D 129 C 144 GLU D 114 GLU^? 14.88 CL CL D 129 C 164 GLU D 36 GLU^? 18.42 CL CL D 129 coo 56.28 104.55 135.84 56.09 105.34 136.05 69.45 91.40 -40.67 69.30 91.29 -39.87 coo 58.46 103.90 139.48 57.57 102.00 139.16 72.08 90.81 -36.72 71.29 91.48 -34.84 coo 51.71 102.03 140.09 53.02 103.62 140.54 74.52 85.40 -40.74 74.64 85.74 -42.81 1dub_c14 source 1dub 2-ENOYL-COA HYDRATASE : 7 hits 1dub_c14 naa= 3 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 1 3 # 1 D 141 GLY A 55 GLY~? -3.63 CL CL A 129s D 144 GLU A 58 GLU~? 7.41 CL CL A 129 D 164 GLU A 57 GLU~? -5.56 CL CL A 129s coo 86.19 80.64 132.77 86.38 79.85 132.93 92.85 48.69 -62.18 92.25 48.83 -62.75 coo 84.75 81.24 136.88 85.62 83.14 136.43 87.85 46.74 -60.89 87.27 48.56 -59.93 coo 91.47 83.05 136.24 90.35 81.38 136.84 91.25 41.69 -61.23 91.08 41.09 -59.17 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 2 3 # 2 D 141 GLY A 115 GLY^? 19.18 CL CL A 129 D 144 GLU A 114 GLU^? 14.59 CL CL A 129 D 164 GLU A 36 GLU~? 18.47 CL CL A 129 coo 86.19 80.64 132.77 86.38 79.85 132.93 105.32 48.49 -75.94 105.17 48.69 -75.15 coo 84.75 81.24 136.88 85.62 83.14 136.43 104.53 45.97 -71.95 105.17 46.78 -70.05 coo 91.47 83.05 136.24 90.35 81.38 136.84 99.16 43.45 -76.17 99.38 43.10 -78.24 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 3 3 # 3 D 141 GLY B 55 GLY^? 3.74 CL CL B 129 D 144 GLU B 58 GLU^? 7.34 CL CL B 129 D 164 GLU B 57 GLU^? -5.29 CL CL B 129s coo 86.19 80.64 132.77 86.38 79.85 132.93 92.76 74.76 -78.82 92.18 74.63 -78.24 coo 84.75 81.24 136.88 85.62 83.14 136.43 87.90 76.66 -80.19 87.42 74.86 -81.30 coo 91.47 83.05 136.24 90.35 81.38 136.84 91.24 81.90 -79.46 91.48 82.48 -81.50 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 4 3 # 4 D 141 GLY B 115 GLY^? 19.14 CL CL B 129 D 144 GLU B 114 GLU^? 14.94 CL CL B 129 D 164 GLU B 36 GLU^? 18.40 CL CL B 129 coo 86.19 80.64 132.77 86.38 79.85 132.93 105.34 74.85 -65.16 105.20 74.69 -65.93 coo 84.75 81.24 136.88 85.62 83.14 136.43 104.70 77.68 -68.99 105.48 76.80 -70.78 coo 91.47 83.05 136.24 90.35 81.38 136.84 99.20 79.77 -64.83 99.58 80.60 -62.91 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 5 3 # 5 D 141 GLY C 55 GLY^? -3.60 CL CL C 129s D 144 GLU C 58 GLU^? 7.49 CL CL C 129 D 164 GLU C 57 GLU^? -5.48 CL CL C 129s coo 86.19 80.64 132.77 86.38 79.85 132.93 90.01 71.78 -26.77 90.18 72.34 -27.33 coo 84.75 81.24 136.88 85.62 83.14 136.43 88.02 76.82 -25.55 89.85 77.43 -24.60 coo 91.47 83.05 136.24 90.35 81.38 136.84 82.94 73.46 -26.00 82.34 73.25 -23.96 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 6 3 # 6 D 141 GLY C 115 GLY^? 19.09 CL CL C 129 D 144 GLU C 114 GLU^? 14.88 CL CL C 129 D 164 GLU C 36 GLU^? 18.27 CL CL C 129 coo 86.19 80.64 132.77 86.38 79.85 132.93 89.73 59.33 -40.54 89.93 59.44 -39.76 coo 84.75 81.24 136.88 85.62 83.14 136.43 87.05 59.85 -36.57 87.99 59.11 -34.78 coo 91.47 83.05 136.24 90.35 81.38 136.84 84.85 65.27 -40.53 84.47 64.86 -42.56 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 7 3 # 7 D 141 GLY D 115 GLY^? 19.26 CL CL D 129 D 144 GLU D 114 GLU^? 14.88 CL CL D 129 D 164 GLU D 36 GLU^? 18.42 CL CL D 129 coo 86.19 80.64 132.77 86.38 79.85 132.93 69.45 91.40 -40.67 69.30 91.29 -39.87 coo 84.75 81.24 136.88 85.62 83.14 136.43 72.08 90.81 -36.72 71.29 91.48 -34.84 coo 91.47 83.05 136.24 90.35 81.38 136.84 74.52 85.40 -40.74 74.64 85.74 -42.81 1dub_c15 source 1dub 2-ENOYL-COA HYDRATASE : 7 hits 1dub_c15 naa= 3 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 1 3 # 1 E 141 GLY A 55 GLY~? -3.63 CL CL A 129s E 144 GLU A 58 GLU~? 7.41 CL CL A 129 E 164 GLU A 57 GLU~? -5.56 CL CL A 129s coo 90.07 81.07 170.50 90.23 80.26 170.38 92.85 48.69 -62.18 92.25 48.83 -62.75 coo 87.05 81.30 167.53 86.38 82.74 168.94 87.85 46.74 -60.89 87.27 48.56 -59.93 coo 84.40 80.02 173.80 85.08 79.06 172.03 91.25 41.69 -61.23 91.08 41.09 -59.17 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 2 3 # 2 E 141 GLY A 115 GLY^? 19.18 CL CL A 129 E 144 GLU A 114 GLU^? 14.59 CL CL A 129 E 164 GLU A 36 GLU~? 18.47 CL CL A 129 coo 90.07 81.07 170.50 90.23 80.26 170.38 105.32 48.49 -75.94 105.17 48.69 -75.15 coo 87.05 81.30 167.53 86.38 82.74 168.94 104.53 45.97 -71.95 105.17 46.78 -70.05 coo 84.40 80.02 173.80 85.08 79.06 172.03 99.16 43.45 -76.17 99.38 43.10 -78.24 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 3 3 # 3 E 141 GLY B 55 GLY^? 3.74 CL CL B 129 E 144 GLU B 58 GLU^? 7.34 CL CL B 129 E 164 GLU B 57 GLU^? -5.29 CL CL B 129s coo 90.07 81.07 170.50 90.23 80.26 170.38 92.76 74.76 -78.82 92.18 74.63 -78.24 coo 87.05 81.30 167.53 86.38 82.74 168.94 87.90 76.66 -80.19 87.42 74.86 -81.30 coo 84.40 80.02 173.80 85.08 79.06 172.03 91.24 81.90 -79.46 91.48 82.48 -81.50 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 4 3 # 4 E 141 GLY B 115 GLY^? 19.14 CL CL B 129 E 144 GLU B 114 GLU^? 14.94 CL CL B 129 E 164 GLU B 36 GLU^? 18.40 CL CL B 129 coo 90.07 81.07 170.50 90.23 80.26 170.38 105.34 74.85 -65.16 105.20 74.69 -65.93 coo 87.05 81.30 167.53 86.38 82.74 168.94 104.70 77.68 -68.99 105.48 76.80 -70.78 coo 84.40 80.02 173.80 85.08 79.06 172.03 99.20 79.77 -64.83 99.58 80.60 -62.91 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 5 3 # 5 E 141 GLY C 55 GLY^? -3.60 CL CL C 129s E 144 GLU C 58 GLU^? 7.49 CL CL C 129 E 164 GLU C 57 GLU^? -5.48 CL CL C 129s coo 90.07 81.07 170.50 90.23 80.26 170.38 90.01 71.78 -26.77 90.18 72.34 -27.33 coo 87.05 81.30 167.53 86.38 82.74 168.94 88.02 76.82 -25.55 89.85 77.43 -24.60 coo 84.40 80.02 173.80 85.08 79.06 172.03 82.94 73.46 -26.00 82.34 73.25 -23.96 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 6 3 # 6 E 141 GLY C 115 GLY^? 19.09 CL CL C 129 E 144 GLU C 114 GLU^? 14.88 CL CL C 129 E 164 GLU C 36 GLU^? 18.27 CL CL C 129 coo 90.07 81.07 170.50 90.23 80.26 170.38 89.73 59.33 -40.54 89.93 59.44 -39.76 coo 87.05 81.30 167.53 86.38 82.74 168.94 87.05 59.85 -36.57 87.99 59.11 -34.78 coo 84.40 80.02 173.80 85.08 79.06 172.03 84.85 65.27 -40.53 84.47 64.86 -42.56 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 7 3 # 7 E 141 GLY D 115 GLY^? 19.26 CL CL D 129 E 144 GLU D 114 GLU^? 14.88 CL CL D 129 E 164 GLU D 36 GLU^? 18.42 CL CL D 129 coo 90.07 81.07 170.50 90.23 80.26 170.38 69.45 91.40 -40.67 69.30 91.29 -39.87 coo 87.05 81.30 167.53 86.38 82.74 168.94 72.08 90.81 -36.72 71.29 91.48 -34.84 coo 84.40 80.02 173.80 85.08 79.06 172.03 74.52 85.40 -40.74 74.64 85.74 -42.81 1dub_c16 source 1dub 2-ENOYL-COA HYDRATASE : 7 hits 1dub_c16 naa= 3 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 1 3 # 1 F 141 GLY A 55 GLY~? -3.63 CL CL A 129s F 144 GLU A 58 GLU~? 7.41 CL CL A 129 F 164 GLU A 57 GLU~? -5.56 CL CL A 129s coo 57.12 70.68 155.10 57.52 69.95 155.02 92.85 48.69 -62.18 92.25 48.83 -62.75 coo 60.62 73.13 154.21 59.05 74.26 153.35 87.85 46.74 -60.89 87.27 48.56 -59.93 coo 56.75 71.71 148.46 58.44 71.01 149.54 91.25 41.69 -61.23 91.08 41.09 -59.17 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 2 3 # 2 F 141 GLY A 115 GLY^? 19.18 CL CL A 129 F 144 GLU A 114 GLU^? 14.59 CL CL A 129 F 164 GLU A 36 GLU~? 18.47 CL CL A 129 coo 57.12 70.68 155.10 57.52 69.95 155.02 105.32 48.49 -75.94 105.17 48.69 -75.15 coo 60.62 73.13 154.21 59.05 74.26 153.35 104.53 45.97 -71.95 105.17 46.78 -70.05 coo 56.75 71.71 148.46 58.44 71.01 149.54 99.16 43.45 -76.17 99.38 43.10 -78.24 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 3 3 # 3 F 141 GLY B 55 GLY^? 3.74 CL CL B 129 F 144 GLU B 58 GLU^? 7.34 CL CL B 129 F 164 GLU B 57 GLU^? -5.29 CL CL B 129s coo 57.12 70.68 155.10 57.52 69.95 155.02 92.76 74.76 -78.82 92.18 74.63 -78.24 coo 60.62 73.13 154.21 59.05 74.26 153.35 87.90 76.66 -80.19 87.42 74.86 -81.30 coo 56.75 71.71 148.46 58.44 71.01 149.54 91.24 81.90 -79.46 91.48 82.48 -81.50 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 4 3 # 4 F 141 GLY B 115 GLY^? 19.14 CL CL B 129 F 144 GLU B 114 GLU^? 14.94 CL CL B 129 F 164 GLU B 36 GLU^? 18.40 CL CL B 129 coo 57.12 70.68 155.10 57.52 69.95 155.02 105.34 74.85 -65.16 105.20 74.69 -65.93 coo 60.62 73.13 154.21 59.05 74.26 153.35 104.70 77.68 -68.99 105.48 76.80 -70.78 coo 56.75 71.71 148.46 58.44 71.01 149.54 99.20 79.77 -64.83 99.58 80.60 -62.91 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 5 3 # 5 F 141 GLY C 55 GLY^? -3.60 CL CL C 129s F 144 GLU C 58 GLU^? 7.49 CL CL C 129 F 164 GLU C 57 GLU^? -5.48 CL CL C 129s coo 57.12 70.68 155.10 57.52 69.95 155.02 90.01 71.78 -26.77 90.18 72.34 -27.33 coo 60.62 73.13 154.21 59.05 74.26 153.35 88.02 76.82 -25.55 89.85 77.43 -24.60 coo 56.75 71.71 148.46 58.44 71.01 149.54 82.94 73.46 -26.00 82.34 73.25 -23.96 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 6 3 # 6 F 141 GLY C 115 GLY^? 19.09 CL CL C 129 F 144 GLU C 114 GLU^? 14.88 CL CL C 129 F 164 GLU C 36 GLU^? 18.27 CL CL C 129 coo 57.12 70.68 155.10 57.52 69.95 155.02 89.73 59.33 -40.54 89.93 59.44 -39.76 coo 60.62 73.13 154.21 59.05 74.26 153.35 87.05 59.85 -36.57 87.99 59.11 -34.78 coo 56.75 71.71 148.46 58.44 71.01 149.54 84.85 65.27 -40.53 84.47 64.86 -42.56 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 7 3 # 7 F 141 GLY D 115 GLY^? 19.26 CL CL D 129 F 144 GLU D 114 GLU^? 14.88 CL CL D 129 F 164 GLU D 36 GLU^? 18.42 CL CL D 129 coo 57.12 70.68 155.10 57.52 69.95 155.02 69.45 91.40 -40.67 69.30 91.29 -39.87 coo 60.62 73.13 154.21 59.05 74.26 153.35 72.08 90.81 -36.72 71.29 91.48 -34.84 coo 56.75 71.71 148.46 58.44 71.01 149.54 74.52 85.40 -40.74 74.64 85.74 -42.81 1dub_c17 source 1dub 2-ENOYL-COA HYDRATASE : 7 hits 1dub_c17 naa= 3 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 1 3 # 1 B 41 HIS A 122 HIS^? 19.05 CL CL A 129 B 43 HIS B 122 HIS^? 19.12 CL CL B 129 B 65 GLU A 93 GLU.? 15.26 CL CL B 129 coo 20.15 22.08 34.36 20.84 20.10 34.21 86.83 60.37 -69.40 85.20 61.24 -68.40 coo 19.55 18.91 30.27 18.21 18.65 31.84 86.93 63.10 -71.62 85.35 62.06 -72.53 coo 10.90 21.31 28.81 12.14 22.15 30.31 84.83 64.69 -81.14 84.26 66.42 -82.32 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 2 3 # 2 B 41 HIS B 122 HIS^? 19.12 CL CL B 129 B 43 HIS A 122 HIS^? 19.05 CL CL A 129 B 65 GLU B 93 GLU^? 15.32 CL CL A 129 coo 20.15 22.08 34.36 20.84 20.10 34.21 86.93 63.10 -71.62 85.35 62.06 -72.53 coo 19.55 18.91 30.27 18.21 18.65 31.84 86.83 60.37 -69.40 85.20 61.24 -68.40 coo 10.90 21.31 28.81 12.14 22.15 30.31 84.67 58.80 -60.02 84.04 57.06 -58.91 1e7l_c01 source 1e7l RECOMBINATION ENDONUCLEASE VII : 2 hits 1e7l_c01 naa= 3 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 1 3 # 1 A 205 LYS B 24 LYS^? 27.82 CL CL B 129 A 207 LYS C 24 LYS^? 26.64 CL CL C 129 A 366 ASP B 72 ASP^? 28.57 CL CL C 129 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 90.54 75.59 -56.27 92.78 80.12 -52.52 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 88.99 74.10 -49.29 84.03 71.99 -51.83 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 80.87 74.36 -54.99 81.74 73.36 -53.35 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 2 3 # 2 A 205 LYS B 24 LYS^? 27.82 CL CL B 129 A 207 LYS C 24 LYS^? 26.64 CL CL C 129 A 366 ASP C 72 ASP^? 28.53 CL CL B 129 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 90.54 75.59 -56.27 92.78 80.12 -52.52 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 88.99 74.10 -49.29 84.03 71.99 -51.83 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 90.38 83.76 -50.64 91.24 82.68 -52.23 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 3 3 # 3 A 205 LYS C 24 LYS^? 26.64 CL CL C 129 A 207 LYS B 24 LYS^? 27.82 CL CL B 129 A 366 ASP B 72 ASP^? 28.57 CL CL C 129 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 88.99 74.10 -49.29 84.03 71.99 -51.83 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 90.54 75.59 -56.27 92.78 80.12 -52.52 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 80.87 74.36 -54.99 81.74 73.36 -53.35 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 4 3 # 4 A 205 LYS C 24 LYS^? 26.64 CL CL C 129 A 207 LYS B 24 LYS^? 27.82 CL CL B 129 A 366 ASP C 72 ASP^? 28.53 CL CL B 129 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 88.99 74.10 -49.29 84.03 71.99 -51.83 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 90.54 75.59 -56.27 92.78 80.12 -52.52 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 90.38 83.76 -50.64 91.24 82.68 -52.23 1ec9_c04 source 1ec9 GLUCARATE DEHYDRATASE : 4 hits 1ec9_c04 naa= 3 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 1 3 # 1 B 205 LYS B 24 LYS^? 27.82 CL CL B 129 B 207 LYS C 24 LYS^? 26.64 CL CL C 129 B 366 ASP B 72 ASP^? 28.57 CL CL C 129 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 90.54 75.59 -56.27 92.78 80.12 -52.52 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 88.99 74.10 -49.29 84.03 71.99 -51.83 coo -11.13 25.71 4.86 -10.82 24.43 3.24 80.87 74.36 -54.99 81.74 73.36 -53.35 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 2 3 # 2 B 205 LYS B 24 LYS^? 27.82 CL CL B 129 B 207 LYS C 24 LYS^? 26.64 CL CL C 129 B 366 ASP C 72 ASP^? 28.53 CL CL B 129 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 90.54 75.59 -56.27 92.78 80.12 -52.52 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 88.99 74.10 -49.29 84.03 71.99 -51.83 coo -11.13 25.71 4.86 -10.82 24.43 3.24 90.38 83.76 -50.64 91.24 82.68 -52.23 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 3 3 # 3 B 205 LYS C 24 LYS^? 26.64 CL CL C 129 B 207 LYS B 24 LYS^? 27.82 CL CL B 129 B 366 ASP B 72 ASP^? 28.57 CL CL C 129 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 88.99 74.10 -49.29 84.03 71.99 -51.83 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 90.54 75.59 -56.27 92.78 80.12 -52.52 coo -11.13 25.71 4.86 -10.82 24.43 3.24 80.87 74.36 -54.99 81.74 73.36 -53.35 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 4 3 # 4 B 205 LYS C 24 LYS^? 26.64 CL CL C 129 B 207 LYS B 24 LYS^? 27.82 CL CL B 129 B 366 ASP C 72 ASP^? 28.53 CL CL B 129 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 88.99 74.10 -49.29 84.03 71.99 -51.83 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 90.54 75.59 -56.27 92.78 80.12 -52.52 coo -11.13 25.71 4.86 -10.82 24.43 3.24 90.38 83.76 -50.64 91.24 82.68 -52.23 1ec9_c05 source 1ec9 GLUCARATE DEHYDRATASE : 4 hits 1ec9_c05 naa= 3 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 1 3 # 1 C 205 LYS B 24 LYS^? 27.82 CL CL B 129 C 207 LYS C 24 LYS^? 26.64 CL CL C 129 C 366 ASP B 72 ASP^? 28.57 CL CL C 129 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 90.54 75.59 -56.27 92.78 80.12 -52.52 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 88.99 74.10 -49.29 84.03 71.99 -51.83 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 80.87 74.36 -54.99 81.74 73.36 -53.35 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 2 3 # 2 C 205 LYS C 24 LYS^? 26.64 CL CL C 129 C 207 LYS B 24 LYS^? 27.82 CL CL B 129 C 366 ASP C 72 ASP^? 28.53 CL CL B 129 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 88.99 74.10 -49.29 84.03 71.99 -51.83 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 90.54 75.59 -56.27 92.78 80.12 -52.52 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 90.38 83.76 -50.64 91.24 82.68 -52.23 1ec9_c06 source 1ec9 GLUCARATE DEHYDRATASE : 2 hits 1ec9_c06 naa= 3 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 1 3 # 1 D 205 LYS B 24 LYS^? 27.82 CL CL B 129 D 207 LYS C 24 LYS^? 26.64 CL CL C 129 D 366 ASP B 72 ASP^? 28.57 CL CL C 129 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 90.54 75.59 -56.27 92.78 80.12 -52.52 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 88.99 74.10 -49.29 84.03 71.99 -51.83 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 80.87 74.36 -54.99 81.74 73.36 -53.35 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 2 3 # 2 D 205 LYS B 24 LYS^? 27.82 CL CL B 129 D 207 LYS C 24 LYS^? 26.64 CL CL C 129 D 366 ASP C 72 ASP^? 28.53 CL CL B 129 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 90.54 75.59 -56.27 92.78 80.12 -52.52 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 88.99 74.10 -49.29 84.03 71.99 -51.83 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 90.38 83.76 -50.64 91.24 82.68 -52.23 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 3 3 # 3 D 205 LYS C 24 LYS^? 26.64 CL CL C 129 D 207 LYS B 24 LYS^? 27.82 CL CL B 129 D 366 ASP B 72 ASP^? 28.57 CL CL C 129 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 88.99 74.10 -49.29 84.03 71.99 -51.83 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 90.54 75.59 -56.27 92.78 80.12 -52.52 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 80.87 74.36 -54.99 81.74 73.36 -53.35 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 4 3 # 4 D 205 LYS C 24 LYS^? 26.64 CL CL C 129 D 207 LYS B 24 LYS^? 27.82 CL CL B 129 D 366 ASP C 72 ASP^? 28.53 CL CL B 129 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 88.99 74.10 -49.29 84.03 71.99 -51.83 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 90.54 75.59 -56.27 92.78 80.12 -52.52 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 90.38 83.76 -50.64 91.24 82.68 -52.23 1ec9_c07 source 1ec9 GLUCARATE DEHYDRATASE : 4 hits 1ec9_c07 naa= 3 ULMN 3 1ef8_c01 METHYLMALONYL COA DECARBOXYLASE user 1 3 # 1 B 66 HIS A 85 HIS.? 26.94 CL CL B 129 B 110 GLY A 84 GLY.? 21.38 CL CL B 129 B 140 TYR A 83 TYR.? 15.31 CL CL B 129 coo 15.25 42.02 9.50 15.08 40.17 8.54 112.09 59.31 -75.65 113.04 59.28 -73.77 coo 16.54 37.86 10.86 17.07 37.78 11.48 109.18 63.55 -76.11 108.53 63.22 -76.56 coo 8.70 35.97 10.91 11.44 36.02 10.35 103.43 65.48 -74.92 101.03 66.78 -75.48 ULMN 3 1ef8_c01 METHYLMALONYL COA DECARBOXYLASE user 2 3 # 2 B 66 HIS B 85 HIS^? 26.88 CL CL A 129 B 110 GLY B 84 GLY^? 21.30 CL CL A 129 B 140 TYR B 83 TYR^? 15.32 CL CL A 129 coo 15.25 42.02 9.50 15.08 40.17 8.54 111.98 64.21 -65.30 113.02 64.33 -67.11 coo 16.54 37.86 10.86 17.07 37.78 11.48 109.15 59.88 -65.08 108.46 60.20 -64.65 coo 8.70 35.97 10.91 11.44 36.02 10.35 103.38 58.05 -66.28 101.08 56.65 -65.75 ULMN 3 1ef8_c01 METHYLMALONYL COA DECARBOXYLASE user 3 3 # 3 B 66 HIS C 85 HIS^? 23.16 CL CL A 129 B 110 GLY C 84 GLY^? 24.82 CL CL A 129 B 140 TYR C 83 TYR^? 26.27 CL CL C 129 coo 15.25 42.02 9.50 15.08 40.17 8.54 100.49 52.59 -40.39 100.40 51.57 -38.55 coo 16.54 37.86 10.86 17.07 37.78 11.48 104.77 55.44 -40.68 104.47 56.12 -41.07 coo 8.70 35.97 10.91 11.44 36.02 10.35 106.70 61.17 -39.39 108.02 63.54 -39.97 ULMN 3 1ef8_c01 METHYLMALONYL COA DECARBOXYLASE user 4 3 # 4 B 66 HIS D 85 HIS^? 27.00 CL CL D 129 B 110 GLY D 84 GLY^? 28.05 CL CL D 129 B 140 TYR D 83 TYR^? 26.42 CL CL D 129 coo 15.25 42.02 9.50 15.08 40.17 8.54 58.77 98.13 -40.30 58.69 99.11 -38.44 coo 16.54 37.86 10.86 17.07 37.78 11.48 54.58 95.23 -40.77 54.92 94.56 -41.18 coo 8.70 35.97 10.91 11.44 36.02 10.35 52.51 89.53 -39.47 51.30 87.12 -40.13 1ef8_c01 source 1ef8 METHYLMALONYL COA DECARBOXYLASE : 4 hits 1ef8_c01 naa= 3 ULMN 3 1ef8_c02 METHYLMALONYL COA DECARBOXYLASE user 1 3 # 1 C 66 HIS A 85 HIS.? 26.94 CL CL B 129 C 110 GLY A 84 GLY.? 21.38 CL CL B 129 C 140 TYR A 83 TYR.? 15.31 CL CL B 129 coo -9.82 10.01 28.41 -9.17 11.02 26.71 112.09 59.31 -75.65 113.04 59.28 -73.77 coo -5.73 12.49 27.77 -5.15 12.61 28.37 109.18 63.55 -76.11 108.53 63.22 -76.56 coo -4.68 8.05 21.05 -4.91 10.19 22.84 103.43 65.48 -74.92 101.03 66.78 -75.48 ULMN 3 1ef8_c02 METHYLMALONYL COA DECARBOXYLASE user 2 3 # 2 C 66 HIS B 85 HIS^? 26.88 CL CL A 129 C 110 GLY B 84 GLY^? 21.30 CL CL A 129 C 140 TYR B 83 TYR^? 15.32 CL CL A 129 coo -9.82 10.01 28.41 -9.17 11.02 26.71 111.98 64.21 -65.30 113.02 64.33 -67.11 coo -5.73 12.49 27.77 -5.15 12.61 28.37 109.15 59.88 -65.08 108.46 60.20 -64.65 coo -4.68 8.05 21.05 -4.91 10.19 22.84 103.38 58.05 -66.28 101.08 56.65 -65.75 ULMN 3 1ef8_c02 METHYLMALONYL COA DECARBOXYLASE user 3 3 # 3 C 66 HIS C 85 HIS^? 23.16 CL CL A 129 C 110 GLY C 84 GLY^? 24.82 CL CL A 129 C 140 TYR C 83 TYR^? 26.27 CL CL C 129 coo -9.82 10.01 28.41 -9.17 11.02 26.71 100.49 52.59 -40.39 100.40 51.57 -38.55 coo -5.73 12.49 27.77 -5.15 12.61 28.37 104.77 55.44 -40.68 104.47 56.12 -41.07 coo -4.68 8.05 21.05 -4.91 10.19 22.84 106.70 61.17 -39.39 108.02 63.54 -39.97 ULMN 3 1ef8_c02 METHYLMALONYL COA DECARBOXYLASE user 4 3 # 4 C 66 HIS D 85 HIS^? 27.00 CL CL D 129 C 110 GLY D 84 GLY^? 28.05 CL CL D 129 C 140 TYR D 83 TYR^? 26.42 CL CL D 129 coo -9.82 10.01 28.41 -9.17 11.02 26.71 58.77 98.13 -40.30 58.69 99.11 -38.44 coo -5.73 12.49 27.77 -5.15 12.61 28.37 54.58 95.23 -40.77 54.92 94.56 -41.18 coo -4.68 8.05 21.05 -4.91 10.19 22.84 52.51 89.53 -39.47 51.30 87.12 -40.13 1ef8_c02 source 1ef8 METHYLMALONYL COA DECARBOXYLASE : 4 hits 1ef8_c02 naa= 3 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 B 107 ASP D 86 ASP^? 23.19 CL CL D 129 B 246 ASP D 4 ASP^? 37.41 CL CL D 129 B 275 HIS D 85 HIS^? 27.00 CL CL D 129 coo 34.84 56.77 81.62 34.95 54.74 82.03 60.79 94.39 -38.32 59.49 95.38 -36.98 coo 43.18 49.30 68.39 44.75 49.87 69.78 46.79 97.75 -45.68 46.52 99.27 -44.27 coo 38.73 55.10 77.62 36.80 55.01 78.46 58.77 98.13 -40.30 58.69 99.11 -38.44 1ehy_c01 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 1 hits 1ehy_c01 naa= 3 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 C 107 ASP D 86 ASP^? 23.19 CL CL D 129 C 246 ASP D 4 ASP^? 37.41 CL CL D 129 C 275 HIS D 85 HIS^? 27.00 CL CL D 129 coo 1.90 35.26 72.76 3.20 35.74 71.18 60.79 94.39 -38.32 59.49 95.38 -36.98 coo 12.03 20.33 71.56 10.48 19.25 70.56 46.79 97.75 -45.68 46.52 99.27 -44.27 coo 3.92 29.96 71.75 4.22 31.96 72.31 58.77 98.13 -40.30 58.69 99.11 -38.44 1ehy_c02 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 1 hits 1ehy_c02 naa= 3 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 D 107 ASP D 86 ASP^? 23.19 CL CL D 129 D 246 ASP D 4 ASP^? 37.41 CL CL D 129 D 275 HIS D 85 HIS^? 27.00 CL CL D 129 coo 37.41 19.89 81.58 37.64 21.98 81.53 60.79 94.39 -38.32 59.49 95.38 -36.98 coo 23.50 26.43 88.52 24.76 26.47 90.29 46.79 97.75 -45.68 46.52 99.27 -44.27 coo 33.16 21.44 85.29 34.07 21.53 83.40 58.77 98.13 -40.30 58.69 99.11 -38.44 1ehy_c03 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 1 hits 1ehy_c03 naa= 3 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 1 3 # 1 A 114 HIS A 40 HIS.? 7.30 CL CL A 129 A 197 ASP A 41 ASP.? 7.60 CL CL A 129 A 223 LYS A 111 LYS^? 25.43 CL CL A 129 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 98.96 43.60 -66.18 98.11 41.92 -65.26 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 99.56 48.98 -63.34 100.43 49.52 -61.53 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 105.91 53.60 -74.08 110.80 53.18 -78.24 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 2 3 # 2 A 114 HIS B 40 HIS^? 7.04 CL CL B 129 A 197 ASP B 41 ASP^? 7.64 CL CL B 129 A 223 LYS B 111 LYS^? 25.35 CL CL B 129 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 98.79 79.91 -74.95 97.97 81.53 -75.99 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 99.50 74.51 -77.69 100.41 73.95 -79.49 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 105.89 69.85 -67.01 110.53 70.43 -62.59 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 3 3 # 3 A 114 HIS C 40 HIS^? 7.21 CL CL C 129 A 197 ASP C 41 ASP^? 7.58 CL CL C 129 A 223 LYS C 111 LYS^? 20.47 CL CL A 129 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 84.82 65.72 -30.75 83.18 66.51 -29.70 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 90.28 65.09 -27.98 90.77 64.12 -26.18 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 94.84 58.73 -38.66 94.21 53.88 -42.04 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 4 3 # 4 A 114 HIS D 40 HIS^? 7.31 CL CL D 129 A 197 ASP D 41 ASP^? 7.55 CL CL D 129 A 223 LYS D 111 LYS^? 25.57 CL CL D 129 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 74.49 84.96 -30.93 76.13 84.16 -29.90 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 69.10 85.54 -28.07 68.60 86.44 -26.19 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 64.48 91.99 -38.71 64.71 96.91 -42.99 1elq_c02 source 1elq L-CYSTEINE/L-CYSTINE C-S LYASE : 4 hits 1elq_c02 naa= 3 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 1 3 # 1 B 114 HIS A 40 HIS.? 7.30 CL CL A 129 B 197 ASP A 41 ASP.? 7.60 CL CL A 129 B 223 LYS A 111 LYS^? 25.43 CL CL A 129 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 98.96 43.60 -66.18 98.11 41.92 -65.26 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 99.56 48.98 -63.34 100.43 49.52 -61.53 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 105.91 53.60 -74.08 110.80 53.18 -78.24 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 2 3 # 2 B 114 HIS B 40 HIS^? 7.04 CL CL B 129 B 197 ASP B 41 ASP^? 7.64 CL CL B 129 B 223 LYS B 111 LYS^? 25.35 CL CL B 129 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 98.79 79.91 -74.95 97.97 81.53 -75.99 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 99.50 74.51 -77.69 100.41 73.95 -79.49 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 105.89 69.85 -67.01 110.53 70.43 -62.59 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 3 3 # 3 B 114 HIS C 40 HIS^? 7.21 CL CL C 129 B 197 ASP C 41 ASP^? 7.58 CL CL C 129 B 223 LYS C 111 LYS^? 20.47 CL CL A 129 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 84.82 65.72 -30.75 83.18 66.51 -29.70 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 90.28 65.09 -27.98 90.77 64.12 -26.18 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 94.84 58.73 -38.66 94.21 53.88 -42.04 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 4 3 # 4 B 114 HIS D 40 HIS^? 7.31 CL CL D 129 B 197 ASP D 41 ASP^? 7.55 CL CL D 129 B 223 LYS D 111 LYS^? 25.57 CL CL D 129 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 74.49 84.96 -30.93 76.13 84.16 -29.90 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 69.10 85.54 -28.07 68.60 86.44 -26.19 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 64.48 91.99 -38.71 64.71 96.91 -42.99 1elq_c03 source 1elq L-CYSTEINE/L-CYSTINE C-S LYASE : 4 hits 1elq_c03 naa= 3 ULMN 3 1emd_c01 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 1 3 # 1 150 ASP C 35 ASP^? 10.26 CL CL C 129 153 ARG C 60 ARG^? 8.92 CL CL C 129 177 HIS C 40 HIS^? 7.21 CL CL C 129 coo 6.83 2.75 19.17 7.40 0.75 19.11 83.63 70.73 -36.85 83.32 69.81 -34.96 coo 1.78 0.50 17.43 2.55 -2.31 16.44 82.52 72.20 -31.52 80.97 69.57 -31.97 coo 9.81 -2.34 18.22 7.84 -2.69 17.56 84.82 65.72 -30.75 83.18 66.51 -29.70 ULMN 3 1emd_c01 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 2 3 # 2 150 ASP D 35 ASP^? 10.18 CL CL D 129 153 ARG D 60 ARG^? 8.57 CL CL D 129 177 HIS D 40 HIS^? 7.31 CL CL D 129 coo 6.83 2.75 19.17 7.40 0.75 19.11 75.66 79.96 -36.93 75.99 80.66 -34.97 coo 1.78 0.50 17.43 2.55 -2.31 16.44 76.65 78.50 -31.75 78.13 81.14 -31.78 coo 9.81 -2.34 18.22 7.84 -2.69 17.56 74.49 84.96 -30.93 76.13 84.16 -29.90 1emd_c01 source 1emd MALATE DEHYDROGENASE (E.C.1.1.1.37) : 2 hits 1emd_c01 naa= 3 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 1 3 # 1 A 229 ALA C 61 ALA^? 9.90 CL CL C 129 A 257 ALA C 65 ALA^? 13.89 CL CL D 129 A 328 ASP D 35 ASP^? 10.18 CL CL D 129 coo 39.84 24.12 8.44 38.50 24.23 9.11 83.43 78.79 -30.72 83.83 79.14 -29.32 coo 43.22 26.73 5.37 41.81 27.09 5.79 82.88 83.84 -34.09 83.60 83.98 -32.74 coo 38.17 34.10 6.67 37.72 32.06 6.84 75.66 79.96 -36.93 75.99 80.66 -34.97 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 2 3 # 2 A 229 ALA C 65 ALA^? 13.89 CL CL D 129 A 257 ALA C 61 ALA^? 9.90 CL CL C 129 A 328 ASP D 35 ASP^? 10.18 CL CL D 129 coo 39.84 24.12 8.44 38.50 24.23 9.11 82.88 83.84 -34.09 83.60 83.98 -32.74 coo 43.22 26.73 5.37 41.81 27.09 5.79 83.43 78.79 -30.72 83.83 79.14 -29.32 coo 38.17 34.10 6.67 37.72 32.06 6.84 75.66 79.96 -36.93 75.99 80.66 -34.97 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 3 3 # 3 A 229 ALA D 61 ALA^? 9.90 CL CL D 129 A 257 ALA D 65 ALA^? 13.98 CL CL C 129 A 328 ASP C 35 ASP^? 10.26 CL CL C 129 coo 39.84 24.12 8.44 38.50 24.23 9.11 75.96 71.88 -30.80 75.66 71.49 -29.34 coo 43.22 26.73 5.37 41.81 27.09 5.79 76.48 66.72 -34.21 75.82 66.53 -32.87 coo 38.17 34.10 6.67 37.72 32.06 6.84 83.63 70.73 -36.85 83.32 69.81 -34.96 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 4 3 # 4 A 229 ALA D 65 ALA^? 13.98 CL CL C 129 A 257 ALA D 61 ALA^? 9.90 CL CL D 129 A 328 ASP C 35 ASP^? 10.26 CL CL C 129 coo 39.84 24.12 8.44 38.50 24.23 9.11 76.48 66.72 -34.21 75.82 66.53 -32.87 coo 43.22 26.73 5.37 41.81 27.09 5.79 75.96 71.88 -30.80 75.66 71.49 -29.34 coo 38.17 34.10 6.67 37.72 32.06 6.84 83.63 70.73 -36.85 83.32 69.81 -34.96 1eo7_c00 source 1eo7 CYCLODEXTRIN GLYCOSYLTRANSFERASE : 4 hits 1eo7_c00 naa= 3 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 38 THR A 78 THR^? 18.06 CL CL B 129 A 159 LYS B 43 LYS^? 9.52 CL CL B 129 A 193 GLU B 58 GLU^? 7.34 CL CL B 129 coo -2.58 16.31 54.79 -4.02 14.93 55.64 91.16 62.77 -84.08 91.28 60.64 -84.40 coo 2.10 10.68 61.44 -2.14 13.16 60.61 96.64 71.22 -80.00 101.30 72.05 -81.50 coo -5.33 11.71 69.72 -4.62 11.92 67.73 87.90 76.66 -80.19 87.42 74.86 -81.30 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 2 3 # 2 A 38 THR A 108 THR^? 18.27 CL CL A 129 A 159 LYS A 111 LYS^? 25.43 CL CL A 129 A 193 GLU A 36 GLU~? 18.47 CL CL A 129 coo -2.58 16.31 54.79 -4.02 14.93 55.64 97.00 58.69 -72.54 97.54 60.16 -71.13 coo 2.10 10.68 61.44 -2.14 13.16 60.61 105.91 53.60 -74.08 110.80 53.18 -78.24 coo -5.33 11.71 69.72 -4.62 11.92 67.73 99.16 43.45 -76.17 99.38 43.10 -78.24 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 3 3 # 3 A 38 THR B 78 THR^? 17.81 CL CL A 129 A 159 LYS A 43 LYS.? 9.42 CL CL A 129 A 193 GLU A 58 GLU~? 7.41 CL CL A 129 coo -2.58 16.31 54.79 -4.02 14.93 55.64 91.10 60.53 -57.02 91.28 62.68 -56.65 coo 2.10 10.68 61.44 -2.14 13.16 60.61 96.70 52.33 -61.01 101.40 51.27 -59.62 coo -5.33 11.71 69.72 -4.62 11.92 67.73 87.85 46.74 -60.89 87.27 48.56 -59.93 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 4 3 # 4 A 38 THR B 108 THR^? 18.08 CL CL B 129 A 159 LYS B 111 LYS^? 25.35 CL CL B 129 A 193 GLU B 36 GLU^? 18.40 CL CL B 129 coo -2.58 16.31 54.79 -4.02 14.93 55.64 97.01 64.71 -68.62 97.41 63.35 -70.22 coo 2.10 10.68 61.44 -2.14 13.16 60.61 105.89 69.85 -67.01 110.53 70.43 -62.59 coo -5.33 11.71 69.72 -4.62 11.92 67.73 99.20 79.77 -64.83 99.58 80.60 -62.91 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 5 3 # 5 A 38 THR C 108 THR^? 18.06 CL CL C 129 A 159 LYS C 111 LYS^? 20.47 CL CL A 129 A 193 GLU C 36 GLU^? 18.27 CL CL C 129 coo -2.58 16.31 54.79 -4.02 14.93 55.64 100.01 67.61 -37.12 101.43 67.13 -35.56 coo 2.10 10.68 61.44 -2.14 13.16 60.61 94.84 58.73 -38.66 94.21 53.88 -42.04 coo -5.33 11.71 69.72 -4.62 11.92 67.73 84.85 65.27 -40.53 84.47 64.86 -42.56 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 6 3 # 6 A 38 THR D 108 THR^? 18.07 CL CL D 129 A 159 LYS D 111 LYS^? 25.57 CL CL D 129 A 193 GLU D 36 GLU^? 18.42 CL CL D 129 coo -2.58 16.31 54.79 -4.02 14.93 55.64 59.33 83.04 -37.21 57.97 83.55 -35.63 coo 2.10 10.68 61.44 -2.14 13.16 60.61 64.48 91.99 -38.71 64.71 96.91 -42.99 coo -5.33 11.71 69.72 -4.62 11.92 67.73 74.52 85.40 -40.74 74.64 85.74 -42.81 1et0_c02 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 6 hits 1et0_c02 naa= 3 ULMN 3 1euu_c00 SIALIDASE user 1 3 # 1 92 ASP A 30 ASP~? 20.80 CL CL A 129 260 GLU A 23 GLU~? 24.22 CL CL A 129 370 TYR A 22 TYR~? 17.56 CL CL A 129 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 89.42 52.54 -84.47 88.08 53.22 -82.95 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 92.72 50.62 -78.45 90.87 50.50 -76.41 ULMN 3 1euu_c00 SIALIDASE user 2 3 # 2 92 ASP A 41 ASP.? 7.60 CL CL A 129 260 GLU A 58 GLU~? 7.41 CL CL A 129 370 TYR A 54 TYR^? 10.29 CL CL A 129 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 99.56 48.98 -63.34 100.43 49.52 -61.53 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 87.85 46.74 -60.89 87.27 48.56 -59.93 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 89.27 53.06 -59.98 88.13 55.63 -59.94 ULMN 3 1euu_c00 SIALIDASE user 3 3 # 3 92 ASP B 30 ASP^? 20.91 CL CL B 129 260 GLU B 23 GLU^? 24.68 CL CL B 129 370 TYR B 22 TYR^? 17.56 CL CL B 129 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 89.49 70.79 -56.44 87.96 70.01 -57.68 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 92.70 72.76 -62.54 90.90 72.79 -64.68 ULMN 3 1euu_c00 SIALIDASE user 4 3 # 4 92 ASP B 41 ASP^? 7.64 CL CL B 129 260 GLU B 58 GLU^? 7.34 CL CL B 129 370 TYR B 54 TYR^? 10.36 CL CL B 129 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 99.50 74.51 -77.69 100.41 73.95 -79.49 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 87.90 76.66 -80.19 87.42 74.86 -81.30 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 89.19 70.43 -81.07 88.03 67.93 -81.20 ULMN 3 1euu_c00 SIALIDASE user 5 3 # 5 92 ASP C 30 ASP^? 20.67 CL CL C 129 260 GLU C 23 GLU^? 24.69 CL CL C 129 370 TYR C 22 TYR^? 17.52 CL CL C 129 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 93.85 75.25 -49.20 94.57 76.88 -48.00 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 91.93 71.84 -43.09 91.81 73.68 -41.00 ULMN 3 1euu_c00 SIALIDASE user 6 3 # 6 92 ASP C 41 ASP^? 7.58 CL CL C 129 260 GLU C 58 GLU^? 7.49 CL CL C 129 370 TYR C 54 TYR^? 10.32 CL CL C 129 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 90.28 65.09 -27.98 90.77 64.12 -26.18 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 88.02 76.82 -25.55 89.85 77.43 -24.60 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 94.43 75.36 -24.67 96.94 76.58 -24.67 ULMN 3 1euu_c00 SIALIDASE user 7 3 # 7 92 ASP D 30 ASP^? 20.62 CL CL D 129 260 GLU D 23 GLU^? 24.49 CL CL D 129 370 TYR D 22 TYR^? 17.52 CL CL D 129 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 65.41 75.40 -49.12 64.81 73.78 -47.86 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 67.44 78.74 -43.16 67.49 76.94 -41.01 ULMN 3 1euu_c00 SIALIDASE user 8 3 # 8 92 ASP D 41 ASP^? 7.55 CL CL D 129 260 GLU D 58 GLU^? 7.39 CL CL D 129 370 TYR D 54 TYR^? 10.35 CL CL D 129 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 69.10 85.54 -28.07 68.60 86.44 -26.19 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 71.21 74.03 -25.57 69.46 73.32 -24.61 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 64.95 75.15 -24.65 62.40 74.09 -24.68 1euu_c00 source 1euu SIALIDASE : 8 hits 1euu_c00 naa= 3 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 1 3 # 1 A 34 GLU A 57 GLU~? -5.56 CL CL A 129s A 260 ARG A 46 ARG^? 15.11 CL CL A 129 A 270 LYS A 43 LYS.? 9.42 CL CL A 129 coo 50.99 29.43 12.86 52.11 29.45 14.65 91.25 41.69 -61.23 91.08 41.09 -59.17 coo 39.80 27.50 22.98 42.20 26.56 21.34 87.96 51.20 -70.32 85.08 51.60 -71.34 coo 48.83 21.70 19.50 47.44 24.99 15.25 96.70 52.33 -61.01 101.40 51.27 -59.62 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 2 3 # 2 A 34 GLU A 57 GLU~? -5.56 CL CL A 129s A 260 ARG A 117 ARG^? 16.03 CL CL A 129 A 270 LYS A 43 LYS.? 9.42 CL CL A 129 coo 50.99 29.43 12.86 52.11 29.45 14.65 91.25 41.69 -61.23 91.08 41.09 -59.17 coo 39.80 27.50 22.98 42.20 26.56 21.34 100.59 48.03 -72.66 102.04 46.10 -74.59 coo 48.83 21.70 19.50 47.44 24.99 15.25 96.70 52.33 -61.01 101.40 51.27 -59.62 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 3 3 # 3 A 34 GLU B 57 GLU^? -5.29 CL CL B 129s A 260 ARG B 46 ARG^? 15.06 CL CL B 129 A 270 LYS B 43 LYS^? 9.52 CL CL B 129 coo 50.99 29.43 12.86 52.11 29.45 14.65 91.24 81.90 -79.46 91.48 82.48 -81.50 coo 39.80 27.50 22.98 42.20 26.56 21.34 87.96 72.13 -70.71 85.05 71.84 -69.78 coo 48.83 21.70 19.50 47.44 24.99 15.25 96.64 71.22 -80.00 101.30 72.05 -81.50 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 4 3 # 4 A 34 GLU B 57 GLU^? -5.29 CL CL B 129s A 260 ARG B 117 ARG^? 16.04 CL CL B 129 A 270 LYS B 43 LYS^? 9.52 CL CL B 129 coo 50.99 29.43 12.86 52.11 29.45 14.65 91.24 81.90 -79.46 91.48 82.48 -81.50 coo 39.80 27.50 22.98 42.20 26.56 21.34 100.63 75.34 -68.25 102.08 77.36 -66.41 coo 48.83 21.70 19.50 47.44 24.99 15.25 96.64 71.22 -80.00 101.30 72.05 -81.50 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 5 3 # 5 A 34 GLU C 57 GLU^? -5.48 CL CL C 129s A 260 ARG C 46 ARG^? 15.12 CL CL C 129 A 270 LYS C 43 LYS^? 9.54 CL CL C 129 coo 50.99 29.43 12.86 52.11 29.45 14.65 82.94 73.46 -26.00 82.34 73.25 -23.96 coo 39.80 27.50 22.98 42.20 26.56 21.34 92.47 76.70 -34.87 92.87 79.50 -36.04 coo 48.83 21.70 19.50 47.44 24.99 15.25 93.55 67.94 -25.84 92.76 63.12 -24.35 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 6 3 # 6 A 34 GLU C 57 GLU^? -5.48 CL CL C 129s A 260 ARG C 117 ARG^? 16.02 CL CL C 129 A 270 LYS C 43 LYS^? 9.54 CL CL C 129 coo 50.99 29.43 12.86 52.11 29.45 14.65 82.94 73.46 -26.00 82.34 73.25 -23.96 coo 39.80 27.50 22.98 42.20 26.56 21.34 89.36 64.01 -37.29 87.40 62.56 -39.24 coo 48.83 21.70 19.50 47.44 24.99 15.25 93.55 67.94 -25.84 92.76 63.12 -24.35 1euy_c00 source 1euy GLUTAMINYL-TRNA SYNTHETASE : 6 hits 1euy_c00 naa= 3 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 1 3 # 1 A 105 HIS A 40 HIS.? 7.30 CL CL A 129 C 62 LYS A 111 LYS^? 25.43 CL CL A 129 F 35 ASP A 41 ASP.? 7.60 CL CL A 129 coo 15.40 22.79 16.66 13.93 24.10 15.98 98.96 43.60 -66.18 98.11 41.92 -65.26 coo 19.95 18.98 4.81 18.82 20.94 10.49 105.91 53.60 -74.08 110.80 53.18 -78.24 coo 16.32 15.30 17.19 17.71 14.73 18.69 99.56 48.98 -63.34 100.43 49.52 -61.53 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 2 3 # 2 A 105 HIS B 40 HIS^? 7.04 CL CL B 129 C 62 LYS B 111 LYS^? 25.35 CL CL B 129 F 35 ASP B 41 ASP^? 7.64 CL CL B 129 coo 15.40 22.79 16.66 13.93 24.10 15.98 98.79 79.91 -74.95 97.97 81.53 -75.99 coo 19.95 18.98 4.81 18.82 20.94 10.49 105.89 69.85 -67.01 110.53 70.43 -62.59 coo 16.32 15.30 17.19 17.71 14.73 18.69 99.50 74.51 -77.69 100.41 73.95 -79.49 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 3 3 # 3 A 105 HIS C 40 HIS^? 7.21 CL CL C 129 C 62 LYS C 111 LYS^? 20.47 CL CL A 129 F 35 ASP C 41 ASP^? 7.58 CL CL C 129 coo 15.40 22.79 16.66 13.93 24.10 15.98 84.82 65.72 -30.75 83.18 66.51 -29.70 coo 19.95 18.98 4.81 18.82 20.94 10.49 94.84 58.73 -38.66 94.21 53.88 -42.04 coo 16.32 15.30 17.19 17.71 14.73 18.69 90.28 65.09 -27.98 90.77 64.12 -26.18 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 4 3 # 4 A 105 HIS D 40 HIS^? 7.31 CL CL D 129 C 62 LYS D 111 LYS^? 25.57 CL CL D 129 F 35 ASP D 41 ASP^? 7.55 CL CL D 129 coo 15.40 22.79 16.66 13.93 24.10 15.98 74.49 84.96 -30.93 76.13 84.16 -29.90 coo 19.95 18.98 4.81 18.82 20.94 10.49 64.48 91.99 -38.71 64.71 96.91 -42.99 coo 16.32 15.30 17.19 17.71 14.73 18.69 69.10 85.54 -28.07 68.60 86.44 -26.19 1f80_c03 source 1f80 ACYL CARRIER PROTEIN : 4 hits 1f80_c03 naa= 3 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 1 3 # 1 B 62 LYS A 111 LYS^? 25.43 CL CL A 129 C 105 HIS A 40 HIS.? 7.30 CL CL A 129 D 35 ASP A 41 ASP.? 7.60 CL CL A 129 coo 38.76 28.25 7.87 36.33 26.41 13.58 105.91 53.60 -74.08 110.80 53.18 -78.24 coo 34.93 19.72 17.37 34.72 18.17 15.98 98.96 43.60 -66.18 98.11 41.92 -65.26 coo 41.01 23.02 20.83 40.65 24.26 22.55 99.56 48.98 -63.34 100.43 49.52 -61.53 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 2 3 # 2 B 62 LYS B 111 LYS^? 25.35 CL CL B 129 C 105 HIS B 40 HIS^? 7.04 CL CL B 129 D 35 ASP B 41 ASP^? 7.64 CL CL B 129 coo 38.76 28.25 7.87 36.33 26.41 13.58 105.89 69.85 -67.01 110.53 70.43 -62.59 coo 34.93 19.72 17.37 34.72 18.17 15.98 98.79 79.91 -74.95 97.97 81.53 -75.99 coo 41.01 23.02 20.83 40.65 24.26 22.55 99.50 74.51 -77.69 100.41 73.95 -79.49 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 3 3 # 3 B 62 LYS C 111 LYS^? 20.47 CL CL A 129 C 105 HIS C 40 HIS^? 7.21 CL CL C 129 D 35 ASP C 41 ASP^? 7.58 CL CL C 129 coo 38.76 28.25 7.87 36.33 26.41 13.58 94.84 58.73 -38.66 94.21 53.88 -42.04 coo 34.93 19.72 17.37 34.72 18.17 15.98 84.82 65.72 -30.75 83.18 66.51 -29.70 coo 41.01 23.02 20.83 40.65 24.26 22.55 90.28 65.09 -27.98 90.77 64.12 -26.18 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 4 3 # 4 B 62 LYS D 111 LYS^? 25.57 CL CL D 129 C 105 HIS D 40 HIS^? 7.31 CL CL D 129 D 35 ASP D 41 ASP^? 7.55 CL CL D 129 coo 38.76 28.25 7.87 36.33 26.41 13.58 64.48 91.99 -38.71 64.71 96.91 -42.99 coo 34.93 19.72 17.37 34.72 18.17 15.98 74.49 84.96 -30.93 76.13 84.16 -29.90 coo 41.01 23.02 20.83 40.65 24.26 22.55 69.10 85.54 -28.07 68.60 86.44 -26.19 1f80_c04 source 1f80 ACYL CARRIER PROTEIN : 4 hits 1f80_c04 naa= 3 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 1 3 # 1 A 62 LYS A 111 LYS^? 25.43 CL CL A 129 B 105 HIS A 40 HIS.? 7.30 CL CL A 129 E 35 ASP A 41 ASP.? 7.60 CL CL A 129 coo 20.51 39.76 8.83 21.23 37.38 14.18 105.91 53.60 -74.08 110.80 53.18 -78.24 coo 27.18 37.56 20.68 29.07 38.28 20.13 98.96 43.60 -66.18 98.11 41.92 -65.26 coo 19.97 40.39 22.03 18.53 39.30 23.18 99.56 48.98 -63.34 100.43 49.52 -61.53 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 2 3 # 2 A 62 LYS B 111 LYS^? 25.35 CL CL B 129 B 105 HIS B 40 HIS^? 7.04 CL CL B 129 E 35 ASP B 41 ASP^? 7.64 CL CL B 129 coo 20.51 39.76 8.83 21.23 37.38 14.18 105.89 69.85 -67.01 110.53 70.43 -62.59 coo 27.18 37.56 20.68 29.07 38.28 20.13 98.79 79.91 -74.95 97.97 81.53 -75.99 coo 19.97 40.39 22.03 18.53 39.30 23.18 99.50 74.51 -77.69 100.41 73.95 -79.49 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 3 3 # 3 A 62 LYS C 111 LYS^? 20.47 CL CL A 129 B 105 HIS C 40 HIS^? 7.21 CL CL C 129 E 35 ASP C 41 ASP^? 7.58 CL CL C 129 coo 20.51 39.76 8.83 21.23 37.38 14.18 94.84 58.73 -38.66 94.21 53.88 -42.04 coo 27.18 37.56 20.68 29.07 38.28 20.13 84.82 65.72 -30.75 83.18 66.51 -29.70 coo 19.97 40.39 22.03 18.53 39.30 23.18 90.28 65.09 -27.98 90.77 64.12 -26.18 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 4 3 # 4 A 62 LYS D 111 LYS^? 25.57 CL CL D 129 B 105 HIS D 40 HIS^? 7.31 CL CL D 129 E 35 ASP D 41 ASP^? 7.55 CL CL D 129 coo 20.51 39.76 8.83 21.23 37.38 14.18 64.48 91.99 -38.71 64.71 96.91 -42.99 coo 27.18 37.56 20.68 29.07 38.28 20.13 74.49 84.96 -30.93 76.13 84.16 -29.90 coo 19.97 40.39 22.03 18.53 39.30 23.18 69.10 85.54 -28.07 68.60 86.44 -26.19 1f80_c05 source 1f80 ACYL CARRIER PROTEIN : 4 hits 1f80_c05 naa= 3 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 112 PHE A 38 PHE~? 11.90 CL CL A 129 A 210 ASP A 41 ASP.? 7.60 CL CL A 129 A 244 LYS A 111 LYS^? 25.43 CL CL A 129 coo 9.23 46.77 25.11 11.48 48.39 24.76 93.74 49.34 -71.31 91.91 51.35 -71.82 coo 10.51 37.86 19.71 9.07 39.38 20.04 99.56 48.98 -63.34 100.43 49.52 -61.53 coo -1.20 42.34 17.67 3.19 45.13 19.06 105.91 53.60 -74.08 110.80 53.18 -78.24 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 A 112 PHE B 38 PHE^? 11.74 CL CL B 129 A 210 ASP B 41 ASP^? 7.64 CL CL B 129 A 244 LYS B 111 LYS^? 25.35 CL CL B 129 coo 9.23 46.77 25.11 11.48 48.39 24.76 93.75 74.07 -69.88 91.89 72.11 -69.38 coo 10.51 37.86 19.71 9.07 39.38 20.04 99.50 74.51 -77.69 100.41 73.95 -79.49 coo -1.20 42.34 17.67 3.19 45.13 19.06 105.89 69.85 -67.01 110.53 70.43 -62.59 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 A 112 PHE C 38 PHE^? 11.87 CL CL C 129 A 210 ASP C 41 ASP^? 7.58 CL CL C 129 A 244 LYS C 111 LYS^? 20.47 CL CL A 129 coo 9.23 46.77 25.11 11.48 48.39 24.76 90.71 70.84 -35.90 92.71 72.72 -36.44 coo 10.51 37.86 19.71 9.07 39.38 20.04 90.28 65.09 -27.98 90.77 64.12 -26.18 coo -1.20 42.34 17.67 3.19 45.13 19.06 94.84 58.73 -38.66 94.21 53.88 -42.04 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 A 112 PHE D 38 PHE^? 11.82 CL CL D 129 A 210 ASP D 41 ASP^? 7.55 CL CL D 129 A 244 LYS D 111 LYS^? 25.57 CL CL D 129 coo 9.23 46.77 25.11 11.48 48.39 24.76 68.57 79.81 -35.85 66.58 77.94 -36.43 coo 10.51 37.86 19.71 9.07 39.38 20.04 69.10 85.54 -28.07 68.60 86.44 -26.19 coo -1.20 42.34 17.67 3.19 45.13 19.06 64.48 91.99 -38.71 64.71 96.91 -42.99 1fc4_c02 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 4 hits 1fc4_c02 naa= 3 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 112 PHE A 38 PHE~? 11.90 CL CL A 129 B 210 ASP A 41 ASP.? 7.60 CL CL A 129 B 244 LYS A 111 LYS^? 25.43 CL CL A 129 coo 8.76 47.85 34.91 11.08 46.36 35.41 93.74 49.34 -71.31 91.91 51.35 -71.82 coo 9.06 56.85 40.30 7.71 55.27 39.90 99.56 48.98 -63.34 100.43 49.52 -61.53 coo -2.38 51.82 41.62 2.07 49.19 40.42 105.91 53.60 -74.08 110.80 53.18 -78.24 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 B 112 PHE B 38 PHE^? 11.74 CL CL B 129 B 210 ASP B 41 ASP^? 7.64 CL CL B 129 B 244 LYS B 111 LYS^? 25.35 CL CL B 129 coo 8.76 47.85 34.91 11.08 46.36 35.41 93.75 74.07 -69.88 91.89 72.11 -69.38 coo 9.06 56.85 40.30 7.71 55.27 39.90 99.50 74.51 -77.69 100.41 73.95 -79.49 coo -2.38 51.82 41.62 2.07 49.19 40.42 105.89 69.85 -67.01 110.53 70.43 -62.59 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 B 112 PHE C 38 PHE^? 11.87 CL CL C 129 B 210 ASP C 41 ASP^? 7.58 CL CL C 129 B 244 LYS C 111 LYS^? 20.47 CL CL A 129 coo 8.76 47.85 34.91 11.08 46.36 35.41 90.71 70.84 -35.90 92.71 72.72 -36.44 coo 9.06 56.85 40.30 7.71 55.27 39.90 90.28 65.09 -27.98 90.77 64.12 -26.18 coo -2.38 51.82 41.62 2.07 49.19 40.42 94.84 58.73 -38.66 94.21 53.88 -42.04 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 B 112 PHE D 38 PHE^? 11.82 CL CL D 129 B 210 ASP D 41 ASP^? 7.55 CL CL D 129 B 244 LYS D 111 LYS^? 25.57 CL CL D 129 coo 8.76 47.85 34.91 11.08 46.36 35.41 68.57 79.81 -35.85 66.58 77.94 -36.43 coo 9.06 56.85 40.30 7.71 55.27 39.90 69.10 85.54 -28.07 68.60 86.44 -26.19 coo -2.38 51.82 41.62 2.07 49.19 40.42 64.48 91.99 -38.71 64.71 96.91 -42.99 1fc4_c03 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 4 hits 1fc4_c03 naa= 3 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 136 HIS A 40 HIS.? 7.30 CL CL A 129 A 210 ASP A 41 ASP.? 7.60 CL CL A 129 A 244 LYS A 111 LYS^? 25.43 CL CL A 129 coo 11.28 44.53 18.60 9.91 46.00 19.20 98.96 43.60 -66.18 98.11 41.92 -65.26 coo 10.51 37.86 19.71 9.07 39.38 20.04 99.56 48.98 -63.34 100.43 49.52 -61.53 coo -1.20 42.34 17.67 3.19 45.13 19.06 105.91 53.60 -74.08 110.80 53.18 -78.24 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 A 136 HIS B 40 HIS^? 7.04 CL CL B 129 A 210 ASP B 41 ASP^? 7.64 CL CL B 129 A 244 LYS B 111 LYS^? 25.35 CL CL B 129 coo 11.28 44.53 18.60 9.91 46.00 19.20 98.79 79.91 -74.95 97.97 81.53 -75.99 coo 10.51 37.86 19.71 9.07 39.38 20.04 99.50 74.51 -77.69 100.41 73.95 -79.49 coo -1.20 42.34 17.67 3.19 45.13 19.06 105.89 69.85 -67.01 110.53 70.43 -62.59 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 A 136 HIS C 40 HIS^? 7.21 CL CL C 129 A 210 ASP C 41 ASP^? 7.58 CL CL C 129 A 244 LYS C 111 LYS^? 20.47 CL CL A 129 coo 11.28 44.53 18.60 9.91 46.00 19.20 84.82 65.72 -30.75 83.18 66.51 -29.70 coo 10.51 37.86 19.71 9.07 39.38 20.04 90.28 65.09 -27.98 90.77 64.12 -26.18 coo -1.20 42.34 17.67 3.19 45.13 19.06 94.84 58.73 -38.66 94.21 53.88 -42.04 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 A 136 HIS D 40 HIS^? 7.31 CL CL D 129 A 210 ASP D 41 ASP^? 7.55 CL CL D 129 A 244 LYS D 111 LYS^? 25.57 CL CL D 129 coo 11.28 44.53 18.60 9.91 46.00 19.20 74.49 84.96 -30.93 76.13 84.16 -29.90 coo 10.51 37.86 19.71 9.07 39.38 20.04 69.10 85.54 -28.07 68.60 86.44 -26.19 coo -1.20 42.34 17.67 3.19 45.13 19.06 64.48 91.99 -38.71 64.71 96.91 -42.99 1fc4_c04 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 4 hits 1fc4_c04 naa= 3 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 136 HIS A 40 HIS.? 7.30 CL CL A 129 B 210 ASP A 41 ASP.? 7.60 CL CL A 129 B 244 LYS A 111 LYS^? 25.43 CL CL A 129 coo 10.08 50.18 41.78 8.91 48.61 41.04 98.96 43.60 -66.18 98.11 41.92 -65.26 coo 9.06 56.85 40.30 7.71 55.27 39.90 99.56 48.98 -63.34 100.43 49.52 -61.53 coo -2.38 51.82 41.62 2.07 49.19 40.42 105.91 53.60 -74.08 110.80 53.18 -78.24 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 B 136 HIS C 40 HIS^? 7.21 CL CL C 129 B 210 ASP C 41 ASP^? 7.58 CL CL C 129 B 244 LYS C 111 LYS^? 20.47 CL CL A 129 coo 10.08 50.18 41.78 8.91 48.61 41.04 84.82 65.72 -30.75 83.18 66.51 -29.70 coo 9.06 56.85 40.30 7.71 55.27 39.90 90.28 65.09 -27.98 90.77 64.12 -26.18 coo -2.38 51.82 41.62 2.07 49.19 40.42 94.84 58.73 -38.66 94.21 53.88 -42.04 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 B 136 HIS D 40 HIS^? 7.31 CL CL D 129 B 210 ASP D 41 ASP^? 7.55 CL CL D 129 B 244 LYS D 111 LYS^? 25.57 CL CL D 129 coo 10.08 50.18 41.78 8.91 48.61 41.04 74.49 84.96 -30.93 76.13 84.16 -29.90 coo 9.06 56.85 40.30 7.71 55.27 39.90 69.10 85.54 -28.07 68.60 86.44 -26.19 coo -2.38 51.82 41.62 2.07 49.19 40.42 64.48 91.99 -38.71 64.71 96.91 -42.99 1fc4_c05 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 3 hits 1fc4_c05 naa= 3 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 47 SER A 91 SER.? 14.42 CL CL B 129 A 48 THR A 92 THR.? 19.17 CL CL B 129 A 165 LYS B 43 LYS^? 9.52 CL CL B 129 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 91.69 62.31 -78.52 92.31 64.05 -76.96 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 88.80 61.61 -80.86 88.36 59.74 -81.92 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 96.64 71.22 -80.00 101.30 72.05 -81.50 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 A 47 SER B 91 SER^? 14.45 CL CL A 129 A 48 THR B 92 THR^? 18.96 CL CL A 129 A 165 LYS A 43 LYS.? 9.42 CL CL A 129 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 91.67 61.18 -62.59 92.49 59.52 -64.12 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 88.84 61.70 -60.19 88.43 63.62 -59.28 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 96.70 52.33 -61.01 101.40 51.27 -59.62 1fdy_c04 source 1fdy N-ACETYLNEURAMINATE LYASE : 2 hits 1fdy_c04 naa= 3 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 B 47 SER B 91 SER^? 14.45 CL CL A 129 B 48 THR B 92 THR^? 18.96 CL CL A 129 B 165 LYS A 43 LYS.? 9.42 CL CL A 129 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 91.67 61.18 -62.59 92.49 59.52 -64.12 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 88.84 61.70 -60.19 88.43 63.62 -59.28 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 96.70 52.33 -61.01 101.40 51.27 -59.62 1fdy_c05 source 1fdy N-ACETYLNEURAMINATE LYASE : 1 hits 1fdy_c05 naa= 3 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 C 47 SER A 91 SER.? 14.42 CL CL B 129 C 48 THR A 92 THR.? 19.17 CL CL B 129 C 165 LYS B 43 LYS^? 9.52 CL CL B 129 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 91.69 62.31 -78.52 92.31 64.05 -76.96 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 88.80 61.61 -80.86 88.36 59.74 -81.92 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 96.64 71.22 -80.00 101.30 72.05 -81.50 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 C 47 SER B 91 SER^? 14.45 CL CL A 129 C 48 THR B 92 THR^? 18.96 CL CL A 129 C 165 LYS A 43 LYS.? 9.42 CL CL A 129 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 91.67 61.18 -62.59 92.49 59.52 -64.12 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 88.84 61.70 -60.19 88.43 63.62 -59.28 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 96.70 52.33 -61.01 101.40 51.27 -59.62 1fdy_c06 source 1fdy N-ACETYLNEURAMINATE LYASE : 2 hits 1fdy_c06 naa= 3 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 1 3 # 1 A 45 ARG A 60 ARG~? 8.61 CL CL A 129 A 136 GLU A 58 GLU~? 7.41 CL CL A 129 A 246 GLU A 57 GLU~? -5.56 CL CL A 129s coo 13.48 30.30 107.06 11.75 30.99 109.44 92.49 41.37 -66.87 95.11 39.81 -67.06 coo 9.46 32.37 115.82 8.50 34.20 115.47 87.85 46.74 -60.89 87.27 48.56 -59.93 coo 11.99 34.33 109.92 10.08 34.19 110.77 91.25 41.69 -61.23 91.08 41.09 -59.17 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 2 3 # 2 A 45 ARG B 60 ARG^? 8.76 CL CL B 129 A 136 GLU B 58 GLU^? 7.34 CL CL B 129 A 246 GLU B 57 GLU^? -5.29 CL CL B 129s coo 13.48 30.30 107.06 11.75 30.99 109.44 92.45 82.18 -73.93 95.13 83.66 -73.65 coo 9.46 32.37 115.82 8.50 34.20 115.47 87.90 76.66 -80.19 87.42 74.86 -81.30 coo 11.99 34.33 109.92 10.08 34.19 110.77 91.24 81.90 -79.46 91.48 82.48 -81.50 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 3 3 # 3 A 45 ARG C 60 ARG^? 8.92 CL CL C 129 A 136 GLU C 58 GLU^? 7.49 CL CL C 129 A 246 GLU C 57 GLU^? -5.48 CL CL C 129s coo 13.48 30.30 107.06 11.75 30.99 109.44 82.52 72.20 -31.52 80.97 69.57 -31.97 coo 9.46 32.37 115.82 8.50 34.20 115.47 88.02 76.82 -25.55 89.85 77.43 -24.60 coo 11.99 34.33 109.92 10.08 34.19 110.77 82.94 73.46 -26.00 82.34 73.25 -23.96 1fhl_c00 source 1fhl BETA-1,4-GALACTANASE : 3 hits 1fhl_c00 naa= 3 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 1 3 # 1 A 45 ARG A 60 ARG~? 8.61 CL CL A 129 A 136 GLU A 58 GLU~? 7.41 CL CL A 129 A 246 GLU A 57 GLU~? -5.56 CL CL A 129s coo 13.94 29.84 106.80 11.67 30.40 108.79 92.49 41.37 -66.87 95.11 39.81 -67.06 coo 9.52 31.97 115.23 8.45 33.74 114.72 87.85 46.74 -60.89 87.27 48.56 -59.93 coo 11.92 33.82 109.35 10.10 33.50 110.39 91.25 41.69 -61.23 91.08 41.09 -59.17 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 2 3 # 2 A 45 ARG B 60 ARG^? 8.76 CL CL B 129 A 136 GLU B 58 GLU^? 7.34 CL CL B 129 A 246 GLU B 57 GLU^? -5.29 CL CL B 129s coo 13.94 29.84 106.80 11.67 30.40 108.79 92.45 82.18 -73.93 95.13 83.66 -73.65 coo 9.52 31.97 115.23 8.45 33.74 114.72 87.90 76.66 -80.19 87.42 74.86 -81.30 coo 11.92 33.82 109.35 10.10 33.50 110.39 91.24 81.90 -79.46 91.48 82.48 -81.50 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 3 3 # 3 A 45 ARG C 60 ARG^? 8.92 CL CL C 129 A 136 GLU C 58 GLU^? 7.49 CL CL C 129 A 246 GLU C 57 GLU^? -5.48 CL CL C 129s coo 13.94 29.84 106.80 11.67 30.40 108.79 82.52 72.20 -31.52 80.97 69.57 -31.97 coo 9.52 31.97 115.23 8.45 33.74 114.72 88.02 76.82 -25.55 89.85 77.43 -24.60 coo 11.92 33.82 109.35 10.10 33.50 110.39 82.94 73.46 -26.00 82.34 73.25 -23.96 1fob_c00 source 1fob BETA-1,4-GALACTANASE : 3 hits 1fob_c00 naa= 3 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 1 3 # 1 A 317 GLU A 23 GLU~? 24.22 CL CL A 129 A 319 ASP A 72 ASP.? 29.77 CL CL A 129 A 359 ARG A 96 ARG.? 24.34 CL CL A 129 coo 14.41 12.40 16.42 12.92 13.74 15.71 89.42 52.54 -84.47 88.08 53.22 -82.95 coo 12.25 13.04 23.85 11.56 15.02 23.93 81.04 48.95 -86.11 82.18 49.75 -87.74 coo 10.89 14.95 28.28 12.39 12.53 29.31 78.03 52.93 -81.60 80.41 52.60 -79.67 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 2 3 # 2 A 317 GLU A 36 GLU~? 18.47 CL CL A 129 A 319 ASP A 35 ASP~? 10.31 CL CL A 129 A 359 ARG A 60 ARG~? 8.61 CL CL A 129 coo 14.41 12.40 16.42 12.92 13.74 15.71 99.16 43.45 -76.17 99.38 43.10 -78.24 coo 12.25 13.04 23.85 11.56 15.02 23.93 93.79 42.35 -72.20 94.79 41.97 -70.38 coo 10.89 14.95 28.28 12.39 12.53 29.31 92.49 41.37 -66.87 95.11 39.81 -67.06 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 3 3 # 3 A 317 GLU A 36 GLU~? 18.47 CL CL A 129 A 319 ASP A 35 ASP~? 10.31 CL CL A 129 A 359 ARG A 63 ARG~? 13.95 CL CL A 129 coo 14.41 12.40 16.42 12.92 13.74 15.71 99.16 43.45 -76.17 99.38 43.10 -78.24 coo 12.25 13.04 23.85 11.56 15.02 23.93 93.79 42.35 -72.20 94.79 41.97 -70.38 coo 10.89 14.95 28.28 12.39 12.53 29.31 87.85 45.63 -72.60 88.58 48.58 -73.24 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 4 3 # 4 A 317 GLU B 23 GLU^? 24.68 CL CL B 129 A 319 ASP B 72 ASP^? 28.57 CL CL C 129 A 359 ARG B 96 ARG^? 24.18 CL CL B 129 coo 14.41 12.40 16.42 12.92 13.74 15.71 89.49 70.79 -56.44 87.96 70.01 -57.68 coo 12.25 13.04 23.85 11.56 15.02 23.93 80.87 74.36 -54.99 81.74 73.36 -53.35 coo 10.89 14.95 28.28 12.39 12.53 29.31 78.35 70.58 -59.29 80.55 70.83 -61.45 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 5 3 # 5 A 317 GLU B 36 GLU^? 18.40 CL CL B 129 A 319 ASP B 35 ASP^? 10.19 CL CL B 129 A 359 ARG B 60 ARG^? 8.76 CL CL B 129 coo 14.41 12.40 16.42 12.92 13.74 15.71 99.20 79.77 -64.83 99.58 80.60 -62.91 coo 12.25 13.04 23.85 11.56 15.02 23.93 93.79 80.98 -68.72 94.61 81.32 -70.62 coo 10.89 14.95 28.28 12.39 12.53 29.31 92.45 82.18 -73.93 95.13 83.66 -73.65 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 6 3 # 6 A 317 GLU B 36 GLU^? 18.40 CL CL B 129 A 319 ASP B 35 ASP^? 10.19 CL CL B 129 A 359 ARG B 63 ARG^? 13.99 CL CL B 129 coo 14.41 12.40 16.42 12.92 13.74 15.71 99.20 79.77 -64.83 99.58 80.60 -62.91 coo 12.25 13.04 23.85 11.56 15.02 23.93 93.79 80.98 -68.72 94.61 81.32 -70.62 coo 10.89 14.95 28.28 12.39 12.53 29.31 87.72 77.76 -68.29 88.60 74.86 -67.71 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 7 3 # 7 A 317 GLU C 23 GLU^? 24.69 CL CL C 129 A 319 ASP C 72 ASP^? 28.53 CL CL B 129 A 359 ARG C 96 ARG^? 24.31 CL CL C 129 coo 14.41 12.40 16.42 12.92 13.74 15.71 93.85 75.25 -49.20 94.57 76.88 -48.00 coo 12.25 13.04 23.85 11.56 15.02 23.93 90.38 83.76 -50.64 91.24 82.68 -52.23 coo 10.89 14.95 28.28 12.39 12.53 29.31 94.28 86.51 -46.29 94.08 84.26 -44.17 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 8 3 # 8 A 317 GLU C 36 GLU^? 18.27 CL CL C 129 A 319 ASP C 35 ASP^? 10.26 CL CL C 129 A 359 ARG C 60 ARG^? 8.92 CL CL C 129 coo 14.41 12.40 16.42 12.92 13.74 15.71 84.85 65.27 -40.53 84.47 64.86 -42.56 coo 12.25 13.04 23.85 11.56 15.02 23.93 83.63 70.73 -36.85 83.32 69.81 -34.96 coo 10.89 14.95 28.28 12.39 12.53 29.31 82.52 72.20 -31.52 80.97 69.57 -31.97 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 9 3 # 9 A 317 GLU D 23 GLU^? 24.49 CL CL D 129 A 319 ASP D 72 ASP^? 29.64 CL CL D 129 A 359 ARG D 96 ARG^? 24.04 CL CL D 129 coo 14.41 12.40 16.42 12.92 13.74 15.71 65.41 75.40 -49.12 64.81 73.78 -47.86 coo 12.25 13.04 23.85 11.56 15.02 23.93 69.04 67.18 -50.81 68.23 68.38 -52.37 coo 10.89 14.95 28.28 12.39 12.53 29.31 64.79 64.44 -46.28 65.73 66.42 -44.08 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 10 3 # 10 A 317 GLU D 36 GLU^? 18.42 CL CL D 129 A 319 ASP D 35 ASP^? 10.18 CL CL D 129 A 359 ARG D 60 ARG^? 8.57 CL CL D 129 coo 14.41 12.40 16.42 12.92 13.74 15.71 74.52 85.40 -40.74 74.64 85.74 -42.81 coo 12.25 13.04 23.85 11.56 15.02 23.93 75.66 79.96 -36.93 75.99 80.66 -34.97 coo 10.89 14.95 28.28 12.39 12.53 29.31 76.65 78.50 -31.75 78.13 81.14 -31.78 1fr8_c00 source 1fr8 BETA 1,4 GALACTOSYLTRANSFERASE : 10 hits 1fr8_c00 naa= 3 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 1 3 # 1 B 317 GLU A 23 GLU~? 24.22 CL CL A 129 B 319 ASP A 72 ASP.? 29.77 CL CL A 129 B 359 ARG A 96 ARG.? 24.34 CL CL A 129 coo 10.77 13.13 40.94 11.03 14.73 39.51 89.42 52.54 -84.47 88.08 53.22 -82.95 coo 3.77 12.64 38.21 3.35 14.53 37.39 81.04 48.95 -86.11 82.18 49.75 -87.74 coo -1.16 15.32 35.60 -3.32 13.56 36.98 78.03 52.93 -81.60 80.41 52.60 -79.67 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 2 3 # 2 B 317 GLU A 36 GLU~? 18.47 CL CL A 129 B 319 ASP A 35 ASP~? 10.31 CL CL A 129 B 359 ARG A 60 ARG~? 8.61 CL CL A 129 coo 10.77 13.13 40.94 11.03 14.73 39.51 99.16 43.45 -76.17 99.38 43.10 -78.24 coo 3.77 12.64 38.21 3.35 14.53 37.39 93.79 42.35 -72.20 94.79 41.97 -70.38 coo -1.16 15.32 35.60 -3.32 13.56 36.98 92.49 41.37 -66.87 95.11 39.81 -67.06 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 3 3 # 3 B 317 GLU A 36 GLU~? 18.47 CL CL A 129 B 319 ASP A 35 ASP~? 10.31 CL CL A 129 B 359 ARG A 63 ARG~? 13.95 CL CL A 129 coo 10.77 13.13 40.94 11.03 14.73 39.51 99.16 43.45 -76.17 99.38 43.10 -78.24 coo 3.77 12.64 38.21 3.35 14.53 37.39 93.79 42.35 -72.20 94.79 41.97 -70.38 coo -1.16 15.32 35.60 -3.32 13.56 36.98 87.85 45.63 -72.60 88.58 48.58 -73.24 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 4 3 # 4 B 317 GLU B 23 GLU^? 24.68 CL CL B 129 B 319 ASP B 72 ASP^? 28.57 CL CL C 129 B 359 ARG B 96 ARG^? 24.18 CL CL B 129 coo 10.77 13.13 40.94 11.03 14.73 39.51 89.49 70.79 -56.44 87.96 70.01 -57.68 coo 3.77 12.64 38.21 3.35 14.53 37.39 80.87 74.36 -54.99 81.74 73.36 -53.35 coo -1.16 15.32 35.60 -3.32 13.56 36.98 78.35 70.58 -59.29 80.55 70.83 -61.45 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 5 3 # 5 B 317 GLU B 36 GLU^? 18.40 CL CL B 129 B 319 ASP B 35 ASP^? 10.19 CL CL B 129 B 359 ARG B 60 ARG^? 8.76 CL CL B 129 coo 10.77 13.13 40.94 11.03 14.73 39.51 99.20 79.77 -64.83 99.58 80.60 -62.91 coo 3.77 12.64 38.21 3.35 14.53 37.39 93.79 80.98 -68.72 94.61 81.32 -70.62 coo -1.16 15.32 35.60 -3.32 13.56 36.98 92.45 82.18 -73.93 95.13 83.66 -73.65 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 6 3 # 6 B 317 GLU B 36 GLU^? 18.40 CL CL B 129 B 319 ASP B 35 ASP^? 10.19 CL CL B 129 B 359 ARG B 63 ARG^? 13.99 CL CL B 129 coo 10.77 13.13 40.94 11.03 14.73 39.51 99.20 79.77 -64.83 99.58 80.60 -62.91 coo 3.77 12.64 38.21 3.35 14.53 37.39 93.79 80.98 -68.72 94.61 81.32 -70.62 coo -1.16 15.32 35.60 -3.32 13.56 36.98 87.72 77.76 -68.29 88.60 74.86 -67.71 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 7 3 # 7 B 317 GLU C 23 GLU^? 24.69 CL CL C 129 B 319 ASP C 72 ASP^? 28.53 CL CL B 129 B 359 ARG C 96 ARG^? 24.31 CL CL C 129 coo 10.77 13.13 40.94 11.03 14.73 39.51 93.85 75.25 -49.20 94.57 76.88 -48.00 coo 3.77 12.64 38.21 3.35 14.53 37.39 90.38 83.76 -50.64 91.24 82.68 -52.23 coo -1.16 15.32 35.60 -3.32 13.56 36.98 94.28 86.51 -46.29 94.08 84.26 -44.17 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 8 3 # 8 B 317 GLU C 36 GLU^? 18.27 CL CL C 129 B 319 ASP C 35 ASP^? 10.26 CL CL C 129 B 359 ARG C 60 ARG^? 8.92 CL CL C 129 coo 10.77 13.13 40.94 11.03 14.73 39.51 84.85 65.27 -40.53 84.47 64.86 -42.56 coo 3.77 12.64 38.21 3.35 14.53 37.39 83.63 70.73 -36.85 83.32 69.81 -34.96 coo -1.16 15.32 35.60 -3.32 13.56 36.98 82.52 72.20 -31.52 80.97 69.57 -31.97 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 9 3 # 9 B 317 GLU C 36 GLU^? 18.27 CL CL C 129 B 319 ASP C 35 ASP^? 10.26 CL CL C 129 B 359 ARG C 63 ARG^? 14.10 CL CL C 129 coo 10.77 13.13 40.94 11.03 14.73 39.51 84.85 65.27 -40.53 84.47 64.86 -42.56 coo 3.77 12.64 38.21 3.35 14.53 37.39 83.63 70.73 -36.85 83.32 69.81 -34.96 coo -1.16 15.32 35.60 -3.32 13.56 36.98 86.96 77.03 -37.50 89.89 76.13 -38.00 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 10 3 # 10 B 317 GLU D 23 GLU^? 24.49 CL CL D 129 B 319 ASP D 72 ASP^? 29.64 CL CL D 129 B 359 ARG D 96 ARG^? 24.04 CL CL D 129 coo 10.77 13.13 40.94 11.03 14.73 39.51 65.41 75.40 -49.12 64.81 73.78 -47.86 coo 3.77 12.64 38.21 3.35 14.53 37.39 69.04 67.18 -50.81 68.23 68.38 -52.37 coo -1.16 15.32 35.60 -3.32 13.56 36.98 64.79 64.44 -46.28 65.73 66.42 -44.08 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 11 3 # 11 B 317 GLU D 36 GLU^? 18.42 CL CL D 129 B 319 ASP D 35 ASP^? 10.18 CL CL D 129 B 359 ARG D 60 ARG^? 8.57 CL CL D 129 coo 10.77 13.13 40.94 11.03 14.73 39.51 74.52 85.40 -40.74 74.64 85.74 -42.81 coo 3.77 12.64 38.21 3.35 14.53 37.39 75.66 79.96 -36.93 75.99 80.66 -34.97 coo -1.16 15.32 35.60 -3.32 13.56 36.98 76.65 78.50 -31.75 78.13 81.14 -31.78 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 12 3 # 12 B 317 GLU D 36 GLU^? 18.42 CL CL D 129 B 319 ASP D 35 ASP^? 10.18 CL CL D 129 B 359 ARG D 63 ARG^? 14.07 CL CL D 129 coo 10.77 13.13 40.94 11.03 14.73 39.51 74.52 85.40 -40.74 74.64 85.74 -42.81 coo 3.77 12.64 38.21 3.35 14.53 37.39 75.66 79.96 -36.93 75.99 80.66 -34.97 coo -1.16 15.32 35.60 -3.32 13.56 36.98 72.33 73.68 -37.44 69.36 74.46 -37.99 1fr8_c01 source 1fr8 BETA 1,4 GALACTOSYLTRANSFERASE : 12 hits 1fr8_c01 naa= 3 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 1 3 # 1 A 314 TRP A 39 TRP.? 10.30 CL CL A 129 A 317 GLU A 114 GLU^? 14.59 CL CL A 129 A 365 ARG A 60 ARG~? 8.61 CL CL A 129 coo 79.91 26.87 38.77 78.95 23.18 37.81 101.24 49.64 -67.32 101.01 52.25 -64.41 coo 85.55 26.30 41.25 85.59 24.97 39.65 104.53 45.97 -71.95 105.17 46.78 -70.05 coo 83.47 25.30 27.10 83.44 27.82 25.29 92.49 41.37 -66.87 95.11 39.81 -67.06 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 2 3 # 2 A 314 TRP B 39 TRP^? 10.25 CL CL B 129 A 317 GLU B 114 GLU^? 14.94 CL CL B 129 A 365 ARG B 60 ARG^? 8.76 CL CL B 129 coo 79.91 26.87 38.77 78.95 23.18 37.81 101.26 73.91 -73.75 100.85 71.27 -76.60 coo 85.55 26.30 41.25 85.59 24.97 39.65 104.70 77.68 -68.99 105.48 76.80 -70.78 coo 83.47 25.30 27.10 83.44 27.82 25.29 92.45 82.18 -73.93 95.13 83.66 -73.65 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 3 3 # 3 A 314 TRP C 39 TRP^? 10.27 CL CL C 129 A 317 GLU C 114 GLU^? 14.88 CL CL C 129 A 365 ARG C 60 ARG^? 8.92 CL CL C 129 coo 79.91 26.87 38.77 78.95 23.18 37.81 90.84 63.27 -31.89 93.54 63.54 -29.07 coo 85.55 26.30 41.25 85.59 24.97 39.65 87.05 59.85 -36.57 87.99 59.11 -34.78 coo 83.47 25.30 27.10 83.44 27.82 25.29 82.52 72.20 -31.52 80.97 69.57 -31.97 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 4 3 # 4 A 314 TRP D 39 TRP^? 10.24 CL CL D 129 A 317 GLU D 114 GLU^? 14.88 CL CL D 129 A 365 ARG D 60 ARG^? 8.57 CL CL D 129 coo 79.91 26.87 38.77 78.95 23.18 37.81 68.34 87.24 -31.98 65.78 86.93 -29.01 coo 85.55 26.30 41.25 85.59 24.97 39.65 72.08 90.81 -36.72 71.29 91.48 -34.84 coo 83.47 25.30 27.10 83.44 27.82 25.29 76.65 78.50 -31.75 78.13 81.14 -31.78 1g8o_c01 source 1g8o N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALACTOSYLTRA: 4 hits 1g8o_c01 naa= 3 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 A 36 GLU A 58 GLU~? 7.41 CL CL A 129 A 47 ASP A 41 ASP.? 7.60 CL CL A 129 A 161 TYR A 54 TYR^? 10.29 CL CL A 129 coo 37.12 18.35 73.76 37.09 16.69 72.44 87.85 46.74 -60.89 87.27 48.56 -59.93 coo 29.81 8.06 73.13 30.21 10.11 72.95 99.56 48.98 -63.34 100.43 49.52 -61.53 coo 37.29 15.56 67.90 37.37 13.79 70.08 89.27 53.06 -59.98 88.13 55.63 -59.94 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 2 3 # 2 A 36 GLU B 58 GLU^? 7.34 CL CL B 129 A 47 ASP B 41 ASP^? 7.64 CL CL B 129 A 161 TYR B 54 TYR^? 10.36 CL CL B 129 coo 37.12 18.35 73.76 37.09 16.69 72.44 87.90 76.66 -80.19 87.42 74.86 -81.30 coo 29.81 8.06 73.13 30.21 10.11 72.95 99.50 74.51 -77.69 100.41 73.95 -79.49 coo 37.29 15.56 67.90 37.37 13.79 70.08 89.19 70.43 -81.07 88.03 67.93 -81.20 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 3 3 # 3 A 36 GLU C 58 GLU^? 7.49 CL CL C 129 A 47 ASP C 41 ASP^? 7.58 CL CL C 129 A 161 TYR C 54 TYR^? 10.32 CL CL C 129 coo 37.12 18.35 73.76 37.09 16.69 72.44 88.02 76.82 -25.55 89.85 77.43 -24.60 coo 29.81 8.06 73.13 30.21 10.11 72.95 90.28 65.09 -27.98 90.77 64.12 -26.18 coo 37.29 15.56 67.90 37.37 13.79 70.08 94.43 75.36 -24.67 96.94 76.58 -24.67 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 4 3 # 4 A 36 GLU D 58 GLU^? 7.39 CL CL D 129 A 47 ASP D 41 ASP^? 7.55 CL CL D 129 A 161 TYR D 54 TYR^? 10.35 CL CL D 129 coo 37.12 18.35 73.76 37.09 16.69 72.44 71.21 74.03 -25.57 69.46 73.32 -24.61 coo 29.81 8.06 73.13 30.21 10.11 72.95 69.10 85.54 -28.07 68.60 86.44 -26.19 coo 37.29 15.56 67.90 37.37 13.79 70.08 64.95 75.15 -24.65 62.40 74.09 -24.68 1geq_c02 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 4 hits 1geq_c02 naa= 3 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 B 36 GLU A 58 GLU~? 7.41 CL CL A 129 B 47 ASP A 41 ASP.? 7.60 CL CL A 129 B 161 TYR A 54 TYR^? 10.29 CL CL A 129 coo 53.87 35.49 53.22 55.44 35.72 54.61 87.85 46.74 -60.89 87.27 48.56 -59.93 coo 63.47 43.65 53.95 61.45 43.07 54.06 99.56 48.98 -63.34 100.43 49.52 -61.53 coo 56.38 35.81 59.19 58.25 35.77 57.10 89.27 53.06 -59.98 88.13 55.63 -59.94 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 2 3 # 2 B 36 GLU B 58 GLU^? 7.34 CL CL B 129 B 47 ASP B 41 ASP^? 7.64 CL CL B 129 B 161 TYR B 54 TYR^? 10.36 CL CL B 129 coo 53.87 35.49 53.22 55.44 35.72 54.61 87.90 76.66 -80.19 87.42 74.86 -81.30 coo 63.47 43.65 53.95 61.45 43.07 54.06 99.50 74.51 -77.69 100.41 73.95 -79.49 coo 56.38 35.81 59.19 58.25 35.77 57.10 89.19 70.43 -81.07 88.03 67.93 -81.20 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 3 3 # 3 B 36 GLU C 58 GLU^? 7.49 CL CL C 129 B 47 ASP C 41 ASP^? 7.58 CL CL C 129 B 161 TYR C 54 TYR^? 10.32 CL CL C 129 coo 53.87 35.49 53.22 55.44 35.72 54.61 88.02 76.82 -25.55 89.85 77.43 -24.60 coo 63.47 43.65 53.95 61.45 43.07 54.06 90.28 65.09 -27.98 90.77 64.12 -26.18 coo 56.38 35.81 59.19 58.25 35.77 57.10 94.43 75.36 -24.67 96.94 76.58 -24.67 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 4 3 # 4 B 36 GLU D 58 GLU^? 7.39 CL CL D 129 B 47 ASP D 41 ASP^? 7.55 CL CL D 129 B 161 TYR D 54 TYR^? 10.35 CL CL D 129 coo 53.87 35.49 53.22 55.44 35.72 54.61 71.21 74.03 -25.57 69.46 73.32 -24.61 coo 63.47 43.65 53.95 61.45 43.07 54.06 69.10 85.54 -28.07 68.60 86.44 -26.19 coo 56.38 35.81 59.19 58.25 35.77 57.10 64.95 75.15 -24.65 62.40 74.09 -24.68 1geq_c03 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 4 hits 1geq_c03 naa= 3 ULMN 3 1gns_c00 SUBTILISIN BPN' user 1 3 # 1 A 32 ASP A 86 ASP.? 23.33 CL CL A 129 A 64 HIS A 85 HIS.? 26.94 CL CL B 129 A 155 ASN A 7 ASN.? 14.61 CL CL B 129 coo 3.12 38.70 24.20 3.24 38.59 26.33 108.46 57.22 -73.78 109.48 58.49 -72.45 coo 1.90 38.00 29.77 3.91 38.35 29.95 112.09 59.31 -75.65 113.04 59.28 -73.77 coo 9.89 36.55 37.38 9.27 37.99 36.08 104.28 66.29 -83.02 102.35 66.19 -82.19 ULMN 3 1gns_c00 SUBTILISIN BPN' user 2 3 # 2 A 32 ASP B 86 ASP^? 23.14 CL CL B 129 A 64 HIS B 85 HIS^? 26.88 CL CL A 129 A 155 ASN B 7 ASN^? 14.42 CL CL A 129 coo 3.12 38.70 24.20 3.24 38.59 26.33 108.40 66.17 -67.38 109.32 64.97 -68.84 coo 1.90 38.00 29.77 3.91 38.35 29.95 111.98 64.21 -65.30 113.02 64.33 -67.11 coo 9.89 36.55 37.38 9.27 37.99 36.08 104.35 57.09 -58.15 102.38 57.14 -58.88 ULMN 3 1gns_c00 SUBTILISIN BPN' user 3 3 # 3 A 32 ASP C 86 ASP^? 23.12 CL CL C 129 A 64 HIS C 85 HIS^? 23.16 CL CL A 129 A 155 ASN C 7 ASN^? 25.55 CL CL A 129 coo 3.12 38.70 24.20 3.24 38.59 26.33 98.39 56.19 -38.35 99.60 55.15 -36.99 coo 1.90 38.00 29.77 3.91 38.35 29.95 100.49 52.59 -40.39 100.40 51.57 -38.55 coo 9.89 36.55 37.38 9.27 37.99 36.08 107.62 60.23 -47.60 107.55 62.23 -46.92 ULMN 3 1gns_c00 SUBTILISIN BPN' user 4 3 # 4 A 32 ASP D 86 ASP^? 23.19 CL CL D 129 A 64 HIS D 85 HIS^? 27.00 CL CL D 129 A 155 ASN D 7 ASN^? 30.85 CL CL D 129 coo 3.12 38.70 24.20 3.24 38.59 26.33 60.79 94.39 -38.32 59.49 95.38 -36.98 coo 1.90 38.00 29.77 3.91 38.35 29.95 58.77 98.13 -40.30 58.69 99.11 -38.44 coo 9.89 36.55 37.38 9.27 37.99 36.08 51.70 90.24 -47.62 51.84 88.27 -46.84 1gns_c00 source 1gns SUBTILISIN BPN' : 4 hits 1gns_c00 naa= 3 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 1 3 # 1 160 LYS A 111 LYS^? 25.43 CL CL A 129 210 ARG A 63 ARG~? 13.95 CL CL A 129 225 ARG A 46 ARG^? 15.11 CL CL A 129 coo 17.51 28.50 73.42 17.24 23.02 75.86 105.91 53.60 -74.08 110.80 53.18 -78.24 coo 24.74 11.56 73.05 25.29 14.32 71.80 87.85 45.63 -72.60 88.58 48.58 -73.24 coo 27.81 15.44 77.10 25.66 16.50 75.19 87.96 51.20 -70.32 85.08 51.60 -71.34 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 2 3 # 2 160 LYS B 24 LYS^? 27.82 CL CL B 129 210 ARG C 63 ARG^? 14.10 CL CL C 129 225 ARG C 66 ARG^? 18.88 CL CL C 129 coo 17.51 28.50 73.42 17.24 23.02 75.86 90.54 75.59 -56.27 92.78 80.12 -52.52 coo 24.74 11.56 73.05 25.29 14.32 71.80 86.96 77.03 -37.50 89.89 76.13 -38.00 coo 27.81 15.44 77.10 25.66 16.50 75.19 88.18 82.59 -38.84 90.98 81.94 -39.92 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 3 3 # 3 160 LYS B 111 LYS^? 25.35 CL CL B 129 210 ARG B 63 ARG^? 13.99 CL CL B 129 225 ARG B 46 ARG^? 15.06 CL CL B 129 coo 17.51 28.50 73.42 17.24 23.02 75.86 105.89 69.85 -67.01 110.53 70.43 -62.59 coo 24.74 11.56 73.05 25.29 14.32 71.80 87.72 77.76 -68.29 88.60 74.86 -67.71 coo 27.81 15.44 77.10 25.66 16.50 75.19 87.96 72.13 -70.71 85.05 71.84 -69.78 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 4 3 # 4 160 LYS C 24 LYS^? 26.64 CL CL C 129 210 ARG B 63 ARG^? 13.99 CL CL B 129 225 ARG B 66 ARG^? 19.13 CL CL B 129 coo 17.51 28.50 73.42 17.24 23.02 75.86 88.99 74.10 -49.29 84.03 71.99 -51.83 coo 24.74 11.56 73.05 25.29 14.32 71.80 87.72 77.76 -68.29 88.60 74.86 -67.71 coo 27.81 15.44 77.10 25.66 16.50 75.19 82.06 76.49 -66.55 82.68 73.67 -65.41 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 5 3 # 5 160 LYS C 43 LYS^? 9.54 CL CL C 129 210 ARG C 66 ARG^? 18.88 CL CL C 129 225 ARG C 63 ARG^? 14.10 CL CL C 129 coo 17.51 28.50 73.42 17.24 23.02 75.86 93.55 67.94 -25.84 92.76 63.12 -24.35 coo 24.74 11.56 73.05 25.29 14.32 71.80 88.18 82.59 -38.84 90.98 81.94 -39.92 coo 27.81 15.44 77.10 25.66 16.50 75.19 86.96 77.03 -37.50 89.89 76.13 -38.00 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 6 3 # 6 160 LYS C 111 LYS^? 20.47 CL CL A 129 210 ARG C 63 ARG^? 14.10 CL CL C 129 225 ARG C 46 ARG^? 15.12 CL CL C 129 coo 17.51 28.50 73.42 17.24 23.02 75.86 94.84 58.73 -38.66 94.21 53.88 -42.04 coo 24.74 11.56 73.05 25.29 14.32 71.80 86.96 77.03 -37.50 89.89 76.13 -38.00 coo 27.81 15.44 77.10 25.66 16.50 75.19 92.47 76.70 -34.87 92.87 79.50 -36.04 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 7 3 # 7 160 LYS D 43 LYS^? 9.72 CL CL D 129 210 ARG D 66 ARG^? 18.85 CL CL D 129 225 ARG D 63 ARG^? 14.07 CL CL D 129 coo 17.51 28.50 73.42 17.24 23.02 75.86 65.85 82.66 -25.79 66.37 87.54 -24.61 coo 24.74 11.56 73.05 25.29 14.32 71.80 71.05 68.08 -38.82 68.22 68.66 -39.87 coo 27.81 15.44 77.10 25.66 16.50 75.19 72.33 73.68 -37.44 69.36 74.46 -37.99 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 8 3 # 8 160 LYS D 111 LYS^? 25.57 CL CL D 129 210 ARG D 63 ARG^? 14.07 CL CL D 129 225 ARG D 46 ARG^? 15.13 CL CL D 129 coo 17.51 28.50 73.42 17.24 23.02 75.86 64.48 91.99 -38.71 64.71 96.91 -42.99 coo 24.74 11.56 73.05 25.29 14.32 71.80 72.33 73.68 -37.44 69.36 74.46 -37.99 coo 27.81 15.44 77.10 25.66 16.50 75.19 66.74 73.93 -35.00 66.45 71.02 -36.02 1gsa_c00 source 1gsa GLUTATHIONE SYNTHETASE : 8 hits 1gsa_c00 naa= 3 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 A 189 PHE A 38 PHE~? 11.90 CL CL A 129 A 298 ASP A 41 ASP.? 7.60 CL CL A 129 A 329 LYS A 111 LYS^? 25.43 CL CL A 129 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 93.74 49.34 -71.31 91.91 51.35 -71.82 coo 2.59 0.29 25.55 4.65 0.18 25.07 99.56 48.98 -63.34 100.43 49.52 -61.53 coo 12.42 6.10 23.27 9.95 1.57 20.16 105.91 53.60 -74.08 110.80 53.18 -78.24 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 A 189 PHE B 38 PHE^? 11.74 CL CL B 129 A 298 ASP B 41 ASP^? 7.64 CL CL B 129 A 329 LYS B 111 LYS^? 25.35 CL CL B 129 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 93.75 74.07 -69.88 91.89 72.11 -69.38 coo 2.59 0.29 25.55 4.65 0.18 25.07 99.50 74.51 -77.69 100.41 73.95 -79.49 coo 12.42 6.10 23.27 9.95 1.57 20.16 105.89 69.85 -67.01 110.53 70.43 -62.59 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 A 189 PHE B 94 PHE^? 23.49 CL CL A 129 A 298 ASP B 72 ASP^? 28.57 CL CL C 129 A 329 LYS B 24 LYS^? 27.82 CL CL B 129 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 83.12 65.84 -60.18 82.47 66.55 -62.78 coo 2.59 0.29 25.55 4.65 0.18 25.07 80.87 74.36 -54.99 81.74 73.36 -53.35 coo 12.42 6.10 23.27 9.95 1.57 20.16 90.54 75.59 -56.27 92.78 80.12 -52.52 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 A 189 PHE C 38 PHE^? 11.87 CL CL C 129 A 298 ASP C 41 ASP^? 7.58 CL CL C 129 A 329 LYS C 111 LYS^? 20.47 CL CL A 129 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 90.71 70.84 -35.90 92.71 72.72 -36.44 coo 2.59 0.29 25.55 4.65 0.18 25.07 90.28 65.09 -27.98 90.77 64.12 -26.18 coo 12.42 6.10 23.27 9.95 1.57 20.16 94.84 58.73 -38.66 94.21 53.88 -42.04 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 A 189 PHE C 94 PHE^? 24.69 CL CL C 129 A 298 ASP C 72 ASP^? 28.53 CL CL B 129 A 329 LYS C 24 LYS^? 26.64 CL CL C 129 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 98.83 81.51 -45.44 98.16 82.08 -42.76 coo 2.59 0.29 25.55 4.65 0.18 25.07 90.38 83.76 -50.64 91.24 82.68 -52.23 coo 12.42 6.10 23.27 9.95 1.57 20.16 88.99 74.10 -49.29 84.03 71.99 -51.83 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 A 189 PHE D 38 PHE^? 11.82 CL CL D 129 A 298 ASP D 41 ASP^? 7.55 CL CL D 129 A 329 LYS D 111 LYS^? 25.57 CL CL D 129 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 68.57 79.81 -35.85 66.58 77.94 -36.43 coo 2.59 0.29 25.55 4.65 0.18 25.07 69.10 85.54 -28.07 68.60 86.44 -26.19 coo 12.42 6.10 23.27 9.95 1.57 20.16 64.48 91.99 -38.71 64.71 96.91 -42.99 1gtx_c00 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 6 hits 1gtx_c00 naa= 3 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 B 189 PHE A 38 PHE~? 11.90 CL CL A 129 B 298 ASP A 41 ASP.? 7.60 CL CL A 129 B 329 LYS A 111 LYS^? 25.43 CL CL A 129 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 93.74 49.34 -71.31 91.91 51.35 -71.82 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 99.56 48.98 -63.34 100.43 49.52 -61.53 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 105.91 53.60 -74.08 110.80 53.18 -78.24 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 B 189 PHE B 38 PHE^? 11.74 CL CL B 129 B 298 ASP B 41 ASP^? 7.64 CL CL B 129 B 329 LYS B 111 LYS^? 25.35 CL CL B 129 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 93.75 74.07 -69.88 91.89 72.11 -69.38 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 99.50 74.51 -77.69 100.41 73.95 -79.49 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 105.89 69.85 -67.01 110.53 70.43 -62.59 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 B 189 PHE B 94 PHE^? 23.49 CL CL A 129 B 298 ASP B 72 ASP^? 28.57 CL CL C 129 B 329 LYS B 24 LYS^? 27.82 CL CL B 129 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 83.12 65.84 -60.18 82.47 66.55 -62.78 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 80.87 74.36 -54.99 81.74 73.36 -53.35 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 90.54 75.59 -56.27 92.78 80.12 -52.52 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 B 189 PHE C 38 PHE^? 11.87 CL CL C 129 B 298 ASP C 41 ASP^? 7.58 CL CL C 129 B 329 LYS C 111 LYS^? 20.47 CL CL A 129 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 90.71 70.84 -35.90 92.71 72.72 -36.44 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 90.28 65.09 -27.98 90.77 64.12 -26.18 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 94.84 58.73 -38.66 94.21 53.88 -42.04 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 B 189 PHE C 94 PHE^? 24.69 CL CL C 129 B 298 ASP C 72 ASP^? 28.53 CL CL B 129 B 329 LYS C 24 LYS^? 26.64 CL CL C 129 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 98.83 81.51 -45.44 98.16 82.08 -42.76 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 90.38 83.76 -50.64 91.24 82.68 -52.23 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 88.99 74.10 -49.29 84.03 71.99 -51.83 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 B 189 PHE D 38 PHE^? 11.82 CL CL D 129 B 298 ASP D 41 ASP^? 7.55 CL CL D 129 B 329 LYS D 111 LYS^? 25.57 CL CL D 129 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 68.57 79.81 -35.85 66.58 77.94 -36.43 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 69.10 85.54 -28.07 68.60 86.44 -26.19 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 64.48 91.99 -38.71 64.71 96.91 -42.99 1gtx_c01 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 6 hits 1gtx_c01 naa= 3 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 C 189 PHE A 38 PHE~? 11.90 CL CL A 129 C 298 ASP A 41 ASP.? 7.60 CL CL A 129 C 329 LYS A 111 LYS^? 25.43 CL CL A 129 coo 17.41 60.57 64.39 18.40 58.12 65.34 93.74 49.34 -71.31 91.91 51.35 -71.82 coo 24.10 66.43 63.33 24.18 64.30 63.40 99.56 48.98 -63.34 100.43 49.52 -61.53 coo 27.64 56.61 58.17 22.18 57.92 60.36 105.91 53.60 -74.08 110.80 53.18 -78.24 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 C 189 PHE B 38 PHE^? 11.74 CL CL B 129 C 298 ASP B 41 ASP^? 7.64 CL CL B 129 C 329 LYS B 111 LYS^? 25.35 CL CL B 129 coo 17.41 60.57 64.39 18.40 58.12 65.34 93.75 74.07 -69.88 91.89 72.11 -69.38 coo 24.10 66.43 63.33 24.18 64.30 63.40 99.50 74.51 -77.69 100.41 73.95 -79.49 coo 27.64 56.61 58.17 22.18 57.92 60.36 105.89 69.85 -67.01 110.53 70.43 -62.59 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 C 189 PHE B 94 PHE^? 23.49 CL CL A 129 C 298 ASP B 72 ASP^? 28.57 CL CL C 129 C 329 LYS B 24 LYS^? 27.82 CL CL B 129 coo 17.41 60.57 64.39 18.40 58.12 65.34 83.12 65.84 -60.18 82.47 66.55 -62.78 coo 24.10 66.43 63.33 24.18 64.30 63.40 80.87 74.36 -54.99 81.74 73.36 -53.35 coo 27.64 56.61 58.17 22.18 57.92 60.36 90.54 75.59 -56.27 92.78 80.12 -52.52 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 C 189 PHE C 38 PHE^? 11.87 CL CL C 129 C 298 ASP C 41 ASP^? 7.58 CL CL C 129 C 329 LYS C 111 LYS^? 20.47 CL CL A 129 coo 17.41 60.57 64.39 18.40 58.12 65.34 90.71 70.84 -35.90 92.71 72.72 -36.44 coo 24.10 66.43 63.33 24.18 64.30 63.40 90.28 65.09 -27.98 90.77 64.12 -26.18 coo 27.64 56.61 58.17 22.18 57.92 60.36 94.84 58.73 -38.66 94.21 53.88 -42.04 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 C 189 PHE C 94 PHE^? 24.69 CL CL C 129 C 298 ASP C 72 ASP^? 28.53 CL CL B 129 C 329 LYS C 24 LYS^? 26.64 CL CL C 129 coo 17.41 60.57 64.39 18.40 58.12 65.34 98.83 81.51 -45.44 98.16 82.08 -42.76 coo 24.10 66.43 63.33 24.18 64.30 63.40 90.38 83.76 -50.64 91.24 82.68 -52.23 coo 27.64 56.61 58.17 22.18 57.92 60.36 88.99 74.10 -49.29 84.03 71.99 -51.83 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 C 189 PHE D 38 PHE^? 11.82 CL CL D 129 C 298 ASP D 41 ASP^? 7.55 CL CL D 129 C 329 LYS D 111 LYS^? 25.57 CL CL D 129 coo 17.41 60.57 64.39 18.40 58.12 65.34 68.57 79.81 -35.85 66.58 77.94 -36.43 coo 24.10 66.43 63.33 24.18 64.30 63.40 69.10 85.54 -28.07 68.60 86.44 -26.19 coo 27.64 56.61 58.17 22.18 57.92 60.36 64.48 91.99 -38.71 64.71 96.91 -42.99 1gtx_c02 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 6 hits 1gtx_c02 naa= 3 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 D 189 PHE A 38 PHE~? 11.90 CL CL A 129 D 298 ASP A 41 ASP.? 7.60 CL CL A 129 D 329 LYS A 111 LYS^? 25.43 CL CL A 129 coo 35.44 53.35 83.81 35.65 54.53 81.28 93.74 49.34 -71.31 91.91 51.35 -71.82 coo 29.72 46.46 83.60 30.79 47.36 81.99 99.56 48.98 -63.34 100.43 49.52 -61.53 coo 36.89 44.91 74.55 37.33 48.94 79.01 105.91 53.60 -74.08 110.80 53.18 -78.24 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 D 189 PHE B 38 PHE^? 11.74 CL CL B 129 D 298 ASP B 41 ASP^? 7.64 CL CL B 129 D 329 LYS B 111 LYS^? 25.35 CL CL B 129 coo 35.44 53.35 83.81 35.65 54.53 81.28 93.75 74.07 -69.88 91.89 72.11 -69.38 coo 29.72 46.46 83.60 30.79 47.36 81.99 99.50 74.51 -77.69 100.41 73.95 -79.49 coo 36.89 44.91 74.55 37.33 48.94 79.01 105.89 69.85 -67.01 110.53 70.43 -62.59 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 D 189 PHE B 94 PHE^? 23.49 CL CL A 129 D 298 ASP B 72 ASP^? 28.57 CL CL C 129 D 329 LYS B 24 LYS^? 27.82 CL CL B 129 coo 35.44 53.35 83.81 35.65 54.53 81.28 83.12 65.84 -60.18 82.47 66.55 -62.78 coo 29.72 46.46 83.60 30.79 47.36 81.99 80.87 74.36 -54.99 81.74 73.36 -53.35 coo 36.89 44.91 74.55 37.33 48.94 79.01 90.54 75.59 -56.27 92.78 80.12 -52.52 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 D 189 PHE C 38 PHE^? 11.87 CL CL C 129 D 298 ASP C 41 ASP^? 7.58 CL CL C 129 D 329 LYS C 111 LYS^? 20.47 CL CL A 129 coo 35.44 53.35 83.81 35.65 54.53 81.28 90.71 70.84 -35.90 92.71 72.72 -36.44 coo 29.72 46.46 83.60 30.79 47.36 81.99 90.28 65.09 -27.98 90.77 64.12 -26.18 coo 36.89 44.91 74.55 37.33 48.94 79.01 94.84 58.73 -38.66 94.21 53.88 -42.04 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 D 189 PHE C 94 PHE^? 24.69 CL CL C 129 D 298 ASP C 72 ASP^? 28.53 CL CL B 129 D 329 LYS C 24 LYS^? 26.64 CL CL C 129 coo 35.44 53.35 83.81 35.65 54.53 81.28 98.83 81.51 -45.44 98.16 82.08 -42.76 coo 29.72 46.46 83.60 30.79 47.36 81.99 90.38 83.76 -50.64 91.24 82.68 -52.23 coo 36.89 44.91 74.55 37.33 48.94 79.01 88.99 74.10 -49.29 84.03 71.99 -51.83 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 D 189 PHE D 38 PHE^? 11.82 CL CL D 129 D 298 ASP D 41 ASP^? 7.55 CL CL D 129 D 329 LYS D 111 LYS^? 25.57 CL CL D 129 coo 35.44 53.35 83.81 35.65 54.53 81.28 68.57 79.81 -35.85 66.58 77.94 -36.43 coo 29.72 46.46 83.60 30.79 47.36 81.99 69.10 85.54 -28.07 68.60 86.44 -26.19 coo 36.89 44.91 74.55 37.33 48.94 79.01 64.48 91.99 -38.71 64.71 96.91 -42.99 1gtx_c03 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 6 hits 1gtx_c03 naa= 3 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 1 3 # 1 A 50 ASP A 14 ASP~? 27.67 CL CL B 129 A 327 GLU C 36 GLU^? 18.27 CL CL C 129 A 339 ARG C 117 ARG^? 16.02 CL CL C 129 coo 85.81 57.99 116.01 86.03 55.86 115.89 105.70 54.30 -82.61 107.63 54.15 -83.44 coo 75.11 41.01 160.30 76.65 40.06 161.41 84.85 65.27 -40.53 84.47 64.86 -42.56 coo 82.23 40.35 159.87 85.09 40.67 161.01 89.36 64.01 -37.29 87.40 62.56 -39.24 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 2 3 # 2 A 50 ASP A 30 ASP~? 20.80 CL CL A 129 A 327 GLU C 36 GLU^? 18.27 CL CL C 129 A 339 ARG C 117 ARG^? 16.02 CL CL C 129 coo 85.81 57.99 116.01 86.03 55.86 115.89 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 75.11 41.01 160.30 76.65 40.06 161.41 84.85 65.27 -40.53 84.47 64.86 -42.56 coo 82.23 40.35 159.87 85.09 40.67 161.01 89.36 64.01 -37.29 87.40 62.56 -39.24 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 3 3 # 3 A 50 ASP A 35 ASP~? 10.31 CL CL A 129 A 327 GLU C 93 GLU^? 31.51 CL CL C 129 A 339 ARG C 76 ARG^? 33.92 CL CL B 129 coo 85.81 57.99 116.01 86.03 55.86 115.89 93.79 42.35 -72.20 94.79 41.97 -70.38 coo 75.11 41.01 160.30 76.65 40.06 161.41 105.96 79.95 -45.75 107.72 80.63 -46.81 coo 82.23 40.35 159.87 85.09 40.67 161.01 105.54 81.89 -51.05 106.65 84.23 -49.40 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 4 3 # 4 A 50 ASP A 35 ASP~? 10.31 CL CL A 129 A 327 GLU D 23 GLU^? 24.49 CL CL D 129 A 339 ARG D 73 ARG^? 22.15 CL CL D 129 coo 85.81 57.99 116.01 86.03 55.86 115.89 93.79 42.35 -72.20 94.79 41.97 -70.38 coo 75.11 41.01 160.30 76.65 40.06 161.41 65.41 75.40 -49.12 64.81 73.78 -47.86 coo 82.23 40.35 159.87 85.09 40.67 161.01 64.06 69.83 -46.45 63.93 71.88 -44.19 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 5 3 # 5 A 50 ASP A 41 ASP.? 7.60 CL CL A 129 A 327 GLU D 36 GLU^? 18.42 CL CL D 129 A 339 ARG D 21 ARG^? 20.73 CL CL D 129 coo 85.81 57.99 116.01 86.03 55.86 115.89 99.56 48.98 -63.34 100.43 49.52 -61.53 coo 75.11 41.01 160.30 76.65 40.06 161.41 74.52 85.40 -40.74 74.64 85.74 -42.81 coo 82.23 40.35 159.87 85.09 40.67 161.01 71.50 84.01 -47.23 73.85 84.97 -45.52 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 6 3 # 6 A 50 ASP A 72 ASP.? 29.77 CL CL A 129 A 327 GLU D 23 GLU^? 24.49 CL CL D 129 A 339 ARG D 73 ARG^? 22.15 CL CL D 129 coo 85.81 57.99 116.01 86.03 55.86 115.89 81.04 48.95 -86.11 82.18 49.75 -87.74 coo 75.11 41.01 160.30 76.65 40.06 161.41 65.41 75.40 -49.12 64.81 73.78 -47.86 coo 82.23 40.35 159.87 85.09 40.67 161.01 64.06 69.83 -46.45 63.93 71.88 -44.19 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 7 3 # 7 A 50 ASP B 5 ASP^? 20.93 CL CL A 129 A 327 GLU C 57 GLU^? -5.48 CL CL C 129s A 339 ARG C 60 ARG^? 8.92 CL CL C 129 coo 85.81 57.99 116.01 86.03 55.86 115.89 110.10 55.77 -64.66 112.04 55.13 -65.31 coo 75.11 41.01 160.30 76.65 40.06 161.41 82.94 73.46 -26.00 82.34 73.25 -23.96 coo 82.23 40.35 159.87 85.09 40.67 161.01 82.52 72.20 -31.52 80.97 69.57 -31.97 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 8 3 # 8 A 50 ASP B 10 ASP^? 27.46 CL CL A 129 A 327 GLU D 23 GLU^? 24.49 CL CL D 129 A 339 ARG D 73 ARG^? 22.15 CL CL D 129 coo 85.81 57.99 116.01 86.03 55.86 115.89 110.59 65.11 -56.28 111.89 65.48 -54.65 coo 75.11 41.01 160.30 76.65 40.06 161.41 65.41 75.40 -49.12 64.81 73.78 -47.86 coo 82.23 40.35 159.87 85.09 40.67 161.01 64.06 69.83 -46.45 63.93 71.88 -44.19 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 9 3 # 9 A 50 ASP B 14 ASP^? 27.62 CL CL A 129 A 327 GLU D 51 GLU^? 16.56 CL CL D 129 A 339 ARG D 46 ARG^? 15.13 CL CL D 129 coo 85.81 57.99 116.01 86.03 55.86 115.89 105.60 69.00 -58.44 107.49 69.47 -57.66 coo 75.11 41.01 160.30 76.65 40.06 161.41 66.99 68.03 -31.91 66.63 66.88 -33.67 coo 82.23 40.35 159.87 85.09 40.67 161.01 66.74 73.93 -35.00 66.45 71.02 -36.02 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 10 3 # 10 A 50 ASP B 86 ASP^? 23.14 CL CL B 129 A 327 GLU D 23 GLU^? 24.49 CL CL D 129 A 339 ARG D 73 ARG^? 22.15 CL CL D 129 coo 85.81 57.99 116.01 86.03 55.86 115.89 108.40 66.17 -67.38 109.32 64.97 -68.84 coo 75.11 41.01 160.30 76.65 40.06 161.41 65.41 75.40 -49.12 64.81 73.78 -47.86 coo 82.23 40.35 159.87 85.09 40.67 161.01 64.06 69.83 -46.45 63.93 71.88 -44.19 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 11 3 # 11 A 50 ASP B 86 ASP^? 23.14 CL CL B 129 A 327 GLU D 36 GLU^? 18.42 CL CL D 129 A 339 ARG D 21 ARG^? 20.73 CL CL D 129 coo 85.81 57.99 116.01 86.03 55.86 115.89 108.40 66.17 -67.38 109.32 64.97 -68.84 coo 75.11 41.01 160.30 76.65 40.06 161.41 74.52 85.40 -40.74 74.64 85.74 -42.81 coo 82.23 40.35 159.87 85.09 40.67 161.01 71.50 84.01 -47.23 73.85 84.97 -45.52 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 12 3 # 12 A 50 ASP C 5 ASP^? 26.16 CL CL A 129 A 327 GLU A 23 GLU~? 24.22 CL CL A 129 A 339 ARG A 73 ARG.? 22.19 CL CL A 129 coo 85.81 57.99 116.01 86.03 55.86 115.89 108.85 54.21 -41.41 109.64 52.31 -40.89 coo 75.11 41.01 160.30 76.65 40.06 161.41 89.42 52.54 -84.47 88.08 53.22 -82.95 coo 82.23 40.35 159.87 85.09 40.67 161.01 83.82 53.79 -81.61 86.00 54.30 -79.51 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 13 3 # 13 A 50 ASP C 5 ASP^? 26.16 CL CL A 129 A 327 GLU B 57 GLU^? -5.29 CL CL B 129s A 339 ARG B 60 ARG^? 8.76 CL CL B 129 coo 85.81 57.99 116.01 86.03 55.86 115.89 108.85 54.21 -41.41 109.64 52.31 -40.89 coo 75.11 41.01 160.30 76.65 40.06 161.41 91.24 81.90 -79.46 91.48 82.48 -81.50 coo 82.23 40.35 159.87 85.09 40.67 161.01 92.45 82.18 -73.93 95.13 83.66 -73.65 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 14 3 # 14 A 50 ASP C 5 ASP^? 26.16 CL CL A 129 A 327 GLU D 23 GLU^? 24.49 CL CL D 129 A 339 ARG D 73 ARG^? 22.15 CL CL D 129 coo 85.81 57.99 116.01 86.03 55.86 115.89 108.85 54.21 -41.41 109.64 52.31 -40.89 coo 75.11 41.01 160.30 76.65 40.06 161.41 65.41 75.40 -49.12 64.81 73.78 -47.86 coo 82.23 40.35 159.87 85.09 40.67 161.01 64.06 69.83 -46.45 63.93 71.88 -44.19 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 15 3 # 15 A 50 ASP C 10 ASP^? 12.83 CL CL A 129 A 327 GLU D 93 GLU^? 31.46 CL CL D 129 A 339 ARG D 76 ARG^? 33.75 CL CL D 129 coo 85.81 57.99 116.01 86.03 55.86 115.89 99.63 54.02 -49.94 99.45 52.98 -51.81 coo 75.11 41.01 160.30 76.65 40.06 161.41 53.41 70.78 -45.84 51.64 70.26 -46.90 coo 82.23 40.35 159.87 85.09 40.67 161.01 54.15 68.69 -51.19 53.07 66.38 -49.46 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 16 3 # 16 A 50 ASP C 10 ASP^? 12.83 CL CL A 129 A 327 GLU D 93 GLU^? 31.46 CL CL D 129 A 339 ARG D 104 ARG^? 26.47 CL CL D 129 coo 85.81 57.99 116.01 86.03 55.86 115.89 99.63 54.02 -49.94 99.45 52.98 -51.81 coo 75.11 41.01 160.30 76.65 40.06 161.41 53.41 70.78 -45.84 51.64 70.26 -46.90 coo 82.23 40.35 159.87 85.09 40.67 161.01 54.44 68.08 -41.08 52.76 68.11 -38.51 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 17 3 # 17 A 50 ASP C 35 ASP^? 10.26 CL CL C 129 A 327 GLU A 36 GLU~? 18.47 CL CL A 129 A 339 ARG A 117 ARG^? 16.03 CL CL A 129 coo 85.81 57.99 116.01 86.03 55.86 115.89 83.63 70.73 -36.85 83.32 69.81 -34.96 coo 75.11 41.01 160.30 76.65 40.06 161.41 99.16 43.45 -76.17 99.38 43.10 -78.24 coo 82.23 40.35 159.87 85.09 40.67 161.01 100.59 48.03 -72.66 102.04 46.10 -74.59 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 18 3 # 18 A 50 ASP C 41 ASP^? 7.58 CL CL C 129 A 327 GLU B 51 GLU^? 16.46 CL CL B 129 A 339 ARG A 104 ARG^? 18.53 CL CL B 129 coo 85.81 57.99 116.01 86.03 55.86 115.89 90.28 65.09 -27.98 90.77 64.12 -26.18 coo 75.11 41.01 160.30 76.65 40.06 161.41 81.98 72.56 -73.89 80.95 72.05 -72.12 coo 82.23 40.35 159.87 85.09 40.67 161.01 82.19 63.80 -76.53 82.09 65.30 -73.83 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 19 3 # 19 A 50 ASP C 86 ASP^? 23.12 CL CL C 129 A 327 GLU A 23 GLU~? 24.22 CL CL A 129 A 339 ARG A 73 ARG.? 22.19 CL CL A 129 coo 85.81 57.99 116.01 86.03 55.86 115.89 98.39 56.19 -38.35 99.60 55.15 -36.99 coo 75.11 41.01 160.30 76.65 40.06 161.41 89.42 52.54 -84.47 88.08 53.22 -82.95 coo 82.23 40.35 159.87 85.09 40.67 161.01 83.82 53.79 -81.61 86.00 54.30 -79.51 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 20 3 # 20 A 50 ASP C 86 ASP^? 23.12 CL CL C 129 A 327 GLU D 93 GLU^? 31.46 CL CL D 129 A 339 ARG D 76 ARG^? 33.75 CL CL D 129 coo 85.81 57.99 116.01 86.03 55.86 115.89 98.39 56.19 -38.35 99.60 55.15 -36.99 coo 75.11 41.01 160.30 76.65 40.06 161.41 53.41 70.78 -45.84 51.64 70.26 -46.90 coo 82.23 40.35 159.87 85.09 40.67 161.01 54.15 68.69 -51.19 53.07 66.38 -49.46 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 21 3 # 21 A 50 ASP C 86 ASP^? 23.12 CL CL C 129 A 327 GLU D 93 GLU^? 31.46 CL CL D 129 A 339 ARG D 104 ARG^? 26.47 CL CL D 129 coo 85.81 57.99 116.01 86.03 55.86 115.89 98.39 56.19 -38.35 99.60 55.15 -36.99 coo 75.11 41.01 160.30 76.65 40.06 161.41 53.41 70.78 -45.84 51.64 70.26 -46.90 coo 82.23 40.35 159.87 85.09 40.67 161.01 54.44 68.08 -41.08 52.76 68.11 -38.51 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 22 3 # 22 A 50 ASP D 4 ASP^? 37.41 CL CL D 129 A 327 GLU C 57 GLU^? -5.48 CL CL C 129s A 339 ARG C 60 ARG^? 8.92 CL CL C 129 coo 85.81 57.99 116.01 86.03 55.86 115.89 46.79 97.75 -45.68 46.52 99.27 -44.27 coo 75.11 41.01 160.30 76.65 40.06 161.41 82.94 73.46 -26.00 82.34 73.25 -23.96 coo 82.23 40.35 159.87 85.09 40.67 161.01 82.52 72.20 -31.52 80.97 69.57 -31.97 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 23 3 # 23 A 50 ASP D 5 ASP^? 32.88 CL CL D 129 A 327 GLU B 23 GLU^? 24.68 CL CL B 129 A 339 ARG B 73 ARG^? 22.29 CL CL B 129 coo 85.81 57.99 116.01 86.03 55.86 115.89 50.37 96.25 -41.36 49.69 98.16 -40.70 coo 75.11 41.01 160.30 76.65 40.06 161.41 89.49 70.79 -56.44 87.96 70.01 -57.68 coo 82.23 40.35 159.87 85.09 40.67 161.01 83.86 69.55 -59.16 85.91 69.18 -61.42 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 24 3 # 24 A 50 ASP D 5 ASP^? 32.88 CL CL D 129 A 327 GLU C 23 GLU^? 24.69 CL CL C 129 A 339 ARG C 73 ARG^? 22.24 CL CL C 129 coo 85.81 57.99 116.01 86.03 55.86 115.89 50.37 96.25 -41.36 49.69 98.16 -40.70 coo 75.11 41.01 160.30 76.65 40.06 161.41 93.85 75.25 -49.20 94.57 76.88 -48.00 coo 82.23 40.35 159.87 85.09 40.67 161.01 95.26 80.79 -46.47 95.45 78.63 -44.29 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 25 3 # 25 A 50 ASP D 41 ASP^? 7.55 CL CL D 129 A 327 GLU B 51 GLU^? 16.46 CL CL B 129 A 339 ARG B 46 ARG^? 15.06 CL CL B 129 coo 85.81 57.99 116.01 86.03 55.86 115.89 69.10 85.54 -28.07 68.60 86.44 -26.19 coo 75.11 41.01 160.30 76.65 40.06 161.41 81.98 72.56 -73.89 80.95 72.05 -72.12 coo 82.23 40.35 159.87 85.09 40.67 161.01 87.96 72.13 -70.71 85.05 71.84 -69.78 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 26 3 # 26 A 50 ASP D 86 ASP^? 23.19 CL CL D 129 A 327 GLU B 36 GLU^? 18.40 CL CL B 129 A 339 ARG B 21 ARG^? 20.28 CL CL B 129 coo 85.81 57.99 116.01 86.03 55.86 115.89 60.79 94.39 -38.32 59.49 95.38 -36.98 coo 75.11 41.01 160.30 76.65 40.06 161.41 99.20 79.77 -64.83 99.58 80.60 -62.91 coo 82.23 40.35 159.87 85.09 40.67 161.01 98.33 76.92 -58.24 98.68 79.03 -60.54 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 27 3 # 27 A 50 ASP D 86 ASP^? 23.19 CL CL D 129 A 327 GLU B 51 GLU^? 16.46 CL CL B 129 A 339 ARG B 46 ARG^? 15.06 CL CL B 129 coo 85.81 57.99 116.01 86.03 55.86 115.89 60.79 94.39 -38.32 59.49 95.38 -36.98 coo 75.11 41.01 160.30 76.65 40.06 161.41 81.98 72.56 -73.89 80.95 72.05 -72.12 coo 82.23 40.35 159.87 85.09 40.67 161.01 87.96 72.13 -70.71 85.05 71.84 -69.78 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 28 3 # 28 A 50 ASP D 86 ASP^? 23.19 CL CL D 129 A 327 GLU B 93 GLU^? 15.32 CL CL A 129 A 339 ARG B 104 ARG^? 18.51 CL CL A 129 coo 85.81 57.99 116.01 86.03 55.86 115.89 60.79 94.39 -38.32 59.49 95.38 -36.98 coo 75.11 41.01 160.30 76.65 40.06 161.41 84.67 58.80 -60.02 84.04 57.06 -58.91 coo 82.23 40.35 159.87 85.09 40.67 161.01 82.09 59.72 -64.70 82.21 58.19 -67.39 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 29 3 # 29 A 50 ASP D 86 ASP^? 23.19 CL CL D 129 A 327 GLU C 93 GLU^? 31.51 CL CL C 129 A 339 ARG C 76 ARG^? 33.92 CL CL B 129 coo 85.81 57.99 116.01 86.03 55.86 115.89 60.79 94.39 -38.32 59.49 95.38 -36.98 coo 75.11 41.01 160.30 76.65 40.06 161.41 105.96 79.95 -45.75 107.72 80.63 -46.81 coo 82.23 40.35 159.87 85.09 40.67 161.01 105.54 81.89 -51.05 106.65 84.23 -49.40 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 30 3 # 30 A 50 ASP D 86 ASP^? 23.19 CL CL D 129 A 327 GLU C 93 GLU^? 31.51 CL CL C 129 A 339 ARG C 104 ARG^? 26.38 CL CL C 129 coo 85.81 57.99 116.01 86.03 55.86 115.89 60.79 94.39 -38.32 59.49 95.38 -36.98 coo 75.11 41.01 160.30 76.65 40.06 161.41 105.96 79.95 -45.75 107.72 80.63 -46.81 coo 82.23 40.35 159.87 85.09 40.67 161.01 105.08 82.46 -41.08 106.56 82.47 -38.36 1hto_c00 source 1hto GLUTAMINE SYNTHETASE : 30 hits 1hto_c00 naa= 3 ULMN 3 1i29_c03 CSDB user 1 3 # 1 A 128 VAL A 45 VAL^? 10.13 CL CL A 129 A 200 ASP A 35 ASP~? 10.31 CL CL A 129 A 226 LYS A 24 LYS~? 27.96 CL CL A 129 coo 19.13 38.05 1.41 19.72 38.80 -0.53 91.94 53.92 -64.94 91.48 55.61 -63.62 coo 24.51 43.28 11.18 25.17 44.50 9.58 93.79 42.35 -72.20 94.79 41.97 -70.38 coo 34.47 51.09 7.19 28.58 51.18 7.53 90.40 47.78 -84.76 92.62 43.20 -88.57 ULMN 3 1i29_c03 CSDB user 2 3 # 2 A 128 VAL A 79 VAL^? 12.58 CL CL B 129 A 200 ASP B 41 ASP^? 7.64 CL CL B 129 A 226 LYS B 111 LYS^? 25.35 CL CL B 129 coo 19.13 38.05 1.41 19.72 38.80 -0.53 94.13 64.53 -82.49 93.75 66.60 -81.81 coo 24.51 43.28 11.18 25.17 44.50 9.58 99.50 74.51 -77.69 100.41 73.95 -79.49 coo 34.47 51.09 7.19 28.58 51.18 7.53 105.89 69.85 -67.01 110.53 70.43 -62.59 ULMN 3 1i29_c03 CSDB user 3 3 # 3 A 128 VAL B 45 VAL^? 10.12 CL CL B 129 A 200 ASP B 35 ASP^? 10.19 CL CL B 129 A 226 LYS B 24 LYS^? 27.82 CL CL B 129 coo 19.13 38.05 1.41 19.72 38.80 -0.53 91.90 69.53 -76.10 91.61 67.92 -77.59 coo 24.51 43.28 11.18 25.17 44.50 9.58 93.79 80.98 -68.72 94.61 81.32 -70.62 coo 34.47 51.09 7.19 28.58 51.18 7.53 90.54 75.59 -56.27 92.78 80.12 -52.52 ULMN 3 1i29_c03 CSDB user 4 3 # 4 A 128 VAL B 79 VAL^? 12.34 CL CL A 129 A 200 ASP A 41 ASP.? 7.60 CL CL A 129 A 226 LYS A 111 LYS^? 25.43 CL CL A 129 coo 19.13 38.05 1.41 19.72 38.80 -0.53 94.15 58.82 -58.60 93.97 56.70 -59.21 coo 24.51 43.28 11.18 25.17 44.50 9.58 99.56 48.98 -63.34 100.43 49.52 -61.53 coo 34.47 51.09 7.19 28.58 51.18 7.53 105.91 53.60 -74.08 110.80 53.18 -78.24 ULMN 3 1i29_c03 CSDB user 5 3 # 5 A 128 VAL B 79 VAL^? 12.34 CL CL A 129 A 200 ASP C 10 ASP^? 12.83 CL CL A 129 A 226 LYS C 111 LYS^? 20.47 CL CL A 129 coo 19.13 38.05 1.41 19.72 38.80 -0.53 94.15 58.82 -58.60 93.97 56.70 -59.21 coo 24.51 43.28 11.18 25.17 44.50 9.58 99.63 54.02 -49.94 99.45 52.98 -51.81 coo 34.47 51.09 7.19 28.58 51.18 7.53 94.84 58.73 -38.66 94.21 53.88 -42.04 ULMN 3 1i29_c03 CSDB user 6 3 # 6 A 128 VAL C 6 VAL^? 27.08 CL CL A 129 A 200 ASP C 10 ASP^? 12.83 CL CL A 129 A 226 LYS A 43 LYS.? 9.42 CL CL A 129 coo 19.13 38.05 1.41 19.72 38.80 -0.53 109.10 58.29 -43.78 110.29 59.98 -42.92 coo 24.51 43.28 11.18 25.17 44.50 9.58 99.63 54.02 -49.94 99.45 52.98 -51.81 coo 34.47 51.09 7.19 28.58 51.18 7.53 96.70 52.33 -61.01 101.40 51.27 -59.62 ULMN 3 1i29_c03 CSDB user 7 3 # 7 A 128 VAL C 6 VAL^? 27.08 CL CL A 129 A 200 ASP C 14 ASP^? 16.95 CL CL A 129 A 226 LYS A 43 LYS.? 9.42 CL CL A 129 coo 19.13 38.05 1.41 19.72 38.80 -0.53 109.10 58.29 -43.78 110.29 59.98 -42.92 coo 24.51 43.28 11.18 25.17 44.50 9.58 95.50 58.88 -47.37 95.04 57.01 -48.29 coo 34.47 51.09 7.19 28.58 51.18 7.53 96.70 52.33 -61.01 101.40 51.27 -59.62 ULMN 3 1i29_c03 CSDB user 8 3 # 8 A 128 VAL C 45 VAL^? 10.07 CL CL C 129 A 200 ASP C 35 ASP^? 10.26 CL CL C 129 A 226 LYS C 24 LYS^? 26.64 CL CL C 129 coo 19.13 38.05 1.41 19.72 38.80 -0.53 95.21 72.64 -29.62 96.92 73.01 -28.28 coo 24.51 43.28 11.18 25.17 44.50 9.58 83.63 70.73 -36.85 83.32 69.81 -34.96 coo 34.47 51.09 7.19 28.58 51.18 7.53 88.99 74.10 -49.29 84.03 71.99 -51.83 ULMN 3 1i29_c03 CSDB user 9 3 # 9 A 128 VAL C 79 VAL^? 29.39 CL CL C 129 A 200 ASP B 10 ASP^? 27.46 CL CL A 129 A 226 LYS B 111 LYS^? 25.35 CL CL B 129 coo 19.13 38.05 1.41 19.72 38.80 -0.53 105.89 70.46 -47.21 107.96 70.66 -46.61 coo 24.51 43.28 11.18 25.17 44.50 9.58 110.59 65.11 -56.28 111.89 65.48 -54.65 coo 34.47 51.09 7.19 28.58 51.18 7.53 105.89 69.85 -67.01 110.53 70.43 -62.59 ULMN 3 1i29_c03 CSDB user 10 3 # 10 A 128 VAL D 33 VAL^? 18.29 CL CL D 129 A 200 ASP C 30 ASP^? 20.67 CL CL C 129 A 226 LYS B 24 LYS^? 27.82 CL CL B 129 coo 19.13 38.05 1.41 19.72 38.80 -0.53 75.10 80.54 -42.51 74.71 80.99 -44.59 coo 24.51 43.28 11.18 25.17 44.50 9.58 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 34.47 51.09 7.19 28.58 51.18 7.53 90.54 75.59 -56.27 92.78 80.12 -52.52 1i29_c03 source 1i29 CSDB : 10 hits 1i29_c03 naa= 3 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 1 3 # 1 54 ASP A 5 ASP~? 21.13 CL CL B 129 158 THR A 82 THR^? 18.91 CL CL B 129 317 ASP B 41 ASP^? 7.64 CL CL B 129 coo -2.63 8.40 35.07 -3.66 9.81 36.17 110.30 67.66 -76.72 112.26 68.26 -76.10 coo -5.30 12.75 41.86 -4.34 13.05 39.99 103.30 63.05 -78.71 104.17 62.08 -80.47 coo -12.63 17.64 33.66 -10.65 17.90 34.40 99.50 74.51 -77.69 100.41 73.95 -79.49 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 2 3 # 2 54 ASP A 41 ASP.? 7.60 CL CL A 129 158 THR B 81 THR^? 12.74 CL CL A 129 317 ASP B 5 ASP^? 20.93 CL CL A 129 coo -2.63 8.40 35.07 -3.66 9.81 36.17 99.56 48.98 -63.34 100.43 49.52 -61.53 coo -5.30 12.75 41.86 -4.34 13.05 39.99 100.07 58.97 -61.29 99.70 56.90 -61.73 coo -12.63 17.64 33.66 -10.65 17.90 34.40 110.10 55.77 -64.66 112.04 55.13 -65.31 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 3 3 # 3 54 ASP A 41 ASP.? 7.60 CL CL A 129 158 THR B 81 THR^? 12.74 CL CL A 129 317 ASP C 10 ASP^? 12.83 CL CL A 129 coo -2.63 8.40 35.07 -3.66 9.81 36.17 99.56 48.98 -63.34 100.43 49.52 -61.53 coo -5.30 12.75 41.86 -4.34 13.05 39.99 100.07 58.97 -61.29 99.70 56.90 -61.73 coo -12.63 17.64 33.66 -10.65 17.90 34.40 99.63 54.02 -49.94 99.45 52.98 -51.81 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 4 3 # 4 54 ASP B 5 ASP^? 20.93 CL CL A 129 158 THR B 82 THR^? 18.93 CL CL A 129 317 ASP A 41 ASP.? 7.60 CL CL A 129 coo -2.63 8.40 35.07 -3.66 9.81 36.17 110.10 55.77 -64.66 112.04 55.13 -65.31 coo -5.30 12.75 41.86 -4.34 13.05 39.99 103.32 60.51 -62.56 104.17 61.53 -60.86 coo -12.63 17.64 33.66 -10.65 17.90 34.40 99.56 48.98 -63.34 100.43 49.52 -61.53 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 5 3 # 5 54 ASP B 5 ASP^? 20.93 CL CL A 129 158 THR B 82 THR^? 18.93 CL CL A 129 317 ASP B 10 ASP^? 27.46 CL CL A 129 coo -2.63 8.40 35.07 -3.66 9.81 36.17 110.10 55.77 -64.66 112.04 55.13 -65.31 coo -5.30 12.75 41.86 -4.34 13.05 39.99 103.32 60.51 -62.56 104.17 61.53 -60.86 coo -12.63 17.64 33.66 -10.65 17.90 34.40 110.59 65.11 -56.28 111.89 65.48 -54.65 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 6 3 # 6 54 ASP B 41 ASP^? 7.64 CL CL B 129 158 THR A 81 THR^? 12.77 CL CL B 129 317 ASP A 5 ASP~? 21.13 CL CL B 129 coo -2.63 8.40 35.07 -3.66 9.81 36.17 99.50 74.51 -77.69 100.41 73.95 -79.49 coo -5.30 12.75 41.86 -4.34 13.05 39.99 100.01 64.50 -79.91 99.59 66.56 -79.34 coo -12.63 17.64 33.66 -10.65 17.90 34.40 110.30 67.66 -76.72 112.26 68.26 -76.10 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 7 3 # 7 54 ASP B 72 ASP^? 28.57 CL CL C 129 158 THR B 95 THR^? 23.42 CL CL A 129 317 ASP D 72 ASP^? 29.64 CL CL D 129 coo -2.63 8.40 35.07 -3.66 9.81 36.17 80.87 74.36 -54.99 81.74 73.36 -53.35 coo -5.30 12.75 41.86 -4.34 13.05 39.99 79.47 64.83 -57.24 79.55 63.29 -55.69 coo -12.63 17.64 33.66 -10.65 17.90 34.40 69.04 67.18 -50.81 68.23 68.38 -52.37 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 8 3 # 8 54 ASP C 5 ASP^? 26.16 CL CL A 129 158 THR C 82 THR^? 23.56 CL CL A 129 317 ASP C 10 ASP^? 12.83 CL CL A 129 coo -2.63 8.40 35.07 -3.66 9.81 36.17 108.85 54.21 -41.41 109.64 52.31 -40.89 coo -5.30 12.75 41.86 -4.34 13.05 39.99 104.35 61.24 -43.23 103.23 60.37 -44.92 coo -12.63 17.64 33.66 -10.65 17.90 34.40 99.63 54.02 -49.94 99.45 52.98 -51.81 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 9 3 # 9 54 ASP C 5 ASP^? 26.16 CL CL A 129 158 THR C 82 THR^? 23.56 CL CL A 129 317 ASP C 14 ASP^? 16.95 CL CL A 129 coo -2.63 8.40 35.07 -3.66 9.81 36.17 108.85 54.21 -41.41 109.64 52.31 -40.89 coo -5.30 12.75 41.86 -4.34 13.05 39.99 104.35 61.24 -43.23 103.23 60.37 -44.92 coo -12.63 17.64 33.66 -10.65 17.90 34.40 95.50 58.88 -47.37 95.04 57.01 -48.29 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 10 3 # 10 54 ASP C 86 ASP^? 23.12 CL CL C 129 158 THR C 82 THR^? 23.56 CL CL A 129 317 ASP C 10 ASP^? 12.83 CL CL A 129 coo -2.63 8.40 35.07 -3.66 9.81 36.17 98.39 56.19 -38.35 99.60 55.15 -36.99 coo -5.30 12.75 41.86 -4.34 13.05 39.99 104.35 61.24 -43.23 103.23 60.37 -44.92 coo -12.63 17.64 33.66 -10.65 17.90 34.40 99.63 54.02 -49.94 99.45 52.98 -51.81 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 11 3 # 11 54 ASP D 72 ASP^? 29.64 CL CL D 129 158 THR B 97 THR^? 28.75 CL CL D 129 317 ASP D 30 ASP^? 20.62 CL CL D 129 coo -2.63 8.40 35.07 -3.66 9.81 36.17 69.04 67.18 -50.81 68.23 68.38 -52.37 coo -5.30 12.75 41.86 -4.34 13.05 39.99 74.83 68.80 -53.92 74.73 70.43 -52.45 coo -12.63 17.64 33.66 -10.65 17.90 34.40 76.16 76.40 -45.40 77.49 78.05 -45.35 1inp_c02 source 1inp INOSITOL POLYPHOSPHATE 1-PHOSPHATASE (1-PTASE): 11 hits 1inp_c02 naa= 3 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 1 3 # 1 A1132 ASP C 30 ASP^? 20.67 CL CL C 129 A1134 ALA D 32 ALA^? 17.56 CL CL D 129 A1137 ASN C 29 ASN^? 19.55 CL CL C 129 coo -27.05 34.58 17.12 -25.81 32.84 17.16 83.14 74.18 -45.33 81.79 72.55 -45.31 coo -20.53 36.39 15.81 -20.80 35.01 16.40 78.15 79.10 -40.71 79.29 79.50 -41.62 coo -23.72 34.69 12.49 -24.32 32.83 13.34 83.86 80.07 -44.03 83.70 80.47 -41.95 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 2 3 # 2 A1132 ASP D 30 ASP^? 20.62 CL CL D 129 A1134 ALA C 32 ALA^? 17.45 CL CL C 129 A1137 ASN D 29 ASN^? 19.54 CL CL D 129 coo -27.05 34.58 17.12 -25.81 32.84 17.16 76.16 76.40 -45.40 77.49 78.05 -45.35 coo -20.53 36.39 15.81 -20.80 35.01 16.40 81.13 71.60 -40.52 79.93 71.23 -41.37 coo -23.72 34.69 12.49 -24.32 32.83 13.34 75.38 70.46 -44.12 75.55 70.12 -42.00 1ir3_c02 source 1ir3 INSULIN RECEPTOR : 2 hits 1ir3_c02 naa= 3 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 1 3 # 1 A 202 ASP A 35 ASP~? 10.31 CL CL A 129 A 204 GLU A 36 GLU~? 18.47 CL CL A 129 A 279 TYR A 22 TYR~? 17.56 CL CL A 129 coo 5.85 5.60 30.32 5.00 7.49 29.88 93.79 42.35 -72.20 94.79 41.97 -70.38 coo 7.79 1.83 27.81 9.08 3.25 26.92 99.16 43.45 -76.17 99.38 43.10 -78.24 coo 8.22 7.77 18.64 7.58 8.47 21.28 92.72 50.62 -78.45 90.87 50.50 -76.41 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 2 3 # 2 A 202 ASP A 41 ASP.? 7.60 CL CL A 129 A 204 GLU A 42 GLU.? 5.77 CL CL A 129 A 279 TYR A 54 TYR^? 10.29 CL CL A 129 coo 5.85 5.60 30.32 5.00 7.49 29.88 99.56 48.98 -63.34 100.43 49.52 -61.53 coo 7.79 1.83 27.81 9.08 3.25 26.92 98.04 48.44 -58.38 99.25 46.68 -58.65 coo 8.22 7.77 18.64 7.58 8.47 21.28 89.27 53.06 -59.98 88.13 55.63 -59.94 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 3 3 # 3 A 202 ASP B 35 ASP^? 10.19 CL CL B 129 A 204 GLU B 36 GLU^? 18.40 CL CL B 129 A 279 TYR B 22 TYR^? 17.56 CL CL B 129 coo 5.85 5.60 30.32 5.00 7.49 29.88 93.79 80.98 -68.72 94.61 81.32 -70.62 coo 7.79 1.83 27.81 9.08 3.25 26.92 99.20 79.77 -64.83 99.58 80.60 -62.91 coo 8.22 7.77 18.64 7.58 8.47 21.28 92.70 72.76 -62.54 90.90 72.79 -64.68 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 4 3 # 4 A 202 ASP B 41 ASP^? 7.64 CL CL B 129 A 204 GLU B 42 GLU^? 6.42 CL CL B 129 A 279 TYR B 54 TYR^? 10.36 CL CL B 129 coo 5.85 5.60 30.32 5.00 7.49 29.88 99.50 74.51 -77.69 100.41 73.95 -79.49 coo 7.79 1.83 27.81 9.08 3.25 26.92 97.73 74.53 -82.81 99.44 75.81 -82.79 coo 8.22 7.77 18.64 7.58 8.47 21.28 89.19 70.43 -81.07 88.03 67.93 -81.20 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 5 3 # 5 A 202 ASP C 35 ASP^? 10.26 CL CL C 129 A 204 GLU C 36 GLU^? 18.27 CL CL C 129 A 279 TYR C 22 TYR^? 17.52 CL CL C 129 coo 5.85 5.60 30.32 5.00 7.49 29.88 83.63 70.73 -36.85 83.32 69.81 -34.96 coo 7.79 1.83 27.81 9.08 3.25 26.92 84.85 65.27 -40.53 84.47 64.86 -42.56 coo 8.22 7.77 18.64 7.58 8.47 21.28 91.93 71.84 -43.09 91.81 73.68 -41.00 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 6 3 # 6 A 202 ASP C 41 ASP^? 7.58 CL CL C 129 A 204 GLU C 42 GLU^? 6.54 CL CL C 129 A 279 TYR C 54 TYR^? 10.32 CL CL C 129 coo 5.85 5.60 30.32 5.00 7.49 29.88 90.28 65.09 -27.98 90.77 64.12 -26.18 coo 7.79 1.83 27.81 9.08 3.25 26.92 90.14 66.47 -23.00 88.99 64.66 -23.57 coo 8.22 7.77 18.64 7.58 8.47 21.28 94.43 75.36 -24.67 96.94 76.58 -24.67 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 7 3 # 7 A 202 ASP D 35 ASP^? 10.18 CL CL D 129 A 204 GLU D 36 GLU^? 18.42 CL CL D 129 A 279 TYR D 22 TYR^? 17.52 CL CL D 129 coo 5.85 5.60 30.32 5.00 7.49 29.88 75.66 79.96 -36.93 75.99 80.66 -34.97 coo 7.79 1.83 27.81 9.08 3.25 26.92 74.52 85.40 -40.74 74.64 85.74 -42.81 coo 8.22 7.77 18.64 7.58 8.47 21.28 67.44 78.74 -43.16 67.49 76.94 -41.01 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 8 3 # 8 A 202 ASP D 41 ASP^? 7.55 CL CL D 129 A 204 GLU D 42 GLU^? 6.22 CL CL D 129 A 279 TYR D 54 TYR^? 10.35 CL CL D 129 coo 5.85 5.60 30.32 5.00 7.49 29.88 69.10 85.54 -28.07 68.60 86.44 -26.19 coo 7.79 1.83 27.81 9.08 3.25 26.92 69.54 84.23 -23.20 71.02 85.79 -23.65 coo 8.22 7.77 18.64 7.58 8.47 21.28 64.95 75.15 -24.65 62.40 74.09 -24.68 1itx_c00 source 1itx GLYCOSYL HYDROLASE : 8 hits 1itx_c00 naa= 3 ULMN 3 1j70_c00 ATP SULPHURYLASE user 1 3 # 1 A 197 ARG A 73 ARG.? 22.19 CL CL A 129 A 201 HIS A 122 HIS^? 19.05 CL CL A 129 A 204 HIS B 122 HIS^? 19.12 CL CL B 129 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 83.82 53.79 -81.61 86.00 54.30 -79.51 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 86.83 60.37 -69.40 85.20 61.24 -68.40 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 86.93 63.10 -71.62 85.35 62.06 -72.53 ULMN 3 1j70_c00 ATP SULPHURYLASE user 2 3 # 2 A 197 ARG A 73 ARG.? 22.19 CL CL A 129 A 201 HIS B 122 HIS^? 19.12 CL CL B 129 A 204 HIS A 122 HIS^? 19.05 CL CL A 129 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 83.82 53.79 -81.61 86.00 54.30 -79.51 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 86.93 63.10 -71.62 85.35 62.06 -72.53 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 86.83 60.37 -69.40 85.20 61.24 -68.40 ULMN 3 1j70_c00 ATP SULPHURYLASE user 3 3 # 3 A 197 ARG B 73 ARG^? 22.29 CL CL B 129 A 201 HIS B 122 HIS^? 19.12 CL CL B 129 A 204 HIS A 122 HIS^? 19.05 CL CL A 129 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 83.86 69.55 -59.16 85.91 69.18 -61.42 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 86.93 63.10 -71.62 85.35 62.06 -72.53 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 86.83 60.37 -69.40 85.20 61.24 -68.40 1j70_c00 source 1j70 ATP SULPHURYLASE : 3 hits 1j70_c00 naa= 3 ULMN 3 1j7g_c00 D-TYROSYL-TRNA(TYR) DEACYLASE user 1 3 # 1 A 78 GLN A 105 GLN^? 20.44 CL CL A 129 A 79 PHE A 94 PHE.? 23.56 CL CL B 129 A 80 THR A 92 THR.? 19.17 CL CL B 129 coo 18.18 6.97 -1.14 17.20 5.70 -2.56 88.61 56.98 -76.47 88.98 55.45 -77.91 coo 24.87 4.39 -2.11 26.74 2.89 -0.67 83.17 57.58 -80.80 82.50 56.91 -78.17 coo 21.26 8.65 -4.24 19.54 7.67 -5.04 88.80 61.61 -80.86 88.36 59.74 -81.92 ULMN 3 1j7g_c00 D-TYROSYL-TRNA(TYR) DEACYLASE user 2 3 # 2 A 78 GLN B 105 GLN^? 20.41 CL CL B 129 A 79 PHE B 94 PHE^? 23.49 CL CL A 129 A 80 THR B 92 THR^? 18.96 CL CL A 129 coo 18.18 6.97 -1.14 17.20 5.70 -2.56 88.72 66.41 -64.44 89.12 67.99 -63.12 coo 24.87 4.39 -2.11 26.74 2.89 -0.67 83.12 65.84 -60.18 82.47 66.55 -62.78 coo 21.26 8.65 -4.24 19.54 7.67 -5.04 88.84 61.70 -60.19 88.43 63.62 -59.28 ULMN 3 1j7g_c00 D-TYROSYL-TRNA(TYR) DEACYLASE user 3 3 # 3 A 78 GLN C 105 GLN^? 20.30 CL CL C 129 A 79 PHE C 94 PHE^? 24.69 CL CL C 129 A 80 THR C 92 THR^? 26.08 CL CL C 129 coo 18.18 6.97 -1.14 17.20 5.70 -2.56 98.17 76.17 -41.10 96.60 75.75 -42.46 coo 24.87 4.39 -2.11 26.74 2.89 -0.67 98.83 81.51 -45.44 98.16 82.08 -42.76 coo 21.26 8.65 -4.24 19.54 7.67 -5.04 103.00 75.79 -45.49 101.15 76.17 -46.51 ULMN 3 1j7g_c00 D-TYROSYL-TRNA(TYR) DEACYLASE user 4 3 # 4 A 78 GLN D 105 GLN^? 20.18 CL CL D 129 A 79 PHE D 94 PHE^? 24.69 CL CL D 129 A 80 THR D 92 THR^? 25.97 CL CL D 129 coo 18.18 6.97 -1.14 17.20 5.70 -2.56 61.23 74.39 -41.13 62.72 75.17 -42.43 coo 24.87 4.39 -2.11 26.74 2.89 -0.67 60.53 69.11 -45.40 61.31 68.31 -42.82 coo 21.26 8.65 -4.24 19.54 7.67 -5.04 56.38 74.82 -45.46 58.23 74.40 -46.42 1j7g_c00 source 1j7g D-TYROSYL-TRNA(TYR) DEACYLASE : 4 hits 1j7g_c00 naa= 3 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 1 3 # 1 A 396 ARG A 73 ARG.? 22.19 CL CL A 129 A 581 ARG A 76 ARG^? 19.15 CL CL B 129 A 713 ARG A 104 ARG^? 18.53 CL CL B 129 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 83.82 53.79 -81.61 86.00 54.30 -79.51 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 82.62 63.89 -86.56 80.46 65.21 -84.78 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 82.19 63.80 -76.53 82.09 65.30 -73.83 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 2 3 # 2 A 396 ARG A 73 ARG.? 22.19 CL CL A 129 A 581 ARG A 104 ARG^? 18.53 CL CL B 129 A 713 ARG A 76 ARG^? 19.15 CL CL B 129 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 83.82 53.79 -81.61 86.00 54.30 -79.51 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 82.19 63.80 -76.53 82.09 65.30 -73.83 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 82.62 63.89 -86.56 80.46 65.21 -84.78 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 3 3 # 3 A 396 ARG A 76 ARG^? 19.15 CL CL B 129 A 581 ARG A 73 ARG.? 22.19 CL CL A 129 A 713 ARG A 104 ARG^? 18.53 CL CL B 129 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 82.62 63.89 -86.56 80.46 65.21 -84.78 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 83.82 53.79 -81.61 86.00 54.30 -79.51 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 82.19 63.80 -76.53 82.09 65.30 -73.83 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 4 3 # 4 A 396 ARG A 76 ARG^? 19.15 CL CL B 129 A 581 ARG A 104 ARG^? 18.53 CL CL B 129 A 713 ARG A 73 ARG.? 22.19 CL CL A 129 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 82.62 63.89 -86.56 80.46 65.21 -84.78 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 82.19 63.80 -76.53 82.09 65.30 -73.83 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 83.82 53.79 -81.61 86.00 54.30 -79.51 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 5 3 # 5 A 396 ARG A 104 ARG^? 18.53 CL CL B 129 A 581 ARG A 73 ARG.? 22.19 CL CL A 129 A 713 ARG A 76 ARG^? 19.15 CL CL B 129 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 82.19 63.80 -76.53 82.09 65.30 -73.83 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 83.82 53.79 -81.61 86.00 54.30 -79.51 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 82.62 63.89 -86.56 80.46 65.21 -84.78 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 6 3 # 6 A 396 ARG A 104 ARG^? 18.53 CL CL B 129 A 581 ARG A 76 ARG^? 19.15 CL CL B 129 A 713 ARG A 73 ARG.? 22.19 CL CL A 129 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 82.19 63.80 -76.53 82.09 65.30 -73.83 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 82.62 63.89 -86.56 80.46 65.21 -84.78 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 83.82 53.79 -81.61 86.00 54.30 -79.51 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 7 3 # 7 A 396 ARG B 73 ARG^? 22.29 CL CL B 129 A 581 ARG B 76 ARG^? 18.98 CL CL A 129 A 713 ARG B 104 ARG^? 18.51 CL CL A 129 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 83.86 69.55 -59.16 85.91 69.18 -61.42 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 82.73 59.03 -54.76 80.31 57.91 -56.24 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 82.09 59.72 -64.70 82.21 58.19 -67.39 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 8 3 # 8 A 396 ARG B 73 ARG^? 22.29 CL CL B 129 A 581 ARG B 104 ARG^? 18.51 CL CL A 129 A 713 ARG B 76 ARG^? 18.98 CL CL A 129 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 83.86 69.55 -59.16 85.91 69.18 -61.42 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 82.09 59.72 -64.70 82.21 58.19 -67.39 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 82.73 59.03 -54.76 80.31 57.91 -56.24 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 9 3 # 9 A 396 ARG B 76 ARG^? 18.98 CL CL A 129 A 581 ARG B 73 ARG^? 22.29 CL CL B 129 A 713 ARG B 104 ARG^? 18.51 CL CL A 129 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 82.73 59.03 -54.76 80.31 57.91 -56.24 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 83.86 69.55 -59.16 85.91 69.18 -61.42 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 82.09 59.72 -64.70 82.21 58.19 -67.39 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 10 3 # 10 A 396 ARG B 76 ARG^? 18.98 CL CL A 129 A 581 ARG B 104 ARG^? 18.51 CL CL A 129 A 713 ARG B 73 ARG^? 22.29 CL CL B 129 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 82.73 59.03 -54.76 80.31 57.91 -56.24 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 82.09 59.72 -64.70 82.21 58.19 -67.39 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 83.86 69.55 -59.16 85.91 69.18 -61.42 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 11 3 # 11 A 396 ARG B 104 ARG^? 18.51 CL CL A 129 A 581 ARG B 73 ARG^? 22.29 CL CL B 129 A 713 ARG B 76 ARG^? 18.98 CL CL A 129 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 82.09 59.72 -64.70 82.21 58.19 -67.39 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 83.86 69.55 -59.16 85.91 69.18 -61.42 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 82.73 59.03 -54.76 80.31 57.91 -56.24 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 12 3 # 12 A 396 ARG B 104 ARG^? 18.51 CL CL A 129 A 581 ARG B 76 ARG^? 18.98 CL CL A 129 A 713 ARG B 73 ARG^? 22.29 CL CL B 129 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 82.09 59.72 -64.70 82.21 58.19 -67.39 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 82.73 59.03 -54.76 80.31 57.91 -56.24 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 83.86 69.55 -59.16 85.91 69.18 -61.42 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 13 3 # 13 A 396 ARG C 60 ARG^? 8.92 CL CL C 129 A 581 ARG C 63 ARG^? 14.10 CL CL C 129 A 713 ARG D 60 ARG^? 8.57 CL CL D 129 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 82.52 72.20 -31.52 80.97 69.57 -31.97 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 86.96 77.03 -37.50 89.89 76.13 -38.00 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 76.65 78.50 -31.75 78.13 81.14 -31.78 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 14 3 # 14 A 396 ARG C 60 ARG^? 8.92 CL CL C 129 A 581 ARG D 60 ARG^? 8.57 CL CL D 129 A 713 ARG C 63 ARG^? 14.10 CL CL C 129 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 82.52 72.20 -31.52 80.97 69.57 -31.97 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 76.65 78.50 -31.75 78.13 81.14 -31.78 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 86.96 77.03 -37.50 89.89 76.13 -38.00 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 15 3 # 15 A 396 ARG C 73 ARG^? 22.24 CL CL C 129 A 581 ARG C 76 ARG^? 33.92 CL CL B 129 A 713 ARG C 104 ARG^? 26.38 CL CL C 129 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 95.26 80.79 -46.47 95.45 78.63 -44.29 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 105.54 81.89 -51.05 106.65 84.23 -49.40 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 105.08 82.46 -41.08 106.56 82.47 -38.36 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 16 3 # 16 A 396 ARG C 73 ARG^? 22.24 CL CL C 129 A 581 ARG C 104 ARG^? 26.38 CL CL C 129 A 713 ARG C 76 ARG^? 33.92 CL CL B 129 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 95.26 80.79 -46.47 95.45 78.63 -44.29 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 105.08 82.46 -41.08 106.56 82.47 -38.36 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 105.54 81.89 -51.05 106.65 84.23 -49.40 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 17 3 # 17 A 396 ARG C 76 ARG^? 33.92 CL CL B 129 A 581 ARG C 73 ARG^? 22.24 CL CL C 129 A 713 ARG C 104 ARG^? 26.38 CL CL C 129 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 105.54 81.89 -51.05 106.65 84.23 -49.40 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 95.26 80.79 -46.47 95.45 78.63 -44.29 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 105.08 82.46 -41.08 106.56 82.47 -38.36 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 18 3 # 18 A 396 ARG C 76 ARG^? 33.92 CL CL B 129 A 581 ARG C 104 ARG^? 26.38 CL CL C 129 A 713 ARG C 73 ARG^? 22.24 CL CL C 129 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 105.54 81.89 -51.05 106.65 84.23 -49.40 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 105.08 82.46 -41.08 106.56 82.47 -38.36 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 95.26 80.79 -46.47 95.45 78.63 -44.29 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 19 3 # 19 A 396 ARG C 104 ARG^? 26.38 CL CL C 129 A 581 ARG C 73 ARG^? 22.24 CL CL C 129 A 713 ARG C 76 ARG^? 33.92 CL CL B 129 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 105.08 82.46 -41.08 106.56 82.47 -38.36 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 95.26 80.79 -46.47 95.45 78.63 -44.29 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 105.54 81.89 -51.05 106.65 84.23 -49.40 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 20 3 # 20 A 396 ARG C 104 ARG^? 26.38 CL CL C 129 A 581 ARG C 76 ARG^? 33.92 CL CL B 129 A 713 ARG C 73 ARG^? 22.24 CL CL C 129 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 105.08 82.46 -41.08 106.56 82.47 -38.36 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 105.54 81.89 -51.05 106.65 84.23 -49.40 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 95.26 80.79 -46.47 95.45 78.63 -44.29 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 21 3 # 21 A 396 ARG D 60 ARG^? 8.57 CL CL D 129 A 581 ARG C 60 ARG^? 8.92 CL CL C 129 A 713 ARG D 63 ARG^? 14.07 CL CL D 129 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 76.65 78.50 -31.75 78.13 81.14 -31.78 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 82.52 72.20 -31.52 80.97 69.57 -31.97 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 72.33 73.68 -37.44 69.36 74.46 -37.99 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 22 3 # 22 A 396 ARG D 60 ARG^? 8.57 CL CL D 129 A 581 ARG D 63 ARG^? 14.07 CL CL D 129 A 713 ARG C 60 ARG^? 8.92 CL CL C 129 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 76.65 78.50 -31.75 78.13 81.14 -31.78 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 72.33 73.68 -37.44 69.36 74.46 -37.99 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 82.52 72.20 -31.52 80.97 69.57 -31.97 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 23 3 # 23 A 396 ARG D 73 ARG^? 22.15 CL CL D 129 A 581 ARG D 76 ARG^? 33.75 CL CL D 129 A 713 ARG D 104 ARG^? 26.47 CL CL D 129 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 64.06 69.83 -46.45 63.93 71.88 -44.19 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 54.15 68.69 -51.19 53.07 66.38 -49.46 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 54.44 68.08 -41.08 52.76 68.11 -38.51 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 24 3 # 24 A 396 ARG D 73 ARG^? 22.15 CL CL D 129 A 581 ARG D 104 ARG^? 26.47 CL CL D 129 A 713 ARG D 76 ARG^? 33.75 CL CL D 129 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 64.06 69.83 -46.45 63.93 71.88 -44.19 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 54.44 68.08 -41.08 52.76 68.11 -38.51 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 54.15 68.69 -51.19 53.07 66.38 -49.46 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 25 3 # 25 A 396 ARG D 76 ARG^? 33.75 CL CL D 129 A 581 ARG D 73 ARG^? 22.15 CL CL D 129 A 713 ARG D 104 ARG^? 26.47 CL CL D 129 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 54.15 68.69 -51.19 53.07 66.38 -49.46 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 64.06 69.83 -46.45 63.93 71.88 -44.19 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 54.44 68.08 -41.08 52.76 68.11 -38.51 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 26 3 # 26 A 396 ARG D 76 ARG^? 33.75 CL CL D 129 A 581 ARG D 104 ARG^? 26.47 CL CL D 129 A 713 ARG D 73 ARG^? 22.15 CL CL D 129 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 54.15 68.69 -51.19 53.07 66.38 -49.46 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 54.44 68.08 -41.08 52.76 68.11 -38.51 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 64.06 69.83 -46.45 63.93 71.88 -44.19 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 27 3 # 27 A 396 ARG D 104 ARG^? 26.47 CL CL D 129 A 581 ARG D 73 ARG^? 22.15 CL CL D 129 A 713 ARG D 76 ARG^? 33.75 CL CL D 129 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 54.44 68.08 -41.08 52.76 68.11 -38.51 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 64.06 69.83 -46.45 63.93 71.88 -44.19 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 54.15 68.69 -51.19 53.07 66.38 -49.46 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 28 3 # 28 A 396 ARG D 104 ARG^? 26.47 CL CL D 129 A 581 ARG D 76 ARG^? 33.75 CL CL D 129 A 713 ARG D 73 ARG^? 22.15 CL CL D 129 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 54.44 68.08 -41.08 52.76 68.11 -38.51 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 54.15 68.69 -51.19 53.07 66.38 -49.46 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 64.06 69.83 -46.45 63.93 71.88 -44.19 1jqn_c01 source 1jqn PHOSPHOENOLPYRUVATE CARBOXYLASE : 28 hits 1jqn_c01 naa= 3 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 A 2 GLU B 23 GLU^? 24.68 CL CL B 129 A 56 LYS C 24 LYS^? 26.64 CL CL C 129 A 258 ARG B 96 ARG^? 24.18 CL CL B 129 coo 42.33 1.56 26.99 42.38 2.91 28.66 89.49 70.79 -56.44 87.96 70.01 -57.68 coo 38.45 -0.44 19.89 37.36 0.90 25.90 88.99 74.10 -49.29 84.03 71.99 -51.83 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 78.35 70.58 -59.29 80.55 70.83 -61.45 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 A 2 GLU B 58 GLU^? 7.34 CL CL B 129 A 56 LYS B 43 LYS^? 9.52 CL CL B 129 A 258 ARG B 63 ARG^? 13.99 CL CL B 129 coo 42.33 1.56 26.99 42.38 2.91 28.66 87.90 76.66 -80.19 87.42 74.86 -81.30 coo 38.45 -0.44 19.89 37.36 0.90 25.90 96.64 71.22 -80.00 101.30 72.05 -81.50 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 87.72 77.76 -68.29 88.60 74.86 -67.71 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 A 2 GLU C 23 GLU^? 24.69 CL CL C 129 A 56 LYS B 24 LYS^? 27.82 CL CL B 129 A 258 ARG C 96 ARG^? 24.31 CL CL C 129 coo 42.33 1.56 26.99 42.38 2.91 28.66 93.85 75.25 -49.20 94.57 76.88 -48.00 coo 38.45 -0.44 19.89 37.36 0.90 25.90 90.54 75.59 -56.27 92.78 80.12 -52.52 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 94.28 86.51 -46.29 94.08 84.26 -44.17 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 A 2 GLU D 58 GLU^? 7.39 CL CL D 129 A 56 LYS D 43 LYS^? 9.72 CL CL D 129 A 258 ARG D 63 ARG^? 14.07 CL CL D 129 coo 42.33 1.56 26.99 42.38 2.91 28.66 71.21 74.03 -25.57 69.46 73.32 -24.61 coo 38.45 -0.44 19.89 37.36 0.90 25.90 65.85 82.66 -25.79 66.37 87.54 -24.61 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 72.33 73.68 -37.44 69.36 74.46 -37.99 1k82_c00 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 4 hits 1k82_c00 naa= 3 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 B 2 GLU B 23 GLU^? 24.68 CL CL B 129 B 56 LYS C 24 LYS^? 26.64 CL CL C 129 B 258 ARG B 96 ARG^? 24.18 CL CL B 129 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 89.49 70.79 -56.44 87.96 70.01 -57.68 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 88.99 74.10 -49.29 84.03 71.99 -51.83 coo 2.64 1.83 34.81 1.56 1.13 32.02 78.35 70.58 -59.29 80.55 70.83 -61.45 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 B 2 GLU B 58 GLU^? 7.34 CL CL B 129 B 56 LYS B 43 LYS^? 9.52 CL CL B 129 B 258 ARG B 63 ARG^? 13.99 CL CL B 129 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 87.90 76.66 -80.19 87.42 74.86 -81.30 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 96.64 71.22 -80.00 101.30 72.05 -81.50 coo 2.64 1.83 34.81 1.56 1.13 32.02 87.72 77.76 -68.29 88.60 74.86 -67.71 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 B 2 GLU C 23 GLU^? 24.69 CL CL C 129 B 56 LYS B 24 LYS^? 27.82 CL CL B 129 B 258 ARG C 96 ARG^? 24.31 CL CL C 129 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 93.85 75.25 -49.20 94.57 76.88 -48.00 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 90.54 75.59 -56.27 92.78 80.12 -52.52 coo 2.64 1.83 34.81 1.56 1.13 32.02 94.28 86.51 -46.29 94.08 84.26 -44.17 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 B 2 GLU D 58 GLU^? 7.39 CL CL D 129 B 56 LYS D 43 LYS^? 9.72 CL CL D 129 B 258 ARG D 63 ARG^? 14.07 CL CL D 129 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 71.21 74.03 -25.57 69.46 73.32 -24.61 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 65.85 82.66 -25.79 66.37 87.54 -24.61 coo 2.64 1.83 34.81 1.56 1.13 32.02 72.33 73.68 -37.44 69.36 74.46 -37.99 1k82_c01 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 4 hits 1k82_c01 naa= 3 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 C 2 GLU B 23 GLU^? 24.68 CL CL B 129 C 56 LYS C 24 LYS^? 26.64 CL CL C 129 C 258 ARG B 96 ARG^? 24.18 CL CL B 129 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 89.49 70.79 -56.44 87.96 70.01 -57.68 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 88.99 74.10 -49.29 84.03 71.99 -51.83 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 78.35 70.58 -59.29 80.55 70.83 -61.45 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 C 2 GLU B 58 GLU^? 7.34 CL CL B 129 C 56 LYS B 43 LYS^? 9.52 CL CL B 129 C 258 ARG B 63 ARG^? 13.99 CL CL B 129 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 87.90 76.66 -80.19 87.42 74.86 -81.30 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 96.64 71.22 -80.00 101.30 72.05 -81.50 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 87.72 77.76 -68.29 88.60 74.86 -67.71 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 C 2 GLU C 23 GLU^? 24.69 CL CL C 129 C 56 LYS B 24 LYS^? 27.82 CL CL B 129 C 258 ARG C 96 ARG^? 24.31 CL CL C 129 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 93.85 75.25 -49.20 94.57 76.88 -48.00 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 90.54 75.59 -56.27 92.78 80.12 -52.52 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 94.28 86.51 -46.29 94.08 84.26 -44.17 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 C 2 GLU D 58 GLU^? 7.39 CL CL D 129 C 56 LYS D 43 LYS^? 9.72 CL CL D 129 C 258 ARG D 63 ARG^? 14.07 CL CL D 129 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 71.21 74.03 -25.57 69.46 73.32 -24.61 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 65.85 82.66 -25.79 66.37 87.54 -24.61 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 72.33 73.68 -37.44 69.36 74.46 -37.99 1k82_c02 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 4 hits 1k82_c02 naa= 3 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 D 2 GLU B 23 GLU^? 24.68 CL CL B 129 D 56 LYS C 24 LYS^? 26.64 CL CL C 129 D 258 ARG B 96 ARG^? 24.18 CL CL B 129 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 89.49 70.79 -56.44 87.96 70.01 -57.68 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 88.99 74.10 -49.29 84.03 71.99 -51.83 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 78.35 70.58 -59.29 80.55 70.83 -61.45 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 D 2 GLU B 58 GLU^? 7.34 CL CL B 129 D 56 LYS B 43 LYS^? 9.52 CL CL B 129 D 258 ARG B 63 ARG^? 13.99 CL CL B 129 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 87.90 76.66 -80.19 87.42 74.86 -81.30 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 96.64 71.22 -80.00 101.30 72.05 -81.50 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 87.72 77.76 -68.29 88.60 74.86 -67.71 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 D 2 GLU C 23 GLU^? 24.69 CL CL C 129 D 56 LYS B 24 LYS^? 27.82 CL CL B 129 D 258 ARG C 96 ARG^? 24.31 CL CL C 129 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 93.85 75.25 -49.20 94.57 76.88 -48.00 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 90.54 75.59 -56.27 92.78 80.12 -52.52 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 94.28 86.51 -46.29 94.08 84.26 -44.17 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 D 2 GLU D 58 GLU^? 7.39 CL CL D 129 D 56 LYS D 43 LYS^? 9.72 CL CL D 129 D 258 ARG D 63 ARG^? 14.07 CL CL D 129 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 71.21 74.03 -25.57 69.46 73.32 -24.61 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 65.85 82.66 -25.79 66.37 87.54 -24.61 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 72.33 73.68 -37.44 69.36 74.46 -37.99 1k82_c03 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 4 hits 1k82_c03 naa= 3 ULMN 3 1kim_c00 THYMIDINE KINASE user 1 3 # 1 A 83 GLU A 36 GLU~? 18.47 CL CL A 129 A 163 ARG A 117 ARG^? 16.03 CL CL A 129 A 222 ARG A 21 ARG~? 20.44 CL CL A 129 coo 51.27 81.34 48.31 51.67 80.79 50.28 99.16 43.45 -76.17 99.38 43.10 -78.24 coo 48.06 78.22 50.94 48.51 78.27 53.98 100.59 48.03 -72.66 102.04 46.10 -74.59 coo 54.85 84.16 52.60 54.26 81.23 53.34 98.35 46.51 -82.89 98.57 44.40 -80.63 ULMN 3 1kim_c00 THYMIDINE KINASE user 2 3 # 2 A 83 GLU A 51 GLU^? 16.44 CL CL A 129 A 163 ARG A 46 ARG^? 15.11 CL CL A 129 A 222 ARG A 66 ARG~? 18.83 CL CL A 129 coo 51.27 81.34 48.31 51.67 80.79 50.28 82.00 50.89 -67.09 80.89 51.23 -68.89 coo 48.06 78.22 50.94 48.51 78.27 53.98 87.96 51.20 -70.32 85.08 51.60 -71.34 coo 54.85 84.16 52.60 54.26 81.23 53.34 82.10 46.84 -74.28 82.78 49.65 -75.31 ULMN 3 1kim_c00 THYMIDINE KINASE user 3 3 # 3 A 83 GLU A 93 GLU.? 15.26 CL CL B 129 A 163 ARG A 76 ARG^? 19.15 CL CL B 129 A 222 ARG A 104 ARG^? 18.53 CL CL B 129 coo 51.27 81.34 48.31 51.67 80.79 50.28 84.83 64.69 -81.14 84.26 66.42 -82.32 coo 48.06 78.22 50.94 48.51 78.27 53.98 82.62 63.89 -86.56 80.46 65.21 -84.78 coo 54.85 84.16 52.60 54.26 81.23 53.34 82.19 63.80 -76.53 82.09 65.30 -73.83 ULMN 3 1kim_c00 THYMIDINE KINASE user 4 3 # 4 A 83 GLU A 93 GLU.? 15.26 CL CL B 129 A 163 ARG A 104 ARG^? 18.53 CL CL B 129 A 222 ARG A 76 ARG^? 19.15 CL CL B 129 coo 51.27 81.34 48.31 51.67 80.79 50.28 84.83 64.69 -81.14 84.26 66.42 -82.32 coo 48.06 78.22 50.94 48.51 78.27 53.98 82.19 63.80 -76.53 82.09 65.30 -73.83 coo 54.85 84.16 52.60 54.26 81.23 53.34 82.62 63.89 -86.56 80.46 65.21 -84.78 ULMN 3 1kim_c00 THYMIDINE KINASE user 5 3 # 5 A 83 GLU B 36 GLU^? 18.40 CL CL B 129 A 163 ARG B 117 ARG^? 16.04 CL CL B 129 A 222 ARG B 21 ARG^? 20.28 CL CL B 129 coo 51.27 81.34 48.31 51.67 80.79 50.28 99.20 79.77 -64.83 99.58 80.60 -62.91 coo 48.06 78.22 50.94 48.51 78.27 53.98 100.63 75.34 -68.25 102.08 77.36 -66.41 coo 54.85 84.16 52.60 54.26 81.23 53.34 98.33 76.92 -58.24 98.68 79.03 -60.54 ULMN 3 1kim_c00 THYMIDINE KINASE user 6 3 # 6 A 83 GLU B 93 GLU^? 15.32 CL CL A 129 A 163 ARG B 76 ARG^? 18.98 CL CL A 129 A 222 ARG B 104 ARG^? 18.51 CL CL A 129 coo 51.27 81.34 48.31 51.67 80.79 50.28 84.67 58.80 -60.02 84.04 57.06 -58.91 coo 48.06 78.22 50.94 48.51 78.27 53.98 82.73 59.03 -54.76 80.31 57.91 -56.24 coo 54.85 84.16 52.60 54.26 81.23 53.34 82.09 59.72 -64.70 82.21 58.19 -67.39 ULMN 3 1kim_c00 THYMIDINE KINASE user 7 3 # 7 A 83 GLU B 93 GLU^? 15.32 CL CL A 129 A 163 ARG B 104 ARG^? 18.51 CL CL A 129 A 222 ARG B 76 ARG^? 18.98 CL CL A 129 coo 51.27 81.34 48.31 51.67 80.79 50.28 84.67 58.80 -60.02 84.04 57.06 -58.91 coo 48.06 78.22 50.94 48.51 78.27 53.98 82.09 59.72 -64.70 82.21 58.19 -67.39 coo 54.85 84.16 52.60 54.26 81.23 53.34 82.73 59.03 -54.76 80.31 57.91 -56.24 ULMN 3 1kim_c00 THYMIDINE KINASE user 8 3 # 8 A 83 GLU C 36 GLU^? 18.27 CL CL C 129 A 163 ARG C 117 ARG^? 16.02 CL CL C 129 A 222 ARG C 21 ARG^? 20.59 CL CL C 129 coo 51.27 81.34 48.31 51.67 80.79 50.28 84.85 65.27 -40.53 84.47 64.86 -42.56 coo 48.06 78.22 50.94 48.51 78.27 53.98 89.36 64.01 -37.29 87.40 62.56 -39.24 coo 54.85 84.16 52.60 54.26 81.23 53.34 87.78 66.49 -47.10 85.32 65.73 -45.33 ULMN 3 1kim_c00 THYMIDINE KINASE user 9 3 # 9 A 83 GLU C 51 GLU^? 16.39 CL CL C 129 A 163 ARG C 46 ARG^? 15.12 CL CL C 129 A 222 ARG C 66 ARG^? 18.88 CL CL C 129 coo 51.27 81.34 48.31 51.67 80.79 50.28 92.20 82.64 -31.68 92.61 83.59 -33.56 coo 48.06 78.22 50.94 48.51 78.27 53.98 92.47 76.70 -34.87 92.87 79.50 -36.04 coo 54.85 84.16 52.60 54.26 81.23 53.34 88.18 82.59 -38.84 90.98 81.94 -39.92 ULMN 3 1kim_c00 THYMIDINE KINASE user 10 3 # 10 A 83 GLU C 93 GLU^? 31.51 CL CL C 129 A 163 ARG C 76 ARG^? 33.92 CL CL B 129 A 222 ARG C 104 ARG^? 26.38 CL CL C 129 coo 51.27 81.34 48.31 51.67 80.79 50.28 105.96 79.95 -45.75 107.72 80.63 -46.81 coo 48.06 78.22 50.94 48.51 78.27 53.98 105.54 81.89 -51.05 106.65 84.23 -49.40 coo 54.85 84.16 52.60 54.26 81.23 53.34 105.08 82.46 -41.08 106.56 82.47 -38.36 ULMN 3 1kim_c00 THYMIDINE KINASE user 11 3 # 11 A 83 GLU C 93 GLU^? 31.51 CL CL C 129 A 163 ARG C 104 ARG^? 26.38 CL CL C 129 A 222 ARG C 76 ARG^? 33.92 CL CL B 129 coo 51.27 81.34 48.31 51.67 80.79 50.28 105.96 79.95 -45.75 107.72 80.63 -46.81 coo 48.06 78.22 50.94 48.51 78.27 53.98 105.08 82.46 -41.08 106.56 82.47 -38.36 coo 54.85 84.16 52.60 54.26 81.23 53.34 105.54 81.89 -51.05 106.65 84.23 -49.40 ULMN 3 1kim_c00 THYMIDINE KINASE user 12 3 # 12 A 83 GLU D 36 GLU^? 18.42 CL CL D 129 A 163 ARG D 117 ARG^? 15.96 CL CL D 129 A 222 ARG D 21 ARG^? 20.73 CL CL D 129 coo 51.27 81.34 48.31 51.67 80.79 50.28 74.52 85.40 -40.74 74.64 85.74 -42.81 coo 48.06 78.22 50.94 48.51 78.27 53.98 69.91 86.62 -37.36 71.94 88.06 -39.21 coo 54.85 84.16 52.60 54.26 81.23 53.34 71.50 84.01 -47.23 73.85 84.97 -45.52 ULMN 3 1kim_c00 THYMIDINE KINASE user 13 3 # 13 A 83 GLU D 51 GLU^? 16.56 CL CL D 129 A 163 ARG D 46 ARG^? 15.13 CL CL D 129 A 222 ARG D 66 ARG^? 18.85 CL CL D 129 coo 51.27 81.34 48.31 51.67 80.79 50.28 66.99 68.03 -31.91 66.63 66.88 -33.67 coo 48.06 78.22 50.94 48.51 78.27 53.98 66.74 73.93 -35.00 66.45 71.02 -36.02 coo 54.85 84.16 52.60 54.26 81.23 53.34 71.05 68.08 -38.82 68.22 68.66 -39.87 ULMN 3 1kim_c00 THYMIDINE KINASE user 14 3 # 14 A 83 GLU D 93 GLU^? 31.46 CL CL D 129 A 163 ARG D 76 ARG^? 33.75 CL CL D 129 A 222 ARG D 104 ARG^? 26.47 CL CL D 129 coo 51.27 81.34 48.31 51.67 80.79 50.28 53.41 70.78 -45.84 51.64 70.26 -46.90 coo 48.06 78.22 50.94 48.51 78.27 53.98 54.15 68.69 -51.19 53.07 66.38 -49.46 coo 54.85 84.16 52.60 54.26 81.23 53.34 54.44 68.08 -41.08 52.76 68.11 -38.51 ULMN 3 1kim_c00 THYMIDINE KINASE user 15 3 # 15 A 83 GLU D 93 GLU^? 31.46 CL CL D 129 A 163 ARG D 104 ARG^? 26.47 CL CL D 129 A 222 ARG D 76 ARG^? 33.75 CL CL D 129 coo 51.27 81.34 48.31 51.67 80.79 50.28 53.41 70.78 -45.84 51.64 70.26 -46.90 coo 48.06 78.22 50.94 48.51 78.27 53.98 54.44 68.08 -41.08 52.76 68.11 -38.51 coo 54.85 84.16 52.60 54.26 81.23 53.34 54.15 68.69 -51.19 53.07 66.38 -49.46 1kim_c00 source 1kim THYMIDINE KINASE : 15 hits 1kim_c00 naa= 3 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 1 3 # 1 A 290 ARG C 60 ARG^? 8.92 CL CL C 129 A 351 HIS C 40 HIS^? 7.21 CL CL C 129 A 386 LEU D 64 LEU^? 12.25 CL CL C 129 coo 57.36 53.34 128.83 58.45 50.56 128.34 82.52 72.20 -31.52 80.97 69.57 -31.97 coo 60.60 50.64 133.59 60.63 48.82 132.56 84.82 65.72 -30.75 83.18 66.51 -29.70 coo 63.28 54.23 126.45 63.53 52.07 126.70 78.86 70.66 -34.79 80.10 72.38 -35.38 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 2 3 # 2 A 290 ARG D 60 ARG^? 8.57 CL CL D 129 A 351 HIS D 40 HIS^? 7.31 CL CL D 129 A 386 LEU C 64 LEU^? 12.09 CL CL D 129 coo 57.36 53.34 128.83 58.45 50.56 128.34 76.65 78.50 -31.75 78.13 81.14 -31.78 coo 60.60 50.64 133.59 60.63 48.82 132.56 74.49 84.96 -30.93 76.13 84.16 -29.90 coo 63.28 54.23 126.45 63.53 52.07 126.70 80.41 79.98 -34.71 79.21 78.24 -35.32 1knp_c00 source 1knp L-ASPARTATE OXIDASE : 2 hits 1knp_c00 naa= 3 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 1 3 # 1 255 ASP A 30 ASP~? 20.80 CL CL A 129 262 LYS A 24 LYS~? 27.96 CL CL A 129 336 ARG A 46 ARG^? 15.11 CL CL A 129 coo 61.88 50.78 12.96 63.84 50.60 13.71 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 63.59 44.40 18.32 63.20 49.74 17.95 90.40 47.78 -84.76 92.62 43.20 -88.57 coo 72.60 57.42 15.86 71.61 56.68 18.70 87.96 51.20 -70.32 85.08 51.60 -71.34 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 2 3 # 2 255 ASP A 30 ASP~? 20.80 CL CL A 129 262 LYS A 24 LYS~? 27.96 CL CL A 129 336 ARG A 117 ARG^? 16.03 CL CL A 129 coo 61.88 50.78 12.96 63.84 50.60 13.71 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 63.59 44.40 18.32 63.20 49.74 17.95 90.40 47.78 -84.76 92.62 43.20 -88.57 coo 72.60 57.42 15.86 71.61 56.68 18.70 100.59 48.03 -72.66 102.04 46.10 -74.59 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 3 3 # 3 255 ASP B 30 ASP^? 20.91 CL CL B 129 262 LYS B 24 LYS^? 27.82 CL CL B 129 336 ARG B 46 ARG^? 15.06 CL CL B 129 coo 61.88 50.78 12.96 63.84 50.60 13.71 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 63.59 44.40 18.32 63.20 49.74 17.95 90.54 75.59 -56.27 92.78 80.12 -52.52 coo 72.60 57.42 15.86 71.61 56.68 18.70 87.96 72.13 -70.71 85.05 71.84 -69.78 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 4 3 # 4 255 ASP B 30 ASP^? 20.91 CL CL B 129 262 LYS B 24 LYS^? 27.82 CL CL B 129 336 ARG B 117 ARG^? 16.04 CL CL B 129 coo 61.88 50.78 12.96 63.84 50.60 13.71 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 63.59 44.40 18.32 63.20 49.74 17.95 90.54 75.59 -56.27 92.78 80.12 -52.52 coo 72.60 57.42 15.86 71.61 56.68 18.70 100.63 75.34 -68.25 102.08 77.36 -66.41 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 5 3 # 5 255 ASP C 30 ASP^? 20.67 CL CL C 129 262 LYS C 24 LYS^? 26.64 CL CL C 129 336 ARG C 46 ARG^? 15.12 CL CL C 129 coo 61.88 50.78 12.96 63.84 50.60 13.71 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 63.59 44.40 18.32 63.20 49.74 17.95 88.99 74.10 -49.29 84.03 71.99 -51.83 coo 72.60 57.42 15.86 71.61 56.68 18.70 92.47 76.70 -34.87 92.87 79.50 -36.04 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 6 3 # 6 255 ASP C 30 ASP^? 20.67 CL CL C 129 262 LYS C 24 LYS^? 26.64 CL CL C 129 336 ARG C 117 ARG^? 16.02 CL CL C 129 coo 61.88 50.78 12.96 63.84 50.60 13.71 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 63.59 44.40 18.32 63.20 49.74 17.95 88.99 74.10 -49.29 84.03 71.99 -51.83 coo 72.60 57.42 15.86 71.61 56.68 18.70 89.36 64.01 -37.29 87.40 62.56 -39.24 1lam_c00 source 1lam LEUCINE AMINOPEPTIDASE : 6 hits 1lam_c00 naa= 3 ULMN 3 1lci_c00 LUCIFERASE user 1 3 # 1 218 ARG A 63 ARG~? 13.95 CL CL A 129 245 HIS A 40 HIS.? 7.30 CL CL A 129 343 THR A 44 THR.? 7.93 CL CL A 129 coo 18.11 85.25 41.19 18.04 83.33 43.59 87.85 45.63 -72.60 88.58 48.58 -73.24 coo 5.34 86.23 43.48 6.16 87.26 45.12 98.96 43.60 -66.18 98.11 41.92 -65.26 coo 9.06 92.76 42.80 7.04 92.63 42.14 95.29 52.07 -64.55 95.81 50.95 -66.27 ULMN 3 1lci_c00 LUCIFERASE user 2 3 # 2 218 ARG B 63 ARG^? 13.99 CL CL B 129 245 HIS B 40 HIS^? 7.04 CL CL B 129 343 THR B 44 THR^? 7.91 CL CL B 129 coo 18.11 85.25 41.19 18.04 83.33 43.59 87.72 77.76 -68.29 88.60 74.86 -67.71 coo 5.34 86.23 43.48 6.16 87.26 45.12 98.79 79.91 -74.95 97.97 81.53 -75.99 coo 9.06 92.76 42.80 7.04 92.63 42.14 95.21 71.44 -76.44 95.74 72.60 -74.74 ULMN 3 1lci_c00 LUCIFERASE user 3 3 # 3 218 ARG C 63 ARG^? 14.10 CL CL C 129 245 HIS C 40 HIS^? 7.21 CL CL C 129 343 THR C 44 THR^? 7.82 CL CL C 129 coo 18.11 85.25 41.19 18.04 83.33 43.59 86.96 77.03 -37.50 89.89 76.13 -38.00 coo 5.34 86.23 43.48 6.16 87.26 45.12 84.82 65.72 -30.75 83.18 66.51 -29.70 coo 9.06 92.76 42.80 7.04 92.63 42.14 93.28 69.34 -29.36 92.05 68.81 -31.01 ULMN 3 1lci_c00 LUCIFERASE user 4 3 # 4 218 ARG D 63 ARG^? 14.07 CL CL D 129 245 HIS D 40 HIS^? 7.31 CL CL D 129 343 THR D 44 THR^? 7.93 CL CL D 129 coo 18.11 85.25 41.19 18.04 83.33 43.59 72.33 73.68 -37.44 69.36 74.46 -37.99 coo 5.34 86.23 43.48 6.16 87.26 45.12 74.49 84.96 -30.93 76.13 84.16 -29.90 coo 9.06 92.76 42.80 7.04 92.63 42.14 65.95 81.28 -29.36 67.15 81.78 -31.05 1lci_c00 source 1lci LUCIFERASE : 4 hits 1lci_c00 naa= 3 ULMN 3 1ldm_c01 M4 LACTATE DEHYDROGENASE user 1 3 # 1 166 ASP C 35 ASP^? 10.26 CL CL C 129 169 ARG C 60 ARG^? 8.92 CL CL C 129 193 HIS C 40 HIS^? 7.21 CL CL C 129 coo 20.88 15.91 3.60 20.25 17.72 4.50 83.63 70.73 -36.85 83.32 69.81 -34.96 coo 17.70 17.91 -0.80 15.74 19.74 0.84 82.52 72.20 -31.52 80.97 69.57 -31.97 coo 18.81 19.85 7.63 17.55 19.89 5.97 84.82 65.72 -30.75 83.18 66.51 -29.70 ULMN 3 1ldm_c01 M4 LACTATE DEHYDROGENASE user 2 3 # 2 166 ASP D 35 ASP^? 10.18 CL CL D 129 169 ARG D 60 ARG^? 8.57 CL CL D 129 193 HIS D 40 HIS^? 7.31 CL CL D 129 coo 20.88 15.91 3.60 20.25 17.72 4.50 75.66 79.96 -36.93 75.99 80.66 -34.97 coo 17.70 17.91 -0.80 15.74 19.74 0.84 76.65 78.50 -31.75 78.13 81.14 -31.78 coo 18.81 19.85 7.63 17.55 19.89 5.97 74.49 84.96 -30.93 76.13 84.16 -29.90 1ldm_c01 source 1ldm M4 LACTATE DEHYDROGENASE : 2 hits 1ldm_c01 naa= 3 ULMN 3 1lij_c01 ADENOSINE KINASE user 1 3 # 1 A 316 ALA A 25 ALA~? 20.03 CL CL A 129 A 317 GLY A 28 GLY~? 24.11 CL CL A 129 A 318 ASP A 30 ASP~? 20.80 CL CL A 129 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 90.53 45.57 -81.64 91.65 45.42 -80.63 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 85.98 43.81 -83.42 85.99 44.13 -82.66 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 90.38 41.71 -80.87 92.04 40.39 -80.79 ULMN 3 1lij_c01 ADENOSINE KINASE user 2 3 # 2 A 316 ALA D 25 ALA^? 20.03 CL CL D 129 A 317 GLY D 28 GLY^? 24.21 CL CL D 129 A 318 ASP D 30 ASP^? 20.62 CL CL D 129 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 72.34 76.44 -46.33 72.34 77.58 -45.33 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 74.11 72.03 -48.24 73.79 72.07 -47.47 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 76.16 76.40 -45.40 77.49 78.05 -45.35 1lij_c01 source 1lij ADENOSINE KINASE : 2 hits 1lij_c01 naa= 3 ULMN 3 1lio_c01 ADENOSINE KINASE user 1 3 # 1 A 316 ALA A 25 ALA~? 20.03 CL CL A 129 A 317 GLY A 28 GLY~? 24.11 CL CL A 129 A 318 ASP A 30 ASP~? 20.80 CL CL A 129 coo 27.04 23.54 41.85 25.72 24.19 42.18 90.53 45.57 -81.64 91.65 45.42 -80.63 coo 27.87 23.16 38.17 28.43 22.97 38.87 85.98 43.81 -83.42 85.99 44.13 -82.66 coo 32.11 22.71 40.58 33.42 24.22 39.78 90.38 41.71 -80.87 92.04 40.39 -80.79 ULMN 3 1lio_c01 ADENOSINE KINASE user 2 3 # 2 A 316 ALA B 25 ALA^? 19.89 CL CL B 129 A 317 GLY B 28 GLY^? 24.16 CL CL B 129 A 318 ASP B 30 ASP^? 20.91 CL CL B 129 coo 27.04 23.54 41.85 25.72 24.19 42.18 90.54 77.68 -59.46 91.65 77.73 -60.49 coo 27.87 23.16 38.17 28.43 22.97 38.87 86.10 79.54 -57.45 86.12 79.23 -58.23 coo 32.11 22.71 40.58 33.42 24.22 39.78 90.60 81.40 -60.16 92.15 82.83 -59.97 ULMN 3 1lio_c01 ADENOSINE KINASE user 3 3 # 3 A 316 ALA C 25 ALA^? 19.84 CL CL C 129 A 317 GLY C 28 GLY^? 24.16 CL CL C 129 A 318 ASP C 30 ASP^? 20.67 CL CL C 129 coo 27.04 23.54 41.85 25.72 24.19 42.18 86.92 74.08 -46.13 86.92 72.96 -45.09 coo 27.87 23.16 38.17 28.43 22.97 38.87 85.20 78.69 -48.08 85.51 78.62 -47.31 coo 32.11 22.71 40.58 33.42 24.22 39.78 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1lio_c01 ADENOSINE KINASE user 4 3 # 4 A 316 ALA D 25 ALA^? 20.03 CL CL D 129 A 317 GLY D 28 GLY^? 24.21 CL CL D 129 A 318 ASP D 30 ASP^? 20.62 CL CL D 129 coo 27.04 23.54 41.85 25.72 24.19 42.18 72.34 76.44 -46.33 72.34 77.58 -45.33 coo 27.87 23.16 38.17 28.43 22.97 38.87 74.11 72.03 -48.24 73.79 72.07 -47.47 coo 32.11 22.71 40.58 33.42 24.22 39.78 76.16 76.40 -45.40 77.49 78.05 -45.35 1lio_c01 source 1lio ADENOSINE KINASE : 4 hits 1lio_c01 naa= 3 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP B 72 ASP^? 28.57 CL CL C 129 A 265 GLU D 23 GLU^? 24.49 CL CL D 129 A 369 ASP C 30 ASP^? 20.67 CL CL C 129 coo 11.74 38.14 80.19 10.63 36.40 80.65 80.87 74.36 -54.99 81.74 73.36 -53.35 coo 17.36 23.57 72.04 18.68 21.92 71.98 65.41 75.40 -49.12 64.81 73.78 -47.86 coo 12.19 31.08 87.29 11.13 32.66 86.38 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP C 30 ASP^? 20.67 CL CL C 129 A 265 GLU D 23 GLU^? 24.49 CL CL D 129 A 369 ASP B 72 ASP^? 28.57 CL CL C 129 coo 11.74 38.14 80.19 10.63 36.40 80.65 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 17.36 23.57 72.04 18.68 21.92 71.98 65.41 75.40 -49.12 64.81 73.78 -47.86 coo 12.19 31.08 87.29 11.13 32.66 86.38 80.87 74.36 -54.99 81.74 73.36 -53.35 1m53_c05 source 1m53 ISOMALTULOSE SYNTHASE : 2 hits 1m53_c05 naa= 3 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 86 ASP.? 23.33 CL CL A 129 A 279 GLU A 42 GLU.? 5.77 CL CL A 129 A 369 ASP A 5 ASP~? 21.13 CL CL B 129 coo 11.74 38.14 80.19 10.63 36.40 80.65 108.46 57.22 -73.78 109.48 58.49 -72.45 coo 16.54 46.37 63.94 14.77 45.79 62.95 98.04 48.44 -58.38 99.25 46.68 -58.65 coo 12.19 31.08 87.29 11.13 32.66 86.38 110.30 67.66 -76.72 112.26 68.26 -76.10 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP B 30 ASP^? 20.91 CL CL B 129 A 279 GLU B 51 GLU^? 16.46 CL CL B 129 A 369 ASP C 72 ASP^? 28.53 CL CL B 129 coo 11.74 38.14 80.19 10.63 36.40 80.65 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 16.54 46.37 63.94 14.77 45.79 62.95 81.98 72.56 -73.89 80.95 72.05 -72.12 coo 12.19 31.08 87.29 11.13 32.66 86.38 90.38 83.76 -50.64 91.24 82.68 -52.23 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP B 30 ASP^? 20.91 CL CL B 129 A 279 GLU B 57 GLU^? -5.29 CL CL B 129s A 369 ASP C 72 ASP^? 28.53 CL CL B 129 coo 11.74 38.14 80.19 10.63 36.40 80.65 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 16.54 46.37 63.94 14.77 45.79 62.95 91.24 81.90 -79.46 91.48 82.48 -81.50 coo 12.19 31.08 87.29 11.13 32.66 86.38 90.38 83.76 -50.64 91.24 82.68 -52.23 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP B 72 ASP^? 28.57 CL CL C 129 A 279 GLU B 51 GLU^? 16.46 CL CL B 129 A 369 ASP C 30 ASP^? 20.67 CL CL C 129 coo 11.74 38.14 80.19 10.63 36.40 80.65 80.87 74.36 -54.99 81.74 73.36 -53.35 coo 16.54 46.37 63.94 14.77 45.79 62.95 81.98 72.56 -73.89 80.95 72.05 -72.12 coo 12.19 31.08 87.29 11.13 32.66 86.38 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 5 3 # 5 A 241 ASP B 72 ASP^? 28.57 CL CL C 129 A 279 GLU B 51 GLU^? 16.46 CL CL B 129 A 369 ASP D 30 ASP^? 20.62 CL CL D 129 coo 11.74 38.14 80.19 10.63 36.40 80.65 80.87 74.36 -54.99 81.74 73.36 -53.35 coo 16.54 46.37 63.94 14.77 45.79 62.95 81.98 72.56 -73.89 80.95 72.05 -72.12 coo 12.19 31.08 87.29 11.13 32.66 86.38 76.16 76.40 -45.40 77.49 78.05 -45.35 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 6 3 # 6 A 241 ASP B 86 ASP^? 23.14 CL CL B 129 A 279 GLU B 42 GLU^? 6.42 CL CL B 129 A 369 ASP B 5 ASP^? 20.93 CL CL A 129 coo 11.74 38.14 80.19 10.63 36.40 80.65 108.40 66.17 -67.38 109.32 64.97 -68.84 coo 16.54 46.37 63.94 14.77 45.79 62.95 97.73 74.53 -82.81 99.44 75.81 -82.79 coo 12.19 31.08 87.29 11.13 32.66 86.38 110.10 55.77 -64.66 112.04 55.13 -65.31 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 7 3 # 7 A 241 ASP C 10 ASP^? 12.83 CL CL A 129 A 279 GLU A 57 GLU~? -5.56 CL CL A 129s A 369 ASP C 86 ASP^? 23.12 CL CL C 129 coo 11.74 38.14 80.19 10.63 36.40 80.65 99.63 54.02 -49.94 99.45 52.98 -51.81 coo 16.54 46.37 63.94 14.77 45.79 62.95 91.25 41.69 -61.23 91.08 41.09 -59.17 coo 12.19 31.08 87.29 11.13 32.66 86.38 98.39 56.19 -38.35 99.60 55.15 -36.99 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 8 3 # 8 A 241 ASP C 10 ASP^? 12.83 CL CL A 129 A 279 GLU A 58 GLU~? 7.41 CL CL A 129 A 369 ASP C 86 ASP^? 23.12 CL CL C 129 coo 11.74 38.14 80.19 10.63 36.40 80.65 99.63 54.02 -49.94 99.45 52.98 -51.81 coo 16.54 46.37 63.94 14.77 45.79 62.95 87.85 46.74 -60.89 87.27 48.56 -59.93 coo 12.19 31.08 87.29 11.13 32.66 86.38 98.39 56.19 -38.35 99.60 55.15 -36.99 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 9 3 # 9 A 241 ASP C 14 ASP^? 16.95 CL CL A 129 A 279 GLU A 58 GLU~? 7.41 CL CL A 129 A 369 ASP C 86 ASP^? 23.12 CL CL C 129 coo 11.74 38.14 80.19 10.63 36.40 80.65 95.50 58.88 -47.37 95.04 57.01 -48.29 coo 16.54 46.37 63.94 14.77 45.79 62.95 87.85 46.74 -60.89 87.27 48.56 -59.93 coo 12.19 31.08 87.29 11.13 32.66 86.38 98.39 56.19 -38.35 99.60 55.15 -36.99 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 10 3 # 10 A 241 ASP C 30 ASP^? 20.67 CL CL C 129 A 279 GLU C 51 GLU^? 16.39 CL CL C 129 A 369 ASP B 72 ASP^? 28.57 CL CL C 129 coo 11.74 38.14 80.19 10.63 36.40 80.65 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 16.54 46.37 63.94 14.77 45.79 62.95 92.20 82.64 -31.68 92.61 83.59 -33.56 coo 12.19 31.08 87.29 11.13 32.66 86.38 80.87 74.36 -54.99 81.74 73.36 -53.35 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 11 3 # 11 A 241 ASP C 30 ASP^? 20.67 CL CL C 129 A 279 GLU C 57 GLU^? -5.48 CL CL C 129s A 369 ASP B 72 ASP^? 28.57 CL CL C 129 coo 11.74 38.14 80.19 10.63 36.40 80.65 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 16.54 46.37 63.94 14.77 45.79 62.95 82.94 73.46 -26.00 82.34 73.25 -23.96 coo 12.19 31.08 87.29 11.13 32.66 86.38 80.87 74.36 -54.99 81.74 73.36 -53.35 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 12 3 # 12 A 241 ASP C 72 ASP^? 28.53 CL CL B 129 A 279 GLU C 51 GLU^? 16.39 CL CL C 129 A 369 ASP B 30 ASP^? 20.91 CL CL B 129 coo 11.74 38.14 80.19 10.63 36.40 80.65 90.38 83.76 -50.64 91.24 82.68 -52.23 coo 16.54 46.37 63.94 14.77 45.79 62.95 92.20 82.64 -31.68 92.61 83.59 -33.56 coo 12.19 31.08 87.29 11.13 32.66 86.38 90.60 81.40 -60.16 92.15 82.83 -59.97 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 13 3 # 13 A 241 ASP C 86 ASP^? 23.12 CL CL C 129 A 279 GLU C 42 GLU^? 6.54 CL CL C 129 A 369 ASP C 5 ASP^? 26.16 CL CL A 129 coo 11.74 38.14 80.19 10.63 36.40 80.65 98.39 56.19 -38.35 99.60 55.15 -36.99 coo 16.54 46.37 63.94 14.77 45.79 62.95 90.14 66.47 -23.00 88.99 64.66 -23.57 coo 12.19 31.08 87.29 11.13 32.66 86.38 108.85 54.21 -41.41 109.64 52.31 -40.89 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 14 3 # 14 A 241 ASP D 30 ASP^? 20.62 CL CL D 129 A 279 GLU C 57 GLU^? -5.48 CL CL C 129s A 369 ASP B 72 ASP^? 28.57 CL CL C 129 coo 11.74 38.14 80.19 10.63 36.40 80.65 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 16.54 46.37 63.94 14.77 45.79 62.95 82.94 73.46 -26.00 82.34 73.25 -23.96 coo 12.19 31.08 87.29 11.13 32.66 86.38 80.87 74.36 -54.99 81.74 73.36 -53.35 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 15 3 # 15 A 241 ASP D 30 ASP^? 20.62 CL CL D 129 A 279 GLU D 51 GLU^? 16.56 CL CL D 129 A 369 ASP B 72 ASP^? 28.57 CL CL C 129 coo 11.74 38.14 80.19 10.63 36.40 80.65 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 16.54 46.37 63.94 14.77 45.79 62.95 66.99 68.03 -31.91 66.63 66.88 -33.67 coo 12.19 31.08 87.29 11.13 32.66 86.38 80.87 74.36 -54.99 81.74 73.36 -53.35 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 16 3 # 16 A 241 ASP D 86 ASP^? 23.19 CL CL D 129 A 279 GLU D 42 GLU^? 6.22 CL CL D 129 A 369 ASP D 5 ASP^? 32.88 CL CL D 129 coo 11.74 38.14 80.19 10.63 36.40 80.65 60.79 94.39 -38.32 59.49 95.38 -36.98 coo 16.54 46.37 63.94 14.77 45.79 62.95 69.54 84.23 -23.20 71.02 85.79 -23.65 coo 12.19 31.08 87.29 11.13 32.66 86.38 50.37 96.25 -41.36 49.69 98.16 -40.70 1m53_c06 source 1m53 ISOMALTULOSE SYNTHASE : 16 hits 1m53_c06 naa= 3 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 1 3 # 1 159 ARG A 104 ARG^? 18.53 CL CL B 129 229 SER A 91 SER.? 14.42 CL CL B 129 325 GLU A 93 GLU.? 15.26 CL CL B 129 coo 2.54 15.84 18.57 3.24 17.85 16.30 82.19 63.80 -76.53 82.09 65.30 -73.83 coo 10.17 13.48 15.92 9.61 15.76 15.27 91.69 62.31 -78.52 92.31 64.05 -76.96 coo 5.42 13.04 19.75 5.74 13.81 17.79 84.83 64.69 -81.14 84.26 66.42 -82.32 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 2 3 # 2 159 ARG B 104 ARG^? 18.51 CL CL A 129 229 SER B 91 SER^? 14.45 CL CL A 129 325 GLU B 93 GLU^? 15.32 CL CL A 129 coo 2.54 15.84 18.57 3.24 17.85 16.30 82.09 59.72 -64.70 82.21 58.19 -67.39 coo 10.17 13.48 15.92 9.61 15.76 15.27 91.67 61.18 -62.59 92.49 59.52 -64.12 coo 5.42 13.04 19.75 5.74 13.81 17.79 84.67 58.80 -60.02 84.04 57.06 -58.91 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 3 3 # 3 159 ARG C 104 ARG^? 26.38 CL CL C 129 229 SER C 91 SER^? 24.66 CL CL C 129 325 GLU C 93 GLU^? 31.51 CL CL C 129 coo 2.54 15.84 18.57 3.24 17.85 16.30 105.08 82.46 -41.08 106.56 82.47 -38.36 coo 10.17 13.48 15.92 9.61 15.76 15.27 103.64 72.95 -43.07 105.41 72.14 -41.61 coo 5.42 13.04 19.75 5.74 13.81 17.79 105.96 79.95 -45.75 107.72 80.63 -46.81 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 4 3 # 4 159 ARG D 104 ARG^? 26.47 CL CL D 129 229 SER D 91 SER^? 24.58 CL CL D 129 325 GLU D 93 GLU^? 31.46 CL CL D 129 coo 2.54 15.84 18.57 3.24 17.85 16.30 54.44 68.08 -41.08 52.76 68.11 -38.51 coo 10.17 13.48 15.92 9.61 15.76 15.27 55.66 77.76 -43.22 54.00 78.42 -41.57 coo 5.42 13.04 19.75 5.74 13.81 17.79 53.41 70.78 -45.84 51.64 70.26 -46.90 1mbb_c00 source 1mbb URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYLGLUCOSAMI: 4 hits 1mbb_c00 naa= 3 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 1 3 # 1 A 465 GLY A 50 GLY.? 19.16 CL CL A 129 A 501 ASP A 30 ASP~? 20.80 CL CL A 129 B 367 TYR B 20 TYR^? 23.21 CL CL A 129 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 78.38 54.03 -67.91 79.15 53.85 -67.91 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 94.47 69.13 -54.42 93.73 66.50 -53.85 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 2 3 # 2 A 465 GLY A 50 GLY.? 19.16 CL CL A 129 A 501 ASP D 72 ASP^? 29.64 CL CL D 129 B 367 TYR B 83 TYR^? 15.32 CL CL A 129 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 78.38 54.03 -67.91 79.15 53.85 -67.91 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 69.04 67.18 -50.81 68.23 68.38 -52.37 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 103.38 58.05 -66.28 101.08 56.65 -65.75 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 3 3 # 3 A 465 GLY A 103 GLY^? 22.14 CL CL B 129 A 501 ASP A 30 ASP~? 20.80 CL CL A 129 B 367 TYR B 20 TYR^? 23.21 CL CL A 129 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 80.97 60.18 -78.34 81.20 60.81 -78.81 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 94.47 69.13 -54.42 93.73 66.50 -53.85 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 4 3 # 4 A 465 GLY B 28 GLY^? 24.16 CL CL B 129 A 501 ASP C 35 ASP^? 10.26 CL CL C 129 B 367 TYR B 83 TYR^? 15.32 CL CL A 129 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 86.10 79.54 -57.45 86.12 79.23 -58.23 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 83.63 70.73 -36.85 83.32 69.81 -34.96 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 103.38 58.05 -66.28 101.08 56.65 -65.75 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 5 3 # 5 A 465 GLY B 28 GLY^? 24.16 CL CL B 129 A 501 ASP D 35 ASP^? 10.18 CL CL D 129 B 367 TYR A 54 TYR^? 10.29 CL CL A 129 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 86.10 79.54 -57.45 86.12 79.23 -58.23 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 75.66 79.96 -36.93 75.99 80.66 -34.97 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 89.27 53.06 -59.98 88.13 55.63 -59.94 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 6 3 # 6 A 465 GLY B 28 GLY^? 24.16 CL CL B 129 A 501 ASP D 72 ASP^? 29.64 CL CL D 129 B 367 TYR B 54 TYR^? 10.36 CL CL B 129 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 86.10 79.54 -57.45 86.12 79.23 -58.23 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 69.04 67.18 -50.81 68.23 68.38 -52.37 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 89.19 70.43 -81.07 88.03 67.93 -81.20 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 7 3 # 7 A 465 GLY B 28 GLY^? 24.16 CL CL B 129 A 501 ASP D 72 ASP^? 29.64 CL CL D 129 B 367 TYR B 83 TYR^? 15.32 CL CL A 129 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 86.10 79.54 -57.45 86.12 79.23 -58.23 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 69.04 67.18 -50.81 68.23 68.38 -52.37 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 103.38 58.05 -66.28 101.08 56.65 -65.75 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 8 3 # 8 A 465 GLY B 50 GLY^? 19.23 CL CL B 129 A 501 ASP B 30 ASP^? 20.91 CL CL B 129 B 367 TYR A 20 TYR~? 23.51 CL CL B 129 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 78.37 69.28 -73.15 79.13 69.49 -73.13 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 94.54 54.15 -86.74 93.79 56.81 -87.24 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 9 3 # 9 A 465 GLY B 50 GLY^? 19.23 CL CL B 129 A 501 ASP D 72 ASP^? 29.64 CL CL D 129 B 367 TYR B 83 TYR^? 15.32 CL CL A 129 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 78.37 69.28 -73.15 79.13 69.49 -73.13 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 69.04 67.18 -50.81 68.23 68.38 -52.37 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 103.38 58.05 -66.28 101.08 56.65 -65.75 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 10 3 # 10 A 465 GLY B 70 GLY^? 27.47 CL CL B 129 A 501 ASP D 35 ASP^? 10.18 CL CL D 129 B 367 TYR A 54 TYR^? 10.29 CL CL A 129 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 76.94 75.84 -58.79 77.57 76.20 -59.08 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 75.66 79.96 -36.93 75.99 80.66 -34.97 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 89.27 53.06 -59.98 88.13 55.63 -59.94 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 11 3 # 11 A 465 GLY B 84 GLY^? 21.30 CL CL A 129 A 501 ASP C 14 ASP^? 16.95 CL CL A 129 B 367 TYR B 54 TYR^? 10.36 CL CL B 129 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 109.15 59.88 -65.08 108.46 60.20 -64.65 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 95.50 58.88 -47.37 95.04 57.01 -48.29 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 89.19 70.43 -81.07 88.03 67.93 -81.20 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 12 3 # 12 A 465 GLY B 98 GLY^? 32.50 CL CL A 129 A 501 ASP C 72 ASP^? 28.53 CL CL B 129 B 367 TYR D 47 TYR^? 14.69 CL CL D 129 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 71.95 69.04 -56.35 72.49 68.46 -56.42 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 90.38 83.76 -50.64 91.24 82.68 -52.23 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 60.23 72.82 -30.22 59.55 73.80 -27.71 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 13 3 # 13 A 465 GLY B 103 GLY^? 22.09 CL CL A 129 A 501 ASP B 30 ASP^? 20.91 CL CL B 129 B 367 TYR A 20 TYR~? 23.51 CL CL B 129 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 80.98 63.30 -62.75 81.21 62.64 -62.28 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 94.54 54.15 -86.74 93.79 56.81 -87.24 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 14 3 # 14 A 465 GLY B 103 GLY^? 22.09 CL CL A 129 A 501 ASP B 35 ASP^? 10.19 CL CL B 129 B 367 TYR D 22 TYR^? 17.52 CL CL D 129 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 80.98 63.30 -62.75 81.21 62.64 -62.28 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 93.79 80.98 -68.72 94.61 81.32 -70.62 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 67.44 78.74 -43.16 67.49 76.94 -41.01 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 15 3 # 15 A 465 GLY B 103 GLY^? 22.09 CL CL A 129 A 501 ASP C 14 ASP^? 16.95 CL CL A 129 B 367 TYR D 20 TYR^? 27.97 CL CL D 129 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 80.98 63.30 -62.75 81.21 62.64 -62.28 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 95.50 58.88 -47.37 95.04 57.01 -48.29 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 63.79 80.64 -51.29 61.18 79.77 -51.83 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 16 3 # 16 A 465 GLY B 103 GLY^? 22.09 CL CL A 129 A 501 ASP C 30 ASP^? 20.67 CL CL C 129 B 367 TYR A 83 TYR.? 15.31 CL CL B 129 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 80.98 63.30 -62.75 81.21 62.64 -62.28 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 103.43 65.48 -74.92 101.03 66.78 -75.48 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 17 3 # 17 A 465 GLY C 28 GLY^? 24.16 CL CL C 129 A 501 ASP B 35 ASP^? 10.19 CL CL B 129 B 367 TYR C 83 TYR^? 26.27 CL CL C 129 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 85.20 78.69 -48.08 85.51 78.62 -47.31 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 93.79 80.98 -68.72 94.61 81.32 -70.62 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 106.70 61.17 -39.39 108.02 63.54 -39.97 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 18 3 # 18 A 465 GLY C 50 GLY^? 19.22 CL CL C 129 A 501 ASP D 35 ASP^? 10.18 CL CL D 129 B 367 TYR C 83 TYR^? 26.27 CL CL C 129 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 95.41 86.26 -32.58 95.19 85.50 -32.58 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 75.66 79.96 -36.93 75.99 80.66 -34.97 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 106.70 61.17 -39.39 108.02 63.54 -39.97 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 19 3 # 19 A 465 GLY C 55 GLY^? -3.60 CL CL C 129s A 501 ASP C 86 ASP^? 23.12 CL CL C 129 B 367 TYR D 22 TYR^? 17.52 CL CL D 129 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 90.01 71.78 -26.77 90.18 72.34 -27.33 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 98.39 56.19 -38.35 99.60 55.15 -36.99 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 67.44 78.74 -43.16 67.49 76.94 -41.01 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 20 3 # 20 A 465 GLY C 84 GLY^? 24.82 CL CL A 129 A 501 ASP B 14 ASP^? 27.62 CL CL A 129 B 367 TYR C 54 TYR^? 10.32 CL CL C 129 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 104.77 55.44 -40.68 104.47 56.12 -41.07 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 105.60 69.00 -58.44 107.49 69.47 -57.66 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 94.43 75.36 -24.67 96.94 76.58 -24.67 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 21 3 # 21 A 465 GLY C 115 GLY^? 19.09 CL CL C 129 A 501 ASP D 72 ASP^? 29.64 CL CL D 129 B 367 TYR B 83 TYR^? 15.32 CL CL A 129 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 89.73 59.33 -40.54 89.93 59.44 -39.76 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 69.04 67.18 -50.81 68.23 68.38 -52.37 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 103.38 58.05 -66.28 101.08 56.65 -65.75 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 22 3 # 22 A 465 GLY D 50 GLY^? 19.27 CL CL D 129 A 501 ASP C 35 ASP^? 10.26 CL CL C 129 B 367 TYR D 83 TYR^? 26.42 CL CL D 129 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 63.87 64.31 -32.56 64.09 65.07 -32.58 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 83.63 70.73 -36.85 83.32 69.81 -34.96 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 52.51 89.53 -39.47 51.30 87.12 -40.13 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 23 3 # 23 A 465 GLY D 55 GLY^? -3.63 CL CL D 129s A 501 ASP D 86 ASP^? 23.19 CL CL D 129 B 367 TYR C 22 TYR^? 17.52 CL CL C 129 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 69.35 78.74 -26.78 69.17 78.19 -27.38 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 60.79 94.39 -38.32 59.49 95.38 -36.98 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 91.93 71.84 -43.09 91.81 73.68 -41.00 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 24 3 # 24 A 465 GLY D 70 GLY^? 27.54 CL CL D 129 A 501 ASP D 35 ASP^? 10.18 CL CL D 129 B 367 TYR A 47 TYR^? 14.66 CL CL A 129 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 70.24 62.89 -46.90 70.65 63.48 -46.59 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 75.66 79.96 -36.93 75.99 80.66 -34.97 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 86.78 57.70 -65.64 87.73 58.42 -63.11 1mro_c00 source 1mro METHYL-COENZYME M REDUCTASE : 24 hits 1mro_c00 naa= 3 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 1 3 # 1 D 465 GLY A 50 GLY.? 19.16 CL CL A 129 D 501 ASP A 30 ASP~? 20.80 CL CL A 129 E 367 TYR B 20 TYR^? 23.21 CL CL A 129 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 78.38 54.03 -67.91 79.15 53.85 -67.91 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 94.47 69.13 -54.42 93.73 66.50 -53.85 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 2 3 # 2 D 465 GLY A 50 GLY.? 19.16 CL CL A 129 D 501 ASP D 72 ASP^? 29.64 CL CL D 129 E 367 TYR B 83 TYR^? 15.32 CL CL A 129 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 78.38 54.03 -67.91 79.15 53.85 -67.91 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 69.04 67.18 -50.81 68.23 68.38 -52.37 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 103.38 58.05 -66.28 101.08 56.65 -65.75 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 3 3 # 3 D 465 GLY A 103 GLY^? 22.14 CL CL B 129 D 501 ASP A 30 ASP~? 20.80 CL CL A 129 E 367 TYR B 20 TYR^? 23.21 CL CL A 129 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 80.97 60.18 -78.34 81.20 60.81 -78.81 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 94.47 69.13 -54.42 93.73 66.50 -53.85 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 4 3 # 4 D 465 GLY B 28 GLY^? 24.16 CL CL B 129 D 501 ASP C 35 ASP^? 10.26 CL CL C 129 E 367 TYR B 83 TYR^? 15.32 CL CL A 129 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 86.10 79.54 -57.45 86.12 79.23 -58.23 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 83.63 70.73 -36.85 83.32 69.81 -34.96 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 103.38 58.05 -66.28 101.08 56.65 -65.75 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 5 3 # 5 D 465 GLY B 28 GLY^? 24.16 CL CL B 129 D 501 ASP D 35 ASP^? 10.18 CL CL D 129 E 367 TYR A 54 TYR^? 10.29 CL CL A 129 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 86.10 79.54 -57.45 86.12 79.23 -58.23 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 75.66 79.96 -36.93 75.99 80.66 -34.97 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 89.27 53.06 -59.98 88.13 55.63 -59.94 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 6 3 # 6 D 465 GLY B 28 GLY^? 24.16 CL CL B 129 D 501 ASP D 72 ASP^? 29.64 CL CL D 129 E 367 TYR B 54 TYR^? 10.36 CL CL B 129 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 86.10 79.54 -57.45 86.12 79.23 -58.23 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 69.04 67.18 -50.81 68.23 68.38 -52.37 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 89.19 70.43 -81.07 88.03 67.93 -81.20 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 7 3 # 7 D 465 GLY B 28 GLY^? 24.16 CL CL B 129 D 501 ASP D 72 ASP^? 29.64 CL CL D 129 E 367 TYR B 83 TYR^? 15.32 CL CL A 129 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 86.10 79.54 -57.45 86.12 79.23 -58.23 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 69.04 67.18 -50.81 68.23 68.38 -52.37 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 103.38 58.05 -66.28 101.08 56.65 -65.75 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 8 3 # 8 D 465 GLY B 50 GLY^? 19.23 CL CL B 129 D 501 ASP B 30 ASP^? 20.91 CL CL B 129 E 367 TYR A 20 TYR~? 23.51 CL CL B 129 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 78.37 69.28 -73.15 79.13 69.49 -73.13 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 94.54 54.15 -86.74 93.79 56.81 -87.24 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 9 3 # 9 D 465 GLY B 50 GLY^? 19.23 CL CL B 129 D 501 ASP D 72 ASP^? 29.64 CL CL D 129 E 367 TYR B 83 TYR^? 15.32 CL CL A 129 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 78.37 69.28 -73.15 79.13 69.49 -73.13 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 69.04 67.18 -50.81 68.23 68.38 -52.37 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 103.38 58.05 -66.28 101.08 56.65 -65.75 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 10 3 # 10 D 465 GLY B 70 GLY^? 27.47 CL CL B 129 D 501 ASP D 35 ASP^? 10.18 CL CL D 129 E 367 TYR A 54 TYR^? 10.29 CL CL A 129 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 76.94 75.84 -58.79 77.57 76.20 -59.08 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 75.66 79.96 -36.93 75.99 80.66 -34.97 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 89.27 53.06 -59.98 88.13 55.63 -59.94 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 11 3 # 11 D 465 GLY B 84 GLY^? 21.30 CL CL A 129 D 501 ASP C 14 ASP^? 16.95 CL CL A 129 E 367 TYR B 54 TYR^? 10.36 CL CL B 129 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 109.15 59.88 -65.08 108.46 60.20 -64.65 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 95.50 58.88 -47.37 95.04 57.01 -48.29 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 89.19 70.43 -81.07 88.03 67.93 -81.20 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 12 3 # 12 D 465 GLY B 98 GLY^? 32.50 CL CL A 129 D 501 ASP C 72 ASP^? 28.53 CL CL B 129 E 367 TYR D 47 TYR^? 14.69 CL CL D 129 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 71.95 69.04 -56.35 72.49 68.46 -56.42 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 90.38 83.76 -50.64 91.24 82.68 -52.23 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 60.23 72.82 -30.22 59.55 73.80 -27.71 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 13 3 # 13 D 465 GLY B 103 GLY^? 22.09 CL CL A 129 D 501 ASP B 30 ASP^? 20.91 CL CL B 129 E 367 TYR A 20 TYR~? 23.51 CL CL B 129 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 80.98 63.30 -62.75 81.21 62.64 -62.28 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 94.54 54.15 -86.74 93.79 56.81 -87.24 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 14 3 # 14 D 465 GLY B 103 GLY^? 22.09 CL CL A 129 D 501 ASP B 35 ASP^? 10.19 CL CL B 129 E 367 TYR D 22 TYR^? 17.52 CL CL D 129 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 80.98 63.30 -62.75 81.21 62.64 -62.28 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 93.79 80.98 -68.72 94.61 81.32 -70.62 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 67.44 78.74 -43.16 67.49 76.94 -41.01 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 15 3 # 15 D 465 GLY B 103 GLY^? 22.09 CL CL A 129 D 501 ASP C 14 ASP^? 16.95 CL CL A 129 E 367 TYR D 20 TYR^? 27.97 CL CL D 129 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 80.98 63.30 -62.75 81.21 62.64 -62.28 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 95.50 58.88 -47.37 95.04 57.01 -48.29 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 63.79 80.64 -51.29 61.18 79.77 -51.83 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 16 3 # 16 D 465 GLY B 103 GLY^? 22.09 CL CL A 129 D 501 ASP C 30 ASP^? 20.67 CL CL C 129 E 367 TYR A 83 TYR.? 15.31 CL CL B 129 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 80.98 63.30 -62.75 81.21 62.64 -62.28 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 103.43 65.48 -74.92 101.03 66.78 -75.48 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 17 3 # 17 D 465 GLY C 28 GLY^? 24.16 CL CL C 129 D 501 ASP B 35 ASP^? 10.19 CL CL B 129 E 367 TYR C 83 TYR^? 26.27 CL CL C 129 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 85.20 78.69 -48.08 85.51 78.62 -47.31 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 93.79 80.98 -68.72 94.61 81.32 -70.62 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 106.70 61.17 -39.39 108.02 63.54 -39.97 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 18 3 # 18 D 465 GLY C 50 GLY^? 19.22 CL CL C 129 D 501 ASP D 35 ASP^? 10.18 CL CL D 129 E 367 TYR C 83 TYR^? 26.27 CL CL C 129 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 95.41 86.26 -32.58 95.19 85.50 -32.58 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 75.66 79.96 -36.93 75.99 80.66 -34.97 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 106.70 61.17 -39.39 108.02 63.54 -39.97 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 19 3 # 19 D 465 GLY C 55 GLY^? -3.60 CL CL C 129s D 501 ASP C 86 ASP^? 23.12 CL CL C 129 E 367 TYR D 22 TYR^? 17.52 CL CL D 129 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 90.01 71.78 -26.77 90.18 72.34 -27.33 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 98.39 56.19 -38.35 99.60 55.15 -36.99 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 67.44 78.74 -43.16 67.49 76.94 -41.01 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 20 3 # 20 D 465 GLY C 84 GLY^? 24.82 CL CL A 129 D 501 ASP B 14 ASP^? 27.62 CL CL A 129 E 367 TYR C 54 TYR^? 10.32 CL CL C 129 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 104.77 55.44 -40.68 104.47 56.12 -41.07 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 105.60 69.00 -58.44 107.49 69.47 -57.66 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 94.43 75.36 -24.67 96.94 76.58 -24.67 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 21 3 # 21 D 465 GLY C 115 GLY^? 19.09 CL CL C 129 D 501 ASP D 72 ASP^? 29.64 CL CL D 129 E 367 TYR B 83 TYR^? 15.32 CL CL A 129 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 89.73 59.33 -40.54 89.93 59.44 -39.76 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 69.04 67.18 -50.81 68.23 68.38 -52.37 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 103.38 58.05 -66.28 101.08 56.65 -65.75 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 22 3 # 22 D 465 GLY D 50 GLY^? 19.27 CL CL D 129 D 501 ASP C 35 ASP^? 10.26 CL CL C 129 E 367 TYR D 83 TYR^? 26.42 CL CL D 129 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 63.87 64.31 -32.56 64.09 65.07 -32.58 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 83.63 70.73 -36.85 83.32 69.81 -34.96 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 52.51 89.53 -39.47 51.30 87.12 -40.13 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 23 3 # 23 D 465 GLY D 55 GLY^? -3.63 CL CL D 129s D 501 ASP D 86 ASP^? 23.19 CL CL D 129 E 367 TYR C 22 TYR^? 17.52 CL CL C 129 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 69.35 78.74 -26.78 69.17 78.19 -27.38 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 60.79 94.39 -38.32 59.49 95.38 -36.98 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 91.93 71.84 -43.09 91.81 73.68 -41.00 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 24 3 # 24 D 465 GLY D 70 GLY^? 27.54 CL CL D 129 D 501 ASP D 35 ASP^? 10.18 CL CL D 129 E 367 TYR A 47 TYR^? 14.66 CL CL A 129 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 70.24 62.89 -46.90 70.65 63.48 -46.59 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 75.66 79.96 -36.93 75.99 80.66 -34.97 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 86.78 57.70 -65.64 87.73 58.42 -63.11 1mro_c01 source 1mro METHYL-COENZYME M REDUCTASE : 24 hits 1mro_c01 naa= 3 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 1 3 # 1 A 50 ASP A 5 ASP~? 21.13 CL CL B 129 A 55 TYR A 83 TYR.? 15.31 CL CL B 129 A 84 LYS B 111 LYS^? 25.35 CL CL B 129 coo 11.09 42.89 24.44 11.32 42.06 22.49 110.30 67.66 -76.72 112.26 68.26 -76.10 coo 4.60 40.33 20.42 7.25 39.50 20.05 103.43 65.48 -74.92 101.03 66.78 -75.48 coo 9.71 44.83 15.47 10.13 41.43 19.93 105.89 69.85 -67.01 110.53 70.43 -62.59 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 2 3 # 2 A 50 ASP B 5 ASP^? 20.93 CL CL A 129 A 55 TYR B 83 TYR^? 15.32 CL CL A 129 A 84 LYS A 111 LYS^? 25.43 CL CL A 129 coo 11.09 42.89 24.44 11.32 42.06 22.49 110.10 55.77 -64.66 112.04 55.13 -65.31 coo 4.60 40.33 20.42 7.25 39.50 20.05 103.38 58.05 -66.28 101.08 56.65 -65.75 coo 9.71 44.83 15.47 10.13 41.43 19.93 105.91 53.60 -74.08 110.80 53.18 -78.24 1mrq_c02 source 1mrq ALDO-KETO REDUCTASE FAMILY 1 MEMBER C1 : 2 hits 1mrq_c02 naa= 3 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 A 114 HIS A 40 HIS.? 7.30 CL CL A 129 A 197 ASP A 35 ASP~? 10.31 CL CL A 129 A 223 ALA A 120 ALA^? 13.72 CL CL A 129 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 98.96 43.60 -66.18 98.11 41.92 -65.26 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 93.79 42.35 -72.20 94.79 41.97 -70.38 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 94.30 56.05 -68.63 94.53 57.34 -67.75 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 2 3 # 2 A 114 HIS A 85 HIS.? 26.94 CL CL B 129 A 197 ASP A 5 ASP~? 21.13 CL CL B 129 A 223 ALA A 9 ALA~? 22.52 CL CL B 129 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 112.09 59.31 -75.65 113.04 59.28 -73.77 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 110.30 67.66 -76.72 112.26 68.26 -76.10 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 107.68 62.21 -86.60 108.32 62.45 -87.96 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 3 3 # 3 A 114 HIS B 40 HIS^? 7.04 CL CL B 129 A 197 ASP B 35 ASP^? 10.19 CL CL B 129 A 223 ALA B 120 ALA^? 13.78 CL CL B 129 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 98.79 79.91 -74.95 97.97 81.53 -75.99 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 93.79 80.98 -68.72 94.61 81.32 -70.62 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 94.31 67.35 -72.53 94.56 66.09 -73.32 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 4 3 # 4 A 114 HIS B 85 HIS^? 26.88 CL CL A 129 A 197 ASP B 5 ASP^? 20.93 CL CL A 129 A 223 ALA B 9 ALA^? 22.60 CL CL A 129 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 111.98 64.21 -65.30 113.02 64.33 -67.11 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 110.10 55.77 -64.66 112.04 55.13 -65.31 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 108.07 61.18 -54.73 108.85 60.95 -53.45 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 5 3 # 5 A 114 HIS B 85 HIS^? 26.88 CL CL A 129 A 197 ASP B 5 ASP^? 20.93 CL CL A 129 A 223 ALA B 13 ALA^? 24.68 CL CL A 129 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 111.98 64.21 -65.30 113.02 64.33 -67.11 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 110.10 55.77 -64.66 112.04 55.13 -65.31 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 104.32 66.04 -54.76 105.49 66.26 -53.78 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 6 3 # 6 A 114 HIS C 40 HIS^? 7.21 CL CL C 129 A 197 ASP C 35 ASP^? 10.26 CL CL C 129 A 223 ALA C 120 ALA^? 13.69 CL CL C 129 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 84.82 65.72 -30.75 83.18 66.51 -29.70 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 83.63 70.73 -36.85 83.32 69.81 -34.96 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 97.38 70.27 -33.15 98.65 69.98 -32.40 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 7 3 # 7 A 114 HIS C 85 HIS^? 23.16 CL CL A 129 A 197 ASP C 5 ASP^? 26.16 CL CL A 129 A 223 ALA C 13 ALA^? 16.81 CL CL A 129 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 100.49 52.59 -40.39 100.40 51.57 -38.55 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 108.85 54.21 -41.41 109.64 52.31 -40.89 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 98.64 60.32 -50.92 98.42 59.22 -51.99 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 8 3 # 8 A 114 HIS D 40 HIS^? 7.31 CL CL D 129 A 197 ASP D 35 ASP^? 10.18 CL CL D 129 A 223 ALA D 120 ALA^? 13.80 CL CL D 129 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 74.49 84.96 -30.93 76.13 84.16 -29.90 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 75.66 79.96 -36.93 75.99 80.66 -34.97 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 61.88 80.37 -33.17 60.58 80.64 -32.40 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 9 3 # 9 A 114 HIS D 85 HIS^? 27.00 CL CL D 129 A 197 ASP D 5 ASP^? 32.88 CL CL D 129 A 223 ALA D 9 ALA^? 35.10 CL CL D 129 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 58.77 98.13 -40.30 58.69 99.11 -38.44 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 50.37 96.25 -41.36 49.69 98.16 -40.70 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 55.69 93.75 -51.18 55.39 94.47 -52.49 1n2t_c02 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 9 hits 1n2t_c02 naa= 3 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 B 114 HIS A 40 HIS.? 7.30 CL CL A 129 B 197 ASP A 35 ASP~? 10.31 CL CL A 129 B 223 ALA A 120 ALA^? 13.72 CL CL A 129 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 98.96 43.60 -66.18 98.11 41.92 -65.26 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 93.79 42.35 -72.20 94.79 41.97 -70.38 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 94.30 56.05 -68.63 94.53 57.34 -67.75 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 2 3 # 2 B 114 HIS A 85 HIS.? 26.94 CL CL B 129 B 197 ASP A 5 ASP~? 21.13 CL CL B 129 B 223 ALA A 9 ALA~? 22.52 CL CL B 129 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 112.09 59.31 -75.65 113.04 59.28 -73.77 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 110.30 67.66 -76.72 112.26 68.26 -76.10 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 107.68 62.21 -86.60 108.32 62.45 -87.96 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 3 3 # 3 B 114 HIS B 40 HIS^? 7.04 CL CL B 129 B 197 ASP B 35 ASP^? 10.19 CL CL B 129 B 223 ALA B 120 ALA^? 13.78 CL CL B 129 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 98.79 79.91 -74.95 97.97 81.53 -75.99 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 93.79 80.98 -68.72 94.61 81.32 -70.62 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 94.31 67.35 -72.53 94.56 66.09 -73.32 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 4 3 # 4 B 114 HIS B 85 HIS^? 26.88 CL CL A 129 B 197 ASP B 5 ASP^? 20.93 CL CL A 129 B 223 ALA B 9 ALA^? 22.60 CL CL A 129 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 111.98 64.21 -65.30 113.02 64.33 -67.11 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 110.10 55.77 -64.66 112.04 55.13 -65.31 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 108.07 61.18 -54.73 108.85 60.95 -53.45 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 5 3 # 5 B 114 HIS B 85 HIS^? 26.88 CL CL A 129 B 197 ASP B 5 ASP^? 20.93 CL CL A 129 B 223 ALA B 13 ALA^? 24.68 CL CL A 129 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 111.98 64.21 -65.30 113.02 64.33 -67.11 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 110.10 55.77 -64.66 112.04 55.13 -65.31 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 104.32 66.04 -54.76 105.49 66.26 -53.78 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 6 3 # 6 B 114 HIS C 40 HIS^? 7.21 CL CL C 129 B 197 ASP C 35 ASP^? 10.26 CL CL C 129 B 223 ALA C 120 ALA^? 13.69 CL CL C 129 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 84.82 65.72 -30.75 83.18 66.51 -29.70 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 83.63 70.73 -36.85 83.32 69.81 -34.96 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 97.38 70.27 -33.15 98.65 69.98 -32.40 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 7 3 # 7 B 114 HIS C 85 HIS^? 23.16 CL CL A 129 B 197 ASP C 5 ASP^? 26.16 CL CL A 129 B 223 ALA C 13 ALA^? 16.81 CL CL A 129 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 100.49 52.59 -40.39 100.40 51.57 -38.55 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 108.85 54.21 -41.41 109.64 52.31 -40.89 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 98.64 60.32 -50.92 98.42 59.22 -51.99 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 8 3 # 8 B 114 HIS D 40 HIS^? 7.31 CL CL D 129 B 197 ASP D 35 ASP^? 10.18 CL CL D 129 B 223 ALA D 120 ALA^? 13.80 CL CL D 129 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 74.49 84.96 -30.93 76.13 84.16 -29.90 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 75.66 79.96 -36.93 75.99 80.66 -34.97 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 61.88 80.37 -33.17 60.58 80.64 -32.40 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 9 3 # 9 B 114 HIS D 85 HIS^? 27.00 CL CL D 129 B 197 ASP D 5 ASP^? 32.88 CL CL D 129 B 223 ALA D 9 ALA^? 35.10 CL CL D 129 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 58.77 98.13 -40.30 58.69 99.11 -38.44 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 50.37 96.25 -41.36 49.69 98.16 -40.70 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 55.69 93.75 -51.18 55.39 94.47 -52.49 1n2t_c03 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 9 hits 1n2t_c03 naa= 3 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 1 3 # 1 A 264 HIS A 40 HIS.? 7.30 CL CL A 129 A 290 LYS A 43 LYS.? 9.42 CL CL A 129 A 405 ARG A 46 ARG^? 15.11 CL CL A 129 coo 41.33 25.99 28.05 41.95 26.95 29.80 98.96 43.60 -66.18 98.11 41.92 -65.26 coo 37.11 33.75 31.82 38.72 27.95 29.90 96.70 52.33 -61.01 101.40 51.27 -59.62 coo 42.28 27.98 41.30 43.16 28.14 38.35 87.96 51.20 -70.32 85.08 51.60 -71.34 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 2 3 # 2 A 264 HIS B 40 HIS^? 7.04 CL CL B 129 A 290 LYS B 43 LYS^? 9.52 CL CL B 129 A 405 ARG B 46 ARG^? 15.06 CL CL B 129 coo 41.33 25.99 28.05 41.95 26.95 29.80 98.79 79.91 -74.95 97.97 81.53 -75.99 coo 37.11 33.75 31.82 38.72 27.95 29.90 96.64 71.22 -80.00 101.30 72.05 -81.50 coo 42.28 27.98 41.30 43.16 28.14 38.35 87.96 72.13 -70.71 85.05 71.84 -69.78 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 3 3 # 3 A 264 HIS C 40 HIS^? 7.21 CL CL C 129 A 290 LYS C 43 LYS^? 9.54 CL CL C 129 A 405 ARG C 46 ARG^? 15.12 CL CL C 129 coo 41.33 25.99 28.05 41.95 26.95 29.80 84.82 65.72 -30.75 83.18 66.51 -29.70 coo 37.11 33.75 31.82 38.72 27.95 29.90 93.55 67.94 -25.84 92.76 63.12 -24.35 coo 42.28 27.98 41.30 43.16 28.14 38.35 92.47 76.70 -34.87 92.87 79.50 -36.04 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 4 3 # 4 A 264 HIS D 40 HIS^? 7.31 CL CL D 129 A 290 LYS D 43 LYS^? 9.72 CL CL D 129 A 405 ARG D 46 ARG^? 15.13 CL CL D 129 coo 41.33 25.99 28.05 41.95 26.95 29.80 74.49 84.96 -30.93 76.13 84.16 -29.90 coo 37.11 33.75 31.82 38.72 27.95 29.90 65.85 82.66 -25.79 66.37 87.54 -24.61 coo 42.28 27.98 41.30 43.16 28.14 38.35 66.74 73.93 -35.00 66.45 71.02 -36.02 1nhx_c00 source 1nhx PHOSPHOENOLPYRUVATE CARBOXYKINASE, CYTOSOLIC : 4 hits 1nhx_c00 naa= 3 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 A 99 ARG A 63 ARG~? 13.95 CL CL A 129 A 101 ASP A 35 ASP~? 10.31 CL CL A 129 A 132 ASP A 30 ASP~? 20.80 CL CL A 129 coo 11.61 22.83 17.30 14.06 21.71 15.78 87.85 45.63 -72.60 88.58 48.58 -73.24 coo 11.37 24.94 11.48 12.48 24.45 13.28 93.79 42.35 -72.20 94.79 41.97 -70.38 coo 16.14 18.17 13.37 15.92 19.81 14.71 90.38 41.71 -80.87 92.04 40.39 -80.79 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 A 99 ARG B 63 ARG^? 13.99 CL CL B 129 A 101 ASP B 35 ASP^? 10.19 CL CL B 129 A 132 ASP B 30 ASP^? 20.91 CL CL B 129 coo 11.61 22.83 17.30 14.06 21.71 15.78 87.72 77.76 -68.29 88.60 74.86 -67.71 coo 11.37 24.94 11.48 12.48 24.45 13.28 93.79 80.98 -68.72 94.61 81.32 -70.62 coo 16.14 18.17 13.37 15.92 19.81 14.71 90.60 81.40 -60.16 92.15 82.83 -59.97 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 3 3 # 3 A 99 ARG C 63 ARG^? 14.10 CL CL C 129 A 101 ASP C 35 ASP^? 10.26 CL CL C 129 A 132 ASP C 30 ASP^? 20.67 CL CL C 129 coo 11.61 22.83 17.30 14.06 21.71 15.78 86.96 77.03 -37.50 89.89 76.13 -38.00 coo 11.37 24.94 11.48 12.48 24.45 13.28 83.63 70.73 -36.85 83.32 69.81 -34.96 coo 16.14 18.17 13.37 15.92 19.81 14.71 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 4 3 # 4 A 99 ARG D 63 ARG^? 14.07 CL CL D 129 A 101 ASP D 35 ASP^? 10.18 CL CL D 129 A 132 ASP D 30 ASP^? 20.62 CL CL D 129 coo 11.61 22.83 17.30 14.06 21.71 15.78 72.33 73.68 -37.44 69.36 74.46 -37.99 coo 11.37 24.94 11.48 12.48 24.45 13.28 75.66 79.96 -36.93 75.99 80.66 -34.97 coo 16.14 18.17 13.37 15.92 19.81 14.71 76.16 76.40 -45.40 77.49 78.05 -45.35 1nu3_c00 source 1nu3 LIMONENE-1,2-EPOXIDE HYDROLASE : 4 hits 1nu3_c00 naa= 3 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 B 99 ARG A 63 ARG~? 13.95 CL CL A 129 B 101 ASP A 35 ASP~? 10.31 CL CL A 129 B 132 ASP A 30 ASP~? 20.80 CL CL A 129 coo 11.61 3.43 18.38 9.11 4.29 16.86 87.85 45.63 -72.60 88.58 48.58 -73.24 coo 11.74 0.51 12.98 10.75 1.32 14.67 93.79 42.35 -72.20 94.79 41.97 -70.38 coo 6.93 7.52 14.08 7.18 6.08 15.65 90.38 41.71 -80.87 92.04 40.39 -80.79 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 B 99 ARG B 63 ARG^? 13.99 CL CL B 129 B 101 ASP B 35 ASP^? 10.19 CL CL B 129 B 132 ASP B 30 ASP^? 20.91 CL CL B 129 coo 11.61 3.43 18.38 9.11 4.29 16.86 87.72 77.76 -68.29 88.60 74.86 -67.71 coo 11.74 0.51 12.98 10.75 1.32 14.67 93.79 80.98 -68.72 94.61 81.32 -70.62 coo 6.93 7.52 14.08 7.18 6.08 15.65 90.60 81.40 -60.16 92.15 82.83 -59.97 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 3 3 # 3 B 99 ARG C 63 ARG^? 14.10 CL CL C 129 B 101 ASP C 35 ASP^? 10.26 CL CL C 129 B 132 ASP C 30 ASP^? 20.67 CL CL C 129 coo 11.61 3.43 18.38 9.11 4.29 16.86 86.96 77.03 -37.50 89.89 76.13 -38.00 coo 11.74 0.51 12.98 10.75 1.32 14.67 83.63 70.73 -36.85 83.32 69.81 -34.96 coo 6.93 7.52 14.08 7.18 6.08 15.65 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 4 3 # 4 B 99 ARG D 63 ARG^? 14.07 CL CL D 129 B 101 ASP D 35 ASP^? 10.18 CL CL D 129 B 132 ASP D 30 ASP^? 20.62 CL CL D 129 coo 11.61 3.43 18.38 9.11 4.29 16.86 72.33 73.68 -37.44 69.36 74.46 -37.99 coo 11.74 0.51 12.98 10.75 1.32 14.67 75.66 79.96 -36.93 75.99 80.66 -34.97 coo 6.93 7.52 14.08 7.18 6.08 15.65 76.16 76.40 -45.40 77.49 78.05 -45.35 1nu3_c01 source 1nu3 LIMONENE-1,2-EPOXIDE HYDROLASE : 4 hits 1nu3_c01 naa= 3 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 A 99 ARG A 63 ARG~? 13.95 CL CL A 129 A 101 ASP A 35 ASP~? 10.31 CL CL A 129 A 132 ASP A 30 ASP~? 20.80 CL CL A 129 coo 11.50 22.77 17.24 14.00 21.62 15.86 87.85 45.63 -72.60 88.58 48.58 -73.24 coo 11.19 25.00 11.76 12.16 24.45 13.59 93.79 42.35 -72.20 94.79 41.97 -70.38 coo 16.04 18.11 13.43 15.88 19.70 14.83 90.38 41.71 -80.87 92.04 40.39 -80.79 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 A 99 ARG B 63 ARG^? 13.99 CL CL B 129 A 101 ASP B 35 ASP^? 10.19 CL CL B 129 A 132 ASP B 30 ASP^? 20.91 CL CL B 129 coo 11.50 22.77 17.24 14.00 21.62 15.86 87.72 77.76 -68.29 88.60 74.86 -67.71 coo 11.19 25.00 11.76 12.16 24.45 13.59 93.79 80.98 -68.72 94.61 81.32 -70.62 coo 16.04 18.11 13.43 15.88 19.70 14.83 90.60 81.40 -60.16 92.15 82.83 -59.97 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 3 3 # 3 A 99 ARG C 63 ARG^? 14.10 CL CL C 129 A 101 ASP C 35 ASP^? 10.26 CL CL C 129 A 132 ASP C 30 ASP^? 20.67 CL CL C 129 coo 11.50 22.77 17.24 14.00 21.62 15.86 86.96 77.03 -37.50 89.89 76.13 -38.00 coo 11.19 25.00 11.76 12.16 24.45 13.59 83.63 70.73 -36.85 83.32 69.81 -34.96 coo 16.04 18.11 13.43 15.88 19.70 14.83 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 4 3 # 4 A 99 ARG D 63 ARG^? 14.07 CL CL D 129 A 101 ASP D 35 ASP^? 10.18 CL CL D 129 A 132 ASP D 30 ASP^? 20.62 CL CL D 129 coo 11.50 22.77 17.24 14.00 21.62 15.86 72.33 73.68 -37.44 69.36 74.46 -37.99 coo 11.19 25.00 11.76 12.16 24.45 13.59 75.66 79.96 -36.93 75.99 80.66 -34.97 coo 16.04 18.11 13.43 15.88 19.70 14.83 76.16 76.40 -45.40 77.49 78.05 -45.35 1nww_c02 source 1nww LIMONENE-1,2-EPOXIDE HYDROLASE : 4 hits 1nww_c02 naa= 3 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 B 99 ARG A 63 ARG~? 13.95 CL CL A 129 B 101 ASP A 35 ASP~? 10.31 CL CL A 129 B 132 ASP A 30 ASP~? 20.80 CL CL A 129 coo 11.48 3.09 18.25 9.01 4.07 16.77 87.85 45.63 -72.60 88.58 48.58 -73.24 coo 11.83 0.33 13.01 10.88 1.04 14.81 93.79 42.35 -72.20 94.79 41.97 -70.38 coo 6.85 7.33 14.07 7.10 5.88 15.60 90.38 41.71 -80.87 92.04 40.39 -80.79 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 B 99 ARG B 63 ARG^? 13.99 CL CL B 129 B 101 ASP B 35 ASP^? 10.19 CL CL B 129 B 132 ASP B 30 ASP^? 20.91 CL CL B 129 coo 11.48 3.09 18.25 9.01 4.07 16.77 87.72 77.76 -68.29 88.60 74.86 -67.71 coo 11.83 0.33 13.01 10.88 1.04 14.81 93.79 80.98 -68.72 94.61 81.32 -70.62 coo 6.85 7.33 14.07 7.10 5.88 15.60 90.60 81.40 -60.16 92.15 82.83 -59.97 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 3 3 # 3 B 99 ARG C 63 ARG^? 14.10 CL CL C 129 B 101 ASP C 35 ASP^? 10.26 CL CL C 129 B 132 ASP C 30 ASP^? 20.67 CL CL C 129 coo 11.48 3.09 18.25 9.01 4.07 16.77 86.96 77.03 -37.50 89.89 76.13 -38.00 coo 11.83 0.33 13.01 10.88 1.04 14.81 83.63 70.73 -36.85 83.32 69.81 -34.96 coo 6.85 7.33 14.07 7.10 5.88 15.60 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 4 3 # 4 B 99 ARG D 63 ARG^? 14.07 CL CL D 129 B 101 ASP D 35 ASP^? 10.18 CL CL D 129 B 132 ASP D 30 ASP^? 20.62 CL CL D 129 coo 11.48 3.09 18.25 9.01 4.07 16.77 72.33 73.68 -37.44 69.36 74.46 -37.99 coo 11.83 0.33 13.01 10.88 1.04 14.81 75.66 79.96 -36.93 75.99 80.66 -34.97 coo 6.85 7.33 14.07 7.10 5.88 15.60 76.16 76.40 -45.40 77.49 78.05 -45.35 1nww_c03 source 1nww LIMONENE-1,2-EPOXIDE HYDROLASE : 4 hits 1nww_c03 naa= 3 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 A 24 ASP A 35 ASP~? 10.31 CL CL A 129 A 146 TYR A 22 TYR~? 17.56 CL CL A 129 A 177 LYS A 24 LYS~? 27.96 CL CL A 129 coo -3.50 124.89 25.05 -2.25 124.77 23.26 93.79 42.35 -72.20 94.79 41.97 -70.38 coo 1.87 119.38 16.45 1.41 122.11 16.84 92.72 50.62 -78.45 90.87 50.50 -76.41 coo -2.59 124.07 12.67 -0.91 126.17 18.42 90.40 47.78 -84.76 92.62 43.20 -88.57 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 A 24 ASP A 41 ASP.? 7.60 CL CL A 129 A 146 TYR B 83 TYR^? 15.32 CL CL A 129 A 177 LYS A 111 LYS^? 25.43 CL CL A 129 coo -3.50 124.89 25.05 -2.25 124.77 23.26 99.56 48.98 -63.34 100.43 49.52 -61.53 coo 1.87 119.38 16.45 1.41 122.11 16.84 103.38 58.05 -66.28 101.08 56.65 -65.75 coo -2.59 124.07 12.67 -0.91 126.17 18.42 105.91 53.60 -74.08 110.80 53.18 -78.24 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 A 24 ASP B 35 ASP^? 10.19 CL CL B 129 A 146 TYR B 22 TYR^? 17.56 CL CL B 129 A 177 LYS B 24 LYS^? 27.82 CL CL B 129 coo -3.50 124.89 25.05 -2.25 124.77 23.26 93.79 80.98 -68.72 94.61 81.32 -70.62 coo 1.87 119.38 16.45 1.41 122.11 16.84 92.70 72.76 -62.54 90.90 72.79 -64.68 coo -2.59 124.07 12.67 -0.91 126.17 18.42 90.54 75.59 -56.27 92.78 80.12 -52.52 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 A 24 ASP B 41 ASP^? 7.64 CL CL B 129 A 146 TYR A 83 TYR.? 15.31 CL CL B 129 A 177 LYS B 111 LYS^? 25.35 CL CL B 129 coo -3.50 124.89 25.05 -2.25 124.77 23.26 99.50 74.51 -77.69 100.41 73.95 -79.49 coo 1.87 119.38 16.45 1.41 122.11 16.84 103.43 65.48 -74.92 101.03 66.78 -75.48 coo -2.59 124.07 12.67 -0.91 126.17 18.42 105.89 69.85 -67.01 110.53 70.43 -62.59 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 A 24 ASP C 35 ASP^? 10.26 CL CL C 129 A 146 TYR C 22 TYR^? 17.52 CL CL C 129 A 177 LYS C 24 LYS^? 26.64 CL CL C 129 coo -3.50 124.89 25.05 -2.25 124.77 23.26 83.63 70.73 -36.85 83.32 69.81 -34.96 coo 1.87 119.38 16.45 1.41 122.11 16.84 91.93 71.84 -43.09 91.81 73.68 -41.00 coo -2.59 124.07 12.67 -0.91 126.17 18.42 88.99 74.10 -49.29 84.03 71.99 -51.83 1ok4_c00 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 5 hits 1ok4_c00 naa= 3 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 B 24 ASP A 35 ASP~? 10.31 CL CL A 129 B 146 TYR A 22 TYR~? 17.56 CL CL A 129 B 177 LYS A 24 LYS~? 27.96 CL CL A 129 coo -7.43 109.06 51.23 -5.84 110.54 50.86 93.79 42.35 -72.20 94.79 41.97 -70.38 coo 0.22 114.56 44.62 -0.76 115.18 47.18 92.72 50.62 -78.45 90.87 50.50 -76.41 coo -4.18 120.17 46.85 -4.02 115.31 51.00 90.40 47.78 -84.76 92.62 43.20 -88.57 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 B 24 ASP A 41 ASP.? 7.60 CL CL A 129 B 146 TYR B 83 TYR^? 15.32 CL CL A 129 B 177 LYS A 111 LYS^? 25.43 CL CL A 129 coo -7.43 109.06 51.23 -5.84 110.54 50.86 99.56 48.98 -63.34 100.43 49.52 -61.53 coo 0.22 114.56 44.62 -0.76 115.18 47.18 103.38 58.05 -66.28 101.08 56.65 -65.75 coo -4.18 120.17 46.85 -4.02 115.31 51.00 105.91 53.60 -74.08 110.80 53.18 -78.24 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 B 24 ASP B 35 ASP^? 10.19 CL CL B 129 B 146 TYR B 22 TYR^? 17.56 CL CL B 129 B 177 LYS B 24 LYS^? 27.82 CL CL B 129 coo -7.43 109.06 51.23 -5.84 110.54 50.86 93.79 80.98 -68.72 94.61 81.32 -70.62 coo 0.22 114.56 44.62 -0.76 115.18 47.18 92.70 72.76 -62.54 90.90 72.79 -64.68 coo -4.18 120.17 46.85 -4.02 115.31 51.00 90.54 75.59 -56.27 92.78 80.12 -52.52 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 B 24 ASP B 41 ASP^? 7.64 CL CL B 129 B 146 TYR A 83 TYR.? 15.31 CL CL B 129 B 177 LYS B 111 LYS^? 25.35 CL CL B 129 coo -7.43 109.06 51.23 -5.84 110.54 50.86 99.50 74.51 -77.69 100.41 73.95 -79.49 coo 0.22 114.56 44.62 -0.76 115.18 47.18 103.43 65.48 -74.92 101.03 66.78 -75.48 coo -4.18 120.17 46.85 -4.02 115.31 51.00 105.89 69.85 -67.01 110.53 70.43 -62.59 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 B 24 ASP C 35 ASP^? 10.26 CL CL C 129 B 146 TYR C 22 TYR^? 17.52 CL CL C 129 B 177 LYS C 24 LYS^? 26.64 CL CL C 129 coo -7.43 109.06 51.23 -5.84 110.54 50.86 83.63 70.73 -36.85 83.32 69.81 -34.96 coo 0.22 114.56 44.62 -0.76 115.18 47.18 91.93 71.84 -43.09 91.81 73.68 -41.00 coo -4.18 120.17 46.85 -4.02 115.31 51.00 88.99 74.10 -49.29 84.03 71.99 -51.83 1ok4_c01 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 5 hits 1ok4_c01 naa= 3 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 C 24 ASP A 35 ASP~? 10.31 CL CL A 129 C 146 TYR A 22 TYR~? 17.56 CL CL A 129 C 177 LYS A 24 LYS~? 27.96 CL CL A 129 coo -13.49 79.65 43.90 -12.13 80.29 45.45 93.79 42.35 -72.20 94.79 41.97 -70.38 coo -5.65 86.78 48.49 -7.16 84.72 49.65 92.72 50.62 -78.45 90.87 50.50 -76.41 coo -11.22 87.18 53.49 -10.94 81.64 50.31 90.40 47.78 -84.76 92.62 43.20 -88.57 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 C 24 ASP A 41 ASP.? 7.60 CL CL A 129 C 146 TYR B 83 TYR^? 15.32 CL CL A 129 C 177 LYS A 111 LYS^? 25.43 CL CL A 129 coo -13.49 79.65 43.90 -12.13 80.29 45.45 99.56 48.98 -63.34 100.43 49.52 -61.53 coo -5.65 86.78 48.49 -7.16 84.72 49.65 103.38 58.05 -66.28 101.08 56.65 -65.75 coo -11.22 87.18 53.49 -10.94 81.64 50.31 105.91 53.60 -74.08 110.80 53.18 -78.24 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 C 24 ASP B 35 ASP^? 10.19 CL CL B 129 C 146 TYR B 22 TYR^? 17.56 CL CL B 129 C 177 LYS B 24 LYS^? 27.82 CL CL B 129 coo -13.49 79.65 43.90 -12.13 80.29 45.45 93.79 80.98 -68.72 94.61 81.32 -70.62 coo -5.65 86.78 48.49 -7.16 84.72 49.65 92.70 72.76 -62.54 90.90 72.79 -64.68 coo -11.22 87.18 53.49 -10.94 81.64 50.31 90.54 75.59 -56.27 92.78 80.12 -52.52 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 C 24 ASP B 41 ASP^? 7.64 CL CL B 129 C 146 TYR A 83 TYR.? 15.31 CL CL B 129 C 177 LYS B 111 LYS^? 25.35 CL CL B 129 coo -13.49 79.65 43.90 -12.13 80.29 45.45 99.50 74.51 -77.69 100.41 73.95 -79.49 coo -5.65 86.78 48.49 -7.16 84.72 49.65 103.43 65.48 -74.92 101.03 66.78 -75.48 coo -11.22 87.18 53.49 -10.94 81.64 50.31 105.89 69.85 -67.01 110.53 70.43 -62.59 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 C 24 ASP C 35 ASP^? 10.26 CL CL C 129 C 146 TYR C 22 TYR^? 17.52 CL CL C 129 C 177 LYS C 24 LYS^? 26.64 CL CL C 129 coo -13.49 79.65 43.90 -12.13 80.29 45.45 83.63 70.73 -36.85 83.32 69.81 -34.96 coo -5.65 86.78 48.49 -7.16 84.72 49.65 91.93 71.84 -43.09 91.81 73.68 -41.00 coo -11.22 87.18 53.49 -10.94 81.64 50.31 88.99 74.10 -49.29 84.03 71.99 -51.83 1ok4_c02 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 5 hits 1ok4_c02 naa= 3 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 D 24 ASP A 35 ASP~? 10.31 CL CL A 129 D 146 TYR A 22 TYR~? 17.56 CL CL A 129 D 177 LYS A 24 LYS~? 27.96 CL CL A 129 coo -13.44 77.36 13.12 -12.53 75.97 14.48 93.79 42.35 -72.20 94.79 41.97 -70.38 coo -7.85 74.44 22.75 -9.22 72.86 20.89 92.72 50.62 -78.45 90.87 50.50 -76.41 coo -14.24 70.61 23.48 -12.55 71.73 17.42 90.40 47.78 -84.76 92.62 43.20 -88.57 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 D 24 ASP A 41 ASP.? 7.60 CL CL A 129 D 146 TYR B 83 TYR^? 15.32 CL CL A 129 D 177 LYS A 111 LYS^? 25.43 CL CL A 129 coo -13.44 77.36 13.12 -12.53 75.97 14.48 99.56 48.98 -63.34 100.43 49.52 -61.53 coo -7.85 74.44 22.75 -9.22 72.86 20.89 103.38 58.05 -66.28 101.08 56.65 -65.75 coo -14.24 70.61 23.48 -12.55 71.73 17.42 105.91 53.60 -74.08 110.80 53.18 -78.24 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 D 24 ASP B 35 ASP^? 10.19 CL CL B 129 D 146 TYR B 22 TYR^? 17.56 CL CL B 129 D 177 LYS B 24 LYS^? 27.82 CL CL B 129 coo -13.44 77.36 13.12 -12.53 75.97 14.48 93.79 80.98 -68.72 94.61 81.32 -70.62 coo -7.85 74.44 22.75 -9.22 72.86 20.89 92.70 72.76 -62.54 90.90 72.79 -64.68 coo -14.24 70.61 23.48 -12.55 71.73 17.42 90.54 75.59 -56.27 92.78 80.12 -52.52 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 D 24 ASP B 41 ASP^? 7.64 CL CL B 129 D 146 TYR A 83 TYR.? 15.31 CL CL B 129 D 177 LYS B 111 LYS^? 25.35 CL CL B 129 coo -13.44 77.36 13.12 -12.53 75.97 14.48 99.50 74.51 -77.69 100.41 73.95 -79.49 coo -7.85 74.44 22.75 -9.22 72.86 20.89 103.43 65.48 -74.92 101.03 66.78 -75.48 coo -14.24 70.61 23.48 -12.55 71.73 17.42 105.89 69.85 -67.01 110.53 70.43 -62.59 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 D 24 ASP C 35 ASP^? 10.26 CL CL C 129 D 146 TYR C 22 TYR^? 17.52 CL CL C 129 D 177 LYS C 24 LYS^? 26.64 CL CL C 129 coo -13.44 77.36 13.12 -12.53 75.97 14.48 83.63 70.73 -36.85 83.32 69.81 -34.96 coo -7.85 74.44 22.75 -9.22 72.86 20.89 91.93 71.84 -43.09 91.81 73.68 -41.00 coo -14.24 70.61 23.48 -12.55 71.73 17.42 88.99 74.10 -49.29 84.03 71.99 -51.83 1ok4_c03 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 5 hits 1ok4_c03 naa= 3 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 E 24 ASP A 35 ASP~? 10.31 CL CL A 129 E 146 TYR A 22 TYR~? 17.56 CL CL A 129 E 177 LYS A 24 LYS~? 27.96 CL CL A 129 coo -7.12 105.25 1.43 -6.30 103.34 0.77 93.79 42.35 -72.20 94.79 41.97 -70.38 coo -3.11 94.55 3.01 -3.83 95.92 0.66 92.72 50.62 -78.45 90.87 50.50 -76.41 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 90.40 47.78 -84.76 92.62 43.20 -88.57 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 E 24 ASP A 41 ASP.? 7.60 CL CL A 129 E 146 TYR B 83 TYR^? 15.32 CL CL A 129 E 177 LYS A 111 LYS^? 25.43 CL CL A 129 coo -7.12 105.25 1.43 -6.30 103.34 0.77 99.56 48.98 -63.34 100.43 49.52 -61.53 coo -3.11 94.55 3.01 -3.83 95.92 0.66 103.38 58.05 -66.28 101.08 56.65 -65.75 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 105.91 53.60 -74.08 110.80 53.18 -78.24 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 E 24 ASP B 35 ASP^? 10.19 CL CL B 129 E 146 TYR B 22 TYR^? 17.56 CL CL B 129 E 177 LYS B 24 LYS^? 27.82 CL CL B 129 coo -7.12 105.25 1.43 -6.30 103.34 0.77 93.79 80.98 -68.72 94.61 81.32 -70.62 coo -3.11 94.55 3.01 -3.83 95.92 0.66 92.70 72.76 -62.54 90.90 72.79 -64.68 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 90.54 75.59 -56.27 92.78 80.12 -52.52 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 E 24 ASP B 41 ASP^? 7.64 CL CL B 129 E 146 TYR A 83 TYR.? 15.31 CL CL B 129 E 177 LYS B 111 LYS^? 25.35 CL CL B 129 coo -7.12 105.25 1.43 -6.30 103.34 0.77 99.50 74.51 -77.69 100.41 73.95 -79.49 coo -3.11 94.55 3.01 -3.83 95.92 0.66 103.43 65.48 -74.92 101.03 66.78 -75.48 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 105.89 69.85 -67.01 110.53 70.43 -62.59 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 E 24 ASP C 35 ASP^? 10.26 CL CL C 129 E 146 TYR C 22 TYR^? 17.52 CL CL C 129 E 177 LYS C 24 LYS^? 26.64 CL CL C 129 coo -7.12 105.25 1.43 -6.30 103.34 0.77 83.63 70.73 -36.85 83.32 69.81 -34.96 coo -3.11 94.55 3.01 -3.83 95.92 0.66 91.93 71.84 -43.09 91.81 73.68 -41.00 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 88.99 74.10 -49.29 84.03 71.99 -51.83 1ok4_c04 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 5 hits 1ok4_c04 naa= 3 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 F 24 ASP A 35 ASP~? 10.31 CL CL A 129 F 146 TYR A 22 TYR~? 17.56 CL CL A 129 F 177 LYS A 24 LYS~? 27.96 CL CL A 129 coo -44.75 128.15 10.28 -45.68 129.67 11.55 93.79 42.35 -72.20 94.79 41.97 -70.38 coo -50.43 131.90 19.60 -49.04 133.31 17.60 92.72 50.62 -78.45 90.87 50.50 -76.41 coo -44.10 135.86 19.99 -45.67 134.21 14.07 90.40 47.78 -84.76 92.62 43.20 -88.57 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 F 24 ASP A 41 ASP.? 7.60 CL CL A 129 F 146 TYR B 83 TYR^? 15.32 CL CL A 129 F 177 LYS A 111 LYS^? 25.43 CL CL A 129 coo -44.75 128.15 10.28 -45.68 129.67 11.55 99.56 48.98 -63.34 100.43 49.52 -61.53 coo -50.43 131.90 19.60 -49.04 133.31 17.60 103.38 58.05 -66.28 101.08 56.65 -65.75 coo -44.10 135.86 19.99 -45.67 134.21 14.07 105.91 53.60 -74.08 110.80 53.18 -78.24 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 F 24 ASP B 35 ASP^? 10.19 CL CL B 129 F 146 TYR B 22 TYR^? 17.56 CL CL B 129 F 177 LYS B 24 LYS^? 27.82 CL CL B 129 coo -44.75 128.15 10.28 -45.68 129.67 11.55 93.79 80.98 -68.72 94.61 81.32 -70.62 coo -50.43 131.90 19.60 -49.04 133.31 17.60 92.70 72.76 -62.54 90.90 72.79 -64.68 coo -44.10 135.86 19.99 -45.67 134.21 14.07 90.54 75.59 -56.27 92.78 80.12 -52.52 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 F 24 ASP B 41 ASP^? 7.64 CL CL B 129 F 146 TYR A 83 TYR.? 15.31 CL CL B 129 F 177 LYS B 111 LYS^? 25.35 CL CL B 129 coo -44.75 128.15 10.28 -45.68 129.67 11.55 99.50 74.51 -77.69 100.41 73.95 -79.49 coo -50.43 131.90 19.60 -49.04 133.31 17.60 103.43 65.48 -74.92 101.03 66.78 -75.48 coo -44.10 135.86 19.99 -45.67 134.21 14.07 105.89 69.85 -67.01 110.53 70.43 -62.59 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 F 24 ASP C 35 ASP^? 10.26 CL CL C 129 F 146 TYR C 22 TYR^? 17.52 CL CL C 129 F 177 LYS C 24 LYS^? 26.64 CL CL C 129 coo -44.75 128.15 10.28 -45.68 129.67 11.55 83.63 70.73 -36.85 83.32 69.81 -34.96 coo -50.43 131.90 19.60 -49.04 133.31 17.60 91.93 71.84 -43.09 91.81 73.68 -41.00 coo -44.10 135.86 19.99 -45.67 134.21 14.07 88.99 74.10 -49.29 84.03 71.99 -51.83 1ok4_c05 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 5 hits 1ok4_c05 naa= 3 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 G 24 ASP A 35 ASP~? 10.31 CL CL A 129 G 146 TYR A 22 TYR~? 17.56 CL CL A 129 G 177 LYS A 24 LYS~? 27.96 CL CL A 129 coo -44.97 128.78 41.20 -46.32 128.26 42.83 93.79 42.35 -72.20 94.79 41.97 -70.38 coo -52.83 122.13 46.42 -51.31 124.30 47.39 92.72 50.62 -78.45 90.87 50.50 -76.41 coo -47.30 122.24 51.49 -47.46 127.44 47.81 90.40 47.78 -84.76 92.62 43.20 -88.57 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 G 24 ASP A 41 ASP.? 7.60 CL CL A 129 G 146 TYR B 83 TYR^? 15.32 CL CL A 129 G 177 LYS A 111 LYS^? 25.43 CL CL A 129 coo -44.97 128.78 41.20 -46.32 128.26 42.83 99.56 48.98 -63.34 100.43 49.52 -61.53 coo -52.83 122.13 46.42 -51.31 124.30 47.39 103.38 58.05 -66.28 101.08 56.65 -65.75 coo -47.30 122.24 51.49 -47.46 127.44 47.81 105.91 53.60 -74.08 110.80 53.18 -78.24 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 G 24 ASP B 35 ASP^? 10.19 CL CL B 129 G 146 TYR B 22 TYR^? 17.56 CL CL B 129 G 177 LYS B 24 LYS^? 27.82 CL CL B 129 coo -44.97 128.78 41.20 -46.32 128.26 42.83 93.79 80.98 -68.72 94.61 81.32 -70.62 coo -52.83 122.13 46.42 -51.31 124.30 47.39 92.70 72.76 -62.54 90.90 72.79 -64.68 coo -47.30 122.24 51.49 -47.46 127.44 47.81 90.54 75.59 -56.27 92.78 80.12 -52.52 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 G 24 ASP B 41 ASP^? 7.64 CL CL B 129 G 146 TYR A 83 TYR.? 15.31 CL CL B 129 G 177 LYS B 111 LYS^? 25.35 CL CL B 129 coo -44.97 128.78 41.20 -46.32 128.26 42.83 99.50 74.51 -77.69 100.41 73.95 -79.49 coo -52.83 122.13 46.42 -51.31 124.30 47.39 103.43 65.48 -74.92 101.03 66.78 -75.48 coo -47.30 122.24 51.49 -47.46 127.44 47.81 105.89 69.85 -67.01 110.53 70.43 -62.59 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 G 24 ASP C 35 ASP^? 10.26 CL CL C 129 G 146 TYR C 22 TYR^? 17.52 CL CL C 129 G 177 LYS C 24 LYS^? 26.64 CL CL C 129 coo -44.97 128.78 41.20 -46.32 128.26 42.83 83.63 70.73 -36.85 83.32 69.81 -34.96 coo -52.83 122.13 46.42 -51.31 124.30 47.39 91.93 71.84 -43.09 91.81 73.68 -41.00 coo -47.30 122.24 51.49 -47.46 127.44 47.81 88.99 74.10 -49.29 84.03 71.99 -51.83 1ok4_c06 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 5 hits 1ok4_c06 naa= 3 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 H 24 ASP A 35 ASP~? 10.31 CL CL A 129 H 146 TYR A 22 TYR~? 17.56 CL CL A 129 H 177 LYS A 24 LYS~? 27.96 CL CL A 129 coo -51.11 100.30 51.41 -52.67 98.82 51.12 93.79 42.35 -72.20 94.79 41.97 -70.38 coo -58.70 94.17 45.32 -57.76 93.82 47.92 92.72 50.62 -78.45 90.87 50.50 -76.41 coo -54.32 88.79 48.13 -54.61 94.04 51.74 90.40 47.78 -84.76 92.62 43.20 -88.57 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 H 24 ASP A 41 ASP.? 7.60 CL CL A 129 H 146 TYR B 83 TYR^? 15.32 CL CL A 129 H 177 LYS A 111 LYS^? 25.43 CL CL A 129 coo -51.11 100.30 51.41 -52.67 98.82 51.12 99.56 48.98 -63.34 100.43 49.52 -61.53 coo -58.70 94.17 45.32 -57.76 93.82 47.92 103.38 58.05 -66.28 101.08 56.65 -65.75 coo -54.32 88.79 48.13 -54.61 94.04 51.74 105.91 53.60 -74.08 110.80 53.18 -78.24 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 H 24 ASP B 35 ASP^? 10.19 CL CL B 129 H 146 TYR B 22 TYR^? 17.56 CL CL B 129 H 177 LYS B 24 LYS^? 27.82 CL CL B 129 coo -51.11 100.30 51.41 -52.67 98.82 51.12 93.79 80.98 -68.72 94.61 81.32 -70.62 coo -58.70 94.17 45.32 -57.76 93.82 47.92 92.70 72.76 -62.54 90.90 72.79 -64.68 coo -54.32 88.79 48.13 -54.61 94.04 51.74 90.54 75.59 -56.27 92.78 80.12 -52.52 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 H 24 ASP B 41 ASP^? 7.64 CL CL B 129 H 146 TYR A 83 TYR.? 15.31 CL CL B 129 H 177 LYS B 111 LYS^? 25.35 CL CL B 129 coo -51.11 100.30 51.41 -52.67 98.82 51.12 99.50 74.51 -77.69 100.41 73.95 -79.49 coo -58.70 94.17 45.32 -57.76 93.82 47.92 103.43 65.48 -74.92 101.03 66.78 -75.48 coo -54.32 88.79 48.13 -54.61 94.04 51.74 105.89 69.85 -67.01 110.53 70.43 -62.59 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 H 24 ASP C 35 ASP^? 10.26 CL CL C 129 H 146 TYR C 22 TYR^? 17.52 CL CL C 129 H 177 LYS C 24 LYS^? 26.64 CL CL C 129 coo -51.11 100.30 51.41 -52.67 98.82 51.12 83.63 70.73 -36.85 83.32 69.81 -34.96 coo -58.70 94.17 45.32 -57.76 93.82 47.92 91.93 71.84 -43.09 91.81 73.68 -41.00 coo -54.32 88.79 48.13 -54.61 94.04 51.74 88.99 74.10 -49.29 84.03 71.99 -51.83 1ok4_c07 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 5 hits 1ok4_c07 naa= 3 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 I 24 ASP A 35 ASP~? 10.31 CL CL A 129 I 146 TYR A 22 TYR~? 17.56 CL CL A 129 I 177 LYS A 24 LYS~? 27.96 CL CL A 129 coo -54.65 81.97 26.87 -55.88 81.89 25.07 93.79 42.35 -72.20 94.79 41.97 -70.38 coo -59.92 86.62 17.74 -59.42 83.94 18.40 92.72 50.62 -78.45 90.87 50.50 -76.41 coo -55.38 81.61 14.50 -57.11 80.05 20.41 90.40 47.78 -84.76 92.62 43.20 -88.57 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 I 24 ASP A 41 ASP.? 7.60 CL CL A 129 I 146 TYR B 83 TYR^? 15.32 CL CL A 129 I 177 LYS A 111 LYS^? 25.43 CL CL A 129 coo -54.65 81.97 26.87 -55.88 81.89 25.07 99.56 48.98 -63.34 100.43 49.52 -61.53 coo -59.92 86.62 17.74 -59.42 83.94 18.40 103.38 58.05 -66.28 101.08 56.65 -65.75 coo -55.38 81.61 14.50 -57.11 80.05 20.41 105.91 53.60 -74.08 110.80 53.18 -78.24 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 I 24 ASP B 35 ASP^? 10.19 CL CL B 129 I 146 TYR B 22 TYR^? 17.56 CL CL B 129 I 177 LYS B 24 LYS^? 27.82 CL CL B 129 coo -54.65 81.97 26.87 -55.88 81.89 25.07 93.79 80.98 -68.72 94.61 81.32 -70.62 coo -59.92 86.62 17.74 -59.42 83.94 18.40 92.70 72.76 -62.54 90.90 72.79 -64.68 coo -55.38 81.61 14.50 -57.11 80.05 20.41 90.54 75.59 -56.27 92.78 80.12 -52.52 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 I 24 ASP B 41 ASP^? 7.64 CL CL B 129 I 146 TYR A 83 TYR.? 15.31 CL CL B 129 I 177 LYS B 111 LYS^? 25.35 CL CL B 129 coo -54.65 81.97 26.87 -55.88 81.89 25.07 99.50 74.51 -77.69 100.41 73.95 -79.49 coo -59.92 86.62 17.74 -59.42 83.94 18.40 103.43 65.48 -74.92 101.03 66.78 -75.48 coo -55.38 81.61 14.50 -57.11 80.05 20.41 105.89 69.85 -67.01 110.53 70.43 -62.59 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 I 24 ASP C 35 ASP^? 10.26 CL CL C 129 I 146 TYR C 22 TYR^? 17.52 CL CL C 129 I 177 LYS C 24 LYS^? 26.64 CL CL C 129 coo -54.65 81.97 26.87 -55.88 81.89 25.07 83.63 70.73 -36.85 83.32 69.81 -34.96 coo -59.92 86.62 17.74 -59.42 83.94 18.40 91.93 71.84 -43.09 91.81 73.68 -41.00 coo -55.38 81.61 14.50 -57.11 80.05 20.41 88.99 74.10 -49.29 84.03 71.99 -51.83 1ok4_c08 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 5 hits 1ok4_c08 naa= 3 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 J 24 ASP A 35 ASP~? 10.31 CL CL A 129 J 146 TYR A 22 TYR~? 17.56 CL CL A 129 J 177 LYS A 24 LYS~? 27.96 CL CL A 129 coo -50.64 99.08 1.52 -51.52 100.83 0.67 93.79 42.35 -72.20 94.79 41.97 -70.38 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 92.72 50.62 -78.45 90.87 50.50 -76.41 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 90.40 47.78 -84.76 92.62 43.20 -88.57 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 J 24 ASP A 41 ASP.? 7.60 CL CL A 129 J 146 TYR B 83 TYR^? 15.32 CL CL A 129 J 177 LYS A 111 LYS^? 25.43 CL CL A 129 coo -50.64 99.08 1.52 -51.52 100.83 0.67 99.56 48.98 -63.34 100.43 49.52 -61.53 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 103.38 58.05 -66.28 101.08 56.65 -65.75 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 105.91 53.60 -74.08 110.80 53.18 -78.24 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 J 24 ASP B 35 ASP^? 10.19 CL CL B 129 J 146 TYR B 22 TYR^? 17.56 CL CL B 129 J 177 LYS B 24 LYS^? 27.82 CL CL B 129 coo -50.64 99.08 1.52 -51.52 100.83 0.67 93.79 80.98 -68.72 94.61 81.32 -70.62 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 92.70 72.76 -62.54 90.90 72.79 -64.68 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 90.54 75.59 -56.27 92.78 80.12 -52.52 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 J 24 ASP B 41 ASP^? 7.64 CL CL B 129 J 146 TYR A 83 TYR.? 15.31 CL CL B 129 J 177 LYS B 111 LYS^? 25.35 CL CL B 129 coo -50.64 99.08 1.52 -51.52 100.83 0.67 99.50 74.51 -77.69 100.41 73.95 -79.49 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 103.43 65.48 -74.92 101.03 66.78 -75.48 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 105.89 69.85 -67.01 110.53 70.43 -62.59 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 J 24 ASP C 35 ASP^? 10.26 CL CL C 129 J 146 TYR C 22 TYR^? 17.52 CL CL C 129 J 177 LYS C 24 LYS^? 26.64 CL CL C 129 coo -50.64 99.08 1.52 -51.52 100.83 0.67 83.63 70.73 -36.85 83.32 69.81 -34.96 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 91.93 71.84 -43.09 91.81 73.68 -41.00 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 88.99 74.10 -49.29 84.03 71.99 -51.83 1ok4_c09 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 5 hits 1ok4_c09 naa= 3 ULMN 3 1onr_c00 TRANSALDOLASE B user 1 3 # 1 A 17 ASP B 30 ASP^? 20.91 CL CL B 129 A 96 GLU C 23 GLU^? 24.69 CL CL C 129 A 132 LYS C 24 LYS^? 26.64 CL CL C 129 coo 31.23 12.29 16.44 30.82 11.56 18.39 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 26.82 3.20 24.36 27.99 4.86 24.98 93.85 75.25 -49.20 94.57 76.88 -48.00 coo 29.99 0.62 22.18 30.38 6.69 20.81 88.99 74.10 -49.29 84.03 71.99 -51.83 ULMN 3 1onr_c00 TRANSALDOLASE B user 2 3 # 2 A 17 ASP C 30 ASP^? 20.67 CL CL C 129 A 96 GLU B 23 GLU^? 24.68 CL CL B 129 A 132 LYS B 24 LYS^? 27.82 CL CL B 129 coo 31.23 12.29 16.44 30.82 11.56 18.39 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 26.82 3.20 24.36 27.99 4.86 24.98 89.49 70.79 -56.44 87.96 70.01 -57.68 coo 29.99 0.62 22.18 30.38 6.69 20.81 90.54 75.59 -56.27 92.78 80.12 -52.52 1onr_c00 source 1onr TRANSALDOLASE B : 2 hits 1onr_c00 naa= 3 ULMN 3 1onr_c01 TRANSALDOLASE B user 1 3 # 1 B 17 ASP B 30 ASP^? 20.91 CL CL B 129 B 96 GLU C 23 GLU^? 24.69 CL CL C 129 B 132 LYS C 24 LYS^? 26.64 CL CL C 129 coo 31.16 57.31 -0.94 30.73 56.64 1.01 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 26.69 48.45 7.18 27.85 50.13 7.74 93.85 75.25 -49.20 94.57 76.88 -48.00 coo 29.82 45.80 5.07 30.26 51.81 3.56 88.99 74.10 -49.29 84.03 71.99 -51.83 ULMN 3 1onr_c01 TRANSALDOLASE B user 2 3 # 2 B 17 ASP C 30 ASP^? 20.67 CL CL C 129 B 96 GLU B 23 GLU^? 24.68 CL CL B 129 B 132 LYS B 24 LYS^? 27.82 CL CL B 129 coo 31.16 57.31 -0.94 30.73 56.64 1.01 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 26.69 48.45 7.18 27.85 50.13 7.74 89.49 70.79 -56.44 87.96 70.01 -57.68 coo 29.82 45.80 5.07 30.26 51.81 3.56 90.54 75.59 -56.27 92.78 80.12 -52.52 1onr_c01 source 1onr TRANSALDOLASE B : 2 hits 1onr_c01 naa= 3 ULMN 3 1oyg_c00 LEVANSUCRASE user 1 3 # 1 A 86 ASP A 30 ASP~? 20.80 CL CL A 129 A 247 ASP A 35 ASP~? 10.31 CL CL A 129 A 342 GLU A 36 GLU~? 18.47 CL CL A 129 coo 44.36 35.68 9.71 43.29 36.20 11.51 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 41.40 28.81 12.91 40.82 30.90 12.97 93.79 42.35 -72.20 94.79 41.97 -70.38 coo 40.37 33.11 18.06 39.99 34.93 17.06 99.16 43.45 -76.17 99.38 43.10 -78.24 ULMN 3 1oyg_c00 LEVANSUCRASE user 2 3 # 2 A 86 ASP B 30 ASP^? 20.91 CL CL B 129 A 247 ASP B 35 ASP^? 10.19 CL CL B 129 A 342 GLU B 36 GLU^? 18.40 CL CL B 129 coo 44.36 35.68 9.71 43.29 36.20 11.51 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 41.40 28.81 12.91 40.82 30.90 12.97 93.79 80.98 -68.72 94.61 81.32 -70.62 coo 40.37 33.11 18.06 39.99 34.93 17.06 99.20 79.77 -64.83 99.58 80.60 -62.91 ULMN 3 1oyg_c00 LEVANSUCRASE user 3 3 # 3 A 86 ASP C 30 ASP^? 20.67 CL CL C 129 A 247 ASP C 35 ASP^? 10.26 CL CL C 129 A 342 GLU C 36 GLU^? 18.27 CL CL C 129 coo 44.36 35.68 9.71 43.29 36.20 11.51 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 41.40 28.81 12.91 40.82 30.90 12.97 83.63 70.73 -36.85 83.32 69.81 -34.96 coo 40.37 33.11 18.06 39.99 34.93 17.06 84.85 65.27 -40.53 84.47 64.86 -42.56 ULMN 3 1oyg_c00 LEVANSUCRASE user 4 3 # 4 A 86 ASP D 30 ASP^? 20.62 CL CL D 129 A 247 ASP D 35 ASP^? 10.18 CL CL D 129 A 342 GLU D 36 GLU^? 18.42 CL CL D 129 coo 44.36 35.68 9.71 43.29 36.20 11.51 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 41.40 28.81 12.91 40.82 30.90 12.97 75.66 79.96 -36.93 75.99 80.66 -34.97 coo 40.37 33.11 18.06 39.99 34.93 17.06 74.52 85.40 -40.74 74.64 85.74 -42.81 1oyg_c00 source 1oyg LEVANSUCRASE : 4 hits 1oyg_c00 naa= 3 ULMN 3 1pd2_c02 HEMATOPOIETIC PROSTAGLADIN D SYNTHASuser 1 3 # 1 1 8 TYR A 20 TYR~? 23.51 CL CL B 129 1 14 ARG A 21 ARG~? 20.44 CL CL A 129 1 104 TRP A 116 TRP^? 22.19 CL CL A 129 coo -6.26 36.66 22.35 -5.62 38.66 24.20 94.54 54.15 -86.74 93.79 56.81 -87.24 coo -1.84 42.97 23.45 -1.37 45.90 22.68 98.35 46.51 -82.89 98.57 44.40 -80.63 coo -2.17 45.44 30.78 -5.80 46.76 31.55 104.36 52.76 -78.95 104.76 56.25 -77.21 ULMN 3 1pd2_c02 HEMATOPOIETIC PROSTAGLADIN D SYNTHASuser 2 3 # 2 1 8 TYR A 22 TYR~? 17.56 CL CL A 129 1 14 ARG A 21 ARG~? 20.44 CL CL A 129 1 104 TRP A 116 TRP^? 22.19 CL CL A 129 coo -6.26 36.66 22.35 -5.62 38.66 24.20 92.72 50.62 -78.45 90.87 50.50 -76.41 coo -1.84 42.97 23.45 -1.37 45.90 22.68 98.35 46.51 -82.89 98.57 44.40 -80.63 coo -2.17 45.44 30.78 -5.80 46.76 31.55 104.36 52.76 -78.95 104.76 56.25 -77.21 ULMN 3 1pd2_c02 HEMATOPOIETIC PROSTAGLADIN D SYNTHASuser 3 3 # 3 1 8 TYR B 20 TYR^? 23.21 CL CL A 129 1 14 ARG B 21 ARG^? 20.28 CL CL B 129 1 104 TRP B 116 TRP^? 22.29 CL CL B 129 coo -6.26 36.66 22.35 -5.62 38.66 24.20 94.47 69.13 -54.42 93.73 66.50 -53.85 coo -1.84 42.97 23.45 -1.37 45.90 22.68 98.33 76.92 -58.24 98.68 79.03 -60.54 coo -2.17 45.44 30.78 -5.80 46.76 31.55 104.47 70.62 -62.04 104.86 67.13 -63.82 ULMN 3 1pd2_c02 HEMATOPOIETIC PROSTAGLADIN D SYNTHASuser 4 3 # 4 1 8 TYR B 22 TYR^? 17.56 CL CL B 129 1 14 ARG B 21 ARG^? 20.28 CL CL B 129 1 104 TRP B 116 TRP^? 22.29 CL CL B 129 coo -6.26 36.66 22.35 -5.62 38.66 24.20 92.70 72.76 -62.54 90.90 72.79 -64.68 coo -1.84 42.97 23.45 -1.37 45.90 22.68 98.33 76.92 -58.24 98.68 79.03 -60.54 coo -2.17 45.44 30.78 -5.80 46.76 31.55 104.47 70.62 -62.04 104.86 67.13 -63.82 ULMN 3 1pd2_c02 HEMATOPOIETIC PROSTAGLADIN D SYNTHASuser 5 3 # 5 1 8 TYR C 20 TYR^? 26.72 CL CL A 129 1 14 ARG C 21 ARG^? 20.59 CL CL C 129 1 104 TRP C 116 TRP^? 22.09 CL CL C 129 coo -6.26 36.66 22.35 -5.62 38.66 24.20 95.56 70.07 -51.22 98.17 70.86 -51.76 coo -1.84 42.97 23.45 -1.37 45.90 22.68 87.78 66.49 -47.10 85.32 65.73 -45.33 coo -2.17 45.44 30.78 -5.80 46.76 31.55 93.93 60.18 -43.49 97.47 59.81 -41.82 ULMN 3 1pd2_c02 HEMATOPOIETIC PROSTAGLADIN D SYNTHASuser 6 3 # 6 1 8 TYR C 22 TYR^? 17.52 CL CL C 129 1 14 ARG C 21 ARG^? 20.59 CL CL C 129 1 104 TRP C 116 TRP^? 22.09 CL CL C 129 coo -6.26 36.66 22.35 -5.62 38.66 24.20 91.93 71.84 -43.09 91.81 73.68 -41.00 coo -1.84 42.97 23.45 -1.37 45.90 22.68 87.78 66.49 -47.10 85.32 65.73 -45.33 coo -2.17 45.44 30.78 -5.80 46.76 31.55 93.93 60.18 -43.49 97.47 59.81 -41.82 1pd2_c02 source 1pd2 HEMATOPOIETIC PROSTAGLADIN D SYNTHASE : 6 hits 1pd2_c02 naa= 3 ULMN 3 1pd2_c03 HEMATOPOIETIC PROSTAGLADIN D SYNTHASuser 1 3 # 1 2 8 TYR A 20 TYR~? 23.51 CL CL B 129 2 14 ARG A 21 ARG~? 20.44 CL CL A 129 2 104 TRP A 116 TRP^? 22.19 CL CL A 129 coo 14.82 62.39 20.28 14.73 60.21 22.02 94.54 54.15 -86.74 93.79 56.81 -87.24 coo 10.81 55.96 22.08 10.04 53.12 21.26 98.35 46.51 -82.89 98.57 44.40 -80.63 coo 13.42 52.88 28.75 17.04 51.48 28.24 104.36 52.76 -78.95 104.76 56.25 -77.21 ULMN 3 1pd2_c03 HEMATOPOIETIC PROSTAGLADIN D SYNTHASuser 2 3 # 2 2 8 TYR A 22 TYR~? 17.56 CL CL A 129 2 14 ARG A 21 ARG~? 20.44 CL CL A 129 2 104 TRP A 116 TRP^? 22.19 CL CL A 129 coo 14.82 62.39 20.28 14.73 60.21 22.02 92.72 50.62 -78.45 90.87 50.50 -76.41 coo 10.81 55.96 22.08 10.04 53.12 21.26 98.35 46.51 -82.89 98.57 44.40 -80.63 coo 13.42 52.88 28.75 17.04 51.48 28.24 104.36 52.76 -78.95 104.76 56.25 -77.21 ULMN 3 1pd2_c03 HEMATOPOIETIC PROSTAGLADIN D SYNTHASuser 3 3 # 3 2 8 TYR B 20 TYR^? 23.21 CL CL A 129 2 14 ARG B 21 ARG^? 20.28 CL CL B 129 2 104 TRP B 116 TRP^? 22.29 CL CL B 129 coo 14.82 62.39 20.28 14.73 60.21 22.02 94.47 69.13 -54.42 93.73 66.50 -53.85 coo 10.81 55.96 22.08 10.04 53.12 21.26 98.33 76.92 -58.24 98.68 79.03 -60.54 coo 13.42 52.88 28.75 17.04 51.48 28.24 104.47 70.62 -62.04 104.86 67.13 -63.82 ULMN 3 1pd2_c03 HEMATOPOIETIC PROSTAGLADIN D SYNTHASuser 4 3 # 4 2 8 TYR B 22 TYR^? 17.56 CL CL B 129 2 14 ARG B 21 ARG^? 20.28 CL CL B 129 2 104 TRP B 116 TRP^? 22.29 CL CL B 129 coo 14.82 62.39 20.28 14.73 60.21 22.02 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 10.81 55.96 22.08 10.04 53.12 21.26 98.33 76.92 -58.24 98.68 79.03 -60.54 coo 13.42 52.88 28.75 17.04 51.48 28.24 104.47 70.62 -62.04 104.86 67.13 -63.82 ULMN 3 1pd2_c03 HEMATOPOIETIC PROSTAGLADIN D SYNTHASuser 5 3 # 5 2 8 TYR C 20 TYR^? 26.72 CL CL A 129 2 14 ARG C 21 ARG^? 20.59 CL CL C 129 2 104 TRP C 116 TRP^? 22.09 CL CL C 129 coo 14.82 62.39 20.28 14.73 60.21 22.02 95.56 70.07 -51.22 98.17 70.86 -51.76 coo 10.81 55.96 22.08 10.04 53.12 21.26 87.78 66.49 -47.10 85.32 65.73 -45.33 coo 13.42 52.88 28.75 17.04 51.48 28.24 93.93 60.18 -43.49 97.47 59.81 -41.82 ULMN 3 1pd2_c03 HEMATOPOIETIC PROSTAGLADIN D SYNTHASuser 6 3 # 6 2 8 TYR C 22 TYR^? 17.52 CL CL C 129 2 14 ARG C 21 ARG^? 20.59 CL CL C 129 2 104 TRP C 116 TRP^? 22.09 CL CL C 129 coo 14.82 62.39 20.28 14.73 60.21 22.02 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 10.81 55.96 22.08 10.04 53.12 21.26 87.78 66.49 -47.10 85.32 65.73 -45.33 coo 13.42 52.88 28.75 17.04 51.48 28.24 93.93 60.18 -43.49 97.47 59.81 -41.82 ULMN 3 1pd2_c03 HEMATOPOIETIC PROSTAGLADIN D SYNTHASuser 7 3 # 7 2 8 TYR D 20 TYR^? 27.97 CL CL D 129 2 14 ARG D 21 ARG^? 20.73 CL CL D 129 2 104 TRP D 116 TRP^? 22.18 CL CL D 129 coo 14.82 62.39 20.28 14.73 60.21 22.02 63.79 80.64 -51.29 61.18 79.77 -51.83 coo 10.81 55.96 22.08 10.04 53.12 21.26 71.50 84.01 -47.23 73.85 84.97 -45.52 coo 13.42 52.88 28.75 17.04 51.48 28.24 65.21 90.46 -43.56 61.70 90.81 -41.84 ULMN 3 1pd2_c03 HEMATOPOIETIC PROSTAGLADIN D SYNTHASuser 8 3 # 8 2 8 TYR D 22 TYR^? 17.52 CL CL D 129 2 14 ARG D 21 ARG^? 20.73 CL CL D 129 2 104 TRP D 116 TRP^? 22.18 CL CL D 129 coo 14.82 62.39 20.28 14.73 60.21 22.02 67.44 78.74 -43.16 67.49 76.94 -41.01 coo 10.81 55.96 22.08 10.04 53.12 21.26 71.50 84.01 -47.23 73.85 84.97 -45.52 coo 13.42 52.88 28.75 17.04 51.48 28.24 65.21 90.46 -43.56 61.70 90.81 -41.84 1pd2_c03 source 1pd2 HEMATOPOIETIC PROSTAGLADIN D SYNTHASE : 8 hits 1pd2_c03 naa= 3 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 A 70 ALA A 18 ALA~? 21.90 CL CL A 129 A 126 LEU A 37 LEU~? 16.93 CL CL A 129 A 158 GLU A 36 GLU~? 18.47 CL CL A 129 coo -2.29 37.66 144.73 -1.46 37.12 145.87 99.18 51.59 -82.01 100.04 51.92 -80.81 coo -4.62 32.83 147.14 -5.50 32.85 149.12 96.51 48.08 -76.23 97.22 47.90 -78.26 coo -0.83 29.57 149.77 -0.39 31.47 148.95 99.16 43.45 -76.17 99.38 43.10 -78.24 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 A 70 ALA A 25 ALA~? 20.03 CL CL A 129 A 126 LEU A 26 LEU~? 19.99 CL CL A 129 A 158 GLU A 23 GLU~? 24.22 CL CL A 129 coo -2.29 37.66 144.73 -1.46 37.12 145.87 90.53 45.57 -81.64 91.65 45.42 -80.63 coo -4.62 32.83 147.14 -5.50 32.85 149.12 87.88 49.17 -79.75 86.71 50.33 -78.46 coo -0.83 29.57 149.77 -0.39 31.47 148.95 89.42 52.54 -84.47 88.08 53.22 -82.95 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 A 70 ALA A 74 ALA^? 25.51 CL CL B 129 A 126 LEU A 75 LEU^? 22.14 CL CL B 129 A 158 GLU A 23 GLU~? 24.22 CL CL A 129 coo -2.29 37.66 144.73 -1.46 37.12 145.87 83.09 56.12 -87.11 82.22 56.78 -88.15 coo -4.62 32.83 147.14 -5.50 32.85 149.12 87.34 57.94 -85.51 88.07 56.56 -84.03 coo -0.83 29.57 149.77 -0.39 31.47 148.95 89.42 52.54 -84.47 88.08 53.22 -82.95 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 A 70 ALA B 18 ALA^? 21.77 CL CL B 129 A 126 LEU B 37 LEU^? 16.91 CL CL B 129 A 158 GLU B 36 GLU^? 18.40 CL CL B 129 coo -2.29 37.66 144.73 -1.46 37.12 145.87 99.18 71.71 -59.12 100.04 71.44 -60.38 coo -4.62 32.83 147.14 -5.50 32.85 149.12 96.50 75.38 -64.79 97.32 75.47 -62.77 coo -0.83 29.57 149.77 -0.39 31.47 148.95 99.20 79.77 -64.83 99.58 80.60 -62.91 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 A 70 ALA B 74 ALA^? 25.18 CL CL A 129 A 126 LEU B 75 LEU^? 21.85 CL CL A 129 A 158 GLU B 23 GLU^? 24.68 CL CL B 129 coo -2.29 37.66 144.73 -1.46 37.12 145.87 83.11 67.09 -53.84 82.12 66.37 -52.99 coo -4.62 32.83 147.14 -5.50 32.85 149.12 87.39 65.27 -55.28 88.04 66.65 -56.89 coo -0.83 29.57 149.77 -0.39 31.47 148.95 89.49 70.79 -56.44 87.96 70.01 -57.68 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 A 70 ALA C 18 ALA^? 21.69 CL CL C 129 A 126 LEU C 37 LEU^? 16.94 CL CL C 129 A 158 GLU C 36 GLU^? 18.27 CL CL C 129 coo -2.29 37.66 144.73 -1.46 37.12 145.87 92.95 65.41 -46.51 93.28 64.58 -45.23 coo -4.62 32.83 147.14 -5.50 32.85 149.12 89.29 68.10 -40.88 89.21 67.27 -42.93 coo -0.83 29.57 149.77 -0.39 31.47 148.95 84.85 65.27 -40.53 84.47 64.86 -42.56 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 A 70 ALA C 25 ALA^? 19.84 CL CL C 129 A 126 LEU C 26 LEU^? 19.92 CL CL C 129 A 158 GLU C 23 GLU^? 24.69 CL CL C 129 coo -2.29 37.66 144.73 -1.46 37.12 145.87 86.92 74.08 -46.13 86.92 72.96 -45.09 coo -4.62 32.83 147.14 -5.50 32.85 149.12 90.57 76.76 -44.41 91.64 77.85 -42.91 coo -0.83 29.57 149.77 -0.39 31.47 148.95 93.85 75.25 -49.20 94.57 76.88 -48.00 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 A 70 ALA C 74 ALA^? 28.16 CL CL B 129 A 126 LEU C 75 LEU^? 27.56 CL CL C 129 A 158 GLU C 23 GLU^? 24.69 CL CL C 129 coo -2.29 37.66 144.73 -1.46 37.12 145.87 97.55 81.50 -51.82 98.27 82.42 -52.76 coo -4.62 32.83 147.14 -5.50 32.85 149.12 99.28 77.24 -50.30 98.02 76.57 -48.72 coo -0.83 29.57 149.77 -0.39 31.47 148.95 93.85 75.25 -49.20 94.57 76.88 -48.00 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 9 3 # 9 A 70 ALA D 18 ALA^? 21.57 CL CL D 129 A 126 LEU D 37 LEU^? 16.93 CL CL D 129 A 158 GLU D 36 GLU^? 18.42 CL CL D 129 coo -2.29 37.66 144.73 -1.46 37.12 145.87 66.51 85.11 -46.53 66.24 85.90 -45.23 coo -4.62 32.83 147.14 -5.50 32.85 149.12 69.99 82.51 -40.93 70.04 83.48 -42.91 coo -0.83 29.57 149.77 -0.39 31.47 148.95 74.52 85.40 -40.74 74.64 85.74 -42.81 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 10 3 # 10 A 70 ALA D 74 ALA^? 31.91 CL CL D 129 A 126 LEU D 75 LEU^? 27.42 CL CL D 129 A 158 GLU D 23 GLU^? 24.49 CL CL D 129 coo -2.29 37.66 144.73 -1.46 37.12 145.87 61.88 69.17 -51.85 61.21 68.28 -52.90 coo -4.62 32.83 147.14 -5.50 32.85 149.12 60.12 73.44 -50.26 61.41 74.10 -48.64 coo -0.83 29.57 149.77 -0.39 31.47 148.95 65.41 75.40 -49.12 64.81 73.78 -47.86 1pjh_c00 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 10 hits 1pjh_c00 naa= 3 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 B 70 ALA A 18 ALA~? 21.90 CL CL A 129 B 126 LEU A 37 LEU~? 16.93 CL CL A 129 B 158 GLU A 36 GLU~? 18.47 CL CL A 129 coo -39.79 4.61 147.27 -39.61 5.56 148.47 99.18 51.59 -82.01 100.04 51.92 -80.81 coo -34.22 5.06 149.25 -33.65 4.24 151.15 96.51 48.08 -76.23 97.22 47.90 -78.26 coo -33.03 9.93 151.71 -34.98 9.38 151.11 99.16 43.45 -76.17 99.38 43.10 -78.24 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 B 70 ALA A 74 ALA^? 25.51 CL CL B 129 B 126 LEU A 75 LEU^? 22.14 CL CL B 129 B 158 GLU A 23 GLU~? 24.22 CL CL A 129 coo -39.79 4.61 147.27 -39.61 5.56 148.47 83.09 56.12 -87.11 82.22 56.78 -88.15 coo -34.22 5.06 149.25 -33.65 4.24 151.15 87.34 57.94 -85.51 88.07 56.56 -84.03 coo -33.03 9.93 151.71 -34.98 9.38 151.11 89.42 52.54 -84.47 88.08 53.22 -82.95 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 B 70 ALA B 18 ALA^? 21.77 CL CL B 129 B 126 LEU B 37 LEU^? 16.91 CL CL B 129 B 158 GLU B 36 GLU^? 18.40 CL CL B 129 coo -39.79 4.61 147.27 -39.61 5.56 148.47 99.18 71.71 -59.12 100.04 71.44 -60.38 coo -34.22 5.06 149.25 -33.65 4.24 151.15 96.50 75.38 -64.79 97.32 75.47 -62.77 coo -33.03 9.93 151.71 -34.98 9.38 151.11 99.20 79.77 -64.83 99.58 80.60 -62.91 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 B 70 ALA B 74 ALA^? 25.18 CL CL A 129 B 126 LEU B 75 LEU^? 21.85 CL CL A 129 B 158 GLU B 23 GLU^? 24.68 CL CL B 129 coo -39.79 4.61 147.27 -39.61 5.56 148.47 83.11 67.09 -53.84 82.12 66.37 -52.99 coo -34.22 5.06 149.25 -33.65 4.24 151.15 87.39 65.27 -55.28 88.04 66.65 -56.89 coo -33.03 9.93 151.71 -34.98 9.38 151.11 89.49 70.79 -56.44 87.96 70.01 -57.68 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 B 70 ALA C 18 ALA^? 21.69 CL CL C 129 B 126 LEU C 37 LEU^? 16.94 CL CL C 129 B 158 GLU C 36 GLU^? 18.27 CL CL C 129 coo -39.79 4.61 147.27 -39.61 5.56 148.47 92.95 65.41 -46.51 93.28 64.58 -45.23 coo -34.22 5.06 149.25 -33.65 4.24 151.15 89.29 68.10 -40.88 89.21 67.27 -42.93 coo -33.03 9.93 151.71 -34.98 9.38 151.11 84.85 65.27 -40.53 84.47 64.86 -42.56 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 B 70 ALA C 74 ALA^? 28.16 CL CL B 129 B 126 LEU C 75 LEU^? 27.56 CL CL C 129 B 158 GLU C 23 GLU^? 24.69 CL CL C 129 coo -39.79 4.61 147.27 -39.61 5.56 148.47 97.55 81.50 -51.82 98.27 82.42 -52.76 coo -34.22 5.06 149.25 -33.65 4.24 151.15 99.28 77.24 -50.30 98.02 76.57 -48.72 coo -33.03 9.93 151.71 -34.98 9.38 151.11 93.85 75.25 -49.20 94.57 76.88 -48.00 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 B 70 ALA D 18 ALA^? 21.57 CL CL D 129 B 126 LEU D 37 LEU^? 16.93 CL CL D 129 B 158 GLU D 36 GLU^? 18.42 CL CL D 129 coo -39.79 4.61 147.27 -39.61 5.56 148.47 66.51 85.11 -46.53 66.24 85.90 -45.23 coo -34.22 5.06 149.25 -33.65 4.24 151.15 69.99 82.51 -40.93 70.04 83.48 -42.91 coo -33.03 9.93 151.71 -34.98 9.38 151.11 74.52 85.40 -40.74 74.64 85.74 -42.81 1pjh_c01 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 7 hits 1pjh_c01 naa= 3 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 C 70 ALA A 18 ALA~? 21.90 CL CL A 129 C 126 LEU A 37 LEU~? 16.93 CL CL A 129 C 158 GLU A 36 GLU~? 18.47 CL CL A 129 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 99.18 51.59 -82.01 100.04 51.92 -80.81 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 96.51 48.08 -76.23 97.22 47.90 -78.26 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 99.16 43.45 -76.17 99.38 43.10 -78.24 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 C 70 ALA A 25 ALA~? 20.03 CL CL A 129 C 126 LEU A 26 LEU~? 19.99 CL CL A 129 C 158 GLU A 23 GLU~? 24.22 CL CL A 129 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 90.53 45.57 -81.64 91.65 45.42 -80.63 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 87.88 49.17 -79.75 86.71 50.33 -78.46 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 89.42 52.54 -84.47 88.08 53.22 -82.95 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 C 70 ALA A 74 ALA^? 25.51 CL CL B 129 C 126 LEU A 75 LEU^? 22.14 CL CL B 129 C 158 GLU A 23 GLU~? 24.22 CL CL A 129 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 83.09 56.12 -87.11 82.22 56.78 -88.15 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 87.34 57.94 -85.51 88.07 56.56 -84.03 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 89.42 52.54 -84.47 88.08 53.22 -82.95 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 C 70 ALA B 18 ALA^? 21.77 CL CL B 129 C 126 LEU B 37 LEU^? 16.91 CL CL B 129 C 158 GLU B 36 GLU^? 18.40 CL CL B 129 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 99.18 71.71 -59.12 100.04 71.44 -60.38 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 96.50 75.38 -64.79 97.32 75.47 -62.77 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 99.20 79.77 -64.83 99.58 80.60 -62.91 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 C 70 ALA B 74 ALA^? 25.18 CL CL A 129 C 126 LEU B 75 LEU^? 21.85 CL CL A 129 C 158 GLU B 23 GLU^? 24.68 CL CL B 129 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 83.11 67.09 -53.84 82.12 66.37 -52.99 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 87.39 65.27 -55.28 88.04 66.65 -56.89 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 89.49 70.79 -56.44 87.96 70.01 -57.68 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 C 70 ALA C 18 ALA^? 21.69 CL CL C 129 C 126 LEU C 37 LEU^? 16.94 CL CL C 129 C 158 GLU C 36 GLU^? 18.27 CL CL C 129 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 92.95 65.41 -46.51 93.28 64.58 -45.23 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 89.29 68.10 -40.88 89.21 67.27 -42.93 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 84.85 65.27 -40.53 84.47 64.86 -42.56 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 C 70 ALA C 25 ALA^? 19.84 CL CL C 129 C 126 LEU C 26 LEU^? 19.92 CL CL C 129 C 158 GLU C 23 GLU^? 24.69 CL CL C 129 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 86.92 74.08 -46.13 86.92 72.96 -45.09 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 90.57 76.76 -44.41 91.64 77.85 -42.91 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 93.85 75.25 -49.20 94.57 76.88 -48.00 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 C 70 ALA C 74 ALA^? 28.16 CL CL B 129 C 126 LEU C 75 LEU^? 27.56 CL CL C 129 C 158 GLU C 23 GLU^? 24.69 CL CL C 129 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 97.55 81.50 -51.82 98.27 82.42 -52.76 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 99.28 77.24 -50.30 98.02 76.57 -48.72 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 93.85 75.25 -49.20 94.57 76.88 -48.00 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 9 3 # 9 C 70 ALA D 18 ALA^? 21.57 CL CL D 129 C 126 LEU D 37 LEU^? 16.93 CL CL D 129 C 158 GLU D 36 GLU^? 18.42 CL CL D 129 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 66.51 85.11 -46.53 66.24 85.90 -45.23 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 69.99 82.51 -40.93 70.04 83.48 -42.91 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 74.52 85.40 -40.74 74.64 85.74 -42.81 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 10 3 # 10 C 70 ALA D 74 ALA^? 31.91 CL CL D 129 C 126 LEU D 75 LEU^? 27.42 CL CL D 129 C 158 GLU D 23 GLU^? 24.49 CL CL D 129 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 61.88 69.17 -51.85 61.21 68.28 -52.90 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 60.12 73.44 -50.26 61.41 74.10 -48.64 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 65.41 75.40 -49.12 64.81 73.78 -47.86 1pjh_c02 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 10 hits 1pjh_c02 naa= 3 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 1 3 # 1 A 248 ASP B 5 ASP^? 20.93 CL CL A 129 A 270 LYS A 111 LYS^? 25.43 CL CL A 129 A 382 MET A 1 MET?? 19.29 CL CL B 129 coo -27.63 121.99 45.48 -26.66 123.86 45.68 110.10 55.77 -64.66 112.04 55.13 -65.31 coo -32.20 115.91 49.56 -31.37 121.03 53.12 105.91 53.60 -74.08 110.80 53.18 -78.24 coo -23.75 127.89 58.42 -26.02 128.79 55.12 109.00 69.38 -72.13 108.17 66.66 -73.76 1pjq_c02 source 1pjq SIROHEME SYNTHASE : 1 hits 1pjq_c02 naa= 3 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 1 3 # 1 111 GLN A 105 GLN^? 20.44 CL CL A 129 294 GLU A 23 GLU~? 24.22 CL CL A 129 304 ARG A 46 ARG^? 15.11 CL CL A 129 coo 15.89 18.45 46.53 15.82 16.91 48.02 88.61 56.98 -76.47 88.98 55.45 -77.91 coo 22.84 13.44 52.91 20.84 13.18 52.38 89.42 52.54 -84.47 88.08 53.22 -82.95 coo 8.71 17.11 46.51 7.23 17.64 49.20 87.96 51.20 -70.32 85.08 51.60 -71.34 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 2 3 # 2 111 GLN A 105 GLN^? 20.44 CL CL A 129 294 GLU A 93 GLU.? 15.26 CL CL B 129 304 ARG A 46 ARG^? 15.11 CL CL A 129 coo 15.89 18.45 46.53 15.82 16.91 48.02 88.61 56.98 -76.47 88.98 55.45 -77.91 coo 22.84 13.44 52.91 20.84 13.18 52.38 84.83 64.69 -81.14 84.26 66.42 -82.32 coo 8.71 17.11 46.51 7.23 17.64 49.20 87.96 51.20 -70.32 85.08 51.60 -71.34 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 3 3 # 3 111 GLN A 107 GLN^? 18.67 CL CL A 129 294 GLU A 23 GLU~? 24.22 CL CL A 129 304 ARG A 46 ARG^? 15.11 CL CL A 129 coo 15.89 18.45 46.53 15.82 16.91 48.02 92.47 56.26 -75.31 92.70 54.84 -76.89 coo 22.84 13.44 52.91 20.84 13.18 52.38 89.42 52.54 -84.47 88.08 53.22 -82.95 coo 8.71 17.11 46.51 7.23 17.64 49.20 87.96 51.20 -70.32 85.08 51.60 -71.34 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 4 3 # 4 111 GLN B 105 GLN^? 20.41 CL CL B 129 294 GLU B 23 GLU^? 24.68 CL CL B 129 304 ARG B 46 ARG^? 15.06 CL CL B 129 coo 15.89 18.45 46.53 15.82 16.91 48.02 88.72 66.41 -64.44 89.12 67.99 -63.12 coo 22.84 13.44 52.91 20.84 13.18 52.38 89.49 70.79 -56.44 87.96 70.01 -57.68 coo 8.71 17.11 46.51 7.23 17.64 49.20 87.96 72.13 -70.71 85.05 71.84 -69.78 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 5 3 # 5 111 GLN B 105 GLN^? 20.41 CL CL B 129 294 GLU B 93 GLU^? 15.32 CL CL A 129 304 ARG B 46 ARG^? 15.06 CL CL B 129 coo 15.89 18.45 46.53 15.82 16.91 48.02 88.72 66.41 -64.44 89.12 67.99 -63.12 coo 22.84 13.44 52.91 20.84 13.18 52.38 84.67 58.80 -60.02 84.04 57.06 -58.91 coo 8.71 17.11 46.51 7.23 17.64 49.20 87.96 72.13 -70.71 85.05 71.84 -69.78 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 6 3 # 6 111 GLN B 107 GLN^? 18.89 CL CL B 129 294 GLU B 23 GLU^? 24.68 CL CL B 129 304 ARG B 46 ARG^? 15.06 CL CL B 129 coo 15.89 18.45 46.53 15.82 16.91 48.02 92.61 67.14 -65.52 92.82 68.54 -63.93 coo 22.84 13.44 52.91 20.84 13.18 52.38 89.49 70.79 -56.44 87.96 70.01 -57.68 coo 8.71 17.11 46.51 7.23 17.64 49.20 87.96 72.13 -70.71 85.05 71.84 -69.78 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 7 3 # 7 111 GLN C 105 GLN^? 20.30 CL CL C 129 294 GLU C 23 GLU^? 24.69 CL CL C 129 304 ARG C 46 ARG^? 15.12 CL CL C 129 coo 15.89 18.45 46.53 15.82 16.91 48.02 98.17 76.17 -41.10 96.60 75.75 -42.46 coo 22.84 13.44 52.91 20.84 13.18 52.38 93.85 75.25 -49.20 94.57 76.88 -48.00 coo 8.71 17.11 46.51 7.23 17.64 49.20 92.47 76.70 -34.87 92.87 79.50 -36.04 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 8 3 # 8 111 GLN C 105 GLN^? 20.30 CL CL C 129 294 GLU C 93 GLU^? 31.51 CL CL C 129 304 ARG C 46 ARG^? 15.12 CL CL C 129 coo 15.89 18.45 46.53 15.82 16.91 48.02 98.17 76.17 -41.10 96.60 75.75 -42.46 coo 22.84 13.44 52.91 20.84 13.18 52.38 105.96 79.95 -45.75 107.72 80.63 -46.81 coo 8.71 17.11 46.51 7.23 17.64 49.20 92.47 76.70 -34.87 92.87 79.50 -36.04 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 9 3 # 9 111 GLN C 107 GLN^? 18.89 CL CL C 129 294 GLU C 23 GLU^? 24.69 CL CL C 129 304 ARG C 46 ARG^? 15.12 CL CL C 129 coo 15.89 18.45 46.53 15.82 16.91 48.02 97.54 72.04 -40.02 96.28 71.88 -41.73 coo 22.84 13.44 52.91 20.84 13.18 52.38 93.85 75.25 -49.20 94.57 76.88 -48.00 coo 8.71 17.11 46.51 7.23 17.64 49.20 92.47 76.70 -34.87 92.87 79.50 -36.04 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 10 3 # 10 111 GLN D 105 GLN^? 20.18 CL CL D 129 294 GLU D 23 GLU^? 24.49 CL CL D 129 304 ARG D 46 ARG^? 15.13 CL CL D 129 coo 15.89 18.45 46.53 15.82 16.91 48.02 61.23 74.39 -41.13 62.72 75.17 -42.43 coo 22.84 13.44 52.91 20.84 13.18 52.38 65.41 75.40 -49.12 64.81 73.78 -47.86 coo 8.71 17.11 46.51 7.23 17.64 49.20 66.74 73.93 -35.00 66.45 71.02 -36.02 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 11 3 # 11 111 GLN D 105 GLN^? 20.18 CL CL D 129 294 GLU D 23 GLU^? 24.49 CL CL D 129 304 ARG D 104 ARG^? 26.47 CL CL D 129 coo 15.89 18.45 46.53 15.82 16.91 48.02 61.23 74.39 -41.13 62.72 75.17 -42.43 coo 22.84 13.44 52.91 20.84 13.18 52.38 65.41 75.40 -49.12 64.81 73.78 -47.86 coo 8.71 17.11 46.51 7.23 17.64 49.20 54.44 68.08 -41.08 52.76 68.11 -38.51 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 12 3 # 12 111 GLN D 105 GLN^? 20.18 CL CL D 129 294 GLU D 51 GLU^? 16.56 CL CL D 129 304 ARG D 73 ARG^? 22.15 CL CL D 129 coo 15.89 18.45 46.53 15.82 16.91 48.02 61.23 74.39 -41.13 62.72 75.17 -42.43 coo 22.84 13.44 52.91 20.84 13.18 52.38 66.99 68.03 -31.91 66.63 66.88 -33.67 coo 8.71 17.11 46.51 7.23 17.64 49.20 64.06 69.83 -46.45 63.93 71.88 -44.19 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 13 3 # 13 111 GLN D 105 GLN^? 20.18 CL CL D 129 294 GLU D 51 GLU^? 16.56 CL CL D 129 304 ARG D 104 ARG^? 26.47 CL CL D 129 coo 15.89 18.45 46.53 15.82 16.91 48.02 61.23 74.39 -41.13 62.72 75.17 -42.43 coo 22.84 13.44 52.91 20.84 13.18 52.38 66.99 68.03 -31.91 66.63 66.88 -33.67 coo 8.71 17.11 46.51 7.23 17.64 49.20 54.44 68.08 -41.08 52.76 68.11 -38.51 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 14 3 # 14 111 GLN D 105 GLN^? 20.18 CL CL D 129 294 GLU D 93 GLU^? 31.46 CL CL D 129 304 ARG D 46 ARG^? 15.13 CL CL D 129 coo 15.89 18.45 46.53 15.82 16.91 48.02 61.23 74.39 -41.13 62.72 75.17 -42.43 coo 22.84 13.44 52.91 20.84 13.18 52.38 53.41 70.78 -45.84 51.64 70.26 -46.90 coo 8.71 17.11 46.51 7.23 17.64 49.20 66.74 73.93 -35.00 66.45 71.02 -36.02 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 15 3 # 15 111 GLN D 107 GLN^? 18.83 CL CL D 129 294 GLU D 23 GLU^? 24.49 CL CL D 129 304 ARG D 46 ARG^? 15.13 CL CL D 129 coo 15.89 18.45 46.53 15.82 16.91 48.02 61.80 78.53 -40.04 63.12 78.79 -41.74 coo 22.84 13.44 52.91 20.84 13.18 52.38 65.41 75.40 -49.12 64.81 73.78 -47.86 coo 8.71 17.11 46.51 7.23 17.64 49.20 66.74 73.93 -35.00 66.45 71.02 -36.02 1pmi_c00 source 1pmi PHOSPHOMANNOSE ISOMERASE : 15 hits 1pmi_c00 naa= 3 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 1 3 # 1 A 264 ARG A 46 ARG^? 15.11 CL CL A 129 A 479 PHE A 62 PHE~? 14.25 CL CL A 129 A 483 GLU A 51 GLU^? 16.44 CL CL A 129 coo 17.33 52.29 2.24 18.71 54.03 0.18 87.96 51.20 -70.32 85.08 51.60 -71.34 coo 20.06 57.44 1.28 18.39 56.19 3.12 84.15 47.24 -69.08 83.00 48.61 -71.25 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 82.00 50.89 -67.09 80.89 51.23 -68.89 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 2 3 # 2 A 264 ARG A 104 ARG^? 18.53 CL CL B 129 A 479 PHE A 94 PHE.? 23.56 CL CL B 129 A 483 GLU A 93 GLU.? 15.26 CL CL B 129 coo 17.33 52.29 2.24 18.71 54.03 0.18 82.19 63.80 -76.53 82.09 65.30 -73.83 coo 20.06 57.44 1.28 18.39 56.19 3.12 83.17 57.58 -80.80 82.50 56.91 -78.17 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 84.83 64.69 -81.14 84.26 66.42 -82.32 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 3 3 # 3 A 264 ARG B 46 ARG^? 15.06 CL CL B 129 A 479 PHE B 62 PHE^? 14.23 CL CL B 129 A 483 GLU B 51 GLU^? 16.46 CL CL B 129 coo 17.33 52.29 2.24 18.71 54.03 0.18 87.96 72.13 -70.71 85.05 71.84 -69.78 coo 20.06 57.44 1.28 18.39 56.19 3.12 84.12 76.18 -71.88 83.06 74.62 -69.84 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 81.98 72.56 -73.89 80.95 72.05 -72.12 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 4 3 # 4 A 264 ARG B 104 ARG^? 18.51 CL CL A 129 A 479 PHE B 94 PHE^? 23.49 CL CL A 129 A 483 GLU B 93 GLU^? 15.32 CL CL A 129 coo 17.33 52.29 2.24 18.71 54.03 0.18 82.09 59.72 -64.70 82.21 58.19 -67.39 coo 20.06 57.44 1.28 18.39 56.19 3.12 83.12 65.84 -60.18 82.47 66.55 -62.78 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 84.67 58.80 -60.02 84.04 57.06 -58.91 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 5 3 # 5 A 264 ARG C 46 ARG^? 15.12 CL CL C 129 A 479 PHE C 62 PHE^? 14.31 CL CL C 129 A 483 GLU C 51 GLU^? 16.39 CL CL C 129 coo 17.33 52.29 2.24 18.71 54.03 0.18 92.47 76.70 -34.87 92.87 79.50 -36.04 coo 20.06 57.44 1.28 18.39 56.19 3.12 88.56 80.49 -33.84 90.05 81.57 -35.91 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 92.20 82.64 -31.68 92.61 83.59 -33.56 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 6 3 # 6 A 264 ARG C 104 ARG^? 26.38 CL CL C 129 A 479 PHE C 94 PHE^? 24.69 CL CL C 129 A 483 GLU C 93 GLU^? 31.51 CL CL C 129 coo 17.33 52.29 2.24 18.71 54.03 0.18 105.08 82.46 -41.08 106.56 82.47 -38.36 coo 20.06 57.44 1.28 18.39 56.19 3.12 98.83 81.51 -45.44 98.16 82.08 -42.76 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 105.96 79.95 -45.75 107.72 80.63 -46.81 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 7 3 # 7 A 264 ARG D 46 ARG^? 15.13 CL CL D 129 A 479 PHE D 62 PHE^? 14.30 CL CL D 129 A 483 GLU D 51 GLU^? 16.56 CL CL D 129 coo 17.33 52.29 2.24 18.71 54.03 0.18 66.74 73.93 -35.00 66.45 71.02 -36.02 coo 20.06 57.44 1.28 18.39 56.19 3.12 70.76 70.07 -33.82 69.25 69.00 -35.89 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 66.99 68.03 -31.91 66.63 66.88 -33.67 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 8 3 # 8 A 264 ARG D 104 ARG^? 26.47 CL CL D 129 A 479 PHE D 94 PHE^? 24.69 CL CL D 129 A 483 GLU D 93 GLU^? 31.46 CL CL D 129 coo 17.33 52.29 2.24 18.71 54.03 0.18 54.44 68.08 -41.08 52.76 68.11 -38.51 coo 20.06 57.44 1.28 18.39 56.19 3.12 60.53 69.11 -45.40 61.31 68.31 -42.82 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 53.41 70.78 -45.84 51.64 70.26 -46.90 1pow_c02 source 1pow PYRUVATE OXIDASE (E.C.1.2.3.3) (WILD TYPE) : 8 hits 1pow_c02 naa= 3 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 1 3 # 1 B 264 ARG A 46 ARG^? 15.11 CL CL A 129 B 479 PHE A 62 PHE~? 14.25 CL CL A 129 B 483 GLU A 51 GLU^? 16.44 CL CL A 129 coo -26.72 93.28 20.13 -28.02 93.55 17.39 87.96 51.20 -70.32 85.08 51.60 -71.34 coo -29.34 90.48 15.69 -27.62 89.95 17.80 84.15 47.24 -69.08 83.00 48.61 -71.25 coo -26.63 95.49 14.65 -25.77 93.77 13.77 82.00 50.89 -67.09 80.89 51.23 -68.89 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 2 3 # 2 B 264 ARG A 104 ARG^? 18.53 CL CL B 129 B 479 PHE A 94 PHE.? 23.56 CL CL B 129 B 483 GLU A 93 GLU.? 15.26 CL CL B 129 coo -26.72 93.28 20.13 -28.02 93.55 17.39 82.19 63.80 -76.53 82.09 65.30 -73.83 coo -29.34 90.48 15.69 -27.62 89.95 17.80 83.17 57.58 -80.80 82.50 56.91 -78.17 coo -26.63 95.49 14.65 -25.77 93.77 13.77 84.83 64.69 -81.14 84.26 66.42 -82.32 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 3 3 # 3 B 264 ARG B 46 ARG^? 15.06 CL CL B 129 B 479 PHE B 62 PHE^? 14.23 CL CL B 129 B 483 GLU B 51 GLU^? 16.46 CL CL B 129 coo -26.72 93.28 20.13 -28.02 93.55 17.39 87.96 72.13 -70.71 85.05 71.84 -69.78 coo -29.34 90.48 15.69 -27.62 89.95 17.80 84.12 76.18 -71.88 83.06 74.62 -69.84 coo -26.63 95.49 14.65 -25.77 93.77 13.77 81.98 72.56 -73.89 80.95 72.05 -72.12 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 4 3 # 4 B 264 ARG B 104 ARG^? 18.51 CL CL A 129 B 479 PHE B 94 PHE^? 23.49 CL CL A 129 B 483 GLU B 93 GLU^? 15.32 CL CL A 129 coo -26.72 93.28 20.13 -28.02 93.55 17.39 82.09 59.72 -64.70 82.21 58.19 -67.39 coo -29.34 90.48 15.69 -27.62 89.95 17.80 83.12 65.84 -60.18 82.47 66.55 -62.78 coo -26.63 95.49 14.65 -25.77 93.77 13.77 84.67 58.80 -60.02 84.04 57.06 -58.91 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 5 3 # 5 B 264 ARG C 46 ARG^? 15.12 CL CL C 129 B 479 PHE C 62 PHE^? 14.31 CL CL C 129 B 483 GLU C 51 GLU^? 16.39 CL CL C 129 coo -26.72 93.28 20.13 -28.02 93.55 17.39 92.47 76.70 -34.87 92.87 79.50 -36.04 coo -29.34 90.48 15.69 -27.62 89.95 17.80 88.56 80.49 -33.84 90.05 81.57 -35.91 coo -26.63 95.49 14.65 -25.77 93.77 13.77 92.20 82.64 -31.68 92.61 83.59 -33.56 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 6 3 # 6 B 264 ARG C 104 ARG^? 26.38 CL CL C 129 B 479 PHE C 94 PHE^? 24.69 CL CL C 129 B 483 GLU C 93 GLU^? 31.51 CL CL C 129 coo -26.72 93.28 20.13 -28.02 93.55 17.39 105.08 82.46 -41.08 106.56 82.47 -38.36 coo -29.34 90.48 15.69 -27.62 89.95 17.80 98.83 81.51 -45.44 98.16 82.08 -42.76 coo -26.63 95.49 14.65 -25.77 93.77 13.77 105.96 79.95 -45.75 107.72 80.63 -46.81 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 7 3 # 7 B 264 ARG D 46 ARG^? 15.13 CL CL D 129 B 479 PHE D 62 PHE^? 14.30 CL CL D 129 B 483 GLU D 51 GLU^? 16.56 CL CL D 129 coo -26.72 93.28 20.13 -28.02 93.55 17.39 66.74 73.93 -35.00 66.45 71.02 -36.02 coo -29.34 90.48 15.69 -27.62 89.95 17.80 70.76 70.07 -33.82 69.25 69.00 -35.89 coo -26.63 95.49 14.65 -25.77 93.77 13.77 66.99 68.03 -31.91 66.63 66.88 -33.67 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 8 3 # 8 B 264 ARG D 104 ARG^? 26.47 CL CL D 129 B 479 PHE D 94 PHE^? 24.69 CL CL D 129 B 483 GLU D 93 GLU^? 31.46 CL CL D 129 coo -26.72 93.28 20.13 -28.02 93.55 17.39 54.44 68.08 -41.08 52.76 68.11 -38.51 coo -29.34 90.48 15.69 -27.62 89.95 17.80 60.53 69.11 -45.40 61.31 68.31 -42.82 coo -26.63 95.49 14.65 -25.77 93.77 13.77 53.41 70.78 -45.84 51.64 70.26 -46.90 1pow_c03 source 1pow PYRUVATE OXIDASE (E.C.1.2.3.3) (WILD TYPE) : 8 hits 1pow_c03 naa= 3 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 1 3 # 1 A 74 ASN B 7 ASN^? 14.42 CL CL A 129 A 192 ASP B 86 ASP^? 23.14 CL CL B 129 A 195 HIS B 85 HIS^? 26.88 CL CL A 129 coo -4.84 51.77 30.37 -3.89 50.12 29.46 104.35 57.09 -58.15 102.38 57.14 -58.88 coo 2.03 47.14 19.75 1.72 46.26 21.64 108.40 66.17 -67.38 109.32 64.97 -68.84 coo 1.41 44.84 24.92 -0.49 45.70 25.19 111.98 64.21 -65.30 113.02 64.33 -67.11 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 2 3 # 2 A 74 ASN C 7 ASN^? 25.55 CL CL A 129 A 192 ASP C 86 ASP^? 23.12 CL CL C 129 A 195 HIS C 85 HIS^? 23.16 CL CL A 129 coo -4.84 51.77 30.37 -3.89 50.12 29.46 107.62 60.23 -47.60 107.55 62.23 -46.92 coo 2.03 47.14 19.75 1.72 46.26 21.64 98.39 56.19 -38.35 99.60 55.15 -36.99 coo 1.41 44.84 24.92 -0.49 45.70 25.19 100.49 52.59 -40.39 100.40 51.57 -38.55 1pp4_c02 source 1pp4 RHAMNOGALACTURONAN ACETYLESTERASE : 2 hits 1pp4_c02 naa= 3 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 1 3 # 1 B 74 ASN A 7 ASN.? 14.61 CL CL B 129 B 192 ASP A 86 ASP.? 23.33 CL CL A 129 B 195 HIS A 85 HIS.? 26.94 CL CL B 129 coo -1.08 51.41 10.34 0.65 52.62 10.17 104.28 66.29 -83.02 102.35 66.19 -82.19 coo 11.36 52.33 5.59 10.18 53.87 6.47 108.46 57.22 -73.78 109.48 58.49 -72.45 coo 7.99 56.74 7.55 6.88 55.39 8.70 112.09 59.31 -75.65 113.04 59.28 -73.77 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 2 3 # 2 B 74 ASN B 7 ASN^? 14.42 CL CL A 129 B 192 ASP B 86 ASP^? 23.14 CL CL B 129 B 195 HIS B 85 HIS^? 26.88 CL CL A 129 coo -1.08 51.41 10.34 0.65 52.62 10.17 104.35 57.09 -58.15 102.38 57.14 -58.88 coo 11.36 52.33 5.59 10.18 53.87 6.47 108.40 66.17 -67.38 109.32 64.97 -68.84 coo 7.99 56.74 7.55 6.88 55.39 8.70 111.98 64.21 -65.30 113.02 64.33 -67.11 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 3 3 # 3 B 74 ASN C 7 ASN^? 25.55 CL CL A 129 B 192 ASP C 86 ASP^? 23.12 CL CL C 129 B 195 HIS C 85 HIS^? 23.16 CL CL A 129 coo -1.08 51.41 10.34 0.65 52.62 10.17 107.62 60.23 -47.60 107.55 62.23 -46.92 coo 11.36 52.33 5.59 10.18 53.87 6.47 98.39 56.19 -38.35 99.60 55.15 -36.99 coo 7.99 56.74 7.55 6.88 55.39 8.70 100.49 52.59 -40.39 100.40 51.57 -38.55 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 4 3 # 4 B 74 ASN D 7 ASN^? 30.85 CL CL D 129 B 192 ASP D 86 ASP^? 23.19 CL CL D 129 B 195 HIS D 85 HIS^? 27.00 CL CL D 129 coo -1.08 51.41 10.34 0.65 52.62 10.17 51.70 90.24 -47.62 51.84 88.27 -46.84 coo 11.36 52.33 5.59 10.18 53.87 6.47 60.79 94.39 -38.32 59.49 95.38 -36.98 coo 7.99 56.74 7.55 6.88 55.39 8.70 58.77 98.13 -40.30 58.69 99.11 -38.44 1pp4_c03 source 1pp4 RHAMNOGALACTURONAN ACETYLESTERASE : 4 hits 1pp4_c03 naa= 3 ULMN 3 1pyl_c00 RIBONUCLEASE user 1 3 # 1 A 56 GLU B 51 GLU^? 16.46 CL CL B 129 A 67 ARG A 104 ARG^? 18.53 CL CL B 129 A 86 HIS B 122 HIS^? 19.12 CL CL B 129 coo 18.15 3.28 18.56 20.10 2.92 19.20 81.98 72.56 -73.89 80.95 72.05 -72.12 coo 21.52 6.83 26.64 21.22 5.53 23.85 82.19 63.80 -76.53 82.09 65.30 -73.83 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 86.93 63.10 -71.62 85.35 62.06 -72.53 1pyl_c00 source 1pyl RIBONUCLEASE : 1 hits 1pyl_c00 naa= 3 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 1 3 # 1 A 48 LEU A 34 LEU~? 15.98 CL CL A 129 A 58 ASP A 30 ASP~? 20.80 CL CL A 129 A 120 LYS A 24 LYS~? 27.96 CL CL A 129 coo 34.02 69.29 75.26 34.82 67.82 76.74 90.86 45.34 -75.60 89.25 46.18 -76.85 coo 34.46 72.45 78.57 32.82 72.75 77.28 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 28.96 77.64 81.19 29.05 74.53 77.51 90.40 47.78 -84.76 92.62 43.20 -88.57 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 2 3 # 2 A 48 LEU A 71 LEU.? 22.78 CL CL A 129 A 58 ASP A 72 ASP.? 29.77 CL CL A 129 A 120 LYS A 24 LYS~? 27.96 CL CL A 129 coo 34.02 69.29 75.26 34.82 67.82 76.74 81.57 47.03 -80.86 81.80 46.13 -78.89 coo 34.46 72.45 78.57 32.82 72.75 77.28 81.04 48.95 -86.11 82.18 49.75 -87.74 coo 28.96 77.64 81.19 29.05 74.53 77.51 90.40 47.78 -84.76 92.62 43.20 -88.57 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 3 3 # 3 A 48 LEU B 34 LEU^? 15.98 CL CL B 129 A 58 ASP B 30 ASP^? 20.91 CL CL B 129 A 120 LYS B 24 LYS^? 27.82 CL CL B 129 coo 34.02 69.29 75.26 34.82 67.82 76.74 90.82 78.18 -65.35 89.23 77.31 -64.16 coo 34.46 72.45 78.57 32.82 72.75 77.28 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 28.96 77.64 81.19 29.05 74.53 77.51 90.54 75.59 -56.27 92.78 80.12 -52.52 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 4 3 # 4 A 48 LEU B 71 LEU^? 22.53 CL CL B 129 A 58 ASP B 72 ASP^? 28.57 CL CL C 129 A 120 LYS B 24 LYS^? 27.82 CL CL B 129 coo 34.02 69.29 75.26 34.82 67.82 76.74 81.62 76.36 -60.24 82.12 77.10 -62.30 coo 34.46 72.45 78.57 32.82 72.75 77.28 80.87 74.36 -54.99 81.74 73.36 -53.35 coo 28.96 77.64 81.19 29.05 74.53 77.51 90.54 75.59 -56.27 92.78 80.12 -52.52 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 5 3 # 5 A 48 LEU B 71 LEU^? 22.53 CL CL B 129 A 58 ASP B 72 ASP^? 28.57 CL CL C 129 A 120 LYS C 24 LYS^? 26.64 CL CL C 129 coo 34.02 69.29 75.26 34.82 67.82 76.74 81.62 76.36 -60.24 82.12 77.10 -62.30 coo 34.46 72.45 78.57 32.82 72.75 77.28 80.87 74.36 -54.99 81.74 73.36 -53.35 coo 28.96 77.64 81.19 29.05 74.53 77.51 88.99 74.10 -49.29 84.03 71.99 -51.83 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 6 3 # 6 A 48 LEU C 71 LEU^? 22.73 CL CL C 129 A 58 ASP C 72 ASP^? 28.53 CL CL B 129 A 120 LYS B 24 LYS^? 27.82 CL CL B 129 coo 34.02 69.29 75.26 34.82 67.82 76.74 88.28 83.15 -45.49 87.58 82.59 -43.49 coo 34.46 72.45 78.57 32.82 72.75 77.28 90.38 83.76 -50.64 91.24 82.68 -52.23 coo 28.96 77.64 81.19 29.05 74.53 77.51 90.54 75.59 -56.27 92.78 80.12 -52.52 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 7 3 # 7 A 48 LEU C 71 LEU^? 22.73 CL CL C 129 A 58 ASP C 72 ASP^? 28.53 CL CL B 129 A 120 LYS C 24 LYS^? 26.64 CL CL C 129 coo 34.02 69.29 75.26 34.82 67.82 76.74 88.28 83.15 -45.49 87.58 82.59 -43.49 coo 34.46 72.45 78.57 32.82 72.75 77.28 90.38 83.76 -50.64 91.24 82.68 -52.23 coo 28.96 77.64 81.19 29.05 74.53 77.51 88.99 74.10 -49.29 84.03 71.99 -51.83 1pym_c00 source 1pym PHOSPHOENOLPYRUVATE MUTASE : 7 hits 1pym_c00 naa= 3 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 1 3 # 1 B 48 LEU A 71 LEU.? 22.78 CL CL A 129 B 58 ASP A 72 ASP.? 29.77 CL CL A 129 B 120 LYS A 24 LYS~? 27.96 CL CL A 129 coo 54.50 104.32 58.69 55.83 105.69 59.81 81.57 47.03 -80.86 81.80 46.13 -78.89 coo 57.63 101.19 59.83 56.60 100.89 57.99 81.04 48.95 -86.11 82.18 49.75 -87.74 coo 61.58 95.88 55.22 58.18 99.30 54.71 90.40 47.78 -84.76 92.62 43.20 -88.57 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 2 3 # 2 B 48 LEU B 71 LEU^? 22.53 CL CL B 129 B 58 ASP B 72 ASP^? 28.57 CL CL C 129 B 120 LYS B 24 LYS^? 27.82 CL CL B 129 coo 54.50 104.32 58.69 55.83 105.69 59.81 81.62 76.36 -60.24 82.12 77.10 -62.30 coo 57.63 101.19 59.83 56.60 100.89 57.99 80.87 74.36 -54.99 81.74 73.36 -53.35 coo 61.58 95.88 55.22 58.18 99.30 54.71 90.54 75.59 -56.27 92.78 80.12 -52.52 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 3 3 # 3 B 48 LEU B 71 LEU^? 22.53 CL CL B 129 B 58 ASP B 72 ASP^? 28.57 CL CL C 129 B 120 LYS C 24 LYS^? 26.64 CL CL C 129 coo 54.50 104.32 58.69 55.83 105.69 59.81 81.62 76.36 -60.24 82.12 77.10 -62.30 coo 57.63 101.19 59.83 56.60 100.89 57.99 80.87 74.36 -54.99 81.74 73.36 -53.35 coo 61.58 95.88 55.22 58.18 99.30 54.71 88.99 74.10 -49.29 84.03 71.99 -51.83 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 4 3 # 4 B 48 LEU C 71 LEU^? 22.73 CL CL C 129 B 58 ASP C 72 ASP^? 28.53 CL CL B 129 B 120 LYS B 24 LYS^? 27.82 CL CL B 129 coo 54.50 104.32 58.69 55.83 105.69 59.81 88.28 83.15 -45.49 87.58 82.59 -43.49 coo 57.63 101.19 59.83 56.60 100.89 57.99 90.38 83.76 -50.64 91.24 82.68 -52.23 coo 61.58 95.88 55.22 58.18 99.30 54.71 90.54 75.59 -56.27 92.78 80.12 -52.52 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 5 3 # 5 B 48 LEU C 71 LEU^? 22.73 CL CL C 129 B 58 ASP C 72 ASP^? 28.53 CL CL B 129 B 120 LYS C 24 LYS^? 26.64 CL CL C 129 coo 54.50 104.32 58.69 55.83 105.69 59.81 88.28 83.15 -45.49 87.58 82.59 -43.49 coo 57.63 101.19 59.83 56.60 100.89 57.99 90.38 83.76 -50.64 91.24 82.68 -52.23 coo 61.58 95.88 55.22 58.18 99.30 54.71 88.99 74.10 -49.29 84.03 71.99 -51.83 1pym_c01 source 1pym PHOSPHOENOLPYRUVATE MUTASE : 5 hits 1pym_c01 naa= 3 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 1 3 # 1 A 67 ASP A 14 ASP~? 27.67 CL CL B 129 A 68 ALA A 13 ALA~? 24.93 CL CL B 129 A 72 LEU A 12 LEU~? 18.85 CL CL B 129 coo 46.76 7.59 18.65 45.27 6.01 18.52 105.70 54.30 -82.61 107.63 54.15 -83.44 coo 48.88 4.35 16.59 48.73 5.09 15.20 104.12 57.17 -86.31 105.19 56.89 -87.32 coo 53.89 6.25 15.09 52.88 7.92 14.14 103.86 61.33 -84.29 102.04 62.51 -84.28 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 2 3 # 2 A 67 ASP A 30 ASP~? 20.80 CL CL A 129 A 68 ALA A 25 ALA~? 20.03 CL CL A 129 A 72 LEU A 26 LEU~? 19.99 CL CL A 129 coo 46.76 7.59 18.65 45.27 6.01 18.52 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 48.88 4.35 16.59 48.73 5.09 15.20 90.53 45.57 -81.64 91.65 45.42 -80.63 coo 53.89 6.25 15.09 52.88 7.92 14.14 87.88 49.17 -79.75 86.71 50.33 -78.46 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 3 3 # 3 A 67 ASP A 30 ASP~? 20.80 CL CL A 129 A 68 ALA A 25 ALA~? 20.03 CL CL A 129 A 72 LEU A 34 LEU~? 15.98 CL CL A 129 coo 46.76 7.59 18.65 45.27 6.01 18.52 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 48.88 4.35 16.59 48.73 5.09 15.20 90.53 45.57 -81.64 91.65 45.42 -80.63 coo 53.89 6.25 15.09 52.88 7.92 14.14 90.86 45.34 -75.60 89.25 46.18 -76.85 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 4 3 # 4 A 67 ASP A 30 ASP~? 20.80 CL CL A 129 A 68 ALA A 32 ALA~? 17.71 CL CL A 129 A 72 LEU A 34 LEU~? 15.98 CL CL A 129 coo 46.76 7.59 18.65 45.27 6.01 18.52 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 48.88 4.35 16.59 48.73 5.09 15.20 93.00 39.79 -76.04 93.38 38.74 -77.08 coo 53.89 6.25 15.09 52.88 7.92 14.14 90.86 45.34 -75.60 89.25 46.18 -76.85 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 5 3 # 5 A 67 ASP B 10 ASP^? 27.46 CL CL A 129 A 68 ALA B 9 ALA^? 22.60 CL CL A 129 A 72 LEU B 12 LEU^? 18.77 CL CL A 129 coo 46.76 7.59 18.65 45.27 6.01 18.52 110.59 65.11 -56.28 111.89 65.48 -54.65 coo 48.88 4.35 16.59 48.73 5.09 15.20 108.07 61.18 -54.73 108.85 60.95 -53.45 coo 53.89 6.25 15.09 52.88 7.92 14.14 104.01 62.10 -56.93 102.21 60.92 -56.87 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 6 3 # 6 A 67 ASP B 14 ASP^? 27.62 CL CL A 129 A 68 ALA B 13 ALA^? 24.68 CL CL A 129 A 72 LEU B 12 LEU^? 18.77 CL CL A 129 coo 46.76 7.59 18.65 45.27 6.01 18.52 105.60 69.00 -58.44 107.49 69.47 -57.66 coo 48.88 4.35 16.59 48.73 5.09 15.20 104.32 66.04 -54.76 105.49 66.26 -53.78 coo 53.89 6.25 15.09 52.88 7.92 14.14 104.01 62.10 -56.93 102.21 60.92 -56.87 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 7 3 # 7 A 67 ASP B 30 ASP^? 20.91 CL CL B 129 A 68 ALA B 25 ALA^? 19.89 CL CL B 129 A 72 LEU B 26 LEU^? 19.82 CL CL B 129 coo 46.76 7.59 18.65 45.27 6.01 18.52 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 48.88 4.35 16.59 48.73 5.09 15.20 90.54 77.68 -59.46 91.65 77.73 -60.49 coo 53.89 6.25 15.09 52.88 7.92 14.14 87.80 74.11 -61.25 86.89 73.13 -62.91 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 8 3 # 8 A 67 ASP B 30 ASP^? 20.91 CL CL B 129 A 68 ALA B 25 ALA^? 19.89 CL CL B 129 A 72 LEU B 34 LEU^? 15.98 CL CL B 129 coo 46.76 7.59 18.65 45.27 6.01 18.52 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 48.88 4.35 16.59 48.73 5.09 15.20 90.54 77.68 -59.46 91.65 77.73 -60.49 coo 53.89 6.25 15.09 52.88 7.92 14.14 90.82 78.18 -65.35 89.23 77.31 -64.16 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 9 3 # 9 A 67 ASP B 30 ASP^? 20.91 CL CL B 129 A 68 ALA B 32 ALA^? 17.49 CL CL B 129 A 72 LEU B 34 LEU^? 15.98 CL CL B 129 coo 46.76 7.59 18.65 45.27 6.01 18.52 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 48.88 4.35 16.59 48.73 5.09 15.20 93.10 83.58 -64.96 93.52 84.77 -64.12 coo 53.89 6.25 15.09 52.88 7.92 14.14 90.82 78.18 -65.35 89.23 77.31 -64.16 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 10 3 # 10 A 67 ASP C 10 ASP^? 12.83 CL CL A 129 A 68 ALA C 9 ALA^? 16.58 CL CL A 129 A 72 LEU C 12 LEU^? 21.95 CL CL A 129 coo 46.76 7.59 18.65 45.27 6.01 18.52 99.63 54.02 -49.94 99.45 52.98 -51.81 coo 48.88 4.35 16.59 48.73 5.09 15.20 103.65 56.58 -50.92 103.86 55.75 -52.15 coo 53.89 6.25 15.09 52.88 7.92 14.14 102.70 60.55 -48.88 103.90 62.36 -48.71 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 11 3 # 11 A 67 ASP C 14 ASP^? 16.95 CL CL A 129 A 68 ALA C 13 ALA^? 16.81 CL CL A 129 A 72 LEU C 12 LEU^? 21.95 CL CL A 129 coo 46.76 7.59 18.65 45.27 6.01 18.52 95.50 58.88 -47.37 95.04 57.01 -48.29 coo 48.88 4.35 16.59 48.73 5.09 15.20 98.64 60.32 -50.92 98.42 59.22 -51.99 coo 53.89 6.25 15.09 52.88 7.92 14.14 102.70 60.55 -48.88 103.90 62.36 -48.71 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 12 3 # 12 A 67 ASP C 30 ASP^? 20.67 CL CL C 129 A 68 ALA C 25 ALA^? 19.84 CL CL C 129 A 72 LEU C 26 LEU^? 19.92 CL CL C 129 coo 46.76 7.59 18.65 45.27 6.01 18.52 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 48.88 4.35 16.59 48.73 5.09 15.20 86.92 74.08 -46.13 86.92 72.96 -45.09 coo 53.89 6.25 15.09 52.88 7.92 14.14 90.57 76.76 -44.41 91.64 77.85 -42.91 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 13 3 # 13 A 67 ASP C 30 ASP^? 20.67 CL CL C 129 A 68 ALA C 25 ALA^? 19.84 CL CL C 129 A 72 LEU C 34 LEU^? 15.98 CL CL C 129 coo 46.76 7.59 18.65 45.27 6.01 18.52 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 48.88 4.35 16.59 48.73 5.09 15.20 86.92 74.08 -46.13 86.92 72.96 -45.09 coo 53.89 6.25 15.09 52.88 7.92 14.14 86.58 73.67 -40.26 87.39 75.22 -41.53 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 14 3 # 14 A 67 ASP C 30 ASP^? 20.67 CL CL C 129 A 68 ALA C 32 ALA^? 17.45 CL CL C 129 A 72 LEU C 34 LEU^? 15.98 CL CL C 129 coo 46.76 7.59 18.65 45.27 6.01 18.52 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 48.88 4.35 16.59 48.73 5.09 15.20 81.13 71.60 -40.52 79.93 71.23 -41.37 coo 53.89 6.25 15.09 52.88 7.92 14.14 86.58 73.67 -40.26 87.39 75.22 -41.53 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 15 3 # 15 A 67 ASP D 14 ASP^? 27.52 CL CL D 129 A 68 ALA D 13 ALA^? 31.05 CL CL D 129 A 72 LEU D 12 LEU^? 30.02 CL CL D 129 coo 46.76 7.59 18.65 45.27 6.01 18.52 63.54 91.53 -47.18 63.81 93.48 -47.82 coo 48.88 4.35 16.59 48.73 5.09 15.20 60.74 90.11 -50.98 60.94 91.23 -52.00 coo 53.89 6.25 15.09 52.88 7.92 14.14 56.67 89.97 -48.93 55.44 88.19 -48.84 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 16 3 # 16 A 67 ASP D 30 ASP^? 20.62 CL CL D 129 A 68 ALA D 25 ALA^? 20.03 CL CL D 129 A 72 LEU D 26 LEU^? 19.77 CL CL D 129 coo 46.76 7.59 18.65 45.27 6.01 18.52 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 48.88 4.35 16.59 48.73 5.09 15.20 72.34 76.44 -46.33 72.34 77.58 -45.33 coo 53.89 6.25 15.09 52.88 7.92 14.14 68.83 73.84 -44.31 67.67 72.87 -42.84 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 17 3 # 17 A 67 ASP D 30 ASP^? 20.62 CL CL D 129 A 68 ALA D 25 ALA^? 20.03 CL CL D 129 A 72 LEU D 34 LEU^? 15.83 CL CL D 129 coo 46.76 7.59 18.65 45.27 6.01 18.52 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 48.88 4.35 16.59 48.73 5.09 15.20 72.34 76.44 -46.33 72.34 77.58 -45.33 coo 53.89 6.25 15.09 52.88 7.92 14.14 72.72 76.94 -40.18 71.79 75.41 -41.41 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 18 3 # 18 A 67 ASP D 30 ASP^? 20.62 CL CL D 129 A 68 ALA D 32 ALA^? 17.56 CL CL D 129 A 72 LEU D 34 LEU^? 15.83 CL CL D 129 coo 46.76 7.59 18.65 45.27 6.01 18.52 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 48.88 4.35 16.59 48.73 5.09 15.20 78.15 79.10 -40.71 79.29 79.50 -41.62 coo 53.89 6.25 15.09 52.88 7.92 14.14 72.72 76.94 -40.18 71.79 75.41 -41.41 1q6l_c05 source 1q6l 3-KETO-L-GULONATE 6-PHOSPHATE DECARBOXYLASE : 18 hits 1q6l_c05 naa= 3 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 1 3 # 1 A 396 ARG A 46 ARG^? 15.11 CL CL A 129 A 581 ARG A 63 ARG~? 13.95 CL CL A 129 A 713 ARG A 60 ARG~? 8.61 CL CL A 129 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 87.96 51.20 -70.32 85.08 51.60 -71.34 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 87.85 45.63 -72.60 88.58 48.58 -73.24 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 92.49 41.37 -66.87 95.11 39.81 -67.06 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 2 3 # 2 A 396 ARG A 63 ARG~? 13.95 CL CL A 129 A 581 ARG A 46 ARG^? 15.11 CL CL A 129 A 713 ARG A 60 ARG~? 8.61 CL CL A 129 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 87.85 45.63 -72.60 88.58 48.58 -73.24 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 87.96 51.20 -70.32 85.08 51.60 -71.34 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 92.49 41.37 -66.87 95.11 39.81 -67.06 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 3 3 # 3 A 396 ARG A 66 ARG~? 18.83 CL CL A 129 A 581 ARG A 46 ARG^? 15.11 CL CL A 129 A 713 ARG A 73 ARG.? 22.19 CL CL A 129 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 82.10 46.84 -74.28 82.78 49.65 -75.31 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 87.96 51.20 -70.32 85.08 51.60 -71.34 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 83.82 53.79 -81.61 86.00 54.30 -79.51 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 4 3 # 4 A 396 ARG B 46 ARG^? 15.06 CL CL B 129 A 581 ARG B 63 ARG^? 13.99 CL CL B 129 A 713 ARG B 60 ARG^? 8.76 CL CL B 129 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 87.96 72.13 -70.71 85.05 71.84 -69.78 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 87.72 77.76 -68.29 88.60 74.86 -67.71 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 92.45 82.18 -73.93 95.13 83.66 -73.65 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 5 3 # 5 A 396 ARG B 63 ARG^? 13.99 CL CL B 129 A 581 ARG B 46 ARG^? 15.06 CL CL B 129 A 713 ARG B 60 ARG^? 8.76 CL CL B 129 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 87.72 77.76 -68.29 88.60 74.86 -67.71 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 87.96 72.13 -70.71 85.05 71.84 -69.78 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 92.45 82.18 -73.93 95.13 83.66 -73.65 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 6 3 # 6 A 396 ARG C 46 ARG^? 15.12 CL CL C 129 A 581 ARG C 63 ARG^? 14.10 CL CL C 129 A 713 ARG C 60 ARG^? 8.92 CL CL C 129 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 92.47 76.70 -34.87 92.87 79.50 -36.04 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 86.96 77.03 -37.50 89.89 76.13 -38.00 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 82.52 72.20 -31.52 80.97 69.57 -31.97 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 7 3 # 7 A 396 ARG C 60 ARG^? 8.92 CL CL C 129 A 581 ARG C 63 ARG^? 14.10 CL CL C 129 A 713 ARG D 60 ARG^? 8.57 CL CL D 129 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 82.52 72.20 -31.52 80.97 69.57 -31.97 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 86.96 77.03 -37.50 89.89 76.13 -38.00 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 76.65 78.50 -31.75 78.13 81.14 -31.78 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 8 3 # 8 A 396 ARG C 60 ARG^? 8.92 CL CL C 129 A 581 ARG D 60 ARG^? 8.57 CL CL D 129 A 713 ARG C 63 ARG^? 14.10 CL CL C 129 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 82.52 72.20 -31.52 80.97 69.57 -31.97 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 76.65 78.50 -31.75 78.13 81.14 -31.78 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 86.96 77.03 -37.50 89.89 76.13 -38.00 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 9 3 # 9 A 396 ARG C 60 ARG^? 8.92 CL CL C 129 A 581 ARG D 60 ARG^? 8.57 CL CL D 129 A 713 ARG D 63 ARG^? 14.07 CL CL D 129 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 82.52 72.20 -31.52 80.97 69.57 -31.97 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 76.65 78.50 -31.75 78.13 81.14 -31.78 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 72.33 73.68 -37.44 69.36 74.46 -37.99 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 10 3 # 10 A 396 ARG C 63 ARG^? 14.10 CL CL C 129 A 581 ARG C 46 ARG^? 15.12 CL CL C 129 A 713 ARG C 60 ARG^? 8.92 CL CL C 129 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 86.96 77.03 -37.50 89.89 76.13 -38.00 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 92.47 76.70 -34.87 92.87 79.50 -36.04 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 82.52 72.20 -31.52 80.97 69.57 -31.97 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 11 3 # 11 A 396 ARG C 63 ARG^? 14.10 CL CL C 129 A 581 ARG C 60 ARG^? 8.92 CL CL C 129 A 713 ARG D 60 ARG^? 8.57 CL CL D 129 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 86.96 77.03 -37.50 89.89 76.13 -38.00 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 82.52 72.20 -31.52 80.97 69.57 -31.97 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 76.65 78.50 -31.75 78.13 81.14 -31.78 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 12 3 # 12 A 396 ARG D 46 ARG^? 15.13 CL CL D 129 A 581 ARG D 63 ARG^? 14.07 CL CL D 129 A 713 ARG D 60 ARG^? 8.57 CL CL D 129 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 66.74 73.93 -35.00 66.45 71.02 -36.02 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 72.33 73.68 -37.44 69.36 74.46 -37.99 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 76.65 78.50 -31.75 78.13 81.14 -31.78 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 13 3 # 13 A 396 ARG D 60 ARG^? 8.57 CL CL D 129 A 581 ARG C 60 ARG^? 8.92 CL CL C 129 A 713 ARG C 63 ARG^? 14.10 CL CL C 129 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 76.65 78.50 -31.75 78.13 81.14 -31.78 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 82.52 72.20 -31.52 80.97 69.57 -31.97 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 86.96 77.03 -37.50 89.89 76.13 -38.00 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 14 3 # 14 A 396 ARG D 60 ARG^? 8.57 CL CL D 129 A 581 ARG C 60 ARG^? 8.92 CL CL C 129 A 713 ARG D 63 ARG^? 14.07 CL CL D 129 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 76.65 78.50 -31.75 78.13 81.14 -31.78 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 82.52 72.20 -31.52 80.97 69.57 -31.97 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 72.33 73.68 -37.44 69.36 74.46 -37.99 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 15 3 # 15 A 396 ARG D 60 ARG^? 8.57 CL CL D 129 A 581 ARG D 63 ARG^? 14.07 CL CL D 129 A 713 ARG C 60 ARG^? 8.92 CL CL C 129 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 76.65 78.50 -31.75 78.13 81.14 -31.78 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 72.33 73.68 -37.44 69.36 74.46 -37.99 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 82.52 72.20 -31.52 80.97 69.57 -31.97 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 16 3 # 16 A 396 ARG D 63 ARG^? 14.07 CL CL D 129 A 581 ARG D 46 ARG^? 15.13 CL CL D 129 A 713 ARG D 60 ARG^? 8.57 CL CL D 129 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 72.33 73.68 -37.44 69.36 74.46 -37.99 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 66.74 73.93 -35.00 66.45 71.02 -36.02 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 76.65 78.50 -31.75 78.13 81.14 -31.78 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 17 3 # 17 A 396 ARG D 63 ARG^? 14.07 CL CL D 129 A 581 ARG D 60 ARG^? 8.57 CL CL D 129 A 713 ARG C 60 ARG^? 8.92 CL CL C 129 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 72.33 73.68 -37.44 69.36 74.46 -37.99 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 76.65 78.50 -31.75 78.13 81.14 -31.78 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 82.52 72.20 -31.52 80.97 69.57 -31.97 1qb4_c01 source 1qb4 PHOSPHOENOLPYRUVATE CARBOXYLASE : 17 hits 1qb4_c01 naa= 3 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 155 HIS A 40 HIS.? 7.30 CL CL A 129 A 236 ASP C 10 ASP^? 12.83 CL CL A 129 A 261 LYS C 111 LYS^? 20.47 CL CL A 129 coo 55.45 46.76 42.08 57.34 46.16 42.75 98.96 43.60 -66.18 98.11 41.92 -65.26 coo 48.87 29.19 44.63 49.10 27.34 43.63 99.63 54.02 -49.94 99.45 52.98 -51.81 coo 47.58 17.35 41.83 51.40 20.85 40.83 94.84 58.73 -38.66 94.21 53.88 -42.04 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 155 HIS D 40 HIS^? 7.31 CL CL D 129 A 236 ASP C 30 ASP^? 20.67 CL CL C 129 A 261 LYS B 24 LYS^? 27.82 CL CL B 129 coo 55.45 46.76 42.08 57.34 46.16 42.75 74.49 84.96 -30.93 76.13 84.16 -29.90 coo 48.87 29.19 44.63 49.10 27.34 43.63 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 47.58 17.35 41.83 51.40 20.85 40.83 90.54 75.59 -56.27 92.78 80.12 -52.52 1qgn_c00 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c00 naa= 3 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 155 HIS A 40 HIS.? 7.30 CL CL A 129 B 236 ASP C 10 ASP^? 12.83 CL CL A 129 B 261 LYS C 111 LYS^? 20.47 CL CL A 129 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 98.96 43.60 -66.18 98.11 41.92 -65.26 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 99.63 54.02 -49.94 99.45 52.98 -51.81 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 94.84 58.73 -38.66 94.21 53.88 -42.04 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 155 HIS D 40 HIS^? 7.31 CL CL D 129 B 236 ASP C 30 ASP^? 20.67 CL CL C 129 B 261 LYS B 24 LYS^? 27.82 CL CL B 129 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 74.49 84.96 -30.93 76.13 84.16 -29.90 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 90.54 75.59 -56.27 92.78 80.12 -52.52 1qgn_c01 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c01 naa= 3 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 C 155 HIS A 40 HIS.? 7.30 CL CL A 129 C 236 ASP C 10 ASP^? 12.83 CL CL A 129 C 261 LYS C 111 LYS^? 20.47 CL CL A 129 coo 55.11 47.10 12.61 53.44 47.85 11.58 98.96 43.60 -66.18 98.11 41.92 -65.26 coo 45.78 31.11 9.51 44.25 30.06 10.53 99.63 54.02 -49.94 99.45 52.98 -51.81 coo 37.54 22.37 12.10 37.83 27.55 13.24 94.84 58.73 -38.66 94.21 53.88 -42.04 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 C 155 HIS D 40 HIS^? 7.31 CL CL D 129 C 236 ASP C 30 ASP^? 20.67 CL CL C 129 C 261 LYS B 24 LYS^? 27.82 CL CL B 129 coo 55.11 47.10 12.61 53.44 47.85 11.58 74.49 84.96 -30.93 76.13 84.16 -29.90 coo 45.78 31.11 9.51 44.25 30.06 10.53 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 37.54 22.37 12.10 37.83 27.55 13.24 90.54 75.59 -56.27 92.78 80.12 -52.52 1qgn_c02 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c02 naa= 3 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 D 155 HIS A 40 HIS.? 7.30 CL CL A 129 D 236 ASP C 10 ASP^? 12.83 CL CL A 129 D 261 LYS C 111 LYS^? 20.47 CL CL A 129 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 98.96 43.60 -66.18 98.11 41.92 -65.26 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 99.63 54.02 -49.94 99.45 52.98 -51.81 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 94.84 58.73 -38.66 94.21 53.88 -42.04 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 D 155 HIS D 40 HIS^? 7.31 CL CL D 129 D 236 ASP C 30 ASP^? 20.67 CL CL C 129 D 261 LYS B 24 LYS^? 27.82 CL CL B 129 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 74.49 84.96 -30.93 76.13 84.16 -29.90 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 90.54 75.59 -56.27 92.78 80.12 -52.52 1qgn_c03 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c03 naa= 3 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 155 HIS A 40 HIS.? 7.30 CL CL A 129 E 236 ASP C 10 ASP^? 12.83 CL CL A 129 E 261 LYS C 111 LYS^? 20.47 CL CL A 129 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 98.96 43.60 -66.18 98.11 41.92 -65.26 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 99.63 54.02 -49.94 99.45 52.98 -51.81 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 94.84 58.73 -38.66 94.21 53.88 -42.04 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 155 HIS D 40 HIS^? 7.31 CL CL D 129 E 236 ASP C 30 ASP^? 20.67 CL CL C 129 E 261 LYS B 24 LYS^? 27.82 CL CL B 129 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 74.49 84.96 -30.93 76.13 84.16 -29.90 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 90.54 75.59 -56.27 92.78 80.12 -52.52 1qgn_c04 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c04 naa= 3 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 155 HIS A 40 HIS.? 7.30 CL CL A 129 F 236 ASP C 10 ASP^? 12.83 CL CL A 129 F 261 LYS C 111 LYS^? 20.47 CL CL A 129 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 98.96 43.60 -66.18 98.11 41.92 -65.26 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 99.63 54.02 -49.94 99.45 52.98 -51.81 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 94.84 58.73 -38.66 94.21 53.88 -42.04 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 155 HIS D 40 HIS^? 7.31 CL CL D 129 F 236 ASP C 30 ASP^? 20.67 CL CL C 129 F 261 LYS B 24 LYS^? 27.82 CL CL B 129 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 74.49 84.96 -30.93 76.13 84.16 -29.90 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 90.54 75.59 -56.27 92.78 80.12 -52.52 1qgn_c05 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c05 naa= 3 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 G 155 HIS A 40 HIS.? 7.30 CL CL A 129 G 236 ASP C 10 ASP^? 12.83 CL CL A 129 G 261 LYS C 111 LYS^? 20.47 CL CL A 129 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 98.96 43.60 -66.18 98.11 41.92 -65.26 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 99.63 54.02 -49.94 99.45 52.98 -51.81 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 94.84 58.73 -38.66 94.21 53.88 -42.04 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 G 155 HIS D 40 HIS^? 7.31 CL CL D 129 G 236 ASP C 30 ASP^? 20.67 CL CL C 129 G 261 LYS B 24 LYS^? 27.82 CL CL B 129 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 74.49 84.96 -30.93 76.13 84.16 -29.90 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 90.54 75.59 -56.27 92.78 80.12 -52.52 1qgn_c06 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c06 naa= 3 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 H 155 HIS A 40 HIS.? 7.30 CL CL A 129 H 236 ASP C 10 ASP^? 12.83 CL CL A 129 H 261 LYS C 111 LYS^? 20.47 CL CL A 129 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 98.96 43.60 -66.18 98.11 41.92 -65.26 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 99.63 54.02 -49.94 99.45 52.98 -51.81 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 94.84 58.73 -38.66 94.21 53.88 -42.04 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 H 155 HIS D 40 HIS^? 7.31 CL CL D 129 H 236 ASP C 30 ASP^? 20.67 CL CL C 129 H 261 LYS B 24 LYS^? 27.82 CL CL B 129 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 74.49 84.96 -30.93 76.13 84.16 -29.90 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 90.54 75.59 -56.27 92.78 80.12 -52.52 1qgn_c07 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c07 naa= 3 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR B 22 TYR^? 17.56 CL CL B 129 A 236 ASP B 30 ASP^? 20.91 CL CL B 129 A 261 LYS C 24 LYS^? 26.64 CL CL C 129 coo 55.48 26.51 40.65 55.39 23.99 39.43 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 48.87 29.19 44.63 49.10 27.34 43.63 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 47.58 17.35 41.83 51.40 20.85 40.83 88.99 74.10 -49.29 84.03 71.99 -51.83 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 163 TYR C 22 TYR^? 17.52 CL CL C 129 A 236 ASP C 30 ASP^? 20.67 CL CL C 129 A 261 LYS B 24 LYS^? 27.82 CL CL B 129 coo 55.48 26.51 40.65 55.39 23.99 39.43 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 48.87 29.19 44.63 49.10 27.34 43.63 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 47.58 17.35 41.83 51.40 20.85 40.83 90.54 75.59 -56.27 92.78 80.12 -52.52 1qgn_c08 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c08 naa= 3 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR B 22 TYR^? 17.56 CL CL B 129 B 236 ASP B 30 ASP^? 20.91 CL CL B 129 B 261 LYS C 24 LYS^? 26.64 CL CL C 129 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 88.99 74.10 -49.29 84.03 71.99 -51.83 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 163 TYR C 22 TYR^? 17.52 CL CL C 129 B 236 ASP C 30 ASP^? 20.67 CL CL C 129 B 261 LYS B 24 LYS^? 27.82 CL CL B 129 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 90.54 75.59 -56.27 92.78 80.12 -52.52 1qgn_c09 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c09 naa= 3 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 C 163 TYR B 22 TYR^? 17.56 CL CL B 129 C 236 ASP B 30 ASP^? 20.91 CL CL B 129 C 261 LYS C 24 LYS^? 26.64 CL CL C 129 coo 39.51 34.34 13.63 37.63 32.61 14.79 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 45.78 31.11 9.51 44.25 30.06 10.53 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 37.54 22.37 12.10 37.83 27.55 13.24 88.99 74.10 -49.29 84.03 71.99 -51.83 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 C 163 TYR C 22 TYR^? 17.52 CL CL C 129 C 236 ASP C 30 ASP^? 20.67 CL CL C 129 C 261 LYS B 24 LYS^? 27.82 CL CL B 129 coo 39.51 34.34 13.63 37.63 32.61 14.79 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 45.78 31.11 9.51 44.25 30.06 10.53 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 37.54 22.37 12.10 37.83 27.55 13.24 90.54 75.59 -56.27 92.78 80.12 -52.52 1qgn_c10 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c10 naa= 3 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 D 163 TYR B 22 TYR^? 17.56 CL CL B 129 D 236 ASP B 30 ASP^? 20.91 CL CL B 129 D 261 LYS C 24 LYS^? 26.64 CL CL C 129 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 88.99 74.10 -49.29 84.03 71.99 -51.83 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 D 163 TYR C 22 TYR^? 17.52 CL CL C 129 D 236 ASP C 30 ASP^? 20.67 CL CL C 129 D 261 LYS B 24 LYS^? 27.82 CL CL B 129 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 90.54 75.59 -56.27 92.78 80.12 -52.52 1qgn_c11 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c11 naa= 3 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR B 22 TYR^? 17.56 CL CL B 129 E 236 ASP B 30 ASP^? 20.91 CL CL B 129 E 261 LYS C 24 LYS^? 26.64 CL CL C 129 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 88.99 74.10 -49.29 84.03 71.99 -51.83 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 163 TYR C 22 TYR^? 17.52 CL CL C 129 E 236 ASP C 30 ASP^? 20.67 CL CL C 129 E 261 LYS B 24 LYS^? 27.82 CL CL B 129 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 90.54 75.59 -56.27 92.78 80.12 -52.52 1qgn_c12 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c12 naa= 3 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR B 22 TYR^? 17.56 CL CL B 129 F 236 ASP B 30 ASP^? 20.91 CL CL B 129 F 261 LYS C 24 LYS^? 26.64 CL CL C 129 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 88.99 74.10 -49.29 84.03 71.99 -51.83 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 163 TYR C 22 TYR^? 17.52 CL CL C 129 F 236 ASP C 30 ASP^? 20.67 CL CL C 129 F 261 LYS B 24 LYS^? 27.82 CL CL B 129 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 90.54 75.59 -56.27 92.78 80.12 -52.52 1qgn_c13 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c13 naa= 3 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 G 163 TYR B 22 TYR^? 17.56 CL CL B 129 G 236 ASP B 30 ASP^? 20.91 CL CL B 129 G 261 LYS C 24 LYS^? 26.64 CL CL C 129 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 88.99 74.10 -49.29 84.03 71.99 -51.83 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 G 163 TYR C 22 TYR^? 17.52 CL CL C 129 G 236 ASP C 30 ASP^? 20.67 CL CL C 129 G 261 LYS B 24 LYS^? 27.82 CL CL B 129 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 90.54 75.59 -56.27 92.78 80.12 -52.52 1qgn_c14 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c14 naa= 3 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 H 163 TYR B 22 TYR^? 17.56 CL CL B 129 H 236 ASP B 30 ASP^? 20.91 CL CL B 129 H 261 LYS C 24 LYS^? 26.64 CL CL C 129 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 88.99 74.10 -49.29 84.03 71.99 -51.83 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 H 163 TYR C 22 TYR^? 17.52 CL CL C 129 H 236 ASP C 30 ASP^? 20.67 CL CL C 129 H 261 LYS B 24 LYS^? 27.82 CL CL B 129 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 90.54 75.59 -56.27 92.78 80.12 -52.52 1qgn_c15 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c15 naa= 3 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 110 ARG A 46 ARG^? 15.11 CL CL A 129 C 163 TYR A 22 TYR~? 17.56 CL CL A 129 C 236 ASP A 30 ASP~? 20.80 CL CL A 129 coo 39.01 29.77 22.02 37.48 31.30 19.84 87.96 51.20 -70.32 85.08 51.60 -71.34 coo 39.51 34.34 13.63 37.63 32.61 14.79 92.72 50.62 -78.45 90.87 50.50 -76.41 coo 45.78 31.11 9.51 44.25 30.06 10.53 90.38 41.71 -80.87 92.04 40.39 -80.79 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 110 ARG A 73 ARG.? 22.19 CL CL A 129 C 163 TYR A 22 TYR~? 17.56 CL CL A 129 C 236 ASP A 30 ASP~? 20.80 CL CL A 129 coo 39.01 29.77 22.02 37.48 31.30 19.84 83.82 53.79 -81.61 86.00 54.30 -79.51 coo 39.51 34.34 13.63 37.63 32.61 14.79 92.72 50.62 -78.45 90.87 50.50 -76.41 coo 45.78 31.11 9.51 44.25 30.06 10.53 90.38 41.71 -80.87 92.04 40.39 -80.79 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 110 ARG A 117 ARG^? 16.03 CL CL A 129 C 163 TYR A 22 TYR~? 17.56 CL CL A 129 C 236 ASP A 30 ASP~? 20.80 CL CL A 129 coo 39.01 29.77 22.02 37.48 31.30 19.84 100.59 48.03 -72.66 102.04 46.10 -74.59 coo 39.51 34.34 13.63 37.63 32.61 14.79 92.72 50.62 -78.45 90.87 50.50 -76.41 coo 45.78 31.11 9.51 44.25 30.06 10.53 90.38 41.71 -80.87 92.04 40.39 -80.79 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 110 ARG B 46 ARG^? 15.06 CL CL B 129 C 163 TYR B 22 TYR^? 17.56 CL CL B 129 C 236 ASP B 30 ASP^? 20.91 CL CL B 129 coo 39.01 29.77 22.02 37.48 31.30 19.84 87.96 72.13 -70.71 85.05 71.84 -69.78 coo 39.51 34.34 13.63 37.63 32.61 14.79 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 45.78 31.11 9.51 44.25 30.06 10.53 90.60 81.40 -60.16 92.15 82.83 -59.97 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 110 ARG B 73 ARG^? 22.29 CL CL B 129 C 163 TYR B 22 TYR^? 17.56 CL CL B 129 C 236 ASP B 30 ASP^? 20.91 CL CL B 129 coo 39.01 29.77 22.02 37.48 31.30 19.84 83.86 69.55 -59.16 85.91 69.18 -61.42 coo 39.51 34.34 13.63 37.63 32.61 14.79 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 45.78 31.11 9.51 44.25 30.06 10.53 90.60 81.40 -60.16 92.15 82.83 -59.97 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 A 110 ARG B 117 ARG^? 16.04 CL CL B 129 C 163 TYR B 22 TYR^? 17.56 CL CL B 129 C 236 ASP B 30 ASP^? 20.91 CL CL B 129 coo 39.01 29.77 22.02 37.48 31.30 19.84 100.63 75.34 -68.25 102.08 77.36 -66.41 coo 39.51 34.34 13.63 37.63 32.61 14.79 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 45.78 31.11 9.51 44.25 30.06 10.53 90.60 81.40 -60.16 92.15 82.83 -59.97 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 A 110 ARG C 46 ARG^? 15.12 CL CL C 129 C 163 TYR C 22 TYR^? 17.52 CL CL C 129 C 236 ASP C 30 ASP^? 20.67 CL CL C 129 coo 39.01 29.77 22.02 37.48 31.30 19.84 92.47 76.70 -34.87 92.87 79.50 -36.04 coo 39.51 34.34 13.63 37.63 32.61 14.79 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 45.78 31.11 9.51 44.25 30.06 10.53 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 A 110 ARG C 73 ARG^? 22.24 CL CL C 129 C 163 TYR C 22 TYR^? 17.52 CL CL C 129 C 236 ASP C 30 ASP^? 20.67 CL CL C 129 coo 39.01 29.77 22.02 37.48 31.30 19.84 95.26 80.79 -46.47 95.45 78.63 -44.29 coo 39.51 34.34 13.63 37.63 32.61 14.79 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 45.78 31.11 9.51 44.25 30.06 10.53 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 A 110 ARG C 117 ARG^? 16.02 CL CL C 129 C 163 TYR C 22 TYR^? 17.52 CL CL C 129 C 236 ASP C 30 ASP^? 20.67 CL CL C 129 coo 39.01 29.77 22.02 37.48 31.30 19.84 89.36 64.01 -37.29 87.40 62.56 -39.24 coo 39.51 34.34 13.63 37.63 32.61 14.79 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 45.78 31.11 9.51 44.25 30.06 10.53 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 A 110 ARG D 46 ARG^? 15.13 CL CL D 129 C 163 TYR D 22 TYR^? 17.52 CL CL D 129 C 236 ASP D 30 ASP^? 20.62 CL CL D 129 coo 39.01 29.77 22.02 37.48 31.30 19.84 66.74 73.93 -35.00 66.45 71.02 -36.02 coo 39.51 34.34 13.63 37.63 32.61 14.79 67.44 78.74 -43.16 67.49 76.94 -41.01 coo 45.78 31.11 9.51 44.25 30.06 10.53 76.16 76.40 -45.40 77.49 78.05 -45.35 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 A 110 ARG D 73 ARG^? 22.15 CL CL D 129 C 163 TYR D 22 TYR^? 17.52 CL CL D 129 C 236 ASP D 30 ASP^? 20.62 CL CL D 129 coo 39.01 29.77 22.02 37.48 31.30 19.84 64.06 69.83 -46.45 63.93 71.88 -44.19 coo 39.51 34.34 13.63 37.63 32.61 14.79 67.44 78.74 -43.16 67.49 76.94 -41.01 coo 45.78 31.11 9.51 44.25 30.06 10.53 76.16 76.40 -45.40 77.49 78.05 -45.35 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 A 110 ARG D 117 ARG^? 15.96 CL CL D 129 C 163 TYR D 22 TYR^? 17.52 CL CL D 129 C 236 ASP D 30 ASP^? 20.62 CL CL D 129 coo 39.01 29.77 22.02 37.48 31.30 19.84 69.91 86.62 -37.36 71.94 88.06 -39.21 coo 39.51 34.34 13.63 37.63 32.61 14.79 67.44 78.74 -43.16 67.49 76.94 -41.01 coo 45.78 31.11 9.51 44.25 30.06 10.53 76.16 76.40 -45.40 77.49 78.05 -45.35 1qgn_c16 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 12 hits 1qgn_c16 naa= 3 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 110 ARG A 46 ARG^? 15.11 CL CL A 129 D 163 TYR A 22 TYR~? 17.56 CL CL A 129 D 236 ASP A 30 ASP~? 20.80 CL CL A 129 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 87.96 51.20 -70.32 85.08 51.60 -71.34 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 92.72 50.62 -78.45 90.87 50.50 -76.41 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 90.38 41.71 -80.87 92.04 40.39 -80.79 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 110 ARG A 73 ARG.? 22.19 CL CL A 129 D 163 TYR A 22 TYR~? 17.56 CL CL A 129 D 236 ASP A 30 ASP~? 20.80 CL CL A 129 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 83.82 53.79 -81.61 86.00 54.30 -79.51 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 92.72 50.62 -78.45 90.87 50.50 -76.41 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 90.38 41.71 -80.87 92.04 40.39 -80.79 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 110 ARG A 117 ARG^? 16.03 CL CL A 129 D 163 TYR A 22 TYR~? 17.56 CL CL A 129 D 236 ASP A 30 ASP~? 20.80 CL CL A 129 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 100.59 48.03 -72.66 102.04 46.10 -74.59 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 92.72 50.62 -78.45 90.87 50.50 -76.41 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 90.38 41.71 -80.87 92.04 40.39 -80.79 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 110 ARG B 46 ARG^? 15.06 CL CL B 129 D 163 TYR B 22 TYR^? 17.56 CL CL B 129 D 236 ASP B 30 ASP^? 20.91 CL CL B 129 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 87.96 72.13 -70.71 85.05 71.84 -69.78 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 90.60 81.40 -60.16 92.15 82.83 -59.97 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 110 ARG B 73 ARG^? 22.29 CL CL B 129 D 163 TYR B 22 TYR^? 17.56 CL CL B 129 D 236 ASP B 30 ASP^? 20.91 CL CL B 129 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 83.86 69.55 -59.16 85.91 69.18 -61.42 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 90.60 81.40 -60.16 92.15 82.83 -59.97 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 110 ARG B 117 ARG^? 16.04 CL CL B 129 D 163 TYR B 22 TYR^? 17.56 CL CL B 129 D 236 ASP B 30 ASP^? 20.91 CL CL B 129 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 100.63 75.34 -68.25 102.08 77.36 -66.41 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 90.60 81.40 -60.16 92.15 82.83 -59.97 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 B 110 ARG C 46 ARG^? 15.12 CL CL C 129 D 163 TYR C 22 TYR^? 17.52 CL CL C 129 D 236 ASP C 30 ASP^? 20.67 CL CL C 129 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 92.47 76.70 -34.87 92.87 79.50 -36.04 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 B 110 ARG C 73 ARG^? 22.24 CL CL C 129 D 163 TYR C 22 TYR^? 17.52 CL CL C 129 D 236 ASP C 30 ASP^? 20.67 CL CL C 129 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 95.26 80.79 -46.47 95.45 78.63 -44.29 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 B 110 ARG C 117 ARG^? 16.02 CL CL C 129 D 163 TYR C 22 TYR^? 17.52 CL CL C 129 D 236 ASP C 30 ASP^? 20.67 CL CL C 129 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 89.36 64.01 -37.29 87.40 62.56 -39.24 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 B 110 ARG D 46 ARG^? 15.13 CL CL D 129 D 163 TYR D 22 TYR^? 17.52 CL CL D 129 D 236 ASP D 30 ASP^? 20.62 CL CL D 129 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 66.74 73.93 -35.00 66.45 71.02 -36.02 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 67.44 78.74 -43.16 67.49 76.94 -41.01 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 76.16 76.40 -45.40 77.49 78.05 -45.35 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 B 110 ARG D 73 ARG^? 22.15 CL CL D 129 D 163 TYR D 22 TYR^? 17.52 CL CL D 129 D 236 ASP D 30 ASP^? 20.62 CL CL D 129 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 64.06 69.83 -46.45 63.93 71.88 -44.19 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 67.44 78.74 -43.16 67.49 76.94 -41.01 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 76.16 76.40 -45.40 77.49 78.05 -45.35 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 B 110 ARG D 117 ARG^? 15.96 CL CL D 129 D 163 TYR D 22 TYR^? 17.52 CL CL D 129 D 236 ASP D 30 ASP^? 20.62 CL CL D 129 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 69.91 86.62 -37.36 71.94 88.06 -39.21 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 67.44 78.74 -43.16 67.49 76.94 -41.01 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 76.16 76.40 -45.40 77.49 78.05 -45.35 1qgn_c17 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 12 hits 1qgn_c17 naa= 3 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR A 22 TYR~? 17.56 CL CL A 129 A 236 ASP A 30 ASP~? 20.80 CL CL A 129 C 110 ARG A 46 ARG^? 15.11 CL CL A 129 coo 55.48 26.51 40.65 55.39 23.99 39.43 92.72 50.62 -78.45 90.87 50.50 -76.41 coo 48.87 29.19 44.63 49.10 27.34 43.63 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 52.39 23.42 32.10 54.51 23.27 34.29 87.96 51.20 -70.32 85.08 51.60 -71.34 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 163 TYR A 22 TYR~? 17.56 CL CL A 129 A 236 ASP A 30 ASP~? 20.80 CL CL A 129 C 110 ARG A 73 ARG.? 22.19 CL CL A 129 coo 55.48 26.51 40.65 55.39 23.99 39.43 92.72 50.62 -78.45 90.87 50.50 -76.41 coo 48.87 29.19 44.63 49.10 27.34 43.63 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 52.39 23.42 32.10 54.51 23.27 34.29 83.82 53.79 -81.61 86.00 54.30 -79.51 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 163 TYR A 22 TYR~? 17.56 CL CL A 129 A 236 ASP A 30 ASP~? 20.80 CL CL A 129 C 110 ARG A 117 ARG^? 16.03 CL CL A 129 coo 55.48 26.51 40.65 55.39 23.99 39.43 92.72 50.62 -78.45 90.87 50.50 -76.41 coo 48.87 29.19 44.63 49.10 27.34 43.63 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 52.39 23.42 32.10 54.51 23.27 34.29 100.59 48.03 -72.66 102.04 46.10 -74.59 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 163 TYR B 22 TYR^? 17.56 CL CL B 129 A 236 ASP B 30 ASP^? 20.91 CL CL B 129 C 110 ARG B 46 ARG^? 15.06 CL CL B 129 coo 55.48 26.51 40.65 55.39 23.99 39.43 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 48.87 29.19 44.63 49.10 27.34 43.63 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 52.39 23.42 32.10 54.51 23.27 34.29 87.96 72.13 -70.71 85.05 71.84 -69.78 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 163 TYR B 22 TYR^? 17.56 CL CL B 129 A 236 ASP B 30 ASP^? 20.91 CL CL B 129 C 110 ARG B 73 ARG^? 22.29 CL CL B 129 coo 55.48 26.51 40.65 55.39 23.99 39.43 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 48.87 29.19 44.63 49.10 27.34 43.63 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 52.39 23.42 32.10 54.51 23.27 34.29 83.86 69.55 -59.16 85.91 69.18 -61.42 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 A 163 TYR B 22 TYR^? 17.56 CL CL B 129 A 236 ASP B 30 ASP^? 20.91 CL CL B 129 C 110 ARG B 117 ARG^? 16.04 CL CL B 129 coo 55.48 26.51 40.65 55.39 23.99 39.43 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 48.87 29.19 44.63 49.10 27.34 43.63 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 52.39 23.42 32.10 54.51 23.27 34.29 100.63 75.34 -68.25 102.08 77.36 -66.41 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 A 163 TYR C 22 TYR^? 17.52 CL CL C 129 A 236 ASP C 30 ASP^? 20.67 CL CL C 129 C 110 ARG C 46 ARG^? 15.12 CL CL C 129 coo 55.48 26.51 40.65 55.39 23.99 39.43 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 48.87 29.19 44.63 49.10 27.34 43.63 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 52.39 23.42 32.10 54.51 23.27 34.29 92.47 76.70 -34.87 92.87 79.50 -36.04 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 A 163 TYR C 22 TYR^? 17.52 CL CL C 129 A 236 ASP C 30 ASP^? 20.67 CL CL C 129 C 110 ARG C 73 ARG^? 22.24 CL CL C 129 coo 55.48 26.51 40.65 55.39 23.99 39.43 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 48.87 29.19 44.63 49.10 27.34 43.63 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 52.39 23.42 32.10 54.51 23.27 34.29 95.26 80.79 -46.47 95.45 78.63 -44.29 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 A 163 TYR C 22 TYR^? 17.52 CL CL C 129 A 236 ASP C 30 ASP^? 20.67 CL CL C 129 C 110 ARG C 117 ARG^? 16.02 CL CL C 129 coo 55.48 26.51 40.65 55.39 23.99 39.43 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 48.87 29.19 44.63 49.10 27.34 43.63 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 52.39 23.42 32.10 54.51 23.27 34.29 89.36 64.01 -37.29 87.40 62.56 -39.24 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 A 163 TYR D 22 TYR^? 17.52 CL CL D 129 A 236 ASP D 30 ASP^? 20.62 CL CL D 129 C 110 ARG D 46 ARG^? 15.13 CL CL D 129 coo 55.48 26.51 40.65 55.39 23.99 39.43 67.44 78.74 -43.16 67.49 76.94 -41.01 coo 48.87 29.19 44.63 49.10 27.34 43.63 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 52.39 23.42 32.10 54.51 23.27 34.29 66.74 73.93 -35.00 66.45 71.02 -36.02 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 A 163 TYR D 22 TYR^? 17.52 CL CL D 129 A 236 ASP D 30 ASP^? 20.62 CL CL D 129 C 110 ARG D 73 ARG^? 22.15 CL CL D 129 coo 55.48 26.51 40.65 55.39 23.99 39.43 67.44 78.74 -43.16 67.49 76.94 -41.01 coo 48.87 29.19 44.63 49.10 27.34 43.63 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 52.39 23.42 32.10 54.51 23.27 34.29 64.06 69.83 -46.45 63.93 71.88 -44.19 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 A 163 TYR D 22 TYR^? 17.52 CL CL D 129 A 236 ASP D 30 ASP^? 20.62 CL CL D 129 C 110 ARG D 117 ARG^? 15.96 CL CL D 129 coo 55.48 26.51 40.65 55.39 23.99 39.43 67.44 78.74 -43.16 67.49 76.94 -41.01 coo 48.87 29.19 44.63 49.10 27.34 43.63 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 52.39 23.42 32.10 54.51 23.27 34.29 69.91 86.62 -37.36 71.94 88.06 -39.21 1qgn_c18 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 12 hits 1qgn_c18 naa= 3 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR A 22 TYR~? 17.56 CL CL A 129 B 236 ASP A 30 ASP~? 20.80 CL CL A 129 D 110 ARG A 46 ARG^? 15.11 CL CL A 129 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 92.72 50.62 -78.45 90.87 50.50 -76.41 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 87.96 51.20 -70.32 85.08 51.60 -71.34 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 163 TYR A 22 TYR~? 17.56 CL CL A 129 B 236 ASP A 30 ASP~? 20.80 CL CL A 129 D 110 ARG A 73 ARG.? 22.19 CL CL A 129 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 92.72 50.62 -78.45 90.87 50.50 -76.41 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 83.82 53.79 -81.61 86.00 54.30 -79.51 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 163 TYR A 22 TYR~? 17.56 CL CL A 129 B 236 ASP A 30 ASP~? 20.80 CL CL A 129 D 110 ARG A 117 ARG^? 16.03 CL CL A 129 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 92.72 50.62 -78.45 90.87 50.50 -76.41 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 100.59 48.03 -72.66 102.04 46.10 -74.59 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 163 TYR B 22 TYR^? 17.56 CL CL B 129 B 236 ASP B 30 ASP^? 20.91 CL CL B 129 D 110 ARG B 46 ARG^? 15.06 CL CL B 129 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 87.96 72.13 -70.71 85.05 71.84 -69.78 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 163 TYR B 22 TYR^? 17.56 CL CL B 129 B 236 ASP B 30 ASP^? 20.91 CL CL B 129 D 110 ARG B 73 ARG^? 22.29 CL CL B 129 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 83.86 69.55 -59.16 85.91 69.18 -61.42 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 163 TYR B 22 TYR^? 17.56 CL CL B 129 B 236 ASP B 30 ASP^? 20.91 CL CL B 129 D 110 ARG B 117 ARG^? 16.04 CL CL B 129 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 100.63 75.34 -68.25 102.08 77.36 -66.41 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 B 163 TYR C 22 TYR^? 17.52 CL CL C 129 B 236 ASP C 30 ASP^? 20.67 CL CL C 129 D 110 ARG C 46 ARG^? 15.12 CL CL C 129 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 92.47 76.70 -34.87 92.87 79.50 -36.04 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 B 163 TYR C 22 TYR^? 17.52 CL CL C 129 B 236 ASP C 30 ASP^? 20.67 CL CL C 129 D 110 ARG C 73 ARG^? 22.24 CL CL C 129 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 95.26 80.79 -46.47 95.45 78.63 -44.29 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 B 163 TYR C 22 TYR^? 17.52 CL CL C 129 B 236 ASP C 30 ASP^? 20.67 CL CL C 129 D 110 ARG C 117 ARG^? 16.02 CL CL C 129 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 89.36 64.01 -37.29 87.40 62.56 -39.24 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 B 163 TYR D 22 TYR^? 17.52 CL CL D 129 B 236 ASP D 30 ASP^? 20.62 CL CL D 129 D 110 ARG D 46 ARG^? 15.13 CL CL D 129 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 67.44 78.74 -43.16 67.49 76.94 -41.01 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 66.74 73.93 -35.00 66.45 71.02 -36.02 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 B 163 TYR D 22 TYR^? 17.52 CL CL D 129 B 236 ASP D 30 ASP^? 20.62 CL CL D 129 D 110 ARG D 73 ARG^? 22.15 CL CL D 129 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 67.44 78.74 -43.16 67.49 76.94 -41.01 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 64.06 69.83 -46.45 63.93 71.88 -44.19 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 B 163 TYR D 22 TYR^? 17.52 CL CL D 129 B 236 ASP D 30 ASP^? 20.62 CL CL D 129 D 110 ARG D 117 ARG^? 15.96 CL CL D 129 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 67.44 78.74 -43.16 67.49 76.94 -41.01 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 69.91 86.62 -37.36 71.94 88.06 -39.21 1qgn_c19 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 12 hits 1qgn_c19 naa= 3 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 110 ARG A 46 ARG^? 15.11 CL CL A 129 G 163 TYR A 22 TYR~? 17.56 CL CL A 129 G 236 ASP A 30 ASP~? 20.80 CL CL A 129 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 87.96 51.20 -70.32 85.08 51.60 -71.34 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 92.72 50.62 -78.45 90.87 50.50 -76.41 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 90.38 41.71 -80.87 92.04 40.39 -80.79 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 110 ARG A 73 ARG.? 22.19 CL CL A 129 G 163 TYR A 22 TYR~? 17.56 CL CL A 129 G 236 ASP A 30 ASP~? 20.80 CL CL A 129 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 83.82 53.79 -81.61 86.00 54.30 -79.51 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 92.72 50.62 -78.45 90.87 50.50 -76.41 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 90.38 41.71 -80.87 92.04 40.39 -80.79 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 110 ARG A 117 ARG^? 16.03 CL CL A 129 G 163 TYR A 22 TYR~? 17.56 CL CL A 129 G 236 ASP A 30 ASP~? 20.80 CL CL A 129 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 100.59 48.03 -72.66 102.04 46.10 -74.59 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 92.72 50.62 -78.45 90.87 50.50 -76.41 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 90.38 41.71 -80.87 92.04 40.39 -80.79 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 E 110 ARG B 46 ARG^? 15.06 CL CL B 129 G 163 TYR B 22 TYR^? 17.56 CL CL B 129 G 236 ASP B 30 ASP^? 20.91 CL CL B 129 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 87.96 72.13 -70.71 85.05 71.84 -69.78 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 90.60 81.40 -60.16 92.15 82.83 -59.97 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 E 110 ARG B 73 ARG^? 22.29 CL CL B 129 G 163 TYR B 22 TYR^? 17.56 CL CL B 129 G 236 ASP B 30 ASP^? 20.91 CL CL B 129 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 83.86 69.55 -59.16 85.91 69.18 -61.42 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 90.60 81.40 -60.16 92.15 82.83 -59.97 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 E 110 ARG B 117 ARG^? 16.04 CL CL B 129 G 163 TYR B 22 TYR^? 17.56 CL CL B 129 G 236 ASP B 30 ASP^? 20.91 CL CL B 129 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 100.63 75.34 -68.25 102.08 77.36 -66.41 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 90.60 81.40 -60.16 92.15 82.83 -59.97 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 E 110 ARG C 46 ARG^? 15.12 CL CL C 129 G 163 TYR C 22 TYR^? 17.52 CL CL C 129 G 236 ASP C 30 ASP^? 20.67 CL CL C 129 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 92.47 76.70 -34.87 92.87 79.50 -36.04 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 E 110 ARG C 73 ARG^? 22.24 CL CL C 129 G 163 TYR C 22 TYR^? 17.52 CL CL C 129 G 236 ASP C 30 ASP^? 20.67 CL CL C 129 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 95.26 80.79 -46.47 95.45 78.63 -44.29 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 E 110 ARG C 117 ARG^? 16.02 CL CL C 129 G 163 TYR C 22 TYR^? 17.52 CL CL C 129 G 236 ASP C 30 ASP^? 20.67 CL CL C 129 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 89.36 64.01 -37.29 87.40 62.56 -39.24 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 E 110 ARG D 46 ARG^? 15.13 CL CL D 129 G 163 TYR D 22 TYR^? 17.52 CL CL D 129 G 236 ASP D 30 ASP^? 20.62 CL CL D 129 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 66.74 73.93 -35.00 66.45 71.02 -36.02 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 67.44 78.74 -43.16 67.49 76.94 -41.01 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 76.16 76.40 -45.40 77.49 78.05 -45.35 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 E 110 ARG D 73 ARG^? 22.15 CL CL D 129 G 163 TYR D 22 TYR^? 17.52 CL CL D 129 G 236 ASP D 30 ASP^? 20.62 CL CL D 129 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 64.06 69.83 -46.45 63.93 71.88 -44.19 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 67.44 78.74 -43.16 67.49 76.94 -41.01 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 76.16 76.40 -45.40 77.49 78.05 -45.35 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 E 110 ARG D 117 ARG^? 15.96 CL CL D 129 G 163 TYR D 22 TYR^? 17.52 CL CL D 129 G 236 ASP D 30 ASP^? 20.62 CL CL D 129 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 69.91 86.62 -37.36 71.94 88.06 -39.21 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 67.44 78.74 -43.16 67.49 76.94 -41.01 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 76.16 76.40 -45.40 77.49 78.05 -45.35 1qgn_c20 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 12 hits 1qgn_c20 naa= 3 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 110 ARG A 46 ARG^? 15.11 CL CL A 129 H 163 TYR A 22 TYR~? 17.56 CL CL A 129 H 236 ASP A 30 ASP~? 20.80 CL CL A 129 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 87.96 51.20 -70.32 85.08 51.60 -71.34 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 92.72 50.62 -78.45 90.87 50.50 -76.41 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 90.38 41.71 -80.87 92.04 40.39 -80.79 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 110 ARG A 73 ARG.? 22.19 CL CL A 129 H 163 TYR A 22 TYR~? 17.56 CL CL A 129 H 236 ASP A 30 ASP~? 20.80 CL CL A 129 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 83.82 53.79 -81.61 86.00 54.30 -79.51 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 92.72 50.62 -78.45 90.87 50.50 -76.41 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 90.38 41.71 -80.87 92.04 40.39 -80.79 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 110 ARG A 117 ARG^? 16.03 CL CL A 129 H 163 TYR A 22 TYR~? 17.56 CL CL A 129 H 236 ASP A 30 ASP~? 20.80 CL CL A 129 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 100.59 48.03 -72.66 102.04 46.10 -74.59 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 92.72 50.62 -78.45 90.87 50.50 -76.41 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 90.38 41.71 -80.87 92.04 40.39 -80.79 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 F 110 ARG B 46 ARG^? 15.06 CL CL B 129 H 163 TYR B 22 TYR^? 17.56 CL CL B 129 H 236 ASP B 30 ASP^? 20.91 CL CL B 129 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 87.96 72.13 -70.71 85.05 71.84 -69.78 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 90.60 81.40 -60.16 92.15 82.83 -59.97 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 F 110 ARG B 73 ARG^? 22.29 CL CL B 129 H 163 TYR B 22 TYR^? 17.56 CL CL B 129 H 236 ASP B 30 ASP^? 20.91 CL CL B 129 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 83.86 69.55 -59.16 85.91 69.18 -61.42 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 90.60 81.40 -60.16 92.15 82.83 -59.97 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 F 110 ARG B 117 ARG^? 16.04 CL CL B 129 H 163 TYR B 22 TYR^? 17.56 CL CL B 129 H 236 ASP B 30 ASP^? 20.91 CL CL B 129 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 100.63 75.34 -68.25 102.08 77.36 -66.41 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 90.60 81.40 -60.16 92.15 82.83 -59.97 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 F 110 ARG C 46 ARG^? 15.12 CL CL C 129 H 163 TYR C 22 TYR^? 17.52 CL CL C 129 H 236 ASP C 30 ASP^? 20.67 CL CL C 129 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 92.47 76.70 -34.87 92.87 79.50 -36.04 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 F 110 ARG C 73 ARG^? 22.24 CL CL C 129 H 163 TYR C 22 TYR^? 17.52 CL CL C 129 H 236 ASP C 30 ASP^? 20.67 CL CL C 129 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 95.26 80.79 -46.47 95.45 78.63 -44.29 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 F 110 ARG C 117 ARG^? 16.02 CL CL C 129 H 163 TYR C 22 TYR^? 17.52 CL CL C 129 H 236 ASP C 30 ASP^? 20.67 CL CL C 129 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 89.36 64.01 -37.29 87.40 62.56 -39.24 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 F 110 ARG D 46 ARG^? 15.13 CL CL D 129 H 163 TYR D 22 TYR^? 17.52 CL CL D 129 H 236 ASP D 30 ASP^? 20.62 CL CL D 129 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 66.74 73.93 -35.00 66.45 71.02 -36.02 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 67.44 78.74 -43.16 67.49 76.94 -41.01 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 76.16 76.40 -45.40 77.49 78.05 -45.35 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 F 110 ARG D 73 ARG^? 22.15 CL CL D 129 H 163 TYR D 22 TYR^? 17.52 CL CL D 129 H 236 ASP D 30 ASP^? 20.62 CL CL D 129 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 64.06 69.83 -46.45 63.93 71.88 -44.19 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 67.44 78.74 -43.16 67.49 76.94 -41.01 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 76.16 76.40 -45.40 77.49 78.05 -45.35 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 F 110 ARG D 117 ARG^? 15.96 CL CL D 129 H 163 TYR D 22 TYR^? 17.52 CL CL D 129 H 236 ASP D 30 ASP^? 20.62 CL CL D 129 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 69.91 86.62 -37.36 71.94 88.06 -39.21 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 67.44 78.74 -43.16 67.49 76.94 -41.01 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 76.16 76.40 -45.40 77.49 78.05 -45.35 1qgn_c21 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 12 hits 1qgn_c21 naa= 3 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR A 22 TYR~? 17.56 CL CL A 129 E 236 ASP A 30 ASP~? 20.80 CL CL A 129 G 110 ARG A 46 ARG^? 15.11 CL CL A 129 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 92.72 50.62 -78.45 90.87 50.50 -76.41 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 87.96 51.20 -70.32 85.08 51.60 -71.34 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 163 TYR A 22 TYR~? 17.56 CL CL A 129 E 236 ASP A 30 ASP~? 20.80 CL CL A 129 G 110 ARG A 73 ARG.? 22.19 CL CL A 129 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 92.72 50.62 -78.45 90.87 50.50 -76.41 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 83.82 53.79 -81.61 86.00 54.30 -79.51 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 163 TYR A 22 TYR~? 17.56 CL CL A 129 E 236 ASP A 30 ASP~? 20.80 CL CL A 129 G 110 ARG A 117 ARG^? 16.03 CL CL A 129 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 92.72 50.62 -78.45 90.87 50.50 -76.41 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 100.59 48.03 -72.66 102.04 46.10 -74.59 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 E 163 TYR B 22 TYR^? 17.56 CL CL B 129 E 236 ASP B 30 ASP^? 20.91 CL CL B 129 G 110 ARG B 46 ARG^? 15.06 CL CL B 129 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 87.96 72.13 -70.71 85.05 71.84 -69.78 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 E 163 TYR B 22 TYR^? 17.56 CL CL B 129 E 236 ASP B 30 ASP^? 20.91 CL CL B 129 G 110 ARG B 73 ARG^? 22.29 CL CL B 129 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 83.86 69.55 -59.16 85.91 69.18 -61.42 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 E 163 TYR B 22 TYR^? 17.56 CL CL B 129 E 236 ASP B 30 ASP^? 20.91 CL CL B 129 G 110 ARG B 117 ARG^? 16.04 CL CL B 129 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 100.63 75.34 -68.25 102.08 77.36 -66.41 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 E 163 TYR C 22 TYR^? 17.52 CL CL C 129 E 236 ASP C 30 ASP^? 20.67 CL CL C 129 G 110 ARG C 46 ARG^? 15.12 CL CL C 129 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 92.47 76.70 -34.87 92.87 79.50 -36.04 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 E 163 TYR C 22 TYR^? 17.52 CL CL C 129 E 236 ASP C 30 ASP^? 20.67 CL CL C 129 G 110 ARG C 73 ARG^? 22.24 CL CL C 129 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 95.26 80.79 -46.47 95.45 78.63 -44.29 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 E 163 TYR C 22 TYR^? 17.52 CL CL C 129 E 236 ASP C 30 ASP^? 20.67 CL CL C 129 G 110 ARG C 117 ARG^? 16.02 CL CL C 129 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 89.36 64.01 -37.29 87.40 62.56 -39.24 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 E 163 TYR D 22 TYR^? 17.52 CL CL D 129 E 236 ASP D 30 ASP^? 20.62 CL CL D 129 G 110 ARG D 46 ARG^? 15.13 CL CL D 129 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 67.44 78.74 -43.16 67.49 76.94 -41.01 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 66.74 73.93 -35.00 66.45 71.02 -36.02 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 E 163 TYR D 22 TYR^? 17.52 CL CL D 129 E 236 ASP D 30 ASP^? 20.62 CL CL D 129 G 110 ARG D 73 ARG^? 22.15 CL CL D 129 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 67.44 78.74 -43.16 67.49 76.94 -41.01 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 64.06 69.83 -46.45 63.93 71.88 -44.19 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 E 163 TYR D 22 TYR^? 17.52 CL CL D 129 E 236 ASP D 30 ASP^? 20.62 CL CL D 129 G 110 ARG D 117 ARG^? 15.96 CL CL D 129 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 67.44 78.74 -43.16 67.49 76.94 -41.01 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 69.91 86.62 -37.36 71.94 88.06 -39.21 1qgn_c22 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 12 hits 1qgn_c22 naa= 3 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR A 22 TYR~? 17.56 CL CL A 129 F 236 ASP A 30 ASP~? 20.80 CL CL A 129 H 110 ARG A 46 ARG^? 15.11 CL CL A 129 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 92.72 50.62 -78.45 90.87 50.50 -76.41 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 87.96 51.20 -70.32 85.08 51.60 -71.34 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 163 TYR A 22 TYR~? 17.56 CL CL A 129 F 236 ASP A 30 ASP~? 20.80 CL CL A 129 H 110 ARG A 73 ARG.? 22.19 CL CL A 129 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 92.72 50.62 -78.45 90.87 50.50 -76.41 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 83.82 53.79 -81.61 86.00 54.30 -79.51 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 163 TYR A 22 TYR~? 17.56 CL CL A 129 F 236 ASP A 30 ASP~? 20.80 CL CL A 129 H 110 ARG A 117 ARG^? 16.03 CL CL A 129 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 92.72 50.62 -78.45 90.87 50.50 -76.41 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 100.59 48.03 -72.66 102.04 46.10 -74.59 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 F 163 TYR B 22 TYR^? 17.56 CL CL B 129 F 236 ASP B 30 ASP^? 20.91 CL CL B 129 H 110 ARG B 46 ARG^? 15.06 CL CL B 129 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 87.96 72.13 -70.71 85.05 71.84 -69.78 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 F 163 TYR B 22 TYR^? 17.56 CL CL B 129 F 236 ASP B 30 ASP^? 20.91 CL CL B 129 H 110 ARG B 73 ARG^? 22.29 CL CL B 129 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 83.86 69.55 -59.16 85.91 69.18 -61.42 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 F 163 TYR B 22 TYR^? 17.56 CL CL B 129 F 236 ASP B 30 ASP^? 20.91 CL CL B 129 H 110 ARG B 117 ARG^? 16.04 CL CL B 129 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 100.63 75.34 -68.25 102.08 77.36 -66.41 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 F 163 TYR C 22 TYR^? 17.52 CL CL C 129 F 236 ASP C 30 ASP^? 20.67 CL CL C 129 H 110 ARG C 46 ARG^? 15.12 CL CL C 129 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 92.47 76.70 -34.87 92.87 79.50 -36.04 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 F 163 TYR C 22 TYR^? 17.52 CL CL C 129 F 236 ASP C 30 ASP^? 20.67 CL CL C 129 H 110 ARG C 73 ARG^? 22.24 CL CL C 129 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 95.26 80.79 -46.47 95.45 78.63 -44.29 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 F 163 TYR C 22 TYR^? 17.52 CL CL C 129 F 236 ASP C 30 ASP^? 20.67 CL CL C 129 H 110 ARG C 117 ARG^? 16.02 CL CL C 129 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 89.36 64.01 -37.29 87.40 62.56 -39.24 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 F 163 TYR D 22 TYR^? 17.52 CL CL D 129 F 236 ASP D 30 ASP^? 20.62 CL CL D 129 H 110 ARG D 46 ARG^? 15.13 CL CL D 129 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 67.44 78.74 -43.16 67.49 76.94 -41.01 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 66.74 73.93 -35.00 66.45 71.02 -36.02 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 F 163 TYR D 22 TYR^? 17.52 CL CL D 129 F 236 ASP D 30 ASP^? 20.62 CL CL D 129 H 110 ARG D 73 ARG^? 22.15 CL CL D 129 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 67.44 78.74 -43.16 67.49 76.94 -41.01 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 64.06 69.83 -46.45 63.93 71.88 -44.19 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 F 163 TYR D 22 TYR^? 17.52 CL CL D 129 F 236 ASP D 30 ASP^? 20.62 CL CL D 129 H 110 ARG D 117 ARG^? 15.96 CL CL D 129 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 67.44 78.74 -43.16 67.49 76.94 -41.01 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 69.91 86.62 -37.36 71.94 88.06 -39.21 1qgn_c23 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 12 hits 1qgn_c23 naa= 3 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 1 3 # 1 A 49 ASP A 5 ASP~? 21.13 CL CL B 129 A 147 THR A 82 THR^? 18.91 CL CL B 129 A 294 ASP A 14 ASP~? 27.67 CL CL B 129 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 110.30 67.66 -76.72 112.26 68.26 -76.10 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 103.30 63.05 -78.71 104.17 62.08 -80.47 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 105.70 54.30 -82.61 107.63 54.15 -83.44 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 2 3 # 2 A 49 ASP A 5 ASP~? 21.13 CL CL B 129 A 147 THR A 82 THR^? 18.91 CL CL B 129 A 294 ASP B 41 ASP^? 7.64 CL CL B 129 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 110.30 67.66 -76.72 112.26 68.26 -76.10 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 103.30 63.05 -78.71 104.17 62.08 -80.47 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 99.50 74.51 -77.69 100.41 73.95 -79.49 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 3 3 # 3 A 49 ASP A 41 ASP.? 7.60 CL CL A 129 A 147 THR A 44 THR.? 7.93 CL CL A 129 A 294 ASP A 35 ASP~? 10.31 CL CL A 129 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 99.56 48.98 -63.34 100.43 49.52 -61.53 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 95.29 52.07 -64.55 95.81 50.95 -66.27 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 93.79 42.35 -72.20 94.79 41.97 -70.38 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 4 3 # 4 A 49 ASP B 5 ASP^? 20.93 CL CL A 129 A 147 THR B 82 THR^? 18.93 CL CL A 129 A 294 ASP A 41 ASP.? 7.60 CL CL A 129 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 110.10 55.77 -64.66 112.04 55.13 -65.31 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 103.32 60.51 -62.56 104.17 61.53 -60.86 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 99.56 48.98 -63.34 100.43 49.52 -61.53 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 5 3 # 5 A 49 ASP B 5 ASP^? 20.93 CL CL A 129 A 147 THR B 82 THR^? 18.93 CL CL A 129 A 294 ASP B 10 ASP^? 27.46 CL CL A 129 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 110.10 55.77 -64.66 112.04 55.13 -65.31 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 103.32 60.51 -62.56 104.17 61.53 -60.86 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 110.59 65.11 -56.28 111.89 65.48 -54.65 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 6 3 # 6 A 49 ASP B 5 ASP^? 20.93 CL CL A 129 A 147 THR B 82 THR^? 18.93 CL CL A 129 A 294 ASP B 14 ASP^? 27.62 CL CL A 129 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 110.10 55.77 -64.66 112.04 55.13 -65.31 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 103.32 60.51 -62.56 104.17 61.53 -60.86 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 105.60 69.00 -58.44 107.49 69.47 -57.66 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 7 3 # 7 A 49 ASP B 41 ASP^? 7.64 CL CL B 129 A 147 THR B 44 THR^? 7.91 CL CL B 129 A 294 ASP B 35 ASP^? 10.19 CL CL B 129 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 99.50 74.51 -77.69 100.41 73.95 -79.49 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 95.21 71.44 -76.44 95.74 72.60 -74.74 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 93.79 80.98 -68.72 94.61 81.32 -70.62 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 8 3 # 8 A 49 ASP B 72 ASP^? 28.57 CL CL C 129 A 147 THR B 27 THR^? 25.10 CL CL B 129 A 294 ASP C 72 ASP^? 28.53 CL CL B 129 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 80.87 74.36 -54.99 81.74 73.36 -53.35 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 85.40 75.83 -58.05 86.15 74.42 -56.65 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 90.38 83.76 -50.64 91.24 82.68 -52.23 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 9 3 # 9 A 49 ASP C 5 ASP^? 26.16 CL CL A 129 A 147 THR C 82 THR^? 23.56 CL CL A 129 A 294 ASP C 10 ASP^? 12.83 CL CL A 129 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 108.85 54.21 -41.41 109.64 52.31 -40.89 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 104.35 61.24 -43.23 103.23 60.37 -44.92 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 99.63 54.02 -49.94 99.45 52.98 -51.81 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 10 3 # 10 A 49 ASP C 5 ASP^? 26.16 CL CL A 129 A 147 THR C 82 THR^? 23.56 CL CL A 129 A 294 ASP C 14 ASP^? 16.95 CL CL A 129 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 108.85 54.21 -41.41 109.64 52.31 -40.89 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 104.35 61.24 -43.23 103.23 60.37 -44.92 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 95.50 58.88 -47.37 95.04 57.01 -48.29 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 11 3 # 11 A 49 ASP C 41 ASP^? 7.58 CL CL C 129 A 147 THR C 44 THR^? 7.82 CL CL C 129 A 294 ASP C 35 ASP^? 10.26 CL CL C 129 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 90.28 65.09 -27.98 90.77 64.12 -26.18 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 93.28 69.34 -29.36 92.05 68.81 -31.01 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 83.63 70.73 -36.85 83.32 69.81 -34.96 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 12 3 # 12 A 49 ASP C 72 ASP^? 28.53 CL CL B 129 A 147 THR C 27 THR^? 25.08 CL CL C 129 A 294 ASP B 72 ASP^? 28.57 CL CL C 129 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 90.38 83.76 -50.64 91.24 82.68 -52.23 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 88.92 79.28 -47.47 90.32 78.59 -48.91 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 80.87 74.36 -54.99 81.74 73.36 -53.35 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 13 3 # 13 A 49 ASP D 5 ASP^? 32.88 CL CL D 129 A 147 THR D 82 THR^? 27.41 CL CL D 129 A 294 ASP D 14 ASP^? 27.52 CL CL D 129 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 50.37 96.25 -41.36 49.69 98.16 -40.70 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 55.03 89.38 -43.21 56.11 90.23 -44.91 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 63.54 91.53 -47.18 63.81 93.48 -47.82 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 14 3 # 14 A 49 ASP D 41 ASP^? 7.55 CL CL D 129 A 147 THR D 44 THR^? 7.93 CL CL D 129 A 294 ASP D 35 ASP^? 10.18 CL CL D 129 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 69.10 85.54 -28.07 68.60 86.44 -26.19 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 65.95 81.28 -29.36 67.15 81.78 -31.05 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 75.66 79.96 -36.93 75.99 80.66 -34.97 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 15 3 # 15 A 49 ASP D 72 ASP^? 29.64 CL CL D 129 A 147 THR B 97 THR^? 28.75 CL CL D 129 A 294 ASP D 30 ASP^? 20.62 CL CL D 129 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 69.04 67.18 -50.81 68.23 68.38 -52.37 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 74.83 68.80 -53.92 74.73 70.43 -52.45 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 76.16 76.40 -45.40 77.49 78.05 -45.35 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 16 3 # 16 A 49 ASP D 72 ASP^? 29.64 CL CL D 129 A 147 THR D 27 THR^? 25.09 CL CL D 129 A 294 ASP B 72 ASP^? 28.57 CL CL C 129 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 69.04 67.18 -50.81 68.23 68.38 -52.37 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 70.41 71.33 -47.57 68.87 71.98 -48.94 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 80.87 74.36 -54.99 81.74 73.36 -53.35 1qgx_c02 source 1qgx 3',5'-ADENOSINE BISPHOSPHATASE : 16 hits 1qgx_c02 naa= 3 ULMN 3 1qho_c05 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 14 ASP~? 27.67 CL CL B 129 A 261 ASP A 41 ASP.? 7.60 CL CL A 129 A 329 ASP A 86 ASP.? 23.33 CL CL A 129 coo 28.46 69.88 26.74 30.40 70.70 26.53 105.70 54.30 -82.61 107.63 54.15 -83.44 coo 34.02 79.89 42.60 34.73 78.01 41.86 99.56 48.98 -63.34 100.43 49.52 -61.53 coo 37.87 70.12 31.80 36.61 69.74 30.15 108.46 57.22 -73.78 109.48 58.49 -72.45 ULMN 3 1qho_c05 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP A 35 ASP~? 10.31 CL CL A 129 A 261 ASP A 86 ASP.? 23.33 CL CL A 129 A 329 ASP A 41 ASP.? 7.60 CL CL A 129 coo 28.46 69.88 26.74 30.40 70.70 26.53 93.79 42.35 -72.20 94.79 41.97 -70.38 coo 34.02 79.89 42.60 34.73 78.01 41.86 108.46 57.22 -73.78 109.48 58.49 -72.45 coo 37.87 70.12 31.80 36.61 69.74 30.15 99.56 48.98 -63.34 100.43 49.52 -61.53 ULMN 3 1qho_c05 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP A 41 ASP.? 7.60 CL CL A 129 A 261 ASP B 14 ASP^? 27.62 CL CL A 129 A 329 ASP B 5 ASP^? 20.93 CL CL A 129 coo 28.46 69.88 26.74 30.40 70.70 26.53 99.56 48.98 -63.34 100.43 49.52 -61.53 coo 34.02 79.89 42.60 34.73 78.01 41.86 105.60 69.00 -58.44 107.49 69.47 -57.66 coo 37.87 70.12 31.80 36.61 69.74 30.15 110.10 55.77 -64.66 112.04 55.13 -65.31 ULMN 3 1qho_c05 ALPHA-AMYLASE user 4 3 # 4 A 228 ASP A 86 ASP.? 23.33 CL CL A 129 A 261 ASP B 14 ASP^? 27.62 CL CL A 129 A 329 ASP B 5 ASP^? 20.93 CL CL A 129 coo 28.46 69.88 26.74 30.40 70.70 26.53 108.46 57.22 -73.78 109.48 58.49 -72.45 coo 34.02 79.89 42.60 34.73 78.01 41.86 105.60 69.00 -58.44 107.49 69.47 -57.66 coo 37.87 70.12 31.80 36.61 69.74 30.15 110.10 55.77 -64.66 112.04 55.13 -65.31 ULMN 3 1qho_c05 ALPHA-AMYLASE user 5 3 # 5 A 228 ASP A 86 ASP.? 23.33 CL CL A 129 A 261 ASP B 41 ASP^? 7.64 CL CL B 129 A 329 ASP B 86 ASP^? 23.14 CL CL B 129 coo 28.46 69.88 26.74 30.40 70.70 26.53 108.46 57.22 -73.78 109.48 58.49 -72.45 coo 34.02 79.89 42.60 34.73 78.01 41.86 99.50 74.51 -77.69 100.41 73.95 -79.49 coo 37.87 70.12 31.80 36.61 69.74 30.15 108.40 66.17 -67.38 109.32 64.97 -68.84 ULMN 3 1qho_c05 ALPHA-AMYLASE user 6 3 # 6 A 228 ASP B 5 ASP^? 20.93 CL CL A 129 A 261 ASP C 10 ASP^? 12.83 CL CL A 129 A 329 ASP A 41 ASP.? 7.60 CL CL A 129 coo 28.46 69.88 26.74 30.40 70.70 26.53 110.10 55.77 -64.66 112.04 55.13 -65.31 coo 34.02 79.89 42.60 34.73 78.01 41.86 99.63 54.02 -49.94 99.45 52.98 -51.81 coo 37.87 70.12 31.80 36.61 69.74 30.15 99.56 48.98 -63.34 100.43 49.52 -61.53 ULMN 3 1qho_c05 ALPHA-AMYLASE user 7 3 # 7 A 228 ASP B 5 ASP^? 20.93 CL CL A 129 A 261 ASP C 10 ASP^? 12.83 CL CL A 129 A 329 ASP B 10 ASP^? 27.46 CL CL A 129 coo 28.46 69.88 26.74 30.40 70.70 26.53 110.10 55.77 -64.66 112.04 55.13 -65.31 coo 34.02 79.89 42.60 34.73 78.01 41.86 99.63 54.02 -49.94 99.45 52.98 -51.81 coo 37.87 70.12 31.80 36.61 69.74 30.15 110.59 65.11 -56.28 111.89 65.48 -54.65 ULMN 3 1qho_c05 ALPHA-AMYLASE user 8 3 # 8 A 228 ASP B 10 ASP^? 27.46 CL CL A 129 A 261 ASP A 5 ASP~? 21.13 CL CL B 129 A 329 ASP B 5 ASP^? 20.93 CL CL A 129 coo 28.46 69.88 26.74 30.40 70.70 26.53 110.59 65.11 -56.28 111.89 65.48 -54.65 coo 34.02 79.89 42.60 34.73 78.01 41.86 110.30 67.66 -76.72 112.26 68.26 -76.10 coo 37.87 70.12 31.80 36.61 69.74 30.15 110.10 55.77 -64.66 112.04 55.13 -65.31 ULMN 3 1qho_c05 ALPHA-AMYLASE user 9 3 # 9 A 228 ASP B 14 ASP^? 27.62 CL CL A 129 A 261 ASP B 41 ASP^? 7.64 CL CL B 129 A 329 ASP B 86 ASP^? 23.14 CL CL B 129 coo 28.46 69.88 26.74 30.40 70.70 26.53 105.60 69.00 -58.44 107.49 69.47 -57.66 coo 34.02 79.89 42.60 34.73 78.01 41.86 99.50 74.51 -77.69 100.41 73.95 -79.49 coo 37.87 70.12 31.80 36.61 69.74 30.15 108.40 66.17 -67.38 109.32 64.97 -68.84 ULMN 3 1qho_c05 ALPHA-AMYLASE user 10 3 # 10 A 228 ASP B 30 ASP^? 20.91 CL CL B 129 A 261 ASP C 30 ASP^? 20.67 CL CL C 129 A 329 ASP C 72 ASP^? 28.53 CL CL B 129 coo 28.46 69.88 26.74 30.40 70.70 26.53 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 34.02 79.89 42.60 34.73 78.01 41.86 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 37.87 70.12 31.80 36.61 69.74 30.15 90.38 83.76 -50.64 91.24 82.68 -52.23 ULMN 3 1qho_c05 ALPHA-AMYLASE user 11 3 # 11 A 228 ASP B 30 ASP^? 20.91 CL CL B 129 A 261 ASP D 30 ASP^? 20.62 CL CL D 129 A 329 ASP C 72 ASP^? 28.53 CL CL B 129 coo 28.46 69.88 26.74 30.40 70.70 26.53 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 34.02 79.89 42.60 34.73 78.01 41.86 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 37.87 70.12 31.80 36.61 69.74 30.15 90.38 83.76 -50.64 91.24 82.68 -52.23 ULMN 3 1qho_c05 ALPHA-AMYLASE user 12 3 # 12 A 228 ASP B 35 ASP^? 10.19 CL CL B 129 A 261 ASP B 86 ASP^? 23.14 CL CL B 129 A 329 ASP B 41 ASP^? 7.64 CL CL B 129 coo 28.46 69.88 26.74 30.40 70.70 26.53 93.79 80.98 -68.72 94.61 81.32 -70.62 coo 34.02 79.89 42.60 34.73 78.01 41.86 108.40 66.17 -67.38 109.32 64.97 -68.84 coo 37.87 70.12 31.80 36.61 69.74 30.15 99.50 74.51 -77.69 100.41 73.95 -79.49 ULMN 3 1qho_c05 ALPHA-AMYLASE user 13 3 # 13 A 228 ASP B 86 ASP^? 23.14 CL CL B 129 A 261 ASP A 14 ASP~? 27.67 CL CL B 129 A 329 ASP A 5 ASP~? 21.13 CL CL B 129 coo 28.46 69.88 26.74 30.40 70.70 26.53 108.40 66.17 -67.38 109.32 64.97 -68.84 coo 34.02 79.89 42.60 34.73 78.01 41.86 105.70 54.30 -82.61 107.63 54.15 -83.44 coo 37.87 70.12 31.80 36.61 69.74 30.15 110.30 67.66 -76.72 112.26 68.26 -76.10 ULMN 3 1qho_c05 ALPHA-AMYLASE user 14 3 # 14 A 228 ASP B 86 ASP^? 23.14 CL CL B 129 A 261 ASP A 41 ASP.? 7.60 CL CL A 129 A 329 ASP A 86 ASP.? 23.33 CL CL A 129 coo 28.46 69.88 26.74 30.40 70.70 26.53 108.40 66.17 -67.38 109.32 64.97 -68.84 coo 34.02 79.89 42.60 34.73 78.01 41.86 99.56 48.98 -63.34 100.43 49.52 -61.53 coo 37.87 70.12 31.80 36.61 69.74 30.15 108.46 57.22 -73.78 109.48 58.49 -72.45 ULMN 3 1qho_c05 ALPHA-AMYLASE user 15 3 # 15 A 228 ASP C 5 ASP^? 26.16 CL CL A 129 A 261 ASP B 10 ASP^? 27.46 CL CL A 129 A 329 ASP C 10 ASP^? 12.83 CL CL A 129 coo 28.46 69.88 26.74 30.40 70.70 26.53 108.85 54.21 -41.41 109.64 52.31 -40.89 coo 34.02 79.89 42.60 34.73 78.01 41.86 110.59 65.11 -56.28 111.89 65.48 -54.65 coo 37.87 70.12 31.80 36.61 69.74 30.15 99.63 54.02 -49.94 99.45 52.98 -51.81 ULMN 3 1qho_c05 ALPHA-AMYLASE user 16 3 # 16 A 228 ASP C 14 ASP^? 16.95 CL CL A 129 A 261 ASP C 41 ASP^? 7.58 CL CL C 129 A 329 ASP C 86 ASP^? 23.12 CL CL C 129 coo 28.46 69.88 26.74 30.40 70.70 26.53 95.50 58.88 -47.37 95.04 57.01 -48.29 coo 34.02 79.89 42.60 34.73 78.01 41.86 90.28 65.09 -27.98 90.77 64.12 -26.18 coo 37.87 70.12 31.80 36.61 69.74 30.15 98.39 56.19 -38.35 99.60 55.15 -36.99 ULMN 3 1qho_c05 ALPHA-AMYLASE user 17 3 # 17 A 228 ASP C 35 ASP^? 10.26 CL CL C 129 A 261 ASP C 72 ASP^? 28.53 CL CL B 129 A 329 ASP C 30 ASP^? 20.67 CL CL C 129 coo 28.46 69.88 26.74 30.40 70.70 26.53 83.63 70.73 -36.85 83.32 69.81 -34.96 coo 34.02 79.89 42.60 34.73 78.01 41.86 90.38 83.76 -50.64 91.24 82.68 -52.23 coo 37.87 70.12 31.80 36.61 69.74 30.15 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1qho_c05 ALPHA-AMYLASE user 18 3 # 18 A 228 ASP C 35 ASP^? 10.26 CL CL C 129 A 261 ASP C 72 ASP^? 28.53 CL CL B 129 A 329 ASP D 30 ASP^? 20.62 CL CL D 129 coo 28.46 69.88 26.74 30.40 70.70 26.53 83.63 70.73 -36.85 83.32 69.81 -34.96 coo 34.02 79.89 42.60 34.73 78.01 41.86 90.38 83.76 -50.64 91.24 82.68 -52.23 coo 37.87 70.12 31.80 36.61 69.74 30.15 76.16 76.40 -45.40 77.49 78.05 -45.35 ULMN 3 1qho_c05 ALPHA-AMYLASE user 19 3 # 19 A 228 ASP C 35 ASP^? 10.26 CL CL C 129 A 261 ASP C 86 ASP^? 23.12 CL CL C 129 A 329 ASP C 41 ASP^? 7.58 CL CL C 129 coo 28.46 69.88 26.74 30.40 70.70 26.53 83.63 70.73 -36.85 83.32 69.81 -34.96 coo 34.02 79.89 42.60 34.73 78.01 41.86 98.39 56.19 -38.35 99.60 55.15 -36.99 coo 37.87 70.12 31.80 36.61 69.74 30.15 90.28 65.09 -27.98 90.77 64.12 -26.18 ULMN 3 1qho_c05 ALPHA-AMYLASE user 20 3 # 20 A 228 ASP C 35 ASP^? 10.26 CL CL C 129 A 261 ASP D 72 ASP^? 29.64 CL CL D 129 A 329 ASP C 30 ASP^? 20.67 CL CL C 129 coo 28.46 69.88 26.74 30.40 70.70 26.53 83.63 70.73 -36.85 83.32 69.81 -34.96 coo 34.02 79.89 42.60 34.73 78.01 41.86 69.04 67.18 -50.81 68.23 68.38 -52.37 coo 37.87 70.12 31.80 36.61 69.74 30.15 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1qho_c05 ALPHA-AMYLASE user 21 3 # 21 A 228 ASP D 14 ASP^? 27.52 CL CL D 129 A 261 ASP D 4 ASP^? 37.41 CL CL D 129 A 329 ASP D 86 ASP^? 23.19 CL CL D 129 coo 28.46 69.88 26.74 30.40 70.70 26.53 63.54 91.53 -47.18 63.81 93.48 -47.82 coo 34.02 79.89 42.60 34.73 78.01 41.86 46.79 97.75 -45.68 46.52 99.27 -44.27 coo 37.87 70.12 31.80 36.61 69.74 30.15 60.79 94.39 -38.32 59.49 95.38 -36.98 ULMN 3 1qho_c05 ALPHA-AMYLASE user 22 3 # 22 A 228 ASP D 14 ASP^? 27.52 CL CL D 129 A 261 ASP D 41 ASP^? 7.55 CL CL D 129 A 329 ASP D 86 ASP^? 23.19 CL CL D 129 coo 28.46 69.88 26.74 30.40 70.70 26.53 63.54 91.53 -47.18 63.81 93.48 -47.82 coo 34.02 79.89 42.60 34.73 78.01 41.86 69.10 85.54 -28.07 68.60 86.44 -26.19 coo 37.87 70.12 31.80 36.61 69.74 30.15 60.79 94.39 -38.32 59.49 95.38 -36.98 ULMN 3 1qho_c05 ALPHA-AMYLASE user 23 3 # 23 A 228 ASP D 35 ASP^? 10.18 CL CL D 129 A 261 ASP C 72 ASP^? 28.53 CL CL B 129 A 329 ASP C 30 ASP^? 20.67 CL CL C 129 coo 28.46 69.88 26.74 30.40 70.70 26.53 75.66 79.96 -36.93 75.99 80.66 -34.97 coo 34.02 79.89 42.60 34.73 78.01 41.86 90.38 83.76 -50.64 91.24 82.68 -52.23 coo 37.87 70.12 31.80 36.61 69.74 30.15 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1qho_c05 ALPHA-AMYLASE user 24 3 # 24 A 228 ASP D 35 ASP^? 10.18 CL CL D 129 A 261 ASP C 72 ASP^? 28.53 CL CL B 129 A 329 ASP D 30 ASP^? 20.62 CL CL D 129 coo 28.46 69.88 26.74 30.40 70.70 26.53 75.66 79.96 -36.93 75.99 80.66 -34.97 coo 34.02 79.89 42.60 34.73 78.01 41.86 90.38 83.76 -50.64 91.24 82.68 -52.23 coo 37.87 70.12 31.80 36.61 69.74 30.15 76.16 76.40 -45.40 77.49 78.05 -45.35 ULMN 3 1qho_c05 ALPHA-AMYLASE user 25 3 # 25 A 228 ASP D 35 ASP^? 10.18 CL CL D 129 A 261 ASP D 72 ASP^? 29.64 CL CL D 129 A 329 ASP C 30 ASP^? 20.67 CL CL C 129 coo 28.46 69.88 26.74 30.40 70.70 26.53 75.66 79.96 -36.93 75.99 80.66 -34.97 coo 34.02 79.89 42.60 34.73 78.01 41.86 69.04 67.18 -50.81 68.23 68.38 -52.37 coo 37.87 70.12 31.80 36.61 69.74 30.15 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1qho_c05 ALPHA-AMYLASE user 26 3 # 26 A 228 ASP D 35 ASP^? 10.18 CL CL D 129 A 261 ASP D 86 ASP^? 23.19 CL CL D 129 A 329 ASP D 41 ASP^? 7.55 CL CL D 129 coo 28.46 69.88 26.74 30.40 70.70 26.53 75.66 79.96 -36.93 75.99 80.66 -34.97 coo 34.02 79.89 42.60 34.73 78.01 41.86 60.79 94.39 -38.32 59.49 95.38 -36.98 coo 37.87 70.12 31.80 36.61 69.74 30.15 69.10 85.54 -28.07 68.60 86.44 -26.19 1qho_c05 source 1qho ALPHA-AMYLASE : 26 hits 1qho_c05 naa= 3 ULMN 3 1qho_c07 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 86 ASP.? 23.33 CL CL A 129 A 260 ASP A 41 ASP.? 7.60 CL CL A 129 A 329 ASP B 5 ASP^? 20.93 CL CL A 129 coo 28.46 69.88 26.74 30.40 70.70 26.53 108.46 57.22 -73.78 109.48 58.49 -72.45 coo 30.73 81.29 37.61 31.23 82.07 35.69 99.56 48.98 -63.34 100.43 49.52 -61.53 coo 37.87 70.12 31.80 36.61 69.74 30.15 110.10 55.77 -64.66 112.04 55.13 -65.31 ULMN 3 1qho_c07 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP B 72 ASP^? 28.57 CL CL C 129 A 260 ASP C 72 ASP^? 28.53 CL CL B 129 A 329 ASP C 30 ASP^? 20.67 CL CL C 129 coo 28.46 69.88 26.74 30.40 70.70 26.53 80.87 74.36 -54.99 81.74 73.36 -53.35 coo 30.73 81.29 37.61 31.23 82.07 35.69 90.38 83.76 -50.64 91.24 82.68 -52.23 coo 37.87 70.12 31.80 36.61 69.74 30.15 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1qho_c07 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP B 72 ASP^? 28.57 CL CL C 129 A 260 ASP D 72 ASP^? 29.64 CL CL D 129 A 329 ASP D 30 ASP^? 20.62 CL CL D 129 coo 28.46 69.88 26.74 30.40 70.70 26.53 80.87 74.36 -54.99 81.74 73.36 -53.35 coo 30.73 81.29 37.61 31.23 82.07 35.69 69.04 67.18 -50.81 68.23 68.38 -52.37 coo 37.87 70.12 31.80 36.61 69.74 30.15 76.16 76.40 -45.40 77.49 78.05 -45.35 ULMN 3 1qho_c07 ALPHA-AMYLASE user 4 3 # 4 A 228 ASP B 86 ASP^? 23.14 CL CL B 129 A 260 ASP B 41 ASP^? 7.64 CL CL B 129 A 329 ASP A 5 ASP~? 21.13 CL CL B 129 coo 28.46 69.88 26.74 30.40 70.70 26.53 108.40 66.17 -67.38 109.32 64.97 -68.84 coo 30.73 81.29 37.61 31.23 82.07 35.69 99.50 74.51 -77.69 100.41 73.95 -79.49 coo 37.87 70.12 31.80 36.61 69.74 30.15 110.30 67.66 -76.72 112.26 68.26 -76.10 ULMN 3 1qho_c07 ALPHA-AMYLASE user 5 3 # 5 A 228 ASP C 30 ASP^? 20.67 CL CL C 129 A 260 ASP D 72 ASP^? 29.64 CL CL D 129 A 329 ASP B 72 ASP^? 28.57 CL CL C 129 coo 28.46 69.88 26.74 30.40 70.70 26.53 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 30.73 81.29 37.61 31.23 82.07 35.69 69.04 67.18 -50.81 68.23 68.38 -52.37 coo 37.87 70.12 31.80 36.61 69.74 30.15 80.87 74.36 -54.99 81.74 73.36 -53.35 ULMN 3 1qho_c07 ALPHA-AMYLASE user 6 3 # 6 A 228 ASP C 72 ASP^? 28.53 CL CL B 129 A 260 ASP B 72 ASP^? 28.57 CL CL C 129 A 329 ASP B 30 ASP^? 20.91 CL CL B 129 coo 28.46 69.88 26.74 30.40 70.70 26.53 90.38 83.76 -50.64 91.24 82.68 -52.23 coo 30.73 81.29 37.61 31.23 82.07 35.69 80.87 74.36 -54.99 81.74 73.36 -53.35 coo 37.87 70.12 31.80 36.61 69.74 30.15 90.60 81.40 -60.16 92.15 82.83 -59.97 ULMN 3 1qho_c07 ALPHA-AMYLASE user 7 3 # 7 A 228 ASP D 30 ASP^? 20.62 CL CL D 129 A 260 ASP C 72 ASP^? 28.53 CL CL B 129 A 329 ASP B 72 ASP^? 28.57 CL CL C 129 coo 28.46 69.88 26.74 30.40 70.70 26.53 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 30.73 81.29 37.61 31.23 82.07 35.69 90.38 83.76 -50.64 91.24 82.68 -52.23 coo 37.87 70.12 31.80 36.61 69.74 30.15 80.87 74.36 -54.99 81.74 73.36 -53.35 1qho_c07 source 1qho ALPHA-AMYLASE : 7 hits 1qho_c07 naa= 3 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 1 3 # 1 A 145 THR A 27 THR~? 25.15 CL CL A 129 A 182 TYR A 22 TYR~? 17.56 CL CL A 129 A 186 LYS A 24 LYS~? 27.96 CL CL A 129 coo 69.38 87.38 24.64 71.11 88.47 25.40 85.32 47.55 -82.88 85.94 49.08 -84.30 coo 73.61 90.42 31.12 71.36 89.66 29.64 92.72 50.62 -78.45 90.87 50.50 -76.41 coo 73.54 84.00 28.64 69.01 86.68 29.71 90.40 47.78 -84.76 92.62 43.20 -88.57 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 2 3 # 2 A 145 THR B 27 THR^? 25.10 CL CL B 129 A 182 TYR B 22 TYR^? 17.56 CL CL B 129 A 186 LYS B 24 LYS^? 27.82 CL CL B 129 coo 69.38 87.38 24.64 71.11 88.47 25.40 85.40 75.83 -58.05 86.15 74.42 -56.65 coo 73.61 90.42 31.12 71.36 89.66 29.64 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 73.54 84.00 28.64 69.01 86.68 29.71 90.54 75.59 -56.27 92.78 80.12 -52.52 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 3 3 # 3 A 145 THR C 27 THR^? 25.08 CL CL C 129 A 182 TYR C 22 TYR^? 17.52 CL CL C 129 A 186 LYS C 24 LYS^? 26.64 CL CL C 129 coo 69.38 87.38 24.64 71.11 88.47 25.40 88.92 79.28 -47.47 90.32 78.59 -48.91 coo 73.61 90.42 31.12 71.36 89.66 29.64 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 73.54 84.00 28.64 69.01 86.68 29.71 88.99 74.10 -49.29 84.03 71.99 -51.83 1qrr_c01 source 1qrr SULFOLIPID BIOSYNTHESIS (SQD1) PROTEIN : 3 hits 1qrr_c01 naa= 3 ULMN 3 1qrz_c20 PLASMINOGEN user 1 3 # 1 A 603 HIS C 85 HIS^? 23.16 CL CL A 129 A 646 ASP C 10 ASP^? 12.83 CL CL A 129 A 739 GLY C 115 GLY^? 19.09 CL CL C 129 coo -20.72 2.99 34.37 -21.94 1.82 35.61 100.49 52.59 -40.39 100.40 51.57 -38.55 coo -18.83 7.68 26.86 -20.89 7.78 26.56 99.63 54.02 -49.94 99.45 52.98 -51.81 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 89.73 59.33 -40.54 89.93 59.44 -39.76 1qrz_c20 source 1qrz PLASMINOGEN : 1 hits 1qrz_c20 naa= 3 ULMN 3 1qrz_c21 PLASMINOGEN user 1 3 # 1 B 603 HIS B 85 HIS^? 26.88 CL CL A 129 B 646 ASP B 10 ASP^? 27.46 CL CL A 129 B 739 GLY B 115 GLY^? 19.14 CL CL B 129 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 111.98 64.21 -65.30 113.02 64.33 -67.11 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 110.59 65.11 -56.28 111.89 65.48 -54.65 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 105.34 74.85 -65.16 105.20 74.69 -65.93 ULMN 3 1qrz_c21 PLASMINOGEN user 2 3 # 2 B 603 HIS C 85 HIS^? 23.16 CL CL A 129 B 646 ASP C 10 ASP^? 12.83 CL CL A 129 B 739 GLY C 115 GLY^? 19.09 CL CL C 129 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 100.49 52.59 -40.39 100.40 51.57 -38.55 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 99.63 54.02 -49.94 99.45 52.98 -51.81 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 89.73 59.33 -40.54 89.93 59.44 -39.76 1qrz_c21 source 1qrz PLASMINOGEN : 2 hits 1qrz_c21 naa= 3 ULMN 3 1qrz_c22 PLASMINOGEN user 1 3 # 1 C 603 HIS C 85 HIS^? 23.16 CL CL A 129 C 646 ASP C 10 ASP^? 12.83 CL CL A 129 C 739 GLY C 115 GLY^? 19.09 CL CL C 129 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 100.49 52.59 -40.39 100.40 51.57 -38.55 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 99.63 54.02 -49.94 99.45 52.98 -51.81 coo 7.82 1.25 3.03 7.30 1.31 3.65 89.73 59.33 -40.54 89.93 59.44 -39.76 1qrz_c22 source 1qrz PLASMINOGEN : 1 hits 1qrz_c22 naa= 3 ULMN 3 1qrz_c23 PLASMINOGEN user 1 3 # 1 D 603 HIS C 85 HIS^? 23.16 CL CL A 129 D 646 ASP C 10 ASP^? 12.83 CL CL A 129 D 739 GLY C 115 GLY^? 19.09 CL CL C 129 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 100.49 52.59 -40.39 100.40 51.57 -38.55 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 99.63 54.02 -49.94 99.45 52.98 -51.81 coo -45.82 1.31 41.67 -46.38 1.39 42.31 89.73 59.33 -40.54 89.93 59.44 -39.76 1qrz_c23 source 1qrz PLASMINOGEN : 1 hits 1qrz_c23 naa= 3 ULMN 3 1qz9_c02 KYNURENINASE user 1 3 # 1 A 129 PHE A 38 PHE~? 11.90 CL CL A 129 A 201 ASP A 35 ASP~? 10.31 CL CL A 129 A 227 LYS A 24 LYS~? 27.96 CL CL A 129 coo 23.39 49.81 32.16 21.33 51.68 32.26 93.74 49.34 -71.31 91.91 51.35 -71.82 coo 25.52 45.12 37.98 23.98 46.65 37.85 93.79 42.35 -72.20 94.79 41.97 -70.38 coo 12.68 46.83 36.69 18.26 48.67 34.51 90.40 47.78 -84.76 92.62 43.20 -88.57 ULMN 3 1qz9_c02 KYNURENINASE user 2 3 # 2 A 129 PHE B 38 PHE^? 11.74 CL CL B 129 A 201 ASP B 41 ASP^? 7.64 CL CL B 129 A 227 LYS B 111 LYS^? 25.35 CL CL B 129 coo 23.39 49.81 32.16 21.33 51.68 32.26 93.75 74.07 -69.88 91.89 72.11 -69.38 coo 25.52 45.12 37.98 23.98 46.65 37.85 99.50 74.51 -77.69 100.41 73.95 -79.49 coo 12.68 46.83 36.69 18.26 48.67 34.51 105.89 69.85 -67.01 110.53 70.43 -62.59 ULMN 3 1qz9_c02 KYNURENINASE user 3 3 # 3 A 129 PHE C 38 PHE^? 11.87 CL CL C 129 A 201 ASP C 35 ASP^? 10.26 CL CL C 129 A 227 LYS C 24 LYS^? 26.64 CL CL C 129 coo 23.39 49.81 32.16 21.33 51.68 32.26 90.71 70.84 -35.90 92.71 72.72 -36.44 coo 25.52 45.12 37.98 23.98 46.65 37.85 83.63 70.73 -36.85 83.32 69.81 -34.96 coo 12.68 46.83 36.69 18.26 48.67 34.51 88.99 74.10 -49.29 84.03 71.99 -51.83 ULMN 3 1qz9_c02 KYNURENINASE user 4 3 # 4 A 129 PHE C 38 PHE^? 11.87 CL CL C 129 A 201 ASP C 41 ASP^? 7.58 CL CL C 129 A 227 LYS C 111 LYS^? 20.47 CL CL A 129 coo 23.39 49.81 32.16 21.33 51.68 32.26 90.71 70.84 -35.90 92.71 72.72 -36.44 coo 25.52 45.12 37.98 23.98 46.65 37.85 90.28 65.09 -27.98 90.77 64.12 -26.18 coo 12.68 46.83 36.69 18.26 48.67 34.51 94.84 58.73 -38.66 94.21 53.88 -42.04 ULMN 3 1qz9_c02 KYNURENINASE user 5 3 # 5 A 129 PHE D 38 PHE^? 11.82 CL CL D 129 A 201 ASP D 41 ASP^? 7.55 CL CL D 129 A 227 LYS D 111 LYS^? 25.57 CL CL D 129 coo 23.39 49.81 32.16 21.33 51.68 32.26 68.57 79.81 -35.85 66.58 77.94 -36.43 coo 25.52 45.12 37.98 23.98 46.65 37.85 69.10 85.54 -28.07 68.60 86.44 -26.19 coo 12.68 46.83 36.69 18.26 48.67 34.51 64.48 91.99 -38.71 64.71 96.91 -42.99 1qz9_c02 source 1qz9 KYNURENINASE : 5 hits 1qz9_c02 naa= 3 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 1 3 # 1 A 10 ASP A 5 ASP~? 21.13 CL CL B 129 A 186 ASN A 7 ASN.? 14.61 CL CL B 129 A 260 ALA A 88 ALA.? 20.00 CL CL B 129 coo 11.81 33.10 11.71 13.07 31.45 11.40 110.30 67.66 -76.72 112.26 68.26 -76.10 coo 11.43 26.53 7.41 13.01 27.56 8.43 104.28 66.29 -83.02 102.35 66.19 -82.19 coo 21.53 26.33 6.96 20.26 25.69 7.52 101.16 60.49 -76.11 101.18 59.57 -77.33 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 2 3 # 2 A 10 ASP A 30 ASP~? 20.80 CL CL A 129 A 186 ASN A 29 ASN.? 19.56 CL CL A 129 A 260 ALA A 69 ALA.? 27.43 CL CL A 129 coo 11.81 33.10 11.71 13.07 31.45 11.40 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 11.43 26.53 7.41 13.01 27.56 8.43 84.48 42.44 -79.38 84.07 42.43 -77.31 coo 21.53 26.33 6.96 20.26 25.69 7.52 76.51 44.18 -80.70 75.05 43.82 -80.50 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 3 3 # 3 A 10 ASP B 5 ASP^? 20.93 CL CL A 129 A 186 ASN B 7 ASN^? 14.42 CL CL A 129 A 260 ALA B 88 ALA^? 19.82 CL CL A 129 coo 11.81 33.10 11.71 13.07 31.45 11.40 110.10 55.77 -64.66 112.04 55.13 -65.31 coo 11.43 26.53 7.41 13.01 27.56 8.43 104.35 57.09 -58.15 102.38 57.14 -58.88 coo 21.53 26.33 6.96 20.26 25.69 7.52 101.17 62.84 -65.03 101.19 63.76 -63.80 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 4 3 # 4 A 10 ASP B 30 ASP^? 20.91 CL CL B 129 A 186 ASN B 29 ASN^? 19.59 CL CL B 129 A 260 ALA B 69 ALA^? 27.44 CL CL B 129 coo 11.81 33.10 11.71 13.07 31.45 11.40 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 11.43 26.53 7.41 13.01 27.56 8.43 84.68 80.89 -61.45 84.18 80.98 -63.53 coo 21.53 26.33 6.96 20.26 25.69 7.52 76.70 79.39 -60.15 75.25 79.85 -60.26 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 5 3 # 5 A 10 ASP C 5 ASP^? 26.16 CL CL A 129 A 186 ASN C 7 ASN^? 25.55 CL CL A 129 A 260 ALA C 88 ALA^? 22.84 CL CL C 129 coo 11.81 33.10 11.71 13.07 31.45 11.40 108.85 54.21 -41.41 109.64 52.31 -40.89 coo 11.43 26.53 7.41 13.01 27.56 8.43 107.62 60.23 -47.60 107.55 62.23 -46.92 coo 21.53 26.33 6.96 20.26 25.69 7.52 101.90 63.39 -40.59 101.03 63.37 -41.82 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 6 3 # 6 A 10 ASP C 30 ASP^? 20.67 CL CL C 129 A 186 ASN C 29 ASN^? 19.55 CL CL C 129 A 260 ALA C 69 ALA^? 25.09 CL CL D 129 coo 11.81 33.10 11.71 13.07 31.45 11.40 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 11.43 26.53 7.41 13.01 27.56 8.43 83.86 80.07 -44.03 83.70 80.47 -41.95 coo 21.53 26.33 6.96 20.26 25.69 7.52 85.43 88.16 -45.22 85.17 89.62 -44.83 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 7 3 # 7 A 10 ASP D 5 ASP^? 32.88 CL CL D 129 A 186 ASN D 7 ASN^? 30.85 CL CL D 129 A 260 ALA D 88 ALA^? 22.82 CL CL D 129 coo 11.81 33.10 11.71 13.07 31.45 11.40 50.37 96.25 -41.36 49.69 98.16 -40.70 coo 11.43 26.53 7.41 13.01 27.56 8.43 51.70 90.24 -47.62 51.84 88.27 -46.84 coo 21.53 26.33 6.96 20.26 25.69 7.52 57.42 87.17 -40.71 58.38 87.17 -41.91 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 8 3 # 8 A 10 ASP D 30 ASP^? 20.62 CL CL D 129 A 186 ASN D 29 ASN^? 19.54 CL CL D 129 A 260 ALA D 65 ALA^? 13.98 CL CL C 129 coo 11.81 33.10 11.71 13.07 31.45 11.40 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 11.43 26.53 7.41 13.01 27.56 8.43 75.38 70.46 -44.12 75.55 70.12 -42.00 coo 21.53 26.33 6.96 20.26 25.69 7.52 76.48 66.72 -34.21 75.82 66.53 -32.87 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 9 3 # 9 A 10 ASP D 30 ASP^? 20.62 CL CL D 129 A 186 ASN D 29 ASN^? 19.54 CL CL D 129 A 260 ALA D 69 ALA^? 25.54 CL CL C 129 coo 11.81 33.10 11.71 13.07 31.45 11.40 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 11.43 26.53 7.41 13.01 27.56 8.43 75.38 70.46 -44.12 75.55 70.12 -42.00 coo 21.53 26.33 6.96 20.26 25.69 7.52 73.81 62.56 -45.54 74.14 61.10 -45.36 1r4f_c00 source 1r4f IAG-NUCLEOSIDE HYDROLASE : 9 hits 1r4f_c00 naa= 3 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 1 3 # 1 A 608 ASP A 86 ASP.? 23.33 CL CL A 129 A 610 HIS A 85 HIS.? 26.94 CL CL B 129 A 661 HIS B 85 HIS^? 26.88 CL CL A 129 coo 75.99 81.56 1.86 73.91 81.34 2.28 108.46 57.22 -73.78 109.48 58.49 -72.45 coo 71.04 78.84 0.46 71.54 76.90 1.02 112.09 59.31 -75.65 113.04 59.28 -73.77 coo 75.40 81.38 12.06 74.88 79.42 12.63 111.98 64.21 -65.30 113.02 64.33 -67.11 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 2 3 # 2 A 608 ASP B 86 ASP^? 23.14 CL CL B 129 A 610 HIS B 85 HIS^? 26.88 CL CL A 129 A 661 HIS A 85 HIS.? 26.94 CL CL B 129 coo 75.99 81.56 1.86 73.91 81.34 2.28 108.40 66.17 -67.38 109.32 64.97 -68.84 coo 71.04 78.84 0.46 71.54 76.90 1.02 111.98 64.21 -65.30 113.02 64.33 -67.11 coo 75.40 81.38 12.06 74.88 79.42 12.63 112.09 59.31 -75.65 113.04 59.28 -73.77 1req_c10 source 1req METHYLMALONYL-COA MUTASE : 2 hits 1req_c10 naa= 3 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 1 3 # 1 C 608 ASP A 86 ASP.? 23.33 CL CL A 129 C 610 HIS A 85 HIS.? 26.94 CL CL B 129 C 661 HIS B 85 HIS^? 26.88 CL CL A 129 coo -17.65 80.52 58.00 -16.23 80.79 56.41 108.46 57.22 -73.78 109.48 58.49 -72.45 coo -16.56 83.18 53.03 -16.33 85.18 53.60 112.09 59.31 -75.65 113.04 59.28 -73.77 coo -8.38 80.78 62.24 -7.53 82.67 62.02 111.98 64.21 -65.30 113.02 64.33 -67.11 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 2 3 # 2 C 608 ASP B 86 ASP^? 23.14 CL CL B 129 C 610 HIS B 85 HIS^? 26.88 CL CL A 129 C 661 HIS A 85 HIS.? 26.94 CL CL B 129 coo -17.65 80.52 58.00 -16.23 80.79 56.41 108.40 66.17 -67.38 109.32 64.97 -68.84 coo -16.56 83.18 53.03 -16.33 85.18 53.60 111.98 64.21 -65.30 113.02 64.33 -67.11 coo -8.38 80.78 62.24 -7.53 82.67 62.02 112.09 59.31 -75.65 113.04 59.28 -73.77 1req_c11 source 1req METHYLMALONYL-COA MUTASE : 2 hits 1req_c11 naa= 3 ULMN 3 1rgq_c01 NS4A PEPTIDE user 1 3 # 1 B 60 HIS A 40 HIS.? 7.30 CL CL A 129 B 84 ASP A 41 ASP.? 7.60 CL CL A 129 B 140 GLY A 115 GLY^? 19.18 CL CL A 129 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 98.96 43.60 -66.18 98.11 41.92 -65.26 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 99.56 48.98 -63.34 100.43 49.52 -61.53 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 105.32 48.49 -75.94 105.17 48.69 -75.15 ULMN 3 1rgq_c01 NS4A PEPTIDE user 2 3 # 2 B 60 HIS B 40 HIS^? 7.04 CL CL B 129 B 84 ASP B 41 ASP^? 7.64 CL CL B 129 B 140 GLY B 115 GLY^? 19.14 CL CL B 129 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 98.79 79.91 -74.95 97.97 81.53 -75.99 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 99.50 74.51 -77.69 100.41 73.95 -79.49 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 105.34 74.85 -65.16 105.20 74.69 -65.93 ULMN 3 1rgq_c01 NS4A PEPTIDE user 3 3 # 3 B 60 HIS C 40 HIS^? 7.21 CL CL C 129 B 84 ASP C 35 ASP^? 10.26 CL CL C 129 B 140 GLY C 115 GLY^? 19.09 CL CL C 129 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 84.82 65.72 -30.75 83.18 66.51 -29.70 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 83.63 70.73 -36.85 83.32 69.81 -34.96 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 89.73 59.33 -40.54 89.93 59.44 -39.76 ULMN 3 1rgq_c01 NS4A PEPTIDE user 4 3 # 4 B 60 HIS C 40 HIS^? 7.21 CL CL C 129 B 84 ASP C 41 ASP^? 7.58 CL CL C 129 B 140 GLY C 115 GLY^? 19.09 CL CL C 129 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 84.82 65.72 -30.75 83.18 66.51 -29.70 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 90.28 65.09 -27.98 90.77 64.12 -26.18 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 89.73 59.33 -40.54 89.93 59.44 -39.76 ULMN 3 1rgq_c01 NS4A PEPTIDE user 5 3 # 5 B 60 HIS D 40 HIS^? 7.31 CL CL D 129 B 84 ASP D 35 ASP^? 10.18 CL CL D 129 B 140 GLY D 115 GLY^? 19.26 CL CL D 129 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 74.49 84.96 -30.93 76.13 84.16 -29.90 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 75.66 79.96 -36.93 75.99 80.66 -34.97 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 69.45 91.40 -40.67 69.30 91.29 -39.87 ULMN 3 1rgq_c01 NS4A PEPTIDE user 6 3 # 6 B 60 HIS D 40 HIS^? 7.31 CL CL D 129 B 84 ASP D 41 ASP^? 7.55 CL CL D 129 B 140 GLY D 115 GLY^? 19.26 CL CL D 129 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 74.49 84.96 -30.93 76.13 84.16 -29.90 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 69.10 85.54 -28.07 68.60 86.44 -26.19 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 69.45 91.40 -40.67 69.30 91.29 -39.87 1rgq_c01 source 1rgq NS4A PEPTIDE : 6 hits 1rgq_c01 naa= 3 ULMN 3 1rhc_c00 F420-DEPENDENT ALCOHOL DEHYDROGENASEuser 1 3 # 1 A 39 HIS A 40 HIS.? 7.30 CL CL A 129 A 43 TRP A 39 TRP.? 10.30 CL CL A 129 A 108 GLU A 114 GLU^? 14.59 CL CL A 129 coo 33.67 25.97 25.39 31.70 26.60 25.75 98.96 43.60 -66.18 98.11 41.92 -65.26 coo 29.43 26.12 28.46 27.08 29.25 29.01 101.24 49.64 -67.32 101.01 52.25 -64.41 coo 29.13 31.14 24.26 29.28 29.08 24.66 104.53 45.97 -71.95 105.17 46.78 -70.05 ULMN 3 1rhc_c00 F420-DEPENDENT ALCOHOL DEHYDROGENASEuser 2 3 # 2 A 39 HIS B 40 HIS^? 7.04 CL CL B 129 A 43 TRP B 39 TRP^? 10.25 CL CL B 129 A 108 GLU B 114 GLU^? 14.94 CL CL B 129 coo 33.67 25.97 25.39 31.70 26.60 25.75 98.79 79.91 -74.95 97.97 81.53 -75.99 coo 29.43 26.12 28.46 27.08 29.25 29.01 101.26 73.91 -73.75 100.85 71.27 -76.60 coo 29.13 31.14 24.26 29.28 29.08 24.66 104.70 77.68 -68.99 105.48 76.80 -70.78 ULMN 3 1rhc_c00 F420-DEPENDENT ALCOHOL DEHYDROGENASEuser 3 3 # 3 A 39 HIS C 40 HIS^? 7.21 CL CL C 129 A 43 TRP C 39 TRP^? 10.27 CL CL C 129 A 108 GLU C 114 GLU^? 14.88 CL CL C 129 coo 33.67 25.97 25.39 31.70 26.60 25.75 84.82 65.72 -30.75 83.18 66.51 -29.70 coo 29.43 26.12 28.46 27.08 29.25 29.01 90.84 63.27 -31.89 93.54 63.54 -29.07 coo 29.13 31.14 24.26 29.28 29.08 24.66 87.05 59.85 -36.57 87.99 59.11 -34.78 ULMN 3 1rhc_c00 F420-DEPENDENT ALCOHOL DEHYDROGENASEuser 4 3 # 4 A 39 HIS D 40 HIS^? 7.31 CL CL D 129 A 43 TRP D 39 TRP^? 10.24 CL CL D 129 A 108 GLU D 114 GLU^? 14.88 CL CL D 129 coo 33.67 25.97 25.39 31.70 26.60 25.75 74.49 84.96 -30.93 76.13 84.16 -29.90 coo 29.43 26.12 28.46 27.08 29.25 29.01 68.34 87.24 -31.98 65.78 86.93 -29.01 coo 29.13 31.14 24.26 29.28 29.08 24.66 72.08 90.81 -36.72 71.29 91.48 -34.84 1rhc_c00 source 1rhc F420-DEPENDENT ALCOHOL DEHYDROGENASE : 4 hits 1rhc_c00 naa= 3 ULMN 3 1ro7_c03 ALPHA-2,3/8-SIALYLTRANSFERASE user 1 3 # 1 D 129 ARG A 104 ARG^? 18.53 CL CL B 129 D 156 TYR A 47 TYR^? 14.66 CL CL A 129 D 188 HIS B 122 HIS^? 19.12 CL CL B 129 coo -19.99 -38.81 30.91 -19.99 -39.90 28.04 82.19 63.80 -76.53 82.09 65.30 -73.83 coo -32.96 -44.88 30.49 -32.31 -42.65 28.92 86.78 57.70 -65.64 87.73 58.42 -63.11 coo -25.33 -42.26 31.79 -24.77 -40.56 30.70 86.93 63.10 -71.62 85.35 62.06 -72.53 ULMN 3 1ro7_c03 ALPHA-2,3/8-SIALYLTRANSFERASE user 2 3 # 2 D 129 ARG B 104 ARG^? 18.51 CL CL A 129 D 156 TYR B 47 TYR^? 14.72 CL CL B 129 D 188 HIS A 122 HIS^? 19.05 CL CL A 129 coo -19.99 -38.81 30.91 -19.99 -39.90 28.04 82.09 59.72 -64.70 82.21 58.19 -67.39 coo -32.96 -44.88 30.49 -32.31 -42.65 28.92 86.74 65.69 -75.43 87.82 65.07 -77.96 coo -25.33 -42.26 31.79 -24.77 -40.56 30.70 86.83 60.37 -69.40 85.20 61.24 -68.40 1ro7_c03 source 1ro7 ALPHA-2,3/8-SIALYLTRANSFERASE : 2 hits 1ro7_c03 naa= 3 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 1 3 # 1 A 137 GLU C 36 GLU^? 18.27 CL CL C 129 A 288 HIS D 40 HIS^? 7.31 CL CL D 129 A 329 LYS D 43 LYS^? 9.72 CL CL D 129 coo 29.27 18.78 14.99 27.16 18.62 14.76 84.85 65.27 -40.53 84.47 64.86 -42.56 coo 49.52 10.06 10.36 50.99 9.65 8.92 74.49 84.96 -30.93 76.13 84.16 -29.90 coo 57.80 12.92 13.83 53.77 8.42 12.15 65.85 82.66 -25.79 66.37 87.54 -24.61 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 2 3 # 2 A 137 GLU D 36 GLU^? 18.42 CL CL D 129 A 288 HIS C 40 HIS^? 7.21 CL CL C 129 A 329 LYS C 43 LYS^? 9.54 CL CL C 129 coo 29.27 18.78 14.99 27.16 18.62 14.76 74.52 85.40 -40.74 74.64 85.74 -42.81 coo 49.52 10.06 10.36 50.99 9.65 8.92 84.82 65.72 -30.75 83.18 66.51 -29.70 coo 57.80 12.92 13.83 53.77 8.42 12.15 93.55 67.94 -25.84 92.76 63.12 -24.35 1roz_c00 source 1roz DEOXYHYPUSINE SYNTHASE : 2 hits 1roz_c00 naa= 3 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 1 3 # 1 B 137 GLU C 36 GLU^? 18.27 CL CL C 129 B 288 HIS D 40 HIS^? 7.31 CL CL D 129 B 329 LYS D 43 LYS^? 9.72 CL CL D 129 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 84.85 65.27 -40.53 84.47 64.86 -42.56 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 74.49 84.96 -30.93 76.13 84.16 -29.90 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 65.85 82.66 -25.79 66.37 87.54 -24.61 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 2 3 # 2 B 137 GLU D 36 GLU^? 18.42 CL CL D 129 B 288 HIS C 40 HIS^? 7.21 CL CL C 129 B 329 LYS C 43 LYS^? 9.54 CL CL C 129 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 74.52 85.40 -40.74 74.64 85.74 -42.81 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 84.82 65.72 -30.75 83.18 66.51 -29.70 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 93.55 67.94 -25.84 92.76 63.12 -24.35 1roz_c01 source 1roz DEOXYHYPUSINE SYNTHASE : 2 hits 1roz_c01 naa= 3 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 1 3 # 1 32 ASP A 86 ASP.? 23.33 CL CL A 129 64 HIS A 85 HIS.? 26.94 CL CL B 129 155 ASN A 7 ASN.? 14.61 CL CL B 129 coo 80.16 73.25 62.48 80.01 71.25 61.82 108.46 57.22 -73.78 109.48 58.49 -72.45 coo 78.27 67.69 61.83 79.58 67.76 60.19 112.09 59.31 -75.65 113.04 59.28 -73.77 coo 80.34 61.88 52.75 81.25 63.19 54.35 104.28 66.29 -83.02 102.35 66.19 -82.19 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 2 3 # 2 32 ASP B 86 ASP^? 23.14 CL CL B 129 64 HIS B 85 HIS^? 26.88 CL CL A 129 155 ASN B 7 ASN^? 14.42 CL CL A 129 coo 80.16 73.25 62.48 80.01 71.25 61.82 108.40 66.17 -67.38 109.32 64.97 -68.84 coo 78.27 67.69 61.83 79.58 67.76 60.19 111.98 64.21 -65.30 113.02 64.33 -67.11 coo 80.34 61.88 52.75 81.25 63.19 54.35 104.35 57.09 -58.15 102.38 57.14 -58.88 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 3 3 # 3 32 ASP C 86 ASP^? 23.12 CL CL C 129 64 HIS C 85 HIS^? 23.16 CL CL A 129 155 ASN C 7 ASN^? 25.55 CL CL A 129 coo 80.16 73.25 62.48 80.01 71.25 61.82 98.39 56.19 -38.35 99.60 55.15 -36.99 coo 78.27 67.69 61.83 79.58 67.76 60.19 100.49 52.59 -40.39 100.40 51.57 -38.55 coo 80.34 61.88 52.75 81.25 63.19 54.35 107.62 60.23 -47.60 107.55 62.23 -46.92 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 4 3 # 4 32 ASP D 86 ASP^? 23.19 CL CL D 129 64 HIS D 85 HIS^? 27.00 CL CL D 129 155 ASN D 7 ASN^? 30.85 CL CL D 129 coo 80.16 73.25 62.48 80.01 71.25 61.82 60.79 94.39 -38.32 59.49 95.38 -36.98 coo 78.27 67.69 61.83 79.58 67.76 60.19 58.77 98.13 -40.30 58.69 99.11 -38.44 coo 80.34 61.88 52.75 81.25 63.19 54.35 51.70 90.24 -47.62 51.84 88.27 -46.84 1sca_c01 source 1sca SUBTILISIN CARLSBERG (E.C.3.4.21.62) (AQUEOUS : 4 hits 1sca_c01 naa= 3 ULMN 3 1sll_c00 SIALIDASE L user 1 3 # 1 318 ASP A 30 ASP~? 20.80 CL CL A 129 595 GLU A 23 GLU~? 24.22 CL CL A 129 713 TYR A 22 TYR~? 17.56 CL CL A 129 coo 5.64 2.82 38.49 4.59 4.19 37.25 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 4.35 13.73 37.63 3.39 12.18 36.55 89.42 52.54 -84.47 88.08 53.22 -82.95 coo 3.76 10.25 31.38 3.16 9.87 34.10 92.72 50.62 -78.45 90.87 50.50 -76.41 ULMN 3 1sll_c00 SIALIDASE L user 2 3 # 2 318 ASP A 41 ASP.? 7.60 CL CL A 129 595 GLU A 58 GLU~? 7.41 CL CL A 129 713 TYR A 54 TYR^? 10.29 CL CL A 129 coo 5.64 2.82 38.49 4.59 4.19 37.25 99.56 48.98 -63.34 100.43 49.52 -61.53 coo 4.35 13.73 37.63 3.39 12.18 36.55 87.85 46.74 -60.89 87.27 48.56 -59.93 coo 3.76 10.25 31.38 3.16 9.87 34.10 89.27 53.06 -59.98 88.13 55.63 -59.94 ULMN 3 1sll_c00 SIALIDASE L user 3 3 # 3 318 ASP B 30 ASP^? 20.91 CL CL B 129 595 GLU B 23 GLU^? 24.68 CL CL B 129 713 TYR B 22 TYR^? 17.56 CL CL B 129 coo 5.64 2.82 38.49 4.59 4.19 37.25 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 4.35 13.73 37.63 3.39 12.18 36.55 89.49 70.79 -56.44 87.96 70.01 -57.68 coo 3.76 10.25 31.38 3.16 9.87 34.10 92.70 72.76 -62.54 90.90 72.79 -64.68 ULMN 3 1sll_c00 SIALIDASE L user 4 3 # 4 318 ASP B 41 ASP^? 7.64 CL CL B 129 595 GLU B 58 GLU^? 7.34 CL CL B 129 713 TYR B 54 TYR^? 10.36 CL CL B 129 coo 5.64 2.82 38.49 4.59 4.19 37.25 99.50 74.51 -77.69 100.41 73.95 -79.49 coo 4.35 13.73 37.63 3.39 12.18 36.55 87.90 76.66 -80.19 87.42 74.86 -81.30 coo 3.76 10.25 31.38 3.16 9.87 34.10 89.19 70.43 -81.07 88.03 67.93 -81.20 ULMN 3 1sll_c00 SIALIDASE L user 5 3 # 5 318 ASP C 30 ASP^? 20.67 CL CL C 129 595 GLU C 23 GLU^? 24.69 CL CL C 129 713 TYR C 22 TYR^? 17.52 CL CL C 129 coo 5.64 2.82 38.49 4.59 4.19 37.25 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 4.35 13.73 37.63 3.39 12.18 36.55 93.85 75.25 -49.20 94.57 76.88 -48.00 coo 3.76 10.25 31.38 3.16 9.87 34.10 91.93 71.84 -43.09 91.81 73.68 -41.00 ULMN 3 1sll_c00 SIALIDASE L user 6 3 # 6 318 ASP C 41 ASP^? 7.58 CL CL C 129 595 GLU C 58 GLU^? 7.49 CL CL C 129 713 TYR C 54 TYR^? 10.32 CL CL C 129 coo 5.64 2.82 38.49 4.59 4.19 37.25 90.28 65.09 -27.98 90.77 64.12 -26.18 coo 4.35 13.73 37.63 3.39 12.18 36.55 88.02 76.82 -25.55 89.85 77.43 -24.60 coo 3.76 10.25 31.38 3.16 9.87 34.10 94.43 75.36 -24.67 96.94 76.58 -24.67 ULMN 3 1sll_c00 SIALIDASE L user 7 3 # 7 318 ASP D 30 ASP^? 20.62 CL CL D 129 595 GLU D 23 GLU^? 24.49 CL CL D 129 713 TYR D 22 TYR^? 17.52 CL CL D 129 coo 5.64 2.82 38.49 4.59 4.19 37.25 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 4.35 13.73 37.63 3.39 12.18 36.55 65.41 75.40 -49.12 64.81 73.78 -47.86 coo 3.76 10.25 31.38 3.16 9.87 34.10 67.44 78.74 -43.16 67.49 76.94 -41.01 ULMN 3 1sll_c00 SIALIDASE L user 8 3 # 8 318 ASP D 41 ASP^? 7.55 CL CL D 129 595 GLU D 58 GLU^? 7.39 CL CL D 129 713 TYR D 54 TYR^? 10.35 CL CL D 129 coo 5.64 2.82 38.49 4.59 4.19 37.25 69.10 85.54 -28.07 68.60 86.44 -26.19 coo 4.35 13.73 37.63 3.39 12.18 36.55 71.21 74.03 -25.57 69.46 73.32 -24.61 coo 3.76 10.25 31.38 3.16 9.87 34.10 64.95 75.15 -24.65 62.40 74.09 -24.68 1sll_c00 source 1sll SIALIDASE L : 8 hits 1sll_c00 naa= 3 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 1 3 # 1 A 87 ARG A 46 ARG^? 15.11 CL CL A 129 A 89 HIS A 122 HIS^? 19.05 CL CL A 129 A 119 ASN A 52 ASN^? 15.85 CL CL A 129 coo 28.44 23.52 73.95 30.13 24.84 76.11 87.96 51.20 -70.32 85.08 51.60 -71.34 coo 21.34 20.13 69.47 22.14 19.11 71.12 86.83 60.37 -69.40 85.20 61.24 -68.40 coo 19.69 29.00 71.61 19.80 26.98 72.20 83.96 54.83 -62.44 82.65 56.42 -62.87 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 2 3 # 2 A 87 ARG B 46 ARG^? 15.06 CL CL B 129 A 89 HIS B 122 HIS^? 19.12 CL CL B 129 A 119 ASN B 52 ASN^? 15.82 CL CL B 129 coo 28.44 23.52 73.95 30.13 24.84 76.11 87.96 72.13 -70.71 85.05 71.84 -69.78 coo 21.34 20.13 69.47 22.14 19.11 71.12 86.93 63.10 -71.62 85.35 62.06 -72.53 coo 19.69 29.00 71.61 19.80 26.98 72.20 83.95 68.72 -78.66 82.81 66.95 -78.31 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 3 3 # 3 A 87 ARG C 46 ARG^? 15.12 CL CL C 129 A 89 HIS C 122 HIS^? 19.06 CL CL C 129 A 119 ASN C 52 ASN^? 15.85 CL CL C 129 coo 28.44 23.52 73.95 30.13 24.84 76.11 92.47 76.70 -34.87 92.87 79.50 -36.04 coo 21.34 20.13 69.47 22.14 19.11 71.12 101.68 77.71 -34.10 102.65 79.31 -33.15 coo 19.69 29.00 71.61 19.80 26.98 72.20 96.20 80.63 -27.08 97.82 81.88 -27.59 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 4 3 # 4 A 87 ARG D 46 ARG^? 15.13 CL CL D 129 A 89 HIS D 122 HIS^? 19.08 CL CL D 129 A 119 ASN D 52 ASN^? 15.83 CL CL D 129 coo 28.44 23.52 73.95 30.13 24.84 76.11 66.74 73.93 -35.00 66.45 71.02 -36.02 coo 21.34 20.13 69.47 22.14 19.11 71.12 57.69 72.86 -34.13 56.74 71.23 -33.18 coo 19.69 29.00 71.61 19.80 26.98 72.20 63.25 69.92 -27.12 61.56 68.74 -27.55 1smn_c00 source 1smn EXTRACELLULAR ENDONUCLEASE : 4 hits 1smn_c00 naa= 3 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 1 3 # 1 B 87 ARG A 46 ARG^? 15.11 CL CL A 129 B 89 HIS A 122 HIS^? 19.05 CL CL A 129 B 119 ASN A 52 ASN^? 15.85 CL CL A 129 coo -30.08 23.20 29.48 -31.80 24.60 27.35 87.96 51.20 -70.32 85.08 51.60 -71.34 coo -22.85 19.92 33.92 -23.63 18.94 32.24 86.83 60.37 -69.40 85.20 61.24 -68.40 coo -21.28 28.91 31.84 -21.35 26.90 31.17 83.96 54.83 -62.44 82.65 56.42 -62.87 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 2 3 # 2 B 87 ARG B 46 ARG^? 15.06 CL CL B 129 B 89 HIS B 122 HIS^? 19.12 CL CL B 129 B 119 ASN B 52 ASN^? 15.82 CL CL B 129 coo -30.08 23.20 29.48 -31.80 24.60 27.35 87.96 72.13 -70.71 85.05 71.84 -69.78 coo -22.85 19.92 33.92 -23.63 18.94 32.24 86.93 63.10 -71.62 85.35 62.06 -72.53 coo -21.28 28.91 31.84 -21.35 26.90 31.17 83.95 68.72 -78.66 82.81 66.95 -78.31 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 3 3 # 3 B 87 ARG C 46 ARG^? 15.12 CL CL C 129 B 89 HIS C 122 HIS^? 19.06 CL CL C 129 B 119 ASN C 52 ASN^? 15.85 CL CL C 129 coo -30.08 23.20 29.48 -31.80 24.60 27.35 92.47 76.70 -34.87 92.87 79.50 -36.04 coo -22.85 19.92 33.92 -23.63 18.94 32.24 101.68 77.71 -34.10 102.65 79.31 -33.15 coo -21.28 28.91 31.84 -21.35 26.90 31.17 96.20 80.63 -27.08 97.82 81.88 -27.59 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 4 3 # 4 B 87 ARG D 46 ARG^? 15.13 CL CL D 129 B 89 HIS D 122 HIS^? 19.08 CL CL D 129 B 119 ASN D 52 ASN^? 15.83 CL CL D 129 coo -30.08 23.20 29.48 -31.80 24.60 27.35 66.74 73.93 -35.00 66.45 71.02 -36.02 coo -22.85 19.92 33.92 -23.63 18.94 32.24 57.69 72.86 -34.13 56.74 71.23 -33.18 coo -21.28 28.91 31.84 -21.35 26.90 31.17 63.25 69.92 -27.12 61.56 68.74 -27.55 1smn_c01 source 1smn EXTRACELLULAR ENDONUCLEASE : 4 hits 1smn_c01 naa= 3 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 A 144 HIS A 85 HIS.? 26.94 CL CL B 129 A 174 ASP A 14 ASP~? 27.67 CL CL B 129 A 404 TYR A 83 TYR.? 15.31 CL CL B 129 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 112.09 59.31 -75.65 113.04 59.28 -73.77 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 105.70 54.30 -82.61 107.63 54.15 -83.44 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 103.43 65.48 -74.92 101.03 66.78 -75.48 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 A 144 HIS B 85 HIS^? 26.88 CL CL A 129 A 174 ASP B 10 ASP^? 27.46 CL CL A 129 A 404 TYR B 83 TYR^? 15.32 CL CL A 129 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 111.98 64.21 -65.30 113.02 64.33 -67.11 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 110.59 65.11 -56.28 111.89 65.48 -54.65 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 103.38 58.05 -66.28 101.08 56.65 -65.75 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 A 144 HIS B 85 HIS^? 26.88 CL CL A 129 A 174 ASP B 14 ASP^? 27.62 CL CL A 129 A 404 TYR B 83 TYR^? 15.32 CL CL A 129 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 111.98 64.21 -65.30 113.02 64.33 -67.11 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 105.60 69.00 -58.44 107.49 69.47 -57.66 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 103.38 58.05 -66.28 101.08 56.65 -65.75 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 A 144 HIS C 85 HIS^? 23.16 CL CL A 129 A 174 ASP C 10 ASP^? 12.83 CL CL A 129 A 404 TYR C 83 TYR^? 26.27 CL CL C 129 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 100.49 52.59 -40.39 100.40 51.57 -38.55 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 99.63 54.02 -49.94 99.45 52.98 -51.81 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 106.70 61.17 -39.39 108.02 63.54 -39.97 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 5 3 # 5 A 144 HIS C 85 HIS^? 23.16 CL CL A 129 A 174 ASP C 14 ASP^? 16.95 CL CL A 129 A 404 TYR C 83 TYR^? 26.27 CL CL C 129 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 100.49 52.59 -40.39 100.40 51.57 -38.55 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 95.50 58.88 -47.37 95.04 57.01 -48.29 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 106.70 61.17 -39.39 108.02 63.54 -39.97 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 6 3 # 6 A 144 HIS D 85 HIS^? 27.00 CL CL D 129 A 174 ASP D 14 ASP^? 27.52 CL CL D 129 A 404 TYR D 83 TYR^? 26.42 CL CL D 129 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 58.77 98.13 -40.30 58.69 99.11 -38.44 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 63.54 91.53 -47.18 63.81 93.48 -47.82 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 52.51 89.53 -39.47 51.30 87.12 -40.13 1ti6_c06 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 6 hits 1ti6_c06 naa= 3 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 C 144 HIS A 85 HIS.? 26.94 CL CL B 129 C 174 ASP A 14 ASP~? 27.67 CL CL B 129 C 404 TYR A 83 TYR.? 15.31 CL CL B 129 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 112.09 59.31 -75.65 113.04 59.28 -73.77 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 105.70 54.30 -82.61 107.63 54.15 -83.44 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 103.43 65.48 -74.92 101.03 66.78 -75.48 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 C 144 HIS B 85 HIS^? 26.88 CL CL A 129 C 174 ASP B 10 ASP^? 27.46 CL CL A 129 C 404 TYR B 83 TYR^? 15.32 CL CL A 129 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 111.98 64.21 -65.30 113.02 64.33 -67.11 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 110.59 65.11 -56.28 111.89 65.48 -54.65 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 103.38 58.05 -66.28 101.08 56.65 -65.75 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 C 144 HIS B 85 HIS^? 26.88 CL CL A 129 C 174 ASP B 14 ASP^? 27.62 CL CL A 129 C 404 TYR B 83 TYR^? 15.32 CL CL A 129 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 111.98 64.21 -65.30 113.02 64.33 -67.11 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 105.60 69.00 -58.44 107.49 69.47 -57.66 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 103.38 58.05 -66.28 101.08 56.65 -65.75 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 C 144 HIS C 85 HIS^? 23.16 CL CL A 129 C 174 ASP C 10 ASP^? 12.83 CL CL A 129 C 404 TYR C 83 TYR^? 26.27 CL CL C 129 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 100.49 52.59 -40.39 100.40 51.57 -38.55 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 99.63 54.02 -49.94 99.45 52.98 -51.81 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 106.70 61.17 -39.39 108.02 63.54 -39.97 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 5 3 # 5 C 144 HIS C 85 HIS^? 23.16 CL CL A 129 C 174 ASP C 14 ASP^? 16.95 CL CL A 129 C 404 TYR C 83 TYR^? 26.27 CL CL C 129 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 100.49 52.59 -40.39 100.40 51.57 -38.55 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 95.50 58.88 -47.37 95.04 57.01 -48.29 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 106.70 61.17 -39.39 108.02 63.54 -39.97 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 6 3 # 6 C 144 HIS D 85 HIS^? 27.00 CL CL D 129 C 174 ASP D 14 ASP^? 27.52 CL CL D 129 C 404 TYR D 83 TYR^? 26.42 CL CL D 129 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 58.77 98.13 -40.30 58.69 99.11 -38.44 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 63.54 91.53 -47.18 63.81 93.48 -47.82 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 52.51 89.53 -39.47 51.30 87.12 -40.13 1ti6_c07 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 6 hits 1ti6_c07 naa= 3 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 E 144 HIS A 85 HIS.? 26.94 CL CL B 129 E 174 ASP A 14 ASP~? 27.67 CL CL B 129 E 404 TYR A 83 TYR.? 15.31 CL CL B 129 coo -7.53-107.59 75.19 -8.14-106.04 76.47 112.09 59.31 -75.65 113.04 59.28 -73.77 coo -3.55-105.39 83.13 -5.21-106.24 82.09 105.70 54.30 -82.61 107.63 54.15 -83.44 coo -16.31-108.78 75.35 -14.20-107.14 76.16 103.43 65.48 -74.92 101.03 66.78 -75.48 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 E 144 HIS B 85 HIS^? 26.88 CL CL A 129 E 174 ASP B 10 ASP^? 27.46 CL CL A 129 E 404 TYR B 83 TYR^? 15.32 CL CL A 129 coo -7.53-107.59 75.19 -8.14-106.04 76.47 111.98 64.21 -65.30 113.02 64.33 -67.11 coo -3.55-105.39 83.13 -5.21-106.24 82.09 110.59 65.11 -56.28 111.89 65.48 -54.65 coo -16.31-108.78 75.35 -14.20-107.14 76.16 103.38 58.05 -66.28 101.08 56.65 -65.75 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 E 144 HIS B 85 HIS^? 26.88 CL CL A 129 E 174 ASP B 14 ASP^? 27.62 CL CL A 129 E 404 TYR B 83 TYR^? 15.32 CL CL A 129 coo -7.53-107.59 75.19 -8.14-106.04 76.47 111.98 64.21 -65.30 113.02 64.33 -67.11 coo -3.55-105.39 83.13 -5.21-106.24 82.09 105.60 69.00 -58.44 107.49 69.47 -57.66 coo -16.31-108.78 75.35 -14.20-107.14 76.16 103.38 58.05 -66.28 101.08 56.65 -65.75 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 E 144 HIS C 85 HIS^? 23.16 CL CL A 129 E 174 ASP C 10 ASP^? 12.83 CL CL A 129 E 404 TYR C 83 TYR^? 26.27 CL CL C 129 coo -7.53-107.59 75.19 -8.14-106.04 76.47 100.49 52.59 -40.39 100.40 51.57 -38.55 coo -3.55-105.39 83.13 -5.21-106.24 82.09 99.63 54.02 -49.94 99.45 52.98 -51.81 coo -16.31-108.78 75.35 -14.20-107.14 76.16 106.70 61.17 -39.39 108.02 63.54 -39.97 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 5 3 # 5 E 144 HIS C 85 HIS^? 23.16 CL CL A 129 E 174 ASP C 14 ASP^? 16.95 CL CL A 129 E 404 TYR C 83 TYR^? 26.27 CL CL C 129 coo -7.53-107.59 75.19 -8.14-106.04 76.47 100.49 52.59 -40.39 100.40 51.57 -38.55 coo -3.55-105.39 83.13 -5.21-106.24 82.09 95.50 58.88 -47.37 95.04 57.01 -48.29 coo -16.31-108.78 75.35 -14.20-107.14 76.16 106.70 61.17 -39.39 108.02 63.54 -39.97 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 6 3 # 6 E 144 HIS D 85 HIS^? 27.00 CL CL D 129 E 174 ASP D 14 ASP^? 27.52 CL CL D 129 E 404 TYR D 83 TYR^? 26.42 CL CL D 129 coo -7.53-107.59 75.19 -8.14-106.04 76.47 58.77 98.13 -40.30 58.69 99.11 -38.44 coo -3.55-105.39 83.13 -5.21-106.24 82.09 63.54 91.53 -47.18 63.81 93.48 -47.82 coo -16.31-108.78 75.35 -14.20-107.14 76.16 52.51 89.53 -39.47 51.30 87.12 -40.13 1ti6_c08 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 6 hits 1ti6_c08 naa= 3 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 G 144 HIS A 85 HIS.? 26.94 CL CL B 129 G 174 ASP A 14 ASP~? 27.67 CL CL B 129 G 404 TYR A 83 TYR.? 15.31 CL CL B 129 coo 60.48-101.16 45.95 60.56-101.20 43.85 112.09 59.31 -75.65 113.04 59.28 -73.77 coo 58.10-108.15 40.62 59.57-106.86 41.51 105.70 54.30 -82.61 107.63 54.15 -83.44 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 103.43 65.48 -74.92 101.03 66.78 -75.48 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 G 144 HIS B 85 HIS^? 26.88 CL CL A 129 G 174 ASP B 10 ASP^? 27.46 CL CL A 129 G 404 TYR B 83 TYR^? 15.32 CL CL A 129 coo 60.48-101.16 45.95 60.56-101.20 43.85 111.98 64.21 -65.30 113.02 64.33 -67.11 coo 58.10-108.15 40.62 59.57-106.86 41.51 110.59 65.11 -56.28 111.89 65.48 -54.65 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 103.38 58.05 -66.28 101.08 56.65 -65.75 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 G 144 HIS B 85 HIS^? 26.88 CL CL A 129 G 174 ASP B 14 ASP^? 27.62 CL CL A 129 G 404 TYR B 83 TYR^? 15.32 CL CL A 129 coo 60.48-101.16 45.95 60.56-101.20 43.85 111.98 64.21 -65.30 113.02 64.33 -67.11 coo 58.10-108.15 40.62 59.57-106.86 41.51 105.60 69.00 -58.44 107.49 69.47 -57.66 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 103.38 58.05 -66.28 101.08 56.65 -65.75 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 G 144 HIS C 85 HIS^? 23.16 CL CL A 129 G 174 ASP C 10 ASP^? 12.83 CL CL A 129 G 404 TYR C 83 TYR^? 26.27 CL CL C 129 coo 60.48-101.16 45.95 60.56-101.20 43.85 100.49 52.59 -40.39 100.40 51.57 -38.55 coo 58.10-108.15 40.62 59.57-106.86 41.51 99.63 54.02 -49.94 99.45 52.98 -51.81 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 106.70 61.17 -39.39 108.02 63.54 -39.97 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 5 3 # 5 G 144 HIS C 85 HIS^? 23.16 CL CL A 129 G 174 ASP C 14 ASP^? 16.95 CL CL A 129 G 404 TYR C 83 TYR^? 26.27 CL CL C 129 coo 60.48-101.16 45.95 60.56-101.20 43.85 100.49 52.59 -40.39 100.40 51.57 -38.55 coo 58.10-108.15 40.62 59.57-106.86 41.51 95.50 58.88 -47.37 95.04 57.01 -48.29 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 106.70 61.17 -39.39 108.02 63.54 -39.97 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 6 3 # 6 G 144 HIS D 85 HIS^? 27.00 CL CL D 129 G 174 ASP D 14 ASP^? 27.52 CL CL D 129 G 404 TYR D 83 TYR^? 26.42 CL CL D 129 coo 60.48-101.16 45.95 60.56-101.20 43.85 58.77 98.13 -40.30 58.69 99.11 -38.44 coo 58.10-108.15 40.62 59.57-106.86 41.51 63.54 91.53 -47.18 63.81 93.48 -47.82 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 52.51 89.53 -39.47 51.30 87.12 -40.13 1ti6_c09 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 6 hits 1ti6_c09 naa= 3 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 I 144 HIS A 85 HIS.? 26.94 CL CL B 129 I 174 ASP A 14 ASP~? 27.67 CL CL B 129 I 404 TYR A 83 TYR.? 15.31 CL CL B 129 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 112.09 59.31 -75.65 113.04 59.28 -73.77 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 105.70 54.30 -82.61 107.63 54.15 -83.44 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 103.43 65.48 -74.92 101.03 66.78 -75.48 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 I 144 HIS B 85 HIS^? 26.88 CL CL A 129 I 174 ASP B 10 ASP^? 27.46 CL CL A 129 I 404 TYR B 83 TYR^? 15.32 CL CL A 129 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 111.98 64.21 -65.30 113.02 64.33 -67.11 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 110.59 65.11 -56.28 111.89 65.48 -54.65 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 103.38 58.05 -66.28 101.08 56.65 -65.75 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 I 144 HIS B 85 HIS^? 26.88 CL CL A 129 I 174 ASP B 14 ASP^? 27.62 CL CL A 129 I 404 TYR B 83 TYR^? 15.32 CL CL A 129 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 111.98 64.21 -65.30 113.02 64.33 -67.11 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 105.60 69.00 -58.44 107.49 69.47 -57.66 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 103.38 58.05 -66.28 101.08 56.65 -65.75 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 I 144 HIS C 85 HIS^? 23.16 CL CL A 129 I 174 ASP C 10 ASP^? 12.83 CL CL A 129 I 404 TYR C 83 TYR^? 26.27 CL CL C 129 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 100.49 52.59 -40.39 100.40 51.57 -38.55 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 99.63 54.02 -49.94 99.45 52.98 -51.81 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 106.70 61.17 -39.39 108.02 63.54 -39.97 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 5 3 # 5 I 144 HIS C 85 HIS^? 23.16 CL CL A 129 I 174 ASP C 14 ASP^? 16.95 CL CL A 129 I 404 TYR C 83 TYR^? 26.27 CL CL C 129 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 100.49 52.59 -40.39 100.40 51.57 -38.55 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 95.50 58.88 -47.37 95.04 57.01 -48.29 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 106.70 61.17 -39.39 108.02 63.54 -39.97 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 6 3 # 6 I 144 HIS D 85 HIS^? 27.00 CL CL D 129 I 174 ASP D 14 ASP^? 27.52 CL CL D 129 I 404 TYR D 83 TYR^? 26.42 CL CL D 129 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 58.77 98.13 -40.30 58.69 99.11 -38.44 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 63.54 91.53 -47.18 63.81 93.48 -47.82 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 52.51 89.53 -39.47 51.30 87.12 -40.13 1ti6_c10 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 6 hits 1ti6_c10 naa= 3 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 K 144 HIS A 85 HIS.? 26.94 CL CL B 129 K 174 ASP A 14 ASP~? 27.67 CL CL B 129 K 404 TYR A 83 TYR.? 15.31 CL CL B 129 coo 100.18 26.45 -1.32 99.24 26.12 0.53 112.09 59.31 -75.65 113.04 59.28 -73.77 coo 102.36 30.86 6.31 102.45 29.08 5.12 105.70 54.30 -82.61 107.63 54.15 -83.44 coo 99.93 17.48 -0.85 99.14 19.86 0.39 103.43 65.48 -74.92 101.03 66.78 -75.48 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 K 144 HIS B 85 HIS^? 26.88 CL CL A 129 K 174 ASP B 10 ASP^? 27.46 CL CL A 129 K 404 TYR B 83 TYR^? 15.32 CL CL A 129 coo 100.18 26.45 -1.32 99.24 26.12 0.53 111.98 64.21 -65.30 113.02 64.33 -67.11 coo 102.36 30.86 6.31 102.45 29.08 5.12 110.59 65.11 -56.28 111.89 65.48 -54.65 coo 99.93 17.48 -0.85 99.14 19.86 0.39 103.38 58.05 -66.28 101.08 56.65 -65.75 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 K 144 HIS B 85 HIS^? 26.88 CL CL A 129 K 174 ASP B 14 ASP^? 27.62 CL CL A 129 K 404 TYR B 83 TYR^? 15.32 CL CL A 129 coo 100.18 26.45 -1.32 99.24 26.12 0.53 111.98 64.21 -65.30 113.02 64.33 -67.11 coo 102.36 30.86 6.31 102.45 29.08 5.12 105.60 69.00 -58.44 107.49 69.47 -57.66 coo 99.93 17.48 -0.85 99.14 19.86 0.39 103.38 58.05 -66.28 101.08 56.65 -65.75 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 K 144 HIS C 85 HIS^? 23.16 CL CL A 129 K 174 ASP C 10 ASP^? 12.83 CL CL A 129 K 404 TYR C 83 TYR^? 26.27 CL CL C 129 coo 100.18 26.45 -1.32 99.24 26.12 0.53 100.49 52.59 -40.39 100.40 51.57 -38.55 coo 102.36 30.86 6.31 102.45 29.08 5.12 99.63 54.02 -49.94 99.45 52.98 -51.81 coo 99.93 17.48 -0.85 99.14 19.86 0.39 106.70 61.17 -39.39 108.02 63.54 -39.97 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 5 3 # 5 K 144 HIS C 85 HIS^? 23.16 CL CL A 129 K 174 ASP C 14 ASP^? 16.95 CL CL A 129 K 404 TYR C 83 TYR^? 26.27 CL CL C 129 coo 100.18 26.45 -1.32 99.24 26.12 0.53 100.49 52.59 -40.39 100.40 51.57 -38.55 coo 102.36 30.86 6.31 102.45 29.08 5.12 95.50 58.88 -47.37 95.04 57.01 -48.29 coo 99.93 17.48 -0.85 99.14 19.86 0.39 106.70 61.17 -39.39 108.02 63.54 -39.97 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 6 3 # 6 K 144 HIS D 85 HIS^? 27.00 CL CL D 129 K 174 ASP D 14 ASP^? 27.52 CL CL D 129 K 404 TYR D 83 TYR^? 26.42 CL CL D 129 coo 100.18 26.45 -1.32 99.24 26.12 0.53 58.77 98.13 -40.30 58.69 99.11 -38.44 coo 102.36 30.86 6.31 102.45 29.08 5.12 63.54 91.53 -47.18 63.81 93.48 -47.82 coo 99.93 17.48 -0.85 99.14 19.86 0.39 52.51 89.53 -39.47 51.30 87.12 -40.13 1ti6_c11 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 6 hits 1ti6_c11 naa= 3 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 5 ASP~? 21.13 CL CL B 129 218 GLU B 93 GLU^? 15.32 CL CL A 129 329 ASP A 86 ASP.? 23.33 CL CL A 129 coo 49.16 35.16 15.19 51.08 34.43 15.65 110.30 67.66 -76.72 112.26 68.26 -76.10 coo 70.09 11.71 8.46 70.56 12.89 6.77 84.67 58.80 -60.02 84.04 57.06 -58.91 coo 59.16 37.82 13.95 57.63 37.03 15.12 108.46 57.22 -73.78 109.48 58.49 -72.45 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 14 ASP~? 27.67 CL CL B 129 218 GLU B 51 GLU^? 16.46 CL CL B 129 329 ASP A 86 ASP.? 23.33 CL CL A 129 coo 49.16 35.16 15.19 51.08 34.43 15.65 105.70 54.30 -82.61 107.63 54.15 -83.44 coo 70.09 11.71 8.46 70.56 12.89 6.77 81.98 72.56 -73.89 80.95 72.05 -72.12 coo 59.16 37.82 13.95 57.63 37.03 15.12 108.46 57.22 -73.78 109.48 58.49 -72.45 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP A 14 ASP~? 27.67 CL CL B 129 218 GLU B 57 GLU^? -5.29 CL CL B 129s 329 ASP A 86 ASP.? 23.33 CL CL A 129 coo 49.16 35.16 15.19 51.08 34.43 15.65 105.70 54.30 -82.61 107.63 54.15 -83.44 coo 70.09 11.71 8.46 70.56 12.89 6.77 91.24 81.90 -79.46 91.48 82.48 -81.50 coo 59.16 37.82 13.95 57.63 37.03 15.12 108.46 57.22 -73.78 109.48 58.49 -72.45 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP A 14 ASP~? 27.67 CL CL B 129 218 GLU B 93 GLU^? 15.32 CL CL A 129 329 ASP A 86 ASP.? 23.33 CL CL A 129 coo 49.16 35.16 15.19 51.08 34.43 15.65 105.70 54.30 -82.61 107.63 54.15 -83.44 coo 70.09 11.71 8.46 70.56 12.89 6.77 84.67 58.80 -60.02 84.04 57.06 -58.91 coo 59.16 37.82 13.95 57.63 37.03 15.12 108.46 57.22 -73.78 109.48 58.49 -72.45 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 5 3 # 5 199 ASP A 86 ASP.? 23.33 CL CL A 129 218 GLU B 51 GLU^? 16.46 CL CL B 129 329 ASP A 5 ASP~? 21.13 CL CL B 129 coo 49.16 35.16 15.19 51.08 34.43 15.65 108.46 57.22 -73.78 109.48 58.49 -72.45 coo 70.09 11.71 8.46 70.56 12.89 6.77 81.98 72.56 -73.89 80.95 72.05 -72.12 coo 59.16 37.82 13.95 57.63 37.03 15.12 110.30 67.66 -76.72 112.26 68.26 -76.10 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 6 3 # 6 199 ASP A 86 ASP.? 23.33 CL CL A 129 218 GLU B 51 GLU^? 16.46 CL CL B 129 329 ASP B 86 ASP^? 23.14 CL CL B 129 coo 49.16 35.16 15.19 51.08 34.43 15.65 108.46 57.22 -73.78 109.48 58.49 -72.45 coo 70.09 11.71 8.46 70.56 12.89 6.77 81.98 72.56 -73.89 80.95 72.05 -72.12 coo 59.16 37.82 13.95 57.63 37.03 15.12 108.40 66.17 -67.38 109.32 64.97 -68.84 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 7 3 # 7 199 ASP A 86 ASP.? 23.33 CL CL A 129 218 GLU C 23 GLU^? 24.69 CL CL C 129 329 ASP B 5 ASP^? 20.93 CL CL A 129 coo 49.16 35.16 15.19 51.08 34.43 15.65 108.46 57.22 -73.78 109.48 58.49 -72.45 coo 70.09 11.71 8.46 70.56 12.89 6.77 93.85 75.25 -49.20 94.57 76.88 -48.00 coo 59.16 37.82 13.95 57.63 37.03 15.12 110.10 55.77 -64.66 112.04 55.13 -65.31 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 8 3 # 8 199 ASP B 5 ASP^? 20.93 CL CL A 129 218 GLU A 93 GLU.? 15.26 CL CL B 129 329 ASP B 86 ASP^? 23.14 CL CL B 129 coo 49.16 35.16 15.19 51.08 34.43 15.65 110.10 55.77 -64.66 112.04 55.13 -65.31 coo 70.09 11.71 8.46 70.56 12.89 6.77 84.83 64.69 -81.14 84.26 66.42 -82.32 coo 59.16 37.82 13.95 57.63 37.03 15.12 108.40 66.17 -67.38 109.32 64.97 -68.84 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 9 3 # 9 199 ASP B 5 ASP^? 20.93 CL CL A 129 218 GLU B 51 GLU^? 16.46 CL CL B 129 329 ASP A 86 ASP.? 23.33 CL CL A 129 coo 49.16 35.16 15.19 51.08 34.43 15.65 110.10 55.77 -64.66 112.04 55.13 -65.31 coo 70.09 11.71 8.46 70.56 12.89 6.77 81.98 72.56 -73.89 80.95 72.05 -72.12 coo 59.16 37.82 13.95 57.63 37.03 15.12 108.46 57.22 -73.78 109.48 58.49 -72.45 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 10 3 # 10 199 ASP B 5 ASP^? 20.93 CL CL A 129 218 GLU B 51 GLU^? 16.46 CL CL B 129 329 ASP B 86 ASP^? 23.14 CL CL B 129 coo 49.16 35.16 15.19 51.08 34.43 15.65 110.10 55.77 -64.66 112.04 55.13 -65.31 coo 70.09 11.71 8.46 70.56 12.89 6.77 81.98 72.56 -73.89 80.95 72.05 -72.12 coo 59.16 37.82 13.95 57.63 37.03 15.12 108.40 66.17 -67.38 109.32 64.97 -68.84 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 11 3 # 11 199 ASP B 10 ASP^? 27.46 CL CL A 129 218 GLU A 51 GLU^? 16.44 CL CL A 129 329 ASP B 86 ASP^? 23.14 CL CL B 129 coo 49.16 35.16 15.19 51.08 34.43 15.65 110.59 65.11 -56.28 111.89 65.48 -54.65 coo 70.09 11.71 8.46 70.56 12.89 6.77 82.00 50.89 -67.09 80.89 51.23 -68.89 coo 59.16 37.82 13.95 57.63 37.03 15.12 108.40 66.17 -67.38 109.32 64.97 -68.84 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 12 3 # 12 199 ASP B 10 ASP^? 27.46 CL CL A 129 218 GLU A 57 GLU~? -5.56 CL CL A 129s 329 ASP B 86 ASP^? 23.14 CL CL B 129 coo 49.16 35.16 15.19 51.08 34.43 15.65 110.59 65.11 -56.28 111.89 65.48 -54.65 coo 70.09 11.71 8.46 70.56 12.89 6.77 91.25 41.69 -61.23 91.08 41.09 -59.17 coo 59.16 37.82 13.95 57.63 37.03 15.12 108.40 66.17 -67.38 109.32 64.97 -68.84 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 13 3 # 13 199 ASP B 14 ASP^? 27.62 CL CL A 129 218 GLU A 51 GLU^? 16.44 CL CL A 129 329 ASP B 86 ASP^? 23.14 CL CL B 129 coo 49.16 35.16 15.19 51.08 34.43 15.65 105.60 69.00 -58.44 107.49 69.47 -57.66 coo 70.09 11.71 8.46 70.56 12.89 6.77 82.00 50.89 -67.09 80.89 51.23 -68.89 coo 59.16 37.82 13.95 57.63 37.03 15.12 108.40 66.17 -67.38 109.32 64.97 -68.84 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 14 3 # 14 199 ASP B 14 ASP^? 27.62 CL CL A 129 218 GLU A 57 GLU~? -5.56 CL CL A 129s 329 ASP B 86 ASP^? 23.14 CL CL B 129 coo 49.16 35.16 15.19 51.08 34.43 15.65 105.60 69.00 -58.44 107.49 69.47 -57.66 coo 70.09 11.71 8.46 70.56 12.89 6.77 91.25 41.69 -61.23 91.08 41.09 -59.17 coo 59.16 37.82 13.95 57.63 37.03 15.12 108.40 66.17 -67.38 109.32 64.97 -68.84 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 15 3 # 15 199 ASP B 14 ASP^? 27.62 CL CL A 129 218 GLU A 93 GLU.? 15.26 CL CL B 129 329 ASP B 86 ASP^? 23.14 CL CL B 129 coo 49.16 35.16 15.19 51.08 34.43 15.65 105.60 69.00 -58.44 107.49 69.47 -57.66 coo 70.09 11.71 8.46 70.56 12.89 6.77 84.83 64.69 -81.14 84.26 66.42 -82.32 coo 59.16 37.82 13.95 57.63 37.03 15.12 108.40 66.17 -67.38 109.32 64.97 -68.84 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 16 3 # 16 199 ASP B 30 ASP^? 20.91 CL CL B 129 218 GLU C 114 GLU^? 14.88 CL CL C 129 329 ASP C 72 ASP^? 28.53 CL CL B 129 coo 49.16 35.16 15.19 51.08 34.43 15.65 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 70.09 11.71 8.46 70.56 12.89 6.77 87.05 59.85 -36.57 87.99 59.11 -34.78 coo 59.16 37.82 13.95 57.63 37.03 15.12 90.38 83.76 -50.64 91.24 82.68 -52.23 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 17 3 # 17 199 ASP B 86 ASP^? 23.14 CL CL B 129 218 GLU A 51 GLU^? 16.44 CL CL A 129 329 ASP A 86 ASP.? 23.33 CL CL A 129 coo 49.16 35.16 15.19 51.08 34.43 15.65 108.40 66.17 -67.38 109.32 64.97 -68.84 coo 70.09 11.71 8.46 70.56 12.89 6.77 82.00 50.89 -67.09 80.89 51.23 -68.89 coo 59.16 37.82 13.95 57.63 37.03 15.12 108.46 57.22 -73.78 109.48 58.49 -72.45 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 18 3 # 18 199 ASP B 86 ASP^? 23.14 CL CL B 129 218 GLU A 51 GLU^? 16.44 CL CL A 129 329 ASP B 5 ASP^? 20.93 CL CL A 129 coo 49.16 35.16 15.19 51.08 34.43 15.65 108.40 66.17 -67.38 109.32 64.97 -68.84 coo 70.09 11.71 8.46 70.56 12.89 6.77 82.00 50.89 -67.09 80.89 51.23 -68.89 coo 59.16 37.82 13.95 57.63 37.03 15.12 110.10 55.77 -64.66 112.04 55.13 -65.31 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 19 3 # 19 199 ASP B 86 ASP^? 23.14 CL CL B 129 218 GLU A 57 GLU~? -5.56 CL CL A 129s 329 ASP B 10 ASP^? 27.46 CL CL A 129 coo 49.16 35.16 15.19 51.08 34.43 15.65 108.40 66.17 -67.38 109.32 64.97 -68.84 coo 70.09 11.71 8.46 70.56 12.89 6.77 91.25 41.69 -61.23 91.08 41.09 -59.17 coo 59.16 37.82 13.95 57.63 37.03 15.12 110.59 65.11 -56.28 111.89 65.48 -54.65 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 20 3 # 20 199 ASP C 30 ASP^? 20.67 CL CL C 129 218 GLU A 58 GLU~? 7.41 CL CL A 129 329 ASP B 72 ASP^? 28.57 CL CL C 129 coo 49.16 35.16 15.19 51.08 34.43 15.65 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 70.09 11.71 8.46 70.56 12.89 6.77 87.85 46.74 -60.89 87.27 48.56 -59.93 coo 59.16 37.82 13.95 57.63 37.03 15.12 80.87 74.36 -54.99 81.74 73.36 -53.35 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 21 3 # 21 199 ASP C 30 ASP^? 20.67 CL CL C 129 218 GLU B 114 GLU^? 14.94 CL CL B 129 329 ASP B 72 ASP^? 28.57 CL CL C 129 coo 49.16 35.16 15.19 51.08 34.43 15.65 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 70.09 11.71 8.46 70.56 12.89 6.77 104.70 77.68 -68.99 105.48 76.80 -70.78 coo 59.16 37.82 13.95 57.63 37.03 15.12 80.87 74.36 -54.99 81.74 73.36 -53.35 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 22 3 # 22 199 ASP C 35 ASP^? 10.26 CL CL C 129 218 GLU D 93 GLU^? 31.46 CL CL D 129 329 ASP C 30 ASP^? 20.67 CL CL C 129 coo 49.16 35.16 15.19 51.08 34.43 15.65 83.63 70.73 -36.85 83.32 69.81 -34.96 coo 70.09 11.71 8.46 70.56 12.89 6.77 53.41 70.78 -45.84 51.64 70.26 -46.90 coo 59.16 37.82 13.95 57.63 37.03 15.12 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 23 3 # 23 199 ASP D 5 ASP^? 32.88 CL CL D 129 218 GLU D 51 GLU^? 16.56 CL CL D 129 329 ASP D 86 ASP^? 23.19 CL CL D 129 coo 49.16 35.16 15.19 51.08 34.43 15.65 50.37 96.25 -41.36 49.69 98.16 -40.70 coo 70.09 11.71 8.46 70.56 12.89 6.77 66.99 68.03 -31.91 66.63 66.88 -33.67 coo 59.16 37.82 13.95 57.63 37.03 15.12 60.79 94.39 -38.32 59.49 95.38 -36.98 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 24 3 # 24 199 ASP D 35 ASP^? 10.18 CL CL D 129 218 GLU C 93 GLU^? 31.51 CL CL C 129 329 ASP D 30 ASP^? 20.62 CL CL D 129 coo 49.16 35.16 15.19 51.08 34.43 15.65 75.66 79.96 -36.93 75.99 80.66 -34.97 coo 70.09 11.71 8.46 70.56 12.89 6.77 105.96 79.95 -45.75 107.72 80.63 -46.81 coo 59.16 37.82 13.95 57.63 37.03 15.12 76.16 76.40 -45.40 77.49 78.05 -45.35 1uok_c04 source 1uok OLIGO-1,6-GLUCOSIDASE : 24 hits 1uok_c04 naa= 3 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 86 ASP.? 23.33 CL CL A 129 242 GLU A 23 GLU~? 24.22 CL CL A 129 329 ASP B 5 ASP^? 20.93 CL CL A 129 coo 49.16 35.16 15.19 51.08 34.43 15.65 108.46 57.22 -73.78 109.48 58.49 -72.45 coo 30.42 34.74 5.00 29.09 35.09 3.38 89.42 52.54 -84.47 88.08 53.22 -82.95 coo 59.16 37.82 13.95 57.63 37.03 15.12 110.10 55.77 -64.66 112.04 55.13 -65.31 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 86 ASP.? 23.33 CL CL A 129 242 GLU A 23 GLU~? 24.22 CL CL A 129 329 ASP B 86 ASP^? 23.14 CL CL B 129 coo 49.16 35.16 15.19 51.08 34.43 15.65 108.46 57.22 -73.78 109.48 58.49 -72.45 coo 30.42 34.74 5.00 29.09 35.09 3.38 89.42 52.54 -84.47 88.08 53.22 -82.95 coo 59.16 37.82 13.95 57.63 37.03 15.12 108.40 66.17 -67.38 109.32 64.97 -68.84 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP A 86 ASP.? 23.33 CL CL A 129 242 GLU A 42 GLU.? 5.77 CL CL A 129 329 ASP A 5 ASP~? 21.13 CL CL B 129 coo 49.16 35.16 15.19 51.08 34.43 15.65 108.46 57.22 -73.78 109.48 58.49 -72.45 coo 30.42 34.74 5.00 29.09 35.09 3.38 98.04 48.44 -58.38 99.25 46.68 -58.65 coo 59.16 37.82 13.95 57.63 37.03 15.12 110.30 67.66 -76.72 112.26 68.26 -76.10 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP A 86 ASP.? 23.33 CL CL A 129 242 GLU B 42 GLU^? 6.42 CL CL B 129 329 ASP B 5 ASP^? 20.93 CL CL A 129 coo 49.16 35.16 15.19 51.08 34.43 15.65 108.46 57.22 -73.78 109.48 58.49 -72.45 coo 30.42 34.74 5.00 29.09 35.09 3.38 97.73 74.53 -82.81 99.44 75.81 -82.79 coo 59.16 37.82 13.95 57.63 37.03 15.12 110.10 55.77 -64.66 112.04 55.13 -65.31 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 5 3 # 5 199 ASP B 30 ASP^? 20.91 CL CL B 129 242 GLU B 57 GLU^? -5.29 CL CL B 129s 329 ASP C 72 ASP^? 28.53 CL CL B 129 coo 49.16 35.16 15.19 51.08 34.43 15.65 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 30.42 34.74 5.00 29.09 35.09 3.38 91.24 81.90 -79.46 91.48 82.48 -81.50 coo 59.16 37.82 13.95 57.63 37.03 15.12 90.38 83.76 -50.64 91.24 82.68 -52.23 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 6 3 # 6 199 ASP B 30 ASP^? 20.91 CL CL B 129 242 GLU B 58 GLU^? 7.34 CL CL B 129 329 ASP C 72 ASP^? 28.53 CL CL B 129 coo 49.16 35.16 15.19 51.08 34.43 15.65 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 30.42 34.74 5.00 29.09 35.09 3.38 87.90 76.66 -80.19 87.42 74.86 -81.30 coo 59.16 37.82 13.95 57.63 37.03 15.12 90.38 83.76 -50.64 91.24 82.68 -52.23 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 7 3 # 7 199 ASP B 72 ASP^? 28.57 CL CL C 129 242 GLU B 36 GLU^? 18.40 CL CL B 129 329 ASP D 30 ASP^? 20.62 CL CL D 129 coo 49.16 35.16 15.19 51.08 34.43 15.65 80.87 74.36 -54.99 81.74 73.36 -53.35 coo 30.42 34.74 5.00 29.09 35.09 3.38 99.20 79.77 -64.83 99.58 80.60 -62.91 coo 59.16 37.82 13.95 57.63 37.03 15.12 76.16 76.40 -45.40 77.49 78.05 -45.35 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 8 3 # 8 199 ASP B 86 ASP^? 23.14 CL CL B 129 242 GLU A 42 GLU.? 5.77 CL CL A 129 329 ASP A 5 ASP~? 21.13 CL CL B 129 coo 49.16 35.16 15.19 51.08 34.43 15.65 108.40 66.17 -67.38 109.32 64.97 -68.84 coo 30.42 34.74 5.00 29.09 35.09 3.38 98.04 48.44 -58.38 99.25 46.68 -58.65 coo 59.16 37.82 13.95 57.63 37.03 15.12 110.30 67.66 -76.72 112.26 68.26 -76.10 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 9 3 # 9 199 ASP B 86 ASP^? 23.14 CL CL B 129 242 GLU B 23 GLU^? 24.68 CL CL B 129 329 ASP A 5 ASP~? 21.13 CL CL B 129 coo 49.16 35.16 15.19 51.08 34.43 15.65 108.40 66.17 -67.38 109.32 64.97 -68.84 coo 30.42 34.74 5.00 29.09 35.09 3.38 89.49 70.79 -56.44 87.96 70.01 -57.68 coo 59.16 37.82 13.95 57.63 37.03 15.12 110.30 67.66 -76.72 112.26 68.26 -76.10 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 10 3 # 10 199 ASP B 86 ASP^? 23.14 CL CL B 129 242 GLU B 23 GLU^? 24.68 CL CL B 129 329 ASP A 86 ASP.? 23.33 CL CL A 129 coo 49.16 35.16 15.19 51.08 34.43 15.65 108.40 66.17 -67.38 109.32 64.97 -68.84 coo 30.42 34.74 5.00 29.09 35.09 3.38 89.49 70.79 -56.44 87.96 70.01 -57.68 coo 59.16 37.82 13.95 57.63 37.03 15.12 108.46 57.22 -73.78 109.48 58.49 -72.45 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 11 3 # 11 199 ASP B 86 ASP^? 23.14 CL CL B 129 242 GLU B 42 GLU^? 6.42 CL CL B 129 329 ASP B 5 ASP^? 20.93 CL CL A 129 coo 49.16 35.16 15.19 51.08 34.43 15.65 108.40 66.17 -67.38 109.32 64.97 -68.84 coo 30.42 34.74 5.00 29.09 35.09 3.38 97.73 74.53 -82.81 99.44 75.81 -82.79 coo 59.16 37.82 13.95 57.63 37.03 15.12 110.10 55.77 -64.66 112.04 55.13 -65.31 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 12 3 # 12 199 ASP B 86 ASP^? 23.14 CL CL B 129 242 GLU B 42 GLU^? 6.42 CL CL B 129 329 ASP B 10 ASP^? 27.46 CL CL A 129 coo 49.16 35.16 15.19 51.08 34.43 15.65 108.40 66.17 -67.38 109.32 64.97 -68.84 coo 30.42 34.74 5.00 29.09 35.09 3.38 97.73 74.53 -82.81 99.44 75.81 -82.79 coo 59.16 37.82 13.95 57.63 37.03 15.12 110.59 65.11 -56.28 111.89 65.48 -54.65 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 13 3 # 13 199 ASP C 30 ASP^? 20.67 CL CL C 129 242 GLU C 57 GLU^? -5.48 CL CL C 129s 329 ASP B 72 ASP^? 28.57 CL CL C 129 coo 49.16 35.16 15.19 51.08 34.43 15.65 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 30.42 34.74 5.00 29.09 35.09 3.38 82.94 73.46 -26.00 82.34 73.25 -23.96 coo 59.16 37.82 13.95 57.63 37.03 15.12 80.87 74.36 -54.99 81.74 73.36 -53.35 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 14 3 # 14 199 ASP C 30 ASP^? 20.67 CL CL C 129 242 GLU C 58 GLU^? 7.49 CL CL C 129 329 ASP B 72 ASP^? 28.57 CL CL C 129 coo 49.16 35.16 15.19 51.08 34.43 15.65 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 30.42 34.74 5.00 29.09 35.09 3.38 88.02 76.82 -25.55 89.85 77.43 -24.60 coo 59.16 37.82 13.95 57.63 37.03 15.12 80.87 74.36 -54.99 81.74 73.36 -53.35 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 15 3 # 15 199 ASP C 30 ASP^? 20.67 CL CL C 129 242 GLU D 58 GLU^? 7.39 CL CL D 129 329 ASP B 72 ASP^? 28.57 CL CL C 129 coo 49.16 35.16 15.19 51.08 34.43 15.65 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 30.42 34.74 5.00 29.09 35.09 3.38 71.21 74.03 -25.57 69.46 73.32 -24.61 coo 59.16 37.82 13.95 57.63 37.03 15.12 80.87 74.36 -54.99 81.74 73.36 -53.35 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 16 3 # 16 199 ASP C 86 ASP^? 23.12 CL CL C 129 242 GLU C 42 GLU^? 6.54 CL CL C 129 329 ASP C 5 ASP^? 26.16 CL CL A 129 coo 49.16 35.16 15.19 51.08 34.43 15.65 98.39 56.19 -38.35 99.60 55.15 -36.99 coo 30.42 34.74 5.00 29.09 35.09 3.38 90.14 66.47 -23.00 88.99 64.66 -23.57 coo 59.16 37.82 13.95 57.63 37.03 15.12 108.85 54.21 -41.41 109.64 52.31 -40.89 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 17 3 # 17 199 ASP C 86 ASP^? 23.12 CL CL C 129 242 GLU C 42 GLU^? 6.54 CL CL C 129 329 ASP C 10 ASP^? 12.83 CL CL A 129 coo 49.16 35.16 15.19 51.08 34.43 15.65 98.39 56.19 -38.35 99.60 55.15 -36.99 coo 30.42 34.74 5.00 29.09 35.09 3.38 90.14 66.47 -23.00 88.99 64.66 -23.57 coo 59.16 37.82 13.95 57.63 37.03 15.12 99.63 54.02 -49.94 99.45 52.98 -51.81 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 18 3 # 18 199 ASP D 30 ASP^? 20.62 CL CL D 129 242 GLU C 57 GLU^? -5.48 CL CL C 129s 329 ASP B 72 ASP^? 28.57 CL CL C 129 coo 49.16 35.16 15.19 51.08 34.43 15.65 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 30.42 34.74 5.00 29.09 35.09 3.38 82.94 73.46 -26.00 82.34 73.25 -23.96 coo 59.16 37.82 13.95 57.63 37.03 15.12 80.87 74.36 -54.99 81.74 73.36 -53.35 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 19 3 # 19 199 ASP D 30 ASP^? 20.62 CL CL D 129 242 GLU C 58 GLU^? 7.49 CL CL C 129 329 ASP B 72 ASP^? 28.57 CL CL C 129 coo 49.16 35.16 15.19 51.08 34.43 15.65 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 30.42 34.74 5.00 29.09 35.09 3.38 88.02 76.82 -25.55 89.85 77.43 -24.60 coo 59.16 37.82 13.95 57.63 37.03 15.12 80.87 74.36 -54.99 81.74 73.36 -53.35 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 20 3 # 20 199 ASP D 30 ASP^? 20.62 CL CL D 129 242 GLU D 58 GLU^? 7.39 CL CL D 129 329 ASP B 72 ASP^? 28.57 CL CL C 129 coo 49.16 35.16 15.19 51.08 34.43 15.65 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 30.42 34.74 5.00 29.09 35.09 3.38 71.21 74.03 -25.57 69.46 73.32 -24.61 coo 59.16 37.82 13.95 57.63 37.03 15.12 80.87 74.36 -54.99 81.74 73.36 -53.35 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 21 3 # 21 199 ASP D 86 ASP^? 23.19 CL CL D 129 242 GLU D 42 GLU^? 6.22 CL CL D 129 329 ASP D 5 ASP^? 32.88 CL CL D 129 coo 49.16 35.16 15.19 51.08 34.43 15.65 60.79 94.39 -38.32 59.49 95.38 -36.98 coo 30.42 34.74 5.00 29.09 35.09 3.38 69.54 84.23 -23.20 71.02 85.79 -23.65 coo 59.16 37.82 13.95 57.63 37.03 15.12 50.37 96.25 -41.36 49.69 98.16 -40.70 1uok_c05 source 1uok OLIGO-1,6-GLUCOSIDASE : 21 hits 1uok_c05 naa= 3 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 1 3 # 1 A 581 GLU A 23 GLU~? 24.22 CL CL A 129 A 596 ARG A 73 ARG.? 22.19 CL CL A 129 A 647 ARG A 96 ARG.? 24.34 CL CL A 129 coo 69.13 32.20 28.58 68.39 32.96 30.44 89.42 52.54 -84.47 88.08 53.22 -82.95 coo 70.89 37.31 29.70 69.54 36.29 32.39 83.82 53.79 -81.61 86.00 54.30 -79.51 coo 66.09 40.54 34.70 66.92 37.69 35.49 78.03 52.93 -81.60 80.41 52.60 -79.67 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 2 3 # 2 A 581 GLU A 51 GLU^? 16.44 CL CL A 129 A 596 ARG A 46 ARG^? 15.11 CL CL A 129 A 647 ARG A 63 ARG~? 13.95 CL CL A 129 coo 69.13 32.20 28.58 68.39 32.96 30.44 82.00 50.89 -67.09 80.89 51.23 -68.89 coo 70.89 37.31 29.70 69.54 36.29 32.39 87.96 51.20 -70.32 85.08 51.60 -71.34 coo 66.09 40.54 34.70 66.92 37.69 35.49 87.85 45.63 -72.60 88.58 48.58 -73.24 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 3 3 # 3 A 581 GLU A 57 GLU~? -5.56 CL CL A 129s A 596 ARG A 60 ARG~? 8.61 CL CL A 129 A 647 ARG A 63 ARG~? 13.95 CL CL A 129 coo 69.13 32.20 28.58 68.39 32.96 30.44 91.25 41.69 -61.23 91.08 41.09 -59.17 coo 70.89 37.31 29.70 69.54 36.29 32.39 92.49 41.37 -66.87 95.11 39.81 -67.06 coo 66.09 40.54 34.70 66.92 37.69 35.49 87.85 45.63 -72.60 88.58 48.58 -73.24 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 4 3 # 4 A 581 GLU B 23 GLU^? 24.68 CL CL B 129 A 596 ARG B 73 ARG^? 22.29 CL CL B 129 A 647 ARG B 96 ARG^? 24.18 CL CL B 129 coo 69.13 32.20 28.58 68.39 32.96 30.44 89.49 70.79 -56.44 87.96 70.01 -57.68 coo 70.89 37.31 29.70 69.54 36.29 32.39 83.86 69.55 -59.16 85.91 69.18 -61.42 coo 66.09 40.54 34.70 66.92 37.69 35.49 78.35 70.58 -59.29 80.55 70.83 -61.45 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 5 3 # 5 A 581 GLU B 51 GLU^? 16.46 CL CL B 129 A 596 ARG B 46 ARG^? 15.06 CL CL B 129 A 647 ARG B 63 ARG^? 13.99 CL CL B 129 coo 69.13 32.20 28.58 68.39 32.96 30.44 81.98 72.56 -73.89 80.95 72.05 -72.12 coo 70.89 37.31 29.70 69.54 36.29 32.39 87.96 72.13 -70.71 85.05 71.84 -69.78 coo 66.09 40.54 34.70 66.92 37.69 35.49 87.72 77.76 -68.29 88.60 74.86 -67.71 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 6 3 # 6 A 581 GLU B 57 GLU^? -5.29 CL CL B 129s A 596 ARG B 60 ARG^? 8.76 CL CL B 129 A 647 ARG B 63 ARG^? 13.99 CL CL B 129 coo 69.13 32.20 28.58 68.39 32.96 30.44 91.24 81.90 -79.46 91.48 82.48 -81.50 coo 70.89 37.31 29.70 69.54 36.29 32.39 92.45 82.18 -73.93 95.13 83.66 -73.65 coo 66.09 40.54 34.70 66.92 37.69 35.49 87.72 77.76 -68.29 88.60 74.86 -67.71 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 7 3 # 7 A 581 GLU C 23 GLU^? 24.69 CL CL C 129 A 596 ARG C 73 ARG^? 22.24 CL CL C 129 A 647 ARG C 96 ARG^? 24.31 CL CL C 129 coo 69.13 32.20 28.58 68.39 32.96 30.44 93.85 75.25 -49.20 94.57 76.88 -48.00 coo 70.89 37.31 29.70 69.54 36.29 32.39 95.26 80.79 -46.47 95.45 78.63 -44.29 coo 66.09 40.54 34.70 66.92 37.69 35.49 94.28 86.51 -46.29 94.08 84.26 -44.17 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 8 3 # 8 A 581 GLU C 51 GLU^? 16.39 CL CL C 129 A 596 ARG C 46 ARG^? 15.12 CL CL C 129 A 647 ARG C 63 ARG^? 14.10 CL CL C 129 coo 69.13 32.20 28.58 68.39 32.96 30.44 92.20 82.64 -31.68 92.61 83.59 -33.56 coo 70.89 37.31 29.70 69.54 36.29 32.39 92.47 76.70 -34.87 92.87 79.50 -36.04 coo 66.09 40.54 34.70 66.92 37.69 35.49 86.96 77.03 -37.50 89.89 76.13 -38.00 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 9 3 # 9 A 581 GLU C 57 GLU^? -5.48 CL CL C 129s A 596 ARG C 60 ARG^? 8.92 CL CL C 129 A 647 ARG C 63 ARG^? 14.10 CL CL C 129 coo 69.13 32.20 28.58 68.39 32.96 30.44 82.94 73.46 -26.00 82.34 73.25 -23.96 coo 70.89 37.31 29.70 69.54 36.29 32.39 82.52 72.20 -31.52 80.97 69.57 -31.97 coo 66.09 40.54 34.70 66.92 37.69 35.49 86.96 77.03 -37.50 89.89 76.13 -38.00 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 10 3 # 10 A 581 GLU C 57 GLU^? -5.48 CL CL C 129s A 596 ARG C 60 ARG^? 8.92 CL CL C 129 A 647 ARG D 60 ARG^? 8.57 CL CL D 129 coo 69.13 32.20 28.58 68.39 32.96 30.44 82.94 73.46 -26.00 82.34 73.25 -23.96 coo 70.89 37.31 29.70 69.54 36.29 32.39 82.52 72.20 -31.52 80.97 69.57 -31.97 coo 66.09 40.54 34.70 66.92 37.69 35.49 76.65 78.50 -31.75 78.13 81.14 -31.78 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 11 3 # 11 A 581 GLU D 51 GLU^? 16.56 CL CL D 129 A 596 ARG D 46 ARG^? 15.13 CL CL D 129 A 647 ARG D 63 ARG^? 14.07 CL CL D 129 coo 69.13 32.20 28.58 68.39 32.96 30.44 66.99 68.03 -31.91 66.63 66.88 -33.67 coo 70.89 37.31 29.70 69.54 36.29 32.39 66.74 73.93 -35.00 66.45 71.02 -36.02 coo 66.09 40.54 34.70 66.92 37.69 35.49 72.33 73.68 -37.44 69.36 74.46 -37.99 1v0e_c00 source 1v0e ENDO-ALPHA-SIALIDASE : 11 hits 1v0e_c00 naa= 3 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 1 3 # 1 B 581 GLU A 23 GLU~? 24.22 CL CL A 129 B 596 ARG A 73 ARG.? 22.19 CL CL A 129 B 647 ARG A 96 ARG.? 24.34 CL CL A 129 coo 38.22 57.83 70.36 36.82 56.74 69.18 89.42 52.54 -84.47 88.08 53.22 -82.95 coo 34.24 60.89 68.08 33.31 57.93 67.63 83.82 53.79 -81.61 86.00 54.30 -79.51 coo 31.43 57.38 61.97 31.90 55.58 64.41 78.03 52.93 -81.60 80.41 52.60 -79.67 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 2 3 # 2 B 581 GLU A 51 GLU^? 16.44 CL CL A 129 B 596 ARG A 46 ARG^? 15.11 CL CL A 129 B 647 ARG A 63 ARG~? 13.95 CL CL A 129 coo 38.22 57.83 70.36 36.82 56.74 69.18 82.00 50.89 -67.09 80.89 51.23 -68.89 coo 34.24 60.89 68.08 33.31 57.93 67.63 87.96 51.20 -70.32 85.08 51.60 -71.34 coo 31.43 57.38 61.97 31.90 55.58 64.41 87.85 45.63 -72.60 88.58 48.58 -73.24 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 3 3 # 3 B 581 GLU A 57 GLU~? -5.56 CL CL A 129s B 596 ARG A 60 ARG~? 8.61 CL CL A 129 B 647 ARG A 63 ARG~? 13.95 CL CL A 129 coo 38.22 57.83 70.36 36.82 56.74 69.18 91.25 41.69 -61.23 91.08 41.09 -59.17 coo 34.24 60.89 68.08 33.31 57.93 67.63 92.49 41.37 -66.87 95.11 39.81 -67.06 coo 31.43 57.38 61.97 31.90 55.58 64.41 87.85 45.63 -72.60 88.58 48.58 -73.24 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 4 3 # 4 B 581 GLU B 23 GLU^? 24.68 CL CL B 129 B 596 ARG B 73 ARG^? 22.29 CL CL B 129 B 647 ARG B 96 ARG^? 24.18 CL CL B 129 coo 38.22 57.83 70.36 36.82 56.74 69.18 89.49 70.79 -56.44 87.96 70.01 -57.68 coo 34.24 60.89 68.08 33.31 57.93 67.63 83.86 69.55 -59.16 85.91 69.18 -61.42 coo 31.43 57.38 61.97 31.90 55.58 64.41 78.35 70.58 -59.29 80.55 70.83 -61.45 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 5 3 # 5 B 581 GLU B 51 GLU^? 16.46 CL CL B 129 B 596 ARG B 46 ARG^? 15.06 CL CL B 129 B 647 ARG B 63 ARG^? 13.99 CL CL B 129 coo 38.22 57.83 70.36 36.82 56.74 69.18 81.98 72.56 -73.89 80.95 72.05 -72.12 coo 34.24 60.89 68.08 33.31 57.93 67.63 87.96 72.13 -70.71 85.05 71.84 -69.78 coo 31.43 57.38 61.97 31.90 55.58 64.41 87.72 77.76 -68.29 88.60 74.86 -67.71 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 6 3 # 6 B 581 GLU B 57 GLU^? -5.29 CL CL B 129s B 596 ARG B 60 ARG^? 8.76 CL CL B 129 B 647 ARG B 63 ARG^? 13.99 CL CL B 129 coo 38.22 57.83 70.36 36.82 56.74 69.18 91.24 81.90 -79.46 91.48 82.48 -81.50 coo 34.24 60.89 68.08 33.31 57.93 67.63 92.45 82.18 -73.93 95.13 83.66 -73.65 coo 31.43 57.38 61.97 31.90 55.58 64.41 87.72 77.76 -68.29 88.60 74.86 -67.71 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 7 3 # 7 B 581 GLU C 23 GLU^? 24.69 CL CL C 129 B 596 ARG C 73 ARG^? 22.24 CL CL C 129 B 647 ARG C 96 ARG^? 24.31 CL CL C 129 coo 38.22 57.83 70.36 36.82 56.74 69.18 93.85 75.25 -49.20 94.57 76.88 -48.00 coo 34.24 60.89 68.08 33.31 57.93 67.63 95.26 80.79 -46.47 95.45 78.63 -44.29 coo 31.43 57.38 61.97 31.90 55.58 64.41 94.28 86.51 -46.29 94.08 84.26 -44.17 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 8 3 # 8 B 581 GLU C 51 GLU^? 16.39 CL CL C 129 B 596 ARG C 46 ARG^? 15.12 CL CL C 129 B 647 ARG C 63 ARG^? 14.10 CL CL C 129 coo 38.22 57.83 70.36 36.82 56.74 69.18 92.20 82.64 -31.68 92.61 83.59 -33.56 coo 34.24 60.89 68.08 33.31 57.93 67.63 92.47 76.70 -34.87 92.87 79.50 -36.04 coo 31.43 57.38 61.97 31.90 55.58 64.41 86.96 77.03 -37.50 89.89 76.13 -38.00 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 9 3 # 9 B 581 GLU C 57 GLU^? -5.48 CL CL C 129s B 596 ARG C 60 ARG^? 8.92 CL CL C 129 B 647 ARG C 63 ARG^? 14.10 CL CL C 129 coo 38.22 57.83 70.36 36.82 56.74 69.18 82.94 73.46 -26.00 82.34 73.25 -23.96 coo 34.24 60.89 68.08 33.31 57.93 67.63 82.52 72.20 -31.52 80.97 69.57 -31.97 coo 31.43 57.38 61.97 31.90 55.58 64.41 86.96 77.03 -37.50 89.89 76.13 -38.00 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 10 3 # 10 B 581 GLU C 57 GLU^? -5.48 CL CL C 129s B 596 ARG C 60 ARG^? 8.92 CL CL C 129 B 647 ARG D 60 ARG^? 8.57 CL CL D 129 coo 38.22 57.83 70.36 36.82 56.74 69.18 82.94 73.46 -26.00 82.34 73.25 -23.96 coo 34.24 60.89 68.08 33.31 57.93 67.63 82.52 72.20 -31.52 80.97 69.57 -31.97 coo 31.43 57.38 61.97 31.90 55.58 64.41 76.65 78.50 -31.75 78.13 81.14 -31.78 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 11 3 # 11 B 581 GLU D 51 GLU^? 16.56 CL CL D 129 B 596 ARG D 46 ARG^? 15.13 CL CL D 129 B 647 ARG D 63 ARG^? 14.07 CL CL D 129 coo 38.22 57.83 70.36 36.82 56.74 69.18 66.99 68.03 -31.91 66.63 66.88 -33.67 coo 34.24 60.89 68.08 33.31 57.93 67.63 66.74 73.93 -35.00 66.45 71.02 -36.02 coo 31.43 57.38 61.97 31.90 55.58 64.41 72.33 73.68 -37.44 69.36 74.46 -37.99 1v0e_c01 source 1v0e ENDO-ALPHA-SIALIDASE : 11 hits 1v0e_c01 naa= 3 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 1 3 # 1 C 581 GLU A 23 GLU~? 24.22 CL CL A 129 C 596 ARG A 73 ARG.? 22.19 CL CL A 129 C 647 ARG A 96 ARG.? 24.34 CL CL A 129 coo 11.31 31.26 27.00 13.31 30.71 26.58 89.42 52.54 -84.47 88.08 53.22 -82.95 coo 13.44 32.78 22.07 15.56 30.91 23.37 83.82 53.79 -81.61 86.00 54.30 -79.51 coo 21.00 33.35 22.82 19.83 30.82 24.09 78.03 52.93 -81.60 80.41 52.60 -79.67 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 2 3 # 2 C 581 GLU A 51 GLU^? 16.44 CL CL A 129 C 596 ARG A 46 ARG^? 15.11 CL CL A 129 C 647 ARG A 63 ARG~? 13.95 CL CL A 129 coo 11.31 31.26 27.00 13.31 30.71 26.58 82.00 50.89 -67.09 80.89 51.23 -68.89 coo 13.44 32.78 22.07 15.56 30.91 23.37 87.96 51.20 -70.32 85.08 51.60 -71.34 coo 21.00 33.35 22.82 19.83 30.82 24.09 87.85 45.63 -72.60 88.58 48.58 -73.24 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 3 3 # 3 C 581 GLU A 57 GLU~? -5.56 CL CL A 129s C 596 ARG A 60 ARG~? 8.61 CL CL A 129 C 647 ARG A 63 ARG~? 13.95 CL CL A 129 coo 11.31 31.26 27.00 13.31 30.71 26.58 91.25 41.69 -61.23 91.08 41.09 -59.17 coo 13.44 32.78 22.07 15.56 30.91 23.37 92.49 41.37 -66.87 95.11 39.81 -67.06 coo 21.00 33.35 22.82 19.83 30.82 24.09 87.85 45.63 -72.60 88.58 48.58 -73.24 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 4 3 # 4 C 581 GLU B 23 GLU^? 24.68 CL CL B 129 C 596 ARG B 73 ARG^? 22.29 CL CL B 129 C 647 ARG B 96 ARG^? 24.18 CL CL B 129 coo 11.31 31.26 27.00 13.31 30.71 26.58 89.49 70.79 -56.44 87.96 70.01 -57.68 coo 13.44 32.78 22.07 15.56 30.91 23.37 83.86 69.55 -59.16 85.91 69.18 -61.42 coo 21.00 33.35 22.82 19.83 30.82 24.09 78.35 70.58 -59.29 80.55 70.83 -61.45 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 5 3 # 5 C 581 GLU B 51 GLU^? 16.46 CL CL B 129 C 596 ARG B 46 ARG^? 15.06 CL CL B 129 C 647 ARG B 63 ARG^? 13.99 CL CL B 129 coo 11.31 31.26 27.00 13.31 30.71 26.58 81.98 72.56 -73.89 80.95 72.05 -72.12 coo 13.44 32.78 22.07 15.56 30.91 23.37 87.96 72.13 -70.71 85.05 71.84 -69.78 coo 21.00 33.35 22.82 19.83 30.82 24.09 87.72 77.76 -68.29 88.60 74.86 -67.71 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 6 3 # 6 C 581 GLU B 57 GLU^? -5.29 CL CL B 129s C 596 ARG B 60 ARG^? 8.76 CL CL B 129 C 647 ARG B 63 ARG^? 13.99 CL CL B 129 coo 11.31 31.26 27.00 13.31 30.71 26.58 91.24 81.90 -79.46 91.48 82.48 -81.50 coo 13.44 32.78 22.07 15.56 30.91 23.37 92.45 82.18 -73.93 95.13 83.66 -73.65 coo 21.00 33.35 22.82 19.83 30.82 24.09 87.72 77.76 -68.29 88.60 74.86 -67.71 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 7 3 # 7 C 581 GLU C 23 GLU^? 24.69 CL CL C 129 C 596 ARG C 73 ARG^? 22.24 CL CL C 129 C 647 ARG C 96 ARG^? 24.31 CL CL C 129 coo 11.31 31.26 27.00 13.31 30.71 26.58 93.85 75.25 -49.20 94.57 76.88 -48.00 coo 13.44 32.78 22.07 15.56 30.91 23.37 95.26 80.79 -46.47 95.45 78.63 -44.29 coo 21.00 33.35 22.82 19.83 30.82 24.09 94.28 86.51 -46.29 94.08 84.26 -44.17 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 8 3 # 8 C 581 GLU C 51 GLU^? 16.39 CL CL C 129 C 596 ARG C 46 ARG^? 15.12 CL CL C 129 C 647 ARG C 63 ARG^? 14.10 CL CL C 129 coo 11.31 31.26 27.00 13.31 30.71 26.58 92.20 82.64 -31.68 92.61 83.59 -33.56 coo 13.44 32.78 22.07 15.56 30.91 23.37 92.47 76.70 -34.87 92.87 79.50 -36.04 coo 21.00 33.35 22.82 19.83 30.82 24.09 86.96 77.03 -37.50 89.89 76.13 -38.00 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 9 3 # 9 C 581 GLU C 57 GLU^? -5.48 CL CL C 129s C 596 ARG C 60 ARG^? 8.92 CL CL C 129 C 647 ARG C 63 ARG^? 14.10 CL CL C 129 coo 11.31 31.26 27.00 13.31 30.71 26.58 82.94 73.46 -26.00 82.34 73.25 -23.96 coo 13.44 32.78 22.07 15.56 30.91 23.37 82.52 72.20 -31.52 80.97 69.57 -31.97 coo 21.00 33.35 22.82 19.83 30.82 24.09 86.96 77.03 -37.50 89.89 76.13 -38.00 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 10 3 # 10 C 581 GLU C 57 GLU^? -5.48 CL CL C 129s C 596 ARG C 60 ARG^? 8.92 CL CL C 129 C 647 ARG D 60 ARG^? 8.57 CL CL D 129 coo 11.31 31.26 27.00 13.31 30.71 26.58 82.94 73.46 -26.00 82.34 73.25 -23.96 coo 13.44 32.78 22.07 15.56 30.91 23.37 82.52 72.20 -31.52 80.97 69.57 -31.97 coo 21.00 33.35 22.82 19.83 30.82 24.09 76.65 78.50 -31.75 78.13 81.14 -31.78 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 11 3 # 11 C 581 GLU D 51 GLU^? 16.56 CL CL D 129 C 596 ARG D 46 ARG^? 15.13 CL CL D 129 C 647 ARG D 63 ARG^? 14.07 CL CL D 129 coo 11.31 31.26 27.00 13.31 30.71 26.58 66.99 68.03 -31.91 66.63 66.88 -33.67 coo 13.44 32.78 22.07 15.56 30.91 23.37 66.74 73.93 -35.00 66.45 71.02 -36.02 coo 21.00 33.35 22.82 19.83 30.82 24.09 72.33 73.68 -37.44 69.36 74.46 -37.99 1v0e_c02 source 1v0e ENDO-ALPHA-SIALIDASE : 11 hits 1v0e_c02 naa= 3 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 1 3 # 1 D 581 GLU A 23 GLU~? 24.22 CL CL A 129 D 596 ARG A 73 ARG.? 22.19 CL CL A 129 D 647 ARG A 96 ARG.? 24.34 CL CL A 129 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 89.42 52.54 -84.47 88.08 53.22 -82.95 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 83.82 53.79 -81.61 86.00 54.30 -79.51 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 78.03 52.93 -81.60 80.41 52.60 -79.67 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 2 3 # 2 D 581 GLU A 51 GLU^? 16.44 CL CL A 129 D 596 ARG A 46 ARG^? 15.11 CL CL A 129 D 647 ARG A 63 ARG~? 13.95 CL CL A 129 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 82.00 50.89 -67.09 80.89 51.23 -68.89 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 87.96 51.20 -70.32 85.08 51.60 -71.34 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 87.85 45.63 -72.60 88.58 48.58 -73.24 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 3 3 # 3 D 581 GLU A 57 GLU~? -5.56 CL CL A 129s D 596 ARG A 60 ARG~? 8.61 CL CL A 129 D 647 ARG A 63 ARG~? 13.95 CL CL A 129 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 91.25 41.69 -61.23 91.08 41.09 -59.17 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 92.49 41.37 -66.87 95.11 39.81 -67.06 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 87.85 45.63 -72.60 88.58 48.58 -73.24 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 4 3 # 4 D 581 GLU B 23 GLU^? 24.68 CL CL B 129 D 596 ARG B 73 ARG^? 22.29 CL CL B 129 D 647 ARG B 96 ARG^? 24.18 CL CL B 129 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 89.49 70.79 -56.44 87.96 70.01 -57.68 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 83.86 69.55 -59.16 85.91 69.18 -61.42 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 78.35 70.58 -59.29 80.55 70.83 -61.45 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 5 3 # 5 D 581 GLU B 51 GLU^? 16.46 CL CL B 129 D 596 ARG B 46 ARG^? 15.06 CL CL B 129 D 647 ARG B 63 ARG^? 13.99 CL CL B 129 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 81.98 72.56 -73.89 80.95 72.05 -72.12 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 87.96 72.13 -70.71 85.05 71.84 -69.78 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 87.72 77.76 -68.29 88.60 74.86 -67.71 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 6 3 # 6 D 581 GLU B 57 GLU^? -5.29 CL CL B 129s D 596 ARG B 60 ARG^? 8.76 CL CL B 129 D 647 ARG B 63 ARG^? 13.99 CL CL B 129 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 91.24 81.90 -79.46 91.48 82.48 -81.50 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 92.45 82.18 -73.93 95.13 83.66 -73.65 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 87.72 77.76 -68.29 88.60 74.86 -67.71 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 7 3 # 7 D 581 GLU C 23 GLU^? 24.69 CL CL C 129 D 596 ARG C 73 ARG^? 22.24 CL CL C 129 D 647 ARG C 96 ARG^? 24.31 CL CL C 129 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 93.85 75.25 -49.20 94.57 76.88 -48.00 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 95.26 80.79 -46.47 95.45 78.63 -44.29 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 94.28 86.51 -46.29 94.08 84.26 -44.17 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 8 3 # 8 D 581 GLU C 51 GLU^? 16.39 CL CL C 129 D 596 ARG C 46 ARG^? 15.12 CL CL C 129 D 647 ARG C 63 ARG^? 14.10 CL CL C 129 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 92.20 82.64 -31.68 92.61 83.59 -33.56 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 92.47 76.70 -34.87 92.87 79.50 -36.04 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 86.96 77.03 -37.50 89.89 76.13 -38.00 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 9 3 # 9 D 581 GLU C 57 GLU^? -5.48 CL CL C 129s D 596 ARG C 60 ARG^? 8.92 CL CL C 129 D 647 ARG C 63 ARG^? 14.10 CL CL C 129 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 82.94 73.46 -26.00 82.34 73.25 -23.96 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 82.52 72.20 -31.52 80.97 69.57 -31.97 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 86.96 77.03 -37.50 89.89 76.13 -38.00 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 10 3 # 10 D 581 GLU C 57 GLU^? -5.48 CL CL C 129s D 596 ARG C 60 ARG^? 8.92 CL CL C 129 D 647 ARG D 60 ARG^? 8.57 CL CL D 129 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 82.94 73.46 -26.00 82.34 73.25 -23.96 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 82.52 72.20 -31.52 80.97 69.57 -31.97 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 76.65 78.50 -31.75 78.13 81.14 -31.78 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 11 3 # 11 D 581 GLU D 51 GLU^? 16.56 CL CL D 129 D 596 ARG D 46 ARG^? 15.13 CL CL D 129 D 647 ARG D 63 ARG^? 14.07 CL CL D 129 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 66.99 68.03 -31.91 66.63 66.88 -33.67 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 66.74 73.93 -35.00 66.45 71.02 -36.02 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 72.33 73.68 -37.44 69.36 74.46 -37.99 1v0e_c03 source 1v0e ENDO-ALPHA-SIALIDASE : 11 hits 1v0e_c03 naa= 3 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 1 3 # 1 E 581 GLU A 23 GLU~? 24.22 CL CL A 129 E 596 ARG A 73 ARG.? 22.19 CL CL A 129 E 647 ARG A 96 ARG.? 24.34 CL CL A 129 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 89.42 52.54 -84.47 88.08 53.22 -82.95 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 83.82 53.79 -81.61 86.00 54.30 -79.51 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 78.03 52.93 -81.60 80.41 52.60 -79.67 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 2 3 # 2 E 581 GLU A 51 GLU^? 16.44 CL CL A 129 E 596 ARG A 46 ARG^? 15.11 CL CL A 129 E 647 ARG A 63 ARG~? 13.95 CL CL A 129 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 82.00 50.89 -67.09 80.89 51.23 -68.89 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 87.96 51.20 -70.32 85.08 51.60 -71.34 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 87.85 45.63 -72.60 88.58 48.58 -73.24 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 3 3 # 3 E 581 GLU A 57 GLU~? -5.56 CL CL A 129s E 596 ARG A 60 ARG~? 8.61 CL CL A 129 E 647 ARG A 63 ARG~? 13.95 CL CL A 129 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 91.25 41.69 -61.23 91.08 41.09 -59.17 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 92.49 41.37 -66.87 95.11 39.81 -67.06 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 87.85 45.63 -72.60 88.58 48.58 -73.24 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 4 3 # 4 E 581 GLU B 23 GLU^? 24.68 CL CL B 129 E 596 ARG B 73 ARG^? 22.29 CL CL B 129 E 647 ARG B 96 ARG^? 24.18 CL CL B 129 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 89.49 70.79 -56.44 87.96 70.01 -57.68 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 83.86 69.55 -59.16 85.91 69.18 -61.42 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 78.35 70.58 -59.29 80.55 70.83 -61.45 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 5 3 # 5 E 581 GLU B 51 GLU^? 16.46 CL CL B 129 E 596 ARG B 46 ARG^? 15.06 CL CL B 129 E 647 ARG B 63 ARG^? 13.99 CL CL B 129 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 81.98 72.56 -73.89 80.95 72.05 -72.12 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 87.96 72.13 -70.71 85.05 71.84 -69.78 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 87.72 77.76 -68.29 88.60 74.86 -67.71 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 6 3 # 6 E 581 GLU B 57 GLU^? -5.29 CL CL B 129s E 596 ARG B 60 ARG^? 8.76 CL CL B 129 E 647 ARG B 63 ARG^? 13.99 CL CL B 129 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 91.24 81.90 -79.46 91.48 82.48 -81.50 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 92.45 82.18 -73.93 95.13 83.66 -73.65 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 87.72 77.76 -68.29 88.60 74.86 -67.71 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 7 3 # 7 E 581 GLU C 23 GLU^? 24.69 CL CL C 129 E 596 ARG C 73 ARG^? 22.24 CL CL C 129 E 647 ARG C 96 ARG^? 24.31 CL CL C 129 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 93.85 75.25 -49.20 94.57 76.88 -48.00 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 95.26 80.79 -46.47 95.45 78.63 -44.29 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 94.28 86.51 -46.29 94.08 84.26 -44.17 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 8 3 # 8 E 581 GLU C 51 GLU^? 16.39 CL CL C 129 E 596 ARG C 46 ARG^? 15.12 CL CL C 129 E 647 ARG C 63 ARG^? 14.10 CL CL C 129 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 92.20 82.64 -31.68 92.61 83.59 -33.56 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 92.47 76.70 -34.87 92.87 79.50 -36.04 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 86.96 77.03 -37.50 89.89 76.13 -38.00 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 9 3 # 9 E 581 GLU C 57 GLU^? -5.48 CL CL C 129s E 596 ARG C 60 ARG^? 8.92 CL CL C 129 E 647 ARG C 63 ARG^? 14.10 CL CL C 129 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 82.94 73.46 -26.00 82.34 73.25 -23.96 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 82.52 72.20 -31.52 80.97 69.57 -31.97 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 86.96 77.03 -37.50 89.89 76.13 -38.00 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 10 3 # 10 E 581 GLU C 57 GLU^? -5.48 CL CL C 129s E 596 ARG C 60 ARG^? 8.92 CL CL C 129 E 647 ARG D 60 ARG^? 8.57 CL CL D 129 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 82.94 73.46 -26.00 82.34 73.25 -23.96 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 82.52 72.20 -31.52 80.97 69.57 -31.97 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 76.65 78.50 -31.75 78.13 81.14 -31.78 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 11 3 # 11 E 581 GLU D 51 GLU^? 16.56 CL CL D 129 E 596 ARG D 46 ARG^? 15.13 CL CL D 129 E 647 ARG D 63 ARG^? 14.07 CL CL D 129 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 66.99 68.03 -31.91 66.63 66.88 -33.67 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 66.74 73.93 -35.00 66.45 71.02 -36.02 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 72.33 73.68 -37.44 69.36 74.46 -37.99 1v0e_c04 source 1v0e ENDO-ALPHA-SIALIDASE : 11 hits 1v0e_c04 naa= 3 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 1 3 # 1 F 581 GLU A 23 GLU~? 24.22 CL CL A 129 F 596 ARG A 73 ARG.? 22.19 CL CL A 129 F 647 ARG A 96 ARG.? 24.34 CL CL A 129 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 89.42 52.54 -84.47 88.08 53.22 -82.95 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 83.82 53.79 -81.61 86.00 54.30 -79.51 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 78.03 52.93 -81.60 80.41 52.60 -79.67 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 2 3 # 2 F 581 GLU A 51 GLU^? 16.44 CL CL A 129 F 596 ARG A 46 ARG^? 15.11 CL CL A 129 F 647 ARG A 63 ARG~? 13.95 CL CL A 129 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 82.00 50.89 -67.09 80.89 51.23 -68.89 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 87.96 51.20 -70.32 85.08 51.60 -71.34 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 87.85 45.63 -72.60 88.58 48.58 -73.24 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 3 3 # 3 F 581 GLU A 57 GLU~? -5.56 CL CL A 129s F 596 ARG A 60 ARG~? 8.61 CL CL A 129 F 647 ARG A 63 ARG~? 13.95 CL CL A 129 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 91.25 41.69 -61.23 91.08 41.09 -59.17 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 92.49 41.37 -66.87 95.11 39.81 -67.06 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 87.85 45.63 -72.60 88.58 48.58 -73.24 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 4 3 # 4 F 581 GLU B 23 GLU^? 24.68 CL CL B 129 F 596 ARG B 73 ARG^? 22.29 CL CL B 129 F 647 ARG B 96 ARG^? 24.18 CL CL B 129 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 89.49 70.79 -56.44 87.96 70.01 -57.68 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 83.86 69.55 -59.16 85.91 69.18 -61.42 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 78.35 70.58 -59.29 80.55 70.83 -61.45 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 5 3 # 5 F 581 GLU B 51 GLU^? 16.46 CL CL B 129 F 596 ARG B 46 ARG^? 15.06 CL CL B 129 F 647 ARG B 63 ARG^? 13.99 CL CL B 129 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 81.98 72.56 -73.89 80.95 72.05 -72.12 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 87.96 72.13 -70.71 85.05 71.84 -69.78 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 87.72 77.76 -68.29 88.60 74.86 -67.71 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 6 3 # 6 F 581 GLU B 57 GLU^? -5.29 CL CL B 129s F 596 ARG B 60 ARG^? 8.76 CL CL B 129 F 647 ARG B 63 ARG^? 13.99 CL CL B 129 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 91.24 81.90 -79.46 91.48 82.48 -81.50 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 92.45 82.18 -73.93 95.13 83.66 -73.65 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 87.72 77.76 -68.29 88.60 74.86 -67.71 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 7 3 # 7 F 581 GLU C 23 GLU^? 24.69 CL CL C 129 F 596 ARG C 73 ARG^? 22.24 CL CL C 129 F 647 ARG C 96 ARG^? 24.31 CL CL C 129 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 93.85 75.25 -49.20 94.57 76.88 -48.00 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 95.26 80.79 -46.47 95.45 78.63 -44.29 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 94.28 86.51 -46.29 94.08 84.26 -44.17 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 8 3 # 8 F 581 GLU C 51 GLU^? 16.39 CL CL C 129 F 596 ARG C 46 ARG^? 15.12 CL CL C 129 F 647 ARG C 63 ARG^? 14.10 CL CL C 129 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 92.20 82.64 -31.68 92.61 83.59 -33.56 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 92.47 76.70 -34.87 92.87 79.50 -36.04 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 86.96 77.03 -37.50 89.89 76.13 -38.00 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 9 3 # 9 F 581 GLU C 57 GLU^? -5.48 CL CL C 129s F 596 ARG C 60 ARG^? 8.92 CL CL C 129 F 647 ARG C 63 ARG^? 14.10 CL CL C 129 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 82.94 73.46 -26.00 82.34 73.25 -23.96 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 82.52 72.20 -31.52 80.97 69.57 -31.97 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 86.96 77.03 -37.50 89.89 76.13 -38.00 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 10 3 # 10 F 581 GLU C 57 GLU^? -5.48 CL CL C 129s F 596 ARG C 60 ARG^? 8.92 CL CL C 129 F 647 ARG D 60 ARG^? 8.57 CL CL D 129 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 82.94 73.46 -26.00 82.34 73.25 -23.96 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 82.52 72.20 -31.52 80.97 69.57 -31.97 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 76.65 78.50 -31.75 78.13 81.14 -31.78 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 11 3 # 11 F 581 GLU D 51 GLU^? 16.56 CL CL D 129 F 596 ARG D 46 ARG^? 15.13 CL CL D 129 F 647 ARG D 63 ARG^? 14.07 CL CL D 129 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 66.99 68.03 -31.91 66.63 66.88 -33.67 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 66.74 73.93 -35.00 66.45 71.02 -36.02 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 72.33 73.68 -37.44 69.36 74.46 -37.99 1v0e_c05 source 1v0e ENDO-ALPHA-SIALIDASE : 11 hits 1v0e_c05 naa= 3 ULMN 3 1vom_c00 MYOSIN user 1 3 # 1 233 ASN A 52 ASN^? 15.85 CL CL A 129 457 GLY A 55 GLY~? -3.63 CL CL A 129s 459 GLU A 58 GLU~? 7.41 CL CL A 129 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 83.96 54.83 -62.44 82.65 56.42 -62.87 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 92.85 48.69 -62.18 92.25 48.83 -62.75 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 87.85 46.74 -60.89 87.27 48.56 -59.93 ULMN 3 1vom_c00 MYOSIN user 2 3 # 2 233 ASN B 52 ASN^? 15.82 CL CL B 129 457 GLY B 55 GLY^? 3.74 CL CL B 129 459 GLU B 58 GLU^? 7.34 CL CL B 129 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 83.95 68.72 -78.66 82.81 66.95 -78.31 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 92.76 74.76 -78.82 92.18 74.63 -78.24 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 87.90 76.66 -80.19 87.42 74.86 -81.30 ULMN 3 1vom_c00 MYOSIN user 3 3 # 3 233 ASN C 52 ASN^? 15.85 CL CL C 129 457 GLY C 55 GLY^? -3.60 CL CL C 129s 459 GLU C 58 GLU^? 7.49 CL CL C 129 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 96.20 80.63 -27.08 97.82 81.88 -27.59 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 90.01 71.78 -26.77 90.18 72.34 -27.33 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 88.02 76.82 -25.55 89.85 77.43 -24.60 ULMN 3 1vom_c00 MYOSIN user 4 3 # 4 233 ASN D 52 ASN^? 15.83 CL CL D 129 457 GLY D 55 GLY^? -3.63 CL CL D 129s 459 GLU D 58 GLU^? 7.39 CL CL D 129 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 63.25 69.92 -27.12 61.56 68.74 -27.55 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 69.35 78.74 -26.78 69.17 78.19 -27.38 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 71.21 74.03 -25.57 69.46 73.32 -24.61 1vom_c00 source 1vom MYOSIN : 4 hits 1vom_c00 naa= 3 ULMN 3 1vzx_c02 2.04.01.0087 user 1 3 # 1 A 314 TYR A 22 TYR~? 17.56 CL CL A 129 A 317 GLU A 23 GLU~? 24.22 CL CL A 129 A 365 ARG A 66 ARG~? 18.83 CL CL A 129 coo 1.77 6.56 57.05 3.05 7.44 59.37 92.72 50.62 -78.45 90.87 50.50 -76.41 coo 3.06 2.85 52.79 4.83 3.89 53.24 89.42 52.54 -84.47 88.08 53.22 -82.95 coo 3.82 17.09 49.56 4.09 14.32 50.84 82.10 46.84 -74.28 82.78 49.65 -75.31 ULMN 3 1vzx_c02 2.04.01.0087 user 2 3 # 2 A 314 TYR B 20 TYR^? 23.21 CL CL A 129 A 317 GLU B 23 GLU^? 24.68 CL CL B 129 A 365 ARG C 73 ARG^? 22.24 CL CL C 129 coo 1.77 6.56 57.05 3.05 7.44 59.37 94.47 69.13 -54.42 93.73 66.50 -53.85 coo 3.06 2.85 52.79 4.83 3.89 53.24 89.49 70.79 -56.44 87.96 70.01 -57.68 coo 3.82 17.09 49.56 4.09 14.32 50.84 95.26 80.79 -46.47 95.45 78.63 -44.29 ULMN 3 1vzx_c02 2.04.01.0087 user 3 3 # 3 A 314 TYR B 22 TYR^? 17.56 CL CL B 129 A 317 GLU B 23 GLU^? 24.68 CL CL B 129 A 365 ARG B 66 ARG^? 19.13 CL CL B 129 coo 1.77 6.56 57.05 3.05 7.44 59.37 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 3.06 2.85 52.79 4.83 3.89 53.24 89.49 70.79 -56.44 87.96 70.01 -57.68 coo 3.82 17.09 49.56 4.09 14.32 50.84 82.06 76.49 -66.55 82.68 73.67 -65.41 ULMN 3 1vzx_c02 2.04.01.0087 user 4 3 # 4 A 314 TYR C 20 TYR^? 26.72 CL CL A 129 A 317 GLU C 23 GLU^? 24.69 CL CL C 129 A 365 ARG B 73 ARG^? 22.29 CL CL B 129 coo 1.77 6.56 57.05 3.05 7.44 59.37 95.56 70.07 -51.22 98.17 70.86 -51.76 coo 3.06 2.85 52.79 4.83 3.89 53.24 93.85 75.25 -49.20 94.57 76.88 -48.00 coo 3.82 17.09 49.56 4.09 14.32 50.84 83.86 69.55 -59.16 85.91 69.18 -61.42 ULMN 3 1vzx_c02 2.04.01.0087 user 5 3 # 5 A 314 TYR C 22 TYR^? 17.52 CL CL C 129 A 317 GLU C 23 GLU^? 24.69 CL CL C 129 A 365 ARG C 66 ARG^? 18.88 CL CL C 129 coo 1.77 6.56 57.05 3.05 7.44 59.37 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 3.06 2.85 52.79 4.83 3.89 53.24 93.85 75.25 -49.20 94.57 76.88 -48.00 coo 3.82 17.09 49.56 4.09 14.32 50.84 88.18 82.59 -38.84 90.98 81.94 -39.92 ULMN 3 1vzx_c02 2.04.01.0087 user 6 3 # 6 A 314 TYR D 22 TYR^? 17.52 CL CL D 129 A 317 GLU D 23 GLU^? 24.49 CL CL D 129 A 365 ARG D 66 ARG^? 18.85 CL CL D 129 coo 1.77 6.56 57.05 3.05 7.44 59.37 67.44 78.74 -43.16 67.49 76.94 -41.01 coo 3.06 2.85 52.79 4.83 3.89 53.24 65.41 75.40 -49.12 64.81 73.78 -47.86 coo 3.82 17.09 49.56 4.09 14.32 50.84 71.05 68.08 -38.82 68.22 68.66 -39.87 1vzx_c02 source 1vzx 2.04.01.0087 : 6 hits 1vzx_c02 naa= 3 ULMN 3 1vzx_c03 2.04.01.0087 user 1 3 # 1 B1314 TYR A 22 TYR~? 17.56 CL CL A 129 B1317 GLU A 23 GLU~? 24.22 CL CL A 129 B1365 ARG A 66 ARG~? 18.83 CL CL A 129 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 92.72 50.62 -78.45 90.87 50.50 -76.41 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 89.42 52.54 -84.47 88.08 53.22 -82.95 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 82.10 46.84 -74.28 82.78 49.65 -75.31 ULMN 3 1vzx_c03 2.04.01.0087 user 2 3 # 2 B1314 TYR B 20 TYR^? 23.21 CL CL A 129 B1317 GLU B 23 GLU^? 24.68 CL CL B 129 B1365 ARG C 73 ARG^? 22.24 CL CL C 129 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 94.47 69.13 -54.42 93.73 66.50 -53.85 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 89.49 70.79 -56.44 87.96 70.01 -57.68 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 95.26 80.79 -46.47 95.45 78.63 -44.29 ULMN 3 1vzx_c03 2.04.01.0087 user 3 3 # 3 B1314 TYR B 22 TYR^? 17.56 CL CL B 129 B1317 GLU B 23 GLU^? 24.68 CL CL B 129 B1365 ARG B 66 ARG^? 19.13 CL CL B 129 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 89.49 70.79 -56.44 87.96 70.01 -57.68 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 82.06 76.49 -66.55 82.68 73.67 -65.41 ULMN 3 1vzx_c03 2.04.01.0087 user 4 3 # 4 B1314 TYR C 20 TYR^? 26.72 CL CL A 129 B1317 GLU C 23 GLU^? 24.69 CL CL C 129 B1365 ARG B 73 ARG^? 22.29 CL CL B 129 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 95.56 70.07 -51.22 98.17 70.86 -51.76 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 93.85 75.25 -49.20 94.57 76.88 -48.00 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 83.86 69.55 -59.16 85.91 69.18 -61.42 ULMN 3 1vzx_c03 2.04.01.0087 user 5 3 # 5 B1314 TYR C 22 TYR^? 17.52 CL CL C 129 B1317 GLU C 23 GLU^? 24.69 CL CL C 129 B1365 ARG C 66 ARG^? 18.88 CL CL C 129 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 93.85 75.25 -49.20 94.57 76.88 -48.00 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 88.18 82.59 -38.84 90.98 81.94 -39.92 ULMN 3 1vzx_c03 2.04.01.0087 user 6 3 # 6 B1314 TYR D 22 TYR^? 17.52 CL CL D 129 B1317 GLU D 23 GLU^? 24.49 CL CL D 129 B1365 ARG D 66 ARG^? 18.85 CL CL D 129 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 67.44 78.74 -43.16 67.49 76.94 -41.01 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 65.41 75.40 -49.12 64.81 73.78 -47.86 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 71.05 68.08 -38.82 68.22 68.66 -39.87 1vzx_c03 source 1vzx 2.04.01.0087 : 6 hits 1vzx_c03 naa= 3 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 1 3 # 1 A 16 TYR A 22 TYR~? 17.56 CL CL A 129 A 40 ASP A 30 ASP~? 20.80 CL CL A 129 A 103 LEU A 26 LEU~? 19.99 CL CL A 129 coo 12.09 16.13 10.57 11.28 18.80 10.73 92.72 50.62 -78.45 90.87 50.50 -76.41 coo 7.55 25.51 14.34 9.65 25.73 14.24 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 11.83 18.73 16.99 10.99 19.71 15.26 87.88 49.17 -79.75 86.71 50.33 -78.46 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 2 3 # 2 A 16 TYR A 22 TYR~? 17.56 CL CL A 129 A 40 ASP A 30 ASP~? 20.80 CL CL A 129 A 103 LEU A 37 LEU~? 16.93 CL CL A 129 coo 12.09 16.13 10.57 11.28 18.80 10.73 92.72 50.62 -78.45 90.87 50.50 -76.41 coo 7.55 25.51 14.34 9.65 25.73 14.24 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 11.83 18.73 16.99 10.99 19.71 15.26 96.51 48.08 -76.23 97.22 47.90 -78.26 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 3 3 # 3 A 16 TYR A 22 TYR~? 17.56 CL CL A 129 A 40 ASP A 35 ASP~? 10.31 CL CL A 129 A 103 LEU A 37 LEU~? 16.93 CL CL A 129 coo 12.09 16.13 10.57 11.28 18.80 10.73 92.72 50.62 -78.45 90.87 50.50 -76.41 coo 7.55 25.51 14.34 9.65 25.73 14.24 93.79 42.35 -72.20 94.79 41.97 -70.38 coo 11.83 18.73 16.99 10.99 19.71 15.26 96.51 48.08 -76.23 97.22 47.90 -78.26 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 4 3 # 4 A 16 TYR B 22 TYR^? 17.56 CL CL B 129 A 40 ASP B 30 ASP^? 20.91 CL CL B 129 A 103 LEU B 26 LEU^? 19.82 CL CL B 129 coo 12.09 16.13 10.57 11.28 18.80 10.73 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 7.55 25.51 14.34 9.65 25.73 14.24 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 11.83 18.73 16.99 10.99 19.71 15.26 87.80 74.11 -61.25 86.89 73.13 -62.91 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 5 3 # 5 A 16 TYR B 22 TYR^? 17.56 CL CL B 129 A 40 ASP B 30 ASP^? 20.91 CL CL B 129 A 103 LEU B 37 LEU^? 16.91 CL CL B 129 coo 12.09 16.13 10.57 11.28 18.80 10.73 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 7.55 25.51 14.34 9.65 25.73 14.24 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 11.83 18.73 16.99 10.99 19.71 15.26 96.50 75.38 -64.79 97.32 75.47 -62.77 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 6 3 # 6 A 16 TYR B 22 TYR^? 17.56 CL CL B 129 A 40 ASP B 35 ASP^? 10.19 CL CL B 129 A 103 LEU B 37 LEU^? 16.91 CL CL B 129 coo 12.09 16.13 10.57 11.28 18.80 10.73 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 7.55 25.51 14.34 9.65 25.73 14.24 93.79 80.98 -68.72 94.61 81.32 -70.62 coo 11.83 18.73 16.99 10.99 19.71 15.26 96.50 75.38 -64.79 97.32 75.47 -62.77 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 7 3 # 7 A 16 TYR C 22 TYR^? 17.52 CL CL C 129 A 40 ASP C 30 ASP^? 20.67 CL CL C 129 A 103 LEU C 26 LEU^? 19.92 CL CL C 129 coo 12.09 16.13 10.57 11.28 18.80 10.73 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 7.55 25.51 14.34 9.65 25.73 14.24 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 11.83 18.73 16.99 10.99 19.71 15.26 90.57 76.76 -44.41 91.64 77.85 -42.91 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 8 3 # 8 A 16 TYR C 22 TYR^? 17.52 CL CL C 129 A 40 ASP C 30 ASP^? 20.67 CL CL C 129 A 103 LEU C 37 LEU^? 16.94 CL CL C 129 coo 12.09 16.13 10.57 11.28 18.80 10.73 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 7.55 25.51 14.34 9.65 25.73 14.24 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 11.83 18.73 16.99 10.99 19.71 15.26 89.29 68.10 -40.88 89.21 67.27 -42.93 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 9 3 # 9 A 16 TYR C 22 TYR^? 17.52 CL CL C 129 A 40 ASP C 35 ASP^? 10.26 CL CL C 129 A 103 LEU C 37 LEU^? 16.94 CL CL C 129 coo 12.09 16.13 10.57 11.28 18.80 10.73 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 7.55 25.51 14.34 9.65 25.73 14.24 83.63 70.73 -36.85 83.32 69.81 -34.96 coo 11.83 18.73 16.99 10.99 19.71 15.26 89.29 68.10 -40.88 89.21 67.27 -42.93 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 10 3 # 10 A 16 TYR D 22 TYR^? 17.52 CL CL D 129 A 40 ASP D 30 ASP^? 20.62 CL CL D 129 A 103 LEU D 26 LEU^? 19.77 CL CL D 129 coo 12.09 16.13 10.57 11.28 18.80 10.73 67.44 78.74 -43.16 67.49 76.94 -41.01 coo 7.55 25.51 14.34 9.65 25.73 14.24 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 11.83 18.73 16.99 10.99 19.71 15.26 68.83 73.84 -44.31 67.67 72.87 -42.84 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 11 3 # 11 A 16 TYR D 22 TYR^? 17.52 CL CL D 129 A 40 ASP D 30 ASP^? 20.62 CL CL D 129 A 103 LEU D 37 LEU^? 16.93 CL CL D 129 coo 12.09 16.13 10.57 11.28 18.80 10.73 67.44 78.74 -43.16 67.49 76.94 -41.01 coo 7.55 25.51 14.34 9.65 25.73 14.24 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 11.83 18.73 16.99 10.99 19.71 15.26 69.99 82.51 -40.93 70.04 83.48 -42.91 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 12 3 # 12 A 16 TYR D 22 TYR^? 17.52 CL CL D 129 A 40 ASP D 35 ASP^? 10.18 CL CL D 129 A 103 LEU D 37 LEU^? 16.93 CL CL D 129 coo 12.09 16.13 10.57 11.28 18.80 10.73 67.44 78.74 -43.16 67.49 76.94 -41.01 coo 7.55 25.51 14.34 9.65 25.73 14.24 75.66 79.96 -36.93 75.99 80.66 -34.97 coo 11.83 18.73 16.99 10.99 19.71 15.26 69.99 82.51 -40.93 70.04 83.48 -42.91 1vzz_c00 source 1vzz STEROID DELTA-ISOMERASE : 12 hits 1vzz_c00 naa= 3 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 1 3 # 1 B 16 TYR A 22 TYR~? 17.56 CL CL A 129 B 40 ASP A 30 ASP~? 20.80 CL CL A 129 B 103 LEU A 26 LEU~? 19.99 CL CL A 129 coo 14.25 20.09 37.35 13.48 17.40 37.38 92.72 50.62 -78.45 90.87 50.50 -76.41 coo 9.39 10.77 34.53 11.50 10.63 34.41 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 12.89 17.60 31.13 12.34 16.51 32.90 87.88 49.17 -79.75 86.71 50.33 -78.46 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 2 3 # 2 B 16 TYR A 22 TYR~? 17.56 CL CL A 129 B 40 ASP A 30 ASP~? 20.80 CL CL A 129 B 103 LEU A 34 LEU~? 15.98 CL CL A 129 coo 14.25 20.09 37.35 13.48 17.40 37.38 92.72 50.62 -78.45 90.87 50.50 -76.41 coo 9.39 10.77 34.53 11.50 10.63 34.41 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 12.89 17.60 31.13 12.34 16.51 32.90 90.86 45.34 -75.60 89.25 46.18 -76.85 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 3 3 # 3 B 16 TYR A 22 TYR~? 17.56 CL CL A 129 B 40 ASP A 30 ASP~? 20.80 CL CL A 129 B 103 LEU A 37 LEU~? 16.93 CL CL A 129 coo 14.25 20.09 37.35 13.48 17.40 37.38 92.72 50.62 -78.45 90.87 50.50 -76.41 coo 9.39 10.77 34.53 11.50 10.63 34.41 90.38 41.71 -80.87 92.04 40.39 -80.79 coo 12.89 17.60 31.13 12.34 16.51 32.90 96.51 48.08 -76.23 97.22 47.90 -78.26 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 4 3 # 4 B 16 TYR A 22 TYR~? 17.56 CL CL A 129 B 40 ASP A 35 ASP~? 10.31 CL CL A 129 B 103 LEU A 37 LEU~? 16.93 CL CL A 129 coo 14.25 20.09 37.35 13.48 17.40 37.38 92.72 50.62 -78.45 90.87 50.50 -76.41 coo 9.39 10.77 34.53 11.50 10.63 34.41 93.79 42.35 -72.20 94.79 41.97 -70.38 coo 12.89 17.60 31.13 12.34 16.51 32.90 96.51 48.08 -76.23 97.22 47.90 -78.26 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 5 3 # 5 B 16 TYR B 22 TYR^? 17.56 CL CL B 129 B 40 ASP B 30 ASP^? 20.91 CL CL B 129 B 103 LEU B 26 LEU^? 19.82 CL CL B 129 coo 14.25 20.09 37.35 13.48 17.40 37.38 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 9.39 10.77 34.53 11.50 10.63 34.41 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 12.89 17.60 31.13 12.34 16.51 32.90 87.80 74.11 -61.25 86.89 73.13 -62.91 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 6 3 # 6 B 16 TYR B 22 TYR^? 17.56 CL CL B 129 B 40 ASP B 30 ASP^? 20.91 CL CL B 129 B 103 LEU B 37 LEU^? 16.91 CL CL B 129 coo 14.25 20.09 37.35 13.48 17.40 37.38 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 9.39 10.77 34.53 11.50 10.63 34.41 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 12.89 17.60 31.13 12.34 16.51 32.90 96.50 75.38 -64.79 97.32 75.47 -62.77 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 7 3 # 7 B 16 TYR B 22 TYR^? 17.56 CL CL B 129 B 40 ASP B 35 ASP^? 10.19 CL CL B 129 B 103 LEU B 37 LEU^? 16.91 CL CL B 129 coo 14.25 20.09 37.35 13.48 17.40 37.38 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 9.39 10.77 34.53 11.50 10.63 34.41 93.79 80.98 -68.72 94.61 81.32 -70.62 coo 12.89 17.60 31.13 12.34 16.51 32.90 96.50 75.38 -64.79 97.32 75.47 -62.77 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 8 3 # 8 B 16 TYR C 22 TYR^? 17.52 CL CL C 129 B 40 ASP C 30 ASP^? 20.67 CL CL C 129 B 103 LEU C 26 LEU^? 19.92 CL CL C 129 coo 14.25 20.09 37.35 13.48 17.40 37.38 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 9.39 10.77 34.53 11.50 10.63 34.41 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 12.89 17.60 31.13 12.34 16.51 32.90 90.57 76.76 -44.41 91.64 77.85 -42.91 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 9 3 # 9 B 16 TYR C 22 TYR^? 17.52 CL CL C 129 B 40 ASP C 30 ASP^? 20.67 CL CL C 129 B 103 LEU C 37 LEU^? 16.94 CL CL C 129 coo 14.25 20.09 37.35 13.48 17.40 37.38 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 9.39 10.77 34.53 11.50 10.63 34.41 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 12.89 17.60 31.13 12.34 16.51 32.90 89.29 68.10 -40.88 89.21 67.27 -42.93 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 10 3 # 10 B 16 TYR C 22 TYR^? 17.52 CL CL C 129 B 40 ASP C 35 ASP^? 10.26 CL CL C 129 B 103 LEU C 37 LEU^? 16.94 CL CL C 129 coo 14.25 20.09 37.35 13.48 17.40 37.38 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 9.39 10.77 34.53 11.50 10.63 34.41 83.63 70.73 -36.85 83.32 69.81 -34.96 coo 12.89 17.60 31.13 12.34 16.51 32.90 89.29 68.10 -40.88 89.21 67.27 -42.93 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 11 3 # 11 B 16 TYR D 22 TYR^? 17.52 CL CL D 129 B 40 ASP D 30 ASP^? 20.62 CL CL D 129 B 103 LEU D 26 LEU^? 19.77 CL CL D 129 coo 14.25 20.09 37.35 13.48 17.40 37.38 67.44 78.74 -43.16 67.49 76.94 -41.01 coo 9.39 10.77 34.53 11.50 10.63 34.41 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 12.89 17.60 31.13 12.34 16.51 32.90 68.83 73.84 -44.31 67.67 72.87 -42.84 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 12 3 # 12 B 16 TYR D 22 TYR^? 17.52 CL CL D 129 B 40 ASP D 30 ASP^? 20.62 CL CL D 129 B 103 LEU D 37 LEU^? 16.93 CL CL D 129 coo 14.25 20.09 37.35 13.48 17.40 37.38 67.44 78.74 -43.16 67.49 76.94 -41.01 coo 9.39 10.77 34.53 11.50 10.63 34.41 76.16 76.40 -45.40 77.49 78.05 -45.35 coo 12.89 17.60 31.13 12.34 16.51 32.90 69.99 82.51 -40.93 70.04 83.48 -42.91 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 13 3 # 13 B 16 TYR D 22 TYR^? 17.52 CL CL D 129 B 40 ASP D 35 ASP^? 10.18 CL CL D 129 B 103 LEU D 37 LEU^? 16.93 CL CL D 129 coo 14.25 20.09 37.35 13.48 17.40 37.38 67.44 78.74 -43.16 67.49 76.94 -41.01 coo 9.39 10.77 34.53 11.50 10.63 34.41 75.66 79.96 -36.93 75.99 80.66 -34.97 coo 12.89 17.60 31.13 12.34 16.51 32.90 69.99 82.51 -40.93 70.04 83.48 -42.91 1vzz_c01 source 1vzz STEROID DELTA-ISOMERASE : 13 hits 1vzz_c01 naa= 3 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 B 124 ALA A 25 ALA~? 20.03 CL CL A 129 B 126 ARG A 63 ARG~? 13.95 CL CL A 129 B 138 GLU A 23 GLU~? 24.22 CL CL A 129 coo 2.11 4.00 19.31 3.14 4.86 19.99 90.53 45.57 -81.64 91.65 45.42 -80.63 coo 2.45 5.53 11.28 3.59 7.56 13.29 87.85 45.63 -72.60 88.58 48.58 -73.24 coo 6.10 2.00 25.24 6.12 1.84 23.13 89.42 52.54 -84.47 88.08 53.22 -82.95 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 B 124 ALA A 49 ALA.? 20.89 CL CL A 129 B 126 ARG A 104 ARG^? 18.53 CL CL B 129 B 138 GLU A 51 GLU^? 16.44 CL CL A 129 coo 2.11 4.00 19.31 3.14 4.86 19.99 80.14 55.77 -70.80 79.39 55.32 -72.04 coo 2.45 5.53 11.28 3.59 7.56 13.29 82.19 63.80 -76.53 82.09 65.30 -73.83 coo 6.10 2.00 25.24 6.12 1.84 23.13 82.00 50.89 -67.09 80.89 51.23 -68.89 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 B 124 ALA A 74 ALA^? 25.51 CL CL B 129 B 126 ARG A 76 ARG^? 19.15 CL CL B 129 B 138 GLU A 23 GLU~? 24.22 CL CL A 129 coo 2.11 4.00 19.31 3.14 4.86 19.99 83.09 56.12 -87.11 82.22 56.78 -88.15 coo 2.45 5.53 11.28 3.59 7.56 13.29 82.62 63.89 -86.56 80.46 65.21 -84.78 coo 6.10 2.00 25.24 6.12 1.84 23.13 89.42 52.54 -84.47 88.08 53.22 -82.95 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 B 124 ALA B 25 ALA^? 19.89 CL CL B 129 B 126 ARG B 63 ARG^? 13.99 CL CL B 129 B 138 GLU B 23 GLU^? 24.68 CL CL B 129 coo 2.11 4.00 19.31 3.14 4.86 19.99 90.54 77.68 -59.46 91.65 77.73 -60.49 coo 2.45 5.53 11.28 3.59 7.56 13.29 87.72 77.76 -68.29 88.60 74.86 -67.71 coo 6.10 2.00 25.24 6.12 1.84 23.13 89.49 70.79 -56.44 87.96 70.01 -57.68 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 3 # 5 B 124 ALA B 49 ALA^? 20.99 CL CL B 129 B 126 ARG B 104 ARG^? 18.51 CL CL A 129 B 138 GLU B 51 GLU^? 16.46 CL CL B 129 coo 2.11 4.00 19.31 3.14 4.86 19.99 80.08 67.54 -70.23 79.32 68.03 -68.99 coo 2.45 5.53 11.28 3.59 7.56 13.29 82.09 59.72 -64.70 82.21 58.19 -67.39 coo 6.10 2.00 25.24 6.12 1.84 23.13 81.98 72.56 -73.89 80.95 72.05 -72.12 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 3 # 6 B 124 ALA B 74 ALA^? 25.18 CL CL A 129 B 126 ARG B 76 ARG^? 18.98 CL CL A 129 B 138 GLU B 23 GLU^? 24.68 CL CL B 129 coo 2.11 4.00 19.31 3.14 4.86 19.99 83.11 67.09 -53.84 82.12 66.37 -52.99 coo 2.45 5.53 11.28 3.59 7.56 13.29 82.73 59.03 -54.76 80.31 57.91 -56.24 coo 6.10 2.00 25.24 6.12 1.84 23.13 89.49 70.79 -56.44 87.96 70.01 -57.68 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 3 # 7 B 124 ALA C 25 ALA^? 19.84 CL CL C 129 B 126 ARG C 63 ARG^? 14.10 CL CL C 129 B 138 GLU C 23 GLU^? 24.69 CL CL C 129 coo 2.11 4.00 19.31 3.14 4.86 19.99 86.92 74.08 -46.13 86.92 72.96 -45.09 coo 2.45 5.53 11.28 3.59 7.56 13.29 86.96 77.03 -37.50 89.89 76.13 -38.00 coo 6.10 2.00 25.24 6.12 1.84 23.13 93.85 75.25 -49.20 94.57 76.88 -48.00 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 3 # 8 B 124 ALA C 32 ALA^? 17.45 CL CL C 129 B 126 ARG D 63 ARG^? 14.07 CL CL D 129 B 138 GLU C 36 GLU^? 18.27 CL CL C 129 coo 2.11 4.00 19.31 3.14 4.86 19.99 81.13 71.60 -40.52 79.93 71.23 -41.37 coo 2.45 5.53 11.28 3.59 7.56 13.29 72.33 73.68 -37.44 69.36 74.46 -37.99 coo 6.10 2.00 25.24 6.12 1.84 23.13 84.85 65.27 -40.53 84.47 64.86 -42.56 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 9 3 # 9 B 124 ALA C 49 ALA^? 20.87 CL CL C 129 B 126 ARG C 104 ARG^? 26.38 CL CL C 129 B 138 GLU C 51 GLU^? 16.39 CL CL C 129 coo 2.11 4.00 19.31 3.14 4.86 19.99 97.10 84.42 -35.47 96.69 85.13 -36.72 coo 2.45 5.53 11.28 3.59 7.56 13.29 105.08 82.46 -41.08 106.56 82.47 -38.36 coo 6.10 2.00 25.24 6.12 1.84 23.13 92.20 82.64 -31.68 92.61 83.59 -33.56 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 10 3 # 10 B 124 ALA C 61 ALA^? 9.90 CL CL C 129 B 126 ARG C 46 ARG^? 15.12 CL CL C 129 B 138 GLU C 57 GLU^? -5.48 CL CL C 129s coo 2.11 4.00 19.31 3.14 4.86 19.99 83.43 78.79 -30.72 83.83 79.14 -29.32 coo 2.45 5.53 11.28 3.59 7.56 13.29 92.47 76.70 -34.87 92.87 79.50 -36.04 coo 6.10 2.00 25.24 6.12 1.84 23.13 82.94 73.46 -26.00 82.34 73.25 -23.96 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 11 3 # 11 B 124 ALA C 61 ALA^? 9.90 CL CL C 129 B 126 ARG C 66 ARG^? 18.88 CL CL C 129 B 138 GLU C 57 GLU^? -5.48 CL CL C 129s coo 2.11 4.00 19.31 3.14 4.86 19.99 83.43 78.79 -30.72 83.83 79.14 -29.32 coo 2.45 5.53 11.28 3.59 7.56 13.29 88.18 82.59 -38.84 90.98 81.94 -39.92 coo 6.10 2.00 25.24 6.12 1.84 23.13 82.94 73.46 -26.00 82.34 73.25 -23.96 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 12 3 # 12 B 124 ALA C 61 ALA^? 9.90 CL CL C 129 B 126 ARG C 66 ARG^? 18.88 CL CL C 129 B 138 GLU C 58 GLU^? 7.49 CL CL C 129 coo 2.11 4.00 19.31 3.14 4.86 19.99 83.43 78.79 -30.72 83.83 79.14 -29.32 coo 2.45 5.53 11.28 3.59 7.56 13.29 88.18 82.59 -38.84 90.98 81.94 -39.92 coo 6.10 2.00 25.24 6.12 1.84 23.13 88.02 76.82 -25.55 89.85 77.43 -24.60 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 13 3 # 13 B 124 ALA C 61 ALA^? 9.90 CL CL C 129 B 126 ARG D 60 ARG^? 8.57 CL CL D 129 B 138 GLU C 58 GLU^? 7.49 CL CL C 129 coo 2.11 4.00 19.31 3.14 4.86 19.99 83.43 78.79 -30.72 83.83 79.14 -29.32 coo 2.45 5.53 11.28 3.59 7.56 13.29 76.65 78.50 -31.75 78.13 81.14 -31.78 coo 6.10 2.00 25.24 6.12 1.84 23.13 88.02 76.82 -25.55 89.85 77.43 -24.60 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 14 3 # 14 B 124 ALA C 74 ALA^? 28.16 CL CL B 129 B 126 ARG C 76 ARG^? 33.92 CL CL B 129 B 138 GLU C 23 GLU^? 24.69 CL CL C 129 coo 2.11 4.00 19.31 3.14 4.86 19.99 97.55 81.50 -51.82 98.27 82.42 -52.76 coo 2.45 5.53 11.28 3.59 7.56 13.29 105.54 81.89 -51.05 106.65 84.23 -49.40 coo 6.10 2.00 25.24 6.12 1.84 23.13 93.85 75.25 -49.20 94.57 76.88 -48.00 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 15 3 # 15 B 124 ALA D 25 ALA^? 20.03 CL CL D 129 B 126 ARG D 63 ARG^? 14.07 CL CL D 129 B 138 GLU D 23 GLU^? 24.49 CL CL D 129 coo 2.11 4.00 19.31 3.14 4.86 19.99 72.34 76.44 -46.33 72.34 77.58 -45.33 coo 2.45 5.53 11.28 3.59 7.56 13.29 72.33 73.68 -37.44 69.36 74.46 -37.99 coo 6.10 2.00 25.24 6.12 1.84 23.13 65.41 75.40 -49.12 64.81 73.78 -47.86 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 16 3 # 16 B 124 ALA D 32 ALA^? 17.56 CL CL D 129 B 126 ARG C 63 ARG^? 14.10 CL CL C 129 B 138 GLU D 36 GLU^? 18.42 CL CL D 129 coo 2.11 4.00 19.31 3.14 4.86 19.99 78.15 79.10 -40.71 79.29 79.50 -41.62 coo 2.45 5.53 11.28 3.59 7.56 13.29 86.96 77.03 -37.50 89.89 76.13 -38.00 coo 6.10 2.00 25.24 6.12 1.84 23.13 74.52 85.40 -40.74 74.64 85.74 -42.81 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 17 3 # 17 B 124 ALA D 49 ALA^? 20.88 CL CL D 129 B 126 ARG D 104 ARG^? 26.47 CL CL D 129 B 138 GLU D 51 GLU^? 16.56 CL CL D 129 coo 2.11 4.00 19.31 3.14 4.86 19.99 62.13 66.16 -35.44 62.61 65.45 -36.70 coo 2.45 5.53 11.28 3.59 7.56 13.29 54.44 68.08 -41.08 52.76 68.11 -38.51 coo 6.10 2.00 25.24 6.12 1.84 23.13 66.99 68.03 -31.91 66.63 66.88 -33.67 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 18 3 # 18 B 124 ALA D 61 ALA^? 9.90 CL CL D 129 B 126 ARG C 60 ARG^? 8.92 CL CL C 129 B 138 GLU D 58 GLU^? 7.39 CL CL D 129 coo 2.11 4.00 19.31 3.14 4.86 19.99 75.96 71.88 -30.80 75.66 71.49 -29.34 coo 2.45 5.53 11.28 3.59 7.56 13.29 82.52 72.20 -31.52 80.97 69.57 -31.97 coo 6.10 2.00 25.24 6.12 1.84 23.13 71.21 74.03 -25.57 69.46 73.32 -24.61 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 19 3 # 19 B 124 ALA D 61 ALA^? 9.90 CL CL D 129 B 126 ARG D 63 ARG^? 14.07 CL CL D 129 B 138 GLU C 57 GLU^? -5.48 CL CL C 129s coo 2.11 4.00 19.31 3.14 4.86 19.99 75.96 71.88 -30.80 75.66 71.49 -29.34 coo 2.45 5.53 11.28 3.59 7.56 13.29 72.33 73.68 -37.44 69.36 74.46 -37.99 coo 6.10 2.00 25.24 6.12 1.84 23.13 82.94 73.46 -26.00 82.34 73.25 -23.96 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 20 3 # 20 B 124 ALA D 61 ALA^? 9.90 CL CL D 129 B 126 ARG D 66 ARG^? 18.85 CL CL D 129 B 138 GLU D 58 GLU^? 7.39 CL CL D 129 coo 2.11 4.00 19.31 3.14 4.86 19.99 75.96 71.88 -30.80 75.66 71.49 -29.34 coo 2.45 5.53 11.28 3.59 7.56 13.29 71.05 68.08 -38.82 68.22 68.66 -39.87 coo 6.10 2.00 25.24 6.12 1.84 23.13 71.21 74.03 -25.57 69.46 73.32 -24.61 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 21 3 # 21 B 124 ALA D 74 ALA^? 31.91 CL CL D 129 B 126 ARG D 76 ARG^? 33.75 CL CL D 129 B 138 GLU D 23 GLU^? 24.49 CL CL D 129 coo 2.11 4.00 19.31 3.14 4.86 19.99 61.88 69.17 -51.85 61.21 68.28 -52.90 coo 2.45 5.53 11.28 3.59 7.56 13.29 54.15 68.69 -51.19 53.07 66.38 -49.46 coo 6.10 2.00 25.24 6.12 1.84 23.13 65.41 75.40 -49.12 64.81 73.78 -47.86 1xs1_c07 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 21 hits 1xs1_c07 naa= 3 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 C 124 ALA A 25 ALA~? 20.03 CL CL A 129 C 126 ARG A 63 ARG~? 13.95 CL CL A 129 C 138 GLU A 23 GLU~? 24.22 CL CL A 129 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 90.53 45.57 -81.64 91.65 45.42 -80.63 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 87.85 45.63 -72.60 88.58 48.58 -73.24 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 89.42 52.54 -84.47 88.08 53.22 -82.95 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 C 124 ALA A 49 ALA.? 20.89 CL CL A 129 C 126 ARG A 104 ARG^? 18.53 CL CL B 129 C 138 GLU A 51 GLU^? 16.44 CL CL A 129 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 80.14 55.77 -70.80 79.39 55.32 -72.04 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 82.19 63.80 -76.53 82.09 65.30 -73.83 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 82.00 50.89 -67.09 80.89 51.23 -68.89 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 C 124 ALA A 74 ALA^? 25.51 CL CL B 129 C 126 ARG A 76 ARG^? 19.15 CL CL B 129 C 138 GLU A 23 GLU~? 24.22 CL CL A 129 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 83.09 56.12 -87.11 82.22 56.78 -88.15 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 82.62 63.89 -86.56 80.46 65.21 -84.78 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 89.42 52.54 -84.47 88.08 53.22 -82.95 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 C 124 ALA B 25 ALA^? 19.89 CL CL B 129 C 126 ARG B 63 ARG^? 13.99 CL CL B 129 C 138 GLU B 23 GLU^? 24.68 CL CL B 129 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 90.54 77.68 -59.46 91.65 77.73 -60.49 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 87.72 77.76 -68.29 88.60 74.86 -67.71 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 89.49 70.79 -56.44 87.96 70.01 -57.68 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 3 # 5 C 124 ALA B 49 ALA^? 20.99 CL CL B 129 C 126 ARG B 104 ARG^? 18.51 CL CL A 129 C 138 GLU B 51 GLU^? 16.46 CL CL B 129 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 80.08 67.54 -70.23 79.32 68.03 -68.99 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 82.09 59.72 -64.70 82.21 58.19 -67.39 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 81.98 72.56 -73.89 80.95 72.05 -72.12 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 3 # 6 C 124 ALA B 74 ALA^? 25.18 CL CL A 129 C 126 ARG B 76 ARG^? 18.98 CL CL A 129 C 138 GLU B 23 GLU^? 24.68 CL CL B 129 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 83.11 67.09 -53.84 82.12 66.37 -52.99 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 82.73 59.03 -54.76 80.31 57.91 -56.24 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 89.49 70.79 -56.44 87.96 70.01 -57.68 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 3 # 7 C 124 ALA C 25 ALA^? 19.84 CL CL C 129 C 126 ARG C 63 ARG^? 14.10 CL CL C 129 C 138 GLU C 23 GLU^? 24.69 CL CL C 129 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 86.92 74.08 -46.13 86.92 72.96 -45.09 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 86.96 77.03 -37.50 89.89 76.13 -38.00 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 93.85 75.25 -49.20 94.57 76.88 -48.00 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 3 # 8 C 124 ALA C 32 ALA^? 17.45 CL CL C 129 C 126 ARG D 63 ARG^? 14.07 CL CL D 129 C 138 GLU C 36 GLU^? 18.27 CL CL C 129 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 81.13 71.60 -40.52 79.93 71.23 -41.37 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 72.33 73.68 -37.44 69.36 74.46 -37.99 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 84.85 65.27 -40.53 84.47 64.86 -42.56 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 9 3 # 9 C 124 ALA C 49 ALA^? 20.87 CL CL C 129 C 126 ARG C 104 ARG^? 26.38 CL CL C 129 C 138 GLU C 51 GLU^? 16.39 CL CL C 129 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 97.10 84.42 -35.47 96.69 85.13 -36.72 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 105.08 82.46 -41.08 106.56 82.47 -38.36 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 92.20 82.64 -31.68 92.61 83.59 -33.56 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 10 3 # 10 C 124 ALA C 61 ALA^? 9.90 CL CL C 129 C 126 ARG C 46 ARG^? 15.12 CL CL C 129 C 138 GLU C 57 GLU^? -5.48 CL CL C 129s coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 83.43 78.79 -30.72 83.83 79.14 -29.32 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 92.47 76.70 -34.87 92.87 79.50 -36.04 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 82.94 73.46 -26.00 82.34 73.25 -23.96 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 11 3 # 11 C 124 ALA C 61 ALA^? 9.90 CL CL C 129 C 126 ARG C 66 ARG^? 18.88 CL CL C 129 C 138 GLU C 57 GLU^? -5.48 CL CL C 129s coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 83.43 78.79 -30.72 83.83 79.14 -29.32 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 88.18 82.59 -38.84 90.98 81.94 -39.92 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 82.94 73.46 -26.00 82.34 73.25 -23.96 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 12 3 # 12 C 124 ALA C 61 ALA^? 9.90 CL CL C 129 C 126 ARG C 66 ARG^? 18.88 CL CL C 129 C 138 GLU C 58 GLU^? 7.49 CL CL C 129 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 83.43 78.79 -30.72 83.83 79.14 -29.32 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 88.18 82.59 -38.84 90.98 81.94 -39.92 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 88.02 76.82 -25.55 89.85 77.43 -24.60 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 13 3 # 13 C 124 ALA C 61 ALA^? 9.90 CL CL C 129 C 126 ARG D 60 ARG^? 8.57 CL CL D 129 C 138 GLU C 58 GLU^? 7.49 CL CL C 129 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 83.43 78.79 -30.72 83.83 79.14 -29.32 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 76.65 78.50 -31.75 78.13 81.14 -31.78 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 88.02 76.82 -25.55 89.85 77.43 -24.60 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 14 3 # 14 C 124 ALA C 74 ALA^? 28.16 CL CL B 129 C 126 ARG C 76 ARG^? 33.92 CL CL B 129 C 138 GLU C 23 GLU^? 24.69 CL CL C 129 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 97.55 81.50 -51.82 98.27 82.42 -52.76 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 105.54 81.89 -51.05 106.65 84.23 -49.40 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 93.85 75.25 -49.20 94.57 76.88 -48.00 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 15 3 # 15 C 124 ALA D 25 ALA^? 20.03 CL CL D 129 C 126 ARG D 63 ARG^? 14.07 CL CL D 129 C 138 GLU D 23 GLU^? 24.49 CL CL D 129 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 72.34 76.44 -46.33 72.34 77.58 -45.33 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 72.33 73.68 -37.44 69.36 74.46 -37.99 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 65.41 75.40 -49.12 64.81 73.78 -47.86 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 16 3 # 16 C 124 ALA D 32 ALA^? 17.56 CL CL D 129 C 126 ARG C 63 ARG^? 14.10 CL CL C 129 C 138 GLU D 36 GLU^? 18.42 CL CL D 129 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 78.15 79.10 -40.71 79.29 79.50 -41.62 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 86.96 77.03 -37.50 89.89 76.13 -38.00 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 74.52 85.40 -40.74 74.64 85.74 -42.81 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 17 3 # 17 C 124 ALA D 49 ALA^? 20.88 CL CL D 129 C 126 ARG D 104 ARG^? 26.47 CL CL D 129 C 138 GLU D 51 GLU^? 16.56 CL CL D 129 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 62.13 66.16 -35.44 62.61 65.45 -36.70 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 54.44 68.08 -41.08 52.76 68.11 -38.51 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 66.99 68.03 -31.91 66.63 66.88 -33.67 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 18 3 # 18 C 124 ALA D 61 ALA^? 9.90 CL CL D 129 C 126 ARG C 60 ARG^? 8.92 CL CL C 129 C 138 GLU D 58 GLU^? 7.39 CL CL D 129 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 75.96 71.88 -30.80 75.66 71.49 -29.34 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 82.52 72.20 -31.52 80.97 69.57 -31.97 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 71.21 74.03 -25.57 69.46 73.32 -24.61 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 19 3 # 19 C 124 ALA D 61 ALA^? 9.90 CL CL D 129 C 126 ARG D 63 ARG^? 14.07 CL CL D 129 C 138 GLU C 57 GLU^? -5.48 CL CL C 129s coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 75.96 71.88 -30.80 75.66 71.49 -29.34 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 72.33 73.68 -37.44 69.36 74.46 -37.99 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 82.94 73.46 -26.00 82.34 73.25 -23.96 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 20 3 # 20 C 124 ALA D 61 ALA^? 9.90 CL CL D 129 C 126 ARG D 66 ARG^? 18.85 CL CL D 129 C 138 GLU D 58 GLU^? 7.39 CL CL D 129 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 75.96 71.88 -30.80 75.66 71.49 -29.34 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 71.05 68.08 -38.82 68.22 68.66 -39.87 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 71.21 74.03 -25.57 69.46 73.32 -24.61 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 21 3 # 21 C 124 ALA D 74 ALA^? 31.91 CL CL D 129 C 126 ARG D 76 ARG^? 33.75 CL CL D 129 C 138 GLU D 23 GLU^? 24.49 CL CL D 129 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 61.88 69.17 -51.85 61.21 68.28 -52.90 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 54.15 68.69 -51.19 53.07 66.38 -49.46 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 65.41 75.40 -49.12 64.81 73.78 -47.86 1xs1_c08 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 21 hits 1xs1_c08 naa= 3 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 D 124 ALA A 25 ALA~? 20.03 CL CL A 129 D 126 ARG A 63 ARG~? 13.95 CL CL A 129 D 138 GLU A 23 GLU~? 24.22 CL CL A 129 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 90.53 45.57 -81.64 91.65 45.42 -80.63 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 87.85 45.63 -72.60 88.58 48.58 -73.24 coo 6.23 0.50 57.10 5.93 0.72 59.19 89.42 52.54 -84.47 88.08 53.22 -82.95 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 D 124 ALA A 49 ALA.? 20.89 CL CL A 129 D 126 ARG A 104 ARG^? 18.53 CL CL B 129 D 138 GLU A 51 GLU^? 16.44 CL CL A 129 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 80.14 55.77 -70.80 79.39 55.32 -72.04 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 82.19 63.80 -76.53 82.09 65.30 -73.83 coo 6.23 0.50 57.10 5.93 0.72 59.19 82.00 50.89 -67.09 80.89 51.23 -68.89 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 D 124 ALA A 74 ALA^? 25.51 CL CL B 129 D 126 ARG A 76 ARG^? 19.15 CL CL B 129 D 138 GLU A 23 GLU~? 24.22 CL CL A 129 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 83.09 56.12 -87.11 82.22 56.78 -88.15 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 82.62 63.89 -86.56 80.46 65.21 -84.78 coo 6.23 0.50 57.10 5.93 0.72 59.19 89.42 52.54 -84.47 88.08 53.22 -82.95 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 D 124 ALA B 25 ALA^? 19.89 CL CL B 129 D 126 ARG B 63 ARG^? 13.99 CL CL B 129 D 138 GLU B 23 GLU^? 24.68 CL CL B 129 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 90.54 77.68 -59.46 91.65 77.73 -60.49 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 87.72 77.76 -68.29 88.60 74.86 -67.71 coo 6.23 0.50 57.10 5.93 0.72 59.19 89.49 70.79 -56.44 87.96 70.01 -57.68 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 3 # 5 D 124 ALA B 49 ALA^? 20.99 CL CL B 129 D 126 ARG B 104 ARG^? 18.51 CL CL A 129 D 138 GLU B 51 GLU^? 16.46 CL CL B 129 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 80.08 67.54 -70.23 79.32 68.03 -68.99 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 82.09 59.72 -64.70 82.21 58.19 -67.39 coo 6.23 0.50 57.10 5.93 0.72 59.19 81.98 72.56 -73.89 80.95 72.05 -72.12 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 3 # 6 D 124 ALA B 74 ALA^? 25.18 CL CL A 129 D 126 ARG B 76 ARG^? 18.98 CL CL A 129 D 138 GLU B 23 GLU^? 24.68 CL CL B 129 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 83.11 67.09 -53.84 82.12 66.37 -52.99 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 82.73 59.03 -54.76 80.31 57.91 -56.24 coo 6.23 0.50 57.10 5.93 0.72 59.19 89.49 70.79 -56.44 87.96 70.01 -57.68 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 3 # 7 D 124 ALA C 25 ALA^? 19.84 CL CL C 129 D 126 ARG C 63 ARG^? 14.10 CL CL C 129 D 138 GLU C 23 GLU^? 24.69 CL CL C 129 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 86.92 74.08 -46.13 86.92 72.96 -45.09 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 86.96 77.03 -37.50 89.89 76.13 -38.00 coo 6.23 0.50 57.10 5.93 0.72 59.19 93.85 75.25 -49.20 94.57 76.88 -48.00 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 3 # 8 D 124 ALA C 32 ALA^? 17.45 CL CL C 129 D 126 ARG D 63 ARG^? 14.07 CL CL D 129 D 138 GLU C 36 GLU^? 18.27 CL CL C 129 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 81.13 71.60 -40.52 79.93 71.23 -41.37 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 72.33 73.68 -37.44 69.36 74.46 -37.99 coo 6.23 0.50 57.10 5.93 0.72 59.19 84.85 65.27 -40.53 84.47 64.86 -42.56 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 9 3 # 9 D 124 ALA C 49 ALA^? 20.87 CL CL C 129 D 126 ARG C 104 ARG^? 26.38 CL CL C 129 D 138 GLU C 51 GLU^? 16.39 CL CL C 129 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 97.10 84.42 -35.47 96.69 85.13 -36.72 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 105.08 82.46 -41.08 106.56 82.47 -38.36 coo 6.23 0.50 57.10 5.93 0.72 59.19 92.20 82.64 -31.68 92.61 83.59 -33.56 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 10 3 # 10 D 124 ALA C 61 ALA^? 9.90 CL CL C 129 D 126 ARG D 60 ARG^? 8.57 CL CL D 129 D 138 GLU C 58 GLU^? 7.49 CL CL C 129 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 83.43 78.79 -30.72 83.83 79.14 -29.32 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 76.65 78.50 -31.75 78.13 81.14 -31.78 coo 6.23 0.50 57.10 5.93 0.72 59.19 88.02 76.82 -25.55 89.85 77.43 -24.60 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 11 3 # 11 D 124 ALA C 74 ALA^? 28.16 CL CL B 129 D 126 ARG C 76 ARG^? 33.92 CL CL B 129 D 138 GLU C 23 GLU^? 24.69 CL CL C 129 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 97.55 81.50 -51.82 98.27 82.42 -52.76 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 105.54 81.89 -51.05 106.65 84.23 -49.40 coo 6.23 0.50 57.10 5.93 0.72 59.19 93.85 75.25 -49.20 94.57 76.88 -48.00 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 12 3 # 12 D 124 ALA D 25 ALA^? 20.03 CL CL D 129 D 126 ARG D 63 ARG^? 14.07 CL CL D 129 D 138 GLU D 23 GLU^? 24.49 CL CL D 129 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 72.34 76.44 -46.33 72.34 77.58 -45.33 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 72.33 73.68 -37.44 69.36 74.46 -37.99 coo 6.23 0.50 57.10 5.93 0.72 59.19 65.41 75.40 -49.12 64.81 73.78 -47.86 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 13 3 # 13 D 124 ALA D 32 ALA^? 17.56 CL CL D 129 D 126 ARG C 63 ARG^? 14.10 CL CL C 129 D 138 GLU D 36 GLU^? 18.42 CL CL D 129 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 78.15 79.10 -40.71 79.29 79.50 -41.62 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 86.96 77.03 -37.50 89.89 76.13 -38.00 coo 6.23 0.50 57.10 5.93 0.72 59.19 74.52 85.40 -40.74 74.64 85.74 -42.81 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 14 3 # 14 D 124 ALA D 49 ALA^? 20.88 CL CL D 129 D 126 ARG D 104 ARG^? 26.47 CL CL D 129 D 138 GLU D 51 GLU^? 16.56 CL CL D 129 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 62.13 66.16 -35.44 62.61 65.45 -36.70 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 54.44 68.08 -41.08 52.76 68.11 -38.51 coo 6.23 0.50 57.10 5.93 0.72 59.19 66.99 68.03 -31.91 66.63 66.88 -33.67 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 15 3 # 15 D 124 ALA D 61 ALA^? 9.90 CL CL D 129 D 126 ARG C 60 ARG^? 8.92 CL CL C 129 D 138 GLU D 58 GLU^? 7.39 CL CL D 129 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 75.96 71.88 -30.80 75.66 71.49 -29.34 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 82.52 72.20 -31.52 80.97 69.57 -31.97 coo 6.23 0.50 57.10 5.93 0.72 59.19 71.21 74.03 -25.57 69.46 73.32 -24.61 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 16 3 # 16 D 124 ALA D 61 ALA^? 9.90 CL CL D 129 D 126 ARG D 63 ARG^? 14.07 CL CL D 129 D 138 GLU C 57 GLU^? -5.48 CL CL C 129s coo 2.08 -1.49 62.94 3.12 -2.39 62.28 75.96 71.88 -30.80 75.66 71.49 -29.34 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 72.33 73.68 -37.44 69.36 74.46 -37.99 coo 6.23 0.50 57.10 5.93 0.72 59.19 82.94 73.46 -26.00 82.34 73.25 -23.96 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 17 3 # 17 D 124 ALA D 74 ALA^? 31.91 CL CL D 129 D 126 ARG D 76 ARG^? 33.75 CL CL D 129 D 138 GLU D 23 GLU^? 24.49 CL CL D 129 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 61.88 69.17 -51.85 61.21 68.28 -52.90 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 54.15 68.69 -51.19 53.07 66.38 -49.46 coo 6.23 0.50 57.10 5.93 0.72 59.19 65.41 75.40 -49.12 64.81 73.78 -47.86 1xs1_c09 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 17 hits 1xs1_c09 naa= 3 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 E 124 ALA A 25 ALA~? 20.03 CL CL A 129 E 126 ARG A 63 ARG~? 13.95 CL CL A 129 E 138 GLU A 23 GLU~? 24.22 CL CL A 129 coo -4.56 10.03 62.36 -4.38 11.31 61.55 90.53 45.57 -81.64 91.65 45.42 -80.63 coo -3.02 12.00 70.07 -1.94 13.84 67.82 87.85 45.63 -72.60 88.58 48.58 -73.24 coo -8.67 12.22 56.54 -8.68 12.09 58.65 89.42 52.54 -84.47 88.08 53.22 -82.95 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 E 124 ALA A 49 ALA.? 20.89 CL CL A 129 E 126 ARG A 104 ARG^? 18.53 CL CL B 129 E 138 GLU A 51 GLU^? 16.44 CL CL A 129 coo -4.56 10.03 62.36 -4.38 11.31 61.55 80.14 55.77 -70.80 79.39 55.32 -72.04 coo -3.02 12.00 70.07 -1.94 13.84 67.82 82.19 63.80 -76.53 82.09 65.30 -73.83 coo -8.67 12.22 56.54 -8.68 12.09 58.65 82.00 50.89 -67.09 80.89 51.23 -68.89 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 E 124 ALA A 74 ALA^? 25.51 CL CL B 129 E 126 ARG A 76 ARG^? 19.15 CL CL B 129 E 138 GLU A 23 GLU~? 24.22 CL CL A 129 coo -4.56 10.03 62.36 -4.38 11.31 61.55 83.09 56.12 -87.11 82.22 56.78 -88.15 coo -3.02 12.00 70.07 -1.94 13.84 67.82 82.62 63.89 -86.56 80.46 65.21 -84.78 coo -8.67 12.22 56.54 -8.68 12.09 58.65 89.42 52.54 -84.47 88.08 53.22 -82.95 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 E 124 ALA B 25 ALA^? 19.89 CL CL B 129 E 126 ARG B 63 ARG^? 13.99 CL CL B 129 E 138 GLU B 23 GLU^? 24.68 CL CL B 129 coo -4.56 10.03 62.36 -4.38 11.31 61.55 90.54 77.68 -59.46 91.65 77.73 -60.49 coo -3.02 12.00 70.07 -1.94 13.84 67.82 87.72 77.76 -68.29 88.60 74.86 -67.71 coo -8.67 12.22 56.54 -8.68 12.09 58.65 89.49 70.79 -56.44 87.96 70.01 -57.68 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 3 # 5 E 124 ALA B 49 ALA^? 20.99 CL CL B 129 E 126 ARG B 104 ARG^? 18.51 CL CL A 129 E 138 GLU B 51 GLU^? 16.46 CL CL B 129 coo -4.56 10.03 62.36 -4.38 11.31 61.55 80.08 67.54 -70.23 79.32 68.03 -68.99 coo -3.02 12.00 70.07 -1.94 13.84 67.82 82.09 59.72 -64.70 82.21 58.19 -67.39 coo -8.67 12.22 56.54 -8.68 12.09 58.65 81.98 72.56 -73.89 80.95 72.05 -72.12 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 3 # 6 E 124 ALA B 74 ALA^? 25.18 CL CL A 129 E 126 ARG B 76 ARG^? 18.98 CL CL A 129 E 138 GLU B 23 GLU^? 24.68 CL CL B 129 coo -4.56 10.03 62.36 -4.38 11.31 61.55 83.11 67.09 -53.84 82.12 66.37 -52.99 coo -3.02 12.00 70.07 -1.94 13.84 67.82 82.73 59.03 -54.76 80.31 57.91 -56.24 coo -8.67 12.22 56.54 -8.68 12.09 58.65 89.49 70.79 -56.44 87.96 70.01 -57.68 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 3 # 7 E 124 ALA C 25 ALA^? 19.84 CL CL C 129 E 126 ARG C 63 ARG^? 14.10 CL CL C 129 E 138 GLU C 23 GLU^? 24.69 CL CL C 129 coo -4.56 10.03 62.36 -4.38 11.31 61.55 86.92 74.08 -46.13 86.92 72.96 -45.09 coo -3.02 12.00 70.07 -1.94 13.84 67.82 86.96 77.03 -37.50 89.89 76.13 -38.00 coo -8.67 12.22 56.54 -8.68 12.09 58.65 93.85 75.25 -49.20 94.57 76.88 -48.00 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 3 # 8 E 124 ALA C 32 ALA^? 17.45 CL CL C 129 E 126 ARG D 63 ARG^? 14.07 CL CL D 129 E 138 GLU C 36 GLU^? 18.27 CL CL C 129 coo -4.56 10.03 62.36 -4.38 11.31 61.55 81.13 71.60 -40.52 79.93 71.23 -41.37 coo -3.02 12.00 70.07 -1.94 13.84 67.82 72.33 73.68 -37.44 69.36 74.46 -37.99 coo -8.67 12.22 56.54 -8.68 12.09 58.65 84.85 65.27 -40.53 84.47 64.86 -42.56 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 9 3 # 9 E 124 ALA C 49 ALA^? 20.87 CL CL C 129 E 126 ARG C 104 ARG^? 26.38 CL CL C 129 E 138 GLU C 51 GLU^? 16.39 CL CL C 129 coo -4.56 10.03 62.36 -4.38 11.31 61.55 97.10 84.42 -35.47 96.69 85.13 -36.72 coo -3.02 12.00 70.07 -1.94 13.84 67.82 105.08 82.46 -41.08 106.56 82.47 -38.36 coo -8.67 12.22 56.54 -8.68 12.09 58.65 92.20 82.64 -31.68 92.61 83.59 -33.56 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 10 3 # 10 E 124 ALA C 61 ALA^? 9.90 CL CL C 129 E 126 ARG D 60 ARG^? 8.57 CL CL D 129 E 138 GLU C 58 GLU^? 7.49 CL CL C 129 coo -4.56 10.03 62.36 -4.38 11.31 61.55 83.43 78.79 -30.72 83.83 79.14 -29.32 coo -3.02 12.00 70.07 -1.94 13.84 67.82 76.65 78.50 -31.75 78.13 81.14 -31.78 coo -8.67 12.22 56.54 -8.68 12.09 58.65 88.02 76.82 -25.55 89.85 77.43 -24.60 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 11 3 # 11 E 124 ALA C 74 ALA^? 28.16 CL CL B 129 E 126 ARG C 76 ARG^? 33.92 CL CL B 129 E 138 GLU C 23 GLU^? 24.69 CL CL C 129 coo -4.56 10.03 62.36 -4.38 11.31 61.55 97.55 81.50 -51.82 98.27 82.42 -52.76 coo -3.02 12.00 70.07 -1.94 13.84 67.82 105.54 81.89 -51.05 106.65 84.23 -49.40 coo -8.67 12.22 56.54 -8.68 12.09 58.65 93.85 75.25 -49.20 94.57 76.88 -48.00 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 12 3 # 12 E 124 ALA D 25 ALA^? 20.03 CL CL D 129 E 126 ARG D 63 ARG^? 14.07 CL CL D 129 E 138 GLU D 23 GLU^? 24.49 CL CL D 129 coo -4.56 10.03 62.36 -4.38 11.31 61.55 72.34 76.44 -46.33 72.34 77.58 -45.33 coo -3.02 12.00 70.07 -1.94 13.84 67.82 72.33 73.68 -37.44 69.36 74.46 -37.99 coo -8.67 12.22 56.54 -8.68 12.09 58.65 65.41 75.40 -49.12 64.81 73.78 -47.86 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 13 3 # 13 E 124 ALA D 32 ALA^? 17.56 CL CL D 129 E 126 ARG C 63 ARG^? 14.10 CL CL C 129 E 138 GLU D 36 GLU^? 18.42 CL CL D 129 coo -4.56 10.03 62.36 -4.38 11.31 61.55 78.15 79.10 -40.71 79.29 79.50 -41.62 coo -3.02 12.00 70.07 -1.94 13.84 67.82 86.96 77.03 -37.50 89.89 76.13 -38.00 coo -8.67 12.22 56.54 -8.68 12.09 58.65 74.52 85.40 -40.74 74.64 85.74 -42.81 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 14 3 # 14 E 124 ALA D 49 ALA^? 20.88 CL CL D 129 E 126 ARG D 104 ARG^? 26.47 CL CL D 129 E 138 GLU D 51 GLU^? 16.56 CL CL D 129 coo -4.56 10.03 62.36 -4.38 11.31 61.55 62.13 66.16 -35.44 62.61 65.45 -36.70 coo -3.02 12.00 70.07 -1.94 13.84 67.82 54.44 68.08 -41.08 52.76 68.11 -38.51 coo -8.67 12.22 56.54 -8.68 12.09 58.65 66.99 68.03 -31.91 66.63 66.88 -33.67 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 15 3 # 15 E 124 ALA D 61 ALA^? 9.90 CL CL D 129 E 126 ARG C 60 ARG^? 8.92 CL CL C 129 E 138 GLU D 58 GLU^? 7.39 CL CL D 129 coo -4.56 10.03 62.36 -4.38 11.31 61.55 75.96 71.88 -30.80 75.66 71.49 -29.34 coo -3.02 12.00 70.07 -1.94 13.84 67.82 82.52 72.20 -31.52 80.97 69.57 -31.97 coo -8.67 12.22 56.54 -8.68 12.09 58.65 71.21 74.03 -25.57 69.46 73.32 -24.61 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 16 3 # 16 E 124 ALA D 61 ALA^? 9.90 CL CL D 129 E 126 ARG D 63 ARG^? 14.07 CL CL D 129 E 138 GLU C 57 GLU^? -5.48 CL CL C 129s coo -4.56 10.03 62.36 -4.38 11.31 61.55 75.96 71.88 -30.80 75.66 71.49 -29.34 coo -3.02 12.00 70.07 -1.94 13.84 67.82 72.33 73.68 -37.44 69.36 74.46 -37.99 coo -8.67 12.22 56.54 -8.68 12.09 58.65 82.94 73.46 -26.00 82.34 73.25 -23.96 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 17 3 # 17 E 124 ALA D 74 ALA^? 31.91 CL CL D 129 E 126 ARG D 76 ARG^? 33.75 CL CL D 129 E 138 GLU D 23 GLU^? 24.49 CL CL D 129 coo -4.56 10.03 62.36 -4.38 11.31 61.55 61.88 69.17 -51.85 61.21 68.28 -52.90 coo -3.02 12.00 70.07 -1.94 13.84 67.82 54.15 68.69 -51.19 53.07 66.38 -49.46 coo -8.67 12.22 56.54 -8.68 12.09 58.65 65.41 75.40 -49.12 64.81 73.78 -47.86 1xs1_c10 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 17 hits 1xs1_c10 naa= 3 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 F 124 ALA A 25 ALA~? 20.03 CL CL A 129 F 126 ARG A 63 ARG~? 13.95 CL CL A 129 F 138 GLU A 23 GLU~? 24.22 CL CL A 129 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 90.53 45.57 -81.64 91.65 45.42 -80.63 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 87.85 45.63 -72.60 88.58 48.58 -73.24 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 89.42 52.54 -84.47 88.08 53.22 -82.95 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 F 124 ALA A 49 ALA.? 20.89 CL CL A 129 F 126 ARG A 104 ARG^? 18.53 CL CL B 129 F 138 GLU A 51 GLU^? 16.44 CL CL A 129 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 80.14 55.77 -70.80 79.39 55.32 -72.04 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 82.19 63.80 -76.53 82.09 65.30 -73.83 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 82.00 50.89 -67.09 80.89 51.23 -68.89 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 F 124 ALA A 74 ALA^? 25.51 CL CL B 129 F 126 ARG A 76 ARG^? 19.15 CL CL B 129 F 138 GLU A 23 GLU~? 24.22 CL CL A 129 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 83.09 56.12 -87.11 82.22 56.78 -88.15 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 82.62 63.89 -86.56 80.46 65.21 -84.78 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 89.42 52.54 -84.47 88.08 53.22 -82.95 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 F 124 ALA B 25 ALA^? 19.89 CL CL B 129 F 126 ARG B 63 ARG^? 13.99 CL CL B 129 F 138 GLU B 23 GLU^? 24.68 CL CL B 129 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 90.54 77.68 -59.46 91.65 77.73 -60.49 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 87.72 77.76 -68.29 88.60 74.86 -67.71 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 89.49 70.79 -56.44 87.96 70.01 -57.68 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 3 # 5 F 124 ALA B 49 ALA^? 20.99 CL CL B 129 F 126 ARG B 104 ARG^? 18.51 CL CL A 129 F 138 GLU B 51 GLU^? 16.46 CL CL B 129 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 80.08 67.54 -70.23 79.32 68.03 -68.99 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 82.09 59.72 -64.70 82.21 58.19 -67.39 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 81.98 72.56 -73.89 80.95 72.05 -72.12 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 3 # 6 F 124 ALA B 74 ALA^? 25.18 CL CL A 129 F 126 ARG B 76 ARG^? 18.98 CL CL A 129 F 138 GLU B 23 GLU^? 24.68 CL CL B 129 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 83.11 67.09 -53.84 82.12 66.37 -52.99 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 82.73 59.03 -54.76 80.31 57.91 -56.24 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 89.49 70.79 -56.44 87.96 70.01 -57.68 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 3 # 7 F 124 ALA C 25 ALA^? 19.84 CL CL C 129 F 126 ARG C 63 ARG^? 14.10 CL CL C 129 F 138 GLU C 23 GLU^? 24.69 CL CL C 129 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 86.92 74.08 -46.13 86.92 72.96 -45.09 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 86.96 77.03 -37.50 89.89 76.13 -38.00 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 93.85 75.25 -49.20 94.57 76.88 -48.00 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 3 # 8 F 124 ALA C 32 ALA^? 17.45 CL CL C 129 F 126 ARG D 63 ARG^? 14.07 CL CL D 129 F 138 GLU C 36 GLU^? 18.27 CL CL C 129 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 81.13 71.60 -40.52 79.93 71.23 -41.37 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 72.33 73.68 -37.44 69.36 74.46 -37.99 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 84.85 65.27 -40.53 84.47 64.86 -42.56 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 9 3 # 9 F 124 ALA C 49 ALA^? 20.87 CL CL C 129 F 126 ARG C 104 ARG^? 26.38 CL CL C 129 F 138 GLU C 51 GLU^? 16.39 CL CL C 129 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 97.10 84.42 -35.47 96.69 85.13 -36.72 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 105.08 82.46 -41.08 106.56 82.47 -38.36 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 92.20 82.64 -31.68 92.61 83.59 -33.56 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 10 3 # 10 F 124 ALA C 61 ALA^? 9.90 CL CL C 129 F 126 ARG C 46 ARG^? 15.12 CL CL C 129 F 138 GLU C 57 GLU^? -5.48 CL CL C 129s coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 83.43 78.79 -30.72 83.83 79.14 -29.32 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 92.47 76.70 -34.87 92.87 79.50 -36.04 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 82.94 73.46 -26.00 82.34 73.25 -23.96 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 11 3 # 11 F 124 ALA C 61 ALA^? 9.90 CL CL C 129 F 126 ARG C 66 ARG^? 18.88 CL CL C 129 F 138 GLU C 57 GLU^? -5.48 CL CL C 129s coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 83.43 78.79 -30.72 83.83 79.14 -29.32 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 88.18 82.59 -38.84 90.98 81.94 -39.92 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 82.94 73.46 -26.00 82.34 73.25 -23.96 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 12 3 # 12 F 124 ALA C 61 ALA^? 9.90 CL CL C 129 F 126 ARG C 66 ARG^? 18.88 CL CL C 129 F 138 GLU C 58 GLU^? 7.49 CL CL C 129 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 83.43 78.79 -30.72 83.83 79.14 -29.32 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 88.18 82.59 -38.84 90.98 81.94 -39.92 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 88.02 76.82 -25.55 89.85 77.43 -24.60 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 13 3 # 13 F 124 ALA C 61 ALA^? 9.90 CL CL C 129 F 126 ARG D 60 ARG^? 8.57 CL CL D 129 F 138 GLU C 58 GLU^? 7.49 CL CL C 129 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 83.43 78.79 -30.72 83.83 79.14 -29.32 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 76.65 78.50 -31.75 78.13 81.14 -31.78 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 88.02 76.82 -25.55 89.85 77.43 -24.60 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 14 3 # 14 F 124 ALA C 74 ALA^? 28.16 CL CL B 129 F 126 ARG C 76 ARG^? 33.92 CL CL B 129 F 138 GLU C 23 GLU^? 24.69 CL CL C 129 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 97.55 81.50 -51.82 98.27 82.42 -52.76 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 105.54 81.89 -51.05 106.65 84.23 -49.40 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 93.85 75.25 -49.20 94.57 76.88 -48.00 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 15 3 # 15 F 124 ALA D 25 ALA^? 20.03 CL CL D 129 F 126 ARG D 63 ARG^? 14.07 CL CL D 129 F 138 GLU D 23 GLU^? 24.49 CL CL D 129 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 72.34 76.44 -46.33 72.34 77.58 -45.33 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 72.33 73.68 -37.44 69.36 74.46 -37.99 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 65.41 75.40 -49.12 64.81 73.78 -47.86 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 16 3 # 16 F 124 ALA D 32 ALA^? 17.56 CL CL D 129 F 126 ARG C 63 ARG^? 14.10 CL CL C 129 F 138 GLU D 36 GLU^? 18.42 CL CL D 129 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 78.15 79.10 -40.71 79.29 79.50 -41.62 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 86.96 77.03 -37.50 89.89 76.13 -38.00 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 74.52 85.40 -40.74 74.64 85.74 -42.81 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 17 3 # 17 F 124 ALA D 49 ALA^? 20.88 CL CL D 129 F 126 ARG D 104 ARG^? 26.47 CL CL D 129 F 138 GLU D 51 GLU^? 16.56 CL CL D 129 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 62.13 66.16 -35.44 62.61 65.45 -36.70 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 54.44 68.08 -41.08 52.76 68.11 -38.51 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 66.99 68.03 -31.91 66.63 66.88 -33.67 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 18 3 # 18 F 124 ALA D 61 ALA^? 9.90 CL CL D 129 F 126 ARG C 60 ARG^? 8.92 CL CL C 129 F 138 GLU D 58 GLU^? 7.39 CL CL D 129 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 75.96 71.88 -30.80 75.66 71.49 -29.34 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 82.52 72.20 -31.52 80.97 69.57 -31.97 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 71.21 74.03 -25.57 69.46 73.32 -24.61 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 19 3 # 19 F 124 ALA D 61 ALA^? 9.90 CL CL D 129 F 126 ARG D 63 ARG^? 14.07 CL CL D 129 F 138 GLU C 57 GLU^? -5.48 CL CL C 129s coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 75.96 71.88 -30.80 75.66 71.49 -29.34 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 72.33 73.68 -37.44 69.36 74.46 -37.99 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 82.94 73.46 -26.00 82.34 73.25 -23.96 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 20 3 # 20 F 124 ALA D 61 ALA^? 9.90 CL CL D 129 F 126 ARG D 66 ARG^? 18.85 CL CL D 129 F 138 GLU D 58 GLU^? 7.39 CL CL D 129 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 75.96 71.88 -30.80 75.66 71.49 -29.34 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 71.05 68.08 -38.82 68.22 68.66 -39.87 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 71.21 74.03 -25.57 69.46 73.32 -24.61 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 21 3 # 21 F 124 ALA D 74 ALA^? 31.91 CL CL D 129 F 126 ARG D 76 ARG^? 33.75 CL CL D 129 F 138 GLU D 23 GLU^? 24.49 CL CL D 129 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 61.88 69.17 -51.85 61.21 68.28 -52.90 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 54.15 68.69 -51.19 53.07 66.38 -49.46 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 65.41 75.40 -49.12 64.81 73.78 -47.86 1xs1_c11 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 21 hits 1xs1_c11 naa= 3 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 1 3 # 1 B 137 GLY A 28 GLY~? 24.11 CL CL A 129 B 175 ARG A 73 ARG.? 22.19 CL CL A 129 B 242 TYR A 22 TYR~? 17.56 CL CL A 129 coo 99.45 58.28 3.33 99.57 58.61 4.10 85.98 43.81 -83.42 85.99 44.13 -82.66 coo 106.37 63.53 0.89 108.02 63.40 -1.62 83.82 53.79 -81.61 86.00 54.30 -79.51 coo 100.93 69.04 4.38 99.52 68.48 2.09 92.72 50.62 -78.45 90.87 50.50 -76.41 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 2 3 # 2 B 137 GLY A 50 GLY.? 19.16 CL CL A 129 B 175 ARG A 46 ARG^? 15.11 CL CL A 129 B 242 TYR A 47 TYR^? 14.66 CL CL A 129 coo 99.45 58.28 3.33 99.57 58.61 4.10 78.38 54.03 -67.91 79.15 53.85 -67.91 coo 106.37 63.53 0.89 108.02 63.40 -1.62 87.96 51.20 -70.32 85.08 51.60 -71.34 coo 100.93 69.04 4.38 99.52 68.48 2.09 86.78 57.70 -65.64 87.73 58.42 -63.11 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 3 3 # 3 B 137 GLY A 55 GLY~? -3.63 CL CL A 129s B 175 ARG A 46 ARG^? 15.11 CL CL A 129 B 242 TYR A 47 TYR^? 14.66 CL CL A 129 coo 99.45 58.28 3.33 99.57 58.61 4.10 92.85 48.69 -62.18 92.25 48.83 -62.75 coo 106.37 63.53 0.89 108.02 63.40 -1.62 87.96 51.20 -70.32 85.08 51.60 -71.34 coo 100.93 69.04 4.38 99.52 68.48 2.09 86.78 57.70 -65.64 87.73 58.42 -63.11 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 4 3 # 4 B 137 GLY B 28 GLY^? 24.16 CL CL B 129 B 175 ARG B 73 ARG^? 22.29 CL CL B 129 B 242 TYR B 22 TYR^? 17.56 CL CL B 129 coo 99.45 58.28 3.33 99.57 58.61 4.10 86.10 79.54 -57.45 86.12 79.23 -58.23 coo 106.37 63.53 0.89 108.02 63.40 -1.62 83.86 69.55 -59.16 85.91 69.18 -61.42 coo 100.93 69.04 4.38 99.52 68.48 2.09 92.70 72.76 -62.54 90.90 72.79 -64.68 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 5 3 # 5 B 137 GLY B 50 GLY^? 19.23 CL CL B 129 B 175 ARG B 46 ARG^? 15.06 CL CL B 129 B 242 TYR B 47 TYR^? 14.72 CL CL B 129 coo 99.45 58.28 3.33 99.57 58.61 4.10 78.37 69.28 -73.15 79.13 69.49 -73.13 coo 106.37 63.53 0.89 108.02 63.40 -1.62 87.96 72.13 -70.71 85.05 71.84 -69.78 coo 100.93 69.04 4.38 99.52 68.48 2.09 86.74 65.69 -75.43 87.82 65.07 -77.96 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 6 3 # 6 B 137 GLY B 55 GLY^? 3.74 CL CL B 129 B 175 ARG B 46 ARG^? 15.06 CL CL B 129 B 242 TYR B 47 TYR^? 14.72 CL CL B 129 coo 99.45 58.28 3.33 99.57 58.61 4.10 92.76 74.76 -78.82 92.18 74.63 -78.24 coo 106.37 63.53 0.89 108.02 63.40 -1.62 87.96 72.13 -70.71 85.05 71.84 -69.78 coo 100.93 69.04 4.38 99.52 68.48 2.09 86.74 65.69 -75.43 87.82 65.07 -77.96 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 7 3 # 7 B 137 GLY C 28 GLY^? 24.16 CL CL C 129 B 175 ARG C 63 ARG^? 14.10 CL CL C 129 B 242 TYR C 22 TYR^? 17.52 CL CL C 129 coo 99.45 58.28 3.33 99.57 58.61 4.10 85.20 78.69 -48.08 85.51 78.62 -47.31 coo 106.37 63.53 0.89 108.02 63.40 -1.62 86.96 77.03 -37.50 89.89 76.13 -38.00 coo 100.93 69.04 4.38 99.52 68.48 2.09 91.93 71.84 -43.09 91.81 73.68 -41.00 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 8 3 # 8 B 137 GLY C 28 GLY^? 24.16 CL CL C 129 B 175 ARG C 73 ARG^? 22.24 CL CL C 129 B 242 TYR C 22 TYR^? 17.52 CL CL C 129 coo 99.45 58.28 3.33 99.57 58.61 4.10 85.20 78.69 -48.08 85.51 78.62 -47.31 coo 106.37 63.53 0.89 108.02 63.40 -1.62 95.26 80.79 -46.47 95.45 78.63 -44.29 coo 100.93 69.04 4.38 99.52 68.48 2.09 91.93 71.84 -43.09 91.81 73.68 -41.00 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 9 3 # 9 B 137 GLY C 50 GLY^? 19.22 CL CL C 129 B 175 ARG C 46 ARG^? 15.12 CL CL C 129 B 242 TYR C 47 TYR^? 14.59 CL CL C 129 coo 99.45 58.28 3.33 99.57 58.61 4.10 95.41 86.26 -32.58 95.19 85.50 -32.58 coo 106.37 63.53 0.89 108.02 63.40 -1.62 92.47 76.70 -34.87 92.87 79.50 -36.04 coo 100.93 69.04 4.38 99.52 68.48 2.09 99.01 77.81 -30.16 99.72 76.81 -27.69 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 10 3 # 10 B 137 GLY C 55 GLY^? -3.60 CL CL C 129s B 175 ARG C 46 ARG^? 15.12 CL CL C 129 B 242 TYR C 47 TYR^? 14.59 CL CL C 129 coo 99.45 58.28 3.33 99.57 58.61 4.10 90.01 71.78 -26.77 90.18 72.34 -27.33 coo 106.37 63.53 0.89 108.02 63.40 -1.62 92.47 76.70 -34.87 92.87 79.50 -36.04 coo 100.93 69.04 4.38 99.52 68.48 2.09 99.01 77.81 -30.16 99.72 76.81 -27.69 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 11 3 # 11 B 137 GLY D 28 GLY^? 24.21 CL CL D 129 B 175 ARG D 73 ARG^? 22.15 CL CL D 129 B 242 TYR D 22 TYR^? 17.52 CL CL D 129 coo 99.45 58.28 3.33 99.57 58.61 4.10 74.11 72.03 -48.24 73.79 72.07 -47.47 coo 106.37 63.53 0.89 108.02 63.40 -1.62 64.06 69.83 -46.45 63.93 71.88 -44.19 coo 100.93 69.04 4.38 99.52 68.48 2.09 67.44 78.74 -43.16 67.49 76.94 -41.01 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 12 3 # 12 B 137 GLY D 50 GLY^? 19.27 CL CL D 129 B 175 ARG D 46 ARG^? 15.13 CL CL D 129 B 242 TYR D 47 TYR^? 14.69 CL CL D 129 coo 99.45 58.28 3.33 99.57 58.61 4.10 63.87 64.31 -32.56 64.09 65.07 -32.58 coo 106.37 63.53 0.89 108.02 63.40 -1.62 66.74 73.93 -35.00 66.45 71.02 -36.02 coo 100.93 69.04 4.38 99.52 68.48 2.09 60.23 72.82 -30.22 59.55 73.80 -27.71 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 13 3 # 13 B 137 GLY D 55 GLY^? -3.63 CL CL D 129s B 175 ARG D 46 ARG^? 15.13 CL CL D 129 B 242 TYR D 47 TYR^? 14.69 CL CL D 129 coo 99.45 58.28 3.33 99.57 58.61 4.10 69.35 78.74 -26.78 69.17 78.19 -27.38 coo 106.37 63.53 0.89 108.02 63.40 -1.62 66.74 73.93 -35.00 66.45 71.02 -36.02 coo 100.93 69.04 4.38 99.52 68.48 2.09 60.23 72.82 -30.22 59.55 73.80 -27.71 1xva_c03 source 1xva GLYCINE N-METHYLTRANSFERASE : 13 hits 1xva_c03 naa= 3 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 1 3 # 1 142 TRP A 39 TRP.? 10.30 CL CL A 129 223 ASP B 5 ASP^? 20.93 CL CL A 129 258 ALA A 88 ALA.? 20.00 CL CL B 129 coo 128.40 33.01 26.67 128.12 36.28 28.81 101.24 49.64 -67.32 101.01 52.25 -64.41 coo 127.91 41.73 23.55 129.18 40.35 24.44 110.10 55.77 -64.66 112.04 55.13 -65.31 coo 141.00 37.49 25.74 139.80 37.53 24.78 101.16 60.49 -76.11 101.18 59.57 -77.33 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 2 3 # 2 142 TRP A 116 TRP^? 22.19 CL CL A 129 223 ASP A 86 ASP.? 23.33 CL CL A 129 258 ALA A 9 ALA~? 22.52 CL CL B 129 coo 128.40 33.01 26.67 128.12 36.28 28.81 104.36 52.76 -78.95 104.76 56.25 -77.21 coo 127.91 41.73 23.55 129.18 40.35 24.44 108.46 57.22 -73.78 109.48 58.49 -72.45 coo 141.00 37.49 25.74 139.80 37.53 24.78 107.68 62.21 -86.60 108.32 62.45 -87.96 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 3 3 # 3 142 TRP A 116 TRP^? 22.19 CL CL A 129 223 ASP A 86 ASP.? 23.33 CL CL A 129 258 ALA A 90 ALA.? 19.12 CL CL B 129 coo 128.40 33.01 26.67 128.12 36.28 28.81 104.36 52.76 -78.95 104.76 56.25 -77.21 coo 127.91 41.73 23.55 129.18 40.35 24.44 108.46 57.22 -73.78 109.48 58.49 -72.45 coo 141.00 37.49 25.74 139.80 37.53 24.78 95.01 60.41 -78.42 95.00 58.95 -78.84 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 4 3 # 4 142 TRP A 116 TRP^? 22.19 CL CL A 129 223 ASP A 86 ASP.? 23.33 CL CL A 129 258 ALA A 120 ALA^? 13.72 CL CL A 129 coo 128.40 33.01 26.67 128.12 36.28 28.81 104.36 52.76 -78.95 104.76 56.25 -77.21 coo 127.91 41.73 23.55 129.18 40.35 24.44 108.46 57.22 -73.78 109.48 58.49 -72.45 coo 141.00 37.49 25.74 139.80 37.53 24.78 94.30 56.05 -68.63 94.53 57.34 -67.75 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 5 3 # 5 142 TRP B 109 TRP^? 18.94 CL CL B 129 223 ASP B 14 ASP^? 27.62 CL CL A 129 258 ALA C 13 ALA^? 16.81 CL CL A 129 coo 128.40 33.01 26.67 128.12 36.28 28.81 97.49 66.86 -64.62 97.45 70.64 -63.54 coo 127.91 41.73 23.55 129.18 40.35 24.44 105.60 69.00 -58.44 107.49 69.47 -57.66 coo 141.00 37.49 25.74 139.80 37.53 24.78 98.64 60.32 -50.92 98.42 59.22 -51.99 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 6 3 # 6 142 TRP B 109 TRP^? 18.94 CL CL B 129 223 ASP B 14 ASP^? 27.62 CL CL A 129 258 ALA C 17 ALA^? 20.57 CL CL A 129 coo 128.40 33.01 26.67 128.12 36.28 28.81 97.49 66.86 -64.62 97.45 70.64 -63.54 coo 127.91 41.73 23.55 129.18 40.35 24.44 105.60 69.00 -58.44 107.49 69.47 -57.66 coo 141.00 37.49 25.74 139.80 37.53 24.78 94.16 64.74 -50.11 93.52 63.43 -50.57 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 7 3 # 7 142 TRP B 109 TRP^? 18.94 CL CL B 129 223 ASP B 86 ASP^? 23.14 CL CL B 129 258 ALA A 88 ALA.? 20.00 CL CL B 129 coo 128.40 33.01 26.67 128.12 36.28 28.81 97.49 66.86 -64.62 97.45 70.64 -63.54 coo 127.91 41.73 23.55 129.18 40.35 24.44 108.40 66.17 -67.38 109.32 64.97 -68.84 coo 141.00 37.49 25.74 139.80 37.53 24.78 101.16 60.49 -76.11 101.18 59.57 -77.33 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 8 3 # 8 142 TRP B 109 TRP^? 18.94 CL CL B 129 223 ASP B 86 ASP^? 23.14 CL CL B 129 258 ALA B 13 ALA^? 24.68 CL CL A 129 coo 128.40 33.01 26.67 128.12 36.28 28.81 97.49 66.86 -64.62 97.45 70.64 -63.54 coo 127.91 41.73 23.55 129.18 40.35 24.44 108.40 66.17 -67.38 109.32 64.97 -68.84 coo 141.00 37.49 25.74 139.80 37.53 24.78 104.32 66.04 -54.76 105.49 66.26 -53.78 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 9 3 # 9 142 TRP B 116 TRP^? 22.29 CL CL B 129 223 ASP B 86 ASP^? 23.14 CL CL B 129 258 ALA B 9 ALA^? 22.60 CL CL A 129 coo 128.40 33.01 26.67 128.12 36.28 28.81 104.47 70.62 -62.04 104.86 67.13 -63.82 coo 127.91 41.73 23.55 129.18 40.35 24.44 108.40 66.17 -67.38 109.32 64.97 -68.84 coo 141.00 37.49 25.74 139.80 37.53 24.78 108.07 61.18 -54.73 108.85 60.95 -53.45 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 10 3 # 10 142 TRP B 116 TRP^? 22.29 CL CL B 129 223 ASP B 86 ASP^? 23.14 CL CL B 129 258 ALA B 90 ALA^? 18.87 CL CL A 129 coo 128.40 33.01 26.67 128.12 36.28 28.81 104.47 70.62 -62.04 104.86 67.13 -63.82 coo 127.91 41.73 23.55 129.18 40.35 24.44 108.40 66.17 -67.38 109.32 64.97 -68.84 coo 141.00 37.49 25.74 139.80 37.53 24.78 95.07 62.93 -62.67 95.13 64.33 -62.19 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 11 3 # 11 142 TRP B 116 TRP^? 22.29 CL CL B 129 223 ASP B 86 ASP^? 23.14 CL CL B 129 258 ALA B 120 ALA^? 13.78 CL CL B 129 coo 128.40 33.01 26.67 128.12 36.28 28.81 104.47 70.62 -62.04 104.86 67.13 -63.82 coo 127.91 41.73 23.55 129.18 40.35 24.44 108.40 66.17 -67.38 109.32 64.97 -68.84 coo 141.00 37.49 25.74 139.80 37.53 24.78 94.31 67.35 -72.53 94.56 66.09 -73.32 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 12 3 # 12 142 TRP C 109 TRP^? 18.92 CL CL C 129 223 ASP C 14 ASP^? 16.95 CL CL A 129 258 ALA B 13 ALA^? 24.68 CL CL A 129 coo 128.40 33.01 26.67 128.12 36.28 28.81 97.95 67.11 -40.99 94.20 67.26 -42.17 coo 127.91 41.73 23.55 129.18 40.35 24.44 95.50 58.88 -47.37 95.04 57.01 -48.29 coo 141.00 37.49 25.74 139.80 37.53 24.78 104.32 66.04 -54.76 105.49 66.26 -53.78 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 13 3 # 13 142 TRP C 109 TRP^? 18.92 CL CL C 129 223 ASP C 14 ASP^? 16.95 CL CL A 129 258 ALA B 17 ALA^? 27.12 CL CL B 129 coo 128.40 33.01 26.67 128.12 36.28 28.81 97.95 67.11 -40.99 94.20 67.26 -42.17 coo 127.91 41.73 23.55 129.18 40.35 24.44 95.50 58.88 -47.37 95.04 57.01 -48.29 coo 141.00 37.49 25.74 139.80 37.53 24.78 99.82 70.45 -55.54 101.06 71.17 -54.97 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 14 3 # 14 142 TRP C 109 TRP^? 18.92 CL CL C 129 223 ASP C 86 ASP^? 23.12 CL CL C 129 258 ALA C 13 ALA^? 16.81 CL CL A 129 coo 128.40 33.01 26.67 128.12 36.28 28.81 97.95 67.11 -40.99 94.20 67.26 -42.17 coo 127.91 41.73 23.55 129.18 40.35 24.44 98.39 56.19 -38.35 99.60 55.15 -36.99 coo 141.00 37.49 25.74 139.80 37.53 24.78 98.64 60.32 -50.92 98.42 59.22 -51.99 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 15 3 # 15 142 TRP C 116 TRP^? 22.09 CL CL C 129 223 ASP C 86 ASP^? 23.12 CL CL C 129 258 ALA C 9 ALA^? 16.58 CL CL A 129 coo 128.40 33.01 26.67 128.12 36.28 28.81 93.93 60.18 -43.49 97.47 59.81 -41.82 coo 127.91 41.73 23.55 129.18 40.35 24.44 98.39 56.19 -38.35 99.60 55.15 -36.99 coo 141.00 37.49 25.74 139.80 37.53 24.78 103.65 56.58 -50.92 103.86 55.75 -52.15 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 16 3 # 16 142 TRP C 116 TRP^? 22.09 CL CL C 129 223 ASP C 86 ASP^? 23.12 CL CL C 129 258 ALA C 90 ALA^? 22.61 CL CL C 129 coo 128.40 33.01 26.67 128.12 36.28 28.81 93.93 60.18 -43.49 97.47 59.81 -41.82 coo 127.91 41.73 23.55 129.18 40.35 24.44 98.39 56.19 -38.35 99.60 55.15 -36.99 coo 141.00 37.49 25.74 139.80 37.53 24.78 101.85 69.57 -42.99 100.42 69.55 -43.49 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 17 3 # 17 142 TRP C 116 TRP^? 22.09 CL CL C 129 223 ASP C 86 ASP^? 23.12 CL CL C 129 258 ALA C 120 ALA^? 13.69 CL CL C 129 coo 128.40 33.01 26.67 128.12 36.28 28.81 93.93 60.18 -43.49 97.47 59.81 -41.82 coo 127.91 41.73 23.55 129.18 40.35 24.44 98.39 56.19 -38.35 99.60 55.15 -36.99 coo 141.00 37.49 25.74 139.80 37.53 24.78 97.38 70.27 -33.15 98.65 69.98 -32.40 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 18 3 # 18 142 TRP D 109 TRP^? 18.96 CL CL D 129 223 ASP D 86 ASP^? 23.19 CL CL D 129 258 ALA D 13 ALA^? 31.05 CL CL D 129 coo 128.40 33.01 26.67 128.12 36.28 28.81 61.45 83.54 -41.13 65.21 83.35 -42.27 coo 127.91 41.73 23.55 129.18 40.35 24.44 60.79 94.39 -38.32 59.49 95.38 -36.98 coo 141.00 37.49 25.74 139.80 37.53 24.78 60.74 90.11 -50.98 60.94 91.23 -52.00 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 19 3 # 19 142 TRP D 116 TRP^? 22.18 CL CL D 129 223 ASP D 86 ASP^? 23.19 CL CL D 129 258 ALA D 9 ALA^? 35.10 CL CL D 129 coo 128.40 33.01 26.67 128.12 36.28 28.81 65.21 90.46 -43.56 61.70 90.81 -41.84 coo 127.91 41.73 23.55 129.18 40.35 24.44 60.79 94.39 -38.32 59.49 95.38 -36.98 coo 141.00 37.49 25.74 139.80 37.53 24.78 55.69 93.75 -51.18 55.39 94.47 -52.49 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 20 3 # 20 142 TRP D 116 TRP^? 22.18 CL CL D 129 223 ASP D 86 ASP^? 23.19 CL CL D 129 258 ALA D 90 ALA^? 22.67 CL CL D 129 coo 128.40 33.01 26.67 128.12 36.28 28.81 65.21 90.46 -43.56 61.70 90.81 -41.84 coo 127.91 41.73 23.55 129.18 40.35 24.44 60.79 94.39 -38.32 59.49 95.38 -36.98 coo 141.00 37.49 25.74 139.80 37.53 24.78 57.47 81.13 -43.09 58.91 81.21 -43.57 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 21 3 # 21 142 TRP D 116 TRP^? 22.18 CL CL D 129 223 ASP D 86 ASP^? 23.19 CL CL D 129 258 ALA D 120 ALA^? 13.80 CL CL D 129 coo 128.40 33.01 26.67 128.12 36.28 28.81 65.21 90.46 -43.56 61.70 90.81 -41.84 coo 127.91 41.73 23.55 129.18 40.35 24.44 60.79 94.39 -38.32 59.49 95.38 -36.98 coo 141.00 37.49 25.74 139.80 37.53 24.78 61.88 80.37 -33.17 60.58 80.64 -32.40 2aat_c01 source 2aat ASPARTATE AMINOTRANSFERASE (E.C.2.6.1.1) MUTAN: 21 hits 2aat_c01 naa= 3 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 1 3 # 1 B 29 HIS A 122 HIS^? 19.05 CL CL A 129 B 50 GLU A 51 GLU^? 16.44 CL CL A 129 B 113 GLN A 105 GLN^? 20.44 CL CL A 129 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 86.83 60.37 -69.40 85.20 61.24 -68.40 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 82.00 50.89 -67.09 80.89 51.23 -68.89 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 88.61 56.98 -76.47 88.98 55.45 -77.91 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 2 3 # 2 B 29 HIS A 122 HIS^? 19.05 CL CL A 129 B 50 GLU A 93 GLU.? 15.26 CL CL B 129 B 113 GLN A 105 GLN^? 20.44 CL CL A 129 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 86.83 60.37 -69.40 85.20 61.24 -68.40 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 84.83 64.69 -81.14 84.26 66.42 -82.32 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 88.61 56.98 -76.47 88.98 55.45 -77.91 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 3 3 # 3 B 29 HIS A 122 HIS^? 19.05 CL CL A 129 B 50 GLU B 51 GLU^? 16.46 CL CL B 129 B 113 GLN B 105 GLN^? 20.41 CL CL B 129 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 86.83 60.37 -69.40 85.20 61.24 -68.40 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 81.98 72.56 -73.89 80.95 72.05 -72.12 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 88.72 66.41 -64.44 89.12 67.99 -63.12 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 4 3 # 4 B 29 HIS B 122 HIS^? 19.12 CL CL B 129 B 50 GLU A 51 GLU^? 16.44 CL CL A 129 B 113 GLN A 105 GLN^? 20.44 CL CL A 129 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 86.93 63.10 -71.62 85.35 62.06 -72.53 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 82.00 50.89 -67.09 80.89 51.23 -68.89 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 88.61 56.98 -76.47 88.98 55.45 -77.91 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 5 3 # 5 B 29 HIS B 122 HIS^? 19.12 CL CL B 129 B 50 GLU B 51 GLU^? 16.46 CL CL B 129 B 113 GLN B 105 GLN^? 20.41 CL CL B 129 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 86.93 63.10 -71.62 85.35 62.06 -72.53 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 81.98 72.56 -73.89 80.95 72.05 -72.12 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 88.72 66.41 -64.44 89.12 67.99 -63.12 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 6 3 # 6 B 29 HIS B 122 HIS^? 19.12 CL CL B 129 B 50 GLU B 93 GLU^? 15.32 CL CL A 129 B 113 GLN B 105 GLN^? 20.41 CL CL B 129 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 86.93 63.10 -71.62 85.35 62.06 -72.53 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 84.67 58.80 -60.02 84.04 57.06 -58.91 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 88.72 66.41 -64.44 89.12 67.99 -63.12 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 7 3 # 7 B 29 HIS C 122 HIS^? 19.06 CL CL C 129 B 50 GLU C 51 GLU^? 16.39 CL CL C 129 B 113 GLN C 105 GLN^? 20.30 CL CL C 129 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 101.68 77.71 -34.10 102.65 79.31 -33.15 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 92.20 82.64 -31.68 92.61 83.59 -33.56 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 98.17 76.17 -41.10 96.60 75.75 -42.46 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 8 3 # 8 B 29 HIS C 122 HIS^? 19.06 CL CL C 129 B 50 GLU C 93 GLU^? 31.51 CL CL C 129 B 113 GLN C 105 GLN^? 20.30 CL CL C 129 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 101.68 77.71 -34.10 102.65 79.31 -33.15 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 105.96 79.95 -45.75 107.72 80.63 -46.81 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 98.17 76.17 -41.10 96.60 75.75 -42.46 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 9 3 # 9 B 29 HIS D 122 HIS^? 19.08 CL CL D 129 B 50 GLU D 51 GLU^? 16.56 CL CL D 129 B 113 GLN D 105 GLN^? 20.18 CL CL D 129 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 57.69 72.86 -34.13 56.74 71.23 -33.18 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 66.99 68.03 -31.91 66.63 66.88 -33.67 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 61.23 74.39 -41.13 62.72 75.17 -42.43 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 10 3 # 10 B 29 HIS D 122 HIS^? 19.08 CL CL D 129 B 50 GLU D 93 GLU^? 31.46 CL CL D 129 B 113 GLN D 105 GLN^? 20.18 CL CL D 129 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 57.69 72.86 -34.13 56.74 71.23 -33.18 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 53.41 70.78 -45.84 51.64 70.26 -46.90 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 61.23 74.39 -41.13 62.72 75.17 -42.43 2ag0_c04 source 2ag0 BENZALDEHYDE LYASE : 10 hits 2ag0_c04 naa= 3 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 1 3 # 1 B 29 HIS A 122 HIS^? 19.05 CL CL A 129 B 50 GLU A 51 GLU^? 16.44 CL CL A 129 B 113 GLN A 105 GLN^? 20.44 CL CL A 129 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 86.83 60.37 -69.40 85.20 61.24 -68.40 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 82.00 50.89 -67.09 80.89 51.23 -68.89 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 88.61 56.98 -76.47 88.98 55.45 -77.91 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 2 3 # 2 B 29 HIS A 122 HIS^? 19.05 CL CL A 129 B 50 GLU A 93 GLU.? 15.26 CL CL B 129 B 113 GLN A 105 GLN^? 20.44 CL CL A 129 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 86.83 60.37 -69.40 85.20 61.24 -68.40 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 84.83 64.69 -81.14 84.26 66.42 -82.32 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 88.61 56.98 -76.47 88.98 55.45 -77.91 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 3 3 # 3 B 29 HIS A 122 HIS^? 19.05 CL CL A 129 B 50 GLU B 51 GLU^? 16.46 CL CL B 129 B 113 GLN B 105 GLN^? 20.41 CL CL B 129 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 86.83 60.37 -69.40 85.20 61.24 -68.40 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 81.98 72.56 -73.89 80.95 72.05 -72.12 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 88.72 66.41 -64.44 89.12 67.99 -63.12 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 4 3 # 4 B 29 HIS B 122 HIS^? 19.12 CL CL B 129 B 50 GLU A 51 GLU^? 16.44 CL CL A 129 B 113 GLN A 105 GLN^? 20.44 CL CL A 129 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 86.93 63.10 -71.62 85.35 62.06 -72.53 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 82.00 50.89 -67.09 80.89 51.23 -68.89 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 88.61 56.98 -76.47 88.98 55.45 -77.91 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 5 3 # 5 B 29 HIS B 122 HIS^? 19.12 CL CL B 129 B 50 GLU B 51 GLU^? 16.46 CL CL B 129 B 113 GLN B 105 GLN^? 20.41 CL CL B 129 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 86.93 63.10 -71.62 85.35 62.06 -72.53 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 81.98 72.56 -73.89 80.95 72.05 -72.12 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 88.72 66.41 -64.44 89.12 67.99 -63.12 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 6 3 # 6 B 29 HIS B 122 HIS^? 19.12 CL CL B 129 B 50 GLU B 93 GLU^? 15.32 CL CL A 129 B 113 GLN B 105 GLN^? 20.41 CL CL B 129 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 86.93 63.10 -71.62 85.35 62.06 -72.53 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 84.67 58.80 -60.02 84.04 57.06 -58.91 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 88.72 66.41 -64.44 89.12 67.99 -63.12 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 7 3 # 7 B 29 HIS C 122 HIS^? 19.06 CL CL C 129 B 50 GLU C 51 GLU^? 16.39 CL CL C 129 B 113 GLN C 105 GLN^? 20.30 CL CL C 129 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 101.68 77.71 -34.10 102.65 79.31 -33.15 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 92.20 82.64 -31.68 92.61 83.59 -33.56 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 98.17 76.17 -41.10 96.60 75.75 -42.46 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 8 3 # 8 B 29 HIS C 122 HIS^? 19.06 CL CL C 129 B 50 GLU C 93 GLU^? 31.51 CL CL C 129 B 113 GLN C 105 GLN^? 20.30 CL CL C 129 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 101.68 77.71 -34.10 102.65 79.31 -33.15 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 105.96 79.95 -45.75 107.72 80.63 -46.81 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 98.17 76.17 -41.10 96.60 75.75 -42.46 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 9 3 # 9 B 29 HIS D 122 HIS^? 19.08 CL CL D 129 B 50 GLU D 51 GLU^? 16.56 CL CL D 129 B 113 GLN D 105 GLN^? 20.18 CL CL D 129 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 57.69 72.86 -34.13 56.74 71.23 -33.18 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 66.99 68.03 -31.91 66.63 66.88 -33.67 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 61.23 74.39 -41.13 62.72 75.17 -42.43 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 10 3 # 10 B 29 HIS D 122 HIS^? 19.08 CL CL D 129 B 50 GLU D 93 GLU^? 31.46 CL CL D 129 B 113 GLN D 105 GLN^? 20.18 CL CL D 129 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 57.69 72.86 -34.13 56.74 71.23 -33.18 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 53.41 70.78 -45.84 51.64 70.26 -46.90 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 61.23 74.39 -41.13 62.72 75.17 -42.43 2ag0_c08 source 2ag0 BENZALDEHYDE LYASE : 10 hits 2ag0_c08 naa= 3 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 1 3 # 1 A 29 HIS A 122 HIS^? 19.05 CL CL A 129 A 50 GLU A 51 GLU^? 16.44 CL CL A 129 A 113 GLN A 105 GLN^? 20.44 CL CL A 129 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 86.83 60.37 -69.40 85.20 61.24 -68.40 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 82.00 50.89 -67.09 80.89 51.23 -68.89 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 88.61 56.98 -76.47 88.98 55.45 -77.91 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 2 3 # 2 A 29 HIS A 122 HIS^? 19.05 CL CL A 129 A 50 GLU A 93 GLU.? 15.26 CL CL B 129 A 113 GLN A 105 GLN^? 20.44 CL CL A 129 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 86.83 60.37 -69.40 85.20 61.24 -68.40 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 84.83 64.69 -81.14 84.26 66.42 -82.32 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 88.61 56.98 -76.47 88.98 55.45 -77.91 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 3 3 # 3 A 29 HIS A 122 HIS^? 19.05 CL CL A 129 A 50 GLU B 51 GLU^? 16.46 CL CL B 129 A 113 GLN B 105 GLN^? 20.41 CL CL B 129 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 86.83 60.37 -69.40 85.20 61.24 -68.40 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 81.98 72.56 -73.89 80.95 72.05 -72.12 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 88.72 66.41 -64.44 89.12 67.99 -63.12 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 4 3 # 4 A 29 HIS B 122 HIS^? 19.12 CL CL B 129 A 50 GLU A 51 GLU^? 16.44 CL CL A 129 A 113 GLN A 105 GLN^? 20.44 CL CL A 129 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 86.93 63.10 -71.62 85.35 62.06 -72.53 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 82.00 50.89 -67.09 80.89 51.23 -68.89 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 88.61 56.98 -76.47 88.98 55.45 -77.91 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 5 3 # 5 A 29 HIS B 122 HIS^? 19.12 CL CL B 129 A 50 GLU B 51 GLU^? 16.46 CL CL B 129 A 113 GLN B 105 GLN^? 20.41 CL CL B 129 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 86.93 63.10 -71.62 85.35 62.06 -72.53 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 81.98 72.56 -73.89 80.95 72.05 -72.12 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 88.72 66.41 -64.44 89.12 67.99 -63.12 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 6 3 # 6 A 29 HIS B 122 HIS^? 19.12 CL CL B 129 A 50 GLU B 93 GLU^? 15.32 CL CL A 129 A 113 GLN B 105 GLN^? 20.41 CL CL B 129 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 86.93 63.10 -71.62 85.35 62.06 -72.53 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 84.67 58.80 -60.02 84.04 57.06 -58.91 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 88.72 66.41 -64.44 89.12 67.99 -63.12 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 7 3 # 7 A 29 HIS C 122 HIS^? 19.06 CL CL C 129 A 50 GLU C 51 GLU^? 16.39 CL CL C 129 A 113 GLN C 105 GLN^? 20.30 CL CL C 129 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 101.68 77.71 -34.10 102.65 79.31 -33.15 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 92.20 82.64 -31.68 92.61 83.59 -33.56 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 98.17 76.17 -41.10 96.60 75.75 -42.46 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 8 3 # 8 A 29 HIS C 122 HIS^? 19.06 CL CL C 129 A 50 GLU C 93 GLU^? 31.51 CL CL C 129 A 113 GLN C 105 GLN^? 20.30 CL CL C 129 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 101.68 77.71 -34.10 102.65 79.31 -33.15 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 105.96 79.95 -45.75 107.72 80.63 -46.81 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 98.17 76.17 -41.10 96.60 75.75 -42.46 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 9 3 # 9 A 29 HIS D 122 HIS^? 19.08 CL CL D 129 A 50 GLU D 51 GLU^? 16.56 CL CL D 129 A 113 GLN D 105 GLN^? 20.18 CL CL D 129 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 57.69 72.86 -34.13 56.74 71.23 -33.18 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 66.99 68.03 -31.91 66.63 66.88 -33.67 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 61.23 74.39 -41.13 62.72 75.17 -42.43 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 10 3 # 10 A 29 HIS D 122 HIS^? 19.08 CL CL D 129 A 50 GLU D 93 GLU^? 31.46 CL CL D 129 A 113 GLN D 105 GLN^? 20.18 CL CL D 129 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 57.69 72.86 -34.13 56.74 71.23 -33.18 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 53.41 70.78 -45.84 51.64 70.26 -46.90 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 61.23 74.39 -41.13 62.72 75.17 -42.43 2ag0_c09 source 2ag0 BENZALDEHYDE LYASE : 10 hits 2ag0_c09 naa= 3 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 1 3 # 1 C 29 HIS A 122 HIS^? 19.05 CL CL A 129 C 50 GLU A 51 GLU^? 16.44 CL CL A 129 C 113 GLN A 105 GLN^? 20.44 CL CL A 129 coo 74.92 8.52 28.42 74.88 6.86 29.70 86.83 60.37 -69.40 85.20 61.24 -68.40 coo 65.25 15.95 28.73 65.73 15.63 30.78 82.00 50.89 -67.09 80.89 51.23 -68.89 coo 70.80 6.73 32.72 71.88 8.55 32.53 88.61 56.98 -76.47 88.98 55.45 -77.91 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 2 3 # 2 C 29 HIS A 122 HIS^? 19.05 CL CL A 129 C 50 GLU A 93 GLU.? 15.26 CL CL B 129 C 113 GLN A 105 GLN^? 20.44 CL CL A 129 coo 74.92 8.52 28.42 74.88 6.86 29.70 86.83 60.37 -69.40 85.20 61.24 -68.40 coo 65.25 15.95 28.73 65.73 15.63 30.78 84.83 64.69 -81.14 84.26 66.42 -82.32 coo 70.80 6.73 32.72 71.88 8.55 32.53 88.61 56.98 -76.47 88.98 55.45 -77.91 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 3 3 # 3 C 29 HIS A 122 HIS^? 19.05 CL CL A 129 C 50 GLU B 51 GLU^? 16.46 CL CL B 129 C 113 GLN B 105 GLN^? 20.41 CL CL B 129 coo 74.92 8.52 28.42 74.88 6.86 29.70 86.83 60.37 -69.40 85.20 61.24 -68.40 coo 65.25 15.95 28.73 65.73 15.63 30.78 81.98 72.56 -73.89 80.95 72.05 -72.12 coo 70.80 6.73 32.72 71.88 8.55 32.53 88.72 66.41 -64.44 89.12 67.99 -63.12 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 4 3 # 4 C 29 HIS B 122 HIS^? 19.12 CL CL B 129 C 50 GLU A 51 GLU^? 16.44 CL CL A 129 C 113 GLN A 105 GLN^? 20.44 CL CL A 129 coo 74.92 8.52 28.42 74.88 6.86 29.70 86.93 63.10 -71.62 85.35 62.06 -72.53 coo 65.25 15.95 28.73 65.73 15.63 30.78 82.00 50.89 -67.09 80.89 51.23 -68.89 coo 70.80 6.73 32.72 71.88 8.55 32.53 88.61 56.98 -76.47 88.98 55.45 -77.91 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 5 3 # 5 C 29 HIS B 122 HIS^? 19.12 CL CL B 129 C 50 GLU B 51 GLU^? 16.46 CL CL B 129 C 113 GLN B 105 GLN^? 20.41 CL CL B 129 coo 74.92 8.52 28.42 74.88 6.86 29.70 86.93 63.10 -71.62 85.35 62.06 -72.53 coo 65.25 15.95 28.73 65.73 15.63 30.78 81.98 72.56 -73.89 80.95 72.05 -72.12 coo 70.80 6.73 32.72 71.88 8.55 32.53 88.72 66.41 -64.44 89.12 67.99 -63.12 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 6 3 # 6 C 29 HIS B 122 HIS^? 19.12 CL CL B 129 C 50 GLU B 93 GLU^? 15.32 CL CL A 129 C 113 GLN B 105 GLN^? 20.41 CL CL B 129 coo 74.92 8.52 28.42 74.88 6.86 29.70 86.93 63.10 -71.62 85.35 62.06 -72.53 coo 65.25 15.95 28.73 65.73 15.63 30.78 84.67 58.80 -60.02 84.04 57.06 -58.91 coo 70.80 6.73 32.72 71.88 8.55 32.53 88.72 66.41 -64.44 89.12 67.99 -63.12 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 7 3 # 7 C 29 HIS C 122 HIS^? 19.06 CL CL C 129 C 50 GLU C 51 GLU^? 16.39 CL CL C 129 C 113 GLN C 105 GLN^? 20.30 CL CL C 129 coo 74.92 8.52 28.42 74.88 6.86 29.70 101.68 77.71 -34.10 102.65 79.31 -33.15 coo 65.25 15.95 28.73 65.73 15.63 30.78 92.20 82.64 -31.68 92.61 83.59 -33.56 coo 70.80 6.73 32.72 71.88 8.55 32.53 98.17 76.17 -41.10 96.60 75.75 -42.46 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 8 3 # 8 C 29 HIS C 122 HIS^? 19.06 CL CL C 129 C 50 GLU C 93 GLU^? 31.51 CL CL C 129 C 113 GLN C 105 GLN^? 20.30 CL CL C 129 coo 74.92 8.52 28.42 74.88 6.86 29.70 101.68 77.71 -34.10 102.65 79.31 -33.15 coo 65.25 15.95 28.73 65.73 15.63 30.78 105.96 79.95 -45.75 107.72 80.63 -46.81 coo 70.80 6.73 32.72 71.88 8.55 32.53 98.17 76.17 -41.10 96.60 75.75 -42.46 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 9 3 # 9 C 29 HIS D 122 HIS^? 19.08 CL CL D 129 C 50 GLU D 51 GLU^? 16.56 CL CL D 129 C 113 GLN D 105 GLN^? 20.18 CL CL D 129 coo 74.92 8.52 28.42 74.88 6.86 29.70 57.69 72.86 -34.13 56.74 71.23 -33.18 coo 65.25 15.95 28.73 65.73 15.63 30.78 66.99 68.03 -31.91 66.63 66.88 -33.67 coo 70.80 6.73 32.72 71.88 8.55 32.53 61.23 74.39 -41.13 62.72 75.17 -42.43 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 10 3 # 10 C 29 HIS D 122 HIS^? 19.08 CL CL D 129 C 50 GLU D 93 GLU^? 31.46 CL CL D 129 C 113 GLN D 105 GLN^? 20.18 CL CL D 129 coo 74.92 8.52 28.42 74.88 6.86 29.70 57.69 72.86 -34.13 56.74 71.23 -33.18 coo 65.25 15.95 28.73 65.73 15.63 30.78 53.41 70.78 -45.84 51.64 70.26 -46.90 coo 70.80 6.73 32.72 71.88 8.55 32.53 61.23 74.39 -41.13 62.72 75.17 -42.43 2ag0_c10 source 2ag0 BENZALDEHYDE LYASE : 10 hits 2ag0_c10 naa= 3 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 1 3 # 1 D 29 HIS A 122 HIS^? 19.05 CL CL A 129 D 50 GLU A 51 GLU^? 16.44 CL CL A 129 D 113 GLN A 105 GLN^? 20.44 CL CL A 129 coo 38.66 11.31 27.15 38.67 12.13 25.22 86.83 60.37 -69.40 85.20 61.24 -68.40 coo 48.72 12.85 33.83 48.36 14.77 32.95 82.00 50.89 -67.09 80.89 51.23 -68.89 coo 42.85 14.77 24.15 41.85 15.11 26.02 88.61 56.98 -76.47 88.98 55.45 -77.91 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 2 3 # 2 D 29 HIS A 122 HIS^? 19.05 CL CL A 129 D 50 GLU A 93 GLU.? 15.26 CL CL B 129 D 113 GLN A 105 GLN^? 20.44 CL CL A 129 coo 38.66 11.31 27.15 38.67 12.13 25.22 86.83 60.37 -69.40 85.20 61.24 -68.40 coo 48.72 12.85 33.83 48.36 14.77 32.95 84.83 64.69 -81.14 84.26 66.42 -82.32 coo 42.85 14.77 24.15 41.85 15.11 26.02 88.61 56.98 -76.47 88.98 55.45 -77.91 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 3 3 # 3 D 29 HIS A 122 HIS^? 19.05 CL CL A 129 D 50 GLU B 51 GLU^? 16.46 CL CL B 129 D 113 GLN B 105 GLN^? 20.41 CL CL B 129 coo 38.66 11.31 27.15 38.67 12.13 25.22 86.83 60.37 -69.40 85.20 61.24 -68.40 coo 48.72 12.85 33.83 48.36 14.77 32.95 81.98 72.56 -73.89 80.95 72.05 -72.12 coo 42.85 14.77 24.15 41.85 15.11 26.02 88.72 66.41 -64.44 89.12 67.99 -63.12 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 4 3 # 4 D 29 HIS B 122 HIS^? 19.12 CL CL B 129 D 50 GLU A 51 GLU^? 16.44 CL CL A 129 D 113 GLN A 105 GLN^? 20.44 CL CL A 129 coo 38.66 11.31 27.15 38.67 12.13 25.22 86.93 63.10 -71.62 85.35 62.06 -72.53 coo 48.72 12.85 33.83 48.36 14.77 32.95 82.00 50.89 -67.09 80.89 51.23 -68.89 coo 42.85 14.77 24.15 41.85 15.11 26.02 88.61 56.98 -76.47 88.98 55.45 -77.91 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 5 3 # 5 D 29 HIS B 122 HIS^? 19.12 CL CL B 129 D 50 GLU B 51 GLU^? 16.46 CL CL B 129 D 113 GLN B 105 GLN^? 20.41 CL CL B 129 coo 38.66 11.31 27.15 38.67 12.13 25.22 86.93 63.10 -71.62 85.35 62.06 -72.53 coo 48.72 12.85 33.83 48.36 14.77 32.95 81.98 72.56 -73.89 80.95 72.05 -72.12 coo 42.85 14.77 24.15 41.85 15.11 26.02 88.72 66.41 -64.44 89.12 67.99 -63.12 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 6 3 # 6 D 29 HIS B 122 HIS^? 19.12 CL CL B 129 D 50 GLU B 93 GLU^? 15.32 CL CL A 129 D 113 GLN B 105 GLN^? 20.41 CL CL B 129 coo 38.66 11.31 27.15 38.67 12.13 25.22 86.93 63.10 -71.62 85.35 62.06 -72.53 coo 48.72 12.85 33.83 48.36 14.77 32.95 84.67 58.80 -60.02 84.04 57.06 -58.91 coo 42.85 14.77 24.15 41.85 15.11 26.02 88.72 66.41 -64.44 89.12 67.99 -63.12 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 7 3 # 7 D 29 HIS C 122 HIS^? 19.06 CL CL C 129 D 50 GLU C 51 GLU^? 16.39 CL CL C 129 D 113 GLN C 105 GLN^? 20.30 CL CL C 129 coo 38.66 11.31 27.15 38.67 12.13 25.22 101.68 77.71 -34.10 102.65 79.31 -33.15 coo 48.72 12.85 33.83 48.36 14.77 32.95 92.20 82.64 -31.68 92.61 83.59 -33.56 coo 42.85 14.77 24.15 41.85 15.11 26.02 98.17 76.17 -41.10 96.60 75.75 -42.46 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 8 3 # 8 D 29 HIS C 122 HIS^? 19.06 CL CL C 129 D 50 GLU C 93 GLU^? 31.51 CL CL C 129 D 113 GLN C 105 GLN^? 20.30 CL CL C 129 coo 38.66 11.31 27.15 38.67 12.13 25.22 101.68 77.71 -34.10 102.65 79.31 -33.15 coo 48.72 12.85 33.83 48.36 14.77 32.95 105.96 79.95 -45.75 107.72 80.63 -46.81 coo 42.85 14.77 24.15 41.85 15.11 26.02 98.17 76.17 -41.10 96.60 75.75 -42.46 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 9 3 # 9 D 29 HIS D 122 HIS^? 19.08 CL CL D 129 D 50 GLU D 51 GLU^? 16.56 CL CL D 129 D 113 GLN D 105 GLN^? 20.18 CL CL D 129 coo 38.66 11.31 27.15 38.67 12.13 25.22 57.69 72.86 -34.13 56.74 71.23 -33.18 coo 48.72 12.85 33.83 48.36 14.77 32.95 66.99 68.03 -31.91 66.63 66.88 -33.67 coo 42.85 14.77 24.15 41.85 15.11 26.02 61.23 74.39 -41.13 62.72 75.17 -42.43 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 10 3 # 10 D 29 HIS D 122 HIS^? 19.08 CL CL D 129 D 50 GLU D 93 GLU^? 31.46 CL CL D 129 D 113 GLN D 105 GLN^? 20.18 CL CL D 129 coo 38.66 11.31 27.15 38.67 12.13 25.22 57.69 72.86 -34.13 56.74 71.23 -33.18 coo 48.72 12.85 33.83 48.36 14.77 32.95 53.41 70.78 -45.84 51.64 70.26 -46.90 coo 42.85 14.77 24.15 41.85 15.11 26.02 61.23 74.39 -41.13 62.72 75.17 -42.43 2ag0_c11 source 2ag0 BENZALDEHYDE LYASE : 10 hits 2ag0_c11 naa= 3 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 3 # 1 193 ASP A 35 ASP~? 10.31 CL CL A 129 231 ASP A 86 ASP.? 23.33 CL CL A 129 294 ASP A 30 ASP~? 20.80 CL CL A 129 coo 27.89 102.52 14.98 29.35 101.92 13.57 93.79 42.35 -72.20 94.79 41.97 -70.38 coo 14.74 93.05 -1.00 14.30 94.22 0.73 108.46 57.22 -73.78 109.48 58.49 -72.45 coo 33.16 106.80 7.72 33.34 104.87 6.92 90.38 41.71 -80.87 92.04 40.39 -80.79 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 2 3 # 2 193 ASP B 5 ASP^? 20.93 CL CL A 129 231 ASP C 14 ASP^? 16.95 CL CL A 129 294 ASP B 86 ASP^? 23.14 CL CL B 129 coo 27.89 102.52 14.98 29.35 101.92 13.57 110.10 55.77 -64.66 112.04 55.13 -65.31 coo 14.74 93.05 -1.00 14.30 94.22 0.73 95.50 58.88 -47.37 95.04 57.01 -48.29 coo 33.16 106.80 7.72 33.34 104.87 6.92 108.40 66.17 -67.38 109.32 64.97 -68.84 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 3 3 # 3 193 ASP B 35 ASP^? 10.19 CL CL B 129 231 ASP B 86 ASP^? 23.14 CL CL B 129 294 ASP B 30 ASP^? 20.91 CL CL B 129 coo 27.89 102.52 14.98 29.35 101.92 13.57 93.79 80.98 -68.72 94.61 81.32 -70.62 coo 14.74 93.05 -1.00 14.30 94.22 0.73 108.40 66.17 -67.38 109.32 64.97 -68.84 coo 33.16 106.80 7.72 33.34 104.87 6.92 90.60 81.40 -60.16 92.15 82.83 -59.97 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 4 3 # 4 193 ASP B 72 ASP^? 28.57 CL CL C 129 231 ASP C 14 ASP^? 16.95 CL CL A 129 294 ASP D 30 ASP^? 20.62 CL CL D 129 coo 27.89 102.52 14.98 29.35 101.92 13.57 80.87 74.36 -54.99 81.74 73.36 -53.35 coo 14.74 93.05 -1.00 14.30 94.22 0.73 95.50 58.88 -47.37 95.04 57.01 -48.29 coo 33.16 106.80 7.72 33.34 104.87 6.92 76.16 76.40 -45.40 77.49 78.05 -45.35 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 5 3 # 5 193 ASP B 86 ASP^? 23.14 CL CL B 129 231 ASP B 30 ASP^? 20.91 CL CL B 129 294 ASP B 10 ASP^? 27.46 CL CL A 129 coo 27.89 102.52 14.98 29.35 101.92 13.57 108.40 66.17 -67.38 109.32 64.97 -68.84 coo 14.74 93.05 -1.00 14.30 94.22 0.73 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 33.16 106.80 7.72 33.34 104.87 6.92 110.59 65.11 -56.28 111.89 65.48 -54.65 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 6 3 # 6 193 ASP B 86 ASP^? 23.14 CL CL B 129 231 ASP B 35 ASP^? 10.19 CL CL B 129 294 ASP A 5 ASP~? 21.13 CL CL B 129 coo 27.89 102.52 14.98 29.35 101.92 13.57 108.40 66.17 -67.38 109.32 64.97 -68.84 coo 14.74 93.05 -1.00 14.30 94.22 0.73 93.79 80.98 -68.72 94.61 81.32 -70.62 coo 33.16 106.80 7.72 33.34 104.87 6.92 110.30 67.66 -76.72 112.26 68.26 -76.10 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 7 3 # 7 193 ASP B 86 ASP^? 23.14 CL CL B 129 231 ASP B 35 ASP^? 10.19 CL CL B 129 294 ASP B 10 ASP^? 27.46 CL CL A 129 coo 27.89 102.52 14.98 29.35 101.92 13.57 108.40 66.17 -67.38 109.32 64.97 -68.84 coo 14.74 93.05 -1.00 14.30 94.22 0.73 93.79 80.98 -68.72 94.61 81.32 -70.62 coo 33.16 106.80 7.72 33.34 104.87 6.92 110.59 65.11 -56.28 111.89 65.48 -54.65 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 8 3 # 8 193 ASP B 86 ASP^? 23.14 CL CL B 129 231 ASP C 10 ASP^? 12.83 CL CL A 129 294 ASP A 86 ASP.? 23.33 CL CL A 129 coo 27.89 102.52 14.98 29.35 101.92 13.57 108.40 66.17 -67.38 109.32 64.97 -68.84 coo 14.74 93.05 -1.00 14.30 94.22 0.73 99.63 54.02 -49.94 99.45 52.98 -51.81 coo 33.16 106.80 7.72 33.34 104.87 6.92 108.46 57.22 -73.78 109.48 58.49 -72.45 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 9 3 # 9 193 ASP C 5 ASP^? 26.16 CL CL A 129 231 ASP A 41 ASP.? 7.60 CL CL A 129 294 ASP C 86 ASP^? 23.12 CL CL C 129 coo 27.89 102.52 14.98 29.35 101.92 13.57 108.85 54.21 -41.41 109.64 52.31 -40.89 coo 14.74 93.05 -1.00 14.30 94.22 0.73 99.56 48.98 -63.34 100.43 49.52 -61.53 coo 33.16 106.80 7.72 33.34 104.87 6.92 98.39 56.19 -38.35 99.60 55.15 -36.99 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 10 3 # 10 193 ASP C 5 ASP^? 26.16 CL CL A 129 231 ASP B 14 ASP^? 27.62 CL CL A 129 294 ASP C 86 ASP^? 23.12 CL CL C 129 coo 27.89 102.52 14.98 29.35 101.92 13.57 108.85 54.21 -41.41 109.64 52.31 -40.89 coo 14.74 93.05 -1.00 14.30 94.22 0.73 105.60 69.00 -58.44 107.49 69.47 -57.66 coo 33.16 106.80 7.72 33.34 104.87 6.92 98.39 56.19 -38.35 99.60 55.15 -36.99 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 11 3 # 11 193 ASP C 35 ASP^? 10.26 CL CL C 129 231 ASP D 41 ASP^? 7.55 CL CL D 129 294 ASP C 30 ASP^? 20.67 CL CL C 129 coo 27.89 102.52 14.98 29.35 101.92 13.57 83.63 70.73 -36.85 83.32 69.81 -34.96 coo 14.74 93.05 -1.00 14.30 94.22 0.73 69.10 85.54 -28.07 68.60 86.44 -26.19 coo 33.16 106.80 7.72 33.34 104.87 6.92 83.14 74.18 -45.33 81.79 72.55 -45.31 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 12 3 # 12 193 ASP C 86 ASP^? 23.12 CL CL C 129 231 ASP C 30 ASP^? 20.67 CL CL C 129 294 ASP C 10 ASP^? 12.83 CL CL A 129 coo 27.89 102.52 14.98 29.35 101.92 13.57 98.39 56.19 -38.35 99.60 55.15 -36.99 coo 14.74 93.05 -1.00 14.30 94.22 0.73 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 33.16 106.80 7.72 33.34 104.87 6.92 99.63 54.02 -49.94 99.45 52.98 -51.81 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 13 3 # 13 193 ASP D 35 ASP^? 10.18 CL CL D 129 231 ASP C 41 ASP^? 7.58 CL CL C 129 294 ASP D 30 ASP^? 20.62 CL CL D 129 coo 27.89 102.52 14.98 29.35 101.92 13.57 75.66 79.96 -36.93 75.99 80.66 -34.97 coo 14.74 93.05 -1.00 14.30 94.22 0.73 90.28 65.09 -27.98 90.77 64.12 -26.18 coo 33.16 106.80 7.72 33.34 104.87 6.92 76.16 76.40 -45.40 77.49 78.05 -45.35 2amg_c06 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 13 hits 2amg_c06 naa= 3 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 1 3 # 1 B 46 HIS A 122 HIS^? 19.05 CL CL A 129 B 163 ALA A 49 ALA.? 20.89 CL CL A 129 B 182 SER A 124 SER^? 21.51 CL CL B 129 coo 30.42 1.98 4.36 29.07 0.41 4.68 86.83 60.37 -69.40 85.20 61.24 -68.40 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 80.14 55.77 -70.80 79.39 55.32 -72.04 coo 24.00 -0.17 2.07 24.51 1.00 0.04 81.71 59.41 -72.63 82.35 61.73 -72.29 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 2 3 # 2 B 46 HIS A 122 HIS^? 19.05 CL CL A 129 B 163 ALA B 49 ALA^? 20.99 CL CL B 129 B 182 SER B 124 SER^? 21.49 CL CL A 129 coo 30.42 1.98 4.36 29.07 0.41 4.68 86.83 60.37 -69.40 85.20 61.24 -68.40 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 80.08 67.54 -70.23 79.32 68.03 -68.99 coo 24.00 -0.17 2.07 24.51 1.00 0.04 81.67 64.01 -68.38 82.23 61.67 -68.72 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 3 3 # 3 B 46 HIS B 122 HIS^? 19.12 CL CL B 129 B 163 ALA B 49 ALA^? 20.99 CL CL B 129 B 182 SER B 124 SER^? 21.49 CL CL A 129 coo 30.42 1.98 4.36 29.07 0.41 4.68 86.93 63.10 -71.62 85.35 62.06 -72.53 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 80.08 67.54 -70.23 79.32 68.03 -68.99 coo 24.00 -0.17 2.07 24.51 1.00 0.04 81.67 64.01 -68.38 82.23 61.67 -68.72 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 4 3 # 4 B 46 HIS C 122 HIS^? 19.06 CL CL C 129 B 163 ALA C 49 ALA^? 20.87 CL CL C 129 B 182 SER C 124 SER^? 23.20 CL CL C 129 coo 30.42 1.98 4.36 29.07 0.41 4.68 101.68 77.71 -34.10 102.65 79.31 -33.15 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 97.10 84.42 -35.47 96.69 85.13 -36.72 coo 24.00 -0.17 2.07 24.51 1.00 0.04 100.74 82.83 -37.31 103.10 82.20 -37.27 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 5 3 # 5 B 46 HIS D 122 HIS^? 19.08 CL CL D 129 B 163 ALA D 49 ALA^? 20.88 CL CL D 129 B 182 SER D 124 SER^? 23.07 CL CL D 129 coo 30.42 1.98 4.36 29.07 0.41 4.68 57.69 72.86 -34.13 56.74 71.23 -33.18 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 62.13 66.16 -35.44 62.61 65.45 -36.70 coo 24.00 -0.17 2.07 24.51 1.00 0.04 58.66 67.61 -37.34 56.37 68.29 -37.09 2bhg_c02 source 2bhg FOOT-AND-MOUTH DISEASE VIRUS 3C PROTEASE : 5 hits 2bhg_c02 naa= 3 ULMN 3 2dbt_c00 CHITINASE C user 1 3 # 1 A 147 GLU A 58 GLU~? 7.41 CL CL A 129 A 156 GLU A 42 GLU.? 5.77 CL CL A 129 A 194 ASN B 77 ASN^? 14.36 CL CL A 129 coo 74.14 15.91 8.55 72.08 15.36 8.63 87.85 46.74 -60.89 87.27 48.56 -59.93 coo 67.47 20.07 1.34 65.99 20.06 2.88 98.04 48.44 -58.38 99.25 46.68 -58.65 coo 67.44 25.26 13.91 67.54 23.65 15.28 87.37 57.25 -56.67 85.96 56.21 -55.44 ULMN 3 2dbt_c00 CHITINASE C user 2 3 # 2 A 147 GLU A 58 GLU~? 7.41 CL CL A 129 A 156 GLU A 51 GLU^? 16.44 CL CL A 129 A 194 ASN B 77 ASN^? 14.36 CL CL A 129 coo 74.14 15.91 8.55 72.08 15.36 8.63 87.85 46.74 -60.89 87.27 48.56 -59.93 coo 67.47 20.07 1.34 65.99 20.06 2.88 82.00 50.89 -67.09 80.89 51.23 -68.89 coo 67.44 25.26 13.91 67.54 23.65 15.28 87.37 57.25 -56.67 85.96 56.21 -55.44 ULMN 3 2dbt_c00 CHITINASE C user 3 3 # 3 A 147 GLU B 42 GLU^? 6.42 CL CL B 129 A 156 GLU B 58 GLU^? 7.34 CL CL B 129 A 194 ASN A 77 ASN^? 14.66 CL CL B 129 coo 74.14 15.91 8.55 72.08 15.36 8.63 97.73 74.53 -82.81 99.44 75.81 -82.79 coo 67.47 20.07 1.34 65.99 20.06 2.88 87.90 76.66 -80.19 87.42 74.86 -81.30 coo 67.44 25.26 13.91 67.54 23.65 15.28 87.29 65.89 -84.51 85.99 67.02 -85.80 ULMN 3 2dbt_c00 CHITINASE C user 4 3 # 4 A 147 GLU B 51 GLU^? 16.46 CL CL B 129 A 156 GLU B 58 GLU^? 7.34 CL CL B 129 A 194 ASN A 77 ASN^? 14.66 CL CL B 129 coo 74.14 15.91 8.55 72.08 15.36 8.63 81.98 72.56 -73.89 80.95 72.05 -72.12 coo 67.47 20.07 1.34 65.99 20.06 2.88 87.90 76.66 -80.19 87.42 74.86 -81.30 coo 67.44 25.26 13.91 67.54 23.65 15.28 87.29 65.89 -84.51 85.99 67.02 -85.80 ULMN 3 2dbt_c00 CHITINASE C user 5 3 # 5 A 147 GLU B 58 GLU^? 7.34 CL CL B 129 A 156 GLU B 42 GLU^? 6.42 CL CL B 129 A 194 ASN A 77 ASN^? 14.66 CL CL B 129 coo 74.14 15.91 8.55 72.08 15.36 8.63 87.90 76.66 -80.19 87.42 74.86 -81.30 coo 67.47 20.07 1.34 65.99 20.06 2.88 97.73 74.53 -82.81 99.44 75.81 -82.79 coo 67.44 25.26 13.91 67.54 23.65 15.28 87.29 65.89 -84.51 85.99 67.02 -85.80 ULMN 3 2dbt_c00 CHITINASE C user 6 3 # 6 A 147 GLU B 58 GLU^? 7.34 CL CL B 129 A 156 GLU B 51 GLU^? 16.46 CL CL B 129 A 194 ASN A 77 ASN^? 14.66 CL CL B 129 coo 74.14 15.91 8.55 72.08 15.36 8.63 87.90 76.66 -80.19 87.42 74.86 -81.30 coo 67.47 20.07 1.34 65.99 20.06 2.88 81.98 72.56 -73.89 80.95 72.05 -72.12 coo 67.44 25.26 13.91 67.54 23.65 15.28 87.29 65.89 -84.51 85.99 67.02 -85.80 2dbt_c00 source 2dbt CHITINASE C : 6 hits 2dbt_c00 naa= 3 ULMN 3 2dbt_c01 CHITINASE C user 1 3 # 1 B 147 GLU A 42 GLU.? 5.77 CL CL A 129 B 156 GLU A 58 GLU~? 7.41 CL CL A 129 B 194 ASN B 77 ASN^? 14.36 CL CL A 129 coo 45.64 63.11 17.20 47.48 62.43 16.45 98.04 48.44 -58.38 99.25 46.68 -58.65 coo 54.43 67.89 19.82 55.62 67.90 18.07 87.85 46.74 -60.89 87.27 48.56 -59.93 coo 49.79 70.75 7.78 50.10 68.90 6.86 87.37 57.25 -56.67 85.96 56.21 -55.44 ULMN 3 2dbt_c01 CHITINASE C user 2 3 # 2 B 147 GLU A 51 GLU^? 16.44 CL CL A 129 B 156 GLU A 58 GLU~? 7.41 CL CL A 129 B 194 ASN B 77 ASN^? 14.36 CL CL A 129 coo 45.64 63.11 17.20 47.48 62.43 16.45 82.00 50.89 -67.09 80.89 51.23 -68.89 coo 54.43 67.89 19.82 55.62 67.90 18.07 87.85 46.74 -60.89 87.27 48.56 -59.93 coo 49.79 70.75 7.78 50.10 68.90 6.86 87.37 57.25 -56.67 85.96 56.21 -55.44 ULMN 3 2dbt_c01 CHITINASE C user 3 3 # 3 B 147 GLU A 58 GLU~? 7.41 CL CL A 129 B 156 GLU A 42 GLU.? 5.77 CL CL A 129 B 194 ASN B 77 ASN^? 14.36 CL CL A 129 coo 45.64 63.11 17.20 47.48 62.43 16.45 87.85 46.74 -60.89 87.27 48.56 -59.93 coo 54.43 67.89 19.82 55.62 67.90 18.07 98.04 48.44 -58.38 99.25 46.68 -58.65 coo 49.79 70.75 7.78 50.10 68.90 6.86 87.37 57.25 -56.67 85.96 56.21 -55.44 ULMN 3 2dbt_c01 CHITINASE C user 4 3 # 4 B 147 GLU A 58 GLU~? 7.41 CL CL A 129 B 156 GLU A 51 GLU^? 16.44 CL CL A 129 B 194 ASN B 77 ASN^? 14.36 CL CL A 129 coo 45.64 63.11 17.20 47.48 62.43 16.45 87.85 46.74 -60.89 87.27 48.56 -59.93 coo 54.43 67.89 19.82 55.62 67.90 18.07 82.00 50.89 -67.09 80.89 51.23 -68.89 coo 49.79 70.75 7.78 50.10 68.90 6.86 87.37 57.25 -56.67 85.96 56.21 -55.44 ULMN 3 2dbt_c01 CHITINASE C user 5 3 # 5 B 147 GLU B 42 GLU^? 6.42 CL CL B 129 B 156 GLU B 58 GLU^? 7.34 CL CL B 129 B 194 ASN A 77 ASN^? 14.66 CL CL B 129 coo 45.64 63.11 17.20 47.48 62.43 16.45 97.73 74.53 -82.81 99.44 75.81 -82.79 coo 54.43 67.89 19.82 55.62 67.90 18.07 87.90 76.66 -80.19 87.42 74.86 -81.30 coo 49.79 70.75 7.78 50.10 68.90 6.86 87.29 65.89 -84.51 85.99 67.02 -85.80 ULMN 3 2dbt_c01 CHITINASE C user 6 3 # 6 B 147 GLU B 51 GLU^? 16.46 CL CL B 129 B 156 GLU B 58 GLU^? 7.34 CL CL B 129 B 194 ASN A 77 ASN^? 14.66 CL CL B 129 coo 45.64 63.11 17.20 47.48 62.43 16.45 81.98 72.56 -73.89 80.95 72.05 -72.12 coo 54.43 67.89 19.82 55.62 67.90 18.07 87.90 76.66 -80.19 87.42 74.86 -81.30 coo 49.79 70.75 7.78 50.10 68.90 6.86 87.29 65.89 -84.51 85.99 67.02 -85.80 ULMN 3 2dbt_c01 CHITINASE C user 7 3 # 7 B 147 GLU B 58 GLU^? 7.34 CL CL B 129 B 156 GLU B 42 GLU^? 6.42 CL CL B 129 B 194 ASN A 77 ASN^? 14.66 CL CL B 129 coo 45.64 63.11 17.20 47.48 62.43 16.45 87.90 76.66 -80.19 87.42 74.86 -81.30 coo 54.43 67.89 19.82 55.62 67.90 18.07 97.73 74.53 -82.81 99.44 75.81 -82.79 coo 49.79 70.75 7.78 50.10 68.90 6.86 87.29 65.89 -84.51 85.99 67.02 -85.80 ULMN 3 2dbt_c01 CHITINASE C user 8 3 # 8 B 147 GLU B 58 GLU^? 7.34 CL CL B 129 B 156 GLU B 51 GLU^? 16.46 CL CL B 129 B 194 ASN A 77 ASN^? 14.66 CL CL B 129 coo 45.64 63.11 17.20 47.48 62.43 16.45 87.90 76.66 -80.19 87.42 74.86 -81.30 coo 54.43 67.89 19.82 55.62 67.90 18.07 81.98 72.56 -73.89 80.95 72.05 -72.12 coo 49.79 70.75 7.78 50.10 68.90 6.86 87.29 65.89 -84.51 85.99 67.02 -85.80 2dbt_c01 source 2dbt CHITINASE C : 8 hits 2dbt_c01 naa= 3 ULMN 3 2dbt_c02 CHITINASE C user 1 3 # 1 C 147 GLU A 58 GLU~? 7.41 CL CL A 129 C 156 GLU A 42 GLU.? 5.77 CL CL A 129 C 194 ASN B 77 ASN^? 14.36 CL CL A 129 coo 41.23 29.31 13.28 43.03 29.85 12.29 87.85 46.74 -60.89 87.27 48.56 -59.93 coo 44.75 23.09 5.51 46.77 22.91 6.12 98.04 48.44 -58.38 99.25 46.68 -58.65 coo 49.75 21.00 18.12 50.45 23.02 18.26 87.37 57.25 -56.67 85.96 56.21 -55.44 ULMN 3 2dbt_c02 CHITINASE C user 2 3 # 2 C 147 GLU A 58 GLU~? 7.41 CL CL A 129 C 156 GLU A 51 GLU^? 16.44 CL CL A 129 C 194 ASN B 77 ASN^? 14.36 CL CL A 129 coo 41.23 29.31 13.28 43.03 29.85 12.29 87.85 46.74 -60.89 87.27 48.56 -59.93 coo 44.75 23.09 5.51 46.77 22.91 6.12 82.00 50.89 -67.09 80.89 51.23 -68.89 coo 49.75 21.00 18.12 50.45 23.02 18.26 87.37 57.25 -56.67 85.96 56.21 -55.44 ULMN 3 2dbt_c02 CHITINASE C user 3 3 # 3 C 147 GLU B 58 GLU^? 7.34 CL CL B 129 C 156 GLU B 42 GLU^? 6.42 CL CL B 129 C 194 ASN A 77 ASN^? 14.66 CL CL B 129 coo 41.23 29.31 13.28 43.03 29.85 12.29 87.90 76.66 -80.19 87.42 74.86 -81.30 coo 44.75 23.09 5.51 46.77 22.91 6.12 97.73 74.53 -82.81 99.44 75.81 -82.79 coo 49.75 21.00 18.12 50.45 23.02 18.26 87.29 65.89 -84.51 85.99 67.02 -85.80 ULMN 3 2dbt_c02 CHITINASE C user 4 3 # 4 C 147 GLU B 58 GLU^? 7.34 CL CL B 129 C 156 GLU B 51 GLU^? 16.46 CL CL B 129 C 194 ASN A 77 ASN^? 14.66 CL CL B 129 coo 41.23 29.31 13.28 43.03 29.85 12.29 87.90 76.66 -80.19 87.42 74.86 -81.30 coo 44.75 23.09 5.51 46.77 22.91 6.12 81.98 72.56 -73.89 80.95 72.05 -72.12 coo 49.75 21.00 18.12 50.45 23.02 18.26 87.29 65.89 -84.51 85.99 67.02 -85.80 2dbt_c02 source 2dbt CHITINASE C : 4 hits 2dbt_c02 naa= 3 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 3 # 1 A 150 TYR B 22 TYR^? 17.56 CL CL B 129 A 245 ASP B 30 ASP^? 20.91 CL CL B 129 A 273 LYS C 24 LYS^? 26.64 CL CL C 129 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 90.60 81.40 -60.16 92.15 82.83 -59.97 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 88.99 74.10 -49.29 84.03 71.99 -51.83 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 3 # 2 A 150 TYR C 22 TYR^? 17.52 CL CL C 129 A 245 ASP C 30 ASP^? 20.67 CL CL C 129 A 273 LYS B 24 LYS^? 27.82 CL CL B 129 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 83.14 74.18 -45.33 81.79 72.55 -45.31 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 90.54 75.59 -56.27 92.78 80.12 -52.52 2gsa_c02 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 2 hits 2gsa_c02 naa= 3 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 A 177 PHE A 38 PHE~? 11.90 CL CL A 129 A 263 ASP A 41 ASP.? 7.60 CL CL A 129 A 292 LYS A 111 LYS^? 25.43 CL CL A 129 coo 51.51 50.32 16.39 52.13 49.68 13.75 93.74 49.34 -71.31 91.91 51.35 -71.82 coo 54.43 44.82 23.74 55.21 45.06 21.80 99.56 48.98 -63.34 100.43 49.52 -61.53 coo 63.95 45.30 16.71 59.11 49.15 16.05 105.91 53.60 -74.08 110.80 53.18 -78.24 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 A 177 PHE B 38 PHE^? 11.74 CL CL B 129 A 263 ASP B 41 ASP^? 7.64 CL CL B 129 A 292 LYS B 111 LYS^? 25.35 CL CL B 129 coo 51.51 50.32 16.39 52.13 49.68 13.75 93.75 74.07 -69.88 91.89 72.11 -69.38 coo 54.43 44.82 23.74 55.21 45.06 21.80 99.50 74.51 -77.69 100.41 73.95 -79.49 coo 63.95 45.30 16.71 59.11 49.15 16.05 105.89 69.85 -67.01 110.53 70.43 -62.59 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 A 177 PHE B 94 PHE^? 23.49 CL CL A 129 A 263 ASP B 72 ASP^? 28.57 CL CL C 129 A 292 LYS B 24 LYS^? 27.82 CL CL B 129 coo 51.51 50.32 16.39 52.13 49.68 13.75 83.12 65.84 -60.18 82.47 66.55 -62.78 coo 54.43 44.82 23.74 55.21 45.06 21.80 80.87 74.36 -54.99 81.74 73.36 -53.35 coo 63.95 45.30 16.71 59.11 49.15 16.05 90.54 75.59 -56.27 92.78 80.12 -52.52 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 A 177 PHE B 94 PHE^? 23.49 CL CL A 129 A 263 ASP B 72 ASP^? 28.57 CL CL C 129 A 292 LYS C 24 LYS^? 26.64 CL CL C 129 coo 51.51 50.32 16.39 52.13 49.68 13.75 83.12 65.84 -60.18 82.47 66.55 -62.78 coo 54.43 44.82 23.74 55.21 45.06 21.80 80.87 74.36 -54.99 81.74 73.36 -53.35 coo 63.95 45.30 16.71 59.11 49.15 16.05 88.99 74.10 -49.29 84.03 71.99 -51.83 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 A 177 PHE C 38 PHE^? 11.87 CL CL C 129 A 263 ASP C 41 ASP^? 7.58 CL CL C 129 A 292 LYS C 111 LYS^? 20.47 CL CL A 129 coo 51.51 50.32 16.39 52.13 49.68 13.75 90.71 70.84 -35.90 92.71 72.72 -36.44 coo 54.43 44.82 23.74 55.21 45.06 21.80 90.28 65.09 -27.98 90.77 64.12 -26.18 coo 63.95 45.30 16.71 59.11 49.15 16.05 94.84 58.73 -38.66 94.21 53.88 -42.04 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 A 177 PHE C 94 PHE^? 24.69 CL CL C 129 A 263 ASP C 72 ASP^? 28.53 CL CL B 129 A 292 LYS B 24 LYS^? 27.82 CL CL B 129 coo 51.51 50.32 16.39 52.13 49.68 13.75 98.83 81.51 -45.44 98.16 82.08 -42.76 coo 54.43 44.82 23.74 55.21 45.06 21.80 90.38 83.76 -50.64 91.24 82.68 -52.23 coo 63.95 45.30 16.71 59.11 49.15 16.05 90.54 75.59 -56.27 92.78 80.12 -52.52 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 7 3 # 7 A 177 PHE C 94 PHE^? 24.69 CL CL C 129 A 263 ASP C 72 ASP^? 28.53 CL CL B 129 A 292 LYS C 24 LYS^? 26.64 CL CL C 129 coo 51.51 50.32 16.39 52.13 49.68 13.75 98.83 81.51 -45.44 98.16 82.08 -42.76 coo 54.43 44.82 23.74 55.21 45.06 21.80 90.38 83.76 -50.64 91.24 82.68 -52.23 coo 63.95 45.30 16.71 59.11 49.15 16.05 88.99 74.10 -49.29 84.03 71.99 -51.83 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 8 3 # 8 A 177 PHE D 38 PHE^? 11.82 CL CL D 129 A 263 ASP D 41 ASP^? 7.55 CL CL D 129 A 292 LYS D 111 LYS^? 25.57 CL CL D 129 coo 51.51 50.32 16.39 52.13 49.68 13.75 68.57 79.81 -35.85 66.58 77.94 -36.43 coo 54.43 44.82 23.74 55.21 45.06 21.80 69.10 85.54 -28.07 68.60 86.44 -26.19 coo 63.95 45.30 16.71 59.11 49.15 16.05 64.48 91.99 -38.71 64.71 96.91 -42.99 2oat_c03 source 2oat ORNITHINE AMINOTRANSFERASE : 8 hits 2oat_c03 naa= 3 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 B 177 PHE A 38 PHE~? 11.90 CL CL A 129 B 263 ASP A 41 ASP.? 7.60 CL CL A 129 B 292 LYS A 111 LYS^? 25.43 CL CL A 129 coo 49.99 26.05 6.28 51.46 26.87 8.49 93.74 49.34 -71.31 91.91 51.35 -71.82 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 99.56 48.98 -63.34 100.43 49.52 -61.53 coo 60.53 31.67 0.97 57.79 27.51 3.63 105.91 53.60 -74.08 110.80 53.18 -78.24 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 B 177 PHE B 38 PHE^? 11.74 CL CL B 129 B 263 ASP B 41 ASP^? 7.64 CL CL B 129 B 292 LYS B 111 LYS^? 25.35 CL CL B 129 coo 49.99 26.05 6.28 51.46 26.87 8.49 93.75 74.07 -69.88 91.89 72.11 -69.38 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 99.50 74.51 -77.69 100.41 73.95 -79.49 coo 60.53 31.67 0.97 57.79 27.51 3.63 105.89 69.85 -67.01 110.53 70.43 -62.59 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 B 177 PHE B 94 PHE^? 23.49 CL CL A 129 B 263 ASP B 72 ASP^? 28.57 CL CL C 129 B 292 LYS B 24 LYS^? 27.82 CL CL B 129 coo 49.99 26.05 6.28 51.46 26.87 8.49 83.12 65.84 -60.18 82.47 66.55 -62.78 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 80.87 74.36 -54.99 81.74 73.36 -53.35 coo 60.53 31.67 0.97 57.79 27.51 3.63 90.54 75.59 -56.27 92.78 80.12 -52.52 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 B 177 PHE B 94 PHE^? 23.49 CL CL A 129 B 263 ASP B 72 ASP^? 28.57 CL CL C 129 B 292 LYS C 24 LYS^? 26.64 CL CL C 129 coo 49.99 26.05 6.28 51.46 26.87 8.49 83.12 65.84 -60.18 82.47 66.55 -62.78 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 80.87 74.36 -54.99 81.74 73.36 -53.35 coo 60.53 31.67 0.97 57.79 27.51 3.63 88.99 74.10 -49.29 84.03 71.99 -51.83 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 B 177 PHE C 38 PHE^? 11.87 CL CL C 129 B 263 ASP C 41 ASP^? 7.58 CL CL C 129 B 292 LYS C 111 LYS^? 20.47 CL CL A 129 coo 49.99 26.05 6.28 51.46 26.87 8.49 90.71 70.84 -35.90 92.71 72.72 -36.44 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 90.28 65.09 -27.98 90.77 64.12 -26.18 coo 60.53 31.67 0.97 57.79 27.51 3.63 94.84 58.73 -38.66 94.21 53.88 -42.04 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 B 177 PHE C 94 PHE^? 24.69 CL CL C 129 B 263 ASP C 72 ASP^? 28.53 CL CL B 129 B 292 LYS B 24 LYS^? 27.82 CL CL B 129 coo 49.99 26.05 6.28 51.46 26.87 8.49 98.83 81.51 -45.44 98.16 82.08 -42.76 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 90.38 83.76 -50.64 91.24 82.68 -52.23 coo 60.53 31.67 0.97 57.79 27.51 3.63 90.54 75.59 -56.27 92.78 80.12 -52.52 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 7 3 # 7 B 177 PHE C 94 PHE^? 24.69 CL CL C 129 B 263 ASP C 72 ASP^? 28.53 CL CL B 129 B 292 LYS C 24 LYS^? 26.64 CL CL C 129 coo 49.99 26.05 6.28 51.46 26.87 8.49 98.83 81.51 -45.44 98.16 82.08 -42.76 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 90.38 83.76 -50.64 91.24 82.68 -52.23 coo 60.53 31.67 0.97 57.79 27.51 3.63 88.99 74.10 -49.29 84.03 71.99 -51.83 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 8 3 # 8 B 177 PHE D 38 PHE^? 11.82 CL CL D 129 B 263 ASP D 41 ASP^? 7.55 CL CL D 129 B 292 LYS D 111 LYS^? 25.57 CL CL D 129 coo 49.99 26.05 6.28 51.46 26.87 8.49 68.57 79.81 -35.85 66.58 77.94 -36.43 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 69.10 85.54 -28.07 68.60 86.44 -26.19 coo 60.53 31.67 0.97 57.79 27.51 3.63 64.48 91.99 -38.71 64.71 96.91 -42.99 2oat_c04 source 2oat ORNITHINE AMINOTRANSFERASE : 8 hits 2oat_c04 naa= 3 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 C 177 PHE A 38 PHE~? 11.90 CL CL A 129 C 263 ASP A 41 ASP.? 7.60 CL CL A 129 C 292 LYS A 111 LYS^? 25.43 CL CL A 129 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 93.74 49.34 -71.31 91.91 51.35 -71.82 coo 19.84 12.02 9.33 18.68 11.23 7.75 99.56 48.98 -63.34 100.43 49.52 -61.53 coo 12.82 3.49 4.98 17.80 5.59 1.90 105.91 53.60 -74.08 110.80 53.18 -78.24 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 C 177 PHE B 38 PHE^? 11.74 CL CL B 129 C 263 ASP B 41 ASP^? 7.64 CL CL B 129 C 292 LYS B 111 LYS^? 25.35 CL CL B 129 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 93.75 74.07 -69.88 91.89 72.11 -69.38 coo 19.84 12.02 9.33 18.68 11.23 7.75 99.50 74.51 -77.69 100.41 73.95 -79.49 coo 12.82 3.49 4.98 17.80 5.59 1.90 105.89 69.85 -67.01 110.53 70.43 -62.59 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 C 177 PHE B 94 PHE^? 23.49 CL CL A 129 C 263 ASP B 72 ASP^? 28.57 CL CL C 129 C 292 LYS C 24 LYS^? 26.64 CL CL C 129 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 83.12 65.84 -60.18 82.47 66.55 -62.78 coo 19.84 12.02 9.33 18.68 11.23 7.75 80.87 74.36 -54.99 81.74 73.36 -53.35 coo 12.82 3.49 4.98 17.80 5.59 1.90 88.99 74.10 -49.29 84.03 71.99 -51.83 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 C 177 PHE C 38 PHE^? 11.87 CL CL C 129 C 263 ASP C 41 ASP^? 7.58 CL CL C 129 C 292 LYS C 111 LYS^? 20.47 CL CL A 129 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 90.71 70.84 -35.90 92.71 72.72 -36.44 coo 19.84 12.02 9.33 18.68 11.23 7.75 90.28 65.09 -27.98 90.77 64.12 -26.18 coo 12.82 3.49 4.98 17.80 5.59 1.90 94.84 58.73 -38.66 94.21 53.88 -42.04 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 C 177 PHE C 94 PHE^? 24.69 CL CL C 129 C 263 ASP C 72 ASP^? 28.53 CL CL B 129 C 292 LYS B 24 LYS^? 27.82 CL CL B 129 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 98.83 81.51 -45.44 98.16 82.08 -42.76 coo 19.84 12.02 9.33 18.68 11.23 7.75 90.38 83.76 -50.64 91.24 82.68 -52.23 coo 12.82 3.49 4.98 17.80 5.59 1.90 90.54 75.59 -56.27 92.78 80.12 -52.52 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 C 177 PHE D 38 PHE^? 11.82 CL CL D 129 C 263 ASP D 41 ASP^? 7.55 CL CL D 129 C 292 LYS D 111 LYS^? 25.57 CL CL D 129 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 68.57 79.81 -35.85 66.58 77.94 -36.43 coo 19.84 12.02 9.33 18.68 11.23 7.75 69.10 85.54 -28.07 68.60 86.44 -26.19 coo 12.82 3.49 4.98 17.80 5.59 1.90 64.48 91.99 -38.71 64.71 96.91 -42.99 2oat_c05 source 2oat ORNITHINE AMINOTRANSFERASE : 6 hits 2oat_c05 naa= 3 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 1 3 # 1 141 ASP A 5 ASP~? 21.13 CL CL B 129 166 GLY A 115 GLY^? 19.18 CL CL A 129 169 GLU A 36 GLU~? 18.47 CL CL A 129 coo 8.28 6.87 1.62 10.08 5.77 1.34 110.30 67.66 -76.72 112.26 68.26 -76.10 coo -8.58 13.22 3.21 -8.90 13.15 4.05 105.32 48.49 -75.94 105.17 48.69 -75.15 coo -16.67 7.89 2.78 -17.65 6.56 1.49 99.16 43.45 -76.17 99.38 43.10 -78.24 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 2 3 # 2 141 ASP A 86 ASP.? 23.33 CL CL A 129 166 GLY B 115 GLY^? 19.14 CL CL B 129 169 GLU B 36 GLU^? 18.40 CL CL B 129 coo 8.28 6.87 1.62 10.08 5.77 1.34 108.46 57.22 -73.78 109.48 58.49 -72.45 coo -8.58 13.22 3.21 -8.90 13.15 4.05 105.34 74.85 -65.16 105.20 74.69 -65.93 coo -16.67 7.89 2.78 -17.65 6.56 1.49 99.20 79.77 -64.83 99.58 80.60 -62.91 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 3 3 # 3 141 ASP B 5 ASP^? 20.93 CL CL A 129 166 GLY B 115 GLY^? 19.14 CL CL B 129 169 GLU B 36 GLU^? 18.40 CL CL B 129 coo 8.28 6.87 1.62 10.08 5.77 1.34 110.10 55.77 -64.66 112.04 55.13 -65.31 coo -8.58 13.22 3.21 -8.90 13.15 4.05 105.34 74.85 -65.16 105.20 74.69 -65.93 coo -16.67 7.89 2.78 -17.65 6.56 1.49 99.20 79.77 -64.83 99.58 80.60 -62.91 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 4 3 # 4 141 ASP B 10 ASP^? 27.46 CL CL A 129 166 GLY B 0 GLY^? 22.38 CL CL A 129 169 GLU A 114 GLU^? 14.59 CL CL A 129 coo 8.28 6.87 1.62 10.08 5.77 1.34 110.59 65.11 -56.28 111.89 65.48 -54.65 coo -8.58 13.22 3.21 -8.90 13.15 4.05 111.19 54.19 -72.18 110.74 54.87 -72.04 coo -16.67 7.89 2.78 -17.65 6.56 1.49 104.53 45.97 -71.95 105.17 46.78 -70.05 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 5 3 # 5 141 ASP B 86 ASP^? 23.14 CL CL B 129 166 GLY A 115 GLY^? 19.18 CL CL A 129 169 GLU A 36 GLU~? 18.47 CL CL A 129 coo 8.28 6.87 1.62 10.08 5.77 1.34 108.40 66.17 -67.38 109.32 64.97 -68.84 coo -8.58 13.22 3.21 -8.90 13.15 4.05 105.32 48.49 -75.94 105.17 48.69 -75.15 coo -16.67 7.89 2.78 -17.65 6.56 1.49 99.16 43.45 -76.17 99.38 43.10 -78.24 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 6 3 # 6 141 ASP D 5 ASP^? 32.88 CL CL D 129 166 GLY D 115 GLY^? 19.26 CL CL D 129 169 GLU D 36 GLU^? 18.42 CL CL D 129 coo 8.28 6.87 1.62 10.08 5.77 1.34 50.37 96.25 -41.36 49.69 98.16 -40.70 coo -8.58 13.22 3.21 -8.90 13.15 4.05 69.45 91.40 -40.67 69.30 91.29 -39.87 coo -16.67 7.89 2.78 -17.65 6.56 1.49 74.52 85.40 -40.74 74.64 85.74 -42.81 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 7 3 # 7 141 ASP D 72 ASP^? 29.64 CL CL D 129 166 GLY C 28 GLY^? 24.16 CL CL C 129 169 GLU C 23 GLU^? 24.69 CL CL C 129 coo 8.28 6.87 1.62 10.08 5.77 1.34 69.04 67.18 -50.81 68.23 68.38 -52.37 coo -8.58 13.22 3.21 -8.90 13.15 4.05 85.20 78.69 -48.08 85.51 78.62 -47.31 coo -16.67 7.89 2.78 -17.65 6.56 1.49 93.85 75.25 -49.20 94.57 76.88 -48.00 2tdt_c00 source 2tdt TETRAHYDRODIPICOLINATE N-SUCCINYLTRANSFERASE : 7 hits 2tdt_c00 naa= 3 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 1 3 # 1 A 122 TYR A 22 TYR~? 17.56 CL CL A 129 A 214 ASP A 35 ASP~? 10.31 CL CL A 129 A 256 LYS A 43 LYS.? 9.42 CL CL A 129 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 92.72 50.62 -78.45 90.87 50.50 -76.41 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 93.79 42.35 -72.20 94.79 41.97 -70.38 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 96.70 52.33 -61.01 101.40 51.27 -59.62 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 2 3 # 2 A 122 TYR B 22 TYR^? 17.56 CL CL B 129 A 214 ASP B 35 ASP^? 10.19 CL CL B 129 A 256 LYS B 43 LYS^? 9.52 CL CL B 129 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 92.70 72.76 -62.54 90.90 72.79 -64.68 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 93.79 80.98 -68.72 94.61 81.32 -70.62 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 96.64 71.22 -80.00 101.30 72.05 -81.50 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 3 3 # 3 A 122 TYR C 20 TYR^? 26.72 CL CL A 129 A 214 ASP C 14 ASP^? 16.95 CL CL A 129 A 256 LYS A 43 LYS.? 9.42 CL CL A 129 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 95.56 70.07 -51.22 98.17 70.86 -51.76 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 95.50 58.88 -47.37 95.04 57.01 -48.29 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 96.70 52.33 -61.01 101.40 51.27 -59.62 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 4 3 # 4 A 122 TYR C 22 TYR^? 17.52 CL CL C 129 A 214 ASP C 35 ASP^? 10.26 CL CL C 129 A 256 LYS C 43 LYS^? 9.54 CL CL C 129 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 91.93 71.84 -43.09 91.81 73.68 -41.00 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 83.63 70.73 -36.85 83.32 69.81 -34.96 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 93.55 67.94 -25.84 92.76 63.12 -24.35 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 5 3 # 5 A 122 TYR D 22 TYR^? 17.52 CL CL D 129 A 214 ASP D 35 ASP^? 10.18 CL CL D 129 A 256 LYS D 43 LYS^? 9.72 CL CL D 129 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 67.44 78.74 -43.16 67.49 76.94 -41.01 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 75.66 79.96 -36.93 75.99 80.66 -34.97 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 65.85 82.66 -25.79 66.37 87.54 -24.61 2tpl_c04 source 2tpl TYROSINE PHENOL-LYASE : 5 hits 2tpl_c04 naa= 3 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 1 3 # 1 B 122 TYR A 22 TYR~? 17.56 CL CL A 129 B 214 ASP A 35 ASP~? 10.31 CL CL A 129 B 256 LYS A 43 LYS.? 9.42 CL CL A 129 coo -32.67 22.74 10.17 -32.85 23.98 7.70 92.72 50.62 -78.45 90.87 50.50 -76.41 coo -26.88 17.61 16.89 -26.08 17.11 15.00 93.79 42.35 -72.20 94.79 41.97 -70.38 coo -16.04 12.06 11.09 -17.97 10.54 5.71 96.70 52.33 -61.01 101.40 51.27 -59.62 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 2 3 # 2 B 122 TYR B 22 TYR^? 17.56 CL CL B 129 B 214 ASP B 35 ASP^? 10.19 CL CL B 129 B 256 LYS B 43 LYS^? 9.52 CL CL B 129 coo -32.67 22.74 10.17 -32.85 23.98 7.70 92.70 72.76 -62.54 90.90 72.79 -64.68 coo -26.88 17.61 16.89 -26.08 17.11 15.00 93.79 80.98 -68.72 94.61 81.32 -70.62 coo -16.04 12.06 11.09 -17.97 10.54 5.71 96.64 71.22 -80.00 101.30 72.05 -81.50 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 3 3 # 3 B 122 TYR C 20 TYR^? 26.72 CL CL A 129 B 214 ASP C 14 ASP^? 16.95 CL CL A 129 B 256 LYS A 43 LYS.? 9.42 CL CL A 129 coo -32.67 22.74 10.17 -32.85 23.98 7.70 95.56 70.07 -51.22 98.17 70.86 -51.76 coo -26.88 17.61 16.89 -26.08 17.11 15.00 95.50 58.88 -47.37 95.04 57.01 -48.29 coo -16.04 12.06 11.09 -17.97 10.54 5.71 96.70 52.33 -61.01 101.40 51.27 -59.62 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 4 3 # 4 B 122 TYR C 54 TYR^? 10.32 CL CL C 129 B 214 ASP C 41 ASP^? 7.58 CL CL C 129 B 256 LYS C 111 LYS^? 20.47 CL CL A 129 coo -32.67 22.74 10.17 -32.85 23.98 7.70 94.43 75.36 -24.67 96.94 76.58 -24.67 coo -26.88 17.61 16.89 -26.08 17.11 15.00 90.28 65.09 -27.98 90.77 64.12 -26.18 coo -16.04 12.06 11.09 -17.97 10.54 5.71 94.84 58.73 -38.66 94.21 53.88 -42.04 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 5 3 # 5 B 122 TYR D 22 TYR^? 17.52 CL CL D 129 B 214 ASP D 35 ASP^? 10.18 CL CL D 129 B 256 LYS D 43 LYS^? 9.72 CL CL D 129 coo -32.67 22.74 10.17 -32.85 23.98 7.70 67.44 78.74 -43.16 67.49 76.94 -41.01 coo -26.88 17.61 16.89 -26.08 17.11 15.00 75.66 79.96 -36.93 75.99 80.66 -34.97 coo -16.04 12.06 11.09 -17.97 10.54 5.71 65.85 82.66 -25.79 66.37 87.54 -24.61 2tpl_c05 source 2tpl TYROSINE PHENOL-LYASE : 5 hits 2tpl_c05 naa= 3 ULMN 3 4mdh_c02 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 1 3 # 1 A 158 ASP C 35 ASP^? 10.26 CL CL C 129 A 161 ARG C 60 ARG^? 8.92 CL CL C 129 A 186 HIS C 40 HIS^? 7.21 CL CL C 129 coo 18.62 26.83 58.17 18.48 28.64 57.08 83.63 70.73 -36.85 83.32 69.81 -34.96 coo 23.76 27.69 57.88 24.05 29.81 55.69 82.52 72.20 -31.52 80.97 69.57 -31.97 coo 16.67 31.22 54.64 18.74 31.15 54.14 84.82 65.72 -30.75 83.18 66.51 -29.70 ULMN 3 4mdh_c02 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 2 3 # 2 A 158 ASP D 35 ASP^? 10.18 CL CL D 129 A 161 ARG D 60 ARG^? 8.57 CL CL D 129 A 186 HIS D 40 HIS^? 7.31 CL CL D 129 coo 18.62 26.83 58.17 18.48 28.64 57.08 75.66 79.96 -36.93 75.99 80.66 -34.97 coo 23.76 27.69 57.88 24.05 29.81 55.69 76.65 78.50 -31.75 78.13 81.14 -31.78 coo 16.67 31.22 54.64 18.74 31.15 54.14 74.49 84.96 -30.93 76.13 84.16 -29.90 4mdh_c02 source 4mdh CYTOPLASMIC MALATE DEHYDROGENASE (E.C.1.1.1.37: 2 hits 4mdh_c02 naa= 3 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 1 3 # 1 71 ARG A 46 ARG^? 15.11 CL CL A 129 127 ARG A 63 ARG~? 13.95 CL CL A 129 270 GLU A 57 GLU~? -5.56 CL CL A 129s coo -1.14 25.72 1.64 0.76 28.10 1.50 87.96 51.20 -70.32 85.08 51.60 -71.34 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 87.85 45.63 -72.60 88.58 48.58 -73.24 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 91.25 41.69 -61.23 91.08 41.09 -59.17 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 2 3 # 2 71 ARG A 46 ARG^? 15.11 CL CL A 129 127 ARG A 63 ARG~? 13.95 CL CL A 129 270 GLU A 58 GLU~? 7.41 CL CL A 129 coo -1.14 25.72 1.64 0.76 28.10 1.50 87.96 51.20 -70.32 85.08 51.60 -71.34 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 87.85 45.63 -72.60 88.58 48.58 -73.24 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 87.85 46.74 -60.89 87.27 48.56 -59.93 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 3 3 # 3 71 ARG A 63 ARG~? 13.95 CL CL A 129 127 ARG A 46 ARG^? 15.11 CL CL A 129 270 GLU A 23 GLU~? 24.22 CL CL A 129 coo -1.14 25.72 1.64 0.76 28.10 1.50 87.85 45.63 -72.60 88.58 48.58 -73.24 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 87.96 51.20 -70.32 85.08 51.60 -71.34 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 89.42 52.54 -84.47 88.08 53.22 -82.95 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 4 3 # 4 71 ARG A 63 ARG~? 13.95 CL CL A 129 127 ARG A 46 ARG^? 15.11 CL CL A 129 270 GLU A 57 GLU~? -5.56 CL CL A 129s coo -1.14 25.72 1.64 0.76 28.10 1.50 87.85 45.63 -72.60 88.58 48.58 -73.24 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 87.96 51.20 -70.32 85.08 51.60 -71.34 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 91.25 41.69 -61.23 91.08 41.09 -59.17 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 5 3 # 5 71 ARG A 63 ARG~? 13.95 CL CL A 129 127 ARG A 66 ARG~? 18.83 CL CL A 129 270 GLU A 23 GLU~? 24.22 CL CL A 129 coo -1.14 25.72 1.64 0.76 28.10 1.50 87.85 45.63 -72.60 88.58 48.58 -73.24 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 82.10 46.84 -74.28 82.78 49.65 -75.31 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 89.42 52.54 -84.47 88.08 53.22 -82.95 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 6 3 # 6 71 ARG A 66 ARG~? 18.83 CL CL A 129 127 ARG A 63 ARG~? 13.95 CL CL A 129 270 GLU A 23 GLU~? 24.22 CL CL A 129 coo -1.14 25.72 1.64 0.76 28.10 1.50 82.10 46.84 -74.28 82.78 49.65 -75.31 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 87.85 45.63 -72.60 88.58 48.58 -73.24 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 89.42 52.54 -84.47 88.08 53.22 -82.95 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 7 3 # 7 71 ARG A 73 ARG.? 22.19 CL CL A 129 127 ARG A 96 ARG.? 24.34 CL CL A 129 270 GLU A 93 GLU.? 15.26 CL CL B 129 coo -1.14 25.72 1.64 0.76 28.10 1.50 83.82 53.79 -81.61 86.00 54.30 -79.51 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 78.03 52.93 -81.60 80.41 52.60 -79.67 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 84.83 64.69 -81.14 84.26 66.42 -82.32 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 8 3 # 8 71 ARG A 96 ARG.? 24.34 CL CL A 129 127 ARG A 73 ARG.? 22.19 CL CL A 129 270 GLU A 93 GLU.? 15.26 CL CL B 129 coo -1.14 25.72 1.64 0.76 28.10 1.50 78.03 52.93 -81.60 80.41 52.60 -79.67 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 83.82 53.79 -81.61 86.00 54.30 -79.51 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 84.83 64.69 -81.14 84.26 66.42 -82.32 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 9 3 # 9 71 ARG B 46 ARG^? 15.06 CL CL B 129 127 ARG B 63 ARG^? 13.99 CL CL B 129 270 GLU B 57 GLU^? -5.29 CL CL B 129s coo -1.14 25.72 1.64 0.76 28.10 1.50 87.96 72.13 -70.71 85.05 71.84 -69.78 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 87.72 77.76 -68.29 88.60 74.86 -67.71 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 91.24 81.90 -79.46 91.48 82.48 -81.50 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 10 3 # 10 71 ARG B 46 ARG^? 15.06 CL CL B 129 127 ARG B 63 ARG^? 13.99 CL CL B 129 270 GLU B 58 GLU^? 7.34 CL CL B 129 coo -1.14 25.72 1.64 0.76 28.10 1.50 87.96 72.13 -70.71 85.05 71.84 -69.78 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 87.72 77.76 -68.29 88.60 74.86 -67.71 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 87.90 76.66 -80.19 87.42 74.86 -81.30 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 11 3 # 11 71 ARG B 63 ARG^? 13.99 CL CL B 129 127 ARG B 46 ARG^? 15.06 CL CL B 129 270 GLU B 23 GLU^? 24.68 CL CL B 129 coo -1.14 25.72 1.64 0.76 28.10 1.50 87.72 77.76 -68.29 88.60 74.86 -67.71 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 87.96 72.13 -70.71 85.05 71.84 -69.78 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 89.49 70.79 -56.44 87.96 70.01 -57.68 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 12 3 # 12 71 ARG B 63 ARG^? 13.99 CL CL B 129 127 ARG B 46 ARG^? 15.06 CL CL B 129 270 GLU B 57 GLU^? -5.29 CL CL B 129s coo -1.14 25.72 1.64 0.76 28.10 1.50 87.72 77.76 -68.29 88.60 74.86 -67.71 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 87.96 72.13 -70.71 85.05 71.84 -69.78 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 91.24 81.90 -79.46 91.48 82.48 -81.50 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 13 3 # 13 71 ARG B 63 ARG^? 13.99 CL CL B 129 127 ARG B 46 ARG^? 15.06 CL CL B 129 270 GLU B 58 GLU^? 7.34 CL CL B 129 coo -1.14 25.72 1.64 0.76 28.10 1.50 87.72 77.76 -68.29 88.60 74.86 -67.71 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 87.96 72.13 -70.71 85.05 71.84 -69.78 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 87.90 76.66 -80.19 87.42 74.86 -81.30 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 14 3 # 14 71 ARG B 63 ARG^? 13.99 CL CL B 129 127 ARG B 66 ARG^? 19.13 CL CL B 129 270 GLU B 23 GLU^? 24.68 CL CL B 129 coo -1.14 25.72 1.64 0.76 28.10 1.50 87.72 77.76 -68.29 88.60 74.86 -67.71 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 82.06 76.49 -66.55 82.68 73.67 -65.41 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 89.49 70.79 -56.44 87.96 70.01 -57.68 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 15 3 # 15 71 ARG B 66 ARG^? 19.13 CL CL B 129 127 ARG B 63 ARG^? 13.99 CL CL B 129 270 GLU B 23 GLU^? 24.68 CL CL B 129 coo -1.14 25.72 1.64 0.76 28.10 1.50 82.06 76.49 -66.55 82.68 73.67 -65.41 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 87.72 77.76 -68.29 88.60 74.86 -67.71 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 89.49 70.79 -56.44 87.96 70.01 -57.68 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 16 3 # 16 71 ARG B 73 ARG^? 22.29 CL CL B 129 127 ARG B 96 ARG^? 24.18 CL CL B 129 270 GLU B 93 GLU^? 15.32 CL CL A 129 coo -1.14 25.72 1.64 0.76 28.10 1.50 83.86 69.55 -59.16 85.91 69.18 -61.42 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 78.35 70.58 -59.29 80.55 70.83 -61.45 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 84.67 58.80 -60.02 84.04 57.06 -58.91 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 17 3 # 17 71 ARG B 96 ARG^? 24.18 CL CL B 129 127 ARG B 73 ARG^? 22.29 CL CL B 129 270 GLU B 93 GLU^? 15.32 CL CL A 129 coo -1.14 25.72 1.64 0.76 28.10 1.50 78.35 70.58 -59.29 80.55 70.83 -61.45 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 83.86 69.55 -59.16 85.91 69.18 -61.42 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 84.67 58.80 -60.02 84.04 57.06 -58.91 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 18 3 # 18 71 ARG C 46 ARG^? 15.12 CL CL C 129 127 ARG C 63 ARG^? 14.10 CL CL C 129 270 GLU C 57 GLU^? -5.48 CL CL C 129s coo -1.14 25.72 1.64 0.76 28.10 1.50 92.47 76.70 -34.87 92.87 79.50 -36.04 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 86.96 77.03 -37.50 89.89 76.13 -38.00 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 82.94 73.46 -26.00 82.34 73.25 -23.96 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 19 3 # 19 71 ARG C 46 ARG^? 15.12 CL CL C 129 127 ARG C 63 ARG^? 14.10 CL CL C 129 270 GLU C 58 GLU^? 7.49 CL CL C 129 coo -1.14 25.72 1.64 0.76 28.10 1.50 92.47 76.70 -34.87 92.87 79.50 -36.04 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 86.96 77.03 -37.50 89.89 76.13 -38.00 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 88.02 76.82 -25.55 89.85 77.43 -24.60 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 20 3 # 20 71 ARG C 63 ARG^? 14.10 CL CL C 129 127 ARG C 46 ARG^? 15.12 CL CL C 129 270 GLU C 23 GLU^? 24.69 CL CL C 129 coo -1.14 25.72 1.64 0.76 28.10 1.50 86.96 77.03 -37.50 89.89 76.13 -38.00 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 92.47 76.70 -34.87 92.87 79.50 -36.04 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 93.85 75.25 -49.20 94.57 76.88 -48.00 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 21 3 # 21 71 ARG C 63 ARG^? 14.10 CL CL C 129 127 ARG C 46 ARG^? 15.12 CL CL C 129 270 GLU C 57 GLU^? -5.48 CL CL C 129s coo -1.14 25.72 1.64 0.76 28.10 1.50 86.96 77.03 -37.50 89.89 76.13 -38.00 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 92.47 76.70 -34.87 92.87 79.50 -36.04 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 82.94 73.46 -26.00 82.34 73.25 -23.96 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 22 3 # 22 71 ARG C 63 ARG^? 14.10 CL CL C 129 127 ARG C 66 ARG^? 18.88 CL CL C 129 270 GLU C 23 GLU^? 24.69 CL CL C 129 coo -1.14 25.72 1.64 0.76 28.10 1.50 86.96 77.03 -37.50 89.89 76.13 -38.00 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 88.18 82.59 -38.84 90.98 81.94 -39.92 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 93.85 75.25 -49.20 94.57 76.88 -48.00 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 23 3 # 23 71 ARG C 63 ARG^? 14.10 CL CL C 129 127 ARG C 66 ARG^? 18.88 CL CL C 129 270 GLU C 58 GLU^? 7.49 CL CL C 129 coo -1.14 25.72 1.64 0.76 28.10 1.50 86.96 77.03 -37.50 89.89 76.13 -38.00 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 88.18 82.59 -38.84 90.98 81.94 -39.92 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 88.02 76.82 -25.55 89.85 77.43 -24.60 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 24 3 # 24 71 ARG C 66 ARG^? 18.88 CL CL C 129 127 ARG C 63 ARG^? 14.10 CL CL C 129 270 GLU C 23 GLU^? 24.69 CL CL C 129 coo -1.14 25.72 1.64 0.76 28.10 1.50 88.18 82.59 -38.84 90.98 81.94 -39.92 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 86.96 77.03 -37.50 89.89 76.13 -38.00 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 93.85 75.25 -49.20 94.57 76.88 -48.00 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 25 3 # 25 71 ARG C 73 ARG^? 22.24 CL CL C 129 127 ARG C 96 ARG^? 24.31 CL CL C 129 270 GLU C 93 GLU^? 31.51 CL CL C 129 coo -1.14 25.72 1.64 0.76 28.10 1.50 95.26 80.79 -46.47 95.45 78.63 -44.29 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 94.28 86.51 -46.29 94.08 84.26 -44.17 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 105.96 79.95 -45.75 107.72 80.63 -46.81 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 26 3 # 26 71 ARG C 96 ARG^? 24.31 CL CL C 129 127 ARG C 73 ARG^? 22.24 CL CL C 129 270 GLU C 93 GLU^? 31.51 CL CL C 129 coo -1.14 25.72 1.64 0.76 28.10 1.50 94.28 86.51 -46.29 94.08 84.26 -44.17 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 95.26 80.79 -46.47 95.45 78.63 -44.29 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 105.96 79.95 -45.75 107.72 80.63 -46.81 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 27 3 # 27 71 ARG D 46 ARG^? 15.13 CL CL D 129 127 ARG D 63 ARG^? 14.07 CL CL D 129 270 GLU D 58 GLU^? 7.39 CL CL D 129 coo -1.14 25.72 1.64 0.76 28.10 1.50 66.74 73.93 -35.00 66.45 71.02 -36.02 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 72.33 73.68 -37.44 69.36 74.46 -37.99 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 71.21 74.03 -25.57 69.46 73.32 -24.61 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 28 3 # 28 71 ARG D 63 ARG^? 14.07 CL CL D 129 127 ARG D 46 ARG^? 15.13 CL CL D 129 270 GLU D 23 GLU^? 24.49 CL CL D 129 coo -1.14 25.72 1.64 0.76 28.10 1.50 72.33 73.68 -37.44 69.36 74.46 -37.99 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 66.74 73.93 -35.00 66.45 71.02 -36.02 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 65.41 75.40 -49.12 64.81 73.78 -47.86 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 29 3 # 29 71 ARG D 63 ARG^? 14.07 CL CL D 129 127 ARG D 66 ARG^? 18.85 CL CL D 129 270 GLU D 23 GLU^? 24.49 CL CL D 129 coo -1.14 25.72 1.64 0.76 28.10 1.50 72.33 73.68 -37.44 69.36 74.46 -37.99 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 71.05 68.08 -38.82 68.22 68.66 -39.87 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 65.41 75.40 -49.12 64.81 73.78 -47.86 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 30 3 # 30 71 ARG D 66 ARG^? 18.85 CL CL D 129 127 ARG D 63 ARG^? 14.07 CL CL D 129 270 GLU D 23 GLU^? 24.49 CL CL D 129 coo -1.14 25.72 1.64 0.76 28.10 1.50 71.05 68.08 -38.82 68.22 68.66 -39.87 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 72.33 73.68 -37.44 69.36 74.46 -37.99 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 65.41 75.40 -49.12 64.81 73.78 -47.86 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 31 3 # 31 71 ARG D 73 ARG^? 22.15 CL CL D 129 127 ARG D 96 ARG^? 24.04 CL CL D 129 270 GLU D 93 GLU^? 31.46 CL CL D 129 coo -1.14 25.72 1.64 0.76 28.10 1.50 64.06 69.83 -46.45 63.93 71.88 -44.19 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 64.79 64.44 -46.28 65.73 66.42 -44.08 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 53.41 70.78 -45.84 51.64 70.26 -46.90 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 32 3 # 32 71 ARG D 96 ARG^? 24.04 CL CL D 129 127 ARG D 73 ARG^? 22.15 CL CL D 129 270 GLU D 93 GLU^? 31.46 CL CL D 129 coo -1.14 25.72 1.64 0.76 28.10 1.50 64.79 64.44 -46.28 65.73 66.42 -44.08 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 64.06 69.83 -46.45 63.93 71.88 -44.19 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 53.41 70.78 -45.84 51.64 70.26 -46.90 5cpa_c01 source 5cpa CARBOXYPEPTIDASE A=ALPHA= (COX) (E.C.3.4.17.1): 32 hits 5cpa_c01 naa= 3 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 1 1 # 1 A 461 ASN A 7 ASN.? 14.61 CL CL B 129 coo 5.80 63.03 55.85 5.52 65.03 56.45 104.28 66.29 -83.02 102.35 66.19 -82.19 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 2 1 # 2 A 461 ASN A 29 ASN.? 19.56 CL CL A 129 coo 5.80 63.03 55.85 5.52 65.03 56.45 84.48 42.44 -79.38 84.07 42.43 -77.31 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 3 1 # 3 A 461 ASN A 52 ASN^? 15.85 CL CL A 129 coo 5.80 63.03 55.85 5.52 65.03 56.45 83.96 54.83 -62.44 82.65 56.42 -62.87 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 4 1 # 4 A 461 ASN A 77 ASN^? 14.66 CL CL B 129 coo 5.80 63.03 55.85 5.52 65.03 56.45 87.29 65.89 -84.51 85.99 67.02 -85.80 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 5 1 # 5 A 461 ASN B 7 ASN^? 14.42 CL CL A 129 coo 5.80 63.03 55.85 5.52 65.03 56.45 104.35 57.09 -58.15 102.38 57.14 -58.88 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 6 1 # 6 A 461 ASN B 29 ASN^? 19.59 CL CL B 129 coo 5.80 63.03 55.85 5.52 65.03 56.45 84.68 80.89 -61.45 84.18 80.98 -63.53 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 7 1 # 7 A 461 ASN B 52 ASN^? 15.82 CL CL B 129 coo 5.80 63.03 55.85 5.52 65.03 56.45 83.95 68.72 -78.66 82.81 66.95 -78.31 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 8 1 # 8 A 461 ASN B 77 ASN^? 14.36 CL CL A 129 coo 5.80 63.03 55.85 5.52 65.03 56.45 87.37 57.25 -56.67 85.96 56.21 -55.44 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 9 1 # 9 A 461 ASN C 7 ASN^? 25.55 CL CL A 129 coo 5.80 63.03 55.85 5.52 65.03 56.45 107.62 60.23 -47.60 107.55 62.23 -46.92 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 10 1 # 10 A 461 ASN C 29 ASN^? 19.55 CL CL C 129 coo 5.80 63.03 55.85 5.52 65.03 56.45 83.86 80.07 -44.03 83.70 80.47 -41.95 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 11 1 # 11 A 461 ASN C 52 ASN^? 15.85 CL CL C 129 coo 5.80 63.03 55.85 5.52 65.03 56.45 96.20 80.63 -27.08 97.82 81.88 -27.59 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 12 1 # 12 A 461 ASN C 77 ASN^? 33.36 CL CL B 129 coo 5.80 63.03 55.85 5.52 65.03 56.45 107.30 77.29 -48.98 108.48 78.56 -50.20 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 13 1 # 13 A 461 ASN D 7 ASN^? 30.85 CL CL D 129 coo 5.80 63.03 55.85 5.52 65.03 56.45 51.70 90.24 -47.62 51.84 88.27 -46.84 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 14 1 # 14 A 461 ASN D 29 ASN^? 19.54 CL CL D 129 coo 5.80 63.03 55.85 5.52 65.03 56.45 75.38 70.46 -44.12 75.55 70.12 -42.00 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 15 1 # 15 A 461 ASN D 52 ASN^? 15.83 CL CL D 129 coo 5.80 63.03 55.85 5.52 65.03 56.45 63.25 69.92 -27.12 61.56 68.74 -27.55 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 16 1 # 16 A 461 ASN D 77 ASN^? 33.84 CL CL D 129 coo 5.80 63.03 55.85 5.52 65.03 56.45 52.00 73.38 -49.12 50.93 71.99 -50.29 1kbk_p00 source 1kbk ALPHA-AMYLASE, PANCREATIC : 16 hits 1kbk_p00 naa= 1 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 1 3 # 1 A 270 ASN A 29 ASN.? 19.56 CL CL A 129 A 384 ASN A 77 ASN^? 14.66 CL CL B 129 A 385 GLU A 93 GLU.? 15.26 CL CL B 129 coo 22.28 63.17 110.61 22.47 65.06 111.53 84.48 42.44 -79.38 84.07 42.43 -77.31 coo 7.06 50.07 96.17 8.50 48.54 96.31 87.29 65.89 -84.51 85.99 67.02 -85.80 coo 11.59 49.83 99.41 10.92 47.97 100.16 84.83 64.69 -81.14 84.26 66.42 -82.32 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 2 3 # 2 A 270 ASN A 29 ASN.? 19.56 CL CL A 129 A 384 ASN B 52 ASN^? 15.82 CL CL B 129 A 385 GLU A 93 GLU.? 15.26 CL CL B 129 coo 22.28 63.17 110.61 22.47 65.06 111.53 84.48 42.44 -79.38 84.07 42.43 -77.31 coo 7.06 50.07 96.17 8.50 48.54 96.31 83.95 68.72 -78.66 82.81 66.95 -78.31 coo 11.59 49.83 99.41 10.92 47.97 100.16 84.83 64.69 -81.14 84.26 66.42 -82.32 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 3 3 # 3 A 270 ASN A 52 ASN^? 15.85 CL CL A 129 A 384 ASN A 77 ASN^? 14.66 CL CL B 129 A 385 GLU A 93 GLU.? 15.26 CL CL B 129 coo 22.28 63.17 110.61 22.47 65.06 111.53 83.96 54.83 -62.44 82.65 56.42 -62.87 coo 7.06 50.07 96.17 8.50 48.54 96.31 87.29 65.89 -84.51 85.99 67.02 -85.80 coo 11.59 49.83 99.41 10.92 47.97 100.16 84.83 64.69 -81.14 84.26 66.42 -82.32 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 4 3 # 4 A 270 ASN B 29 ASN^? 19.59 CL CL B 129 A 384 ASN A 52 ASN^? 15.85 CL CL A 129 A 385 GLU B 93 GLU^? 15.32 CL CL A 129 coo 22.28 63.17 110.61 22.47 65.06 111.53 84.68 80.89 -61.45 84.18 80.98 -63.53 coo 7.06 50.07 96.17 8.50 48.54 96.31 83.96 54.83 -62.44 82.65 56.42 -62.87 coo 11.59 49.83 99.41 10.92 47.97 100.16 84.67 58.80 -60.02 84.04 57.06 -58.91 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 5 3 # 5 A 270 ASN B 29 ASN^? 19.59 CL CL B 129 A 384 ASN B 77 ASN^? 14.36 CL CL A 129 A 385 GLU B 93 GLU^? 15.32 CL CL A 129 coo 22.28 63.17 110.61 22.47 65.06 111.53 84.68 80.89 -61.45 84.18 80.98 -63.53 coo 7.06 50.07 96.17 8.50 48.54 96.31 87.37 57.25 -56.67 85.96 56.21 -55.44 coo 11.59 49.83 99.41 10.92 47.97 100.16 84.67 58.80 -60.02 84.04 57.06 -58.91 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 6 3 # 6 A 270 ASN B 52 ASN^? 15.82 CL CL B 129 A 384 ASN B 77 ASN^? 14.36 CL CL A 129 A 385 GLU B 93 GLU^? 15.32 CL CL A 129 coo 22.28 63.17 110.61 22.47 65.06 111.53 83.95 68.72 -78.66 82.81 66.95 -78.31 coo 7.06 50.07 96.17 8.50 48.54 96.31 87.37 57.25 -56.67 85.96 56.21 -55.44 coo 11.59 49.83 99.41 10.92 47.97 100.16 84.67 58.80 -60.02 84.04 57.06 -58.91 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 7 3 # 7 A 270 ASN C 29 ASN^? 19.55 CL CL C 129 A 384 ASN C 77 ASN^? 33.36 CL CL B 129 A 385 GLU C 93 GLU^? 31.51 CL CL C 129 coo 22.28 63.17 110.61 22.47 65.06 111.53 83.86 80.07 -44.03 83.70 80.47 -41.95 coo 7.06 50.07 96.17 8.50 48.54 96.31 107.30 77.29 -48.98 108.48 78.56 -50.20 coo 11.59 49.83 99.41 10.92 47.97 100.16 105.96 79.95 -45.75 107.72 80.63 -46.81 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 8 3 # 8 A 270 ASN C 52 ASN^? 15.85 CL CL C 129 A 384 ASN C 77 ASN^? 33.36 CL CL B 129 A 385 GLU C 93 GLU^? 31.51 CL CL C 129 coo 22.28 63.17 110.61 22.47 65.06 111.53 96.20 80.63 -27.08 97.82 81.88 -27.59 coo 7.06 50.07 96.17 8.50 48.54 96.31 107.30 77.29 -48.98 108.48 78.56 -50.20 coo 11.59 49.83 99.41 10.92 47.97 100.16 105.96 79.95 -45.75 107.72 80.63 -46.81 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 9 3 # 9 A 270 ASN D 29 ASN^? 19.54 CL CL D 129 A 384 ASN A 52 ASN^? 15.85 CL CL A 129 A 385 GLU B 93 GLU^? 15.32 CL CL A 129 coo 22.28 63.17 110.61 22.47 65.06 111.53 75.38 70.46 -44.12 75.55 70.12 -42.00 coo 7.06 50.07 96.17 8.50 48.54 96.31 83.96 54.83 -62.44 82.65 56.42 -62.87 coo 11.59 49.83 99.41 10.92 47.97 100.16 84.67 58.80 -60.02 84.04 57.06 -58.91 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 10 3 # 10 A 270 ASN D 29 ASN^? 19.54 CL CL D 129 A 384 ASN D 77 ASN^? 33.84 CL CL D 129 A 385 GLU D 93 GLU^? 31.46 CL CL D 129 coo 22.28 63.17 110.61 22.47 65.06 111.53 75.38 70.46 -44.12 75.55 70.12 -42.00 coo 7.06 50.07 96.17 8.50 48.54 96.31 52.00 73.38 -49.12 50.93 71.99 -50.29 coo 11.59 49.83 99.41 10.92 47.97 100.16 53.41 70.78 -45.84 51.64 70.26 -46.90 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 11 3 # 11 A 270 ASN D 52 ASN^? 15.83 CL CL D 129 A 384 ASN D 77 ASN^? 33.84 CL CL D 129 A 385 GLU D 93 GLU^? 31.46 CL CL D 129 coo 22.28 63.17 110.61 22.47 65.06 111.53 63.25 69.92 -27.12 61.56 68.74 -27.55 coo 7.06 50.07 96.17 8.50 48.54 96.31 52.00 73.38 -49.12 50.93 71.99 -50.29 coo 11.59 49.83 99.41 10.92 47.97 100.16 53.41 70.78 -45.84 51.64 70.26 -46.90 2v3r_p00 source 2v3r EXOGLUCANASE 1 : 11 hits 2v3r_p00 naa= 3 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 1 3 # 1 A 82 HIS A 122 HIS^? 19.05 CL CL A 129 A 166 SER A 124 SER^? 21.51 CL CL B 129 A 168 HIS B 122 HIS^? 19.12 CL CL B 129 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 86.83 60.37 -69.40 85.20 61.24 -68.40 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 81.71 59.41 -72.63 82.35 61.73 -72.29 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 86.93 63.10 -71.62 85.35 62.06 -72.53 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 2 3 # 2 A 82 HIS A 122 HIS^? 19.05 CL CL A 129 A 166 SER B 124 SER^? 21.49 CL CL A 129 A 168 HIS B 122 HIS^? 19.12 CL CL B 129 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 86.83 60.37 -69.40 85.20 61.24 -68.40 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 81.67 64.01 -68.38 82.23 61.67 -68.72 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 86.93 63.10 -71.62 85.35 62.06 -72.53 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 3 3 # 3 A 82 HIS B 122 HIS^? 19.12 CL CL B 129 A 166 SER A 124 SER^? 21.51 CL CL B 129 A 168 HIS A 122 HIS^? 19.05 CL CL A 129 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 86.93 63.10 -71.62 85.35 62.06 -72.53 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 81.71 59.41 -72.63 82.35 61.73 -72.29 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 86.83 60.37 -69.40 85.20 61.24 -68.40 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 4 3 # 4 A 82 HIS B 122 HIS^? 19.12 CL CL B 129 A 166 SER B 124 SER^? 21.49 CL CL A 129 A 168 HIS A 122 HIS^? 19.05 CL CL A 129 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 86.93 63.10 -71.62 85.35 62.06 -72.53 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 81.67 64.01 -68.38 82.23 61.67 -68.72 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 86.83 60.37 -69.40 85.20 61.24 -68.40 2vmg_p00 source 2vmg FIBRONECTIN TYPE III DOMAIN PROTEIN : 4 hits 2vmg_p00 naa= 3 ULMN 3 1b01_d00 GENE REGULATION/DNA user 1 3 # 1 B 4 ARG A 73 ARG.? 22.19 CL CL A 129 B 6 THR A 95 THR.? 23.66 CL CL B 129 B 8 THR A 100 THR.? 28.72 CL CL B 129 coo 40.52 16.08 100.90 37.97 16.41 102.60 83.82 53.79 -81.61 86.00 54.30 -79.51 coo 36.11 13.64 95.03 34.54 14.86 95.91 79.48 58.54 -83.85 79.37 60.11 -85.39 coo 32.72 8.05 92.39 31.25 9.11 91.35 72.15 60.48 -81.89 70.47 61.51 -80.96 ULMN 3 1b01_d00 GENE REGULATION/DNA user 2 3 # 2 B 4 ARG B 73 ARG^? 22.29 CL CL B 129 B 6 THR B 95 THR^? 23.42 CL CL A 129 B 8 THR B 100 THR^? 28.81 CL CL A 129 coo 40.52 16.08 100.90 37.97 16.41 102.60 83.86 69.55 -59.16 85.91 69.18 -61.42 coo 36.11 13.64 95.03 34.54 14.86 95.91 79.47 64.83 -57.24 79.55 63.29 -55.69 coo 32.72 8.05 92.39 31.25 9.11 91.35 72.27 62.59 -58.79 70.28 61.78 -58.67 ULMN 3 1b01_d00 GENE REGULATION/DNA user 3 3 # 3 B 4 ARG B 76 ARG^? 18.98 CL CL A 129 B 6 THR B 95 THR^? 23.42 CL CL A 129 B 8 THR B 97 THR^? 28.75 CL CL D 129 coo 40.52 16.08 100.90 37.97 16.41 102.60 82.73 59.03 -54.76 80.31 57.91 -56.24 coo 36.11 13.64 95.03 34.54 14.86 95.91 79.47 64.83 -57.24 79.55 63.29 -55.69 coo 32.72 8.05 92.39 31.25 9.11 91.35 74.83 68.80 -53.92 74.73 70.43 -52.45 ULMN 3 1b01_d00 GENE REGULATION/DNA user 4 3 # 4 B 4 ARG B 96 ARG^? 24.18 CL CL B 129 B 6 THR B 97 THR^? 28.75 CL CL D 129 B 8 THR D 27 THR^? 25.09 CL CL D 129 coo 40.52 16.08 100.90 37.97 16.41 102.60 78.35 70.58 -59.29 80.55 70.83 -61.45 coo 36.11 13.64 95.03 34.54 14.86 95.91 74.83 68.80 -53.92 74.73 70.43 -52.45 coo 32.72 8.05 92.39 31.25 9.11 91.35 70.41 71.33 -47.57 68.87 71.98 -48.94 ULMN 3 1b01_d00 GENE REGULATION/DNA user 5 3 # 5 B 4 ARG B 104 ARG^? 18.51 CL CL A 129 B 6 THR B 95 THR^? 23.42 CL CL A 129 B 8 THR B 97 THR^? 28.75 CL CL D 129 coo 40.52 16.08 100.90 37.97 16.41 102.60 82.09 59.72 -64.70 82.21 58.19 -67.39 coo 36.11 13.64 95.03 34.54 14.86 95.91 79.47 64.83 -57.24 79.55 63.29 -55.69 coo 32.72 8.05 92.39 31.25 9.11 91.35 74.83 68.80 -53.92 74.73 70.43 -52.45 ULMN 3 1b01_d00 GENE REGULATION/DNA user 6 3 # 6 B 4 ARG C 76 ARG^? 33.92 CL CL B 129 B 6 THR C 95 THR^? 31.97 CL CL C 129 B 8 THR C 97 THR^? 29.17 CL CL B 129 coo 40.52 16.08 100.90 37.97 16.41 102.60 105.54 81.89 -51.05 106.65 84.23 -49.40 coo 36.11 13.64 95.03 34.54 14.86 95.91 99.92 85.14 -48.37 101.51 85.07 -49.86 coo 32.72 8.05 92.39 31.25 9.11 91.35 96.29 89.95 -51.83 94.80 89.38 -53.40 ULMN 3 1b01_d00 GENE REGULATION/DNA user 7 3 # 7 B 4 ARG C 104 ARG^? 26.38 CL CL C 129 B 6 THR C 95 THR^? 31.97 CL CL C 129 B 8 THR C 97 THR^? 29.17 CL CL B 129 coo 40.52 16.08 100.90 37.97 16.41 102.60 105.08 82.46 -41.08 106.56 82.47 -38.36 coo 36.11 13.64 95.03 34.54 14.86 95.91 99.92 85.14 -48.37 101.51 85.07 -49.86 coo 32.72 8.05 92.39 31.25 9.11 91.35 96.29 89.95 -51.83 94.80 89.38 -53.40 ULMN 3 1b01_d00 GENE REGULATION/DNA user 8 3 # 8 B 4 ARG D 66 ARG^? 18.85 CL CL D 129 B 6 THR D 27 THR^? 25.09 CL CL D 129 B 8 THR B 97 THR^? 28.75 CL CL D 129 coo 40.52 16.08 100.90 37.97 16.41 102.60 71.05 68.08 -38.82 68.22 68.66 -39.87 coo 36.11 13.64 95.03 34.54 14.86 95.91 70.41 71.33 -47.57 68.87 71.98 -48.94 coo 32.72 8.05 92.39 31.25 9.11 91.35 74.83 68.80 -53.92 74.73 70.43 -52.45 ULMN 3 1b01_d00 GENE REGULATION/DNA user 9 3 # 9 B 4 ARG D 73 ARG^? 22.15 CL CL D 129 B 6 THR D 27 THR^? 25.09 CL CL D 129 B 8 THR B 97 THR^? 28.75 CL CL D 129 coo 40.52 16.08 100.90 37.97 16.41 102.60 64.06 69.83 -46.45 63.93 71.88 -44.19 coo 36.11 13.64 95.03 34.54 14.86 95.91 70.41 71.33 -47.57 68.87 71.98 -48.94 coo 32.72 8.05 92.39 31.25 9.11 91.35 74.83 68.80 -53.92 74.73 70.43 -52.45 ULMN 3 1b01_d00 GENE REGULATION/DNA user 10 3 # 10 B 4 ARG D 73 ARG^? 22.15 CL CL D 129 B 6 THR D 95 THR^? 32.06 CL CL D 129 B 8 THR D 100 THR^? 36.08 CL CL D 129 coo 40.52 16.08 100.90 37.97 16.41 102.60 64.06 69.83 -46.45 63.93 71.88 -44.19 coo 36.11 13.64 95.03 34.54 14.86 95.91 59.52 65.53 -48.53 57.85 65.41 -49.95 coo 32.72 8.05 92.39 31.25 9.11 91.35 57.24 58.21 -46.98 56.27 56.26 -47.24 ULMN 3 1b01_d00 GENE REGULATION/DNA user 11 3 # 11 B 4 ARG D 76 ARG^? 33.75 CL CL D 129 B 6 THR D 95 THR^? 32.06 CL CL D 129 B 8 THR D 97 THR^? 33.73 CL CL A 129 coo 40.52 16.08 100.90 37.97 16.41 102.60 54.15 68.69 -51.19 53.07 66.38 -49.46 coo 36.11 13.64 95.03 34.54 14.86 95.91 59.52 65.53 -48.53 57.85 65.41 -49.95 coo 32.72 8.05 92.39 31.25 9.11 91.35 63.35 60.51 -51.69 64.51 60.28 -53.55 ULMN 3 1b01_d00 GENE REGULATION/DNA user 12 3 # 12 B 4 ARG D 96 ARG^? 24.04 CL CL D 129 B 6 THR D 27 THR^? 25.09 CL CL D 129 B 8 THR B 97 THR^? 28.75 CL CL D 129 coo 40.52 16.08 100.90 37.97 16.41 102.60 64.79 64.44 -46.28 65.73 66.42 -44.08 coo 36.11 13.64 95.03 34.54 14.86 95.91 70.41 71.33 -47.57 68.87 71.98 -48.94 coo 32.72 8.05 92.39 31.25 9.11 91.35 74.83 68.80 -53.92 74.73 70.43 -52.45 ULMN 3 1b01_d00 GENE REGULATION/DNA user 13 3 # 13 B 4 ARG D 104 ARG^? 26.47 CL CL D 129 B 6 THR D 95 THR^? 32.06 CL CL D 129 B 8 THR D 97 THR^? 33.73 CL CL A 129 coo 40.52 16.08 100.90 37.97 16.41 102.60 54.44 68.08 -41.08 52.76 68.11 -38.51 coo 36.11 13.64 95.03 34.54 14.86 95.91 59.52 65.53 -48.53 57.85 65.41 -49.95 coo 32.72 8.05 92.39 31.25 9.11 91.35 63.35 60.51 -51.69 64.51 60.28 -53.55 1b01_d00 source 1b01 GENE REGULATION/DNA : 13 hits 1b01_d00 naa= 3 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 1 3 # 1 I 303 TYR A 22 TYR~? 17.56 CL CL A 129 I 306 VAL A 33 VAL~? 18.18 CL CL A 129 I 308 VAL A 31 VAL~? 15.97 CL CL A 129 coo 26.18 35.24 6.87 24.33 35.18 8.97 92.72 50.62 -78.45 90.87 50.50 -76.41 coo 23.55 29.53 9.81 23.15 27.39 10.24 94.50 42.85 -77.72 94.93 43.29 -79.75 coo 16.43 30.18 9.35 15.05 30.67 11.01 89.54 41.41 -75.94 88.06 40.83 -74.41 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 2 3 # 2 I 303 TYR A 47 TYR^? 14.66 CL CL A 129 I 306 VAL A 45 VAL^? 10.13 CL CL A 129 I 308 VAL A 119 VAL^? 13.01 CL CL A 129 coo 26.18 35.24 6.87 24.33 35.18 8.97 86.78 57.70 -65.64 87.73 58.42 -63.11 coo 23.55 29.53 9.81 23.15 27.39 10.24 91.94 53.92 -64.94 91.48 55.61 -63.62 coo 16.43 30.18 9.35 15.05 30.67 11.01 97.61 54.09 -68.83 99.46 55.28 -68.82 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 3 3 # 3 I 303 TYR A 47 TYR^? 14.66 CL CL A 129 I 306 VAL A 45 VAL^? 10.13 CL CL A 129 I 308 VAL B 79 VAL^? 12.34 CL CL A 129 coo 26.18 35.24 6.87 24.33 35.18 8.97 86.78 57.70 -65.64 87.73 58.42 -63.11 coo 23.55 29.53 9.81 23.15 27.39 10.24 91.94 53.92 -64.94 91.48 55.61 -63.62 coo 16.43 30.18 9.35 15.05 30.67 11.01 94.15 58.82 -58.60 93.97 56.70 -59.21 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 4 3 # 4 I 303 TYR A 54 TYR^? 10.29 CL CL A 129 I 306 VAL A 45 VAL^? 10.13 CL CL A 129 I 308 VAL A 119 VAL^? 13.01 CL CL A 129 coo 26.18 35.24 6.87 24.33 35.18 8.97 89.27 53.06 -59.98 88.13 55.63 -59.94 coo 23.55 29.53 9.81 23.15 27.39 10.24 91.94 53.92 -64.94 91.48 55.61 -63.62 coo 16.43 30.18 9.35 15.05 30.67 11.01 97.61 54.09 -68.83 99.46 55.28 -68.82 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 5 3 # 5 I 303 TYR A 54 TYR^? 10.29 CL CL A 129 I 306 VAL B 79 VAL^? 12.34 CL CL A 129 I 308 VAL B 89 VAL^? 16.64 CL CL A 129 coo 26.18 35.24 6.87 24.33 35.18 8.97 89.27 53.06 -59.98 88.13 55.63 -59.94 coo 23.55 29.53 9.81 23.15 27.39 10.24 94.15 58.82 -58.60 93.97 56.70 -59.21 coo 16.43 30.18 9.35 15.05 30.67 11.01 97.59 61.73 -65.29 96.79 60.29 -66.76 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 6 3 # 6 I 303 TYR A 83 TYR.? 15.31 CL CL B 129 I 306 VAL A 89 VAL.? 16.70 CL CL B 129 I 308 VAL A 15 VAL~? 22.78 CL CL B 129 coo 26.18 35.24 6.87 24.33 35.18 8.97 103.43 65.48 -74.92 101.03 66.78 -75.48 coo 23.55 29.53 9.81 23.15 27.39 10.24 97.57 61.74 -75.96 96.80 63.07 -74.45 coo 16.43 30.18 9.35 15.05 30.67 11.01 101.87 55.80 -81.42 101.82 57.45 -79.99 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 7 3 # 7 I 303 TYR A 83 TYR.? 15.31 CL CL B 129 I 306 VAL A 89 VAL.? 16.70 CL CL B 129 I 308 VAL A 79 VAL^? 12.58 CL CL B 129 coo 26.18 35.24 6.87 24.33 35.18 8.97 103.43 65.48 -74.92 101.03 66.78 -75.48 coo 23.55 29.53 9.81 23.15 27.39 10.24 97.57 61.74 -75.96 96.80 63.07 -74.45 coo 16.43 30.18 9.35 15.05 30.67 11.01 94.13 64.53 -82.49 93.75 66.60 -81.81 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 8 3 # 8 I 303 TYR A 83 TYR.? 15.31 CL CL B 129 I 306 VAL A 89 VAL.? 16.70 CL CL B 129 I 308 VAL A 110 VAL^? 17.64 CL CL A 129 coo 26.18 35.24 6.87 24.33 35.18 8.97 103.43 65.48 -74.92 101.03 66.78 -75.48 coo 23.55 29.53 9.81 23.15 27.39 10.24 97.57 61.74 -75.96 96.80 63.07 -74.45 coo 16.43 30.18 9.35 15.05 30.67 11.01 103.10 55.63 -72.46 103.58 56.38 -70.46 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 9 3 # 9 I 303 TYR A 83 TYR.? 15.31 CL CL B 129 I 306 VAL B 110 VAL^? 17.50 CL CL B 129 I 308 VAL B 89 VAL^? 16.64 CL CL A 129 coo 26.18 35.24 6.87 24.33 35.18 8.97 103.43 65.48 -74.92 101.03 66.78 -75.48 coo 23.55 29.53 9.81 23.15 27.39 10.24 103.15 67.83 -68.76 103.52 67.23 -70.84 coo 16.43 30.18 9.35 15.05 30.67 11.01 97.59 61.73 -65.29 96.79 60.29 -66.76 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 10 3 # 10 I 303 TYR A 83 TYR.? 15.31 CL CL B 129 I 306 VAL B 119 VAL^? 13.02 CL CL B 129 I 308 VAL B 45 VAL^? 10.12 CL CL B 129 coo 26.18 35.24 6.87 24.33 35.18 8.97 103.43 65.48 -74.92 101.03 66.78 -75.48 coo 23.55 29.53 9.81 23.15 27.39 10.24 97.61 69.35 -72.25 99.50 68.20 -72.30 coo 16.43 30.18 9.35 15.05 30.67 11.01 91.90 69.53 -76.10 91.61 67.92 -77.59 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 11 3 # 11 I 303 TYR B 22 TYR^? 17.56 CL CL B 129 I 306 VAL B 33 VAL^? 18.16 CL CL B 129 I 308 VAL B 31 VAL^? 16.02 CL CL B 129 coo 26.18 35.24 6.87 24.33 35.18 8.97 92.70 72.76 -62.54 90.90 72.79 -64.68 coo 23.55 29.53 9.81 23.15 27.39 10.24 94.50 80.50 -63.22 94.87 80.04 -61.25 coo 16.43 30.18 9.35 15.05 30.67 11.01 89.60 82.04 -64.98 88.09 82.65 -66.42 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 12 3 # 12 I 303 TYR B 47 TYR^? 14.72 CL CL B 129 I 306 VAL B 45 VAL^? 10.12 CL CL B 129 I 308 VAL A 79 VAL^? 12.58 CL CL B 129 coo 26.18 35.24 6.87 24.33 35.18 8.97 86.74 65.69 -75.43 87.82 65.07 -77.96 coo 23.55 29.53 9.81 23.15 27.39 10.24 91.90 69.53 -76.10 91.61 67.92 -77.59 coo 16.43 30.18 9.35 15.05 30.67 11.01 94.13 64.53 -82.49 93.75 66.60 -81.81 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 13 3 # 13 I 303 TYR B 47 TYR^? 14.72 CL CL B 129 I 306 VAL B 45 VAL^? 10.12 CL CL B 129 I 308 VAL B 119 VAL^? 13.02 CL CL B 129 coo 26.18 35.24 6.87 24.33 35.18 8.97 86.74 65.69 -75.43 87.82 65.07 -77.96 coo 23.55 29.53 9.81 23.15 27.39 10.24 91.90 69.53 -76.10 91.61 67.92 -77.59 coo 16.43 30.18 9.35 15.05 30.67 11.01 97.61 69.35 -72.25 99.50 68.20 -72.30 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 14 3 # 14 I 303 TYR B 54 TYR^? 10.36 CL CL B 129 I 306 VAL A 79 VAL^? 12.58 CL CL B 129 I 308 VAL A 89 VAL.? 16.70 CL CL B 129 coo 26.18 35.24 6.87 24.33 35.18 8.97 89.19 70.43 -81.07 88.03 67.93 -81.20 coo 23.55 29.53 9.81 23.15 27.39 10.24 94.13 64.53 -82.49 93.75 66.60 -81.81 coo 16.43 30.18 9.35 15.05 30.67 11.01 97.57 61.74 -75.96 96.80 63.07 -74.45 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 15 3 # 15 I 303 TYR B 54 TYR^? 10.36 CL CL B 129 I 306 VAL B 45 VAL^? 10.12 CL CL B 129 I 308 VAL B 119 VAL^? 13.02 CL CL B 129 coo 26.18 35.24 6.87 24.33 35.18 8.97 89.19 70.43 -81.07 88.03 67.93 -81.20 coo 23.55 29.53 9.81 23.15 27.39 10.24 91.90 69.53 -76.10 91.61 67.92 -77.59 coo 16.43 30.18 9.35 15.05 30.67 11.01 97.61 69.35 -72.25 99.50 68.20 -72.30 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 16 3 # 16 I 303 TYR B 83 TYR^? 15.32 CL CL A 129 I 306 VAL A 110 VAL^? 17.64 CL CL A 129 I 308 VAL A 89 VAL.? 16.70 CL CL B 129 coo 26.18 35.24 6.87 24.33 35.18 8.97 103.38 58.05 -66.28 101.08 56.65 -65.75 coo 23.55 29.53 9.81 23.15 27.39 10.24 103.10 55.63 -72.46 103.58 56.38 -70.46 coo 16.43 30.18 9.35 15.05 30.67 11.01 97.57 61.74 -75.96 96.80 63.07 -74.45 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 17 3 # 17 I 303 TYR B 83 TYR^? 15.32 CL CL A 129 I 306 VAL A 119 VAL^? 13.01 CL CL A 129 I 308 VAL A 45 VAL^? 10.13 CL CL A 129 coo 26.18 35.24 6.87 24.33 35.18 8.97 103.38 58.05 -66.28 101.08 56.65 -65.75 coo 23.55 29.53 9.81 23.15 27.39 10.24 97.61 54.09 -68.83 99.46 55.28 -68.82 coo 16.43 30.18 9.35 15.05 30.67 11.01 91.94 53.92 -64.94 91.48 55.61 -63.62 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 18 3 # 18 I 303 TYR B 83 TYR^? 15.32 CL CL A 129 I 306 VAL B 89 VAL^? 16.64 CL CL A 129 I 308 VAL B 15 VAL^? 22.66 CL CL A 129 coo 26.18 35.24 6.87 24.33 35.18 8.97 103.38 58.05 -66.28 101.08 56.65 -65.75 coo 23.55 29.53 9.81 23.15 27.39 10.24 97.59 61.73 -65.29 96.79 60.29 -66.76 coo 16.43 30.18 9.35 15.05 30.67 11.01 101.77 67.55 -59.70 101.82 66.12 -61.38 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 19 3 # 19 I 303 TYR B 83 TYR^? 15.32 CL CL A 129 I 306 VAL B 89 VAL^? 16.64 CL CL A 129 I 308 VAL B 79 VAL^? 12.34 CL CL A 129 coo 26.18 35.24 6.87 24.33 35.18 8.97 103.38 58.05 -66.28 101.08 56.65 -65.75 coo 23.55 29.53 9.81 23.15 27.39 10.24 97.59 61.73 -65.29 96.79 60.29 -66.76 coo 16.43 30.18 9.35 15.05 30.67 11.01 94.15 58.82 -58.60 93.97 56.70 -59.21 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 20 3 # 20 I 303 TYR B 83 TYR^? 15.32 CL CL A 129 I 306 VAL B 89 VAL^? 16.64 CL CL A 129 I 308 VAL B 110 VAL^? 17.50 CL CL B 129 coo 26.18 35.24 6.87 24.33 35.18 8.97 103.38 58.05 -66.28 101.08 56.65 -65.75 coo 23.55 29.53 9.81 23.15 27.39 10.24 97.59 61.73 -65.29 96.79 60.29 -66.76 coo 16.43 30.18 9.35 15.05 30.67 11.01 103.15 67.83 -68.76 103.52 67.23 -70.84 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 21 3 # 21 I 303 TYR C 22 TYR^? 17.52 CL CL C 129 I 306 VAL C 33 VAL^? 18.27 CL CL C 129 I 308 VAL C 31 VAL^? 15.89 CL CL C 129 coo 26.18 35.24 6.87 24.33 35.18 8.97 91.93 71.84 -43.09 91.81 73.68 -41.00 coo 23.55 29.53 9.81 23.15 27.39 10.24 84.07 70.05 -42.41 84.47 69.65 -44.48 coo 16.43 30.18 9.35 15.05 30.67 11.01 82.69 75.11 -40.44 81.94 76.50 -38.90 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 22 3 # 22 I 303 TYR C 47 TYR^? 14.59 CL CL C 129 I 306 VAL C 45 VAL^? 10.07 CL CL C 129 I 308 VAL C 119 VAL^? 12.93 CL CL C 129 coo 26.18 35.24 6.87 24.33 35.18 8.97 99.01 77.81 -30.16 99.72 76.81 -27.69 coo 23.55 29.53 9.81 23.15 27.39 10.24 95.21 72.64 -29.62 96.92 73.01 -28.28 coo 16.43 30.18 9.35 15.05 30.67 11.01 95.41 66.97 -33.41 96.59 65.13 -33.37 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 23 3 # 23 I 303 TYR C 54 TYR^? 10.32 CL CL C 129 I 306 VAL C 45 VAL^? 10.07 CL CL C 129 I 308 VAL C 119 VAL^? 12.93 CL CL C 129 coo 26.18 35.24 6.87 24.33 35.18 8.97 94.43 75.36 -24.67 96.94 76.58 -24.67 coo 23.55 29.53 9.81 23.15 27.39 10.24 95.21 72.64 -29.62 96.92 73.01 -28.28 coo 16.43 30.18 9.35 15.05 30.67 11.01 95.41 66.97 -33.41 96.59 65.13 -33.37 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 24 3 # 24 I 303 TYR C 83 TYR^? 26.27 CL CL C 129 I 306 VAL C 89 VAL^? 22.34 CL CL C 129 I 308 VAL C 79 VAL^? 29.39 CL CL C 129 coo 26.18 35.24 6.87 24.33 35.18 8.97 106.70 61.17 -39.39 108.02 63.54 -39.97 coo 23.55 29.53 9.81 23.15 27.39 10.24 103.05 66.99 -40.39 104.49 67.79 -38.99 coo 16.43 30.18 9.35 15.05 30.67 11.01 105.89 70.46 -47.21 107.96 70.66 -46.61 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 25 3 # 25 I 303 TYR C 83 TYR^? 26.27 CL CL C 129 I 306 VAL C 89 VAL^? 22.34 CL CL C 129 I 308 VAL C 110 VAL^? 17.49 CL CL C 129 coo 26.18 35.24 6.87 24.33 35.18 8.97 106.70 61.17 -39.39 108.02 63.54 -39.97 coo 23.55 29.53 9.81 23.15 27.39 10.24 103.05 66.99 -40.39 104.49 67.79 -38.99 coo 16.43 30.18 9.35 15.05 30.67 11.01 96.93 61.48 -37.01 97.53 61.06 -34.97 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 26 3 # 26 I 303 TYR D 22 TYR^? 17.52 CL CL D 129 I 306 VAL D 33 VAL^? 18.29 CL CL D 129 I 308 VAL D 31 VAL^? 15.85 CL CL D 129 coo 26.18 35.24 6.87 24.33 35.18 8.97 67.44 78.74 -43.16 67.49 76.94 -41.01 coo 23.55 29.53 9.81 23.15 27.39 10.24 75.10 80.54 -42.51 74.71 80.99 -44.59 coo 16.43 30.18 9.35 15.05 30.67 11.01 76.61 75.61 -40.55 77.04 74.14 -39.02 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 27 3 # 27 I 303 TYR D 47 TYR^? 14.69 CL CL D 129 I 306 VAL D 45 VAL^? 10.12 CL CL D 129 I 308 VAL D 119 VAL^? 12.94 CL CL D 129 coo 26.18 35.24 6.87 24.33 35.18 8.97 60.23 72.82 -30.22 59.55 73.80 -27.71 coo 23.55 29.53 9.81 23.15 27.39 10.24 64.11 77.97 -29.63 62.42 77.49 -28.32 coo 16.43 30.18 9.35 15.05 30.67 11.01 63.92 83.59 -33.46 62.77 85.44 -33.39 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 28 3 # 28 I 303 TYR D 54 TYR^? 10.35 CL CL D 129 I 306 VAL D 45 VAL^? 10.12 CL CL D 129 I 308 VAL D 119 VAL^? 12.94 CL CL D 129 coo 26.18 35.24 6.87 24.33 35.18 8.97 64.95 75.15 -24.65 62.40 74.09 -24.68 coo 23.55 29.53 9.81 23.15 27.39 10.24 64.11 77.97 -29.63 62.42 77.49 -28.32 coo 16.43 30.18 9.35 15.05 30.67 11.01 63.92 83.59 -33.46 62.77 85.44 -33.39 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 29 3 # 29 I 303 TYR D 83 TYR^? 26.42 CL CL D 129 I 306 VAL D 89 VAL^? 22.42 CL CL D 129 I 308 VAL D 15 VAL^? 23.96 CL CL D 129 coo 26.18 35.24 6.87 24.33 35.18 8.97 52.51 89.53 -39.47 51.30 87.12 -40.13 coo 23.55 29.53 9.81 23.15 27.39 10.24 56.22 83.59 -40.44 54.81 82.70 -39.09 coo 16.43 30.18 9.35 15.05 30.67 11.01 62.13 87.75 -46.06 60.71 87.82 -44.39 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 30 3 # 30 I 303 TYR D 83 TYR^? 26.42 CL CL D 129 I 306 VAL D 89 VAL^? 22.42 CL CL D 129 I 308 VAL D 79 VAL^? 29.36 CL CL D 129 coo 26.18 35.24 6.87 24.33 35.18 8.97 52.51 89.53 -39.47 51.30 87.12 -40.13 coo 23.55 29.53 9.81 23.15 27.39 10.24 56.22 83.59 -40.44 54.81 82.70 -39.09 coo 16.43 30.18 9.35 15.05 30.67 11.01 53.65 80.15 -47.29 51.51 79.87 -46.79 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 31 3 # 31 I 303 TYR D 83 TYR^? 26.42 CL CL D 129 I 306 VAL D 89 VAL^? 22.42 CL CL D 129 I 308 VAL D 110 VAL^? 17.58 CL CL D 129 coo 26.18 35.24 6.87 24.33 35.18 8.97 52.51 89.53 -39.47 51.30 87.12 -40.13 coo 23.55 29.53 9.81 23.15 27.39 10.24 56.22 83.59 -40.44 54.81 82.70 -39.09 coo 16.43 30.18 9.35 15.05 30.67 11.01 62.38 89.19 -37.09 61.69 89.52 -35.02 1cqt_d00 source 1cqt GENE REGULATION/DNA : 31 hits 1cqt_d00 naa= 3 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 1 3 # 1 C 70 ARG A 117 ARG^? 16.03 CL CL A 129 C 71 LYS A 111 LYS^? 25.43 CL CL A 129 C 72 VAL A 110 VAL^? 17.64 CL CL A 129 coo 23.89 33.54 29.21 26.59 34.86 28.68 100.59 48.03 -72.66 102.04 46.10 -74.59 coo 25.82 26.89 29.68 23.33 22.98 25.84 105.91 53.60 -74.08 110.80 53.18 -78.24 coo 28.86 29.08 30.37 28.04 31.02 29.93 103.10 55.63 -72.46 103.58 56.38 -70.46 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 2 3 # 2 C 70 ARG B 117 ARG^? 16.04 CL CL B 129 C 71 LYS B 111 LYS^? 25.35 CL CL B 129 C 72 VAL B 110 VAL^? 17.50 CL CL B 129 coo 23.89 33.54 29.21 26.59 34.86 28.68 100.63 75.34 -68.25 102.08 77.36 -66.41 coo 25.82 26.89 29.68 23.33 22.98 25.84 105.89 69.85 -67.01 110.53 70.43 -62.59 coo 28.86 29.08 30.37 28.04 31.02 29.93 103.15 67.83 -68.76 103.52 67.23 -70.84 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 3 3 # 3 C 70 ARG C 117 ARG^? 16.02 CL CL C 129 C 71 LYS C 111 LYS^? 20.47 CL CL A 129 C 72 VAL C 110 VAL^? 17.49 CL CL C 129 coo 23.89 33.54 29.21 26.59 34.86 28.68 89.36 64.01 -37.29 87.40 62.56 -39.24 coo 25.82 26.89 29.68 23.33 22.98 25.84 94.84 58.73 -38.66 94.21 53.88 -42.04 coo 28.86 29.08 30.37 28.04 31.02 29.93 96.93 61.48 -37.01 97.53 61.06 -34.97 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 4 3 # 4 C 70 ARG D 117 ARG^? 15.96 CL CL D 129 C 71 LYS D 111 LYS^? 25.57 CL CL D 129 C 72 VAL D 110 VAL^? 17.58 CL CL D 129 coo 23.89 33.54 29.21 26.59 34.86 28.68 69.91 86.62 -37.36 71.94 88.06 -39.21 coo 25.82 26.89 29.68 23.33 22.98 25.84 64.48 91.99 -38.71 64.71 96.91 -42.99 coo 28.86 29.08 30.37 28.04 31.02 29.93 62.38 89.19 -37.09 61.69 89.52 -35.02 1hwt_d00 source 1hwt GENE REGULATION/DNA : 4 hits 1hwt_d00 naa= 3 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 1 3 # 1 E 40 ARG A 21 ARG~? 20.44 CL CL A 129 E 41 TYR A 20 TYR~? 23.51 CL CL B 129 E 83 ARG C 73 ARG^? 22.24 CL CL C 129 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 98.35 46.51 -82.89 98.57 44.40 -80.63 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 94.54 54.15 -86.74 93.79 56.81 -87.24 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 95.26 80.79 -46.47 95.45 78.63 -44.29 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 2 3 # 2 E 40 ARG A 21 ARG~? 20.44 CL CL A 129 E 41 TYR A 20 TYR~? 23.51 CL CL B 129 E 83 ARG C 117 ARG^? 16.02 CL CL C 129 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 98.35 46.51 -82.89 98.57 44.40 -80.63 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 94.54 54.15 -86.74 93.79 56.81 -87.24 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 89.36 64.01 -37.29 87.40 62.56 -39.24 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 3 3 # 3 E 40 ARG A 21 ARG~? 20.44 CL CL A 129 E 41 TYR A 20 TYR~? 23.51 CL CL B 129 E 83 ARG D 96 ARG^? 24.04 CL CL D 129 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 98.35 46.51 -82.89 98.57 44.40 -80.63 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 94.54 54.15 -86.74 93.79 56.81 -87.24 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 64.79 64.44 -46.28 65.73 66.42 -44.08 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 4 3 # 4 E 40 ARG A 63 ARG~? 13.95 CL CL A 129 E 41 TYR A 22 TYR~? 17.56 CL CL A 129 E 83 ARG C 66 ARG^? 18.88 CL CL C 129 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 87.85 45.63 -72.60 88.58 48.58 -73.24 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 92.72 50.62 -78.45 90.87 50.50 -76.41 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 88.18 82.59 -38.84 90.98 81.94 -39.92 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 5 3 # 5 E 40 ARG A 63 ARG~? 13.95 CL CL A 129 E 41 TYR A 22 TYR~? 17.56 CL CL A 129 E 83 ARG C 104 ARG^? 26.38 CL CL C 129 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 87.85 45.63 -72.60 88.58 48.58 -73.24 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 92.72 50.62 -78.45 90.87 50.50 -76.41 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 105.08 82.46 -41.08 106.56 82.47 -38.36 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 6 3 # 6 E 40 ARG D 21 ARG^? 20.73 CL CL D 129 E 41 TYR D 20 TYR^? 27.97 CL CL D 129 E 83 ARG A 60 ARG~? 8.61 CL CL A 129 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 71.50 84.01 -47.23 73.85 84.97 -45.52 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 63.79 80.64 -51.29 61.18 79.77 -51.83 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 92.49 41.37 -66.87 95.11 39.81 -67.06 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 7 3 # 7 E 40 ARG D 21 ARG^? 20.73 CL CL D 129 E 41 TYR D 22 TYR^? 17.52 CL CL D 129 E 83 ARG A 60 ARG~? 8.61 CL CL A 129 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 71.50 84.01 -47.23 73.85 84.97 -45.52 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 67.44 78.74 -43.16 67.49 76.94 -41.01 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 92.49 41.37 -66.87 95.11 39.81 -67.06 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 8 3 # 8 E 40 ARG D 63 ARG^? 14.07 CL CL D 129 E 41 TYR D 22 TYR^? 17.52 CL CL D 129 E 83 ARG A 73 ARG.? 22.19 CL CL A 129 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 72.33 73.68 -37.44 69.36 74.46 -37.99 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 67.44 78.74 -43.16 67.49 76.94 -41.01 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 83.82 53.79 -81.61 86.00 54.30 -79.51 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 9 3 # 9 E 40 ARG D 63 ARG^? 14.07 CL CL D 129 E 41 TYR D 22 TYR^? 17.52 CL CL D 129 E 83 ARG A 76 ARG^? 19.15 CL CL B 129 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 72.33 73.68 -37.44 69.36 74.46 -37.99 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 67.44 78.74 -43.16 67.49 76.94 -41.01 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 82.62 63.89 -86.56 80.46 65.21 -84.78 1id3_d00 source 1id3 STRUCTURAL PROTEIN/DNA : 9 hits 1id3_d00 naa= 3 ULMN 4 1kx5_d03 STRUCTURAL PROTEIN/DNA user 1 4 # 1 G 5 LYS C 43 LYS^? 9.54 CL CL C 129 G 13 LYS C 111 LYS^? 20.47 CL CL A 129 G 42 ARG C 73 ARG^? 22.24 CL CL C 129 G 77 ARG A 63 ARG~? 13.95 CL CL A 129 coo 49.14 40.97 -14.96 48.29 43.12 -10.00 93.55 67.94 -25.84 92.76 63.12 -24.35 coo 61.00 51.09 -9.44 63.25 53.14 -4.71 94.84 58.73 -38.66 94.21 53.88 -42.04 coo 39.46 58.80 1.48 39.21 55.92 0.43 95.26 80.79 -46.47 95.45 78.63 -44.29 coo 76.41 82.78 -7.59 79.44 82.43 -7.90 87.85 45.63 -72.60 88.58 48.58 -73.24 ULMN 4 1kx5_d03 STRUCTURAL PROTEIN/DNA user 2 4 # 2 G 5 LYS C 43 LYS^? 9.54 CL CL C 129 G 13 LYS C 111 LYS^? 20.47 CL CL A 129 G 42 ARG D 66 ARG^? 18.85 CL CL D 129 G 77 ARG A 63 ARG~? 13.95 CL CL A 129 coo 49.14 40.97 -14.96 48.29 43.12 -10.00 93.55 67.94 -25.84 92.76 63.12 -24.35 coo 61.00 51.09 -9.44 63.25 53.14 -4.71 94.84 58.73 -38.66 94.21 53.88 -42.04 coo 39.46 58.80 1.48 39.21 55.92 0.43 71.05 68.08 -38.82 68.22 68.66 -39.87 coo 76.41 82.78 -7.59 79.44 82.43 -7.90 87.85 45.63 -72.60 88.58 48.58 -73.24 1kx5_d03 source 1kx5 STRUCTURAL PROTEIN/DNA : 2 hits 1kx5_d03 naa= 4 ULMN 3 1mjo_d00 TRANSCRIPTION/DNA user 1 3 # 1 D 23 LYS A 24 LYS~? 27.96 CL CL A 129 D 25 THR A 27 THR~? 25.15 CL CL A 129 D 27 SER A 68 SER.? 24.03 CL CL A 129 coo 86.60 33.38 44.00 87.05 39.52 42.71 90.40 47.78 -84.76 92.62 43.20 -88.57 coo 81.20 31.58 48.03 79.23 32.24 47.54 85.32 47.55 -82.88 85.94 49.08 -84.30 coo 79.09 29.82 54.20 77.17 28.90 53.05 79.44 42.90 -78.55 79.17 40.51 -78.96 ULMN 3 1mjo_d00 TRANSCRIPTION/DNA user 2 3 # 2 D 23 LYS C 24 LYS^? 26.64 CL CL C 129 D 25 THR C 27 THR^? 25.08 CL CL C 129 D 27 SER C 68 SER^? 21.24 CL CL D 129 coo 86.60 33.38 44.00 87.05 39.52 42.71 88.99 74.10 -49.29 84.03 71.99 -51.83 coo 81.20 31.58 48.03 79.23 32.24 47.54 88.92 79.28 -47.47 90.32 78.59 -48.91 coo 79.09 29.82 54.20 77.17 28.90 53.05 84.11 85.18 -43.24 81.76 85.64 -43.69 1mjo_d00 source 1mjo TRANSCRIPTION/DNA : 2 hits 1mjo_d00 naa= 3 ULMN 4 1mnm_d00 TRANSCRIPTION/DNA user 1 4 # 1 A 19 ARG A 46 ARG^? 15.11 CL CL A 129 A 30 THR B 92 THR^? 18.96 CL CL A 129 A 34 VAL B 79 VAL^? 12.34 CL CL A 129 A 38 LYS A 43 LYS.? 9.42 CL CL A 129 coo 30.09 31.19 5.41 30.53 28.24 4.72 87.96 51.20 -70.32 85.08 51.60 -71.34 coo 19.67 42.24 -1.18 20.37 41.83 -3.18 88.84 61.70 -60.19 88.43 63.62 -59.28 coo 18.16 36.88 2.14 19.60 35.97 0.73 94.15 58.82 -58.60 93.97 56.70 -59.21 coo 16.75 32.35 6.21 21.42 30.93 2.22 96.70 52.33 -61.01 101.40 51.27 -59.62 ULMN 4 1mnm_d00 TRANSCRIPTION/DNA user 2 4 # 2 A 19 ARG B 46 ARG^? 15.06 CL CL B 129 A 30 THR A 92 THR.? 19.17 CL CL B 129 A 34 VAL A 79 VAL^? 12.58 CL CL B 129 A 38 LYS B 43 LYS^? 9.52 CL CL B 129 coo 30.09 31.19 5.41 30.53 28.24 4.72 87.96 72.13 -70.71 85.05 71.84 -69.78 coo 19.67 42.24 -1.18 20.37 41.83 -3.18 88.80 61.61 -80.86 88.36 59.74 -81.92 coo 18.16 36.88 2.14 19.60 35.97 0.73 94.13 64.53 -82.49 93.75 66.60 -81.81 coo 16.75 32.35 6.21 21.42 30.93 2.22 96.64 71.22 -80.00 101.30 72.05 -81.50 1mnm_d00 source 1mnm TRANSCRIPTION/DNA : 2 hits 1mnm_d00 naa= 4 ULMN 3 2bsq_d00 TRANSCRIPTION user 1 3 # 1 E 3 SER A 91 SER.? 14.42 CL CL B 129 E 5 VAL B 45 VAL^? 10.12 CL CL B 129 E 7 ARG B 46 ARG^? 15.06 CL CL B 129 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 91.69 62.31 -78.52 92.31 64.05 -76.96 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 91.90 69.53 -76.10 91.61 67.92 -77.59 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 87.96 72.13 -70.71 85.05 71.84 -69.78 ULMN 3 2bsq_d00 TRANSCRIPTION user 2 3 # 2 E 3 SER B 91 SER^? 14.45 CL CL A 129 E 5 VAL A 45 VAL^? 10.13 CL CL A 129 E 7 ARG A 46 ARG^? 15.11 CL CL A 129 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 91.67 61.18 -62.59 92.49 59.52 -64.12 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 91.94 53.92 -64.94 91.48 55.61 -63.62 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 87.96 51.20 -70.32 85.08 51.60 -71.34 2bsq_d00 source 2bsq TRANSCRIPTION : 2 hits 2bsq_d00 naa= 3 ULMN 4 2q2t_d00 LIGASE/DNA user 1 4 # 1 A 48 ARG B 96 ARG^? 24.18 CL CL B 129 A 249 THR D 100 THR^? 36.08 CL CL D 129 A 285 ARG D 73 ARG^? 22.15 CL CL D 129 A 286 PHE D 94 PHE^? 24.69 CL CL D 129 coo -81.95 4.55 64.73 -81.11 4.84 61.78 78.35 70.58 -59.29 80.55 70.83 -61.45 coo -64.79 -0.51 43.10 -64.46 -1.42 45.04 57.24 58.21 -46.98 56.27 56.26 -47.24 coo -72.24 -8.41 51.99 -72.03 -9.47 54.89 64.06 69.83 -46.45 63.93 71.88 -44.19 coo -68.50 -7.10 50.68 -69.42 -6.74 53.31 60.53 69.11 -45.40 61.31 68.31 -42.82 2q2t_d00 source 2q2t LIGASE/DNA : 1 hits 2q2t_d00 naa= 4 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 B 34 SER B 68 SER^? 24.10 CL CL B 129 B 37 ASN B 29 ASN^? 19.59 CL CL B 129 B 45 THR C 27 THR^? 25.08 CL CL C 129 coo -19.49 41.97 71.08 -17.37 40.80 71.17 79.50 80.74 -62.38 78.97 83.11 -62.08 coo -23.05 39.62 69.74 -22.86 39.59 67.61 84.68 80.89 -61.45 84.18 80.98 -63.53 coo -30.87 34.84 80.57 -28.94 34.51 81.49 88.92 79.28 -47.47 90.32 78.59 -48.91 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 B 34 SER C 68 SER^? 21.24 CL CL D 129 B 37 ASN C 29 ASN^? 19.55 CL CL C 129 B 45 THR B 27 THR^? 25.10 CL CL B 129 coo -19.49 41.97 71.08 -17.37 40.80 71.17 84.11 85.18 -43.24 81.76 85.64 -43.69 coo -23.05 39.62 69.74 -22.86 39.59 67.61 83.86 80.07 -44.03 83.70 80.47 -41.95 coo -30.87 34.84 80.57 -28.94 34.51 81.49 85.40 75.83 -58.05 86.15 74.42 -56.65 2z3x_d00 source 2z3x DNA BINDING PROTEIN/DNA : 2 hits 2z3x_d00 naa= 3 ULMN 3 3qrf_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 G 386 ARG A 46 ARG^? 15.11 CL CL A 129 G 387 HIS A 122 HIS^? 19.05 CL CL A 129 G 390 SER A 124 SER^? 21.51 CL CL B 129 coo 93.17 52.97 31.81 95.66 54.71 32.14 87.96 51.20 -70.32 85.08 51.60 -71.34 coo 95.60 53.07 40.31 97.10 52.52 41.67 86.83 60.37 -69.40 85.20 61.24 -68.40 coo 93.25 46.91 38.79 94.12 47.43 36.62 81.71 59.41 -72.63 82.35 61.73 -72.29 ULMN 3 3qrf_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 G 386 ARG A 104 ARG^? 18.53 CL CL B 129 G 387 HIS A 122 HIS^? 19.05 CL CL A 129 G 390 SER B 124 SER^? 21.49 CL CL A 129 coo 93.17 52.97 31.81 95.66 54.71 32.14 82.19 63.80 -76.53 82.09 65.30 -73.83 coo 95.60 53.07 40.31 97.10 52.52 41.67 86.83 60.37 -69.40 85.20 61.24 -68.40 coo 93.25 46.91 38.79 94.12 47.43 36.62 81.67 64.01 -68.38 82.23 61.67 -68.72 ULMN 3 3qrf_d00 DNA BINDING PROTEIN/DNA user 3 3 # 3 G 386 ARG A 104 ARG^? 18.53 CL CL B 129 G 387 HIS B 122 HIS^? 19.12 CL CL B 129 G 390 SER A 91 SER.? 14.42 CL CL B 129 coo 93.17 52.97 31.81 95.66 54.71 32.14 82.19 63.80 -76.53 82.09 65.30 -73.83 coo 95.60 53.07 40.31 97.10 52.52 41.67 86.93 63.10 -71.62 85.35 62.06 -72.53 coo 93.25 46.91 38.79 94.12 47.43 36.62 91.69 62.31 -78.52 92.31 64.05 -76.96 ULMN 3 3qrf_d00 DNA BINDING PROTEIN/DNA user 4 3 # 4 G 386 ARG A 104 ARG^? 18.53 CL CL B 129 G 387 HIS B 122 HIS^? 19.12 CL CL B 129 G 390 SER B 124 SER^? 21.49 CL CL A 129 coo 93.17 52.97 31.81 95.66 54.71 32.14 82.19 63.80 -76.53 82.09 65.30 -73.83 coo 95.60 53.07 40.31 97.10 52.52 41.67 86.93 63.10 -71.62 85.35 62.06 -72.53 coo 93.25 46.91 38.79 94.12 47.43 36.62 81.67 64.01 -68.38 82.23 61.67 -68.72 ULMN 3 3qrf_d00 DNA BINDING PROTEIN/DNA user 5 3 # 5 G 386 ARG B 46 ARG^? 15.06 CL CL B 129 G 387 HIS B 122 HIS^? 19.12 CL CL B 129 G 390 SER B 124 SER^? 21.49 CL CL A 129 coo 93.17 52.97 31.81 95.66 54.71 32.14 87.96 72.13 -70.71 85.05 71.84 -69.78 coo 95.60 53.07 40.31 97.10 52.52 41.67 86.93 63.10 -71.62 85.35 62.06 -72.53 coo 93.25 46.91 38.79 94.12 47.43 36.62 81.67 64.01 -68.38 82.23 61.67 -68.72 ULMN 3 3qrf_d00 DNA BINDING PROTEIN/DNA user 6 3 # 6 G 386 ARG B 104 ARG^? 18.51 CL CL A 129 G 387 HIS B 122 HIS^? 19.12 CL CL B 129 G 390 SER A 124 SER^? 21.51 CL CL B 129 coo 93.17 52.97 31.81 95.66 54.71 32.14 82.09 59.72 -64.70 82.21 58.19 -67.39 coo 95.60 53.07 40.31 97.10 52.52 41.67 86.93 63.10 -71.62 85.35 62.06 -72.53 coo 93.25 46.91 38.79 94.12 47.43 36.62 81.71 59.41 -72.63 82.35 61.73 -72.29 ULMN 3 3qrf_d00 DNA BINDING PROTEIN/DNA user 7 3 # 7 G 386 ARG C 46 ARG^? 15.12 CL CL C 129 G 387 HIS C 122 HIS^? 19.06 CL CL C 129 G 390 SER C 124 SER^? 23.20 CL CL C 129 coo 93.17 52.97 31.81 95.66 54.71 32.14 92.47 76.70 -34.87 92.87 79.50 -36.04 coo 95.60 53.07 40.31 97.10 52.52 41.67 101.68 77.71 -34.10 102.65 79.31 -33.15 coo 93.25 46.91 38.79 94.12 47.43 36.62 100.74 82.83 -37.31 103.10 82.20 -37.27 ULMN 3 3qrf_d00 DNA BINDING PROTEIN/DNA user 8 3 # 8 G 386 ARG D 46 ARG^? 15.13 CL CL D 129 G 387 HIS D 122 HIS^? 19.08 CL CL D 129 G 390 SER D 124 SER^? 23.07 CL CL D 129 coo 93.17 52.97 31.81 95.66 54.71 32.14 66.74 73.93 -35.00 66.45 71.02 -36.02 coo 95.60 53.07 40.31 97.10 52.52 41.67 57.69 72.86 -34.13 56.74 71.23 -33.18 coo 93.25 46.91 38.79 94.12 47.43 36.62 58.66 67.61 -37.34 56.37 68.29 -37.09 3qrf_d00 source 3qrf DNA BINDING PROTEIN/DNA : 8 hits 3qrf_d00 naa= 3 ULMN 5 3sm4_d00 HYDROLASE/DNA user 1 5 # 1 B 53 MET B 87 MET?? 20.22 CL CL A 129 B 73 VAL A 15 VAL~? 22.78 CL CL B 129 B 75 ALA A 13 ALA~? 24.93 CL CL B 129 B 77 ALA A 9 ALA~? 22.52 CL CL B 129 B 78 LEU A 12 LEU~? 18.85 CL CL B 129 coo 6.68 -12.20 6.91 4.65 -8.54 6.72 104.09 63.70 -67.20 102.12 61.34 -70.42 coo 4.09 -11.16 -10.83 4.39 -11.22 -8.63 101.87 55.80 -81.42 101.82 57.45 -79.99 coo -0.13 -5.63 -11.43 -0.24 -5.75 -9.91 104.12 57.17 -86.31 105.19 56.89 -87.32 coo 0.92 -0.50 -9.34 0.65 -0.74 -7.86 107.68 62.21 -86.60 108.32 62.45 -87.96 coo 4.14 -4.02 -10.28 4.18 -5.28 -8.49 103.86 61.33 -84.29 102.04 62.51 -84.28 3sm4_d00 source 3sm4 HYDROLASE/DNA : 1 hits 3sm4_d00 naa= 5 ULMN 3 3ssc_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 A 21 GLN C 8 GLN^? 21.18 CL CL A 129 A 41 TYR C 83 TYR^? 26.27 CL CL C 129 A 43 ASN C 7 ASN^? 25.55 CL CL A 129 coo 22.03 6.35 12.16 20.71 6.08 10.54 106.01 54.20 -45.71 105.55 52.52 -44.41 coo 18.67 0.21 9.03 16.70 -1.66 8.55 106.70 61.17 -39.39 108.02 63.54 -39.97 coo 14.90 7.30 8.78 14.25 8.14 6.97 107.62 60.23 -47.60 107.55 62.23 -46.92 ULMN 3 3ssc_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 A 21 GLN D 8 GLN^? 32.53 CL CL D 129 A 41 TYR D 83 TYR^? 26.42 CL CL D 129 A 43 ASN D 7 ASN^? 30.85 CL CL D 129 coo 22.03 6.35 12.16 20.71 6.08 10.54 53.54 96.16 -45.88 53.94 98.13 -45.10 coo 18.67 0.21 9.03 16.70 -1.66 8.55 52.51 89.53 -39.47 51.30 87.12 -40.13 coo 14.90 7.30 8.78 14.25 8.14 6.97 51.70 90.24 -47.62 51.84 88.27 -46.84 3ssc_d00 source 3ssc DNA BINDING PROTEIN/DNA : 2 hits 3ssc_d00 naa= 3 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 A 78 ARG A 21 ARG~? 20.44 CL CL A 129 A 82 LYS A 24 LYS~? 27.96 CL CL A 129 A 97 ARG A 117 ARG^? 16.03 CL CL A 129 coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 98.35 46.51 -82.89 98.57 44.40 -80.63 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 90.40 47.78 -84.76 92.62 43.20 -88.57 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 100.59 48.03 -72.66 102.04 46.10 -74.59 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 A 78 ARG A 117 ARG^? 16.03 CL CL A 129 A 82 LYS A 111 LYS^? 25.43 CL CL A 129 A 97 ARG A 21 ARG~? 20.44 CL CL A 129 coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 100.59 48.03 -72.66 102.04 46.10 -74.59 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 105.91 53.60 -74.08 110.80 53.18 -78.24 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 98.35 46.51 -82.89 98.57 44.40 -80.63 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 3 3 # 3 A 78 ARG B 21 ARG^? 20.28 CL CL B 129 A 82 LYS B 24 LYS^? 27.82 CL CL B 129 A 97 ARG B 117 ARG^? 16.04 CL CL B 129 coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 98.33 76.92 -58.24 98.68 79.03 -60.54 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 90.54 75.59 -56.27 92.78 80.12 -52.52 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 100.63 75.34 -68.25 102.08 77.36 -66.41 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 4 3 # 4 A 78 ARG B 117 ARG^? 16.04 CL CL B 129 A 82 LYS B 111 LYS^? 25.35 CL CL B 129 A 97 ARG B 21 ARG^? 20.28 CL CL B 129 coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 100.63 75.34 -68.25 102.08 77.36 -66.41 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 105.89 69.85 -67.01 110.53 70.43 -62.59 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 98.33 76.92 -58.24 98.68 79.03 -60.54 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 5 3 # 5 A 78 ARG C 21 ARG^? 20.59 CL CL C 129 A 82 LYS C 24 LYS^? 26.64 CL CL C 129 A 97 ARG C 117 ARG^? 16.02 CL CL C 129 coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 87.78 66.49 -47.10 85.32 65.73 -45.33 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 88.99 74.10 -49.29 84.03 71.99 -51.83 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 89.36 64.01 -37.29 87.40 62.56 -39.24 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 6 3 # 6 A 78 ARG C 117 ARG^? 16.02 CL CL C 129 A 82 LYS C 111 LYS^? 20.47 CL CL A 129 A 97 ARG C 21 ARG^? 20.59 CL CL C 129 coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 89.36 64.01 -37.29 87.40 62.56 -39.24 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 94.84 58.73 -38.66 94.21 53.88 -42.04 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 87.78 66.49 -47.10 85.32 65.73 -45.33 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 7 3 # 7 A 78 ARG D 117 ARG^? 15.96 CL CL D 129 A 82 LYS D 111 LYS^? 25.57 CL CL D 129 A 97 ARG D 21 ARG^? 20.73 CL CL D 129 coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 69.91 86.62 -37.36 71.94 88.06 -39.21 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 64.48 91.99 -38.71 64.71 96.91 -42.99 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 71.50 84.01 -47.23 73.85 84.97 -45.52 4er8_d00 source 4er8 DNA BINDING PROTEIN/DNA : 7 hits 4er8_d00 naa= 3 ULMN 3 4hp3_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 C 61 LYS A 43 LYS.? 9.42 CL CL A 129 C 90 HIS A 122 HIS^? 19.05 CL CL A 129 C 91 GLN B 105 GLN^? 20.41 CL CL B 129 coo -19.62 -7.95 11.61 -14.74 -11.23 10.80 96.70 52.33 -61.01 101.40 51.27 -59.62 coo -14.60 -21.92 8.98 -13.75 -22.48 7.16 86.83 60.37 -69.40 85.20 61.24 -68.40 coo -19.27 -22.51 13.20 -20.06 -20.67 12.43 88.72 66.41 -64.44 89.12 67.99 -63.12 4hp3_d00 source 4hp3 DNA BINDING PROTEIN/DNA : 1 hits 4hp3_d00 naa= 3 ULMN 3 2odj_o00 PORIN D user 1 3 # 1 A 156 HIS B 85 HIS^? 26.88 CL CL A 129 A 208 ASP A 5 ASP~? 21.13 CL CL B 129 A 296 SER B 91 SER^? 14.45 CL CL A 129 coo 12.72 17.48 24.71 12.80 19.37 23.81 111.98 64.21 -65.30 113.02 64.33 -67.11 coo 18.47 29.19 29.68 19.30 29.17 27.75 110.30 67.66 -76.72 112.26 68.26 -76.10 coo 6.89 17.22 46.63 5.08 16.21 47.91 91.67 61.18 -62.59 92.49 59.52 -64.12 ULMN 3 2odj_o00 PORIN D user 2 3 # 2 A 156 HIS D 85 HIS^? 27.00 CL CL D 129 A 208 ASP D 4 ASP^? 37.41 CL CL D 129 A 296 SER D 91 SER^? 24.58 CL CL D 129 coo 12.72 17.48 24.71 12.80 19.37 23.81 58.77 98.13 -40.30 58.69 99.11 -38.44 coo 18.47 29.19 29.68 19.30 29.17 27.75 46.79 97.75 -45.68 46.52 99.27 -44.27 coo 6.89 17.22 46.63 5.08 16.21 47.91 55.66 77.76 -43.22 54.00 78.42 -41.57 2odj_o00 source 2ODJ PORIN D : 2 hits 2odj_o00 naa= 3 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 C 49 ASP C 35 ASP^? 10.26 CL CL C 129 C 86 HIS C 40 HIS^? 7.21 CL CL C 129 C 250 ALA D 65 ALA^? 13.98 CL CL C 129 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 83.63 70.73 -36.85 83.32 69.81 -34.96 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 84.82 65.72 -30.75 83.18 66.51 -29.70 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 76.48 66.72 -34.21 75.82 66.53 -32.87 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 C 49 ASP D 35 ASP^? 10.18 CL CL D 129 C 86 HIS D 40 HIS^? 7.31 CL CL D 129 C 250 ALA C 65 ALA^? 13.89 CL CL D 129 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 75.66 79.96 -36.93 75.99 80.66 -34.97 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 74.49 84.96 -30.93 76.13 84.16 -29.90 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 82.88 83.84 -34.09 83.60 83.98 -32.74 2wwt_o02 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 2 hits 2wwt_o02 naa= 3 ULMN 3 3hde_o00 LYSOZYME user 1 3 # 1 A 35 GLU A 57 GLU~? -5.56 CL CL A 129s A 44 ASP A 41 ASP.? 7.60 CL CL A 129 A 50 THR A 44 THR.? 7.93 CL CL A 129 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 91.25 41.69 -61.23 91.08 41.09 -59.17 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 99.56 48.98 -63.34 100.43 49.52 -61.53 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 95.29 52.07 -64.55 95.81 50.95 -66.27 ULMN 3 3hde_o00 LYSOZYME user 2 3 # 2 A 35 GLU A 58 GLU~? 7.41 CL CL A 129 A 44 ASP A 41 ASP.? 7.60 CL CL A 129 A 50 THR A 44 THR.? 7.93 CL CL A 129 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 87.85 46.74 -60.89 87.27 48.56 -59.93 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 99.56 48.98 -63.34 100.43 49.52 -61.53 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 95.29 52.07 -64.55 95.81 50.95 -66.27 ULMN 3 3hde_o00 LYSOZYME user 3 3 # 3 A 35 GLU B 57 GLU^? -5.29 CL CL B 129s A 44 ASP B 41 ASP^? 7.64 CL CL B 129 A 50 THR B 44 THR^? 7.91 CL CL B 129 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 91.24 81.90 -79.46 91.48 82.48 -81.50 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 99.50 74.51 -77.69 100.41 73.95 -79.49 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 95.21 71.44 -76.44 95.74 72.60 -74.74 ULMN 3 3hde_o00 LYSOZYME user 4 3 # 4 A 35 GLU B 58 GLU^? 7.34 CL CL B 129 A 44 ASP B 41 ASP^? 7.64 CL CL B 129 A 50 THR B 44 THR^? 7.91 CL CL B 129 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 87.90 76.66 -80.19 87.42 74.86 -81.30 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 99.50 74.51 -77.69 100.41 73.95 -79.49 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 95.21 71.44 -76.44 95.74 72.60 -74.74 ULMN 3 3hde_o00 LYSOZYME user 5 3 # 5 A 35 GLU C 57 GLU^? -5.48 CL CL C 129s A 44 ASP C 41 ASP^? 7.58 CL CL C 129 A 50 THR C 44 THR^? 7.82 CL CL C 129 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 82.94 73.46 -26.00 82.34 73.25 -23.96 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 90.28 65.09 -27.98 90.77 64.12 -26.18 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 93.28 69.34 -29.36 92.05 68.81 -31.01 ULMN 3 3hde_o00 LYSOZYME user 6 3 # 6 A 35 GLU C 58 GLU^? 7.49 CL CL C 129 A 44 ASP C 41 ASP^? 7.58 CL CL C 129 A 50 THR C 44 THR^? 7.82 CL CL C 129 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 88.02 76.82 -25.55 89.85 77.43 -24.60 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 90.28 65.09 -27.98 90.77 64.12 -26.18 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 93.28 69.34 -29.36 92.05 68.81 -31.01 ULMN 3 3hde_o00 LYSOZYME user 7 3 # 7 A 35 GLU D 58 GLU^? 7.39 CL CL D 129 A 44 ASP D 41 ASP^? 7.55 CL CL D 129 A 50 THR D 44 THR^? 7.93 CL CL D 129 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 71.21 74.03 -25.57 69.46 73.32 -24.61 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 69.10 85.54 -28.07 68.60 86.44 -26.19 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 65.95 81.28 -29.36 67.15 81.78 -31.05 3hde_o00 source 3HDE LYSOZYME : 7 hits 3hde_o00 naa= 3 ULMN 3 3hde_o01 LYSOZYME user 1 3 # 1 B 35 GLU A 57 GLU~? -5.56 CL CL A 129s B 44 ASP A 41 ASP.? 7.60 CL CL A 129 B 50 THR A 44 THR.? 7.93 CL CL A 129 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 91.25 41.69 -61.23 91.08 41.09 -59.17 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 99.56 48.98 -63.34 100.43 49.52 -61.53 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 95.29 52.07 -64.55 95.81 50.95 -66.27 ULMN 3 3hde_o01 LYSOZYME user 2 3 # 2 B 35 GLU A 58 GLU~? 7.41 CL CL A 129 B 44 ASP A 41 ASP.? 7.60 CL CL A 129 B 50 THR A 44 THR.? 7.93 CL CL A 129 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 87.85 46.74 -60.89 87.27 48.56 -59.93 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 99.56 48.98 -63.34 100.43 49.52 -61.53 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 95.29 52.07 -64.55 95.81 50.95 -66.27 ULMN 3 3hde_o01 LYSOZYME user 3 3 # 3 B 35 GLU B 23 GLU^? 24.68 CL CL B 129 B 44 ASP C 30 ASP^? 20.67 CL CL C 129 B 50 THR C 27 THR^? 25.08 CL CL C 129 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 89.49 70.79 -56.44 87.96 70.01 -57.68 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 83.14 74.18 -45.33 81.79 72.55 -45.31 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 88.92 79.28 -47.47 90.32 78.59 -48.91 ULMN 3 3hde_o01 LYSOZYME user 4 3 # 4 B 35 GLU B 57 GLU^? -5.29 CL CL B 129s B 44 ASP B 41 ASP^? 7.64 CL CL B 129 B 50 THR B 44 THR^? 7.91 CL CL B 129 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 91.24 81.90 -79.46 91.48 82.48 -81.50 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 99.50 74.51 -77.69 100.41 73.95 -79.49 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 95.21 71.44 -76.44 95.74 72.60 -74.74 ULMN 3 3hde_o01 LYSOZYME user 5 3 # 5 B 35 GLU B 58 GLU^? 7.34 CL CL B 129 B 44 ASP B 41 ASP^? 7.64 CL CL B 129 B 50 THR B 44 THR^? 7.91 CL CL B 129 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 87.90 76.66 -80.19 87.42 74.86 -81.30 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 99.50 74.51 -77.69 100.41 73.95 -79.49 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 95.21 71.44 -76.44 95.74 72.60 -74.74 ULMN 3 3hde_o01 LYSOZYME user 6 3 # 6 B 35 GLU C 23 GLU^? 24.69 CL CL C 129 B 44 ASP B 30 ASP^? 20.91 CL CL B 129 B 50 THR B 27 THR^? 25.10 CL CL B 129 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 93.85 75.25 -49.20 94.57 76.88 -48.00 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 90.60 81.40 -60.16 92.15 82.83 -59.97 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 85.40 75.83 -58.05 86.15 74.42 -56.65 ULMN 3 3hde_o01 LYSOZYME user 7 3 # 7 B 35 GLU C 57 GLU^? -5.48 CL CL C 129s B 44 ASP C 41 ASP^? 7.58 CL CL C 129 B 50 THR C 44 THR^? 7.82 CL CL C 129 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 82.94 73.46 -26.00 82.34 73.25 -23.96 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 90.28 65.09 -27.98 90.77 64.12 -26.18 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 93.28 69.34 -29.36 92.05 68.81 -31.01 ULMN 3 3hde_o01 LYSOZYME user 8 3 # 8 B 35 GLU C 58 GLU^? 7.49 CL CL C 129 B 44 ASP C 41 ASP^? 7.58 CL CL C 129 B 50 THR C 44 THR^? 7.82 CL CL C 129 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 88.02 76.82 -25.55 89.85 77.43 -24.60 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 90.28 65.09 -27.98 90.77 64.12 -26.18 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 93.28 69.34 -29.36 92.05 68.81 -31.01 ULMN 3 3hde_o01 LYSOZYME user 9 3 # 9 B 35 GLU D 58 GLU^? 7.39 CL CL D 129 B 44 ASP D 41 ASP^? 7.55 CL CL D 129 B 50 THR D 44 THR^? 7.93 CL CL D 129 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 71.21 74.03 -25.57 69.46 73.32 -24.61 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 69.10 85.54 -28.07 68.60 86.44 -26.19 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 65.95 81.28 -29.36 67.15 81.78 -31.05 3hde_o01 source 3HDE LYSOZYME : 9 hits 3hde_o01 naa= 3 ULMN 3 3hde_o02 LYSOZYME user 1 3 # 1 C 35 GLU A 57 GLU~? -5.56 CL CL A 129s C 44 ASP A 41 ASP.? 7.60 CL CL A 129 C 50 THR A 44 THR.? 7.93 CL CL A 129 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 91.25 41.69 -61.23 91.08 41.09 -59.17 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 99.56 48.98 -63.34 100.43 49.52 -61.53 coo 25.48 4.87 1.60 23.90 4.95 0.15 95.29 52.07 -64.55 95.81 50.95 -66.27 ULMN 3 3hde_o02 LYSOZYME user 2 3 # 2 C 35 GLU A 58 GLU~? 7.41 CL CL A 129 C 44 ASP A 41 ASP.? 7.60 CL CL A 129 C 50 THR A 44 THR.? 7.93 CL CL A 129 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 87.85 46.74 -60.89 87.27 48.56 -59.93 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 99.56 48.98 -63.34 100.43 49.52 -61.53 coo 25.48 4.87 1.60 23.90 4.95 0.15 95.29 52.07 -64.55 95.81 50.95 -66.27 ULMN 3 3hde_o02 LYSOZYME user 3 3 # 3 C 35 GLU B 23 GLU^? 24.68 CL CL B 129 C 44 ASP C 30 ASP^? 20.67 CL CL C 129 C 50 THR C 27 THR^? 25.08 CL CL C 129 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 89.49 70.79 -56.44 87.96 70.01 -57.68 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 83.14 74.18 -45.33 81.79 72.55 -45.31 coo 25.48 4.87 1.60 23.90 4.95 0.15 88.92 79.28 -47.47 90.32 78.59 -48.91 ULMN 3 3hde_o02 LYSOZYME user 4 3 # 4 C 35 GLU B 57 GLU^? -5.29 CL CL B 129s C 44 ASP B 41 ASP^? 7.64 CL CL B 129 C 50 THR B 44 THR^? 7.91 CL CL B 129 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 91.24 81.90 -79.46 91.48 82.48 -81.50 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 99.50 74.51 -77.69 100.41 73.95 -79.49 coo 25.48 4.87 1.60 23.90 4.95 0.15 95.21 71.44 -76.44 95.74 72.60 -74.74 ULMN 3 3hde_o02 LYSOZYME user 5 3 # 5 C 35 GLU B 58 GLU^? 7.34 CL CL B 129 C 44 ASP B 41 ASP^? 7.64 CL CL B 129 C 50 THR B 44 THR^? 7.91 CL CL B 129 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 87.90 76.66 -80.19 87.42 74.86 -81.30 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 99.50 74.51 -77.69 100.41 73.95 -79.49 coo 25.48 4.87 1.60 23.90 4.95 0.15 95.21 71.44 -76.44 95.74 72.60 -74.74 ULMN 3 3hde_o02 LYSOZYME user 6 3 # 6 C 35 GLU C 23 GLU^? 24.69 CL CL C 129 C 44 ASP B 30 ASP^? 20.91 CL CL B 129 C 50 THR B 27 THR^? 25.10 CL CL B 129 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 93.85 75.25 -49.20 94.57 76.88 -48.00 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 90.60 81.40 -60.16 92.15 82.83 -59.97 coo 25.48 4.87 1.60 23.90 4.95 0.15 85.40 75.83 -58.05 86.15 74.42 -56.65 ULMN 3 3hde_o02 LYSOZYME user 7 3 # 7 C 35 GLU C 57 GLU^? -5.48 CL CL C 129s C 44 ASP C 41 ASP^? 7.58 CL CL C 129 C 50 THR C 44 THR^? 7.82 CL CL C 129 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 82.94 73.46 -26.00 82.34 73.25 -23.96 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 90.28 65.09 -27.98 90.77 64.12 -26.18 coo 25.48 4.87 1.60 23.90 4.95 0.15 93.28 69.34 -29.36 92.05 68.81 -31.01 ULMN 3 3hde_o02 LYSOZYME user 8 3 # 8 C 35 GLU C 58 GLU^? 7.49 CL CL C 129 C 44 ASP C 41 ASP^? 7.58 CL CL C 129 C 50 THR C 44 THR^? 7.82 CL CL C 129 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 88.02 76.82 -25.55 89.85 77.43 -24.60 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 90.28 65.09 -27.98 90.77 64.12 -26.18 coo 25.48 4.87 1.60 23.90 4.95 0.15 93.28 69.34 -29.36 92.05 68.81 -31.01 ULMN 3 3hde_o02 LYSOZYME user 9 3 # 9 C 35 GLU D 58 GLU^? 7.39 CL CL D 129 C 44 ASP D 41 ASP^? 7.55 CL CL D 129 C 50 THR D 44 THR^? 7.93 CL CL D 129 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 71.21 74.03 -25.57 69.46 73.32 -24.61 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 69.10 85.54 -28.07 68.60 86.44 -26.19 coo 25.48 4.87 1.60 23.90 4.95 0.15 65.95 81.28 -29.36 67.15 81.78 -31.05 3hde_o02 source 3HDE LYSOZYME : 9 hits 3hde_o02 naa= 3